Citrus Sinensis ID: 013487
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 442 | 2.2.26 [Sep-21-2011] | |||||||
| Q9MAM1 | 447 | CBL-interacting serine/th | yes | no | 0.984 | 0.973 | 0.800 | 0.0 | |
| Q10SC8 | 456 | CBL-interacting protein k | yes | no | 0.975 | 0.945 | 0.762 | 0.0 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.966 | 0.885 | 0.719 | 0.0 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.979 | 0.962 | 0.707 | 0.0 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.975 | 0.984 | 0.703 | 0.0 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.972 | 0.975 | 0.685 | 0.0 | |
| Q2RAX3 | 454 | CBL-interacting protein k | no | no | 0.975 | 0.949 | 0.678 | 0.0 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.968 | 0.953 | 0.674 | 1e-180 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.972 | 0.979 | 0.675 | 1e-179 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.975 | 0.968 | 0.644 | 1e-169 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/436 (80%), Positives = 399/436 (91%), Gaps = 1/436 (0%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAK 248
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVT 303
++IKRIL+PNP TR++I+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVT
Sbjct: 249 RVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVT 308
Query: 304 EKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPL 363
EKKEKPVSMNAFELIS + FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPL
Sbjct: 309 EKKEKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPL 368
Query: 364 GFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFS 423
GFNVRK NYK+K++GDK+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FS
Sbjct: 369 GFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFS 428
Query: 424 SGLKDVVWQAEENKEE 439
SGLKDVVW + EE
Sbjct: 429 SGLKDVVWNTDAAAEE 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/433 (76%), Positives = 381/433 (87%), Gaps = 2/433 (0%)
Query: 6 PASRT-RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PA RT RVG+YELG+T+GEGSFAKVK A++ TGD +AIK++DR+ VLRHKMVEQIKREI
Sbjct: 17 PARRTTRVGRYELGKTIGEGSFAKVKVARDTRTGDTLAIKVLDRNHVLRHKMVEQIKREI 76
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV+++ EVMASK+KIY+VLE++DGGELFDKI GRL EDEARRYF QLIN
Sbjct: 77 STMKLIKHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLIN 136
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENLLLDS+G LK+SDFGLSA + Q +EDGLLHTACGTPNYVAP
Sbjct: 137 AVDYCHSRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAP 196
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244
EVL DKGYDG A+DVWSCG+ILFVLMAG+LPFD+ NLM LY+ IC+A SCP WFSSGAK
Sbjct: 197 EVLADKGYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHWFSSGAK 256
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTE 304
K IKRILDPNP TR+TI+Q+LED+WFKK YKPP F++ E+V+LDDVDA F+ S+ENLV E
Sbjct: 257 KFIKRILDPNPCTRITIAQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCSEENLVAE 316
Query: 305 KKEKPVSMNAFELISRTKSFSLENLFEKQ-TGLVKRETRFTSQRPPNEIMSKIEEAAKPL 363
K+EKP SMNAF LISR++ F+L NLFEK+ G+VKRET FTSQ P EIMSKIEEA PL
Sbjct: 317 KREKPESMNAFALISRSQGFNLGNLFEKEMMGMVKRETSFTSQCTPQEIMSKIEEACGPL 376
Query: 364 GFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFS 423
GFNVRK NYKMKL+GDKTGRKG LSVATEVFEVAP+LH+VE+RKTGGDTLEFH FY FS
Sbjct: 377 GFNVRKQNYKMKLKGDKTGRKGYLSVATEVFEVAPSLHMVELRKTGGDTLEFHNFYNNFS 436
Query: 424 SGLKDVVWQAEEN 436
S LKD+VW++E +
Sbjct: 437 SELKDIVWKSESD 449
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/435 (71%), Positives = 385/435 (88%), Gaps = 8/435 (1%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
VGKYELGRTLGEG+FAKVKFA+NVE GD VAIK++D+++VL++KM+ QIKREISTMKLIK
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HPNVI++ EVMASKTKIY VLEF+ GGELFDKI+ +GRLKEDEAR+YFQQLINAVDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
RGV+HRDLKPENLLLD+ G LK+SDFGLSA+ QQVREDGLLHT CGTPNYVAPEV+N+KG
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251
YDG +D+WSCGVILFVLMAG+LPF++SNL +LY+KI +A+F+CP WFS+ AKKLIKRIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 252 DPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE--NLVTEKKEK- 308
DPNP TR+T ++++E+EWFKKGYK P F+ +V+LDDVDAIF+DS E NLV E++E+
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFE-NADVSLDDVDAIFDDSGESKNLVVERREEG 326
Query: 309 ---PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGF 365
PV+MNAFELIS ++ +L +LFEKQ GLVKR+TRFTS+ NEI++KIE AA P+GF
Sbjct: 327 LKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGF 386
Query: 366 NVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSG 425
+V+ NYKMKL G+K+GRKGQL+VATEVF+VAP+L++VE+RK+GGDTLEFHKFYK ++G
Sbjct: 387 DVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTG 446
Query: 426 LKDVVWQA-EENKEE 439
LKD+VW+ +E KEE
Sbjct: 447 LKDIVWKTIDEEKEE 461
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/438 (70%), Positives = 383/438 (87%), Gaps = 5/438 (1%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
+ V RTRVG+YELGRTLGEG+FAKVKFA+N ++G+ VAIKI+D+D+VL+HKM+ QIKR
Sbjct: 1 MSVSGGRTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKR 60
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
EISTMKLI+HPNVI++ EVMASKTKIYIV+E + GGELFDKIA GRLKED+AR+YFQQL
Sbjct: 61 EISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQL 120
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
INAVDYCHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+SQQVREDGLLHT CGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYV 180
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 242
APEV+N+KGYDG +D+WSCGVILFVLMAG+LPF++SNLM+LY+KI +ADFSCPSWFS+
Sbjct: 181 APEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTS 240
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDS--KEN 300
AKKLIK+ILDPNP TR+TI++++ +EWFKKGY+PP F+ +VNLDD+++IFN+S +
Sbjct: 241 AKKLIKKILDPNPSTRITIAELINNEWFKKGYQPPRFET-ADVNLDDINSIFNESGDQTQ 299
Query: 301 LVTEKK-EKPVSMNAFELISRTKSFSLENLFEKQT-GLVKRETRFTSQRPPNEIMSKIEE 358
LV E++ E+P MNAFELIS ++ +L LFEKQ+ G VKRETRF S+ P NEI+SKIE
Sbjct: 300 LVVERREERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEA 359
Query: 359 AAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKF 418
AA P+GFNV+K NYK+KLQG+ GRKGQL++ATEVFEV P+L++VE+RK+ GDTLEFHKF
Sbjct: 360 AAGPMGFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKF 419
Query: 419 YKKFSSGLKDVVWQAEEN 436
Y S+GLKDV+W+ E +
Sbjct: 420 YHNISNGLKDVMWKPESS 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 651 bits (1680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/432 (70%), Positives = 372/432 (86%), Gaps = 1/432 (0%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYELGRT+GEG+FAKVKFA++ ETGD VAIKI+D+++VL+HKMVEQIKREISTMK
Sbjct: 7 KRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMK 66
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV++I EVM SKTKIYIVLE++ GGELFD I HGR++EDEARRYFQQLINAVDY
Sbjct: 67 LIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDY 126
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LK+SDFGLSA+SQQ+++DGLLHT CGTPNYVAPEVL
Sbjct: 127 CHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLE 186
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+KI A+F+ P W S AK+L+
Sbjct: 187 DQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLT 246
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK 308
RILDPNP TR+TI ++LEDEWFKKGYK P FD++ + LDDV A+FNDS+E+ VTEKKE+
Sbjct: 247 RILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEE 306
Query: 309 PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVR 368
P ++NAFELIS + +L NLF+ + KRETRFTS+ PP EI+ KIEEAAKPLGF+V+
Sbjct: 307 PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKPLGFDVQ 365
Query: 369 KGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKD 428
K NYK++L+ K GRKG L+VATE+ +VAP+LH+VEVRK GDTLEFHKFYK S LKD
Sbjct: 366 KKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNLSRTLKD 425
Query: 429 VVWQAEENKEEL 440
VVW++++ + +L
Sbjct: 426 VVWKSDDLQNQL 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 296/432 (68%), Positives = 372/432 (86%), Gaps = 2/432 (0%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYE+GRT+GEG+FAKVKFA+N ETG+ VA+KI+D+++VL+HKM EQI+REI+TMK
Sbjct: 8 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMK 67
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV+++ EVMASKTKI+I+LE++ GGELFDKI GR+KEDEARRYFQQLI+AVDY
Sbjct: 68 LIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDY 127
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LKISDFGLSA+SQQVR+DGLLHT+CGTPNYVAPEVLN
Sbjct: 128 CHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLN 187
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D+GYDG +D+WSCGV+L+VL+AG+LPFD+SNLM LY+KI +F+CP W S GA KLI
Sbjct: 188 DRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLIT 247
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKK-E 307
RILDPNP TR+T ++ EDEWFKK YKPP F++ ++ N+DD+DA+F DS+E+LVTEK+ E
Sbjct: 248 RILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREE 307
Query: 308 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 367
+P ++NAFE+IS ++ +LENLF+ + KRETR T + NEI+ KIEEAAKPLGF+V
Sbjct: 308 QPAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGFDV 366
Query: 368 RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 427
+K NYKM+L+ K GRKG L+VATE+F+VAP+LH+V+V K+ GDTLEFHKFYKK S+ L+
Sbjct: 367 QKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSLE 426
Query: 428 DVVWQAEENKEE 439
VVW E K+E
Sbjct: 427 QVVWTNNEVKKE 438
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/448 (67%), Positives = 372/448 (83%), Gaps = 17/448 (3%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYELGRT+GEG+FAKVKFA++ ETGD VAIKI+D+++VL+HKMVEQIKREISTMK
Sbjct: 7 KRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMK 66
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV++I EVM SKT IYIVLE++ GGELFD I HGR++EDEARRYFQQLINAVDY
Sbjct: 67 LIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDY 126
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LK+SDFGLSA+SQQ+++DGLLHT CGTPNYVAPEVL
Sbjct: 127 CHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLE 186
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+KI A+F+ P W S AK+L+
Sbjct: 187 DQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLT 246
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK 308
RILDPNP TR+TI ++LEDEWFKKGYK P FD++ + LDDVDA+FNDS+E+ VTEKKE+
Sbjct: 247 RILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHVTEKKEE 306
Query: 309 PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVR 368
P ++NAFELIS + +L NLF+ + KRETRFTS+ PP EI+ KIEEAAKPLGF+V+
Sbjct: 307 PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKPLGFDVQ 365
Query: 369 KGNY----------------KMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDT 412
K NY K++L+ K GRKG L+VATE+ +VAP+LH+VEVRK GDT
Sbjct: 366 KKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDT 425
Query: 413 LEFHKFYKKFSSGLKDVVWQAEENKEEL 440
LEFHKFYK S LKDVVW++++ + +L
Sbjct: 426 LEFHKFYKNLSRTLKDVVWKSDDLQNQL 453
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1627), Expect = e-180, Method: Compositional matrix adjust.
Identities = 290/430 (67%), Positives = 367/430 (85%), Gaps = 2/430 (0%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P + RVGKYELGRT+GEG+FAKV+FAKN E + VAIKI+D+++V +H++VEQI+REI
Sbjct: 11 PKVKRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREIC 70
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
TMKL+KHPNV+++ EVM SK +I+IVLE++ GGELF+ IA +GRLKE+EAR+YFQQLINA
Sbjct: 71 TMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINA 130
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLK ENLLLD+ G LK+SDFGLSA+++QV+ DGLLHT CGTPNYVAPE
Sbjct: 131 VDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPE 190
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245
V+ D+GYDG A+D+WSCGVIL+VL+AGFLPF++ N++ALY+KI A F+CPSWFS+GAKK
Sbjct: 191 VIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKK 250
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK 305
LI RILDPNP TR+TISQ+LED WFKKGYKPP FD++ E + DDVDA F DS++ V E+
Sbjct: 251 LITRILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEE 310
Query: 306 KE-KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG 364
E +P SMNAFELIS ++ +L+NLFE + KRETRFTSQ PP EI++KIEEAAKPLG
Sbjct: 311 TEDQPTSMNAFELISLNQALNLDNLFEAKKEY-KRETRFTSQCPPKEIITKIEEAAKPLG 369
Query: 365 FNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSS 424
F+++K NYKM+++ K GRKG L+VATEVF+VAP+LH+VE++K GDTLEF KFY+ S+
Sbjct: 370 FDIQKKNYKMRMENLKAGRKGNLNVATEVFQVAPSLHVVELKKAKGDTLEFQKFYRTLST 429
Query: 425 GLKDVVWQAE 434
LKDVVW+ +
Sbjct: 430 QLKDVVWKCD 439
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 627 bits (1617), Expect = e-179, Method: Compositional matrix adjust.
Identities = 292/432 (67%), Positives = 363/432 (84%), Gaps = 2/432 (0%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P + RVGKYE+G+TLG+G+FAKV+ A N ETG+ VA+KI+D+++VL+HKM EQI+REI
Sbjct: 4 PKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREIC 63
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
TMKLI HPNV+++ EV+ASKTKIYIVLEF GGELFDKI GRLKE+ AR+YFQQLINA
Sbjct: 64 TMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINA 123
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+S+QVR DGLLHTACGTPNY APE
Sbjct: 124 VDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245
VLND+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+KI ++ CP W S GAK
Sbjct: 184 VLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKN 243
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK 305
LI RILDPNP TR+TI ++L D WFKK YKP F+++EE NLDDVDA+F DS+E+ VTEK
Sbjct: 244 LIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEK 303
Query: 306 K-EKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG 364
K E+P SMNAFELIS +++ L NLFE++ G KRETRF ++ N+++ KIEEA+KPLG
Sbjct: 304 KEEQPTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKPLG 362
Query: 365 FNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSS 424
F+++K NYKM+L+ GRKG L VATE+F+V+P+LH++EVRKT GDTLEFHKFYKK S+
Sbjct: 363 FDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLST 422
Query: 425 GLKDVVWQAEEN 436
L DVVW++ E+
Sbjct: 423 SLNDVVWKSGES 434
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1529), Expect = e-169, Method: Compositional matrix adjust.
Identities = 279/433 (64%), Positives = 352/433 (81%), Gaps = 2/433 (0%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
R +GKYELGR +G+G+FAKV+FAKN+ETGD VAIKI+D+ +V +H++VEQI+REI TMK
Sbjct: 13 RRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQIRREICTMK 72
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LI+HPNV+ + EVM SKT+I+IVLE++ GGEL D IA GRLKEDEAR+YFQQLINAVDY
Sbjct: 73 LIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAVDY 132
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLK ENLLLD+ G +K+SDFGLSAIS+QV+ DGLLHT CGTPNYVAPEV+
Sbjct: 133 CHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEVIE 192
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
DKGYDG +D+WSCGVILFVL+AG+LPF++ N+++LY KI A F+CPSWFS+ AK+LI
Sbjct: 193 DKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWFSAEAKRLIA 252
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK-KE 307
RILDPNP TR+T SQ+L+D+WFKKGY+ P FD + DV F DS+E V E +E
Sbjct: 253 RILDPNPATRITTSQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSEEKHVKEAMEE 312
Query: 308 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 367
+P MNAFELIS K +L+N FE KRETRFTSQ PP EI+++IEEAA LGFN+
Sbjct: 313 QPTLMNAFELISLNKGLNLDNFFESDKKY-KRETRFTSQCPPKEIINRIEEAANLLGFNI 371
Query: 368 RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 427
+K NY+M+++ K GRKG L++ATEVF+VAP+LH+VE++K GDTLEF KFY+ S+ LK
Sbjct: 372 QKRNYRMRMENIKEGRKGHLNIATEVFQVAPSLHVVELKKAKGDTLEFQKFYQTLSTQLK 431
Query: 428 DVVWQAEENKEEL 440
DVVW+ E+ E++
Sbjct: 432 DVVWELEDAAEDM 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 442 | ||||||
| 296088995 | 440 | unnamed protein product [Vitis vinifera] | 0.995 | 1.0 | 0.829 | 0.0 | |
| 224064356 | 441 | predicted protein [Populus trichocarpa] | 0.997 | 1.0 | 0.834 | 0.0 | |
| 224993580 | 441 | CBL-interacting protein kinase 12 [Popul | 0.997 | 1.0 | 0.827 | 0.0 | |
| 224128033 | 442 | predicted protein [Populus trichocarpa] | 1.0 | 1.0 | 0.816 | 0.0 | |
| 15223317 | 447 | CBL-interacting serine/threonine-protein | 0.984 | 0.973 | 0.800 | 0.0 | |
| 14423524 | 447 | similar to wpk4 protein kinase [Arabidop | 0.984 | 0.973 | 0.798 | 0.0 | |
| 359489408 | 419 | PREDICTED: CBL-interacting serine/threon | 0.943 | 0.995 | 0.836 | 0.0 | |
| 449520201 | 441 | PREDICTED: CBL-interacting serine/threon | 0.993 | 0.995 | 0.797 | 0.0 | |
| 449432000 | 441 | PREDICTED: CBL-interacting serine/threon | 0.993 | 0.995 | 0.794 | 0.0 | |
| 30677898 | 449 | CBL-interacting serine/threonine-protein | 0.984 | 0.968 | 0.796 | 0.0 |
| >gi|296088995|emb|CBI38698.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2022), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/440 (82%), Positives = 412/440 (93%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
+KVPA+RTRVG+YE+G+TLGEGSFAKVK+A+N +TGD VAIK++DRD VLRHKMVEQIKR
Sbjct: 1 MKVPATRTRVGRYEIGKTLGEGSFAKVKYARNSDTGDSVAIKVLDRDHVLRHKMVEQIKR 60
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
EISTMKLIKHPNV+ I EVMASKTKIYIV+EF+DGGELFD+IAK+GRLKEDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVTIFEVMASKTKIYIVVEFVDGGELFDRIAKNGRLKEDEARRYFQQL 120
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
INAVDYCHSRGV+HRDLKPENLLLDSYGVLKISDFGLSA+SQQVREDGL HTACGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGVLKISDFGLSALSQQVREDGLFHTACGTPNYV 180
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 242
APEVLN+KGYDG ++D+WSCGVILFVL+AG+LPFDE +LMALY+KIC+ADFSCPSW S G
Sbjct: 181 APEVLNNKGYDGASADIWSCGVILFVLLAGYLPFDEVSLMALYKKICKADFSCPSWLSPG 240
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLV 302
AKKLI RILDPNP TR+TI ++LED WFKKGY+P F +EE+VN+DDVDA FN+S+ENLV
Sbjct: 241 AKKLINRILDPNPVTRITIPEILEDGWFKKGYQPTCFQQEEDVNVDDVDAAFNNSEENLV 300
Query: 303 TEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKP 362
TE+KEKPVSMNAFELISR++SF+LENLF KQ GLVKRET FTSQRP +EIMSKIEE AKP
Sbjct: 301 TERKEKPVSMNAFELISRSQSFNLENLFGKQAGLVKRETSFTSQRPAHEIMSKIEETAKP 360
Query: 363 LGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKF 422
LGFNVRK NYKMKLQGDKTGRKG LSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK F
Sbjct: 361 LGFNVRKQNYKMKLQGDKTGRKGHLSVATEVFEVAPSLHMVELRKTGGDTLEFHKFYKSF 420
Query: 423 SSGLKDVVWQAEENKEELRA 442
SSGLKD+VW++E N EELR+
Sbjct: 421 SSGLKDIVWKSEANTEELRS 440
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064356|ref|XP_002301435.1| predicted protein [Populus trichocarpa] gi|116265942|gb|ABJ91219.1| CBL-interacting protein kinase 12 [Populus trichocarpa] gi|222843161|gb|EEE80708.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2010), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/441 (83%), Positives = 410/441 (92%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MSVKVPA+RTRVGKYELG+T+GEGSFAKVK AKNV+TGD VAIKI+DRDQVLRHKMVEQ+
Sbjct: 1 MSVKVPAARTRVGKYELGKTIGEGSFAKVKVAKNVQTGDVVAIKILDRDQVLRHKMVEQL 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNVIKI EVMASKTKIYIV+EF+DGGELFDKIAKHGRLKEDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVIKIFEVMASKTKIYIVIEFVDGGELFDKIAKHGRLKEDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLI AVDYCHSRGVFHRDLKPENLLLDS GVLK+SDFGLSA+SQQ+R DGLLHTACGTPN
Sbjct: 121 QLIKAVDYCHSRGVFHRDLKPENLLLDSRGVLKVSDFGLSALSQQLRGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240
YVAPEVL D+GYDG ASDVWSCGVIL+VLMAGFLPF ES+L+ LYRKICRADF+ PSWFS
Sbjct: 181 YVAPEVLRDQGYDGTASDVWSCGVILYVLMAGFLPFSESSLVVLYRKICRADFTFPSWFS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
SGAKKLIKRILDP P TR+T+S++LEDEWFKKGYKPP F++EE+VN+DDVDA+FNDSKE+
Sbjct: 241 SGAKKLIKRILDPKPLTRITVSEILEDEWFKKGYKPPQFEQEEDVNIDDVDAVFNDSKEH 300
Query: 301 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAA 360
LVTE+K KPVS+NAFELIS+T+ FSL+NLF KQ G+VKRET S P NEIMS+IEEAA
Sbjct: 301 LVTERKVKPVSINAFELISKTQGFSLDNLFGKQAGVVKRETHIASHSPANEIMSRIEEAA 360
Query: 361 KPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK 420
KPLGFNV K NYKMKL+GDK+GRKGQLSVATEVFEVAP+LH+VE+RK GGDTLEFHKFYK
Sbjct: 361 KPLGFNVDKRNYKMKLKGDKSGRKGQLSVATEVFEVAPSLHMVELRKIGGDTLEFHKFYK 420
Query: 421 KFSSGLKDVVWQAEENKEELR 441
FSSGLKDVVW++++ E LR
Sbjct: 421 SFSSGLKDVVWKSDQTIEGLR 441
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224993580|gb|ACN76469.1| CBL-interacting protein kinase 12 [Populus euphratica] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/441 (82%), Positives = 407/441 (92%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MSVKVPA+RTRVGKYELG+T+GEGSFAKVK AKNV+TGD VAIKI+DRDQVLRHK VEQ+
Sbjct: 1 MSVKVPAARTRVGKYELGKTIGEGSFAKVKVAKNVQTGDVVAIKILDRDQVLRHKTVEQL 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNVIKI EVMAS+TKIYIV+EF++GGELFDKIAKHGRLKEDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVIKIFEVMASRTKIYIVIEFVEGGELFDKIAKHGRLKEDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLI A DYCHSRGVFHRDLKPENLLLDS GVLK+SDFGLSA+SQQ+R DGLLH ACGTPN
Sbjct: 121 QLIKAADYCHSRGVFHRDLKPENLLLDSRGVLKVSDFGLSALSQQLRGDGLLHAACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240
YVAPEVL D+GYDG ASDVWSCGVIL+VLMAGFLPF ES+L+ LYRKICRADF+ PSWFS
Sbjct: 181 YVAPEVLRDQGYDGTASDVWSCGVILYVLMAGFLPFSESSLVVLYRKICRADFTFPSWFS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
SGAKKLIKRILDP P TR+T+S++LEDEWFKKGYKPP F++EE+VN+DDVDA+FNDSKE+
Sbjct: 241 SGAKKLIKRILDPQPLTRITVSEILEDEWFKKGYKPPQFEQEEDVNIDDVDAVFNDSKEH 300
Query: 301 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAA 360
LVTE+K KPVSMNAFELISRT+ FSL+NLF KQ G+VKRET S P NEIMS+IEEAA
Sbjct: 301 LVTERKVKPVSMNAFELISRTQGFSLDNLFGKQAGVVKRETHIASHSPANEIMSRIEEAA 360
Query: 361 KPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK 420
KPLGFNV K NYKMKL+GDK+GRKGQLSVATEVFEVAP+LH+VE+RK GGDTLEFHKFYK
Sbjct: 361 KPLGFNVDKRNYKMKLKGDKSGRKGQLSVATEVFEVAPSLHMVELRKIGGDTLEFHKFYK 420
Query: 421 KFSSGLKDVVWQAEENKEELR 441
FSSGLKDVVW++++ E LR
Sbjct: 421 SFSSGLKDVVWKSDQTIEGLR 441
|
Source: Populus euphratica Species: Populus euphratica Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128033|ref|XP_002320224.1| predicted protein [Populus trichocarpa] gi|116265944|gb|ABJ91220.1| CBL-interacting protein kinase 13 [Populus trichocarpa] gi|222860997|gb|EEE98539.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/442 (81%), Positives = 405/442 (91%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MS K +RTRVGKYELG+T+GEGSFAKVK AKNVETGD VAIKI+DR+QVLRHKMVEQ+
Sbjct: 1 MSAKGQGTRTRVGKYELGKTIGEGSFAKVKVAKNVETGDVVAIKILDREQVLRHKMVEQL 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNVIKI EVMASKTKIYIV+EF+DGGELFDKIAKHGRL+EDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVIKIFEVMASKTKIYIVIEFVDGGELFDKIAKHGRLREDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGVFHRDLKPENLLLDS+GVLK+SDFGLSA+SQQ++ DGLLHTACGTPN
Sbjct: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSHGVLKVSDFGLSALSQQLQGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240
YVAPEVL DKGYDG ASDVWSCGVIL+VLMAG+LPFDE++LMALY KIC ADF+ PSWFS
Sbjct: 181 YVAPEVLKDKGYDGTASDVWSCGVILYVLMAGYLPFDETSLMALYLKICSADFTFPSWFS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
SGAKKLIKRILDP P TR+T+++++EDEWFKKGY+PP F++EE VN+DDVDA+FND KE+
Sbjct: 241 SGAKKLIKRILDPEPLTRITVAEIIEDEWFKKGYRPPQFEQEEHVNVDDVDAVFNDLKEH 300
Query: 301 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAA 360
LVTEKK+KP SMNAFELIS+T+ FSLENLF KQ G VKRETR S P NEIMS+IEEAA
Sbjct: 301 LVTEKKKKPASMNAFELISKTQGFSLENLFGKQAGFVKRETRIASHSPANEIMSRIEEAA 360
Query: 361 KPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK 420
KPLGFNV K NYKMKL+GDK GRKGQLSVATEVFEVAP+LH+VE+RK GGDTLEFH FYK
Sbjct: 361 KPLGFNVDKRNYKMKLKGDKGGRKGQLSVATEVFEVAPSLHMVELRKIGGDTLEFHNFYK 420
Query: 421 KFSSGLKDVVWQAEENKEELRA 442
FSSGLKDVVW++++ E LR+
Sbjct: 421 SFSSGLKDVVWKSDQTIEGLRS 442
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223317|ref|NP_171622.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|259016207|sp|Q9MAM1.2|CIPK9_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 9; AltName: Full=SNF1-related kinase 3.12; AltName: Full=SOS2-like protein kinase PKS6 gi|332189123|gb|AEE27244.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/436 (80%), Positives = 399/436 (91%), Gaps = 1/436 (0%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAK 248
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVT 303
++IKRIL+PNP TR++I+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVT
Sbjct: 249 RVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVT 308
Query: 304 EKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPL 363
EKKEKPVSMNAFELIS + FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPL
Sbjct: 309 EKKEKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPL 368
Query: 364 GFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFS 423
GFNVRK NYK+K++GDK+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FS
Sbjct: 369 GFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFS 428
Query: 424 SGLKDVVWQAEENKEE 439
SGLKDVVW + EE
Sbjct: 429 SGLKDVVWNTDAAAEE 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14423524|gb|AAK62444.1|AF386999_1 similar to wpk4 protein kinase [Arabidopsis thaliana] gi|20259788|gb|AAM13241.1| similar to wpk4 protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/436 (79%), Positives = 398/436 (91%), Gaps = 1/436 (0%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAK K+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKAKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAK 248
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVT 303
++IKRIL+PNP TR++I+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVT
Sbjct: 249 RVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVT 308
Query: 304 EKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPL 363
EKKEKPVSMNAFELIS + FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPL
Sbjct: 309 EKKEKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPL 368
Query: 364 GFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFS 423
GFNVRK NYK+K++GDK+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FS
Sbjct: 369 GFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFS 428
Query: 424 SGLKDVVWQAEENKEE 439
SGLKDVVW + EE
Sbjct: 429 SGLKDVVWNTDAAAEE 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489408|ref|XP_002267089.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 9 [Vitis vinifera] gi|229609825|gb|ACQ83528.1| CBL-interacting protein kinase 12 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/417 (83%), Positives = 392/417 (94%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MS+KVPA+RTRVG+YE+G+TLGEGSFAKVK+A+N +TGD VAIK++DRD VLRHKMVEQI
Sbjct: 1 MSMKVPATRTRVGRYEIGKTLGEGSFAKVKYARNSDTGDSVAIKVLDRDHVLRHKMVEQI 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNV+ I EVMASKTKIYIV+EF+DGGELFD+IAK+GRLKEDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVVTIFEVMASKTKIYIVVEFVDGGELFDRIAKNGRLKEDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGV+HRDLKPENLLLDSYGVLKISDFGLSA+SQQVREDGL HTACGTPN
Sbjct: 121 QLINAVDYCHSRGVYHRDLKPENLLLDSYGVLKISDFGLSALSQQVREDGLFHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240
YVAPEVLN+KGYDG ++D+WSCGVILFVL+AG+LPFDE +LMALY+KIC+ADFSCPSW S
Sbjct: 181 YVAPEVLNNKGYDGASADIWSCGVILFVLLAGYLPFDEVSLMALYKKICKADFSCPSWLS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
GAKKLI RILDPNP TR+TI ++LED WFKKGY+P F +EE+VN+DDVDA FN+S+EN
Sbjct: 241 PGAKKLINRILDPNPVTRITIPEILEDGWFKKGYQPTCFQQEEDVNVDDVDAAFNNSEEN 300
Query: 301 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAA 360
LVTE+KEKPVSMNAFELISR++SF+LENLF KQ GLVKRET FTSQRP +EIMSKIEE A
Sbjct: 301 LVTERKEKPVSMNAFELISRSQSFNLENLFGKQAGLVKRETSFTSQRPAHEIMSKIEETA 360
Query: 361 KPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHK 417
KPLGFNVRK NYKMKLQGDKTGRKG LSVATEVFEVAP+LH+VE+RKTGGDTLEFHK
Sbjct: 361 KPLGFNVRKQNYKMKLQGDKTGRKGHLSVATEVFEVAPSLHMVELRKTGGDTLEFHK 417
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520201|ref|XP_004167122.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/439 (79%), Positives = 396/439 (90%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M+VK P +RTRVGKYELG+TLGEG+FAKVKFAKNVE GD+VAIKI+DR++ LRH+MVEQI
Sbjct: 1 MNVKSPPTRTRVGKYELGKTLGEGTFAKVKFAKNVENGDYVAIKILDREKALRHRMVEQI 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREIST+K+IKHPNV KI EVMASK+KIYIVLE+ DGGELFDKIA GRLKEDEAR+YF
Sbjct: 61 KREISTLKVIKHPNVCKIYEVMASKSKIYIVLEYADGGELFDKIAAKGRLKEDEARKYFH 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGV+HRDLKPENLLLDS+ VLK+SDFGLSA SQQVR DGLLHTACGTPN
Sbjct: 121 QLINAVDYCHSRGVYHRDLKPENLLLDSHDVLKVSDFGLSAFSQQVRGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240
YVAPEVLNDKGYDG +SD+WSCGVILFVLMAGFLPFDE NLM LYRKI +ADF+ PSWFS
Sbjct: 181 YVAPEVLNDKGYDGSSSDLWSCGVILFVLMAGFLPFDEPNLMCLYRKISKADFAFPSWFS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
SGAK L++RILDP+P TR++I+++ ED WFKK Y P HF+ EE++ LDDVDA F+ SKE+
Sbjct: 241 SGAKNLVRRILDPDPTTRISIAEIQEDPWFKKDYTPAHFEVEEDITLDDVDAAFSSSKEH 300
Query: 301 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAA 360
LVTE+KEKPVSMNAFELISR+ FSLENLFEKQ + KRETRFTSQ P NEIMSKIEE A
Sbjct: 301 LVTERKEKPVSMNAFELISRSPGFSLENLFEKQKTVAKRETRFTSQSPANEIMSKIEETA 360
Query: 361 KPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK 420
KP+GFNVRK +YKMKLQGDKTGRKG LS+ATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK
Sbjct: 361 KPMGFNVRKRDYKMKLQGDKTGRKGHLSIATEVFEVAPSLHMVELRKTGGDTLEFHKFYK 420
Query: 421 KFSSGLKDVVWQAEENKEE 439
FSSGLKD+VW+ +EN E
Sbjct: 421 SFSSGLKDIVWRTDENTVE 439
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432000|ref|XP_004133788.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/439 (79%), Positives = 396/439 (90%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M+VK P +RTRVGKYELG+TLGEG+FAKVKFAKNVE GD+VAIKI+DR++ LRH+MVEQI
Sbjct: 1 MNVKSPPTRTRVGKYELGKTLGEGTFAKVKFAKNVENGDYVAIKILDREKALRHRMVEQI 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREIST+K+IKHPNV KI EVMASK+KIYIVLE+ DGGELFDKIA GRLKEDEAR+YF
Sbjct: 61 KREISTLKVIKHPNVCKIYEVMASKSKIYIVLEYADGGELFDKIAAKGRLKEDEARKYFH 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGV+HRDLKPENLLLDS+ VLK+SDFGLSA SQQVR DGLLHTACGTPN
Sbjct: 121 QLINAVDYCHSRGVYHRDLKPENLLLDSHDVLKVSDFGLSAFSQQVRGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240
YVAPEVLNDKGYDG +SD+WSCGVILFVLMAGFLPFDE NLM LYRKI +ADF+ PSWFS
Sbjct: 181 YVAPEVLNDKGYDGSSSDLWSCGVILFVLMAGFLPFDEPNLMCLYRKISKADFAFPSWFS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
SGAK L++RILDP+P TR++I+++ ED WFKK Y P HF+ EE++ LDDVDA F+ SKE+
Sbjct: 241 SGAKNLVRRILDPDPTTRISIAEIQEDPWFKKDYTPAHFEVEEDITLDDVDAAFSSSKEH 300
Query: 301 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAA 360
LVTE+KEKPVSMNAFELISR+ FSLENLFE+Q + KRETRFTSQ P NEIMSKIEE A
Sbjct: 301 LVTERKEKPVSMNAFELISRSPGFSLENLFERQKTVAKRETRFTSQSPANEIMSKIEETA 360
Query: 361 KPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK 420
KP+GFNVRK +YKMKLQGDKTGRKG LS+ATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK
Sbjct: 361 KPMGFNVRKRDYKMKLQGDKTGRKGHLSIATEVFEVAPSLHMVELRKTGGDTLEFHKFYK 420
Query: 421 KFSSGLKDVVWQAEENKEE 439
FSSGLKD+VW+ +EN E
Sbjct: 421 SFSSGLKDIVWRTDENTVE 439
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30677898|ref|NP_849570.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|13249117|gb|AAK16684.1|AF295664_1 CBL-interacting protein kinase 9 [Arabidopsis thaliana] gi|332189122|gb|AEE27243.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/438 (79%), Positives = 399/438 (91%), Gaps = 3/438 (0%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR--KICRADFSCPSWFSSG 242
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY+ +IC+A+FSCP WFS G
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRVRICKAEFSCPPWFSQG 248
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENL 301
AK++IKRIL+PNP TR++I+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE L
Sbjct: 249 AKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECL 308
Query: 302 VTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAK 361
VTEKKEKPVSMNAFELIS + FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AK
Sbjct: 309 VTEKKEKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAK 368
Query: 362 PLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK 421
PLGFNVRK NYK+K++GDK+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK
Sbjct: 369 PLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKN 428
Query: 422 FSSGLKDVVWQAEENKEE 439
FSSGLKDVVW + EE
Sbjct: 429 FSSGLKDVVWNTDAAAEE 446
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 442 | ||||||
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.972 | 0.892 | 0.721 | 9.9e-174 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.972 | 0.953 | 0.685 | 5.4e-166 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.972 | 0.979 | 0.675 | 9.3e-162 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.968 | 0.959 | 0.561 | 1.1e-133 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.950 | 0.943 | 0.562 | 3.5e-130 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.934 | 0.940 | 0.523 | 1.5e-120 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.925 | 0.927 | 0.522 | 1.6e-118 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.957 | 0.927 | 0.511 | 3.1e-115 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.947 | 0.941 | 0.523 | 3.1e-115 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.667 | 0.610 | 0.554 | 4.2e-115 |
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1688 (599.3 bits), Expect = 9.9e-174, P = 9.9e-174
Identities = 316/438 (72%), Positives = 388/438 (88%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
RTRVGKYELGRTLGEG+FAKVKFA+NVE GD VAIK++D+++VL++KM+ QIKREISTMK
Sbjct: 25 RTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMK 84
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNVI++ EVMASKTKIY VLEF+ GGELFDKI+ +GRLKEDEAR+YFQQLINAVDY
Sbjct: 85 LIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDY 144
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+ QQVREDGLLHT CGTPNYVAPEV+N
Sbjct: 145 CHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 204
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
+KGYDG +D+WSCGVILFVLMAG+LPF++SNL +LY+KI +A+F+CP WFS+ AKKLIK
Sbjct: 205 NKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIK 264
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE--NLVTEKK 306
RILDPNP TR+T ++++E+EWFKKGYK P F+ + V+LDDVDAIF+DS E NLV E++
Sbjct: 265 RILDPNPATRITFAEVIENEWFKKGYKAPKFENAD-VSLDDVDAIFDDSGESKNLVVERR 323
Query: 307 EK----PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKP 362
E+ PV+MNAFELIS ++ +L +LFEKQ GLVKR+TRFTS+ NEI++KIE AA P
Sbjct: 324 EEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAP 383
Query: 363 LGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKF 422
+GF+V+ NYKMKL G+K+GRKGQL+VATEVF+VAP+L++VE+RK+GGDTLEFHKFYK
Sbjct: 384 MGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNL 443
Query: 423 SSGLKDVVWQA-EENKEE 439
++GLKD+VW+ +E KEE
Sbjct: 444 TTGLKDIVWKTIDEEKEE 461
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 296/432 (68%), Positives = 372/432 (86%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYE+GRT+GEG+FAKVKFA+N ETG+ VA+KI+D+++VL+HKM EQI+REI+TMK
Sbjct: 18 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMK 77
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV+++ EVMASKTKI+I+LE++ GGELFDKI GR+KEDEARRYFQQLI+AVDY
Sbjct: 78 LIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDY 137
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LKISDFGLSA+SQQVR+DGLLHT+CGTPNYVAPEVLN
Sbjct: 138 CHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLN 197
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D+GYDG +D+WSCGV+L+VL+AG+LPFD+SNLM LY+KI +F+CP W S GA KLI
Sbjct: 198 DRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLIT 257
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK 308
RILDPNP TR+T ++ EDEWFKK YKPP F++ ++ N+DD+DA+F DS+E+LVTEK+E+
Sbjct: 258 RILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREE 317
Query: 309 -PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 367
P ++NAFE+IS ++ +LENLF+ + KRETR T + NEI+ KIEEAAKPLGF+V
Sbjct: 318 QPAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGFDV 376
Query: 368 RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 427
+K NYKM+L+ K GRKG L+VATE+F+VAP+LH+V+V K+ GDTLEFHKFYKK S+ L+
Sbjct: 377 QKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSLE 436
Query: 428 DVVWQAEENKEE 439
VVW E K+E
Sbjct: 437 QVVWTNNEVKKE 448
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1575 (559.5 bits), Expect = 9.3e-162, P = 9.3e-162
Identities = 292/432 (67%), Positives = 363/432 (84%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P + RVGKYE+G+TLG+G+FAKV+ A N ETG+ VA+KI+D+++VL+HKM EQI+REI
Sbjct: 4 PKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREIC 63
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
TMKLI HPNV+++ EV+ASKTKIYIVLEF GGELFDKI GRLKE+ AR+YFQQLINA
Sbjct: 64 TMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINA 123
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+S+QVR DGLLHTACGTPNY APE
Sbjct: 124 VDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245
VLND+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+KI ++ CP W S GAK
Sbjct: 184 VLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKN 243
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK 305
LI RILDPNP TR+TI ++L D WFKK YKP F+++EE NLDDVDA+F DS+E+ VTEK
Sbjct: 244 LIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEK 303
Query: 306 KEK-PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG 364
KE+ P SMNAFELIS +++ L NLFE++ G KRETRF ++ N+++ KIEEA+KPLG
Sbjct: 304 KEEQPTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKPLG 362
Query: 365 FNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSS 424
F+++K NYKM+L+ GRKG L VATE+F+V+P+LH++EVRKT GDTLEFHKFYKK S+
Sbjct: 363 FDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLST 422
Query: 425 GLKDVVWQAEEN 436
L DVVW++ E+
Sbjct: 423 SLNDVVWKSGES 434
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1310 (466.2 bits), Expect = 1.1e-133, P = 1.1e-133
Identities = 245/436 (56%), Positives = 336/436 (77%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
RVGKYE+GRT+GEG+FAKVKFA+N +TGD VAIKI+ + +L+++MV+QIKREIS MK++
Sbjct: 7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPN++++ EV+AS +KIYIVLEF+ GGELFD+I GRL+E E+R+YFQQL++AV +CH
Sbjct: 67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+GV+HRDLKPENLLLD+ G LK+SDFGLSA+ Q+ E LL T CGTPNYVAPEVL+ +
Sbjct: 127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250
GYDG A+D+WSCGVILFV++AG+LPF E++L LYRKI A+FSCP WFS+ K LI RI
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244
Query: 251 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK-- 308
LDPNP TR+ I + +D WF+ Y P +EEEVNLDD+ A+F+ + + V E E+
Sbjct: 245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERND 304
Query: 309 --PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFN 366
P+ MNAFE+I+ ++ +L LF+++ VKR+TRF S+R P+EI++ IE A +GF
Sbjct: 305 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 364
Query: 367 VRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 426
N+K +L+G + + GQL+V E++EVAP+L +V+VRK G+TLE+HKFYKK S L
Sbjct: 365 SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 424
Query: 427 KDVVWQAEEN--KEEL 440
++++W+A E K E+
Sbjct: 425 ENIIWRATEGIPKSEI 440
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1277 (454.6 bits), Expect = 3.5e-130, P = 3.5e-130
Identities = 239/425 (56%), Positives = 321/425 (75%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+VGKYELGRT+GEG+FAKVKFA+N ETG+ VA+KIVDR +++ KMV+QIKREIS MKL+
Sbjct: 5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HP V+++ EV+AS+TKIYI+LE+I GGELFDKI ++GRL E EAR+YF QLI+ VDYCH
Sbjct: 65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
S+GV+HRDLKPENLLLDS G LKISDFGLSA+ +Q +L T CGTPNYVAPEVL+ K
Sbjct: 125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVT--ILKTTCGTPNYVAPEVLSHK 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250
GY+G +D+WSCGVIL+VLMAG+LPFDE +L LY KI +A+FSCPS+F+ GAK LI RI
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRI 242
Query: 251 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK-- 308
LDPNP+TR+TI+++ +DEWF K Y P E VNLDDV A F+D +E + +
Sbjct: 243 LDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDT 302
Query: 309 -PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 367
P+++NAF+LI ++ +L LF++ +K +TRF S +P N ++S +E ++ +GF
Sbjct: 303 GPLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKT 362
Query: 368 RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 427
NYKM+++G + SV EVF+VAP++ +V+++ GD E+ KFYK F S L
Sbjct: 363 HIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLD 422
Query: 428 DVVWQ 432
D++W+
Sbjct: 423 DIIWK 427
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1186 (422.6 bits), Expect = 1.5e-120, P = 1.5e-120
Identities = 223/426 (52%), Positives = 315/426 (73%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYELGR LG+G+FAKV A+N++TG+ VAIK++D+ +V + +++QIKREIS M+L++HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+V+ + EVMASKTKIY +E++ GGELFDK++K G+LKE+ AR+YFQQLI A+DYCHSRG
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDKVSK-GKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V+HRDLKPENLLLD G LKISDFGLSA+ + ++DGLLHT CGTP YVAPEV+ KGYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
G +DVWSCGV+L+VL+AGFLPF E NL+ +YRKI + +F CP+WF KKL+ RILDP
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 254 NPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMN 313
NP++R+ I +++E+ WF+KG+K K E + +D++ +D KP+S N
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESH--QIDSLISDVHAAFSV----KPMSYN 303
Query: 314 AFELISR-TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEE-AAKPLGFNVRKGN 371
AF+LIS ++ F L LFEK+ + E++FT+++ EI+SK EE A FN+ K +
Sbjct: 304 AFDLISSLSQGFDLSGLFEKEE---RSESKFTTKKDAKEIVSKFEEIATSSERFNLTKSD 360
Query: 372 YKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFY-KKFSSGLKDVV 430
+K++ + GRKG L++ E+FEV + H+VE +K+GGDT+E+ +F ++ LKD+V
Sbjct: 361 VGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKDIV 420
Query: 431 WQAEEN 436
W+ + N
Sbjct: 421 WKWQGN 426
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
Identities = 222/425 (52%), Positives = 314/425 (73%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
G+YELGR LG G+FAKV A+N++TG VA+K+V +++V++ MV+QIKREIS M+++KH
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
PN++++ EVMASK+KIY +E + GGELF K+AK GRL+ED AR YFQQLI+AVD+CHSR
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
GV+HRDLKPENLLLD G LK++DFGLSA ++ +++DGLLHT CGTP YVAPEV+ KGY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252
DG +D+WSCGVILFVL+AG+LPF + NL+ +YRKI R DF CP W SS A++L+ ++LD
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLD 260
Query: 253 PNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN---LVTEKKEKP 309
PNP+TR+TI ++++ WFKK + + V A ++E+ LV + KE+
Sbjct: 261 PNPNTRITIEKVMDSPWFKK--------QATRSRNEPVAATITTTEEDVDFLVHKSKEET 312
Query: 310 VSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG--FNV 367
++NAF +I+ ++ F L LFE++ KRE RF + RP + ++S +EEAA+ +G F+V
Sbjct: 313 ETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAAR-VGNKFDV 371
Query: 368 RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK-FSSGL 426
RK +++++G + GRKG+L+V E+F VAP+ +VEV+K GDTLE++ F L
Sbjct: 372 RKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPAL 431
Query: 427 KDVVW 431
KD+ W
Sbjct: 432 KDIFW 436
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
Identities = 223/436 (51%), Positives = 312/436 (71%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+YE+GR LG+G+FAKV F ++ T + VAIK++D+D+V+R + +QIKREIS M++ KHP
Sbjct: 11 RYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREISVMRIAKHP 70
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
NV+++ EVMA+K++IY V+E+ GGELF+K+AK G+LKED A +YF QLI+AVD+CHSRG
Sbjct: 71 NVVELYEVMATKSRIYFVIEYCKGGELFNKVAK-GKLKEDVAWKYFYQLISAVDFCHSRG 129
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V+HRD+KPENLLLD LK+SDFGLSA++ R+DGLLHT CGTP YVAPEV+N KGY+
Sbjct: 130 VYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYE 189
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
G +D+WSCGV+LFVL+AG+LPF ++NLM +YRKI +ADF CPSWF+ K+L+ ++LDP
Sbjct: 190 GTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRLLCKMLDP 249
Query: 254 NPDTRMTISQMLEDEWFKKGY--KPPHFDKEEEVNLDDVDAIFN--DSKENLVTEKKEKP 309
N +TR+TI+++ E WF+KG K +K E+ + + S +N E E P
Sbjct: 250 NHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQNENGENHEPP 309
Query: 310 --VSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 367
++NAF++I+ + F L LF KRE+RF SQ+P +EI+SK+ E AK L +
Sbjct: 310 RLATLNAFDIIALSTGFGLAGLFGDVYD--KRESRFASQKPASEIISKLVEVAKCLKLKI 367
Query: 368 RK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK-FSSG 425
RK G KL+ K G+ G L++ E+F+V PT H+VEV+K GDT+E+ K ++
Sbjct: 368 RKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKLVEEDLRPA 427
Query: 426 LKDVVW--QAEENKEE 439
L D+VW Q E+ KEE
Sbjct: 428 LADIVWVWQGEKEKEE 443
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
Identities = 225/430 (52%), Positives = 304/430 (70%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-MVEQIKREISTM 67
R GKYE+GR LG+G+FAKV + K + G+ VAIK++++DQV++ M+EQIKREIS M
Sbjct: 6 RVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKREISIM 65
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
KL++HPN++++ EVMA+KTKI+ V+EF+ GGELF KI+K G+L ED ARRYFQQLI+AVD
Sbjct: 66 KLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISK-GKLHEDAARRYFQQLISAVD 124
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
YCHSRGV HRDLKPENLLLD G LKISDFGLSA+ +Q+ +DGLLHT CGTP YVAPEVL
Sbjct: 125 YCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVL 184
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247
KGYDG +D+WSCGV+L+VL+AG LPF + NLM +YRKI RADF P WFS A++LI
Sbjct: 185 KKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLI 244
Query: 248 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 307
++L +PD R++I ++ W +K + PP K +E + +E+ E +
Sbjct: 245 SKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDCENQT 304
Query: 308 KPVS---MNAFELISRTKS-FSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPL 363
+P+S NAFE IS S F L +LFE + K ++ FTS+ E+M KIE K +
Sbjct: 305 EPISPKFFNAFEFISSMSSGFDLSSLFESKR---KVQSVFTSRSSATEVMEKIETVTKEM 361
Query: 364 GFNVRKG-NYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK- 421
V++ ++K+K++G GRKG+LS+ EVFEVAP + +VE K+ GDTLE+ + Y++
Sbjct: 362 NMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRLYEEE 421
Query: 422 FSSGLKDVVW 431
L D+VW
Sbjct: 422 VRPALNDIVW 431
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 4.2e-115, Sum P(2) = 4.2e-115
Identities = 168/303 (55%), Positives = 233/303 (76%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+GKYE+GR LG G+FAKV A+N ++G+ VAIK++D+++VL+ ++ IKREIS ++ ++
Sbjct: 25 LGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRRVR 84
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HPN++++ EVMA+K+KIY V+E++ GGELF+K+AK GRLKE+ AR+YFQQLI+AV +CH
Sbjct: 85 HPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAK-GRLKEEMARKYFQQLISAVSFCHF 143
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
RGV+HRDLKPENLLLD G LK+SDFGLSA+S Q+R+DGL HT CGTP YVAPEVL KG
Sbjct: 144 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 203
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251
YDG D+WSCGVILFVLMAGFLPF + N+MA+Y+KI R DF CP WF +L+ R+L
Sbjct: 204 YDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRML 263
Query: 252 DPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNL------DDVDAIFNDS-KENLVTE 304
+ P+ R T+ ++E WFKKG+K F E++ L D++++I + S + + V+E
Sbjct: 264 ETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRSSTVSE 323
Query: 305 KKE 307
++
Sbjct: 324 PED 326
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9MAM1 | CIPK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8004 | 0.9841 | 0.9731 | yes | no |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7037 | 0.9751 | 0.9840 | no | no |
| Q10SC8 | CIPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7621 | 0.9751 | 0.9451 | yes | no |
| Q93VD3 | CIPKN_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7195 | 0.9660 | 0.8858 | no | no |
| Q6ZLP5 | CIPKN_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7077 | 0.9796 | 0.9622 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 442 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-108 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-96 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-79 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-77 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-74 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-72 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-70 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-65 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-64 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-63 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-60 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-55 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-55 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-55 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-52 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-52 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-49 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-48 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-48 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-48 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-46 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-46 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 4e-46 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-45 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-45 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-45 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-45 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-45 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-45 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-44 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-44 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-44 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-43 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-43 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-43 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-43 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-43 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-42 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-42 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-41 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-41 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-41 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-41 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-41 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-41 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-40 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-40 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-40 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-39 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-39 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-38 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-38 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-38 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-38 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-38 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-38 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-37 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-37 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-37 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-37 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-37 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-36 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-36 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-35 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-35 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-35 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-35 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-34 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-34 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-34 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-34 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-34 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-34 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-34 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-34 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-34 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-33 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-33 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-33 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-32 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-32 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-32 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-31 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-31 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-30 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-30 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-30 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-30 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-30 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-29 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-29 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-29 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-27 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-27 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-27 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-27 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-26 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-26 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-25 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-24 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-24 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 2e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-14 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = e-108
Identities = 114/260 (43%), Positives = 172/260 (66%), Gaps = 10/260 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YE+ LGEGSF KV A++ +TG VAIK++ + ++ K E+I REI +K +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++++ +V + K+Y+V+E+ +GG+LFD + K GRL EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRDLKPEN+LLD G +K++DFGL+ Q+ L T GTP Y+APEVL KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYG- 174
Query: 195 RASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFSCPSW---FSSGAKKLIKRI 250
+A D+WS GVIL+ L+ G PF + L+ L++KI + P S AK LI+++
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 251 LDPNPDTRMTISQMLEDEWF 270
L +P+ R+T + L+ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 289 bits (742), Expect = 2e-96
Identities = 108/263 (41%), Positives = 159/263 (60%), Gaps = 10/263 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL R LG GSF V AK+ TG VA+KI+ + + K + +REI ++ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++++I+ K +Y+V+E+ +GG+LFD +++ G L EDEA++ Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRDLKPEN+LLD GV+KI+DFGL+ + ++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 195 RASDVWSCGVILFVLMAGFLPFDES---NLMALYRKI--CRADFSCPSW--FSSGAKKLI 247
DVWS GVIL+ L+ G PF + + L R+I +F P W S AK LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 248 KRILDPNPDTRMTISQMLEDEWF 270
K+ L+ +P R T ++L+ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 3e-79
Identities = 94/244 (38%), Positives = 151/244 (61%), Gaps = 6/244 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E +TLG GSF +V ++ +G + A+KI+ + ++++ K VE + E ++ I+HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + + +Y+V+E++ GGELF + K GR E AR Y Q++ A++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPENLLLDS G +KI+DFG + R G +T CGTP Y+APE++ KGY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
+A D W+ G++++ ++AG+ PF + N + +Y KI PS+FS AK LI+ +L +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 255 PDTR 258
R
Sbjct: 237 LTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 8e-77
Identities = 94/240 (39%), Positives = 146/240 (60%), Gaps = 3/240 (1%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+GSF KV + +TG A+K++ + ++++ K VE E + + I HP ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
++ K+Y+VLE+ GGELF ++K GR E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200
PEN+LLD+ G +K++DFGL+ E +T CGTP Y+APEVL KGY G+A D W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 201 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 260
S GV+L+ ++ G PF + +Y KI + P + S A+ LI +L +P R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 2e-74
Identities = 93/249 (37%), Positives = 140/249 (56%), Gaps = 37/249 (14%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LGEG F V A++ +TG VAIKI+ ++ ++E++ REI +K + HPN++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
V + +Y+V+E+ +GG L D + ++ G+L EDE R Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 140 KPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
KPEN+LLDS G +K++DFGLS + + LL T GTP Y+APEVL KGY SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258
+WS GVIL+ L K LI+++L +P+ R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 259 MTISQMLED 267
+ ++LE
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 4e-72
Identities = 92/258 (35%), Positives = 145/258 (56%), Gaps = 9/258 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYE+ + +G+GSF KV + G +K +D + K E E+ +K + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYC 129
N+IK E K K+ IV+E+ DGG+L KI K + E++ +F QL A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
HSR + HRD+KP+N+ L S G++K+ DFG+S + + L T GTP Y++PE+ +
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQN 177
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIK 248
K Y+ SD+WS G +L+ L PF+ NL+ L KI + + PS +SS + L+
Sbjct: 178 KPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236
Query: 249 RILDPNPDTRMTISQMLE 266
+L +P+ R +I+Q+L+
Sbjct: 237 SLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-70
Identities = 85/263 (32%), Positives = 141/263 (53%), Gaps = 9/263 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ G LG GSF V A + +TG+ +A+K V+ + +E ++REI + ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59
Query: 74 NVIKII--EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
N+++ E K + I LE++ GG L + K G+L E R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+K N+L+DS GV+K++DFG + + + GTP ++APEV+ +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFSC---PSWFSSGAKKLI 247
Y GRA+D+WS G + + G P+ E N MA KI + P S AK +
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFL 237
Query: 248 KRILDPNPDTRMTISQMLEDEWF 270
++ L +P R T ++L+ +
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 8e-65
Identities = 94/272 (34%), Positives = 155/272 (56%), Gaps = 20/272 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHP 73
++ G+ +GEGSF+ V AK ET AIKI+D+ Q+++ K V+ +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+IK+ + +Y VLE+ GEL I K+G L E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAI------SQQVREDGLLH------------TA 175
+ HRDLKPEN+LLD +KI+DFG + + + + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC 235
GT YV+PE+LN+K G++SD+W+ G I++ ++ G PF SN ++KI + ++S
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
P F AK LI+++L +P R+ +++ ++
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 7e-64
Identities = 87/259 (33%), Positives = 141/259 (54%), Gaps = 12/259 (4%)
Query: 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83
G++ +V AK TGD AIK++ + ++R V+Q+ E + + P V+K+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143
K +Y+V+E++ GG+L + G L ED AR Y +++ A++Y HS G+ HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 144 LLLDSYGVLKISDFGLSAISQQVREDGLL------HTACGTPNYVAPEVLNDKGYDGRAS 197
+L+DS G LK++DFGLS + R+ L GTP+Y+APEV+ +G+ +
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF--SSGAKKLIKRILDPNP 255
D WS G IL+ + G PF +++ I P S A LI ++L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 256 DTRM---TISQMLEDEWFK 271
+ R+ +I ++ +FK
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 6e-63
Identities = 96/256 (37%), Positives = 157/256 (61%), Gaps = 6/256 (2%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K S ++ +E+G TLG GSF +V+ AK+ TG++ AIK + + ++L+ K V+ + +E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
S + + HP ++ ++ + ++Y +LEF+ GGELF + K GR D A+ Y +L+
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
A +Y HS+ + +RDLKPENLLLD+ G +K++DFG +++V + T CGTP Y+A
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF---AKKVPDR--TFTLCGTPEYLA 183
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 243
PEV+ KG+ G+A D W+ GV+L+ +AG+ PF + +Y KI P+WF A
Sbjct: 184 PEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242
Query: 244 KKLIKRILDPNPDTRM 259
+ L+K +L + R+
Sbjct: 243 RDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 3e-60
Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G F +V+ K A+K V + ++ E I E ++ HP ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
K IY+++E+ GGEL+ + G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200
PENLLLDS G +K+ DFG + + ++ T CGTP YVAPE++ +KGYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 201 SCGVILFVLMAGFLPFDESNL--MALYRKICRAD--FSCPSWFSSGAKKLIKRILDPNPD 256
S G++L+ L+ G PF E + M +Y I + + P++ AK LIK++L NP+
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 257 TRM-----TISQMLEDEWF 270
R+ I + + +WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 1e-55
Identities = 92/261 (35%), Positives = 142/261 (54%), Gaps = 13/261 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+ +G+G F +V A++ TG VAIK++ + K E+I EI +K KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKK--EKIINEIQILKKCKHP 57
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSR 132
N++K K +++IV+EF GG L D + + + L E + ++L+ ++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
G+ HRD+K N+LL S G +K+ DFGLSA Q+ + +T GTP ++APEV+N K Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 193 DGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIK 248
D +A D+WS G I + +A G P+ E M KI P +S K +K
Sbjct: 175 DYKA-DIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 249 RILDPNPDTRMTISQMLEDEW 269
+ L NP+ R T Q+L+ +
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 1e-55
Identities = 89/262 (33%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ----IKREISTMKL 69
Y+LG +G G+F V N+ETGDFVAIK Q+ K+ E+ I +EI +K
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIK-----QISLEKIKEEALKSIMQEIDLLKN 55
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+KHPN++K I + + +YI+LE+ + G L I K G E Y Q++ + Y
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
H +GV HRD+K N+L GV+K++DFG++ + GTP ++APEV+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEM 173
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIK 248
G ASD+WS G + L+ G P+ + N MA +I + D P S K +
Sbjct: 174 SGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232
Query: 249 RILDPNPDTRMTISQMLEDEWF 270
+ +P+ R T Q+L+ W
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-55
Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 15/267 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+++ G +G G+F KV A N++TG+ +A+K + R Q K +++I E+ ++L+KHP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA--RRYFQQLINAVDYCHS 131
N++K V + K+YI +E+ GG L + + +HGR+ DE R Y QL+ + Y HS
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHS 117
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVL-- 187
G+ HRD+KP N+ LD GV+K+ DFG + + + + GTP Y+APEV+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 188 -NDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKIC---RADFSCPSWFSSG 242
KG+ GRA+D+WS G ++ + G P+ E N + + + S
Sbjct: 178 GKGKGH-GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEW 269
K + R L+ +P R T S++L+ +
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 6e-55
Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 16/266 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
YE+ T+G+GSF V+ + G + K +D + + +Q+ E++ ++ +KHP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59
Query: 74 NVIKII--EVMASKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVD 127
N+++ + S +YIV+E+ +GG+L I K ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 128 YCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
CH+R V HRDLKP N+ LD+ +K+ DFGL+ I + T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSS 241
+PE LN YD SD+WS G +++ L A PF N + L KI F P +SS
Sbjct: 178 SPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 242 GAKKLIKRILDPNPDTRMTISQMLED 267
++IK +L+ +PD R + ++L+
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 181 bits (458), Expect = 1e-52
Identities = 104/370 (28%), Positives = 168/370 (45%), Gaps = 28/370 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + R LGEGSF +V A++ + VA+K++ + + K VE+ REI + + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 74 -NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYC 129
N++K+ + + +Y+V+E++DGG L D + K GR L E EA Q+++A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 130 HSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAI----SQQVREDGLLHTACGTPNYVAP 184
HS+G+ HRD+KPEN+LLD G V+K+ DFGL+ + L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 185 EVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFD----ESNLMALYRKICRADF----- 233
EVL Y +SD+WS G+ L+ L+ G PF+ S + I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 ----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDD 289
S P S A L+K++L +P R++ S L + K D + + DD
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH-LKLKESDLSDLLKPDD 296
Query: 290 VDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPP 349
+ +L + + S + L +
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTA 356
Query: 350 NEIMSKIEEA 359
+ S + +
Sbjct: 357 SSKRSSLPKI 366
|
Length = 384 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-52
Identities = 76/237 (32%), Positives = 137/237 (57%), Gaps = 6/237 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
E +T+G G+F +V ++ + + A+K++ +V+R K + + E +K + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I++ + +Y+++E++ GGELF + GR Y +++ A++Y HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD G +K++DFG ++++R+ T CGTP Y+APEV+ KG+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGF---AKKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251
+A D W+ G++++ ++ G+ PF + N +Y KI P AK LIK++L
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-49
Identities = 85/267 (31%), Positives = 137/267 (51%), Gaps = 19/267 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKI--VDRDQVLRHKMVEQIKREISTMKLIKHP 73
E + LG+GS V ++ TG A+K VD D+ R Q+ RE+ T++ + P
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSCESP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-R 132
V+K + +I IVLE++DGG L D + K G++ E +Q++ +DY H+ R
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRD+KP NLL++S G +KI+DFG+S + + +T GT Y++PE + +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGE-S 176
Query: 193 DGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRADFSCPSW----FSSGAKK 245
A+D+WS G+ L G PF + + L + IC D PS FS +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAEEFSPEFRD 234
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKK 272
I L +P R + +++L+ + KK
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 85/242 (35%), Positives = 131/242 (54%), Gaps = 14/242 (5%)
Query: 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVM 82
G+F V AK TGD+ AIK++ + ++ V +K E + M + P V K+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 83 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 142
SK +Y+V+E+++GG+ I G L ED A++Y +++ V+ H RG+ HRD+KPE
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWS 201
NLL+D G LK++DFGLS +GL + GTP+Y+APE + G D + SD WS
Sbjct: 127 NLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWWS 178
Query: 202 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPDT 257
G ++F + G+ PF A++ I + P + S A LI R+L +P
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238
Query: 258 RM 259
R+
Sbjct: 239 RL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 84/302 (27%), Positives = 143/302 (47%), Gaps = 66/302 (21%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-------REISTM 67
YE LGEG++ V A++ +TG+ VA+K + ++ + + REIS +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--------RLDNEEEGIPSTALREISLL 52
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAV 126
K +KHPN++K+++V+ ++ K+Y+V E+ D +L + K L + + QL+ +
Sbjct: 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN----- 180
YCHS + HRDLKP+N+L++ GVLK++DFGL+ A +R T
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--------THEVVTLW 163
Query: 181 YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYR--KIC------- 229
Y APE+L K Y A D+WS G I ++ G F +S + L++ +I
Sbjct: 164 YRAPEILLGSKHYST-AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 230 ----------RADFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDE 268
+ F P + L+ ++L NP R++ + L+
Sbjct: 223 WPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280
Query: 269 WF 270
+F
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-48
Identities = 85/242 (35%), Positives = 142/242 (58%), Gaps = 4/242 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T + A+K++ +D +L+ VE E + L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K +++ V+E+++GG+L I + GR E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLDS G +KI+DFG+ + + T CGTP+Y+APE+L+ + Y G A
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W+ GV+L+ ++AG PF+ + L++ I + P W S AK ++K L NP+
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 258 RM 259
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 83/245 (33%), Positives = 145/245 (59%), Gaps = 7/245 (2%)
Query: 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRH-KMVEQIKREISTMKLIKHPN 74
+ LG+G + KV + V +TG A+K++ + ++R+ K K E + ++ +KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ +I + K+Y++LE++ GGELF + + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD+ G +K++DFGL + + E + HT CGT Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
+A D WS G +++ ++ G PF N KI + + P + + A+ L+K++L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 255 PDTRM 259
P +R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-46
Identities = 83/241 (34%), Positives = 133/241 (55%), Gaps = 3/241 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV + TG + A+KI+ ++ ++ V E ++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+ ++ V+E+ +GGELF +++ ED AR Y ++++A+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
LK ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258
W GV+++ +M G LPF + L+ I + P S AK L+ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 259 M 259
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 81/242 (33%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIK 77
R LG+GSF KV A+ E+G A+K++ +D +L+ VE E + L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + +++ V+EF++GG+L I K R E AR Y ++ +A+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD G K++DFG+ + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W+ GV+L+ ++ G PF+ N L+ I + P+W S A ++K + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 258 RM 259
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-46
Identities = 65/117 (55%), Positives = 84/117 (71%), Gaps = 2/117 (1%)
Query: 313 NAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN- 371
NAF+LIS + L LFE++ VKRETRFTS++P EI+ K+EEAAK LGF VRK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEE-DEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
Query: 372 YKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKD 428
+KL+G K GRKG+L+V+ EVFEV P+L +VEV+K+ GDTLE+HKF+K L
Sbjct: 60 GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 84/257 (32%), Positives = 141/257 (54%), Gaps = 7/257 (2%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIK 71
++ G LG GSF V N++ GDF A+K V D + V+Q+++EI+ + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HPN+++ + + +YI LE + GG L + K+G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R HRD+K N+L+D+ GV+K++DFG+ ++QV E + G+P ++APEV+ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIKR 249
G A+D+WS G + + G P+ + +A KI R+ P S AK I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 250 ILDPNPDTRMTISQMLE 266
L +P R T +++LE
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 76/256 (29%), Positives = 126/256 (49%), Gaps = 11/256 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ + LG+GS+ V K + F A+K VD + K E EI + + HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDL-GSMSQKEREDAVNEIRILASVNHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLK----EDEARRYFQQLINAVDYCH 130
+I E K+ IV+E+ G+L I+K + + E E R F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ + HRDLK N+LL + ++KI D G+S + ++ + T GTP+Y+APEV +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKR 249
Y SD+WS G +L+ + PF+ ++ L K+ R + P +S + I+
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 250 ILDPNPDTRMTISQML 265
+L P R ++L
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 83/296 (28%), Positives = 135/296 (45%), Gaps = 49/296 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YE +GEG++ +V A+N +TG+ VA+K + + + REI ++ ++HPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPN 59
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFD--KIAKHGRLK--EDEARRYFQQLINAVDY 128
++++ E++ SK K IY+V E++D D + +K E + + Y +QL+ + Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL- 187
HS G+ HRD+K N+L+++ GVLK++DFGL A R T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKIC--------------- 229
Y G D+WS G IL L G F E + ++C
Sbjct: 175 GATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233
Query: 230 ---------------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
R F A L+ ++L +P R++ Q L+ E+F
Sbjct: 234 WFENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 89/337 (26%), Positives = 153/337 (45%), Gaps = 53/337 (15%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V ++ +TG A+K++ + +++ + ++ E + P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++K+ + +Y+V+E++ GG+L + + + E+ AR Y +L+ A+D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSA---------------ISQQVREDGLLH------ 173
HRD+KP+N+L+D+ G +K++DFGL + R++ L+
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 174 ------TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227
+ GTP+Y+APEVL Y G D WS GVIL+ ++ GF PF L Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 228 IC--RADFSCPS--WFSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK-------GYK 275
I + P S A LI R+L P+ R+ ++ +FK K
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKGIDWENLRETK 300
Query: 276 PP------------HFDKEEEVNLDDVDAIFNDSKEN 300
PP +FD E+ N K N
Sbjct: 301 PPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLN 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 79/256 (30%), Positives = 136/256 (53%), Gaps = 6/256 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIKH 72
+ G+ LG+G+F +V +V+TG +A+K V D K V ++ EI +K ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
+++ + + I +E++ GG + D++ +G L E R+Y +Q++ V+Y HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-LLHTACGTPNYVAPEVLNDKG 191
+ HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++ +G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLIKR 249
Y GR +DVWS G + ++ P+ E MA KI + PS S A+ ++R
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 250 ILDPNPDTRMTISQML 265
N R + ++L
Sbjct: 243 TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 84/241 (34%), Positives = 137/241 (56%), Gaps = 3/241 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV + +G + A+KI+ ++ ++ V E +K +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+K ++ V+E+++GGELF +++ ED R Y ++++A+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
LK ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258
W GV+++ +M G LPF + L+ I D P S+ AK L+ +L +P+ R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 259 M 259
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 9e-45
Identities = 81/263 (30%), Positives = 139/263 (52%), Gaps = 11/263 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y+ +GEG+ +V A + TG VAIK + LR + E I EI MK KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
N++ + ++++V+E++DGG L D I ++ R+ E + ++++ ++Y HS+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
V HRD+K +N+LL G +K++DFG +A Q +E ++ GTP ++APEV+ K Y
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAA--QLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 193 DGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKR 249
+ D+WS G++ + G P E L AL+ + P +S K + +
Sbjct: 194 GPKV-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252
Query: 250 ILDPNPDTRMTISQMLEDEWFKK 272
L +P+ R + ++L+ + KK
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 81/242 (33%), Positives = 132/242 (54%), Gaps = 4/242 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV AK+ G F A+K++ + +L+ K + I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL++++GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + + T CGTP Y+APEVL + YD R
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W G +L+ ++ G PF + +Y I S A+ L++ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 258 RM 259
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 82/241 (34%), Positives = 135/241 (56%), Gaps = 3/241 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV + TG + A+KI+ ++ ++ V E ++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+ ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
+K ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258
W GV+++ +M G LPF + L+ I + P S AK L+ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 259 M 259
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 4e-44
Identities = 96/296 (32%), Positives = 151/296 (51%), Gaps = 29/296 (9%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF KV + +T A+K + + ++ V E + + + P ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
S K+Y+VL FI+GGELF + + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200
PEN+LLD G + + DFGL ++ +++D +T CGTP Y+APE+L GY +A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 201 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 260
+ GV+L+ ++ G PF + N+ +YRKI + P F AK L+ +L +P R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 261 ISQMLE---------DEWFK---KGYKPP------------HFDKE--EEVNLDDV 290
+ E W K KG +PP +FD+E E +D V
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSV 293
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 91/261 (34%), Positives = 141/261 (54%), Gaps = 19/261 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG+G+F KV A++ ETG F A KI+ ++ L MVE I + KHPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-----IDILSECKHPNIVGL 67
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
E + K++I++EF DGG L + + R L E + R +Q++ A+++ HS V HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGY 192
DLK N+LL G +K++DFG+SA ++ T GTP ++APEV+ D Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKR 249
D +A D+WS G+ L L P E N M + KI +++ PS +SS +K
Sbjct: 186 DYKA-DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244
Query: 250 ILDPNPDTRMTISQMLEDEWF 270
L +PD R T +++L+ +
Sbjct: 245 CLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 87/307 (28%), Positives = 145/307 (47%), Gaps = 29/307 (9%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+G + +V AK +TG+ VA+K + + + + V + E + K ++K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
+Y+ +E++ GG+ + G L ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
PEN L+D+ G +K++DFGLS ++ ++ G+P+Y+APEVL KGYD D
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYD-FTVD 180
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW------FSSGAKKLIKRI 250
WS G +L+ + GF PF S + + + P + S A LI ++
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240
Query: 251 LDPNPDTRMTISQMLEDEWFKK-------GYKPPHFDKEEEVNLDDVDAIFNDSKENLVT 303
++ ++ + +FK+ KPP + E ++D + D EN
Sbjct: 241 INDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELE----SEIDTGYFDDFENEDD 296
Query: 304 EKKEKPV 310
K K V
Sbjct: 297 MAKYKDV 303
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 96/318 (30%), Positives = 146/318 (45%), Gaps = 70/318 (22%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
+YE G+ LGEG++A V A++ ETG VAIK + + R + + I REI ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQE 58
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVD 127
+KHPN+I +++V K+ I +V EF++ +K+ K L + + Y + ++
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN------- 180
Y HS + HRDLKP NLL+ S GVLK++DFGL+ + G+PN
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163
Query: 181 ----YVAPEVLNDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRADFS 234
Y APE+L + G D+WS G I L+ FLP +S++ L KI A
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEA-LG 220
Query: 235 CPS---W-----------FSSGAKK---------------LIKRILDPNPDTRMTISQML 265
P+ W F L++R+L NP+ R+T Q L
Sbjct: 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280
Query: 266 EDEWFKKGYKPPHFDKEE 283
E +F P +
Sbjct: 281 EHPYFSN--DPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 86/253 (33%), Positives = 147/253 (58%), Gaps = 25/253 (9%)
Query: 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVD------RDQVLRHKMVEQIKREISTMKL 69
+ LG+GSF KV + + + G A+K++ RD+V R KM I E++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVN---- 56
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
HP ++K+ ++ K+Y++L+F+ GG+LF +++K E++ + Y +L A+D+
Sbjct: 57 --HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
HS G+ +RDLKPEN+LLD G +K++DFGLS + + + ++ CGT Y+APEV+N
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGAKKL 246
+G+ +++D WS GV++F ++ G LPF D M + I +A P + S A+ L
Sbjct: 173 RGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSL 228
Query: 247 IKRILDPNPDTRM 259
++ + NP R+
Sbjct: 229 LRALFKRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 92/290 (31%), Positives = 144/290 (49%), Gaps = 29/290 (10%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV AK G F A+K++ + +L+ K I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL++++GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + V + T CGTP Y+APEVL + YD R
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W G +L+ ++ G PF ++ +Y I P + A L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 258 RM-TISQMLE------------DEWFKKGYKPP------------HFDKE 282
R+ + LE D+ + K PP HFD E
Sbjct: 238 RLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPE 287
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 87/264 (32%), Positives = 149/264 (56%), Gaps = 13/264 (4%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+G +++ + +G+G F+ V A + G VA+K V +++ K + +EI +K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGEL---FDKIAKHGRL-KEDEARRYFQQLINAVD 127
HPNVIK + ++ IVLE D G+L K RL E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEV 186
+ HS+ + HRD+KP N+ + + GV+K+ D GL S + H+ GTP Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPER 177
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRADFS-CPS-WFSSG 242
+++ GY+ + SD+WS G +L+ + A PF D+ NL +L +KI + D+ P+ +S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 243 AKKLIKRILDPNPDTRMTISQMLE 266
+ L+ R ++P+P+ R IS +L+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 71/248 (28%), Positives = 135/248 (54%), Gaps = 7/248 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+EL R +G+G+F KV + +T A+K +++ + + V + E ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + + +Y+V++ + GG+L +++ + E++ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRD+KP+N+LLD G + I+DF ++ V D L + GTP Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMA---LYRKICRADFSCPSWFSSGAKKLIKRIL 251
A D WS GV + + G P+ + + K AD P+ +S+ A I ++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 252 DPNPDTRM 259
+ +P R+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 84/258 (32%), Positives = 137/258 (53%), Gaps = 9/258 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYE R +G G+F V + V IK + +Q+ + + E +KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHS 131
N+I+ E + IV+E+ GG L + I K L ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 132 RGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ + HRDLK +N+LLD + V+KI DFG IS+ + +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFG---ISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-WFSSGAKKLIKR 249
Y+ + SD+W+ G +L+ L + F+ +NL AL KI F+ S +S ++LI
Sbjct: 177 PYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 250 ILDPNPDTRMTISQMLED 267
+L+ +P R +SQ++
Sbjct: 236 MLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 84/253 (33%), Positives = 140/253 (55%), Gaps = 6/253 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T + AIK++ +D +L+ V+ E + L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K +++ V+E+++GG+L +I + + E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G K++DFG+ + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W+ GV+++ +MAG PF+ N L+ I D P W S A ++K + NP+
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 258 RM--TISQMLEDE 268
R+ SQ ED
Sbjct: 238 RLGCVASQGGEDA 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-42
Identities = 85/242 (35%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV K TG + A+KI+ ++ ++ V E ++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHR 137
+ ++ V+E+ +GGELF +++ ED AR Y ++++A+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK ENL+LD G +KI+DFGL + +++ + T CGTP Y+APEVL D Y GRA
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W GV+++ +M G LPF + L+ I + P S AK L+ +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 258 RM 259
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 92/294 (31%), Positives = 136/294 (46%), Gaps = 49/294 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKH 72
Y+ +GEG++ V A++ TG+ VAIK + REI +K + H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNH 57
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
PN+IK+++V K +Y+V EF+D +L + L E + Y QL+ + +CH
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCH 115
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVL-N 188
S G+ HRDLKPENLL+++ GVLK++DFGL ++ +T T Y APE+L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGL---ARSFGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 189 DKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA--------------- 231
DKGY D+WS G I L++ P S + L+ KI R
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRRPLFPGK-SEIDQLF-KIFRTLGTPDPEVWPKFTSL 229
Query: 232 ----DFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
FS P S A L+ ++L +P R+T Q L +F
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 1e-41
Identities = 86/255 (33%), Positives = 142/255 (55%), Gaps = 13/255 (5%)
Query: 2 SVKVPASRTRVGKYE---LGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKM 56
S K P + ++ KYE RTLG GSF +V A + DF VAIK ++ ++++ K
Sbjct: 17 STKEPKRKNKM-KYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQ 74
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR 116
V+ + E + I HP + + ++ +Y+VLEF+ GGE F + ++ R D
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176
Y Q++ +Y S + +RDLKPENLLLD G +K++DFG + + D +T C
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLC 189
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 236
GTP Y+APE+L + G+ G+A+D W+ G+ ++ ++ G PF + + +Y+KI P
Sbjct: 190 GTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP 248
Query: 237 SWFSSGAKKLIKRIL 251
+ + K L+K++L
Sbjct: 249 KFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-41
Identities = 78/267 (29%), Positives = 142/267 (53%), Gaps = 16/267 (5%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIK-------IVDRDQVLRHKMVEQIKREISTMKLI 70
G +G+G++ +V A NV TG+ +A+K I R + MV+ ++ EI T+K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
H N+++ + ++ + I LE++ GG + + +GR +E R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND- 189
S+G+ HRDLK +NLL+D+ G+ KISDFG+S S + ++ + G+ ++APEV++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 190 -KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP------SWFSSG 242
+GY + D+WS G ++ + AG P+ + +A K+ + P S
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEW 269
A + NPD R T ++L+ +
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 3e-41
Identities = 81/242 (33%), Positives = 135/242 (55%), Gaps = 4/242 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV A++ F A+K++ + +L+ K + I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL++I+GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + + +G T CGTP Y+APEVL+ + YD R
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W G +L+ ++ G PF N +Y I ++ A+ L++ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 258 RM 259
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 95/307 (30%), Positives = 155/307 (50%), Gaps = 15/307 (4%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T +F AIK + +D VL VE E + L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K ++ V+E+++GG+L I GR E AR Y ++I + + H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD G +KI+DFG+ + + +G T CGTP+Y+APE+L + Y+ +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D WS GV+L+ ++ G PF + L+ I P W S AK + ++ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 258 RMTISQMLEDEWFKKGYK---------PPHFDKEEEVNLD--DVDAIFNDSKENLVTEKK 306
R+ + + F +G PP F + + D + D F + K L K
Sbjct: 238 RLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDK 297
Query: 307 EKPVSMN 313
+ SM+
Sbjct: 298 KLLASMD 304
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 6e-41
Identities = 80/256 (31%), Positives = 145/256 (56%), Gaps = 13/256 (5%)
Query: 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI 70
+EL R LG G++ KV + V + G A+K++ + ++ + K E + E ++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 71 KH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ P ++ + + TK++++L++++GGELF + + E E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN- 188
H G+ +RD+K EN+LLDS G + ++DFGLS E+ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 189 -DKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMA-LYRKICRADFSCPSWFSSGA 243
G+D +A D WS GV+ F L+ G PF E N + + R+I ++ P S+ A
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 244 KKLIKRILDPNPDTRM 259
+ I+++L+ +P R+
Sbjct: 240 RDFIQKLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 71/205 (34%), Positives = 111/205 (54%), Gaps = 12/205 (5%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIK---IVDRDQVLRHKMVEQIKREISTMKL 69
KYE+ +GEG++ V +N TG+ VAIK + D+ ++ + RE+ ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
++H N++ + E K ++Y+V E+++ L A G L D R Y QL+ A+ YC
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL- 187
HS + HRD+KPEN+L+ GVLK+ DFG + A+ + L T Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELLV 174
Query: 188 NDKGYDGRASDVWSCGVILFVLMAG 212
D Y G+ DVW+ G I+ L+ G
Sbjct: 175 GDTNY-GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 88/293 (30%), Positives = 150/293 (51%), Gaps = 18/293 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV AK G A+K++ + VL K + I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL+F++GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + + + T CGTP Y+APEV+ + YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D W G +L+ ++ G PF ++ +Y I S A +++ +L+ +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 258 RM----TISQMLEDEWFK--------KGYKPPHFDK--EEEVNLDDVDAIFND 296
R+ ++ E +F+ + PP F+ E ++ + DA+F +
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 8e-40
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 12/204 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
+Y++ +GEG+ V AK+ ETG+ VA+K +V ++ I REI ++
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK-----KVALRRLEGGIPNQALREIKALQA 55
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDY 128
+HP V+K+++V + +V+E++ +L + + R L E + + Y + L+ V Y
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
H+ G+ HRDLKP NLL+ + GVLKI+DFGL+ + E L T Y APE+L
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 189 DKGYDGRASDVWSCGVILFVLMAG 212
D+W+ G I L+ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-40
Identities = 81/269 (30%), Positives = 135/269 (50%), Gaps = 17/269 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL +G G+ A V A + + VAIK +D ++ V+++++E+ M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--CQTSVDELRKEVQAMSQCNHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCH 130
V+K ++++V+ ++ GG L D I K G L E ++++ ++Y H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQV-REDGLLHTACGTPNYVAPEVLN 188
S G HRD+K N+LL G +KI+DFG+SA ++ R + T GTP ++APEV+
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 189 -DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC------PSWFSS 241
GYD +A D+WS G+ L G P+ + M + + D +S
Sbjct: 180 QVHGYDFKA-DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWF 270
+K+I L +P R T ++L+ ++F
Sbjct: 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 78/244 (31%), Positives = 137/244 (56%), Gaps = 8/244 (3%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI--KREISTMKLIKH-PNVIK 77
+G+G+F +V + +T A+K++ + +++ K V +R I L+ P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + + +Y+V +++ GGELF + K GR ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRA 196
DLKPEN+LLD+ G + + DFGLS + ++ +T CGT Y+APEV L++KGY +
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-SWFSSGAKKLIKRILDPNP 255
D WS GV++F + G+ PF + +YR I P + S ++ +K +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 256 DTRM 259
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-39
Identities = 83/257 (32%), Positives = 142/257 (55%), Gaps = 8/257 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+YE+ + +GEGSF K+ AK + IK +D + + K E K+E+ + +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRL-KEDEARRYFQQLINAVDYCHS 131
N++ +++IV+E+ DGG+L +I + G L ED+ +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 132 RGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
R + HRD+K +N+ L G V K+ DFG++ E L +T GTP Y++PE+ ++
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR 177
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-WFSSGAKKLIKR 249
Y+ + +D+WS G +L+ L PF+ +NL L KIC+ F+ S FS + LI +
Sbjct: 178 PYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236
Query: 250 ILDPNPDTRMTISQMLE 266
+ +P R +I+ +L+
Sbjct: 237 LFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 79/256 (30%), Positives = 142/256 (55%), Gaps = 7/256 (2%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + +GEGSF K K+ E G IK ++ + + K E+ ++E++ + +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRL-KEDEARRYFQQLINAVDYCHS 131
N+++ E +YIV+++ +GG+L+ KI A+ G L ED+ +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R + HRD+K +N+ L G +K+ DFG++ + E L T GTP Y++PE+ ++
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRI 250
Y+ + SD+W+ G +L+ + F+ N+ L KI R + S +S + L+ ++
Sbjct: 178 YNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 251 LDPNPDTRMTISQMLE 266
NP R +++ +LE
Sbjct: 237 FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 81/265 (30%), Positives = 140/265 (52%), Gaps = 12/265 (4%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLIKHPN 74
G+ LG G+F+ A++V+TG +A+K V + + ++VE +++EI M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I+++ + + +E++ GG + ++K+G KE Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 135 FHRDLKPENLLLDSYG-VLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
HRD+K NLL+DS G L+I+DFG +A ++ GT ++APEVL +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADF--SCPSWFSSGAKKL 246
Y GR+ DVWS G ++ + P++ SN +AL KI A S P S G + +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 247 IKRILDPNPDTRMTISQMLEDEWFK 271
R L+ P+ R ++L+ F+
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-38
Identities = 81/254 (31%), Positives = 146/254 (57%), Gaps = 10/254 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQ-VLRHKMVEQIKREISTMKLI 70
+EL + LG G++ KV + V +TG A+K++ + V + K VE + E + ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 71 KH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ P ++ + ++ K++++L+++ GGE+F + + EDE R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
H G+ +RD+K EN+LLDS G + ++DFGLS E ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFD---ESNLMA-LYRKICRADFSCPSWFSSGAKK 245
KG G+A D WS G+++F L+ G PF E N + + R+I + D PS+ A+
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240
Query: 246 LIKRILDPNPDTRM 259
L+ ++L +P R+
Sbjct: 241 LLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 7/255 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
Y R LG+G+F + + E V K V+ + L K EI + L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSR 132
+I + I +E+ +GG L+DKI K +E+ Y Q+++AV Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
G+ HRD+K N+ L G++K+ DFG+S I E + T GTP Y++PE+ Y
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPELCQGVKY 178
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRIL 251
+ + SD+W+ G +L+ L+ FD +N + L KI + +++ S +SS L+ +L
Sbjct: 179 NFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
Query: 252 DPNPDTRMTISQMLE 266
+P+ R T ++L+
Sbjct: 238 QQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 91/298 (30%), Positives = 134/298 (44%), Gaps = 57/298 (19%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------REI-S 65
Y++ + LG+G+F V A+N ETG+ VAIK KM ++ RE+ S
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK----------KMKKKFYSWEECMNLREVKS 50
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLI 123
KL +HPN++K+ EV ++Y V E+++G L+ K K E R Q++
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+ + H G FHRDLKPENLL+ V+KI+DFGL ++++R T Y A
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRA 166
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKIC------------- 229
PE+L D+W+ G I+ L P F S+ + KIC
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 230 ------RADFSCPSWF-----------SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
+ F P + S A LIK +L +P R T SQ L+ +F
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 78/240 (32%), Positives = 136/240 (56%), Gaps = 4/240 (1%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKII 79
LG+GSF KV A+ T + AIKI+ +D +++ VE E + L P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++Y V+E+++GG+L I + G+ KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
K +N++LD+ G +KI+DFG+ + + T CGTP+Y+APE++ + Y G++ D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 259
W+ GV+L+ ++AG PFD + L++ I + S P S A + K +L +P R+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 42/285 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + +G G+F +V+ + +TG A+K + + ++L + V ++ E + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+K+ + +Y+++E++ GG++ + K E+E R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGL-------------------------SAISQQVRED 169
HRD+KP+NLLLD+ G +K+SDFGL IS+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 170 GLLHT-----------ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE 218
T GTP+Y+APEV GY + D WS GVI++ ++ G+ PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 219 SNLMALYRKI--CRADFSCPS--WFSSGAKKLIKRILDPNPDTRM 259
N YRKI + P S AK LIKR+ + R+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 7/254 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ +G+GSF V A+K +D ++ R + E+ E + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSY 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSR 132
+I+ E K K+ IV+E+ + G+L + L ED+ R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRD+K NL LD+Y +KI D G++ + +T GTP Y++PE+ DK Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRIL 251
+ + SDVW+ GV+L+ G PFD +N AL KI R F +S +LI + L
Sbjct: 179 NEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 252 DPNPDTRMTISQML 265
+ R Q+L
Sbjct: 238 TKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 78/260 (30%), Positives = 131/260 (50%), Gaps = 12/260 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ LGEGS+ V A + ETG VAIK+V ++ L ++I +EIS +K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPY 59
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRG 133
++K T ++IV+E+ G + D + + L E+E Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
HRD+K N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---ADFSCPSWFSSGAKKLIKRI 250
+A D+WS G+ + G P+ + + M I S P +S +K+
Sbjct: 178 NKA-DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 251 LDPNPDTRMTISQMLEDEWF 270
L +P+ R + Q+L+ +
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 23/271 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIKH 72
+E+ LG+G+F KV AKN ETG A K+++ ++ L MVE I + H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-----IEILATCNH 68
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHS 131
P ++K++ K++I++EF GG + + + R L E + + +Q++ A+ Y HS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV--REDGLLHTACGTPNYVAPEV--- 186
+ HRDLK N+LL G +K++DFG+SA + + R D + GTP ++APEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMC 184
Query: 187 --LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSS 241
+ D YD +A D+WS G+ L + P E N M + KI +++ S PS +S
Sbjct: 185 ETMKDTPYDYKA-DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
+ +K LD +P+TR + +Q+LE +
Sbjct: 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 80/240 (33%), Positives = 138/240 (57%), Gaps = 4/240 (1%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKII 79
LG+GSF KV A+ T + AIKI+ +D V++ VE E + L K P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++Y V+E+++GG+L I + G+ KE +A Y ++ + + H RG+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
K +N++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 259
W+ GV+L+ ++AG PFD + L++ I + S P S A + K ++ +P R+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 86/309 (27%), Positives = 158/309 (51%), Gaps = 29/309 (9%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
R +G GS+AKV + +T A+K++ ++ V + ++ ++ E + HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++++++ V+EF+ GG+L + + +L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G +K++D+G+ + +R T CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 198 DVWSCGVILFVLMAGFLPFD---------ESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D W+ GV++F +MAG PFD ++ L++ I P S A ++K
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 249 RILDPNPDTRM------TISQMLEDEWFK---------KGYKPP-HFDKEEEVNLDDVDA 292
L+ +P R+ + +F+ K PP + E + +LD+ D
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
Query: 293 IFNDSKENL 301
F D L
Sbjct: 298 QFTDEPVQL 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-37
Identities = 78/263 (29%), Positives = 142/263 (53%), Gaps = 20/263 (7%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHK-MVEQIKREISTMKLIK 71
G +G GSF V N +G+ +A+K V+ V R + M++ + REI+ +K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H N+++ + + I LE++ GG + + +G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--PN------YVA 183
RG+ HRD+K N+L+D+ G +KISDFG IS+++ E L T P+ ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFG---ISKKL-EANSLSTKTNGARPSLQGSVFWMA 180
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFSCPSWFSSG 242
PEV+ Y R +D+WS G ++ ++ G PF D + L A+++ A PS SS
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239
Query: 243 AKKLIKRILDPNPDTRMTISQML 265
A +++ + + + R T +++L
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 9e-37
Identities = 79/240 (32%), Positives = 139/240 (57%), Gaps = 4/240 (1%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKII 79
LG+GSF KV A+ T + AIKI+ +D V++ VE E + L K P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++Y V+E+++GG+L +I + GR KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
K +N++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 259
W+ GV+L+ ++AG PF+ + L++ I + + P S A + K ++ +P R+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 9e-37
Identities = 97/296 (32%), Positives = 145/296 (48%), Gaps = 50/296 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKI-VDRDQVLRHKMVEQIK-REISTMKLIK 71
KYE +GEGS+ V K+ ETG VAIK ++ + KMV++I REI +K ++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H N++ +IEV K ++Y+V EF+D L D L E R+Y Q++ +++CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVL- 187
+ HRD+KPEN+L+ GV+K+ DFG + A +V D + T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173
Query: 188 NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKI-CRADFS---------- 234
D Y GRA D+W+ G ++ ++ G P D S++ LY I C +
Sbjct: 174 GDTKY-GRAVDIWAVGCLVTEMLTGEPLFPGD-SDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 235 --------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
P S L K+ L +PD R + SQ+L E+F
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 90/291 (30%), Positives = 168/291 (57%), Gaps = 24/291 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI 70
+EL + LG G++ KV + V ++G A+K++ + ++ + K E + E ++ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 71 KH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ P ++ + + TK++++L++I+GGELF +++ R KE E + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL--LHTACGTPNYVAPEVL 187
H G+ +RD+K EN+LLDS G + ++DFGL S++ ED + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 188 --NDKGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSS 241
D G+D +A D WS GV+++ L+ G PF ++++ + R+I +++ P S+
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDA 292
AK +I+R+L +P R+ DE K P F K +N DD+ A
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH----PFFQK---INWDDLAA 281
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 86/259 (33%), Positives = 141/259 (54%), Gaps = 11/259 (4%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ + + + +G G F++V A + G VA+K V ++ K +EI +K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI---AKHGRL-KEDEARRYFQQLINAVD 127
HPNVIK ++ IVLE D G+L I K RL E +YF QL +A++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
+ HSR V HRD+KP N+ + + GV+K+ D GL + H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRADF-SCPS-WFSSGA 243
++ GY+ + SD+WS G +L+ + A PF D+ NL +L +KI + D+ PS +S
Sbjct: 179 HENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 244 KKLIKRILDPNPDTRMTIS 262
++L+ ++P+P+ R I+
Sbjct: 238 RQLVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 86/263 (32%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ +++ + +G G F++V A + VA+K V +++ K + +EI +K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI---AKHGRL-KEDEARRYFQQLINAVD 127
HPNVIK ++ ++ IVLE D G+L I K RL E +YF QL +AV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
+ HSR V HRD+KP N+ + + GV+K+ D GL + H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRADF-SCPS-WFSSGA 243
++ GY+ + SD+WS G +L+ + A PF D+ NL +L +KI + D+ P+ +S
Sbjct: 179 HENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 244 KKLIKRILDPNPDTRMTISQMLE 266
++L+ + P+PD R I + +
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-36
Identities = 77/251 (30%), Positives = 141/251 (56%), Gaps = 13/251 (5%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
R +G GS+AKV + +T A+K+V ++ V + ++ ++ E + HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 198 DVWSCGVILFVLMAGFLPF---------DESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D W+ GV++F +MAG PF D++ L++ I P S A ++K
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 249 RILDPNPDTRM 259
L+ +P R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 81/245 (33%), Positives = 134/245 (54%), Gaps = 6/245 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T F AIK + +D VL VE E + L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K ++ V+E+++GG+L I + A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G +KI+DFG+ + + D T CGTP+Y+APE+L + Y +
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRILDPNPD 256
D WS GV+L+ ++ G PF + L++ I R D C P W + AK ++ ++ P+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-RMDNPCYPRWLTREAKDILVKLFVREPE 236
Query: 257 TRMTI 261
R+ +
Sbjct: 237 RRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 87/279 (31%), Positives = 135/279 (48%), Gaps = 28/279 (10%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---DRDQVLRHKMVE 58
S P++ + + E +G G+ V + TG A+K++ D V R
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----- 117
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
QI REI ++ + HPNV+K ++ +I ++LEF+DGG L + D AR
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-- 175
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
Q+++ + Y H R + HRD+KP NLL++S +KI+DFG+S I Q + +++ GT
Sbjct: 176 --QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGT 231
Query: 179 PNYVAPEV----LNDKGYDGRASDVWSCGVILFVLMAGFLPF------DESNLMALYRKI 228
Y++PE LN YDG A D+WS GV + G PF D ++LM I
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AI 288
Query: 229 CRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
C + P+ S + I L P R + Q+L+
Sbjct: 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 78/264 (29%), Positives = 135/264 (51%), Gaps = 14/264 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ L +G+GSF +V A + T VAIK++D ++ +E I++EI + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ K +K++I++E+ GG D + K G+L E ++++ ++Y H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGY 192
HRD+K N+LL G +K++DFG+S Q+ +T GTP ++APEV+ GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKLIK 248
D +A D+WS G+ L G P + + M + I + + PS FS K +
Sbjct: 176 DEKA-DIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPSLEGNKFSKPFKDFVS 232
Query: 249 RILDPNPDTRMTISQMLEDEWFKK 272
L+ +P R + ++L+ ++ KK
Sbjct: 233 LCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 5e-35
Identities = 81/255 (31%), Positives = 134/255 (52%), Gaps = 8/255 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + R +GEGSF + ++V + A+K + R VE ++E + +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSA-VEDSRKEAVLLAKMKHP 58
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIA-KHGRL-KEDEARRYFQQLINAVDYCHS 131
N++ E + +YIV+E+ DGG+L KI + G+L ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ V HRD+K +N+ L G +K+ DFG + + T GTP YV PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRI 250
Y+ + SD+WS G IL+ L PF ++ L K+C+ + PS +S + LIK++
Sbjct: 177 YNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 251 LDPNPDTRMTISQML 265
NP +R + + +L
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-35
Identities = 74/259 (28%), Positives = 128/259 (49%), Gaps = 12/259 (4%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVD---RDQVLRHKMVEQIKREISTMKLIKHPN 74
G LG+G++ V + G +A+K V+ + + K E+++ E+ +K +KH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+++ + I I +EF+ GG + + + G L E +Y +Q+++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 135 FHRDLKPENLLLDSYGVLKISDFG----LSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
HRD+K N++L G++K+ DFG L+ + +L + GTP ++APEV+N+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW---FSSGAKKLI 247
GY GR SD+WS G +F + G P + +A I P FS+ A +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 248 KRILDPNPDTRMTISQMLE 266
L + R + Q+L
Sbjct: 243 TSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-35
Identities = 78/255 (30%), Positives = 135/255 (52%), Gaps = 4/255 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ G++ A+K + +D VL VE E + L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K ++ V+EF++GG+L I GR A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N++LD G +KI+DFG+ + V D T CGTP+Y+APE+L Y +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYT-FSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257
D WS GV+L+ ++ G PF + L+ I P W + +K +++++ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 258 RMTISQMLEDEWFKK 272
R+ + + F K
Sbjct: 238 RLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 82/260 (31%), Positives = 143/260 (55%), Gaps = 20/260 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A + TG VA+K +D R Q R E + E+ M+ +HPN++++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHPNIVEMY 82
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++++V+EF++GG L D I H R+ E++ ++ A+ + H++GV HRD+
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDI 141
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQV-REDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
K +++LL S G +K+SDFG A +S++V R L+ GTP ++APEV++ Y
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEV- 196
Query: 198 DVWSCGVILFVLMAGFLP-FDESNLMALYRKICRAD----FSCPSWFSSGAKKLIKRILD 252
D+WS G+++ ++ G P F+E L A+ ++I R + S + + R+L
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRI-RDNLPPKLKNLHKVSPRLRSFLDRMLV 254
Query: 253 PNPDTRMTISQMLEDEWFKK 272
+P R T +++L + K
Sbjct: 255 RDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-34
Identities = 71/230 (30%), Positives = 130/230 (56%), Gaps = 9/230 (3%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ + + Y++ + +G G+F +V+ ++ + A+K++ + ++++ E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M P V+++ +Y+V+E++ GG+L + ++ + + E A+ Y +++
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVV 152
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TACGTPNY 181
A+D HS G+ HRD+KP+N+LLD +G LK++DFG ++ E G++ TA GTP+Y
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDY 209
Query: 182 VAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
++PEVL + GY GR D WS GV LF ++ G PF +L+ Y KI
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 78/268 (29%), Positives = 135/268 (50%), Gaps = 17/268 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + + G++ V ++ ET A+K +++ ++ ++Q+ E + ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+ + +K + +V+E+++GG+ + G L D AR YF + + A++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH-------------TACGTPNY 181
HRDLKP+NLL+ S G +K++DFGLS I L CGTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--- 238
+APEV+ +GY G+ D W+ G+IL+ + G +PF L+ ++ D P
Sbjct: 183 IAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ A+ LI R+L NP R+ E
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFE 269
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 87/263 (33%), Positives = 143/263 (54%), Gaps = 19/263 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ LG+G+F KV A+N ETG A K++D + +E EI + HPN
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 63
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRG 133
++K+++ + ++I++EF GG + + + R L E + R +Q + A++Y H
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQV--REDGLLHTACGTPNYVAPEVL---- 187
+ HRDLK N+L G +K++DFG+SA + + R D + GTP ++APEV+
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCET 179
Query: 188 -NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGA 243
D+ YD +A DVWS G+ L + P E N M + KI +++ + PS +SS
Sbjct: 180 SKDRPYDYKA-DVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238
Query: 244 KKLIKRILDPNPDTRMTISQMLE 266
K +K+ L+ N D R T +Q+L+
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 80/264 (30%), Positives = 126/264 (47%), Gaps = 20/264 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
ELG+ LGEG+F +V G+ VA+K + + E+ E S MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLS 59
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCH 130
HPN+++++ V +YIV E++ GG+L D + KHG L + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVL 187
S+ HRDL N L+ V+KISDFGL S+ + ED G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 188 NDKGYDGRASDVWSCGVILFVLMA-GFLPFDE---SNLMALYRKICRADFSCPSWFSSGA 243
D + SDVWS GV+L+ + G P+ ++ L R P
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP--RPENCPDEL 233
Query: 244 KKLIKRILDPNPDTRMTISQMLED 267
+L+ + +P+ R T S+++ED
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 85/272 (31%), Positives = 142/272 (52%), Gaps = 31/272 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---DRDQVLRHKMVEQIKREISTMKLI 70
YEL + +G G++ V A+++ TG+ VAIK++ D E I++EIS +K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKEC 57
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDY 128
+HPN++ + K++IV+E+ GG L D I + R L E + ++ + + Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL 187
H G HRD+K N+LL G +K++DFG+SA ++ + + + GTP ++APEV
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVA 173
Query: 188 NDK---GYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRADFSCPS----- 237
+ GYDG+ D+W+ G I + +A P FD + AL+ I +++F P
Sbjct: 174 AVERKGGYDGKC-DIWALG-ITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKE 230
Query: 238 -WFSSGAKKLIKRILDPNPDTRMTISQMLEDE 268
W S IK+ L +P R T +++L+
Sbjct: 231 KW-SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 32/272 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G +V + TG A+K++D+ ++++ V+++ E + + HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
++T + +V+++ GGELF + L E+ AR Y +++ A++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 137 RDLKPENLLLDSYGVLKISDFGLS--------AISQQVR------------------EDG 170
RDLKPEN+LL G + +SDF LS +S+ +R E
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 171 LLHTAC-GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC 229
+ GT Y+APEV++ G+ A D W+ G++L+ ++ G PF SN + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 230 RADFSCPS--WFSSGAKKLIKRILDPNPDTRM 259
+ + + P SS A+ LI+++L +P R+
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 71/261 (27%), Positives = 123/261 (47%), Gaps = 16/261 (6%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
LG+ LGEG+F +V VA+K + D + E+ RE M+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQQLINAVDYC 129
HPN++K++ V + + IV+E++ GG+L + + + L + + Q+ ++Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVL 187
S+ HRDL N L+ V+KISDFGL S+ + +D G P ++APE L
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKK 245
+ + SDVWS GV+L+ + G P+ + + + + P K
Sbjct: 177 KEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235
Query: 246 LIKRILDPNPDTRMTISQMLE 266
L+ + +P+ R T S+++E
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 76/247 (30%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI---KREISTMKLIKHPNVIK 77
LG G F KV A+ +TG+ AIK + + ++ VE + KR T +HP ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++ + V+E+ GG+L I E A Y ++ + Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH-----TACGTPNYVAPEVLNDKGY 192
DLK +NLLLD+ G +KI+DFGL ++G+ T CGTP ++APEVL + Y
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252
RA D W GV+++ ++ G PF + ++ I + P + S A +++R+L
Sbjct: 179 -TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237
Query: 253 PNPDTRM 259
NP+ R+
Sbjct: 238 RNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 7/220 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ +G G F +V+ + TGD A+K++ + +L + V + E + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRG 133
+ ++ K +Y+V+E+ GG+L + ++ + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
HRD+KPEN+L+D G +K++DFG SA + GTP+Y+APEVL D
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 194 GRAS-----DVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
G+ + D WS GVI + ++ G PF E Y I
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 90/278 (32%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLI 70
G +EL +GEG++ KV A++ +TG VAIKI+D + E+IK E + + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 71 KHPNVIKIIEVMASKT------KIYIVLEFIDGG---ELFDKIAKHG-RLKEDEARRYFQ 120
HPN+ K ++++V+E GG +L + K G RLKE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
+ + + Y H V HRD+K +N+LL +K+ DFG+SA Q G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178
Query: 181 YVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD-- 232
++APEV+ D YD R SDVWS G+ L G P D + AL+ KI R
Sbjct: 179 WMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPP 236
Query: 233 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 269
P +S I L N + R + ++LE +
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 6e-34
Identities = 73/230 (31%), Positives = 129/230 (56%), Gaps = 9/230 (3%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ R + YE+ + +G G+F +V+ ++ T A+K++ + ++++ E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M P V+++ +Y+V+E++ GG+L + ++ + + E AR Y +++
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 152
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TACGTPNY 181
A+D HS G HRD+KP+N+LLD G LK++DFG ++ ++G++ TA GTP+Y
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDY 209
Query: 182 VAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
++PEVL + GY GR D WS GV L+ ++ G PF +L+ Y KI
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 88/334 (26%), Positives = 145/334 (43%), Gaps = 74/334 (22%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-I--VDRDQVLRHKMVEQIKREISTMKLI 70
+YEL + +G G++ V A + TG VAIK I V D + ++I REI ++ +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID----AKRILREIKLLRHL 56
Query: 71 KHPNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLIN 124
+H N+I +++++ + +YIV E ++ K+ K + D+ +YF Q++
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV- 182
+ Y HS V HRDLKP N+L++S LKI DFGL+ + E G L T YV
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-----TE-YVV 168
Query: 183 -----APEV-LNDKGYDGRASDVWSCGVILFVLMAG--FLP----FDESNL-MALYRKIC 229
APE+ L+ Y +A D+WS G I L+ P D+ NL + +
Sbjct: 169 TRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 230 RADFSCPSWFSSGAKK--------------------------LIKRILDPNPDTRMTISQ 263
D + S A+ L++++L +P R+T +
Sbjct: 228 EEDLKFIT--SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
Query: 264 MLEDEWFKKGYKP---------PHFDKEEEVNLD 288
L + + + P FD ++ L
Sbjct: 286 ALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELT 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 72/249 (28%), Positives = 139/249 (55%), Gaps = 11/249 (4%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIK 77
R +G GS+AKV + + A+K+V ++ V + ++ ++ E + +P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + +++++V+E+++GG+L + + +L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G +K++D+G+ + + T CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 198 DVWSCGVILFVLMAGFLPF-------DESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250
D W+ GV++F +MAG PF D + L++ I P + S A ++K
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 251 LDPNPDTRM 259
L+ +P R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 73/219 (33%), Positives = 121/219 (55%), Gaps = 6/219 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIKH 72
+ LG+ LG G+F +V + +TG +A+K V D D K V ++ EI +K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 73 PNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+++ + K+ I +E++ GG + D++ +G L E+ RRY +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLND 189
S + HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
+GY GR +DVWS + ++ P+ E MA KI
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 75/262 (28%), Positives = 136/262 (51%), Gaps = 13/262 (4%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ R + +++ + +G G+F +V+ ++ + A+K++ + ++++ E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M ++++ +Y+V+E++ GG+L + ++ + + E AR Y +++
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVV 152
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TACGTPNY 181
A+D HS G HRD+KP+N+LLD G LK++DFG ++ +G++ TA GTP+Y
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTAVGTPDY 209
Query: 182 VAPEVLNDKGYD---GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCP 236
++PEVL +G D GR D WS GV L+ ++ G PF +L+ Y KI + + P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP 269
Query: 237 S--WFSSGAKKLIKRILDPNPD 256
S AK LI L
Sbjct: 270 DDIEISKQAKDLICAFLTDREV 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 75/260 (28%), Positives = 127/260 (48%), Gaps = 15/260 (5%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
LG+ LGEG+F +V K G VA+K + D + +E+ RE M+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
HPNV+K++ V + +YIV+E+++GG+L + K+ +L + + Q+ ++Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLN 188
S+ HRDL N L+ V+KISDFGL S+ + +D G P ++APE L
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKL 246
+ + SDVWS GV+L+ + G P+ + + + P L
Sbjct: 177 EGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235
Query: 247 IKRILDPNPDTRMTISQMLE 266
+ + +P+ R T S+++E
Sbjct: 236 MLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 86/296 (29%), Positives = 146/296 (49%), Gaps = 54/296 (18%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIK-----IVDRDQVLRHKMVEQIKREISTMK- 68
Y++ +GEG+F++V A++ +TG + AIK +QV REI ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-------REIQALRR 53
Query: 69 LIKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINA 125
L HPN++++IEV+ + ++ +V E +D L++ I R L E + Y QL+ +
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG-LSAISQQVREDGLLHTA-CGTPNYVA 183
+D+ H G+FHRD+KPEN+L+ +LK++DFG I + +T T Y A
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK-----PPYTEYISTRWYRA 166
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN------------------LMALY 225
PE L GY G D+W+ G + F +++ F F +N ++ +
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226
Query: 226 RKICRADFSCPSWFSSGAKK-----------LIKRILDPNPDTRMTISQMLEDEWF 270
RK +++ PS +G +K L+K++L +PD R+T Q L +F
Sbjct: 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+T+G G+F +V + V+T A+K + + VL +K E + + V+K+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
K +Y V+++I GG++ + + G +ED AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLSA------------ISQQVREDG---------------- 170
+KP+N+L+D G +K++DFGL R+D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 171 -------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
L H+ GTPNY+APEVL GY + D WS GVIL+ ++ G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 72/194 (37%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+GEG++ V A++ TG+ VA+K + + I REIS +K + HPN++++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-REISLLKELNHPNIVRLLD 65
Query: 81 VMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ S+ K+Y+V EF+D + D G L + Y QL+ + YCHS V HRD
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 139 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
LKP+NLL+D G LK++DFGL+ A VR H T Y APE+L
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQYSTPV 181
Query: 198 DVWSCGVILFVLMA 211
D+WS G I F M
Sbjct: 182 DIWSIGCI-FAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 1e-32
Identities = 75/241 (31%), Positives = 129/241 (53%), Gaps = 8/241 (3%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIKHPNV 75
G+ LG+G+F +V +V+TG +A K V D + K V ++ EI +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 76 IKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + + + + I +E++ GG + D++ +G L E R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGY 192
+ HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++ +GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLIKRI 250
GR +DVWS G + ++ P+ E MA KI + PS S A+ + I
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCI 245
Query: 251 L 251
Sbjct: 246 F 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 85/296 (28%), Positives = 135/296 (45%), Gaps = 49/296 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--- 71
YE +GEG++ V A+++ TG FVA+K V R + + REI+ +K ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 72 HPNVIKIIEV-----MASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLIN 124
HPN++++++V + K+ +V E +D K K G L + + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLR 118
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVA 183
VD+ HS + HRDLKP+N+L+ S G +KI+DFGL+ I S ++ L + T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LTSVVVTLWYRA 174
Query: 184 PEVLNDKGYDGRASDVWSCGVI---LFVLMAGFLPFDESNLMAL---------------- 224
PEVL Y D+WS G I LF F E++ +
Sbjct: 175 PEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 225 ----------YRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
Y F P G L+K++L NP R++ + L+ +F
Sbjct: 234 VSLPRSSFPSYTPRSFKSF-VPEICEEGL-DLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 75/244 (30%), Positives = 129/244 (52%), Gaps = 8/244 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIKH 72
+ LG+ LG+G+F +V + +TG +A+K V D + K V ++ EI +K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 73 PNVIKIIEVM--ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+++ + + + I +E + GG + D++ +G L E+ R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLND 189
S + HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLI 247
+GY GR +D+WS G + ++ P+ E MA KI + P S + +
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 248 KRIL 251
KRI
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 72/193 (37%), Positives = 108/193 (55%), Gaps = 9/193 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+GEG++ V A+N TG+ VA+K + D I REIS +K + HPN++K+++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 81 VMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ ++ K+Y+V EF+ D + D G + + Y QL+ + +CHS V HRD
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 139 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
LKP+NLL+++ G +K++DFGL+ A VR H T Y APE+L Y A
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTAV 182
Query: 198 DVWSCGVILFVLM 210
D+WS G I F M
Sbjct: 183 DIWSLGCI-FAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 75/301 (24%)
Query: 23 EGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-------REISTMKLIKHPNV 75
EG++ V A++ +TG+ VA+K + KM ++ + REI+ + ++HPN+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 76 IKIIEVMASKT--KIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSR 132
+ + EV+ KIY+V+E+++ +L + + E + QL++ V + H
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------Y 181
+ HRDLK NLLL++ G+LKI DFGL+ RE G+P Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-----DFSCP 236
APE+L A D+WS G I L+ F + + KI + + P
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232
Query: 237 SWFS-SGAKK--------------------------LIKRILDPNPDTRMTISQMLEDEW 269
+ GAKK L+ R+L +P R++ L+ +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
Query: 270 F 270
F
Sbjct: 293 F 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 71/247 (28%), Positives = 120/247 (48%), Gaps = 34/247 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + +G G+F +V+ + +TG A+KI+ + +L + V I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+K+ K +Y+++EF+ GG++ + K L E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGL---------------------------------SA 161
HRD+KP+NLLLD+ G +K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
+ + L ++ GTP+Y+APEV GY+ + D WS GVI++ ++ G+ PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 222 MALYRKI 228
YRK+
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 76/272 (27%), Positives = 141/272 (51%), Gaps = 19/272 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH- 72
+ EL +G G++ V K+V TG VA+KI++ D V I+RE++ + ++
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQS 59
Query: 73 --PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
PN+ K +++I++E+ +GG + + K G + E ++++ A+ Y H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND- 189
GV HRD+K N+L+ + G +K+ DFG++A+ Q T GTP ++APEV+ +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEG 176
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGAKK 245
K YD +A D+WS G+ ++ + G P+ + + I ++ P + +S ++
Sbjct: 177 KYYDTKA-DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
+ LD P R++ ++L+ +W K K P
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTP 265
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 93/300 (31%), Positives = 138/300 (46%), Gaps = 58/300 (19%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE-----QIK----REI 64
KYE +GEGS+ V +N ETG VAIK K VE IK REI
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIK----------KFVESEDDPVIKKIALREI 51
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLI 123
+K +KHPN++ +IEV K K+++V E+ D + +++ K+ R + E ++ Q +
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
AV++CH HRD+KPEN+L+ G +K+ DFG + I T Y A
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRA 168
Query: 184 PEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALY--RKIC-------RA 231
PE+L D Y G DVW+ G + L+ G P +S++ LY RK +
Sbjct: 169 PELLVGDTQY-GPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226
Query: 232 DFSCPSWF---------------------SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
FS +F SS A +K L +P R++ ++LE +F
Sbjct: 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 19 RTLGEGSFAKVKFAK---NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LGEG+F +V K VA+K + D + + +E MK + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLI-------NAV 126
++++ V + +Y+VLE+++GG+L D + K + + + L+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---A 183
+Y S+ HRDL N L+ V+KISDFGL S+ V +D G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SCPSWFS 240
PE L D + SDVWS GV+L+ + G P+ + + + R + P +
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCP 233
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLE 266
+L+ +P+ R T S+++E
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 22/267 (8%)
Query: 15 YELGRTLGEGSFAKV-KFAKNVETGDFVAIKIVD-------RDQVLRHKMVEQIKREIST 66
Y + LG G+F V K K + +A+K ++ +D+ R K + I E++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 67 MK-LIKHPNVIKIIEVMASKTKIYIVLEFIDG---GELFDKIA-KHGRLKEDEARRYFQQ 121
+K ++HPN+++ + ++YIV++ I+G GE F+ + K R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 122 LINAVDYCH-SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
++ A+ Y H + + HRDL P N++L + I+DFGL ++Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTIL 178
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---S 237
Y PE++ ++ Y G +DVW+ G IL+ + PF +N+++L KI A + P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPEG 236
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQM 264
+S +I L P+ + R I Q+
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-31
Identities = 72/247 (29%), Positives = 120/247 (48%), Gaps = 34/247 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + +G G+F +V+ + +TG A+KI+ + +L + V I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+K+ K +Y+++EF+ GG++ + K L E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGL---------------------------------SA 161
HRD+KP+NLLLDS G +K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
+ + L + GTP+Y+APEV GY+ + D WS GVI++ ++ G+ PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 222 MALYRKI 228
Y+K+
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 69/194 (35%), Positives = 110/194 (56%), Gaps = 8/194 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+GEG++ V +N +TG VA+K + R + + REIS +K ++HPN++ + +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 81 VMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ ++++Y++ EF+ D + D + K + + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
LKP+NLL+D+ GV+K++DFGL+ A VR H T Y APEVL
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVV-TLWYRAPEVLLGSPRYSTPV 183
Query: 198 DVWSCGVILFVLMA 211
D+WS G I F MA
Sbjct: 184 DIWSIGTI-FAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 51/289 (17%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LGEG++A V +N TG+ VA+K + D REIS MK +KH N++++ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 81 VMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ ++ K+ +V E++D + D G L + + + QL+ + +CH V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 139 LKPENLLLDSYGVLKISDFGL--------SAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
LKP+NLL++ G LK++DFGL + S +V T Y AP+VL
Sbjct: 126 LKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----------TLWYRAPDVLLGS 175
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYR-----------------KIC 229
+ D+WS G I+ ++ G F +E L+ ++R +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 230 RADFSCPSW--------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270
P L+ R+L NP+ R++ L+ WF
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 75/243 (30%), Positives = 113/243 (46%), Gaps = 46/243 (18%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+TLG G+F +V A+ V+T A+K + + VL V +K E + + V+++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
K +Y V+++I GG++ + + G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLSA------------ISQQVREDG---------------- 170
+KP+N+L+D G +K++DFGL VR+D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 171 -----------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213
L H+ GTPNY+APEVL GY + D WS GVIL+ ++ G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 214 LPF 216
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 24/267 (8%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+ V + TG +A+K + + + +QI RE+ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGF 64
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHS-RGVF 135
+ I I +E++DGG L DKI K GR+ E + ++ + Y H +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 195
HRD+KP N+L++S G +K+ DFG+S Q V + L T GT +Y+APE + Y +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 196 ASDVWSCGVILFVLMAGFLPFDESNLMA-----LYRKICRADFSCP-----SWFSSGAKK 245
SD+WS G+ L L G P+ N L + I P FS +
Sbjct: 180 -SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQD 235
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKK 272
+ L +P R + ++LE + KK
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------RE 63
V KYE +G+G+F +V A++ +T VA+K V ++E K RE
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---------LMENEKEGFPITALRE 61
Query: 64 ISTMKLIKHPNVIKIIEVMASKTK--------IYIVLEFID---GGELFDKIAKHGRLKE 112
I ++L+KH NV+ +IE+ +K Y+V EF + G L +K K
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTL 118
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGL 171
E ++ + L+N + Y H + HRD+K N+L+ G+LK++DFGL+ A S
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 172 LHTA-CGTPNYVAPEV-LNDKGYDGRASDVWSCGVIL 206
+T T Y PE+ L ++ Y G D+W G I+
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 76/243 (31%), Positives = 114/243 (46%), Gaps = 46/243 (18%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+TLG G+F +V A V+T A+K + + VL V +K E + + V+K+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
K +Y V+++I GG++ + + E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGL---------SAISQQ---VREDG---------------- 170
+KP+N+L+D G +K++DFGL S Q+ +R+D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 171 -----------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213
L H+ GTPNY+APEVL KGY + D WS GVILF ++ G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 214 LPF 216
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 80/253 (31%), Positives = 125/253 (49%), Gaps = 16/253 (6%)
Query: 33 KNVETGDFVAIKIVDRDQVLRHKMV--------EQIKREISTMKLIKHPNVIKIIEVMAS 84
+N T FVA + D + + K V + E+ + H ++K + S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 85 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
K+ +++E+ GG+L +I + H +E E F Q++ A+D HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 141 PENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
N+ L G++K+ DFG S S V D + + CGTP Y+APE+ K Y +A D+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYSKKA-DM 254
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTR 258
WS GVIL+ L+ PF + + +++ + P SSG K L+ +L NP R
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
Query: 259 MTISQMLEDEWFK 271
T Q+L E+ K
Sbjct: 315 PTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 76/263 (28%), Positives = 132/263 (50%), Gaps = 11/263 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIK 71
+Y L + LG+GSF V K+ + +K++ V L Q +E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIA--KHG--RLKEDEARRYFQQLINAVD 127
HP ++K + I+ E+ +G +L K+ KH L E++ +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y H R + HRDLK +N+ L + +LKI DFG+S + + L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKL 246
+GYD + SD+WS G IL+ + F+ N +++ +I S P +S +
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 247 IKRILDPNPDTRMTISQMLEDEW 269
++ +L+ +P R + +++L + +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 78/261 (29%), Positives = 135/261 (51%), Gaps = 10/261 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAIK ++ Q + E I EI M+ KHP
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + E + ++ + A+++ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRI 250
G D+WS G++ ++ G P+ +E+ L ALY + P S+ + + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252
Query: 251 LDPNPDTRMTISQMLEDEWFK 271
L+ + + R + ++L+ + K
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 92/316 (29%), Positives = 141/316 (44%), Gaps = 61/316 (19%)
Query: 12 VGKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
V ++E L R +GEG++ V A++ +G+ VA+K V D R + REI+ + +
Sbjct: 6 VTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNL 63
Query: 71 KHPNVIKIIEVMASK--TKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
+HPN++++ EV+ K I++V+E+ D L D + E + + QL+ +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRGL 121
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----Y 181
Y H + HRDLK NLLL G LKI+DFGL+ R G L TP Y
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA------RTYG-LPAKPMTPKVVTLWY 174
Query: 182 VAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLP----FDESNLMA----------- 223
APE+L Y A D+W+ G IL L+A LP ++ +L+
Sbjct: 175 RAPELLLGCTTYT-TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233
Query: 224 -------LYRKI---------CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
L K + F W S +L+ +L +P R T + LE
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKF---PWLSEAGLRLLNFLLMYDPKKRATAEEALES 290
Query: 268 EWFKKGYKPPHFDKEE 283
+FK+ KP + E
Sbjct: 291 SYFKE--KPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 96/329 (29%), Positives = 151/329 (45%), Gaps = 51/329 (15%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKHP 73
Y+ +GEG++ V A + TG VAIK + H+ Q REI ++ KH
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI---SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 74 NVIKIIEVMASKT-----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N+I I++++ + +YIV E ++ +L+ K+ K L D + + Q++ + Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS-QQVREDGLLHTACGTPNYVAPEV- 186
HS V HRDLKP NLLL++ LKI DFGL+ I+ + G L T Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF------DESNL---------MALYRKIC-- 229
LN KGY +A D+WS G IL +++ F + NL I
Sbjct: 182 LNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 230 RA-DF--SCP-----SW------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275
RA ++ S P W A L+ ++L NP R+T+ + L + ++ +
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300
Query: 276 P---PHFDKEEEVNLDDVDAIFNDSKENL 301
P P ++ + + D + KE L
Sbjct: 301 PSDEPVAEEPFPFDFELFDDL---PKEKL 326
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 77/290 (26%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ +G+G+F +V+ + +TG A+K + + ++ + + +K E + P V+ +
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+Y+++EF+ GG+L + K+ ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLS---------AISQQVREDG------------------- 170
+KP+N+L+D G +K+SDFGLS A Q++ +
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 171 -----------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213
+ ++ GTP+Y+APE+ +GY G+ D WS G I+F + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 214 LPFDESNLMALYRKIC--RADFSCPS--WFSSGAKKLIKRILDPNPDTRM 259
PF N YRKI R P S A+ LI+R++ N + R+
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 9e-29
Identities = 73/249 (29%), Positives = 132/249 (53%), Gaps = 15/249 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V K A+KI+++ ++L+ + E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRG 133
+ + + +Y+V+++ GG+L ++K RL ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL---- 187
HRD+KP+N+L+D G ++++DFG ++ EDG + + A GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW---FSSG 242
+ KG G D WS GV ++ ++ G PF +L+ Y KI + F P+ S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 243 AKKLIKRIL 251
AK LI+R++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 1e-28
Identities = 77/261 (29%), Positives = 137/261 (52%), Gaps = 10/261 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A ++ TG VAIK ++ Q + ++ I EI M+ K+P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + + E + ++ + A+D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQ 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRI 250
G D+WS G++ ++ G P+ +E+ L ALY + P S+ + + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 251 LDPNPDTRMTISQMLEDEWFK 271
L+ + D R + ++L+ + K
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 81/262 (30%), Positives = 135/262 (51%), Gaps = 18/262 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+EL + +G G++ V A+NV TG+ AIK++ + +V+Q EI MK KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + K++I +EF GG L D G L E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEV--LNDKG 191
HRD+K N+LL G +K++DFG+SA I+ + + + GTP ++APEV + KG
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAAVERKG 184
Query: 192 YDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRADFSCPSW-----FSSGAK 244
+ D+W+ G I + +A P FD + AL+ + +++F P +S+
Sbjct: 185 GYNQLCDIWAVG-ITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKWSNSFH 242
Query: 245 KLIKRILDPNPDTRMTISQMLE 266
+K L NP R T ++L+
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 80/259 (30%), Positives = 138/259 (53%), Gaps = 17/259 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
LG+G++ V A+++ T +AIK I +RD + V+ + EI+ +KH N+++ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 80 EVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEA--RRYFQQLINAVDYCHSRGVFH 136
+ I +E + GG L + +K G LK++E Y +Q++ + Y H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 137 RDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYD 193
RD+K +N+L+++Y GV+KISDFG S + + T GT Y+APEV++ +GY
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRGY- 188
Query: 194 GRASDVWSCGVILFVLMAGFLPFDE--SNLMALYR-KICRADFSCPSWFSSGAKKLIKRI 250
G +D+WS G + + G PF E A+++ + + P S+ AK I R
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248
Query: 251 LDPNPDTRMTISQMLEDEW 269
+P+PD R + +L+D +
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 17/200 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---DRDQVLRHKMVEQIKREISTMKLI 70
KYE +GEG++ V AKN ET + VA+K V D D+ + + REI +K +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 56
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
KH N++++ +V+ S K+ +V E+ D + FD + +G + + + + QL+ + +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL 187
CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVL 171
Query: 188 -NDKGYDGRASDVWSCGVIL 206
K Y + D+WS G I
Sbjct: 172 FGAKLYS-TSIDMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 11/265 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF +V + T VAIKI+D ++ +E I++EI+ + P V K
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
TK++I++E++ GG D + + G L E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
N+LL +G +K++DFG++ Q++ + + GTP ++APEV+ YD +A D
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYDSKA-D 183
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDT 257
+WS G+ L G P E + M + I + + + +S K+ ++ L+ P
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 243
Query: 258 RMTISQMLEDEWFKKGYKPPHFDKE 282
R T ++L+ ++ + K + E
Sbjct: 244 RPTAKELLKHKFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 74/209 (35%), Positives = 119/209 (56%), Gaps = 12/209 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A TG VA+K +D R Q R E + E+ M+ H NV+ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR----ELLFNEVVIMRDYHHENVVDMY 85
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++++V+EF++GG L D I H R+ E++ ++ A+ Y H++GV HRD+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
K +++LL S G +K+SDFG A +S++V + L GTP ++APEV++ Y G D
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVD 200
Query: 199 VWSCGVILFVLMAGFLP-FDESNLMALYR 226
+WS G+++ ++ G P F+E L A+ R
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 78/267 (29%), Positives = 135/267 (50%), Gaps = 15/267 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF +V + T VAIKI+D ++ +E I++EI+ + P V K
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
TK++I++E++ GG D + + G E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
N+LL G +K++DFG++ Q++ + T GTP ++APEV+ YD +A D
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQSAYDSKA-D 183
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW---FSSGAKKLIKRILDPNP 255
+WS G+ L G P + + M + I + + P+ FS K+ I L+ +P
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDP 241
Query: 256 DTRMTISQMLEDEWFKKGYKPPHFDKE 282
R T ++L+ ++ K K + E
Sbjct: 242 SFRPTAKELLKHKFIVKNAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 77/261 (29%), Positives = 137/261 (52%), Gaps = 10/261 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAI+ ++ Q + E I EI M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + + E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRI 250
G D+WS G++ ++ G P+ +E+ L ALY + P S+ + + R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 251 LDPNPDTRMTISQMLEDEWFK 271
LD + + R + ++L+ ++ K
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 80/257 (31%), Positives = 139/257 (54%), Gaps = 16/257 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V K TG A+KI+++ ++L+ + E +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRG 133
+ + + +Y+V+++ GG+L ++K RL ED AR Y +++ A+D H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL---- 187
HRD+KP+N+LLD G ++++DFG S + ++ DG + + A GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW---FSSG 242
+ KG G D WS GV ++ ++ G PF +L+ Y KI + F P S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 243 AKKLIKRILDPNPDTRM 259
AK LI+R++ P+TR+
Sbjct: 240 AKDLIRRLICS-PETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 96/324 (29%), Positives = 151/324 (46%), Gaps = 34/324 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR----EISTMKL 69
KY + R LG G+ V AK V G+ A+K+VD + M E K E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME-----GMSEADKNRAQAEVCCLLN 87
Query: 70 IKHPNVIKIIEVMASKTK--------IYIVLEFIDGGELFDKI---AKHGR-LKEDEARR 117
+++K E A K I +VL++ + G+L +I AK R +E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
F Q++ AV + HS+ + HRD+K N+LL S G++K+ DFG S + D + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CP 236
TP YVAPE+ K Y +A D++S GV+L+ L+ PFD N+ + K + P
Sbjct: 208 TPYYVAPEIWRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLED---EWFKKGYKP-----PHFDKEEEVNLD 288
S ++++ +L +P R + S++L + F G P F D
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLR---D 323
Query: 289 DVDAIFNDSKENLVTEKKEKPVSM 312
+ +K+ L E++ M
Sbjct: 324 TISRQIQQTKQLLQVERRRIVRQM 347
|
Length = 496 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 91/335 (27%), Positives = 161/335 (48%), Gaps = 50/335 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVD--RDQVLRHKMVEQIKREISTMK-L 69
KYE+ + LG+G++ V A + T + VA+K I D R+ ++ REI ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT----DAQRTFREIMFLQEL 63
Query: 70 IKHPNVIKIIEVMASK--TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
HPN++K++ V+ ++ IY+V E+++ +L I + L++ R QL+ A+
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALK 121
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ--QVREDGLLHTACGTPNYVAP 184
Y HS V HRDLKP N+LL+S +K++DFGL+ ++S+ + E+ +L T Y AP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--------------R 230
E+L + D+WS G IL ++ G F ++ + KI +
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241
Query: 231 ADFSCPSWFSSGAKK-----------------LIKRILDPNPDTRMTISQMLEDEWFKKG 273
+ F+ S ++ L+K++L NP+ R+T + LE + +
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301
Query: 274 YKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK 308
+ P +E V + +D+ + V E + K
Sbjct: 302 HNP----SDEPVLPYPITIPLDDNVKLSVAEYRNK 332
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 72/245 (29%), Positives = 123/245 (50%), Gaps = 10/245 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G F +V + TG A K +D+ ++ + K + E ++ + ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRD 138
+K + +V+ ++GG+L I G EAR F Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
LKPEN+LLD +G ++ISD GL+ +++ + GTP Y+APEVL + YD D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV-D 176
Query: 199 VWSCGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
++ G L+ ++AG PF + L R+ P FS AK L + +L +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 255 PDTRM 259
P+ R+
Sbjct: 237 PEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 87/336 (25%), Positives = 150/336 (44%), Gaps = 61/336 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ +V A + +TG VAIK + R Q H ++ RE+ +K + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTYRELRLLKHMDH 73
Query: 73 PNVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V + +Y+V + G +L + I K +L +D + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-DGLLHTACGTPNYVAPE 185
Y HS G+ HRDLKP N+ ++ LKI DFGL+ R D + T Y APE
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA------RHTDDEMTGYVATRWYRAPE 185
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC---------------- 229
++ + + + D+WS G I+ L+ G F S+ + ++I
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 230 --------------RADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274
+ DF S + A L++++L +PD R+T ++ L +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA--- 302
Query: 275 KPPHFDKEEEVNLDDVDAIFNDSKENL---VTEKKE 307
+ D E+E V ++ S E+ V E KE
Sbjct: 303 --EYHDPEDE----PVAPPYDQSFESRDLTVDEWKE 332
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 14/261 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A +G VA+K +D R Q R E + E+ M+ +H NV+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 83
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++++V+EF++GG L D I H R+ E++ ++ A+ H++GV HRD+
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
K +++LL G +K+SDFG A +S++V L GTP ++APE+++ Y G D
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVD 198
Query: 199 VWSCGVILFVLMAGFLP-FDESNL--MALYRKICRADFSCPSWFSSGAKKLIKRILDPNP 255
+WS G+++ ++ G P F+E L M + R S K + R+L +P
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 256 DTRMTISQMLEDEWFKKGYKP 276
R T +++L+ + K P
Sbjct: 259 AQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 76/261 (29%), Positives = 136/261 (52%), Gaps = 10/261 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAIK ++ + + E I EI MK +K+P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + + E + ++ + A+++ H+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQ 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRI 250
G D+WS G++ ++ G P+ +E+ L ALY + P S + + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 251 LDPNPDTRMTISQMLEDEWFK 271
L+ + + R + ++L+ + K
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 74/262 (28%), Positives = 136/262 (51%), Gaps = 11/262 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF +V + T + VAIKI+D ++ +E I++EI+ + P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
TK++I++E++ GG D + K G L+E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
N+LL G +K++DFG++ Q++ + T GTP ++APEV+ YD +A D
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYDFKA-D 183
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKICR-ADFSCPSWFSSGAKKLIKRILDPNPDT 257
+WS G+ L G P + + M + I + + + +S K+ ++ L+ +P
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRF 243
Query: 258 RMTISQMLEDEWFKKGYKPPHF 279
R T ++L+ ++ + K F
Sbjct: 244 RPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-27
Identities = 77/252 (30%), Positives = 131/252 (51%), Gaps = 37/252 (14%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M K +R+ +YE+ + +G G F +V K+ T +F K + + L+ + Q+
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQL 59
Query: 61 KREISTMKLIKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAK----HGRLKEDE 114
E++ M+ +KH N+++ I+ +K K+YI++EF D G+L I K G+++E
Sbjct: 60 VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 115 ARRYFQQLINAVDYCHS-------RGVFHRDLKPENLLLDS-----------------YG 150
+QL++A+ YCH+ V HRDLKP+N+ L +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKGYDGRASDVWSCGVILFV 208
+ KI DFGLS + + + + H+ GTP Y +PE+L K YD + SD+W+ G I++
Sbjct: 180 IAKIGDFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYE 235
Query: 209 LMAGFLPFDESN 220
L +G PF ++N
Sbjct: 236 LCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 89/278 (32%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
EL R LGEG+ V + TG A+K + D + +QI RE+ K K P +
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYI 61
Query: 76 IKIIE--VMASKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDY 128
+K + S + I I +E+ +GG L D I K GR+ E + + ++ + Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS--AISQQVREDGLLHTACGTPNYVAPEV 186
HSR + HRD+KP N+LL G +K+ DFG+S ++ T GT Y+APE
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG------TFTGTSFYMAPER 174
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMA--LYRKICRADF----SCPS 237
+ K Y SDVWS G+ L + PF E L L I P
Sbjct: 175 IQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233
Query: 238 ----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
W S K IK+ L+ +P R T MLE W K
Sbjct: 234 NGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 73/249 (29%), Positives = 131/249 (52%), Gaps = 15/249 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V K T A+KI+++ ++L+ + E + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRG 133
+ + + +Y+V+++ GG+L ++K RL ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL---- 187
HRD+KP+N+LLD G ++++DFG ++ +DG + + A GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCL---KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSWF---SSG 242
+ G G D WS GV ++ ++ G PF +L+ Y KI + F PS S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 243 AKKLIKRIL 251
AK LI+R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 20/262 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL + +G G++ V A+N+ TG+ A+KI+ + +++Q EI +K KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCN 67
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ S+ K++I +E+ GG L D G L E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL---NDK 190
HRD+K N+LL G +K++DFG++A I+ + + + GTP ++APEV +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVAAVEKNG 184
Query: 191 GYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRADFSCPSW-----FSSGA 243
GY+ + D+W+ G I + +A P FD + AL+ + +++F P +SS
Sbjct: 185 GYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKWSSTF 241
Query: 244 KKLIKRILDPNPDTRMTISQML 265
+K L NP R T ++L
Sbjct: 242 HNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 81/254 (31%), Positives = 137/254 (53%), Gaps = 20/254 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A+ +G VA+K++D R Q R E + E+ M+ +H NV+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHQNVVEMY 84
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++++++EF+ GG L D I RL E++ + ++ A+ Y HS+GV HRD+
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
K +++LL G +K+SDFG A IS+ V + L GTP ++APEV++ Y G D
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPY-GTEVD 199
Query: 199 VWSCGVILFVLMAGFLP-FDESNLMALYRKICRADFSCP-----SWFSSGAKKLIKRILD 252
+WS G+++ ++ G P F +S + A+ R D P S + ++R+L
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 253 PNPDTRMTISQMLE 266
P R T ++L+
Sbjct: 257 REPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 19 RTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQ----IKREISTMKLI 70
+ LGEG F KV+ + TG+ VA+K L H EQ +REI ++ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 71 KHPNVIKIIEVM--ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAV 126
H N++K V + +++E++ G L D + +H R + + R + Q+ +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGM 122
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ------VREDGLLHTACGTP- 179
DY S+ HRDL N+L++S ++KISDFGL+ + + V+E G P
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES------PI 176
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVL 209
+ APE L + ASDVWS GV L+ L
Sbjct: 177 FWYAPECLRTSKFS-SASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 70/257 (27%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIKH 72
Y R +G+GS+ +V ++ G IK ++ R K EQ E + +KH
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKH 58
Query: 73 PNVIKIIEVMASKT-KIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYC 129
PN++ E + +YIV+ F +GG+L+ K+ K L E++ +F Q+ A+ Y
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
H + + HRDLK +N+ L ++K+ D G++ + + + + T GTP Y++PE+ ++
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSN 176
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIK 248
K Y+ + SDVW+ G ++ + F+ ++ +L +I P +S +LI
Sbjct: 177 KPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 249 RILDPNPDTRMTISQML 265
+L P+ R ++ +L
Sbjct: 236 TMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 82/320 (25%), Positives = 138/320 (43%), Gaps = 72/320 (22%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REIS 65
+++ YE+ LGEG+F +V A+ ++TG VA+K ++L H + REI
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIK 59
Query: 66 TMKLIKHPNVIKIIEVMASKTK--------IYIVLEFID---GGELFDKIAKHGRLKEDE 114
+K +KHPNV+ +I++ + +Y+V ++D G L + K L E +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQ 116
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI----SQQVREDG 170
+ Y QL+ ++Y H + HRD+K N+L+D+ G+LKI+DFGL+ + G
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 171 LLHTACGTPN-----YVAPE-VLNDKGYDGRASDVWSCGVIL------------------ 206
T T Y PE +L ++ Y A D+W G +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 207 ----FVLMAGFLPFDESNLMALYRKI--CRADFSCPSW----------FSSGAKKLIKRI 250
F L P +E+ +R + C S ++ L+ ++
Sbjct: 236 LHLIFKLCGT--PTEET--WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291
Query: 251 LDPNPDTRMTISQMLEDEWF 270
L +P R+T S LE +F
Sbjct: 292 LSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 76/281 (27%), Positives = 136/281 (48%), Gaps = 17/281 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH---PNVIK 77
+G G F +V + +TG A+K +D+ ++ + E + L+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+ +L+ ++GG+L +++HG E E R Y ++I +++ H+R V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND-KGYDGRA 196
DLKP N+LLD +G ++ISD GL+ + + H + GT Y+APEVL YD A
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 197 SDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
D +S G +LF L+ G PF + + + R + P FS K L++ +L
Sbjct: 178 -DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 254 NPDTRMTI----SQMLEDEWFKKGYKPPH-FDKEEEVNLDD 289
+ R+ +Q +++ F KG + ++ L
Sbjct: 237 DVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 73/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK--------IVDRDQVLRHKMVEQIKREIS 65
KY + +G G++ V AKN ET + VAIK +D + LR EI
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR---------EIK 56
Query: 66 TMKLIKHPNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
++ + H NVI I ++M + +YIV E +D +L I L +D + +
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QL+ + Y HS V HRDLKP NLLL++ LKI DFGL+ + + + + T
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRW 173
Query: 181 YVAPEV-LNDKGYDGRASDVWSCGVILFVLM 210
Y APE+ LN Y A DVWS G I L+
Sbjct: 174 YRAPELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-----IKREISTMK 68
YE +GEG++ KV A++ TG VA+K R +M E+ REIS ++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT------RLEMDEEGIPPTALREISLLQ 55
Query: 69 LIKH-PNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGR-----LKEDEARR 117
++ ++++++V + K +Y+V E++D +L + +GR L +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS-AISQQVREDGLLHTA 175
+ QL+ V +CH GV HRDLKP+NLL+D G+LKI+D GL A S V+ H
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEI 172
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVI 205
T Y APEVL + D+WS G I
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 89/297 (29%), Positives = 139/297 (46%), Gaps = 50/297 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+YE +GEG++ V A++ T + +A+K + +Q I REIS +K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR------YFQQLINAVD 127
N++++ +V+ S+ ++Y+V E++D D + KH D A+ Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD----LD-LKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 128 YCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPE 185
YCHS V HRDLKP+NLL+D LK++DFGL+ A VR H T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYRAPE 173
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICR------------- 230
+L + D+WS G I F M P +S + L+ KI R
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGV 231
Query: 231 ---ADF--SCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
D+ + P W L+ ++L +P R+T LE E+FK
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 56/305 (18%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V K+++ +GEG++ +V A++ +TG+ VA+K V D + I REI ++ +
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLN 64
Query: 72 HPNVIKIIEVMASKTK----------IYIVLEFIDG---GELFDKIAKHGRLKEDEARRY 118
H N++ + E++ K Y+V E++D G L + ED + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACG 177
+QL+ ++YCH + HRD+K N+LL++ G +K++DFGL+ + E+ +T
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVI 179
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-------------- 223
T Y PE+L + G A DVWSCG IL L F + +A
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 224 -------------------LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 264
YR+ R +F S+ + A L+ +L +P R T +
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF---SFIPTPALDLLDHMLTLDPSKRCTAEEA 296
Query: 265 LEDEW 269
L W
Sbjct: 297 LNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 30/280 (10%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-REISTMKLIKH---PNVI 76
+G G F +V + +TG A+K +D+ ++ + K E + E + L+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
+ + K+ +L+ ++GG+L +++HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG--YDG 194
RDLKP N+LLD +G ++ISD GL+ + + H + GT Y+APEVL KG YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQ-KGVAYDS 175
Query: 195 RASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251
A D +S G +LF L+ G PF + + + R P FS + L++ +L
Sbjct: 176 SA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234
Query: 252 DPNPDTRMTI-----SQMLEDEWFK---------KGYKPP 277
+ + R+ ++ E +F+ + Y PP
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-25
Identities = 66/248 (26%), Positives = 116/248 (46%), Gaps = 26/248 (10%)
Query: 36 ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKII-EVMASKTKIYIVLEF 94
TG VAIK++ D + +RE + + HPN++ ++ A ++ V E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--- 151
+ G L + +A G L E R Q+++A+ H++G+ HRDLKP+N+++ GV
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 152 LKISDFGLSAISQQVREDGLL-----HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 206
K+ DFG+ + VR+ + GTP Y APE L + SD+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP-NSDLYAWGLIF 179
Query: 207 F------VLMAGFLPFDESNLMALYRKICRADFSCPSWFSS---GAKKLIKRILDPNPDT 257
++ G S LY+++ D S P W + G ++++ L+ +P
Sbjct: 180 LECLTGQRVVQG-----ASVAEILYQQLSPVDVSLPPWIAGHPLGQ--VLRKALNKDPRQ 232
Query: 258 RMTISQML 265
R + L
Sbjct: 233 RAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 19/267 (7%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R +G GSF V FA++V T + VAIK + ++ + I +E+ ++ ++HPN I+
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++V+E+ G D + H + L+E E + + Y HS HR
Sbjct: 81 KGCYLREHTAWLVMEYCLGSAS-DILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKG-YDG 194
D+K N+LL G +K++DFG +++ ++ GTP ++APEV+ D+G YDG
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRAD---FSCPSWFSSGAKKLIKRI 250
+ DVWS G+ L P N M ALY I + D S W S + +
Sbjct: 194 KV-DVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNDSPTLSSNDW-SDYFRNFVDSC 250
Query: 251 LDPNPDTRMTISQMLEDEWFKKGYKPP 277
L P R + ++L+ + + +PP
Sbjct: 251 LQKIPQDRPSSEELLKHRFVLRE-RPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ V A + +G VAIK I V + ++ RE+ ++ KH
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKH 63
Query: 73 PNVIKIIEVMASKTK----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N+I I +++ +Y+V++ + +L I L E+ R + QL+ + Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGL--SAISQQVREDGLLHTACGTPNYVAPEV 186
HS V HRDLKP NLL++ L+I DFG+ S + T Y APE+
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 187 LNDKGYDGRASDVWSCGVIL 206
L A D+WS G I
Sbjct: 183 LLSLPEYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 75/238 (31%), Positives = 121/238 (50%), Gaps = 22/238 (9%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
+ + A R G +EL +G G++ +V ++V+TG AIK++D + E+IK
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKL 61
Query: 63 EISTMKLIKH-PNVIKIIEVMASKT------KIYIVLEFIDGGELFD--KIAKHGRLKED 113
EI+ +K H N+ K+ ++++V+EF G + D K K LKED
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173
++++ + + H+ V HRD+K +N+LL +K+ DFG+SA Q R G +
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRN 179
Query: 174 TACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
T GTP ++APEV+ D YD R SD+WS G+ + G P D + AL+
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 83/272 (30%), Positives = 137/272 (50%), Gaps = 29/272 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHP 73
+E+ T+G+G++ KV N + G A+KI+D H + E+I+ E + +K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75
Query: 74 NVIKIIEVMASKT-----KIYIVLEFIDGGELFDKIA---KHG-RLKEDEARRYFQQLIN 124
NV+K + K ++++VLE +GG + D + K G R++E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYV 182
+ + H HRD+K N+LL + G +K+ DFG+SA S ++R + T+ GTP ++
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFWM 191
Query: 183 APEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---ADFS 234
APEV+ D YD R DVWS G+ L G P + + M KI R
Sbjct: 192 APEVIACEQQLDSTYDARC-DVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
P +S+ I++ L + + R T+S +L+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 7/201 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
K+E+ +GEG++ V ++ ET + VAIK +D ++ E RE+ ++ +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
N++++ E + K+Y+V E+++ EL +++ + ++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ HRD+KPENLL+ VLK+ DFG A + + T Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 192 YDGRASDVWSCGVILFVLMAG 212
Y G+A D+WS G IL L G
Sbjct: 178 Y-GKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 44/140 (31%), Positives = 82/140 (58%)
Query: 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83
G+F KV + A+K+V + ++ MV Q++ E + L K P ++ + +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143
S +Y+V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLKP+N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 144 LLLDSYGVLKISDFGLSAIS 163
+L+ + G +K++DFGLS ++
Sbjct: 135 MLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 68/247 (27%), Positives = 123/247 (49%), Gaps = 10/247 (4%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD YG ++ISD GL+ ++ E + GT Y+APEVLN++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 197 SDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252
D W G +++ ++ G PF ++ + R++ + + FS AK + K +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 253 PNPDTRM 259
+P R+
Sbjct: 242 KDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77
R LG GS V A + + VA+K IV D + V+ REI ++ + H N++K
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVK 66
Query: 78 IIEVMASKTK--------------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
+ EV+ +YIV E+++ + + G L E+ AR + QL+
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLL 124
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAI-SQQVREDGLLHTACGTPNY 181
+ Y HS V HRDLKP N+ +++ VLKI DFGL+ I G L T Y
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM 222
+P +L +A D+W+ G I ++ G F ++ +
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-23
Identities = 31/58 (53%), Positives = 43/58 (74%)
Query: 312 MNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK 369
+NAF+LIS + L LFE++ K+ETRFTS++P +EI+SK+EE AK LGF V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 84/282 (29%), Positives = 136/282 (48%), Gaps = 35/282 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMK-L 69
+E+ T+G+G++ KV N + G A+KI+D D + E+I+ E + ++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------VDEEIEAEYNILQSL 75
Query: 70 IKHPNVIKIIEVMASKTK-----IYIVLEFIDGG---ELFDKIAKHG-RLKEDEARRYFQ 120
HPNV+K + K +++VLE +GG EL + G RL E
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGT 178
+ + + H+ + HRD+K N+LL + G +K+ DFG+SA S ++R + T+ GT
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGT 191
Query: 179 PNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICR-- 230
P ++APEV+ D YD R DVWS G+ L G P FD + L+ KI R
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARC-DVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNP 249
Query: 231 -ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
P + I + L + + R +++ +LE + K
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 16/194 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+LG T+G+G F V G VA+K + D + E S M ++HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
++++ V+ +YIV E++ G L D + GR + + + + ++Y +
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGY 192
HRDL N+L+ V K+SDFGL+ + Q ++ G L P + APE L +K +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEALREKKF 176
Query: 193 DGRASDVWSCGVIL 206
+ SDVWS G++L
Sbjct: 177 STK-SDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 4e-23
Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 18/204 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-- 71
+YE +G G++ V A++ +G FVA+K V R Q + RE++ +K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 72 -HPNVIKIIEVMAS-----KTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLI 123
HPN++++++V A+ +TK+ +V E +D DK+ G L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYV 182
+D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ I S Q+ ++ T Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YR 174
Query: 183 APEVLNDKGYDGRASDVWSCGVIL 206
APEVL Y D+WS G I
Sbjct: 175 APEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 65/247 (26%), Positives = 120/247 (48%), Gaps = 10/247 (4%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G DE R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD YG ++ISD GL+ ++ E + GT Y+APEV+ ++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 197 SDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252
D W G +++ ++ G PF ++ + R++ FS A+ + +++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 253 PNPDTRM 259
+P R+
Sbjct: 242 KDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 76/311 (24%), Positives = 121/311 (38%), Gaps = 52/311 (16%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIV-----DRDQVLRHKMVEQIK------REIS 65
G LGEG++ KV+ A + TG VAIK V D ++V RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
M IKH N++ +++V I +V++ + +L + + RL E + + Q++N
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPN-- 180
++ H HRDL P N+ ++S G+ KI+DFGL+ T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 181 -------YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI----- 228
Y APE+L A D+WS G I L+ G F N + +I
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 229 ----------------CRADFSCPSWFSSGAK-------KLIKRILDPNPDTRMTISQML 265
P + L++ +L NP R++ + L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 266 EDEWFKKGYKP 276
+ E+FK P
Sbjct: 312 KHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-KMVEQIKREISTMKLIKH 72
+Y++ +G+GS+ V A + TG+ VAIK ++ V H +I REI ++L++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRH 58
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
P++++I +M ++ IY+V E ++ +L I + L + + + QL+ A+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEV 186
Y H+ VFHRDLKP+N+L ++ LKI DFGL+ ++ + T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 187 LNDKGYDGR---ASDVWSCGVILFVLMAG 212
+ + A D+WS G I ++ G
Sbjct: 178 CG--SFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 52/145 (35%), Positives = 81/145 (55%), Gaps = 12/145 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKLIKHPNVI 76
LGEGS+A V ++ TG VA+K +R + E RE S +K +KH N++
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK------EIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVF 135
+ +++ +K + +V E++D +L + G L R + QL+ + YCH R V
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 136 HRDLKPENLLLDSYGVLKISDFGLS 160
HRDLKP+NLL+ G LK++DFGL+
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 63/197 (31%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKI--VDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
+G+G+F V + ++ VA+K L+ K ++ E +K HPN++
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ----EAEILKQYDHPNIV 55
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
K+I V K IYIV+E + GG L + K RL + + ++Y S+
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG----TP-NYVAPEVLNDK 190
HRDL N L+ VLKISDFG+S E+G ++T P + APE LN
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 191 GYDGRASDVWSCGVILF 207
Y SDVWS G++L+
Sbjct: 171 RYTS-ESDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 74/256 (28%), Positives = 122/256 (47%), Gaps = 20/256 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRD--QVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG+G+F +V F ++ VA+K D Q L+ K + + + +K HPN++K+
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR----ILKQYDHPNIVKL 57
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
I V + IYIV+E + GG+ + K LK + ++ + Y S+ HR
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----YVAPEVLNDKGYD 193
DL N L+ VLKISDFG+S +ED ++++ G + APE LN Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 194 GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRIL 251
SDVWS G++L+ + G P+ ++ + SCP K+++R
Sbjct: 173 SE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCW 231
Query: 252 DPNPDTRMTISQMLED 267
D P+ R S++ ++
Sbjct: 232 DYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 68/249 (27%), Positives = 127/249 (51%), Gaps = 15/249 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G F +V + TG A K +++ ++ + K E E + + ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 81 VMASKTKIYIVLEFIDGGEL----FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
+KT + +V+ ++GG+L ++ ++ E A Y Q+I+ +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 137 RDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
RDLKPEN+LLD+ G ++ISD GL+ Q + G GTP ++APE+L + YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYD- 175
Query: 195 RASDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250
+ D ++ GV L+ ++A PF ++ L ++I + P FS +K + +
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 251 LDPNPDTRM 259
L +P+ R+
Sbjct: 236 LAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 27/236 (11%)
Query: 15 YELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ L R LG G F +V + V VAIKI+ D +L+ + ++E+ +K ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQD---FQKEVQALKRLR 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQ-QLINAVDYC 129
H ++I + V + +YI+ E ++ G L + G++ + Q+ + Y
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLN 188
+ HRDL N+L+ V K++DFGL+ + ++ED L + P + APE +
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 189 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESN-------LMALYRKICRADFSCP 236
+ + SDVWS G++L+ + G +P+ N + A YR C A CP
Sbjct: 178 HGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA--KCP 230
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 72/232 (31%), Positives = 117/232 (50%), Gaps = 22/232 (9%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
R G +EL +G G++ +V ++V+TG AIK++D + E+IK+EI+ +K
Sbjct: 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLK 57
Query: 69 LIKH-PNVIKIIEVMASKT------KIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYF 119
H N+ K ++++V+EF G + D I K LKE+
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
++++ + + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTP 175
Query: 180 NYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
++APEV+ D YD + SD+WS G+ + G P D + AL+
Sbjct: 176 YWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 70/252 (27%), Positives = 120/252 (47%), Gaps = 20/252 (7%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G +E R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD +G ++ISD GL+ V E + GT Y+APEV+ ++ Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---------SCPSWFSSGAKKLI 247
D W+ G +L+ ++AG PF + +KI R + FS A+ L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARSLC 236
Query: 248 KRILDPNPDTRM 259
K +L +P R+
Sbjct: 237 KMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 20/278 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G++ V + TG +A+K + + L QI E+ + P ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 81 VMASKTKIYIVLEFIDGG---ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFH 136
+ +Y+ +E++D G +L+ + ED RR ++ + + + H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RD+KP N+L++ G +K+ DFG+S L T G +Y+APE + G +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSG----NLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 197 -----SDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRAD-FSCPSWFSSGAKKLI 247
SDVWS G+ + + G P+ +N+ A I D + PS +S A+ +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 248 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
+ L+ P+ R T +Q+LE W K YK D E V
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWLVK-YKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 17/264 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G GSF V FA N T + VA+K + ++ + I +E+ ++ +KHPN I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++V+E+ G D + H + L+E E + + Y HS + HRD+
Sbjct: 89 CYLKEHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKG-YDGRA 196
K N+LL G +K++DFG ++ S ++ GTP ++APEV+ D+G YDG+
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDP 253
DVWS G+ L P N M+ I + D W + + + L
Sbjct: 202 -DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQK 259
Query: 254 NPDTRMTISQMLEDEWFKKGYKPP 277
P R +++L ++ ++ +P
Sbjct: 260 IPQERPASAELLRHDFVRRD-RPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 68/247 (27%), Positives = 117/247 (47%), Gaps = 10/247 (4%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G DE R F +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD G ++ISD GL+ Q+ E + GT Y+APEV+N++ Y +
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKY-TFS 181
Query: 197 SDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252
D W G +++ ++ G PF + + R++ FS AK + + +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 253 PNPDTRM 259
NP R+
Sbjct: 242 KNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 14 KYELGRTLGEGSFAKV--KFAKNVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMK 68
K L R LG+GSF V AK V G+ VAIK V+ + +R ++ + E S MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--------RYFQ 120
+V++++ V+++ +V+E + G+L + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123
Query: 121 ---QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQ--VREDG--LL 172
++ + + Y ++ HRDL N ++ +KI DFG++ I + R+ G LL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 173 HTACGTP-NYVAPEVLNDKGYDGRASDVWSCGVILF 207
P ++APE L D G SDVWS GV+L+
Sbjct: 184 ------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ YE LGEGS+A V K+ G VA+K++ R Q I RE S +K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAI-REASLLKGL 60
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
KH N++ + +++ +K + +V E++ +L + KH G L + + + QL+ + Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG---TPNYVAPEV 186
H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT T Y P+V
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPDV 174
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
L D+W G I ++ G F
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
YEL + LG+G++ V A+N ET + VAIK + V K++ KR + +KL++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN--VFSKKIL--AKRALRELKLLRH 57
Query: 72 ---HPNVIKIIE---VMASK-TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF-QQLI 123
H N+ + + V ++Y+ E ++ +I + G+ D + F Q++
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-QVREDGLLHTACGTPNY 181
+ Y HS V HRDLKP NLL+++ LKI DFGL+ S+ G + T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 182 VAPEV-LNDKGYDGRASDVWSCGVILFVLMAG 212
APE+ L+ + Y +A DVWS G IL L+
Sbjct: 176 RAPEIMLSFQSYT-KAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 19/205 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGD-FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
+YE +GEG++ KV A++++ G FVA+K V R Q M RE++ ++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 72 --HPNVIKIIEVMA-----SKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQL 122
HPNV+++ +V +TK+ +V E +D DK+ + G + + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNY 181
+ +D+ HS V HRDLKP+N+L+ S G +K++DFGL+ I S Q+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 175
Query: 182 VAPEVLNDKGYDGRASDVWSCGVIL 206
APEVL Y D+WS G I
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 23/205 (11%)
Query: 19 RTLGEGSFAKVKF----AKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
R LGEG F KV N TG+ VA+K + R+ ++ K+EI+ +K + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
++K + + + +++E++ G L D + KH +L + + QQ+ + Y HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTPNY-VAPE 185
HRDL N+LLD+ ++KI DFGL+ A+ + +VREDG +P + A E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVE 180
Query: 186 VLNDKGYDGRASDVWSCGVILFVLM 210
L + + ASDVWS GV L+ L+
Sbjct: 181 CLKENKF-SYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 7e-21
Identities = 70/256 (27%), Positives = 119/256 (46%), Gaps = 20/256 (7%)
Query: 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
LG G+ V A ++ T +A+K++ D + ++ +QI E+ + P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFY 65
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ +I I EF+DGG L + ++ E R ++ + Y S + HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
KP N+L+++ G +K+ DFG+S +Q V + + T GT Y+APE ++ + Y G SDV
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 200 WSCGVILFVLMAGFLPF-----DESNLMALYRKICRADFSCP----SWFSSGAKKLIKRI 250
WS G+ L G P+ ++ +LM L C D P FS I +
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC 236
Query: 251 LDPNPDTRMTISQMLE 266
+ P R +++
Sbjct: 237 MRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 63/192 (32%), Positives = 95/192 (49%), Gaps = 12/192 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G G+F +V + VA+K R+ L + + +E +K HPN++++I
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
V K IYIV+E + GG+ + G RLK E + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----YVAPEVLNDKGYDGR 195
N L+ VLKISDFG+S + EDG+ + G + APE LN Y
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 196 ASDVWSCGVILF 207
SDVWS G++L+
Sbjct: 177 -SDVWSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R +G GSF V FA++V T + VAIK + ++ + I +E+ ++ IKHPN I+
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++V+E+ G D + H + L+E E + + Y HS + HR
Sbjct: 91 KGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDG 194
D+K N+LL G +K++DFG ++I+ ++ GTP ++APEV +++ YDG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALY 225
+ DVWS G+ L P N M ALY
Sbjct: 204 KV-DVWSLGITCIELAERKPPLFNMNAMSALY 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 15/221 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+G+ + V AK+ T VA+K ++ D + ++ +++EI T + ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHS 131
++ + +++Y+V + G D + H G L E + ++NA+DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDF--GLSAISQQVRE---DGLLHTACGTPNYVAPEV 186
+G HR +K ++LL G + +S +S I R+ ++ +++PEV
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 187 L--NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225
L N +GY+ + SD++S G+ L G +PF + +
Sbjct: 180 LQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+ V K++ TG +A K+V + + +QI RE+ M + P ++
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSF 68
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFH 136
++ I + +EF+D G L D+I K G + + + ++ + Y ++ + H
Sbjct: 69 YGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 137 RDLKPENLLLDSYGVLKISDFGLS-----AISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
RD+KP N+L++S G +K+ DFG+S +I+ T GT Y++PE +
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---------TFVGTSTYMSPERIQGGK 178
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESN------------LMALYRKICRADFSCPS-W 238
Y + SDVWS G+ + L G PF SN L L + + PS
Sbjct: 179 YTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 280
F + + L +P R T Q+ F + + + D
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVD 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 84/333 (25%), Positives = 147/333 (44%), Gaps = 53/333 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + +G G++ V A + TG VAIK + R ++ RE+ +K +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 74 NVIKIIEVMASKTKI------YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
NVI +++V + Y+V+ F+ G K+ KH +L ED + Q++ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y H+ G+ HRDLKP NL ++ LKI DFGL+ + D + T Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF------------------------------D 217
+ + + D+WS G I+ ++ G F D
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 218 ESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
N + + + DF S + A +++++L + ++R+T ++ L +F++ + P
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 277 PHFDKEEEV-----NLDDVDAIFNDSKENLVTE 304
+ E E + D+VD + K TE
Sbjct: 308 ---EDETEAPPYDDSFDEVDQSLEEWKRLTFTE 337
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R +G GSF V FA++V + VAIK + ++ + I +E+ ++ ++HPN I+
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++V+E+ G D + H + L+E E + + Y HS + HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDG 194
D+K N+LL G++K+ DFG ++I + GTP ++APEV +++ YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALY 225
+ DVWS G+ L P N M ALY
Sbjct: 194 KV-DVWSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ +G G+F V A++ TG VAIK + + ++ RE+ +K ++H N+I +
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 79 IEVMAS-KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
++ S IY V E + G ++ L++ + + Q++ + Y HS GV HR
Sbjct: 75 SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRA 196
DLKP N+L++ LKI DFGL+ I Q + G + T Y APE+ L + YD
Sbjct: 133 DLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIMLTWQKYD-VE 186
Query: 197 SDVWSCGVILFVLMAG 212
D+WS G I ++ G
Sbjct: 187 VDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ V A + VA+K + R Q L H + RE+ +K +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH--ARRTYRELRLLKHMKH 73
Query: 73 PNVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V T ++Y+V + G + I K +L ++ + QL+ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
Y HS G+ HRDLKP N+ ++ L+I DFGL ++Q ++ + A T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL---ARQADDEMTGYVA--TRWYRAPEI 186
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
+ + + + D+WS G I+ L+ G F ++ + ++I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 21 LGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQI---KREISTMKLIKHP 73
LG+G+F V+ + TG+ VA+K L+H E + +REI +K ++H
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK------KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 74 NVIKIIEVM--ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
N++K V A + + +V+E++ G L D + KH RL + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-VAPEVLND 189
S+ HRDL N+L++S +KI DFGL+ + Q +E + +P + APE L +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 190 KGYDGRASDVWSCGVILFVL 209
+ ASDVWS GV+L+ L
Sbjct: 186 SKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-19
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 53 RHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRL 110
+ + + I I H PN++ + + + S+ +++VL+ +GG+L+ I+K +
Sbjct: 28 KSSEYSRERLTI-----IPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI 82
Query: 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG-LSAISQQVRED 169
E+ +R+ +++ A+D H G+ RDL P N+LLD G ++++ F S + +
Sbjct: 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE 142
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC 229
+ + C APEV + A D WS G ILF L+ G E + +
Sbjct: 143 AVENMYC------APEV-GGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINT--- 191
Query: 230 RADFSCPSWFSSGAKKLIKRILDPNPDTRM 259
+ P W S A+ L++++L NP R+
Sbjct: 192 HTTLNIPEWVSEEARSLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 25/262 (9%)
Query: 21 LGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77
LG+GSF V+ + + G VA+K + D++ +++ +E + M + H N+I+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIR 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--------RYFQQLINAVDYC 129
+ V+ + + +V E G L D RL++D Y Q+ N + Y
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLN 188
S+ HRDL N+LL S +KI DFGL Q + ++ P + APE L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRAD--FSCPSWFSSGAKK 245
+ + ASDVW GV L+ + G P+ + + +KI + P
Sbjct: 174 TRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN 232
Query: 246 LIKRILDPNPDTRMTISQMLED 267
++ + NP R T + + E
Sbjct: 233 VMLQCWAHNPADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG G F V K VAIK ++ + +E+ K M + HP ++++
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
V + +YIV EF++ G L + + + G+L +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDG 194
DL N L+ S GV+K+SDFG+ ++ V +D ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGM---TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 195 RASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRAD 232
+ SDVWS GV+++ V G +PF++ + + I R
Sbjct: 181 K-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKLIKHPNVI 76
LGEGS+A V + G VA+K V+ K E + RE S +K +KH N++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK------VISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
+ +++ +K + V E++ +L + +H G L R + QL+ + Y H + +
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 136 HRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRDLKP+NLL+ G LK++DFGL+ +I Q ++ T Y P+VL
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATD 180
Query: 193 DGRASDVWSCGVILFVLMAG 212
A D+W G I ++ G
Sbjct: 181 YSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 19 RTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
R LGEG F KV+ + TG+ VA+K + + H + +K+EI ++ + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 75 VIKI--IEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
++K I I +++EF+ G L + + ++ ++ + +Y Q+ +DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-VAPEVL-ND 189
R HRDL N+L++S +KI DFGL+ + +E + +P + APE L
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 190 KGYDGRASDVWSCGVILFVLM 210
K Y ASDVWS GV L+ L+
Sbjct: 188 KFY--IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVIKI 78
LGEG++A V ++ T + VA+K + L H+ RE+S +K +KH N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHSRGVFHR 137
+++ ++ + +V E++D +L + G L + F QL+ + YCH R + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 138 DLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
DLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P+VL
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSTEYS 182
Query: 195 RASDVWSCGVILFVLMAG 212
D+W G IL+ + G
Sbjct: 183 TPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMV---------EQIKREIST 66
E R +G G+F V + G VA+K KM +++ RE+
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK----------KMPNVFQNLVSCKRVFRELKM 52
Query: 67 MKLIKHPNVIKIIEVMASK-----TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQ 121
+ KH NV+ ++++ +IY+V E + +L I L D + + Q
Sbjct: 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQ 111
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
++ + Y HS G+ HRD+KP NLL++S VLKI DFGL A ++ E + T Y
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDESKHMTQEVVTQYY 170
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220
APE+L + A D+WS G I L+ + F +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR-EISTMKLIKHPNVIKII 79
LG+G F +V + TG A K +D+ + L+ K E++ E ++ + P ++ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHSRGVFHR 137
SKT + +V+ ++GG+L I G + R Y Q+ + + HS + +R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
D+KPEN+LLD G ++SD GL+ ++++ + GT Y+APE+L ++ Y
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPV 175
Query: 198 DVWSCGVILFVLMAGFLPF 216
D ++ G ++ ++AG PF
Sbjct: 176 DWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 67 MKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
MK +PN IK+ + + +++++I G+LFD + K G+L E E ++ +QL+ A+
Sbjct: 65 MK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGV-LKISDFGLSAI--SQQVREDGLLHTACGTPNYVA 183
+ H + H D+K EN+L D + + D+GL I + + GT +Y +
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFS 174
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--------LMALYRKICRADFSC 235
PE + YD + D W+ GV+ + L+ G PF E L+ +K
Sbjct: 175 PEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPF 229
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMT 260
S A ++ +L N + R+T
Sbjct: 230 IKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 8 SRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKI--VDRDQVLRHKMVEQI 60
R + LGR +GEG F V +N + VA+K +R K ++
Sbjct: 4 QREDI---TLGRCIGEGQFGDVYQGVYMSPENEKIA--VAVKTCKNCTSPSVREKFLQ-- 56
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYF 119
E M+ HP+++K+I V+ ++ ++IV+E GEL + + L Y
Sbjct: 57 --EAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
QL A+ Y S+ HRD+ N+L+ S +K+ DFGLS + ED + A
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS----RYLEDESYYKASKGK 169
Query: 180 ---NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
++APE +N + + ASDVW GV ++ +LM G PF
Sbjct: 170 LPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 25/258 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ V A + +TG VA+K + R Q + H ++ RE+ +K +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMKH 75
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V +Y+V + G + I K +L +D + Q++ +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
Y HS + HRDLKP NL ++ LKI DFGL+ D + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 188
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246
+ + + + D+WS G I+ L+ G F ++ + + I R + + +L
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA-------EL 241
Query: 247 IKRILDPNPDTRMTISQM 264
+K+I + R I +
Sbjct: 242 LKKI--SSESARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ + +G G+ V A + TG VAIK + R Q + H ++ RE+ MKL+ H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYRELVLMKLVNH 74
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYF-QQLI 123
N+I ++ V + +Y+V+E +D ++ H R+ Y Q++
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQML 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+ + HS G+ HRDLKP N+++ S LKI DFGL+ + ++ T Y A
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 185
Query: 184 PEVLNDKGYDGRASDVWSCGVIL 206
PEV+ GY D+WS G I+
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG G F VK+ K D VAIK++ + + +E+ K M + H ++++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQL 64
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHR 137
V + IYIV E++ G L + + +HG R + + + + + Y S+ HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDG 194
DL N L+D G +K+SDFGL S+ V +D ++ G+ + PEVL +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGL---SRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 195 RASDVWSCGVILF-VLMAGFLPFDESN 220
+ SDVW+ GV+++ V G +P++ N
Sbjct: 181 K-SDVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 82/328 (25%), Positives = 133/328 (40%), Gaps = 83/328 (25%)
Query: 14 KYELGRTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
KYE+ +G G++ +V A KN + G AIK D+ + + REI+ ++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 72 HPNVIKIIEVMASKT--KIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ------- 120
H NV+ ++EV +Y++ ++ + D +I K R R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHR---QAKRVSIPPSMVKSL 113
Query: 121 --QLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQ-----VRED 169
Q++N V Y HS V HRDLKP N+L+ GV+KI D GL+ + D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 170 GLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVI---LFVLMAGF----------LP 215
++ T Y APE+ L + Y +A D+W+ G I L L F P
Sbjct: 174 PVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 216 FDESNLMAL--------------------YRKICRADFSCPSWFSSGAK----------- 244
F L + Y + + + +S AK
Sbjct: 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288
Query: 245 --KLIKRILDPNPDTRMTISQMLEDEWF 270
L++++L+ +P R+T + LE +F
Sbjct: 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-18
Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 20/226 (8%)
Query: 15 YELGRT-------LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+E+ RT LG G + +V + VA+K + D + VE+ +E + M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVM 56
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ--QLINA 125
K IKHPN+++++ V + YI+ EF+ G L D + + R + + + Q+ +A
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL-HTACGTP-NYVA 183
++Y + HRDL N L+ ++K++DFGLS + + D H P + A
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 173
Query: 184 PEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
PE L + + SDVW+ GV+L+ + G P+ +L +Y +
Sbjct: 174 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
K LG +GEG F V + TG VA+K + D V +E E + M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCD-VTAQAFLE----ETAVMTKLHHK 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHS 131
N+++++ V+ +YIV+E + G L + + GR + ++ + ++Y S
Sbjct: 60 NLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ + HRDL N+L+ GV K+SDFGL+ + ++ L + APE L K
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNL 221
+ + SDVWS GV+L+ V G P+ + +L
Sbjct: 174 FSSK-SDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVIKI 78
LGEG++A V ++ T + VA+K + L H+ RE+S +K +KH N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHR 137
+++ ++ + +V E++D +L + G + + QL+ ++YCH R V HR
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 138 DLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
DLKP+NLL++ G LK++DFGL+ +I + + ++ T Y P++L
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYS 183
Query: 195 RASDVWSCGVILFVLMAG 212
D+W G I + + G
Sbjct: 184 TQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 72/301 (23%), Positives = 136/301 (45%), Gaps = 59/301 (19%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ +Y++ R +G+G +V A + VA+K + D + ++ RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR------------RYF 119
HP ++ + + + +Y + +I+G L + K KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED---------- 169
++ ++Y HS+GV HRDLKP+N+LL +G + I D+G AI +++ E+
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA-AIFKKLEEEDLLDIDVDER 178
Query: 170 GLLHTA-------CGTPNYVAPEVLNDKGYDGRAS-DVWSCGVILF-VLMAGF------- 213
+ +++ GTP+Y+APE L G S D+++ GVIL+ +L F
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
Query: 214 --LPFDESNL----MALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
+ + + L +A YR+I P + S ++ + L +P R + Q L+
Sbjct: 237 RKISYRDVILSPIEVAPYREI-------PPFLS----QIAMKALAVDPAERYSSVQELKQ 285
Query: 268 E 268
+
Sbjct: 286 D 286
|
Length = 932 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
+ LG G F V K D VAIK++ + +E+ K M + HPN++
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLV 62
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
++ V + I+IV E++ G L + + + G+L + + A++Y S G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY----VAPEVLNDKG 191
HRDL N L+ V+K+SDFGL ++ V +D +T+ + PEV +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGL---ARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFD 217
+ + SDVWS GV+++ V G +P++
Sbjct: 178 FSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 63/285 (22%)
Query: 19 RTLGEGSFAKV---KFAKNVETGDFVAIKIV-------DRDQVLRHKMVEQIKREISTMK 68
+ +G G F +V + + VAIK + R L E S M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT---------EASIMG 60
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN---- 124
HPN+I++ V+ + I+ E+++ G L DK L+E++ + QL+
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRG 114
Query: 125 ---AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP- 179
+ Y HRDL N+L++S V K+SDFGLS + + T G P
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPI 172
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF 239
+ APE + + + ASDVWS G++++ +M+ + E P W
Sbjct: 173 RWTAPEAIAYRKFT-SASDVWSFGIVMWEVMS----YGER----------------PYWD 211
Query: 240 SSGAKKLIKRILD----PNP-DTRMTISQMLEDEWFKKGYKPPHF 279
S + +IK + D P P D + Q++ D W K + P F
Sbjct: 212 MSN-QDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTF 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVIKI 78
LGEG++A V ++ T + VA+K + L H+ RE+S +K +KH N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKE-DEARRYFQQLINAVDYCHSRGVFHR 137
+++ + + +V E++D +L + G + + + Q++ + YCH R V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 138 DLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
DLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P+VL
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSSEYS 183
Query: 195 RASDVWSCGVILFVLMAG 212
D+W G I F + +G
Sbjct: 184 TQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 40/297 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI--KH--PNVI 76
+G G+ +V + +TG +A+K Q+ R E+ KR + + ++ H P ++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSR-G 133
K + + ++I +E + DK+ K G + ED + ++ A+ Y + G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPNYVAPEVL----- 187
V HRD+KP N+LLD+ G +K+ DFG+S + V D T + G Y+APE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADFSCPSW---FSSGA 243
N K YD RA DVWS G+ L L G P+ + KI + + FS
Sbjct: 192 NPK-YDIRA-DVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
+ L + R ++L+ + + ++ E DV F D
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIR------RYETAE----VDVAGWFQDVMAE 296
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L +T+G+G F V G+ VA+K + D + E S M ++H N+
Sbjct: 9 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNL 61
Query: 76 IKIIEVMAS-KTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSR 132
++++ V+ K +YIV E++ G L D + GR L D ++ + A++Y +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRDL N+L+ V K+SDFGL+ + ++ G L + APE L +K +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF 176
Query: 193 DGRASDVWSCGVILFVLMA-GFLPF 216
+ SDVWS G++L+ + + G +P+
Sbjct: 177 STK-SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 82/329 (24%), Positives = 142/329 (43%), Gaps = 59/329 (17%)
Query: 2 SVKVPASR-TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQ 59
SV+V S T + +Y+ + +G G+ V A + G VA+K + R Q H ++
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH--AKR 66
Query: 60 IKREISTMKLIKHPNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKED 113
RE+ +K + H N+I ++ V + +Y+V+E +D L I H L +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--HMELDHE 123
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173
Q++ + + HS G+ HRDLKP N+++ S LKI DFGL ++ + ++
Sbjct: 124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTACTNFMMT 180
Query: 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--- 230
T Y APEV+ GY D+WS G I+ L+ G + F ++ + + K+
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 231 ---ADFSC-------------------------PSWF-----------SSGAKKLIKRIL 251
A+F P W +S A+ L+ ++L
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299
Query: 252 DPNPDTRMTISQMLEDEWFKKGYKPPHFD 280
+PD R+++ + L + Y P +
Sbjct: 300 VIDPDKRISVDEALRHPYITVWYDPAEAE 328
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
Y + +TL GS +V A D V +KI + L M+ ++ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAML---------LQNVNHPS 118
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRG 133
VI++ + + S +VL +L+ + K L D+A +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRD+K EN+ ++ + I D G A V L A GT APEVL Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG--AAQFPVVAPAFLGLA-GTVETNAPEVLARDKYN 234
Query: 194 GRASDVWSCGVILFVLMA 211
+A D+WS G++LF ++A
Sbjct: 235 SKA-DIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 61/237 (25%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ LG+ LGEG+F +V A+ V + VA+K++ D K + + E+ MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMK 70
Query: 69 LI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED-EARR--------- 117
+I KH N+I ++ V + +Y+V+E+ A HG L++ ARR
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEY----------AAHGNLRDFLRARRPPGEYASPD 120
Query: 118 ----------------YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161
+ Q+ +++ S+ HRDL N+L+ V+KI+DFGL
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL-- 178
Query: 162 ISQQVRE--------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++ + +G L ++APE L D+ Y SDVWS GV+L+ +
Sbjct: 179 -ARDIHHIDYYRKTTNGRLPV-----KWMAPEALFDRVYT-HQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + +G G++ V A + TG+ VAIK + R ++ RE++ +K ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 74 NVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
NVI +++V S Y+V+ ++ KI H L ED+ + Q++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGLK 131
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y HS G+ HRDLKP NL ++ LKI DFGL+ D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 186
Query: 188 NDKGYDGRASDVWSCGVILFVLMAG 212
+ + + D+WS G I+ ++ G
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G+ V ++ +G +A K++ + ++ + QI RE+ + P ++
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG------- 133
S +I I +E +DGG L D++ K EA+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 134 --VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ HRD+KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 178
Query: 192 YDGRASDVWSCGVILFVLMAGFLPF---DESNLMALY 225
Y + SD+WS G+ L L G P D L A++
Sbjct: 179 YSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-KM-VEQIKREISTMKLIKHPN 74
L R LG G F +V T VA+K L+ M E +E MK ++H
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVK------TLKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR-YFQQLI-------NAV 126
++++ V + + IYIV E++ G L D LK E ++ QL+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVA 183
Y SR HRDL N+L+ V KI+DFGL+ ++ ED G + A
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIKWTA 172
Query: 184 PEVLNDKGYDGR---ASDVWSCGVILFVLM 210
PE N Y GR SDVWS G++L ++
Sbjct: 173 PEAAN---Y-GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G+ V + +G +A K++ + ++ + QI RE+ + P ++
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDL 139
S +I I +E +DGG L + K GR+ E + +I + Y + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L Y + SD+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYSVQ-SDI 185
Query: 200 WSCGVILFVLMAGFLP 215
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 15 YELGRTLGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ LGR LG+G F V+ A+ E G F VA+K++ D + +E+ RE + MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFD 59
Query: 72 HPNVIKIIEV-MASKTK-----IYIVLEFIDGGEL--FDKIAKHGR----LKEDEARRYF 119
HPNVIK+I V + S+ K ++L F+ G+L F +++ G L R+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+ + ++Y S+ HRDL N +L+ + ++DFGL S+++ C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL---SKKIYSGDYYRQGCASK 176
Query: 180 ---NYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++A E L D Y SDVW+ GV ++ +M
Sbjct: 177 LPVKWLALESLADNVYTTH-SDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 50/278 (17%)
Query: 21 LGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKR----EISTMKLIKHP 73
+G G F +V + G FVAIK L+ E+ +R E S M HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI-------NAV 126
N+I + V+ + I+ EF++ G L D L++++ + QL+ +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL-DSF-----LRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVA 183
Y HRDL N+L++S V K+SDFGLS + D ++ G + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF-DESNLMALYRKICRADFSCPSWFSS 241
PE + + + ASDVWS G++++ +M+ G P+ D SN + D+ P
Sbjct: 180 PEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP----- 231
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 279
P D + Q++ D W K P F
Sbjct: 232 -----------PPMDCPTALHQLMLDCWQKDRNARPKF 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 17 LGRTLGEGSFAKVKFAK-------NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
LG+ LGEG F +V A+ + VA+K++ + K + + E+ MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKL 73
Query: 70 I-KHPNVIKIIEVMASKTKIYIVLEFIDGGEL---------------FDKIAKH-GRLKE 112
I KH N+I ++ V + +Y+++E+ G L FD +L
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172
+ Q+ ++Y SR HRDL N+L+ V+KI+DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 173 HTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVIL---FVLMAG---FLPFDESNLMAL 224
T+ G ++APE L D+ Y SDVWS G+++ F L +P +E L L
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKL 248
Query: 225 YRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
R+ R D PS + L++ P R T Q++E
Sbjct: 249 LREGHRMD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIK-----IVDRDQVLRHKMVEQIKREISTMKLIKHP 73
LG G++ V ++V TG +A+K + ++Q +++ + +IS M+ + P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDL--DIS-MRSVDCP 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCH 130
+ + + ++I +E +D + + K+ G + ED + ++ A++Y H
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 131 SR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPE--- 185
S+ V HRD+KP N+L++ G +K+ DFG+S V D + T G Y+APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLV--DSVAKTIDAGCKPYMAPERIN 176
Query: 186 -VLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
LN KGYD + SDVWS G+ + L G P+D
Sbjct: 177 PELNQKGYDVK-SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 70/264 (26%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
ELG G G KV + +G +A K++ + ++ + QI RE+ + P +
Sbjct: 8 ELGAGNG-GVVTKVL---HRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYI 61
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG-- 133
+ S +I I +E +DGG L D++ K +A R + ++ + RG
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLT 113
Query: 134 -------VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ HRD+KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPER 169
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGA 243
L Y + SD+WS G+ L + G P D L A+ F P
Sbjct: 170 LQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAM--------FGRPVSEGEAK 220
Query: 244 KKLIKRILDPNPDTR-MTISQMLE 266
+ P R M I ++L+
Sbjct: 221 ESHRPVSGHPPDSPRPMAIFELLD 244
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 18/227 (7%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
T + +Y+ + +G G+ V A + VAIK + R ++ RE+ MK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 70 IKHPNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQ 121
+ H N+I ++ V + +YIV+E +D + + +++ D R + Q
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-----NLCQVIQMELDHERMSYLLYQ 134
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
++ + + HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 191
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
APEV+ GY D+WS G I+ ++ G + F ++ + + K+
Sbjct: 192 RAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGD-------FVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
LG+ LGEG F +V A+ + VA+K++ D K + + E+ MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 79
Query: 70 I-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY---------- 118
I KH N+I ++ +Y+++E+ G L + + R + Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQVPEE 135
Query: 119 ---FQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168
F+ L++ ++Y S+ HRDL N+L+ V+KI+DFGL+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 193
Query: 169 DGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE---SNLM 222
D T G ++APE L D+ Y SDVWS GV+L+ + G P+ L
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 223 ALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
L ++ R D PS ++ +++ P R T Q++ED
Sbjct: 253 KLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 19 RTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKR----EISTMKLIK 71
+ +G G F +V + G VAIK L+ E+ +R E S M
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIK------TLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
HPN+I + V+ + IV E+++ G L + KH G+ + + + + + Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLND 189
G HRDL N+L++S V K+SDFGLS + + E P + APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 190 KGYDGRASDVWSCGVILFVLMA 211
+ + ASDVWS G++++ +M+
Sbjct: 184 RKFTS-ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G G F V +E VAIK + R+ + E E M + HP ++++
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 81 VMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
V ++ I +V EF++ G L D + A+ G+ ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRA 196
N L+ V+K+SDFG++ D ++ GT + +PEV + Y +
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVL----DDQYTSSTGTKFPVKWSSPEVFSFSKYSSK- 181
Query: 197 SDVWSCGVILF-VLMAGFLPFD 217
SDVWS GV+++ V G P++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 49/167 (29%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 55 KMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED- 113
+ Q++ EI + + H N++KI E++ S+ Y++ + D +L+ + +D
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDR 263
Query: 114 ----EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
+ R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG + ++ RE
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE- 322
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLP 215
+ GT +PE+L GY +D+WSCG+IL +++ F P
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCP 368
|
Length = 501 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 16 ELGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
EL +G G V A+ TG++V ++ ++ + ++MV ++ E+ KL HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINL-EACTNEMVTFLQGELHVSKLFNHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHS 131
N++ + ++++V F+ G D I H + E Q ++ A+DY H
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-------VAP 184
G HR +K ++L+ G + +S GL + + L P Y ++P
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177
Query: 185 EVL--NDKGYDGRASDVWSCGVILFVLMAGFLPFDE 218
EVL N +GYD + SD++S G+ L G +PF +
Sbjct: 178 EVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 19 RTLGEGSFAKV-------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ LG G+F V K K VE VA+K + ++ + K ++ RE S M +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE----VAVKTLKQEHIAAGK--KEFLREASVMAQLD 54
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HP ++++I V + + +V+E G L + K + + + Q+ + Y S
Sbjct: 55 HPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLS----AISQQVREDGLLHTACGTP-NYVAPEV 186
+ HRDL N+LL + KISDFG+S A S R TA P + APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPEC 169
Query: 187 LNDKGYDGRASDVWSCGVIL 206
+N + + SDVWS GV L
Sbjct: 170 INYGKFSSK-SDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
T + +Y+ + +G G+ V A + VAIK + R ++ RE+ MK
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 70 IKHPNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQ 121
+ H N+I ++ V + +Y+V+E +D + + +++ D R + Q
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQ 127
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
++ + + HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 184
Query: 182 VAPEVLNDKGYDGRASDVWSCGVIL 206
APEV+ GY D+WS G I+
Sbjct: 185 RAPEVILGMGYKENV-DIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 80/292 (27%), Positives = 131/292 (44%), Gaps = 44/292 (15%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQI 60
SRTR+ LG+ LGEG F +V A+ + VA+K++ D K + +
Sbjct: 10 SRTRL---TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDL 64
Query: 61 KREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------FDKIAKHG 108
E+ MK+I KH N+I ++ +Y+++E+ G L D
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 109 RLKEDEARRYFQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161
+L E++ F+ L++ ++Y S+ HRDL N+L+ V+KI+DFGL+
Sbjct: 125 KLPEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 162 ISQQVREDGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE 218
+ D T G ++APE L D+ Y SDVWS GV+L+ + G P+
Sbjct: 183 DVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 219 ---SNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
L L ++ R D P+ + +++ P R T Q++ED
Sbjct: 240 IPVEELFKLLKEGHRMD--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L + LG G F +V A N T VA+K + + VE E + MK ++H
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLAEANVMKTLQHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR--------YFQQLINAV 126
++K+ V+ +K IYI+ EF+ G L D LK DE + + Q+ +
Sbjct: 63 LVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGM 115
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI---SQQVREDGLLHTACGTPNYVA 183
+ R HRDL+ N+L+ + V KI+DFGL+ + ++ +G A + A
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----AKFPIKWTA 171
Query: 184 PEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
PE +N + + SDVWS G++L ++ G +P+
Sbjct: 172 PEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 12/212 (5%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ E + LG G+F V + G+ VAIK++ + K ++I E M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVD 127
+ HP+V++++ + S + ++ + + G L D + H + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEV 186
Y + + HRDL N+L+ + +KI+DFGL+ + V E P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LDVDEKEYHAEGGKVPIKWMALES 182
Query: 187 LNDKGYDGRASDVWSCGVILFVLMA-GFLPFD 217
+ + Y + SDVWS GV ++ LM G P++
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 17 LGRTLGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
LG+ LGEG F V + + + G VA+K + D + + +E+ E + MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHP 61
Query: 74 NVIKIIEV---MASKTKI---YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AV 126
NV+K+I V +S KI ++L F+ G+L + + RL + Q L+ V
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMV 120
Query: 127 D------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS--AISQQVREDGLLHTACGT 178
D Y +R HRDL N +L + ++DFGLS S G A
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG--RIAKMP 178
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++A E L D+ Y + SDVW+ GV ++ +
Sbjct: 179 VKWIAIESLADRVYTSK-SDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 38/271 (14%)
Query: 16 ELGRTLGEGSFAKV-KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L R LG G F +V + N T VA+K + + + E MK ++HP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTM----DPKDFLAEAQIMKKLRHPK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
+I++ V + IYIV E + G L + + LK + Q+ + + Y ++
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTP-NYVAPEVLNDK 190
HRDL N+L+ + K++DFGL+ + ++ED P + APE
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 191 GYDGRASDVWSCGVILFVLMA-GFLPF-DESNLMAL------YRKICRADFSCPSWFSSG 242
+ + SDVWS G++L ++ G +P+ +N L YR C CP
Sbjct: 180 RFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP--GCP------ 230
Query: 243 AKKLIKRILD---PNPDTRMTISQM---LED 267
K+L +LD +PD R T + LED
Sbjct: 231 -KELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 18/196 (9%)
Query: 21 LGEGSFAKVK--FAKNVETGDFVAIKIV---DRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LG G+F VK K ++ VA+KI+ + D L+ +++ RE + M+ + +P +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL----REANVMQQLDNPYI 58
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVF 135
+++I + +++ + +V+E + G L + K+ + E Q+ + Y
Sbjct: 59 VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP----NYVAPEVLNDKG 191
HRDL N+LL + KISDFGL S+ + D + A + APE +N
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGL---SKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 192 YDGRASDVWSCGVILF 207
+ + SDVWS GV+++
Sbjct: 175 FSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREIST 66
K LG+ LGEG F +V A+ + + VA+K++ D K + + E+
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 73
Query: 67 MKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED---------EAR 116
MK+I KH N+I ++ +Y+++E+ G L + + + + +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 117 RYFQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
F+ L++ ++Y S+ HRDL N+L+ V+KI+DFGL+ + D
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--D 191
Query: 170 GLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE---SNLMA 223
T G ++APE L D+ Y SDVWS GV+++ + G P+ L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 224 LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
L ++ R D P+ ++ +++ P R T Q++ED
Sbjct: 251 LLKEGHRMD--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 337 VKRETRFTSQRPPNEIMSKIEEAAKPLGFN--VRKGNYKMKLQG--DKTGRKGQLSVATE 392
K E S+ P+EI I + + G N R N+ + + D E
Sbjct: 2 KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61
Query: 393 VFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 426
V+EV P L +V+ +K G T F K K L
Sbjct: 62 VYEVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIK----IVD-RDQVLRHKMVEQIKREI-STMKLIKHPN 74
+G G+F V + +G +A+K VD ++Q +++ ++ M+ P
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-------KRLLMDLDVVMRSSDCPY 64
Query: 75 VIKIIEVMASKTKIYIVLEFIDGG-ELFDKIA---KHGRLKEDEARRYFQQLINAVDYCH 130
++K + + +I +E +D + F K + E+ + + A++Y
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 131 SR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLN 188
+ HRD+KP N+LLD G +K+ DFG IS Q+ D + T G Y+APE ++
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQL-VDSIAKTRDAGCRPYMAPERID 180
Query: 189 ---DKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220
GYD R SDVWS G+ L+ + G P+ + N
Sbjct: 181 PSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 16 ELGRTLGEGSFAKVKFA-KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L + LG G F +V N T VA+K + + V+ E + MK ++H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTM----SVQAFLEEANLMKTLQHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
++++ V+ + IYI+ E++ G L D K + G++ + + Q+ + Y +
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLND 189
HRDL+ N+L+ + KI+DFGL+ +V ED G + APE +N
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + SDVWS G++L+ ++ G +P+
Sbjct: 179 GSFTIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/236 (30%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+R+ Y+LG +G GSF V A ++T + VAIK V +D ++ RE+ M
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIM 113
Query: 68 KLIKHPNVIKIIE------VMASKTKIY--IVLEFIDGGELFDKIAKHGRLKEDE----- 114
K + H N+I + + ++ I+ +V+EFI + K KH
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFL 171
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLH 173
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG SA + + + +
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSY 230
Query: 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKI 228
+ Y APE++ D+WS G I+ ++ G+ F +S++ L R I
Sbjct: 231 IC--SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
|
Length = 440 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 73/270 (27%), Positives = 115/270 (42%), Gaps = 35/270 (12%)
Query: 20 TLGEGSFAKVKFAK---NVETGD--FVAIKIVDRDQVLRHKMVEQI----KREISTMKLI 70
TLG G F +V AK E G V +K L+ E + +RE+ + +
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK------ALQKTKDENLQSEFRRELDMFRKL 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQQLINAVDY 128
H NV++++ + Y++LE+ D G+L F + K K +Q + A+
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCT 124
Query: 129 CHSRGV--------FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
+ G+ HRDL N L+ S +K+S LS E L A
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLR 183
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF----DESNLMALYRKICRADFSC 235
++APE + + + + SDVWS GV+++ V G LPF DE L L + +
Sbjct: 184 WLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPV 240
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMTISQML 265
P S KL+ R NP R + S+++
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 56/248 (22%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 21 LGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LGEG+F KV + + VAIK + + K+ ++ ++E M ++HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYF 119
+ ++ V + ++ E++ G+L + + ++ L +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
Q+ ++Y S HRDL N L+ +KISDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 180 NYVAPEVLNDKGYDGR---ASDVWSCGVILFVLMA-GFLPF-----DESNLMALYRKICR 230
++ PE + G+ SD+WS GV+L+ + + G P+ E M R++
Sbjct: 191 RWMPPEAI----LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 231 ADFSCPSW 238
CP+
Sbjct: 247 CPEDCPAR 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 37/270 (13%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L + LG G F +V + VAIK + + + E E + MK ++HP
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK---VAIKSLKQGSM----SPEAFLAEANLMKQLQHP 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHS 131
++++ V+ ++ IYI+ E+++ G L D K + +L ++ Q+ + +
Sbjct: 62 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLN 188
+ HRDL+ N+L+ KI+DFGL+ + ++ +G A + APE +N
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG----AKFPIKWTAPEAIN 176
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPFDE-------SNLMALYRKICRADFSCPSWFS 240
G SDVWS G++L ++ G +P+ NL YR +CP
Sbjct: 177 -YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD--NCPEELY 233
Query: 241 SGAKKLIKRILDPNPDTRMT---ISQMLED 267
L++ P+ R T + +LED
Sbjct: 234 E----LMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 72/289 (24%), Positives = 114/289 (39%), Gaps = 42/289 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTMK 68
LG+TLGEG F KV A VA+K++ + + E + +K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLK 58
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL----------------FDKIAKHGRLKE 112
+ HP+VIK+ + + +++E+ G L D L
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 113 DEAR--------RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
+ R + Q+ + Y + HRDL N+L+ +KISDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 165 QVREDGLLHTACG-TP-NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFD---E 218
ED + + G P ++A E L D Y + SDVWS GV+L+ ++ G P+
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 219 SNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
L L + R + P S L+ PD R T + + ++
Sbjct: 236 ERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
+YE G +G G++ V AK + D DRD L+ I REI+ ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 70 IKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGRLKEDE---------ARRY 118
+KHPNVI + +V S K++++ ++ + +L+ I H K ++ +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAI-SQQVREDGLLH 173
Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + + + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
T Y APE+L + +A D+W+ G I L+
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-----TMKLIKHPNV 75
+GEG+F +V A + G + I ++L+ E R+ + KL HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA----------------RRYF 119
I ++ ++ +YI +E+ G L D + K L+ D A ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+ + Y + HRDL N+L+ KI+DFGLS + E + T P
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGRLP 181
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228
++A E LN Y + SDVWS GV+L+ +++ G P+ LY K+
Sbjct: 182 VRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 32/231 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-----TMKLIKHPNV 75
+GEG+F +V A+ + G +++ + ++ + R+ + KL HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA----------------RRYF 119
I ++ + +Y+ +E+ G L D + K L+ D A +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+ +DY + HRDL N+L+ V KI+DFGLS + +E + T P
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLP 174
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228
++A E LN Y SDVWS GV+L+ +++ G P+ LY K+
Sbjct: 175 VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNV-ETGDFV--AIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L R LG G+F +V GD V + + + + E M H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY-FQQLIN-AVD--- 127
N++++I V + +I+LE + GG+L + R + + + L+ A D
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 128 ---YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSA---ISQQVREDGLLHTACGT 178
Y HRD+ N LL G V KI+DFG++ + R+ G A
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLP 184
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
++ PE D G +DVWS GV+L+ + + G++P+
Sbjct: 185 IKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+QL++A+DY H G+ HRD+K EN+L++ + + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF 207
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 67/263 (25%), Positives = 118/263 (44%), Gaps = 22/263 (8%)
Query: 19 RTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
R +G+G F V +++ A+K ++R + + VEQ +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 76 IKIIEVMASKTKI-YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHSRG 133
+ ++ + +VL ++ G+L + I + F Q+ ++Y S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTP-NYVAPEVLNDKG 191
HRDL N +LD +K++DFGL+ I + HT P ++A E L +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 192 YDGRASDVWSCGVILFVLMAGFLP-------FDESNLMALYRKICRADFSCPSWFSSGAK 244
+ + SDVWS GV+L+ LM P FD + + R++ + ++ CP
Sbjct: 179 FTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPDPLYE--- 233
Query: 245 KLIKRILDPNPDTRMTISQMLED 267
++ P P+ R T S+++
Sbjct: 234 -VMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 75/257 (29%), Positives = 111/257 (43%), Gaps = 21/257 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G F +V T VAIK + + M E +E MK ++H ++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 81 VMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ S+ IYIV EF+ G L D K LK + Q+ + + Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR--- 195
L+ N+L+ V KI+DFGL+ + + E A + APE GR
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEA----ALYGRFTI 182
Query: 196 ASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDP 253
SDVWS G++L L+ G +P+ + ++ R CP +L+K
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKK 242
Query: 254 NPDTRMT---ISQMLED 267
+PD R T I LED
Sbjct: 243 DPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 49/287 (17%)
Query: 19 RTLGEGSFAKV-----KFAKNVETGDF-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
LG G+F +V +G VA+K + + + K ++ +E M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD---- 127
PN++K++ V YI++E ++GG+L + + ++L++ +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 128 --YCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGL-----SAISQQVREDGLLHTA 175
Y HRDL N L+ G V+KI DFGL + + +GLL
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRADFS 234
++APE L D G SDVWS GV+++ +L G P+ N +
Sbjct: 178 ----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----------NQE 221
Query: 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 281
++G + L + I Q++ + W + + P FD+
Sbjct: 222 VLQHVTAGGR------LQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 73/263 (27%), Positives = 115/263 (43%), Gaps = 23/263 (8%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L + LG G F +V N T VA+K + + +E E MK ++H
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKKLRHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGR-LKEDEARRYFQQLINAVDYCHSR 132
++++ V+ S+ IYIV E++ G L D + GR LK Q+ + Y
Sbjct: 63 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRDL+ N+L+ V KI+DFGL+ + + E A + APE
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEA----AL 176
Query: 193 DGR---ASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247
GR SDVWS G++L L+ G +P+ N + ++ R CP +L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236
Query: 248 KRILDPNPDTRMT---ISQMLED 267
+ +P+ R T + LED
Sbjct: 237 LQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 62 REISTMKLIKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGRLKEDE----- 114
REI+ ++ +KHPNVI + +V S + K++++ ++ + +L+ I H K ++
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQL 105
Query: 115 ----ARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAI-SQQ 165
+ Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + + +
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++ L T Y APE+L + +A D+W+ G I L+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
E S M H N+I++ V+ I+ E+++ G L DK L++ + QL
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQL 109
Query: 123 IN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
+ + Y HRDL N+L++S K+SDFGLS + + E +
Sbjct: 110 VGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 176 CGTP-NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF-DESN 220
P + APE + + + ASDVWS G++++ +M+ G P+ D SN
Sbjct: 170 GKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 21 LGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVI 76
+GEG+F +V A+ + G D ++ + H+ E+ + KL HPN+I
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 71
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA---------RRYFQQLIN--- 124
++ + +Y+ +E+ G L D + K L+ D A QQL++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 125 ----AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP- 179
+DY + HRDL N+L+ V KI+DFGLS Q+V + T P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY---VKKTMGRLPV 187
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
++A E LN Y SDVWS GV+L+ ++ G P+ LY K+
Sbjct: 188 RWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMV---- 57
S PAS R+ +Y + +L GS +V FV K R K++
Sbjct: 82 SSSDPASVVRM-QYNILSSLTPGSEGEV----------FVCTK---HGDEQRKKVIVKAV 127
Query: 58 ---EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDE 114
+ REI +K I H +I +I K+ + +V+ +LF + + G L ++
Sbjct: 128 TGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQ 186
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174
A ++L+ A+ Y H RG+ HRD+K EN+ LD + DFG + + +
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
GT +PE+L Y + +D+WS G++LF + +
Sbjct: 247 WSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH----KMVEQIKREISTMKLIKHPN 74
+ LG G+F V + G+ V I + + LR K ++I E M + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 70
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ----QLINAVDYCH 130
V +++ + + T + ++ + + G L D + +H K++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVLN 188
R + HRDL N+L+ + +KI+DFGL+ + ++ H G P ++A E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESIL 184
Query: 189 DKGYDGRASDVWSCGVILFVLMA-GFLPFD 217
+ Y SDVWS GV ++ LM G P+D
Sbjct: 185 HRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF----------VAIKIVDRDQVLRHKMVEQIKREIS 65
G+TLG G+F KV VE + VA+K++ + E + E+
Sbjct: 38 SFGKTLGAGAFGKV-----VEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELK 90
Query: 66 TM-KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQL 122
M L H N++ ++ I ++ E+ G+L + + + L ++ + Q+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ + S+ HRDL N+LL ++KI DFGL ++ + D NYV
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL---ARDIMNDS---------NYV 198
Query: 183 ------------APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKIC 229
APE + + Y SDVWS G++L+ + + G P+ + + + K+
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257
Query: 230 RADF--SCPSWFSSGAKKLIKRILDPNPDTRMTISQM 264
+ + + P + ++K D +P R T Q+
Sbjct: 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR---EI 64
SR RV +L L EG+F ++ + ++ + V V H Q+ E
Sbjct: 4 SRDRVTLSDL---LQEGTFGRIFYGILIDE-KPGKEEEVFVKTVKDHASEIQVTLLLQES 59
Query: 65 STMKLIKHPNVIKIIEVMASKT-KIYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQ- 120
+ + H N++ I+ V +++ +++ G L F + + G +A Q
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 121 -----QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
Q+ + Y H RGV H+D+ N ++D +KI+D +A+S+ + H
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDY-HCL 175
Query: 176 CGTPN----YVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDE 218
N ++A E L +K Y ASDVWS GV+L+ LM G P+ E
Sbjct: 176 GDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLI 70
++++ LGEG+F KV A + + ++ A+KIV R+ K K EI M+ +
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV------RNVPKYTRDAKIEIQFMEKV 182
Query: 71 KHPNV------IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI- 123
+ + +KI ++T ++ G L D I KHG + R+ Q+I
Sbjct: 183 RQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF----SHRHLAQIIF 238
Query: 124 ---NAVDYCHSR-GVFHRDLKPENLLLDSYGV----------------LKISDFGLSAIS 163
A+DY H+ + H DLKPEN+L+++ ++I D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE 298
Query: 164 QQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
+ R TA T +Y +PEV+ G+ ++D+WS G I++ L G L +D
Sbjct: 299 RHSR------TAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
LG+TLGEG F V + + VA+K + R +M E E MK HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPN 61
Query: 75 VIKIIEV--MASKTKIY----IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI----- 123
V+++I V +++ Y ++L F+ G+L + + RL + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTD 120
Query: 124 --NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTP 179
+ ++Y S+ HRDL N +L+ + ++DFGLS + G + A
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI--AKMPV 178
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF 207
++A E L D+ Y + SDVWS GV ++
Sbjct: 179 KWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 19/213 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
E+GR G + V A++ TG V ++I D + + + ++ E+ +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 76 IKIIEVMASKTKIYIVLEFIDGG---ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
+ V + + ++++ F+ G L G + E + ++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-------VAPE 185
G HR++K ++L+ G++ +S GLS + VR P + ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 186 VLNDK--GYDGRASDVWSCGVILFVLMAGFLPF 216
+L GY+ + SD++S G+ L G +PF
Sbjct: 179 LLRQDLYGYNVK-SDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 13 GKYELGRTLGEGSFAKVKFAKN---VETGDF--VAIKIVDRDQVLRHKMVEQIKREISTM 67
E R +G+G+F +V A+ + F VA+K++ + + +RE + M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALM 62
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL------------------FDKIAKHGR 109
HPN++K++ V A + ++ E++ G+L K G
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 110 ----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS----- 160
L E +Q+ + Y R HRDL N L+ V+KI+DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
A + E+ + ++ PE + Y SDVW+ GV+L+ + + G P+
Sbjct: 183 ADYYKASENDAIPI-----RWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 58 EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGR-LKEDEA 115
E +E MK ++H ++++ V+ S+ IYIV E++ G L D + + G+ L+ +
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
Q+ + + Y HRDL+ N+L+ V K++DFGL+ + + E A
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 163
Query: 176 CGTPNYVAPEVLNDKGYDGR---ASDVWSCGVILFVLMA-GFLPF 216
+ APE GR SDVWS G++L L G +P+
Sbjct: 164 KFPIKWTAPEA----ALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 6/203 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDR--DQVLRHKMVEQIKREISTMKLIKHPNVI 76
+ LG G+F V V G+ V I + + ++ K + E M + HP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
+++ V S T I +V + + G L D + +H + + Q+ + Y R +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 195
HRDL N+L+ S +KI+DFGL+ + + ++ ++A E ++ + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT-H 190
Query: 196 ASDVWSCGVILFVLMA-GFLPFD 217
SDVWS GV ++ LM G P+D
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 19/232 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-KMVEQIKREISTMKLIKHPNVIKII 79
+G G F KV G A +V + +E+ + + HPNV++ +
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 80 EVMASKTKIYIVLEFIDGGEL-----FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+VLEF G+L ++ ++D +R ++ + + + H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC-GTP-NYVAPEVLNDKGY 192
H DL N L + +KI D+GL+ +Q ED + C P ++APE++ +G
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 193 D------GRASDVWSCGVILFVLM-AGFLPF-DESNLMALYRKICRADFSCP 236
D + S++WS GV ++ L A P+ D S+ L + + D P
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 27 AKVKFAKNVETGDFVAI-----KIVDRD------QVLRHKMVEQIKR----EISTMKLIK 71
+K + + TG F + K+ + LR ++ +R E T+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
H N++++ V+ + IV E++ G L + KH G+L + L + + Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN--YVAPEVLN 188
G H+ L +L++S V KIS F Q+ + + + T G + APE +
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 189 DKGYDGRASDVWSCGVILFVLMA 211
+ ASDVWS G++++ +M+
Sbjct: 182 -YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 38/169 (22%)
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 226
Query: 178 TPNYV------------APEVLNDKGYDGRASDVWSCGVIL---FVLMAGFLP---FDES 219
P+YV APE + DK Y + SDVWS GV+L F L A P DE
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
Query: 220 NLMALYR--KICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
L ++ +++ P +S ++ NP+ R T S+++E
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYS-----IMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 57/246 (23%), Positives = 106/246 (43%), Gaps = 40/246 (16%)
Query: 21 LGEGSFAKVK----FAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
LGE +F K+ + ++ VAIK + + + ++E S M + HPN++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIA-------------KHGRLKEDEARRYFQ--- 120
++ V+ + + ++ E+++ G+L + + + G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 121 -QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL-----SAISQQVREDGLLHT 174
Q+ ++Y S H+DL N+L+ +KISD GL SA +V+ LL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLP---FDESNLMALYRKICR 230
++ PE + + SD+WS GV+L+ + + G P F ++ + RK R
Sbjct: 191 -----RWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--R 242
Query: 231 ADFSCP 236
C
Sbjct: 243 QLLPCS 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 17 LGRTLGEGSFAKV---KFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
L R LGEG+F KV + D VA+K + ++ + +RE + +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASN-DARKDFEREAELLTNFQ 66
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI--------------AKHGRLKEDEARR 117
H N++K V +V E+++ G+L + + G L + +
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
Q+ + + Y S+ HRDL N L+ V+KI DFG+S
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 14 KYELGRTLGEGSFAKV--KFAKNVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMK 68
K L R LG+GSF V A+++ G+ VA+K V+ LR ++ + E S MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELF--------DKIAKHGRLKE--DEARRY 118
+V++++ V++ +V+E + G+L + GR E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--------DG 170
++ + + Y +++ HRDL N ++ +KI DFG+ ++ + E G
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM---TRDIYETDYYRKGGKG 181
Query: 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
LL ++APE L D G +SD+WS GV+L+
Sbjct: 182 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 17 LGRTLGEGSFAKVKFAK--NVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
L R LGEG+F KV A+ N+ T D VA+K + +D L + + +RE + ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAAR--KDFQREAELLTNLQ 65
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEA 115
H +++K V + +V E++ G+L + HG L +
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLL 172
Q+ + + Y S+ HRDL N L+ + ++KI DFG+S + R G
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183
Query: 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
HT ++ PE + + + SDVWS GVIL+
Sbjct: 184 HTMLPI-RWMPPESIMYRKFTTE-SDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 17 LGRTLGEGSFAKVKFAK--NV---ETGDFVAIKIV-DRDQVLRHKMVEQIKREISTMKLI 70
L R LGEG+F KV A+ N+ + VA+K + D R + RE + +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNL 64
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-------------RLKEDEARR 117
+H +++K V + +V E++ G+L + HG L + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLLHT 174
QQ+ + Y S+ HRDL N L+ ++KI DFG+S + R G HT
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HT 182
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
++ PE + + + SDVWS GV+L+
Sbjct: 183 MLPI-RWMPPESIMYRKFTTE-SDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 21 LGEGSFAKVK---FAKNVETGDFVAIKI--VDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LG G+F VK + + D VAIK+ + ++ +R +M+ RE M + +P +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID-VAIKVLKNENEKSVRDEMM----REAEIMHQLDNPYI 57
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+++I V ++ + +V+E GG L + K + Q+ + Y +
Sbjct: 58 VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYD 193
HRDL N+LL + KISDFGLS +A P + APE +N + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 194 GRASDVWSCGVILF 207
R SDVWS G+ ++
Sbjct: 177 SR-SDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 3/150 (2%)
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
E ++ I HP++I++ ++L +L+ +A + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ A+ Y H + HRD+K EN+ ++ G + + DFG + + + A GT
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIATN 250
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAG 212
APE+L Y G A D+WS G++LF +
Sbjct: 251 APELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH----KMVEQIKREISTMKLIKHPN 74
+ LG G+F V K + D +KI +VLR K ++I E M + P
Sbjct: 13 KVLGSGAFGTV--YKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRG 133
V +++ + + T + +V + + G L D + ++ R+ + + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGY 192
+ HRDL N+L+ S +KI+DFGL+ + + E P ++A E + + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 193 DGRASDVWSCGVILFVLMA-GFLPFD 217
SDVWS GV ++ LM G P+D
Sbjct: 189 T-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS----TMKLIKHP 73
+ LG G F V + GD +IKI + ++ + Q +EI+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSR 132
+++++ + + +V + G L D + +H L + Q+ + Y
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKG 191
+ HR+L N+LL S +++I+DFG++ + + ++ TP ++A E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFGR 187
Query: 192 YDGRASDVWSCGVILFVLMA 211
Y SDVWS GV ++ +M+
Sbjct: 188 YT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 14 KYELGRTLGEGSFAKV--KFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
K + R LG+GSF V AK V E VAIK V+ +R ++ + E S MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-------- 120
+V++++ V++ +++E + G+L + L+ + Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS---LRPEMENNPVQAPPSLKKM 121
Query: 121 -----QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE------- 168
++ + + Y ++ HRDL N ++ +KI DFG+ ++ + E
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIYETDYYRKG 178
Query: 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
GLL +++PE L D G SDVWS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK------------REI 64
L LGEG F +V + +F+ + D V+ ++ +EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ---- 120
M +K+PN+I+++ V S + ++ E+++ G+L + L + E F
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL------NQFLSQREIESTFTHANN 122
Query: 121 --------------QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
Q+ + + Y S HRDL N L+ ++ +KI+DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 227
Query: 178 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
P+YV APE + DK Y + SDVWS GV+L+
Sbjct: 228 -PDYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDF----------------VAIKIVDRDQVLRHKM 56
LGEG F +V + DF VA+K++ R +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH----GRLKE 112
+ +K E+ + + PN+ +++ V + +++E+++ G+L + KH L
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 113 DEARRYFQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
+ F L+ + Y S HRDL N L+ +KI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 35/170 (20%)
Query: 21 LGEGSFAKV---------KFAKNVETGD-------FVAIKIV--DRDQVLRHKMVEQIKR 62
LGEG F +V KF + D VA+K++ D ++ R+ + +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL----K 68
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA------- 115
EI M +K PN+I+++ V + + ++ E+++ G+L +++H +E
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTI 127
Query: 116 -----RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
Q+ + + Y S HRDL N L+ +KI+DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 232
Query: 178 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
P+YV APE + D+ Y + SDVWS GV+L+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 42/189 (22%)
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++M SK Y V ++ G + K + + +Q++ A+D HS G+ HRD+
Sbjct: 224 DLMQSKEFPYNVEPYLLGK--VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281
Query: 140 KPENLLLD-SYGVLKISDFGLSA-----ISQQVREDGLLHTACGTPNYVAPE-------- 185
KP+N++ G KI D G +A I+ +E L P Y APE
Sbjct: 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL------DPRYAAPEQYIMSTQT 335
Query: 186 --------------VLNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKIC 229
VL R D++S G+I F+ MA P +SNL+ R++
Sbjct: 336 PSAPSAPVATALSPVLWQLNLPDRF-DIYSAGLI-FLQMA--FPNLRSDSNLIQFNRQLK 391
Query: 230 RADFSCPSW 238
R D+ +W
Sbjct: 392 RNDYDLVAW 400
|
Length = 566 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 30/245 (12%)
Query: 21 LGEGSFAKVK----FAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LGE F KV F E VAIK + +D+ + E+ K E ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKI---AKHGRLKEDEARRYFQQLINAVDYCH-- 130
+ ++ V+ + + ++ + +L + + + H + + + + + D+ H
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 131 -----------SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
S V H+DL N+L+ +KISD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF-DESNL----MALYRKICRADF 233
+++PE + G SD+WS GV+L+ V G P+ SN M R++
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 234 SCPSW 238
CP+W
Sbjct: 250 DCPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 54 HKMVEQIKR-------EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK 106
+V++I EI+ M ++HPN++K+I + S+ Y++ E+I+G L + +
Sbjct: 717 QFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 107 HGRLKEDEARRYFQQLINAVDYCH---SRGVFHRDLKPENLLLDSYGV--LKISDFGLSA 161
L + R+ + A+ + H S V +L PE +++D L++S GL
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC 833
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
+ YVAPE K + SD++ G+IL L+ G P D
Sbjct: 834 TDT---------KCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 21 LGEGSFAKV--------------KFAKNVETGD--FVAIKIV--DRDQVLRHKMVEQIKR 62
LGEG F +V +F NV G VA+KI+ D ++ R+ ++++K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK- 71
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR------ 116
+ +K PN+I+++ V + + ++ E+++ G+L ++ L + E
Sbjct: 72 ---ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVP 127
Query: 117 --------------RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA- 161
Q+ + + Y S HRDL N L+ +KI+DFG+S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 162 --ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLM 210
R G A ++A E + G ASDVW+ GV L+ +LM
Sbjct: 188 LYAGDYYRIQG---RAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 31/177 (17%)
Query: 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
L D+ R+ Q+ +D+ S+ HRD+ N+LL V KI DFGL ++ + D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL---ARDIMND 265
Query: 170 GLLHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
NYV APE + D Y + SDVWS G++L+ + + G P+
Sbjct: 266 S---------NYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
Query: 217 DESNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDE 268
+ + + K+ + + S P + ++K + P R T ISQ+++ +
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 21 LGEGSFAKVKFAKNV-----ETGDFVAIKIV-DRDQVLRHKMVEQIKREISTMKLIKHPN 74
LGEG+F KV A+ + VA+K + + + R + +RE + +++H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTVLQHQH 68
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQ---------- 120
+++ V + +V E++ G+L + HG L E Q
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 121 -QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLLHTAC 176
Q+ + + Y S HRDL N L+ V+KI DFG+S + R G
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
++ PE + + + SD+WS GV+L+
Sbjct: 189 ---RWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 236
GTP+Y+APE+L K + G A D W+ GV LF + G PF++ +++ I D P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 25/109 (22%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 58 EQIKREISTMKLIKHPNVI--KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA 115
+RE++ ++L+ + K++ S Y+++E+I+G L + KED A
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---SEEEKEDIA 92
Query: 116 RRYFQQL--INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162
+ + L ++ + + H DL P N+L+D +L I D+ +
Sbjct: 93 EQLAELLAKLHQLP---LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 48/244 (19%), Positives = 96/244 (39%), Gaps = 35/244 (14%)
Query: 41 VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI----IEVMASKTKIYIVLEFID 96
V I+ + +++ + EI ++ I N++KI I+++ ++ ++LE+
Sbjct: 46 VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105
Query: 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-------HSRGVFHRDLKPENLLLDSY 149
G L + + K L + +L A+D C +++L + L+
Sbjct: 106 RGYLREVLDKEKDLS------FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN 159
Query: 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILF 207
LKI GL I + Y + ++LND Y + D++S GV+L+
Sbjct: 160 YKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIK-DDIYSLGVVLW 213
Query: 208 VLMAGFLPFDESNLMALYRKIC------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 261
+ G +PF+ +Y I + CP K +++ + R I
Sbjct: 214 EIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI----KCIVEACTSHDSIKRPNI 269
Query: 262 SQML 265
++L
Sbjct: 270 KEIL 273
|
Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 28/161 (17%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
Q+ + + S+ HRDL N+LL + KI DFGL ++ +R D N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIRNDS---------N 269
Query: 181 YV------------APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 227
YV APE + + Y SDVWS G++L+ + + G P+ + + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 228 ICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ + + P S ++K D +P R T Q+++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 43/203 (21%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRHKMVEQIKREISTMKLIKHPNVIKII 79
+G G F KV ++ + T VA +V + K + ++ ++++HPN+++ +
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED----EARRYFQQLINAVDYCHSRGVF 135
+V E+ + G+L +++ + + +R ++ V + H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNYVAPEVLNDKGYD 193
H DL N L S +K+ D+G+ + +ED + C ++APE++ + +
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGP--SRYKEDYIETEDDKCVPLRWLAPELVGEF-HG 178
Query: 194 G-------RASDVWSCGVILFVL 209
G + S+VW+ GV L+ L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-- 178
Q+ +++ S+ HRDL N+LL ++KI DFGL ++ + D + T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGL---ARDIMHDSNYVSKGSTFL 301
Query: 179 -PNYVAPEVLNDKGYDGRASDVWSCGVILF 207
++APE + D Y SDVWS G++L+
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLW 330
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-- 178
Q+ N +++ S+ HRDL N+L+ ++KI DFGL ++ + D + T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGL---ARDIMRDSNYISKGSTFL 303
Query: 179 P-NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMAL-YRKICRA-DFS 234
P ++APE + + Y SDVWS G++L+ + G P+ E + Y I R +
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQML 265
P+ S +++++ + + R SQ++
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVI 76
+ +G G F KV V +G + ++V ++ + + EQ+K E + ++H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA------RRYFQQLINAVDYCH 130
+ + T +V+EF G+L + R E +R ++ + + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-------YVA 183
H DL N LL + +KI D+GLS + +ED + TP+ ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIA 170
Query: 184 PEVLNDKGYD------GRASDVWSCGVILFVL 209
PE++++ + + S+VWS GV ++ L
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 18/39 (46%), Positives = 26/39 (66%)
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158
+Q++ + H G+ HRD+KPENLL+ G +KI DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 42/274 (15%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR------HKMVEQIKREISTMKLIKH 72
LG+G+F + D + V+ H+ S M + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGEL--FDKIAKHG---RLKEDEARRYFQQLINAVD 127
+++K+ V I +V E++ G L F K+ K D A +QL +A+
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA----KQLASALH 115
Query: 128 YCHSRGVFHRDLKPENLLLDSYGV-------LKISDFG--LSAISQQVREDGLLHTACGT 178
Y + + H ++ +N+L+ YG+ +K+SD G ++ +S++ R + +
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI------- 168
Query: 179 PNYVAPEVL-NDKGYDGRASDVWSCGVILF-VLMAGFLPF---DESNLMALYRKICRADF 233
P ++APE + N + A+D WS G L + G P S Y+ R
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--L 225
Query: 234 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
P LI + +P R + +L D
Sbjct: 226 PMPDCAELAN--LINQCWTYDPTKRPSFRAILRD 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 43/273 (15%)
Query: 20 TLGEGSFAKVKFAKNVETGDF-------VAIKIVDRDQVLRHK-MVEQIKREISTMKLIK 71
+LG+G+F K+ E GD+ V +K++D+ H+ E S M +
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK----SHRNYSESFFEAASMMSQLS 57
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRL-----KEDEARRYFQQLINAV 126
H +++ V + +V E++ G L + K+ L K + A+ QL A+
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAK----QLAWAL 113
Query: 127 DYCHSRGVFHRDLKPENLLLDSYG--------VLKISDFGLSAISQQVREDGLLHTACGT 178
+ +G+ H ++ +N+LL +K+SD G+S I+ +E L
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIP--- 169
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLP---FDESNLMALYRKICRADFS 234
+V PE + + A+D WS G L+ + G P D + Y R
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLP 225
Query: 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
P W LI + +D PD R + ++ D
Sbjct: 226 APKWTELAN--LINQCMDYEPDFRPSFRAIIRD 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149
IV+E+I+G L D I E +++ V HS G+ H DL N++L
Sbjct: 76 IVMEYIEGEPLKDLINS----NGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGG 131
Query: 150 GVLKISDFGLSAISQQVRE 168
+ I DFGL+ S+ + +
Sbjct: 132 KIYLI-DFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 40/195 (20%), Positives = 73/195 (37%), Gaps = 68/195 (34%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK--------LIKH 72
+ S A+V A +++G+ VA+K V R + E+I+ ++ ++ L
Sbjct: 133 IASASIAQVHRAV-LKSGEEVAVK------VQRPGIRERIEADLKLLRRLARLIKRLPPG 185
Query: 73 PNVIKIIEVMA--SKT------------------------------KIY--------IVL 92
+ ++EV+ K K+Y + +
Sbjct: 186 GRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTM 245
Query: 93 EFIDGGEL--FDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146
E+IDG ++ + G L E R + +QL+ G FH D P N+L+
Sbjct: 246 EWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNILV 298
Query: 147 DSYGVLKISDFGLSA 161
S G + + DFG+
Sbjct: 299 RSDGRIVLLDFGIVG 313
|
Length = 517 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLI 123
S M + H ++ + V ++ +V EF++ G L + K GR+ QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGV-------LKISDFGLS--AISQQVREDGLLHT 174
+A+ Y + + H ++ +N+LL G+ +K+SD G+S A+S++ R + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE---SNLMALYRKICR 230
++APE + A+D WS G L + G +P E S Y K R
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR 239
Query: 231 -ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
+ SC + LI + L P R + +L D
Sbjct: 240 LPEPSCKELAT-----LISQCLTYEPTQRPSFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 442 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.6 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.14 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.82 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.72 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.95 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.83 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.54 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.05 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.98 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.97 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.76 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.96 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.84 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.76 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-65 Score=483.16 Aligned_cols=260 Identities=40% Similarity=0.742 Sum_probs=234.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH----HHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK----MVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.-..|.+.+.||+|+||.|.+|..+.||+.||||++++....... ....+.+|++||++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456789999999999999999999999999999999887654311 2345789999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC---CceEEeeccchhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAIS 163 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~---~~~kl~DFGla~~~ 163 (442)
..||||||+.||+|++++..++.+.++..+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999766 68999999999876
Q ss_pred hhcccCCccccccCCCcccCcccccccC--CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH-HHHHHhhCCCCCC--CC
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKICRADFSCP--SW 238 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~~--~~ 238 (442)
. ..+.+.+.||||.|.|||++.+.+ +++.++|+||+||+||.+|+|.+||.+..... +.++|.++.+.+- .|
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 4 456789999999999999998665 44568999999999999999999998876554 8889999987654 34
Q ss_pred --CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 239 --FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 239 --~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 79999999999999999999999999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-63 Score=490.44 Aligned_cols=261 Identities=62% Similarity=1.063 Sum_probs=247.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh--HHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 86 (442)
...++|.+++.||+|+||+|+.|.+..++..||+|++++..... ....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 67889999999999999999999999999999999888763321 135677889999999998 999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-CceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DFGla~~~~~ 165 (442)
.+|+|||||.||+|+++|...+++.|..++++|+||++|++|||++||+||||||+|||+|.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998764
Q ss_pred cccCCccccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCC-CHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF-SSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~ 243 (442)
..+..+.+.||||.|+|||++.+.. |.+.++|||||||+||.|++|..||+..+...++.++..+.+.+|.|+ |+++
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 3567789999999999999999988 999999999999999999999999999999999999999999999999 9999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+|+++||..||.+|+|+.+|+.||||+.
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-63 Score=487.81 Aligned_cols=265 Identities=37% Similarity=0.697 Sum_probs=250.9
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|..++.||+|+|+.||.+++..+|+.||+|++.+..+.+....+.+.+||+|++.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 35999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|+|+.++|..+++..++++|.+|+.|++||+.||.|||+++|+|||||..|+|++++-++||+|||||+.....+ ..-
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876432 345
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
.+.||||.|+||||+...++. ..+||||+||++|.||.|++||+..+..+.|.+|...++..|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999988874 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccCCCCCCCC
Q 013487 253 PNPDTRMTISQMLEDEWFKKGYKPPHFD 280 (442)
Q Consensus 253 ~dP~~R~s~~eil~hp~~~~~~~~~~~~ 280 (442)
+||.+|||+++||.|+||+.++.|...+
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 9999999999999999998887664443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-63 Score=493.33 Aligned_cols=265 Identities=46% Similarity=0.849 Sum_probs=251.4
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
....-+|-|+++++||.|+-|.|.+|.+..||+.+|||++.+..-........+.+||.||+.+.||||+++|+++++..
T Consensus 6 ~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 6 SHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 44567899999999999999999999999999999999998774444556778999999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
++|+|+||++||+||+++...|+++|.++.++|+||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.+-.
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998643
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
.+..+.+.||+|.|.|||++.|.+|+|.++||||||||||.||+|.+||++.+...++.++.++.|..|..+|+++++|
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL 242 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence 4678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|++||++||.+|+|.+||++|||+....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999998644
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-61 Score=437.09 Aligned_cols=260 Identities=37% Similarity=0.751 Sum_probs=248.4
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.+...+.+|++.++||.|+||.|.+++++.+|..+|+|+++++.+.+.++.++..+|..+|+.+.||.++++++.+.+.+
T Consensus 38 ~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 38 QNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred CCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 33478899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+||||||++||+|+.++.+.++|++..+++|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
+...+.||||.|+|||++.+++|. .++|+|||||++|||++|.+||...+...+|++|..+...+|+.+++++++|
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDL 271 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHH
Confidence 336789999999999999999996 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 247 IKRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 247 i~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
|+++|+.|-.+|. ...+|..||||+.
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999994 4789999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-61 Score=449.35 Aligned_cols=261 Identities=36% Similarity=0.727 Sum_probs=244.7
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++++.||+|+||+|++++.+.|++.+|+|+++|..+...+..++.+.|..||..++||.||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35678999999999999999999999999999999999999988887889999999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+|+||+.||+|+.+|++.+.++|+.++.|+..|+.||.|||++||+||||||+|||+|.+|+++|+|||||+..-. .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--D 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985433 2
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC-CCCCCHHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLI 247 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li 247 (442)
+....+.|||+.|||||++.+.+|+ ..+|+||||+++|+|++|.+||.+.+...++++|..+.... |..++.++++||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 3455678999999999999999996 89999999999999999999999999999999999998544 455999999999
Q ss_pred HHccCCCCCCCC----CHHHHhcCccccc
Q 013487 248 KRILDPNPDTRM----TISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~----s~~eil~hp~~~~ 272 (442)
+++|+.||++|. ++.+|.+||||..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999996 6899999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-58 Score=450.45 Aligned_cols=263 Identities=36% Similarity=0.671 Sum_probs=246.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
.....+|.+++.||+|+|++|++|+++.++..||||++++..+.++...+.+.+|-.+|.+| .||+|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 55678999999999999999999999999999999999999988888888999999999999 79999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+|+||+++|+|.++|.+.|.|++..++.|+.||+.||+|||++|||||||||+|||+|+++++||+|||.|.++....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred cC-----------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC
Q 013487 168 ED-----------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 236 (442)
Q Consensus 168 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (442)
.. ....+..||-.|++||++.+... +..+|+|+||||||.|++|.+||.+.+..-++++|..-.+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 22 11245789999999999987655 5899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.+++.+.+||+++|..||.+|+|+.||.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-58 Score=432.15 Aligned_cols=263 Identities=36% Similarity=0.670 Sum_probs=240.7
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.+...+++|.+.+.||+|+||+||+|+++.++..||||.+.+.+. ..+..+.+..|+.||+.++|||||.++++....+
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 345678999999999999999999999999999999999998864 4456788999999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC------CceEEeeccch
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY------GVLKISDFGLS 160 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~------~~~kl~DFGla 160 (442)
.+|+|||||.||+|.++|...+.++|..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999865 35899999999
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCC
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPS 237 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~ 237 (442)
+... ......+.||||.|||||++....|+ .|+|+||+|+|||+|++|..||+..+..+++..+..+.. ..+.
T Consensus 163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 9876 34567889999999999999988997 899999999999999999999999999999887776643 3345
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++++...+|+...|..+|..|.+..+.+.|+++....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 6888899999999999999999999999999987543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-58 Score=429.97 Aligned_cols=259 Identities=42% Similarity=0.765 Sum_probs=247.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++.++||+|+||+|.+|+....|+.||||.|+++.+.+++.+-++++||+||..|+||||+.+|++|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999999999999888999999999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||+.+|+|.|+|...+.++|.+++.+|+||++|+.|||.++++|||||.+|||+|.++++||+||||+..+.. ...+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---ccHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987654 5678
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
.++||+|.|.+||++.+.+|.|+.+|-|||||+||.|..|..||++.+...+.++|.++.+.-|.. +.++.-||+.||.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999999998877664 7789999999999
Q ss_pred CCCCCCCCHHHHhcCcccccCCC
Q 013487 253 PNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 253 ~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
+||++|.|+.+|-.|=|++=+|.
T Consensus 289 VNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred cCcccchhHHHHhhhheeecccc
Confidence 99999999999999999886654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=435.31 Aligned_cols=263 Identities=34% Similarity=0.661 Sum_probs=239.4
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+..+++|++++.||+|+||.||+|+.+.||+.+|+|++++......+.+++++.|-.+|....+|+||+||..|++..+
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 35678999999999999999999999999999999999999998888899999999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||.+||++..+|.+.+.|+|+++++|+.+++.|++-||+.|++||||||+|+|||..|++||+||||++......
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986422100
Q ss_pred --------------------cC-------------------------CccccccCCCcccCcccccccCCCCCcccHhHH
Q 013487 168 --------------------ED-------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 202 (442)
Q Consensus 168 --------------------~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 202 (442)
.+ .......|||-|+||||+.+.+|. ..+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHH
Confidence 00 011234699999999999999985 99999999
Q ss_pred HHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCCCC--CCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013487 203 GVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSW--FSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 272 (442)
Q Consensus 203 Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 272 (442)
|||+||||.|.+||.+.++.+.+.+|..-. +.+|.. +++++.+||.+||. ||++|.. ++||.+||||+.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999999999999999987643 566654 78999999999999 9999985 999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=418.06 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=232.7
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE-EEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-IYI 90 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 90 (442)
..+.+.++.||+|+.|+||+++|+.|+..+|+|++... .+....+++.+|+++++.++||+||++|+.|..+.. +++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 34677889999999999999999999999999999533 345567899999999999999999999999999994 999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||+||+|.+.+...++++|....+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.++..-.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn---- 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN---- 231 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh----
Confidence 99999999999999999999999999999999999999996 8999999999999999999999999999986543
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-----cHHHHHHHHhhCC-CCCCCC-CCHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKICRAD-FSCPSW-FSSG 242 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~ 242 (442)
+...+..||..|||||.+.+..|. .++||||||+.++||.+|+.||... +..+++..|..+. ...|.. +|++
T Consensus 232 S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE 310 (364)
T ss_pred hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 356788999999999999998885 8899999999999999999999875 6678888888854 456665 9999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+++|+..||++||.+|||+.|+++|||+++..
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999999999999999999999999998643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=420.43 Aligned_cols=269 Identities=37% Similarity=0.682 Sum_probs=237.2
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH-----------HHHHHHHHHHHHhhCCCCCcc
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----------MVEQIKREISTMKLIKHPNVI 76 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv 76 (442)
....++.|++.+.||+|.||+|.+|++..+++.||||++++....... -++.+++||.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 456789999999999999999999999999999999999876543321 247899999999999999999
Q ss_pred eEEEEEEeC--CEEEEEEEccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 77 KIIEVMASK--TKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 77 ~l~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
+|+++..+. +.+|||+|||..|.+.. ...+.+ +++.++++|+++++.||+|||.+||+||||||+|+|++++|++|
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999999764 67999999999998854 344455 99999999999999999999999999999999999999999999
Q ss_pred Eeeccchhhhhhc---ccCCccccccCCCcccCcccccc---cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH
Q 013487 154 ISDFGLSAISQQV---REDGLLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (442)
Q Consensus 154 l~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (442)
|+|||.+..+... +.+..+....|||.|+|||.+.+ ..|.+.+.||||+||+||.|+.|+.||.+....+++.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998755222 12234555789999999999887 56789999999999999999999999999999999999
Q ss_pred HhhCCCCCCCC--CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCCC
Q 013487 228 ICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277 (442)
Q Consensus 228 i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 277 (442)
|....+.+|.. +.+++++||.+||.+||.+|+++.+|..|||.......+
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 99998888765 799999999999999999999999999999998876544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-55 Score=435.31 Aligned_cols=260 Identities=30% Similarity=0.612 Sum_probs=243.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (442)
...+.+|++.+.||+|+||+|++|..+.+++.+|||+++|..+...+..+..+.|.+|+...+ ||.++.++..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 567889999999999999999999999999999999999999988888999999999999885 9999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||+.||++. .+...+.|++..++.|+..++.||+|||++||+|||||.+|||+|.+|++||+|||+++-. ..
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence 99999999999954 4455578999999999999999999999999999999999999999999999999999743 23
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
.+....+.||||.|+|||++.+..|. .++|+|||||+||+||.|+.||.+.+.++++..|...+..+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 44567899999999999999999885 99999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 248 KRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
+++|++||++|.. +.+|.+||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999986 589999999985
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=388.36 Aligned_cols=260 Identities=35% Similarity=0.704 Sum_probs=246.2
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
....+++|++++.||+|.||.||+|+.++++-.||+|++.+.++...+...++++|++|.+.|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45678899999999999999999999999999999999999998888888899999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 88 IYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~--~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+|+++||+++|+|+..+. ...++++..+..|+.|++.||.|||..+|+||||||+|+|++..|.+||+|||-+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999999 66689999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 245 (442)
.+.-.+.|||.-|.|||...+..++ ..+|+|++|++.|+++.|.+||...+..+.|++|.+.++.+|+.++.++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 3344688999999999999999987 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
||.+||..+|.+|.+..|++.|||...
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-55 Score=426.18 Aligned_cols=258 Identities=32% Similarity=0.610 Sum_probs=241.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|.+.+.||+|+||.||+|+.+.|.+.||||++++..- .++.+..+++|++|++.++||||+.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 4689999999999999999999999999999999988753 344578899999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
.|||.| +|+.++..++.++|+.++.++.|+++||.|||+++|.|||+||.|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999987654 2345
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 251 (442)
+....|||.|||||++.+.+|+ ..+|+||+|||||||.+|++||-..+..++.+.|.......|...|..+.+|++.+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6677899999999999999997 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCC
Q 013487 252 DPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 252 ~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+||.+|+|..+++.|||++...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999998644
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-56 Score=393.86 Aligned_cols=258 Identities=34% Similarity=0.707 Sum_probs=235.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..-+.|++-+.||+|.|+.|+++.+..||+.+|+|+++...+... ..+.+.+|++|-+.|+||||+++.+.+.+....|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 344679999999999999999999999999999999987765443 5788999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---cCCceEEeeccchhhhhhc
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~---~~~~~kl~DFGla~~~~~~ 166 (442)
+|+|+++|++|+.-|...-.++|..+-.+++||+.||.|||.+||+|||+||+|+|+- ....+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999999999998888777899999999999999999999999999999999999995 34469999999997554
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC--C--CCHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS--W--FSSG 242 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~ 242 (442)
.........|||.|+|||++...+|. .++|||++|||||-||.|.+||.+.+...+|++|..+.+..|+ | ++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 34456677899999999999988885 8999999999999999999999999999999999999876654 3 8999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+++|+++||..||.+|+|+.|.|+|||+.+
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 999999999999999999999999999975
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=415.90 Aligned_cols=265 Identities=40% Similarity=0.750 Sum_probs=246.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+.+.|=|.+.++||+|.|+.|.+|++.-||+.||+|++++.+.. .-...++.+|++.|+.++|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 45677899999999999999999999999999999999988753 33467889999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-ccCCceEEeeccchhhhhhc
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL-DSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll-~~~~~~kl~DFGla~~~~~~ 166 (442)
|+|+|+-+||+|+|+|.++. ++.|+.+++||.||+.|+.|||+..+|||||||+|+++ ..-|-+||.|||++..+.+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 99999999999999998764 79999999999999999999999999999999999877 4679999999999876654
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
...+.+.||+..|.|||++.+..|+.+++||||||||||.|.+|++||...+.-+.+..|....+..|..+|.+.++|
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 456889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCCCCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 277 (442)
|..||..||++|.|+++|..|+|++....++
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999999876544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=394.87 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=219.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|+.+..+|+|+||.|++|+++.||+.||||.+-... .++...+-..|||++|++++|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 368999999999999999999999999999999985432 2344566788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
+|||+. ++.+-++. ..+++++.++.|+.|++.|+.|||+++++||||||+|||++.+|.+||||||+|+.... ++.
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 999998 55454544 45799999999999999999999999999999999999999999999999999998764 344
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------------- 231 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 231 (442)
..+.+..|.+|+|||.+.+...+|.++||||+||++.||++|++.|.+.+..+....|...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5677889999999999998666689999999999999999999999987766555444221
Q ss_pred --CCCCCC----------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 232 --DFSCPS----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 232 --~~~~~~----------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
.++.|. .++.-+.+|+++||..||++|+|.+|+|.||||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111111 2567789999999999999999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=395.45 Aligned_cols=249 Identities=32% Similarity=0.594 Sum_probs=223.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE-EEEeC-C
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE-VMASK-T 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~-~ 86 (442)
...+..|+|.+.||+|+||.||++++..+|..||.|.+.-.. .+.+..+.+..|+.+|++|+|||||++++ .+... .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 345667999999999999999999999999999999998544 34456788999999999999999999998 34444 4
Q ss_pred EEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEEccCCceEEeecc
Q 013487 87 KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS--RG--VFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~--~g--ivHrDlkp~NIll~~~~~~kl~DFG 158 (442)
.+++|||||.+|+|...|+. ...++|..+++++.||+.||..||+ .. |.||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 48999999999999998864 3469999999999999999999999 44 9999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-CC-
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CP- 236 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~- 236 (442)
|++.+... .....+..|||.||+||++.+.+|+ .++||||+||++|||+.-++||.+.+...+.++|..++++ +|
T Consensus 174 L~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 174 LGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 99987653 3345678999999999999999997 9999999999999999999999999999999999999886 66
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCH
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTI 261 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~ 261 (442)
..+|.++..||..|+.+||..||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 5689999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=405.67 Aligned_cols=260 Identities=32% Similarity=0.576 Sum_probs=222.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--EEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--KIY 89 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 89 (442)
..+|..++.||+|+||.||++.+.++|..+|+|.+...... ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 44689999999999999999999999999999999876321 2677999999999999999999999854444 699
Q ss_pred EEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhhhh-c
Q 013487 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQ-V 166 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~~~-~ 166 (442)
++|||++||+|.+++...+ .++|+.+++|.+|++.||+|||++||+||||||+|||++. +|.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999988 7999999999999999999999999999999999999999 79999999999886553 1
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhhC--CCCCCCCCCHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRA--DFSCPSWFSSGA 243 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~s~~~ 243 (442)
..........|||.|||||++........++||||+||++.||+||..||.. .........+... ...+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122334578999999999998633334599999999999999999999987 4444434444333 357788899999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++||.+||..||++|||++++|+|||.+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999999997644
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=411.28 Aligned_cols=261 Identities=36% Similarity=0.732 Sum_probs=239.4
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..+...+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 45567789999999999999999999999999999999999876554545567889999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+.+|++|||+.||+|.+++...+.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 245 (442)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.+++..+.+
T Consensus 171 -----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 244 (329)
T PTZ00263 171 -----RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244 (329)
T ss_pred -----CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHH
Confidence 12356899999999999887774 899999999999999999999999888888888888888899999999999
Q ss_pred HHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 246 LIKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 246 li~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
||.+||+.||.+|++ +++++.||||..
T Consensus 245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999999997 799999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=409.33 Aligned_cols=260 Identities=34% Similarity=0.569 Sum_probs=227.6
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TK 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 87 (442)
.....|+.++.||+|+||.||+|++..||+.||+|.+..+.. +.+......|||.||++|+||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 455679999999999999999999999999999999987753 344566778999999999999999999999877 68
Q ss_pred EEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
+|||+|||+. ||.-++... -.|++.++..|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999998 888887764 37999999999999999999999999999999999999999999999999999987654
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--C--------CCCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--D--------FSCP 236 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~--------~~~~ 236 (442)
.. ..++...-|.+|+|||++.|...++.++|+||+||||.||++|++.|.+.+..+...+|.+- . ..+|
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 33 34666778999999999999888889999999999999999999999999988777766431 0 0111
Q ss_pred -------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 -------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 -------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+++.+.+|+..||..||.+|.|+.++|+|+||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 015788999999999999999999999999999954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-52 Score=409.75 Aligned_cols=260 Identities=40% Similarity=0.740 Sum_probs=236.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (442)
...-..|++.+.||+|.||.||.|+++.||+.+|+|++.+.........+.+.+|+.||++++ ||||+.++++|++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 344557999999999999999999999999999999999887655445678999999999998 9999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC----CceEEeeccchhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDFGLSAIS 163 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~----~~~kl~DFGla~~~ 163 (442)
+|+|||+|.||+|++.|... .++|..+..++.|++.|++|||+.||+||||||+|+|+... +.+|++|||+|...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999887 59999999999999999999999999999999999999633 57999999999876
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC--CCC--C
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PSW--F 239 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~ 239 (442)
.. ...+.+.||||.|+|||++...+|. ..+||||+|+++|.|++|.+||.+.+....+..+..+.+.+ +.| +
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 54 4567889999999999999988885 89999999999999999999999999988888998887654 444 7
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|..++++|++||..||.+|+|+.++|+|||++..
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=408.81 Aligned_cols=259 Identities=34% Similarity=0.563 Sum_probs=226.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCC-E
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT-K 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-~ 87 (442)
...++|.+.+.||.|+||.||+|+.+.+|+.||||.+.+....-++ .- -.||+..|++|+ |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~-nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4567999999999999999999999999999999998765433222 22 248999999998 999999999998887 9
Q ss_pred EEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
+|+|||||+. .|.+.++.++ .|++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+-...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc-
Confidence 9999999976 9999998765 599999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh----------------
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------------- 230 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------- 230 (442)
....+.+..|.+|+|||++...++++.+.|||++|||++|+.+-++.|.+.+..+...+|+.
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 34567788999999999999999999999999999999999999999999888777666643
Q ss_pred ---CCCCCCC-----------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 231 ---ADFSCPS-----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 231 ---~~~~~~~-----------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
-.+.+|. ..+.++.+||.+||.+||++|||+.|+|+||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1222221 2578999999999999999999999999999998654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=383.25 Aligned_cols=259 Identities=36% Similarity=0.646 Sum_probs=232.1
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-----hhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
...+|.-.+.||+|..++|.++.++.+|..+|+|+++.... ......+.-.+|+.||+++ .||+|+++.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34678888999999999999999999999999999964221 1234567778999999999 59999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+..+++|+|+|+.|+|||++.....++|+..+++++||+.|++|||.++||||||||+|||+|++-++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred hcccCCccccccCCCcccCccccccc-----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC--CC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PS 237 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~ 237 (442)
. +..+...||||+|.|||.+... +-++..+|+|+||||+|.||.|.+||-.....-+++.|..+.+++ |.
T Consensus 175 ~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 P---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred C---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 4 4557889999999999998643 223578999999999999999999999888888889999887654 66
Q ss_pred C--CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~--~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
| +|...++||++||+.||.+|+|+.|+|.||||.+
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 6 7999999999999999999999999999999964
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-52 Score=399.63 Aligned_cols=254 Identities=31% Similarity=0.641 Sum_probs=232.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997665444445677899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999988999999999999999999999999999999999999999999999999999875432 12
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++.+.+||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999887764 8999999999999999999999999888888888888888888899999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 013487 253 PNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.||.+|++ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=372.94 Aligned_cols=258 Identities=34% Similarity=0.514 Sum_probs=223.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|...+.||+|+||.||+|++..||+.||||.+...+.. ........|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5789999999999999999999999999999999876533 233456789999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++. +|...|+... .++..++..|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+..... .
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--I 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--c
Confidence 99987 9999887654 689999999999999999999999999999999999999999999999999998776433 2
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-------------------
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------------- 232 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------- 232 (442)
.....-|.+|+|||.+.|...++..+||||.|||+.||+-|.+-|.+.+..+....|.+.-
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3344789999999999998888899999999999999999999999888776666554310
Q ss_pred ---CCCC------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 233 ---FSCP------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 233 ---~~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.| +-.+.++.+|+.+||..||.+|+|+.|+|+|+||+...
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 0001 01467889999999999999999999999999998743
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-52 Score=391.14 Aligned_cols=268 Identities=28% Similarity=0.475 Sum_probs=239.3
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
......-+..|++++.||.|.-|+||+|..+.++..+|+|++++......+...++..|-+||+.++||.++.||..+++
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 34456677789999999999999999999999999999999999988777778899999999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
+...|++||||+||+|+...+++. .|+++.+++|+..++.||+|||-.|||+||||||||||-++|++.|+||.|+..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999999999999999887764 699999999999999999999999999999999999999999999999999742
Q ss_pred hhh---------------------------------ccc---------------------CCccccccCCCcccCccccc
Q 013487 163 SQQ---------------------------------VRE---------------------DGLLHTACGTPNYVAPEVLN 188 (442)
Q Consensus 163 ~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~ 188 (442)
... ... +.......||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 100 000 00112346899999999999
Q ss_pred ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC--CCCHHHHHHHHHccCCCCCCCCC----HH
Q 013487 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMT----IS 262 (442)
Q Consensus 189 ~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~s----~~ 262 (442)
|.+.. .++|+|+|||+|||||.|..||.+.+..+.+.++......+|. .++..+++||+++|.+||.+|+. +.
T Consensus 309 G~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 309 GEGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred cCCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 98885 8999999999999999999999999999999999988777765 47899999999999999999998 99
Q ss_pred HHhcCcccccC
Q 013487 263 QMLEDEWFKKG 273 (442)
Q Consensus 263 eil~hp~~~~~ 273 (442)
||.+||||+.-
T Consensus 388 eIK~HpFF~gV 398 (459)
T KOG0610|consen 388 EIKRHPFFEGV 398 (459)
T ss_pred HhhcCccccCC
Confidence 99999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=401.91 Aligned_cols=251 Identities=33% Similarity=0.632 Sum_probs=227.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455667889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCC
Q 013487 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (442)
Q Consensus 99 ~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 178 (442)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999988999999999999999999999999999999999999999999999999999864321 12234457899
Q ss_pred CcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013487 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 258 (442)
+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+......+|..+++++.+||.+||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999887774 8999999999999999999999988888888888888888888999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 013487 259 M-----TISQMLEDEWFKK 272 (442)
Q Consensus 259 ~-----s~~eil~hp~~~~ 272 (442)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=411.73 Aligned_cols=263 Identities=43% Similarity=0.796 Sum_probs=248.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...++-|.+.++||+|.|++|.+|++..|+..||||++++...... .++.+.+|+++|+.|+|||||+++.++.+...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 4578899999999999999999999999999999999998875443 455699999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+.+|++++++.+++++.+..++.+|.|+++|++|||+++|+|||||++|||++.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998776 3
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 248 (442)
...+.+.||+|.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+......+.+.+|-.++.+..+||+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 56788999999999999999999999999999999999999999999999999999989999999999999999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
++|..+|.+|+++++|+.|+|....+.
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999876543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-52 Score=386.50 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=224.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-----CC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-----KT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~ 86 (442)
-.+|...+.||+|+||.|+.|.++.||+.||||.+... +...-..++..||+++|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566679999999999999999999999999998643 2344467888999999999999999999999865 45
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+|+|+++. +|...|+.+..++++.++.++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||+|+.....
T Consensus 100 DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 79999999954 99999998888999999999999999999999999999999999999999999999999999987654
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh----------------
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------------- 230 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------- 230 (442)
.....++.+..|.+|.|||++.....++.++||||+||||.||++|++-|.+.+..+....|..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 4455677888999999999987766667999999999999999999999988776554433321
Q ss_pred -------CCCCCC--------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 231 -------ADFSCP--------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 231 -------~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+.....|
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 111111 2368999999999999999999999999999999875543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=402.07 Aligned_cols=258 Identities=31% Similarity=0.623 Sum_probs=234.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCC-CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETG-DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
...+++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 456778999999999999999999976655 6899999987655555556788899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.|+||||+.||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+....+..+..+...+|..+++.+.++|
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 2245689999999999987766 489999999999999999999999988888888888888888999999999999
Q ss_pred HHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 248 KRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
++||+.||.+|+ |++++++||||..
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999996 8999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=394.50 Aligned_cols=250 Identities=34% Similarity=0.641 Sum_probs=226.6
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999866544445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCc
Q 013487 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180 (442)
Q Consensus 101 ~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (442)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99999888999999999999999999999999999999999999999999999999999875322 1223345689999
Q ss_pred ccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCC-
Q 013487 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM- 259 (442)
Q Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~- 259 (442)
|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+......+|..+++++.+||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887775 88999999999999999999999988888888888888888889999999999999999999997
Q ss_pred --CHHHHhcCcccccC
Q 013487 260 --TISQMLEDEWFKKG 273 (442)
Q Consensus 260 --s~~eil~hp~~~~~ 273 (442)
++.++++||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=400.76 Aligned_cols=258 Identities=31% Similarity=0.576 Sum_probs=224.9
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555556678899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc----
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---- 168 (442)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999989999999999999999999999999999999999999999999999999999875322100
Q ss_pred -----------------------------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC
Q 013487 169 -----------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (442)
Q Consensus 169 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 219 (442)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112346899999999999887775 8999999999999999999999988
Q ss_pred cHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHccCCCCC---CCCCHHHHhcCccccc
Q 013487 220 NLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPD---TRMTISQMLEDEWFKK 272 (442)
Q Consensus 220 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~---~R~s~~eil~hp~~~~ 272 (442)
+....+.++... ...+|+ .+++++.+||.+|+. +|. .||+++||++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888777653 344454 378999999999775 444 4589999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=382.21 Aligned_cols=262 Identities=32% Similarity=0.545 Sum_probs=228.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...+.|++...||.|..++||+|+...+++.||||+++.+++... .+.+++|+..|+.++||||++++..|...+.+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 556789999999999999999999999999999999999886553 788999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+||.||.+|++++.+...- +++|..+..++++++.||.|||++|.+|||||+.||||+.+|.+||+|||.+..+-..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999999998753 59999999999999999999999999999999999999999999999999876443322
Q ss_pred cC-Cc-cccccCCCcccCccccc--ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC------
Q 013487 168 ED-GL-LHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS------ 237 (442)
Q Consensus 168 ~~-~~-~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------ 237 (442)
.. .. ..+..|||+|||||++. ..+|+ .|+|||||||+..||.+|..||..-.+..++-.-.++..+.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 11 11 15678999999999953 34565 8999999999999999999999988777766555555544221
Q ss_pred ----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 238 ----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 238 ----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.++..++.++..||..||.+|||++++|+|+||++.-
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 2678899999999999999999999999999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=394.58 Aligned_cols=251 Identities=34% Similarity=0.650 Sum_probs=227.0
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCC
Q 013487 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (442)
Q Consensus 99 ~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 178 (442)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999999888999999999999999999999999999999999999999999999999999864321 12233456899
Q ss_pred CcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013487 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 258 (442)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987776 48999999999999999999999988888888888878888888999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 013487 259 M-----TISQMLEDEWFKK 272 (442)
Q Consensus 259 ~-----s~~eil~hp~~~~ 272 (442)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=392.32 Aligned_cols=251 Identities=33% Similarity=0.636 Sum_probs=226.8
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||.||+|.+..+|..||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCC
Q 013487 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (442)
Q Consensus 99 ~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 178 (442)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999999888999999999999999999999999999999999999999999999999999864221 12223456899
Q ss_pred CcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013487 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 258 (442)
+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999877764 8999999999999999999999988888888888878888888899999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 013487 259 M-----TISQMLEDEWFKK 272 (442)
Q Consensus 259 ~-----s~~eil~hp~~~~ 272 (442)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=374.93 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=226.4
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-- 84 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 84 (442)
.+...++.|+.+..|++|+||.||+|+|+.|++.||+|.++.+.- ....-=.-.|||.+|.+++|||||.+.++...
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 455678899999999999999999999999999999999987652 22222235689999999999999999998754
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
-+.+|||||||+. +|...+..-+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 4679999999988 9999998766 8999999999999999999999999999999999999999999999999999977
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh-----------CC
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR-----------AD 232 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-----------~~ 232 (442)
... -..+....-|.+|+|||++.+...++.++|+||+|||+.||+++.+-|.+.+..+...+|.+ +-
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 653 23455667899999999999988778999999999999999999999999887776666532 00
Q ss_pred --------CCCCC------------C-CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 233 --------FSCPS------------W-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 233 --------~~~~~------------~-~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
..++. . +++...+|++.+|..||.+|.|+.|.|+|+||.....
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 11111 0 4588899999999999999999999999999987443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=392.78 Aligned_cols=254 Identities=30% Similarity=0.568 Sum_probs=226.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 23
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCC------CCCHHHH
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS------WFSSGAK 244 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~------~~s~~~~ 244 (442)
...+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..+.+..+... ....|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456799999999999887665 8999999999999999999999988877776665432 222232 3589999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+||.+||..+|.+|||+.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=397.74 Aligned_cols=258 Identities=32% Similarity=0.626 Sum_probs=225.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC---
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--- 169 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--- 169 (442)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998643221100
Q ss_pred ---------------------------------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCC
Q 013487 170 ---------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216 (442)
Q Consensus 170 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf 216 (442)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999887775 8999999999999999999999
Q ss_pred CCCcHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013487 217 DESNLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 272 (442)
Q Consensus 217 ~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 272 (442)
...+....+..+... .+..|. .+++++.+||.+||. +|.+|++ +.++++||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 988877777666543 233343 368999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=391.39 Aligned_cols=251 Identities=33% Similarity=0.641 Sum_probs=225.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566777888888876 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+.......|.++++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877664 889999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCH------HHHhcCccccc
Q 013487 258 RMTI------SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~------~eil~hp~~~~ 272 (442)
||++ +++++||||+.
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=389.83 Aligned_cols=256 Identities=31% Similarity=0.581 Sum_probs=230.0
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC-CcceEEEEEEeCCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP-NVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~ 92 (442)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444567788999999999764 6889999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864221 12233
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
...+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+.......|..+++++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887774 8999999999999999999999998888888888888888888899999999999999
Q ss_pred CCCCCCCCH-----HHHhcCccccc
Q 013487 253 PNPDTRMTI-----SQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~s~-----~eil~hp~~~~ 272 (442)
.||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=376.89 Aligned_cols=261 Identities=33% Similarity=0.636 Sum_probs=245.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
..-+++|..++.||+|+||+|-+++.+.+++.+|||+++++-+.......+-..|-++|+..+||.+..+...|++.+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34677899999999999999999999999999999999998887777788888999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+.||+|+-++.....++|+.++.|...|++||.|||+++||+||||.+|+|+|.+|++||+||||++- ....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccc
Confidence 99999999999999999989999999999999999999999999999999999999999999999999999863 2334
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 248 (442)
.....+.||||.|+|||++....| +.++|+|.+||++|+|++|++||-..+...++..|......+|..++++++.|+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred cceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 456788999999999999999888 5999999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCC-----HHHHhcCccccc
Q 013487 249 RILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 249 ~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.+|.+||++|.. +.||.+|+||..
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 999999999985 899999999975
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=398.85 Aligned_cols=258 Identities=29% Similarity=0.584 Sum_probs=223.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997765545556778899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC---
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--- 169 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--- 169 (442)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHH
Q 013487 170 ------------------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207 (442)
Q Consensus 170 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (442)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 000135799999999999887774 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhh--CCCCCCC--CCCHHHHHHHHHccCCCCCCC---CCHHHHhcCccccc
Q 013487 208 VLMAGFLPFDESNLMALYRKICR--ADFSCPS--WFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKK 272 (442)
Q Consensus 208 ~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L~~dP~~R---~s~~eil~hp~~~~ 272 (442)
+|++|.+||...+....+..+.. ....+|. .++.++.+||.+||. +|.+| +|+.++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999998887777776654 2344444 378999999999998 67765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=397.55 Aligned_cols=258 Identities=31% Similarity=0.514 Sum_probs=222.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555567789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc-----
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE----- 168 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~----- 168 (442)
|++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999999999988999999999999999999999999999999999999999999999999999753311000
Q ss_pred ----------------------------------------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHH
Q 013487 169 ----------------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFV 208 (442)
Q Consensus 169 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ 208 (442)
.....+.+||+.|+|||++.+..+. .++||||+||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999887775 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHhh--CCCCCCC--CCCHHHHHHHHHcc--CCCCCCCCCHHHHhcCccccc
Q 013487 209 LMAGFLPFDESNLMALYRKICR--ADFSCPS--WFSSGAKKLIKRIL--DPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 209 ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L--~~dP~~R~s~~eil~hp~~~~ 272 (442)
|++|..||...+.......+.. .....|. .+++++.+||.+|+ ..+|..|+++.++++||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999988776665555543 2344444 47999999999955 455666999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=389.99 Aligned_cols=251 Identities=32% Similarity=0.608 Sum_probs=226.5
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444566777899998866 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999864322 1223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+.......|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887774 899999999999999999999999998888988988888889999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q 013487 258 RM-------TISQMLEDEWFKK 272 (442)
Q Consensus 258 R~-------s~~eil~hp~~~~ 272 (442)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=397.68 Aligned_cols=258 Identities=32% Similarity=0.573 Sum_probs=223.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765555556778999999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc-----
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR----- 167 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~----- 167 (442)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHH
Q 013487 168 ----------------------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207 (442)
Q Consensus 168 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (442)
........+||+.|+|||++.+..|. .++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011235799999999999888875 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhh--CCCCCC--CCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013487 208 VLMAGFLPFDESNLMALYRKICR--ADFSCP--SWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 272 (442)
Q Consensus 208 ~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 272 (442)
+|++|.+||...+.......+.. .....| ..+++++.+||.+|+ .||.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999998877666655543 223333 347999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=396.72 Aligned_cols=256 Identities=28% Similarity=0.528 Sum_probs=226.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
-..+|.....||+|+.|.||.|....+++.||||.++.....+ .+-+.+|+.+|+..+|+|||++++.|--.+.+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3457999999999999999999999999999999998765333 4678899999999999999999999988899999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||++||+|.|.+.. ..++|.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||++........
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999999999876 4599999999999999999999999999999999999999999999999999986655332
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHh-hC--CCCCCCCCCHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC-RA--DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~--~~~~~~~~s~~~~~li 247 (442)
.-.+..|||+|||||++....| |.++||||||++++||+-|++||-..+.......|. .+ .+..|..+|+.+++||
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 3356789999999999998888 599999999999999999999998666554444443 33 3456778999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccC
Q 013487 248 KRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||+.||.+|+|+.|+|+||||+..
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999999999999999999643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=380.97 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=220.1
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999986654443444567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+++|+|.+.+... ..+++..+..++.|++.||+|||+.||+||||||+|||+++++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998887643 3689999999999999999999999999999999999999999999999999875422 122
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH----HHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
....+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.. .....+.......+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999887775 8899999999999999999999875432 2233344444566677899999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 248 KRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
++||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=387.60 Aligned_cols=254 Identities=29% Similarity=0.562 Sum_probs=225.6
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHH---hhCCCCCcceEEEEEEeCCEEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM---KLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544444556777777765 456799999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||++||+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999988865 5799999999999999999999999999999999999999999999999999864322 1223
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 251 (442)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..+++++.+||.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 345789999999999988766 4889999999999999999999999888888888888888888889999999999999
Q ss_pred CCCCCCCC-----CHHHHhcCccccc
Q 013487 252 DPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 252 ~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
+.||.+|| ++.++++||||+.
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999 6999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=390.97 Aligned_cols=251 Identities=34% Similarity=0.640 Sum_probs=226.1
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||+||+|.+..+|..||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445667789999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 99 ~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
+|.+++...+.+++..+..++.||+.||+|||+ .||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999988899999999999999999999998 7999999999999999999999999999864321 1223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887764 899999999999999999999999888888888887888888889999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q 013487 258 RM-----TISQMLEDEWFKK 272 (442)
Q Consensus 258 R~-----s~~eil~hp~~~~ 272 (442)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=386.52 Aligned_cols=251 Identities=31% Similarity=0.603 Sum_probs=222.8
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||.||+|.+..+|+.||+|++.+.........+....|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875433333455667788888754 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999999888999999999999999999999999999999999999999999999999999863221 1223456789
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|.+++.++.+||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999998888888888877777888899999999999999999999
Q ss_pred CCCH-HHHhcCccccc
Q 013487 258 RMTI-SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~-~eil~hp~~~~ 272 (442)
|+++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9997 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=396.93 Aligned_cols=258 Identities=31% Similarity=0.546 Sum_probs=222.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc----
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---- 168 (442)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999753211000
Q ss_pred -------------------------------------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc
Q 013487 169 -------------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA 211 (442)
Q Consensus 169 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~ 211 (442)
.......+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0011235799999999999887775 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhhC--CCCCC--CCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 013487 212 GFLPFDESNLMALYRKICRA--DFSCP--SWFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKK 272 (442)
Q Consensus 212 g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 272 (442)
|..||.+.+.......+... ....| ..+++++.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988776665555432 23333 347999999999977 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=393.40 Aligned_cols=258 Identities=30% Similarity=0.616 Sum_probs=228.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc-----
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR----- 167 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~----- 167 (442)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987544322
Q ss_pred ----------------------cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH
Q 013487 168 ----------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225 (442)
Q Consensus 168 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 225 (442)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00123345799999999999887764 8999999999999999999999998877777
Q ss_pred HHHhh--CCCCCCCC--CCHHHHHHHHHccCCCCCCCCC-HHHHhcCccccc
Q 013487 226 RKICR--ADFSCPSW--FSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 272 (442)
Q Consensus 226 ~~i~~--~~~~~~~~--~s~~~~~li~~~L~~dP~~R~s-~~eil~hp~~~~ 272 (442)
..+.. .....|.. +++++.+||.+||. ||.+|++ +.++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77765 44444443 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=387.71 Aligned_cols=251 Identities=29% Similarity=0.591 Sum_probs=221.1
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554555567788999999988 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1223446789
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---------cHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---------NLMALYRKICRADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 248 (442)
|+.|+|||++.+..++ .++|+||+||++|+|++|..||+.. .....+..+.......|..++.++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887775 8999999999999999999999631 12234555667777888899999999999
Q ss_pred HccCCCCCCCCC------HHHHhcCccccc
Q 013487 249 RILDPNPDTRMT------ISQMLEDEWFKK 272 (442)
Q Consensus 249 ~~L~~dP~~R~s------~~eil~hp~~~~ 272 (442)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 799999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=380.37 Aligned_cols=255 Identities=25% Similarity=0.454 Sum_probs=214.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 56789999999999999999999999999999999865431 1123457789999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||+.| +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999986 9999887654 479999999999999999999999999999999999999999999999999865332 12
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC------------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------------ 231 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------ 231 (442)
.......||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22345678999999999876554468999999999999999999999887765544333210
Q ss_pred -CCCC-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 -DFSC-----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 -~~~~-----------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.... .+.+++++.+||++||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0001 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=385.94 Aligned_cols=256 Identities=31% Similarity=0.581 Sum_probs=229.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+|++.+.||+|+||.||+|++..+++.||+|++.+.........+....|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444456677888888877 5899999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321 12233
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
...+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999887775 8999999999999999999999999888888888888888888899999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 013487 253 PNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.||.+|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999998 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=392.33 Aligned_cols=264 Identities=29% Similarity=0.520 Sum_probs=228.8
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
......++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34456789999999999999999999999999999999998655444444566889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999999998865 46899999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCccccccCCCcccCcccccccC---CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCCC--CC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPS--WF 239 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~ 239 (442)
. .......+||+.|+|||++.+.. +.+.++|||||||++|+|++|.+||.+.+....+..+.... ..+|. .+
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 1 11223568999999999987543 34689999999999999999999999988888888776543 44454 47
Q ss_pred CHHHHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 240 SSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
|.++.+||++||+.+|.+ |+|++++++||||+.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999999999998 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=384.20 Aligned_cols=251 Identities=33% Similarity=0.648 Sum_probs=222.0
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||.||+|.+..+++.||+|++.+.........+....|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544334455566777777654 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccccccC
Confidence 999999998889999999999999999999999999999999999999999999999999998743221 223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887764 889999999999999999999999888888888877777788889999999999999999999
Q ss_pred CCCH-HHHhcCccccc
Q 013487 258 RMTI-SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~-~eil~hp~~~~ 272 (442)
||++ .++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 9986 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=392.12 Aligned_cols=258 Identities=31% Similarity=0.603 Sum_probs=225.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765545556778899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc----
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---- 168 (442)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864322100
Q ss_pred -----------------------------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC
Q 013487 169 -----------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (442)
Q Consensus 169 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 219 (442)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0012245799999999999888775 8999999999999999999999988
Q ss_pred cHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHccCCCCCCCC---CHHHHhcCccccc
Q 013487 220 NLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKK 272 (442)
Q Consensus 220 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 272 (442)
+....+..+... ...+|+ .+++++++||.+|+. ||.+|+ ++.++++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888777776642 334444 378999999999874 999998 4899999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=378.23 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=213.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 2234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 999998776666556679999999999999999999999999999999999999999999999999987643221 1223
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------CC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------DF 233 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 233 (442)
...+||+.|+|||++.+..++ .++||||+||++|+|++|.+||...+.......+... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 346799999999999887764 8999999999999999999999876544332222110 00
Q ss_pred CCC-------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 SCP-------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 ~~~-------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..| ..+|.++.+||++||+.||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=384.43 Aligned_cols=251 Identities=33% Similarity=0.667 Sum_probs=224.2
Q ss_pred eeecccCceEEEEEEEc---CCCCEEEEEEecchhhhh-HHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
+.||+|+||.||+|.+. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++...+.+|++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999874 578899999997654322 23456678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccc
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 174 (442)
++||+|.+++...+.++++.+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCcccc
Confidence 99999999999988999999999999999999999999999999999999999999999999999864322 1223345
Q ss_pred ccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCC
Q 013487 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 254 (442)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..+....|+.+++++.+||.+||+.|
T Consensus 160 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred cCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 6899999999999877664 899999999999999999999999888888888888888889999999999999999999
Q ss_pred CCCCC-----CHHHHhcCccccc
Q 013487 255 PDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 255 P~~R~-----s~~eil~hp~~~~ 272 (442)
|++|| +++++++||||..
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=385.25 Aligned_cols=251 Identities=33% Similarity=0.617 Sum_probs=222.1
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHH-HHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+...+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443333445555555 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.......++.+++.+.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887765 889999999999999999999999888888888888877888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 013487 258 RMTI----SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~----~eil~hp~~~~ 272 (442)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=383.47 Aligned_cols=251 Identities=34% Similarity=0.656 Sum_probs=226.1
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566778899999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..+. .++|+||+||++|+|++|..||...+....+..+.......|..++.++.+||++||..||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999998888888888888888888889999999999999999999
Q ss_pred CCCH-----HHHhcCccccc
Q 013487 258 RMTI-----SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~-----~eil~hp~~~~ 272 (442)
|||+ .++++||||+.
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=382.11 Aligned_cols=256 Identities=31% Similarity=0.585 Sum_probs=228.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|..+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444445667788999998886 578889999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874322 11223
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
...+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+.......|..++.++.+|+.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999887764 8999999999999999999999998888888888888888888899999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 013487 253 PNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.||.+|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 579999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=390.30 Aligned_cols=262 Identities=30% Similarity=0.553 Sum_probs=225.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999765544444456788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~- 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG- 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence 999999999999999876 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccCcccccccC---CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCCC--CCCH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPS--WFSS 241 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~ 241 (442)
.....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+..+.... +..|. .++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 11224568999999999987643 34689999999999999999999999988877777776532 44444 4699
Q ss_pred HHHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 242 GAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
.+++|+.+||..+|.+ |+|+.++++||||+.
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 9999999999866654 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=384.40 Aligned_cols=251 Identities=30% Similarity=0.602 Sum_probs=219.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554555567788999998877 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864322 1223345789
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC---------CcHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---------SNLMALYRKICRADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 248 (442)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.. .........+.......|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 899999999999999999999952 122334555666777888889999999999
Q ss_pred HccCCCCCCCCC------HHHHhcCccccc
Q 013487 249 RILDPNPDTRMT------ISQMLEDEWFKK 272 (442)
Q Consensus 249 ~~L~~dP~~R~s------~~eil~hp~~~~ 272 (442)
+||+.||++||| +.++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=380.38 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=211.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 457899999999999999999999999999999998754321 123456789999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||+. ++|.+++... +.++++.++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 157 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PS 157 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CC
Confidence 999996 5888877654 5689999999999999999999999999999999999999999999999999864322 12
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-HHHHHHHhh--CC--------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICR--AD-------------- 232 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~--~~-------------- 232 (442)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.. +.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 2234567899999999987665556889999999999999999999986432 222222110 00
Q ss_pred -----CC--CCC---------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 233 -----FS--CPS---------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 233 -----~~--~~~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+. .+. .+++++.+||++||+.||++|||+.|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 000 135688999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=383.51 Aligned_cols=258 Identities=31% Similarity=0.609 Sum_probs=222.6
Q ss_pred CeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhh-hHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (442)
+|++.+.||+|+||.||+|++. .++..||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999765432 223456788999999999 599999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC----cHHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+.......|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335689999999999987655568999999999999999999999643 2334445566666677778999999
Q ss_pred HHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
+||.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 8899999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=381.64 Aligned_cols=251 Identities=31% Similarity=0.605 Sum_probs=221.5
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|++..+++.||+|++.+.........+....|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999866433333345566788888764 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999999888899999999999999999999999999999999999999999999999999864221 1223345679
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..++ .++||||+||++|+|++|..||...+....+..+.......|.+++.++.+||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999887764 899999999999999999999998888888887777777788889999999999999999999
Q ss_pred CCCHH-HHhcCccccc
Q 013487 258 RMTIS-QMLEDEWFKK 272 (442)
Q Consensus 258 R~s~~-eil~hp~~~~ 272 (442)
||++. ++++||||+.
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 9999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=385.75 Aligned_cols=258 Identities=29% Similarity=0.520 Sum_probs=224.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccCCCcccCcccccc-----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCC--CCCCCHH
Q 013487 172 LHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSC--PSWFSSG 242 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~--~~~~s~~ 242 (442)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+..+.... ... .+.++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233588999999999999999999999888777777665432 223 3357999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.+||++||. ||.+|||++++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=369.26 Aligned_cols=259 Identities=29% Similarity=0.483 Sum_probs=222.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCC----
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKT---- 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 86 (442)
...|..++.||+|+||+||+|+++.+|+.||+|.+..+.-. +..-....+|+.+|+.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 55688888999999999999999999999999999866421 223456789999999999999 999999998877
Q ss_pred --EEEEEEEccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 87 --KIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 87 --~~~lv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
.+++|+||++. +|..++...+ .++...++.+++||+.||+|||++||+||||||+|||+++.|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999987 9999998766 5888999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh----------
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------- 230 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------- 230 (442)
+.+.- +........+|.+|+|||++.+..+++...||||+|||++||+++.+-|.+.+..+....|.+
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86543 223356678999999999999987778999999999999999999999999887766655532
Q ss_pred --------CCCCCCCC------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 231 --------ADFSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 231 --------~~~~~~~~------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
....++.| .+++..+|+.+||+.+|.+|.|+..+|+||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 11122222 235889999999999999999999999999998754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=364.66 Aligned_cols=276 Identities=34% Similarity=0.630 Sum_probs=230.6
Q ss_pred cccccCeEEE-eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe--
Q 013487 9 RTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS-- 84 (442)
Q Consensus 9 ~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-- 84 (442)
..+.++|++. +.||-|-.|+|-.+.++.|++.+|+|++... ...++|+++.-.. .|||||.++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3467788885 6799999999999999999999999987422 3467899987666 59999999999854
Q ss_pred --CCEEEEEEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEeec
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~DF 157 (442)
..++.+|||.++||+||+.|+.++. ++|.++..+++||..|+.|||+.+|+||||||+|+|... |..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4678899999999999999998875 999999999999999999999999999999999999974 457999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc----HHHHHHHHhhCCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADF 233 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~ 233 (442)
|+|+... ....+.+.|-||+|+|||++....|+ ..+|+||+||++|.||+|.+||-... ...+..+|..+.+
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9998543 24668899999999999999887876 89999999999999999999996432 3466677888776
Q ss_pred CCC--CC--CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCCCCCCcccccCccchhhhhcc
Q 013487 234 SCP--SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFND 296 (442)
Q Consensus 234 ~~~--~~--~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (442)
.+| .| +|++++++|+.+|..+|.+|.|+.+++.|||+.+...-+...-.....+++....+++
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~a~e~w~d 351 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKEAVEAWDD 351 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcchhhhhhHH
Confidence 665 45 7999999999999999999999999999999988665554443333333333333333
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=387.13 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=228.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
..|+..+.||+|+||.||+|++..+++.||||+++.+... ..++.+.+|+.+|..+++|||.++|+.|.....+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3588889999999999999999999999999999987643 35788999999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|||.||++.+.++..+.++|..+..++++++.||.|||.++.+|||||+.|||+..+|.+|++|||.+........ .-
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999876554322 22
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHcc
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRIL 251 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L 251 (442)
.+..|||.||||||+.+.+|+ .++||||||++.+||++|.+||....++.....|.+..+ .....+|+.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999999988887 899999999999999999999988777554444444332 223358999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccC
Q 013487 252 DPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 252 ~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++||+.|||+.++|+|+|++..
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999873
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=379.66 Aligned_cols=251 Identities=33% Similarity=0.608 Sum_probs=221.6
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHH-HHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765444334445555554 67889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......|+..+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 789999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 013487 258 RMTI----SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~----~eil~hp~~~~ 272 (442)
|+++ .++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=381.52 Aligned_cols=251 Identities=32% Similarity=0.584 Sum_probs=221.2
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHH-HHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997664433334455556655 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......++..+..+.++|++||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887775 899999999999999999999999888888888888777777788999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 013487 258 RMTI----SQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~----~eil~hp~~~~ 272 (442)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=383.64 Aligned_cols=250 Identities=30% Similarity=0.591 Sum_probs=219.3
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC---CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
||+|+||+||+|++..+++.||+|++.+..............|..++..+ .||||+++++++.+.+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999766544444445556677777655 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999988999999999999999999999999999999999999999999999999999864322 1223456789
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC-CCCHHHHHHHHHccCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-WFSSGAKKLIKRILDPNPD 256 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~~~L~~dP~ 256 (442)
|+.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+..+....|. .+++++.+||++||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976654568999999999999999999999998888888888777766665 3799999999999999999
Q ss_pred CCC----CHHHHhcCccccc
Q 013487 257 TRM----TISQMLEDEWFKK 272 (442)
Q Consensus 257 ~R~----s~~eil~hp~~~~ 272 (442)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=385.05 Aligned_cols=263 Identities=31% Similarity=0.547 Sum_probs=225.8
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44566899999999999999999999999999999999976554444445678899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999999999999876 468999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCccccccCCCcccCcccccccC---CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCC--CCCC
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCP--SWFS 240 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s 240 (442)
.......+||+.|+|||++.+.. +.+.++||||+||++|+|++|..||...+....+..+.... ..+| ..++
T Consensus 197 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred -cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 11224568999999999987543 34689999999999999999999999988888888776542 3334 3589
Q ss_pred HHHHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
..+++||.+||..+|.+ |++++++++||||+.
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 99999999999854443 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=378.77 Aligned_cols=251 Identities=29% Similarity=0.595 Sum_probs=220.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876655555677888999999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1223456789
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-------cHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-------NLMALYRKICRADFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 250 (442)
|+.|+|||++.+..+. .++|||||||++|+|++|..||... .....+..+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999887774 8999999999999999999999532 2234555666667778888999999999999
Q ss_pred cCCCCCCCCC------HHHHhcCccccc
Q 013487 251 LDPNPDTRMT------ISQMLEDEWFKK 272 (442)
Q Consensus 251 L~~dP~~R~s------~~eil~hp~~~~ 272 (442)
|+.||.+|++ ++++++||||+.
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=380.68 Aligned_cols=250 Identities=32% Similarity=0.639 Sum_probs=223.2
Q ss_pred eeecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
+.||+|+||.||++.+. .+|+.||+|++.+.... ......+.+|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999873 57899999999865432 223456778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccc
Q 013487 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (442)
Q Consensus 96 ~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 175 (442)
+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceecc
Confidence 99999999988888999999999999999999999999999999999999999999999999998754321 1233456
Q ss_pred cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCC
Q 013487 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP 255 (442)
+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......|..+++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999877764 8999999999999999999999998888888888888888888899999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q 013487 256 DTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 256 ~~R~s-----~~eil~hp~~~~ 272 (442)
.+||| +.+++.||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=378.68 Aligned_cols=258 Identities=30% Similarity=0.470 Sum_probs=210.1
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----CEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----TKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 88 (442)
+|++.+.||+|+||.||+|++..++..||+|.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 6999999999999999999999999999999986432 1222345678999999999999999999988543 358
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 59999999888899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHh-----------------
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC----------------- 229 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~----------------- 229 (442)
.......+||+.|+|||++.+. ...+.++||||+||++|+|++|.+||.+.+.......+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1122456799999999998652 233589999999999999999999997765432221110
Q ss_pred ---------hCCCCC-----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 230 ---------RADFSC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 230 ---------~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
....+. .+.+++.+.++|.+||+.||++|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 000000 12357889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=378.80 Aligned_cols=251 Identities=33% Similarity=0.620 Sum_probs=220.2
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHH-HHHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI-STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865543333334444444 456889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999864322 2223456789
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 257 (442)
|+.|+|||++.+..++ .++||||+||++|+|++|.+||...+..+.+..+.......++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887765 899999999999999999999999888888888887777777889999999999999999999
Q ss_pred CCCHH----HHhcCccccc
Q 013487 258 RMTIS----QMLEDEWFKK 272 (442)
Q Consensus 258 R~s~~----eil~hp~~~~ 272 (442)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99865 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=368.99 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=214.5
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||+|+||+||+|.+..+++.||+|++.+.........+.+..|+.+++.++||||+++++++...+..|++|||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544444456778999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccccc
Q 013487 101 FDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (442)
Q Consensus 101 ~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 176 (442)
.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887743 346899999999999999999999999999999999999999999999999998654332 12233457
Q ss_pred CCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
||+.|+|||++.+..++ .++|+||+||++|+|++|..||...+. ......+.......|..+++++.+|+.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999887775 889999999999999999999976432 2333344445556677789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 013487 253 PNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~-----s~~eil~hp~~~~ 272 (442)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=376.52 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=215.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCE-EEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-EEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDF-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-KIY 89 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 89 (442)
.....+.+.||+|+||+||+|... |+. ||+|++......... .+.+.+|+.+|++++|||||++++++.++. .++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 345566777999999999999984 444 999999876544433 788999999999999999999999999887 799
Q ss_pred EEEEccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEccCC-ceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENLLLDSYG-VLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~g-ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~ 165 (442)
+||||+++|+|.+++.. ...++...+..++.||+.||+|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999988 678999999999999999999999999 99999999999999998 999999999986543
Q ss_pred cccCCccccccCCCcccCccccc--ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh--CCCCCCCCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~ 241 (442)
.. .......||+.|||||++. ...|+ .++||||+||+||||+||..||......+....+.. ....+|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2233368999999999999 45675 999999999999999999999999887655555432 34566777999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+..|+.+||..||.+||++.+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=373.21 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=219.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|++..++..+|+|++.... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999987542 23345778999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999999888899999999999999999999986 699999999999999999999999999875432
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHh--------------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC-------------------- 229 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-------------------- 229 (442)
......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..++...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 223456799999999999887764 89999999999999999999997665443322111
Q ss_pred --------------------------hCC-CCC-CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 230 --------------------------RAD-FSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 230 --------------------------~~~-~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
... ... ...+++++.+||.+||..||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 011 11367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=374.00 Aligned_cols=259 Identities=29% Similarity=0.536 Sum_probs=220.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998655444445667889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999976 45799999999999999999999999999999999999999999999999999865432111 11
Q ss_pred cccccCCCcccCcccccc----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCC---CCCCHH
Q 013487 172 LHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCP---SWFSSG 242 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 242 (442)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||...+..+.+..+.... +..| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2344688999999999999999999999888777777665432 3333 347999
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
+++||++||..++++ |+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999998765444 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=366.10 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=219.3
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+...+.+|++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554433344567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+.||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999888654 4589999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHH----HHHHhhCCCCCCCCCCHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL----YRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li 247 (442)
....+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.... ...+.......+..++..+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2345799999999999877664 789999999999999999999987654332 22233344455667899999999
Q ss_pred HHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 248 KRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
.+||..||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=380.27 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=237.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE-EE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-IY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 89 (442)
.++.|..++.+|+|+||.+++++++..+..+++|.++....... ......+|+.+++++.|||||.+.+.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 35789999999999999999999999999999999987765433 34578899999999999999999999998888 99
Q ss_pred EEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+|+||+||+|.+.|.... -++|+.+..|+.|++.|+.|||+++|+|||||+.||+++.++.+||+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~- 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE- 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence 9999999999999998765 5899999999999999999999999999999999999999999999999999987653
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKL 246 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 246 (442)
.....+..|||.|+.||++.+.+|. .++|||||||++|||++-+++|.+.+...+..+|.++. .+.|..++.+++.|
T Consensus 160 -~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 -DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred -hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 2466788999999999999999996 99999999999999999999999999999999999887 57788899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccc
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
|..||..+|..||++.++|.+|..+.
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999988763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=363.64 Aligned_cols=255 Identities=31% Similarity=0.488 Sum_probs=214.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (442)
..-.|+-.+.+|.|+||.||.|....+++.||||.+-.+.-. -.+|+.+|+.++|||||++..+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 334689999999999999999999999999999988654422 238999999999999999999885432
Q ss_pred -EEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-CceEEeeccch
Q 013487 87 -KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLS 160 (442)
Q Consensus 87 -~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DFGla 160 (442)
+..+||||++. +|.+.+.. +..++.-.++-|..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 34589999986 99998884 5779999999999999999999999999999999999999965 99999999999
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh----------
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------- 230 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------- 230 (442)
+......+ ..++..|..|+|||.+.+...++.+.||||+||++.||+-|++-|.+.+..+....|.+
T Consensus 174 K~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 97765433 35566799999999999988778999999999999999999999999877665554432
Q ss_pred -------CCCCCC------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 231 -------ADFSCP------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 231 -------~~~~~~------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
..+.+| ...++++.+|+.++|..+|.+|.++.|++.||||.....+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 011111 1258999999999999999999999999999999865443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=370.50 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=233.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..+.|+..+.||+|+||.||-++.+.||+.+|+|.+++.++..........+|-.||.+++.|.||.+-..|++.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34568899999999999999999999999999999999988777777788899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||..|.||+|.-+|.+.+ .|++..+++|+.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|||.-...
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--- 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--- 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC---
Confidence 999999999999998877 899999999999999999999999999999999999999999999999999986543
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc----HHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
........||.+|||||++.+..|+ ..+|+|||||+||+|+.|+.||.... ..++-+.+......+|..+|++++
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK 418 (591)
T ss_pred CCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence 3344556899999999999988875 89999999999999999999997543 234555566667778888999999
Q ss_pred HHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
+|.+.+|++||.+|.. ++++.+||||+.
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999985 679999999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=362.98 Aligned_cols=254 Identities=37% Similarity=0.743 Sum_probs=231.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++...+.+|++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555556778899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999999889999999999999999999999999999999999999999999999999998754332 3
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
...+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+....|..++..+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 35579999999999877665 48899999999999999999999888877777777777788888899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 013487 253 PNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~-----s~~eil~hp~~~~ 272 (442)
.||.+|+ +++++++||||+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=387.67 Aligned_cols=251 Identities=29% Similarity=0.389 Sum_probs=206.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC------
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (442)
.++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999886432 2234799999999999999999887432
Q ss_pred --CEEEEEEEccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeecc
Q 013487 86 --TKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFG 158 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFG 158 (442)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 257799999986 6766664 346799999999999999999999999999999999999999665 79999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------- 231 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------- 231 (442)
+|+..... ......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 217 la~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99754321 22335678999999999877654568999999999999999999999887655444333210
Q ss_pred ----------CC------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 ----------DF------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 ----------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.. .+|...++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00 1233467899999999999999999999999999999764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=379.64 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=209.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++||||+++++++......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 345689999999999999999999999999999997532 23568999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
++||++. ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... .
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 9999996 5999999888889999999999999999999999999999999999999999999999999986432211 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-------HHHHHHHH--------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKI-------------- 228 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i-------------- 228 (442)
......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.... .......+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22345689999999999988776 489999999999999999998874321 01111111
Q ss_pred ------------hhCC----CCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 229 ------------CRAD----FSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 229 ------------~~~~----~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.... ...|. .++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0100 01111 1466899999999999999999999999999998643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.74 Aligned_cols=259 Identities=28% Similarity=0.512 Sum_probs=221.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997655444445566889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence 99999999999987 4679999999999999999999999999999999999999999999999999986432211 112
Q ss_pred cccccCCCcccCcccccc----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCCC---CCCHH
Q 013487 172 LHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPS---WFSSG 242 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 242 (442)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+....+..+.... ...|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234679999999999863 2334589999999999999999999999888888877776543 23333 47999
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
+.+||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=389.69 Aligned_cols=261 Identities=31% Similarity=0.505 Sum_probs=226.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC---
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (442)
...++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445799999999999999999999999999999999976543 2334567889999999999999999988775332
Q ss_pred -----EEEEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeec
Q 013487 87 -----KIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (442)
Q Consensus 87 -----~~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DF 157 (442)
.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999988653 46899999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCP 236 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~ 236 (442)
|+++............+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+.......+..+.. +.|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 998765433233334567899999999999887775 899999999999999999999999888777777665544 467
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.+++++.+|+.+||..||.+|||+.++++|||++.
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 778999999999999999999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.56 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=215.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 3567899999999999999999999999999999998754321 12345678999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 157 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-- 157 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--
Confidence 99999986 8888876644 5899999999999999999999999999999999999999999999999998653221
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-----------------
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------------- 231 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------- 231 (442)
........+|+.|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 122234568999999999876555568999999999999999999999877654443322110
Q ss_pred --CCCC-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 --DFSC-----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 --~~~~-----------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.... .+.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0111 123688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=387.36 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=224.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCC-CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVET-GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
....|.+.+.||+|+||.||.|.+..+ ++.||+|.+.... ......+++|+.+++.++||||+++++++...+.+|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 345599999999999999999999877 7889999875432 233467789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+||||++||+|.+++.. ..++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999987753 45689999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAK 244 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~ 244 (442)
..........+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..+....+..+.. +.|..+++++.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 2222234567899999999999887764 899999999999999999999998888777777766554 45667899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+||.+||..||++|||+.+++.|||++.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999974
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=370.00 Aligned_cols=259 Identities=29% Similarity=0.499 Sum_probs=220.9
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444444566889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 99999999999987 46799999999999999999999999999999999999999999999999999865432111 11
Q ss_pred cccccCCCcccCccccccc----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCCCC---CCCHH
Q 013487 172 LHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPS---WFSSG 242 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 242 (442)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|..||...+....+..+.... ++.|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2346799999999998652 223578999999999999999999999888777777765533 33443 36899
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
+.+||.+||..++++ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 568999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=372.21 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=211.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC---
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (442)
..+++|++.+.||+|+||.||+|.+..+|..||+|++.+.. ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 46789999999999999999999999999999999987543 22334567789999999999999999999986543
Q ss_pred ---EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 87 ---KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 87 ---~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.+|++|||+.+ +|.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 6766664 35899999999999999999999999999999999999999999999999998643
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh-------------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------- 230 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------- 230 (442)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 22 2223456789999999999887775 789999999999999999999987654332221110
Q ss_pred ---------CCCC---------CCC-----------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 231 ---------ADFS---------CPS-----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 231 ---------~~~~---------~~~-----------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
.... .+. ..++++.+||.+||..||++|||+.|+|+||||+..+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 0000 011 135788999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=377.16 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=215.8
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-----EE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----KI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 88 (442)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986432 22234567889999999999999999999998776 79
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 589999988888999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh------------------
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------------ 230 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------ 230 (442)
........+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233456899999999998766556899999999999999999999987765544433321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 231 -----ADF---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 231 -----~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
... ......++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223357899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=353.84 Aligned_cols=257 Identities=31% Similarity=0.550 Sum_probs=221.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
+.|++.+.||+|++|.||.|.+..+++.||+|.+...... .......+.+|+.++++++||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999998654321 12235678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
++||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543321111
Q ss_pred -ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHHH
Q 013487 171 -LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li 247 (442)
......|++.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1134568899999999988765 48999999999999999999999876655544444332 3456667899999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccc
Q 013487 248 KRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=373.40 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=214.4
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 44678999999999999999999999999999999986442 2334567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||+++|+|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--M 222 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--c
Confidence 99999999998653 34578888999999999999999999999999999999999999999999998765322 1
Q ss_pred CccccccCCCcccCcccccc----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---HHHHHHHh-hCCCCCCCCCCH
Q 013487 170 GLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKIC-RADFSCPSWFSS 241 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~-~~~~~~~~~~s~ 241 (442)
.......||+.|+|||++.. ..+.+.++|||||||++|+|++|..||..... ......+. ......+..++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 12234579999999998753 24556789999999999999999999974332 22222222 223344566899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.+||.+||..||++|||+.|+++||||.+..
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=357.74 Aligned_cols=253 Identities=38% Similarity=0.686 Sum_probs=215.2
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987754333 233445699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccc
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 174 (442)
+.+++|.+++...+.+++..+..++.|++.||++||++|++|+||||+||++++++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998643 112234456
Q ss_pred ccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---HHHHHHHHhhCCCCCCC----CCCHHHHHHH
Q 013487 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADFSCPS----WFSSGAKKLI 247 (442)
Q Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~s~~~~~li 247 (442)
.++++.|+|||++......+.++|+||||+++|+|++|..||.... ...............+. ..+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7799999999998833444689999999999999999999999873 33333333322221111 1248999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccc
Q 013487 248 KRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=402.39 Aligned_cols=262 Identities=31% Similarity=0.553 Sum_probs=236.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+...++|++++.||+|+||.|.+++++.|++.||+|++++-...+......+..|-.+|..-+.+-|+.++..|++++++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 35567899999999999999999999999999999999886655555567889999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||++||+|...+.+.++++|+.|++|+..|+.||+-||+.|+|||||||+|||+|.+|++||+|||.+-.+...+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998866553322
Q ss_pred CCccccccCCCcccCcccccc----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCC--CCCC
Q 013487 169 DGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCP--SWFS 240 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s 240 (442)
-......|||-|++||++.. .+.+|..+|+||+||++|||+.|..||-..+..+.|.+|... .+.+| ..+|
T Consensus 231 -V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 231 -VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred -EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 23345689999999999863 356689999999999999999999999999999999999876 67788 4589
Q ss_pred HHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 272 (442)
+++++||++++. +|..|.. +++|..||||..
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 999999999996 5999998 999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=366.83 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=217.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.-++|++.+.||+|+||.||+|.+..++..+|+|++.... .....+.+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3478999999999999999999999999999999987542 23345678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999999999888899999999999999999999985 7999999999999999999999999998754321
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHH---------------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI--------------------- 228 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i--------------------- 228 (442)
.....+||+.|+|||++.+..+. .++|+||+||++|+|++|..||............
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 22345799999999999876664 8899999999999999999999765443322111
Q ss_pred -----------------------hhCC-CCCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 229 -----------------------CRAD-FSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 229 -----------------------~~~~-~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.... ...+ ..++.++.+||.+||+.||++|||+.|++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1110 1111 13578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=360.67 Aligned_cols=252 Identities=31% Similarity=0.457 Sum_probs=206.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcC-CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC---CCCCcceEEEEEE-----
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMA----- 83 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 83 (442)
.+|++.+.||+|+||+||+|.+.. ++..||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 56889999986543221 2233455777777766 6999999999885
Q ss_pred eCCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
....++++|||+. ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 4899988753 358999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC--------
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-------- 233 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------- 233 (442)
..... ......+||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+..+....+.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54321 233456799999999999877764 789999999999999999999998776655555432100
Q ss_pred -------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 -------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
...+.+++.+.+|+.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112367888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=353.27 Aligned_cols=263 Identities=32% Similarity=0.613 Sum_probs=227.1
Q ss_pred cccccCeEE-EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCC
Q 013487 9 RTRVGKYEL-GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT 86 (442)
Q Consensus 9 ~~~~~~y~i-~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 86 (442)
+...+-|.+ .+.||+|++|.|-.++...||..||+|++++.. .....++.+|++++.+++ |+||+.++++|+++.
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 334444666 578999999999999999999999999999873 335688999999999995 999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEeeccchhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAIS 163 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~DFGla~~~ 163 (442)
.+|+|||-+.||.|..+|.++..|+|.++.++.++|+.||+|||.+||.||||||+|||-.... -+|||||.|+...
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999997544 5899999997643
Q ss_pred hhccc-----CCccccccCCCcccCccccc----ccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---------------
Q 013487 164 QQVRE-----DGLLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDES--------------- 219 (442)
Q Consensus 164 ~~~~~-----~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--------------- 219 (442)
..... ...+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+.
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 32211 22456789999999999863 2334458999999999999999999999542
Q ss_pred cHHHHHHHHhhCCCCCCC--C--CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 220 NLMALYRKICRADFSCPS--W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~--~--~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
-...++..|..+.+.+|. | +|.++++|++.+|..||.+|.++.++++|||++...
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 135678889999988885 3 899999999999999999999999999999998654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=357.32 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=215.8
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+..|++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999876544444445567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+.||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 999999999886543 589999999999999999999999999999999999999999999999999864322 112
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH---HHHHHH-hhCCCCCCCCCCHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALYRKI-CRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i-~~~~~~~~~~~s~~~~~li 247 (442)
....+||+.|+|||++.+..+. .++|+||+|+++|+|++|..||...... ...... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877764 8899999999999999999999864321 111111 1122334566899999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 248 KRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.+||+.||.+||| +.|+++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=369.76 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=212.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 457899999999999999999999999999999999875432 223456678999999999999999999987543
Q ss_pred --CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 457999999976 77777754 4889999999999999999999999999999999999999999999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-----------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD----------- 232 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 232 (442)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+....
T Consensus 177 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 177 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 22 2223456789999999999887775 89999999999999999999998776555444332210
Q ss_pred -----------CC--------------C------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 233 -----------FS--------------C------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 233 -----------~~--------------~------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
.. . ....+..+++||.+||..||.+|||+.|+|+||||...+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 00 0 00124678999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=368.31 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=211.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 467899999999999999999999999999999999875432 233456778999999999999999999988543
Q ss_pred --CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
...|++|||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 67777653 5889999999999999999999999999999999999999999999999998753
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC------------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 231 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 231 (442)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+...
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 2223456799999999999887775 8899999999999999999999876654333221110
Q ss_pred ----------C-----CC---------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 232 ----------D-----FS---------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 232 ----------~-----~~---------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
. .. .+...+.++.+||.+||..||.+|||+.|+|+||||+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01113567899999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=367.21 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=211.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (442)
..++|++.+.||+|+||+||+|.+..++..||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45789999999999999999999999999999999875432 222345677899999999999999999987543
Q ss_pred -CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
..+|++|+++ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 6799887754 579999999999999999999999999999999999999999999999999987543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 232 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 232 (442)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||...+..+....+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999999875555689999999999999999999998766544433322100
Q ss_pred ----------C-CCC--------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 233 ----------F-SCP--------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 233 ----------~-~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
. ..+ ...++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0 001 12466789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.50 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=215.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 3578899999999999999999999999999999998654321 12345678999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||+.+ +|.+.+... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 157 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 157 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--
Confidence 99999975 898888764 46899999999999999999999999999999999999999999999999998653321
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-----------------
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------------- 231 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------- 231 (442)
........+++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 122234467899999999877655568999999999999999999999887655443322110
Q ss_pred --CCCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 --DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 --~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
....| ..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2368889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.38 Aligned_cols=248 Identities=26% Similarity=0.449 Sum_probs=208.4
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||+|+||.||++.++.+|+.||+|.+.............+..|+.++++++||||+++++++.+...+|++|||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCC
Q 013487 101 FDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (442)
Q Consensus 101 ~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 178 (442)
.+.+...+ .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...... .......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCC
Confidence 98886543 5889999999999999999999999999999999999999999999999998754321 122345799
Q ss_pred CcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH----HHHHHHHhhCCCCCC-CCCCHHHHHHHHHccCC
Q 013487 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCP-SWFSSGAKKLIKRILDP 253 (442)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~ 253 (442)
+.|+|||++.+..+ +.++|+||+||++|+|++|..||..... ..............+ ..+++++.+||++||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999988775 4899999999999999999999975432 233333333333322 35799999999999999
Q ss_pred CCCCCCCH----HHHhcCccccc
Q 013487 254 NPDTRMTI----SQMLEDEWFKK 272 (442)
Q Consensus 254 dP~~R~s~----~eil~hp~~~~ 272 (442)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=381.66 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=203.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC------CCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH------PNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~ 85 (442)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 468999999999999999999999999999999986432 123345567777776654 5688999988765
Q ss_pred -CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCC-------------
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYG------------- 150 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~------------- 150 (442)
..+|+|||++ |++|.+++...+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 67999999988899999999999999999999998 5999999999999998765
Q ss_pred ---ceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH
Q 013487 151 ---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (442)
Q Consensus 151 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (442)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|++||++.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 123456899999999999988775 899999999999999999999987665443332
Q ss_pred HhhCCCCCC-----------------------C-------------------CCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013487 228 ICRADFSCP-----------------------S-------------------WFSSGAKKLIKRILDPNPDTRMTISQML 265 (442)
Q Consensus 228 i~~~~~~~~-----------------------~-------------------~~s~~~~~li~~~L~~dP~~R~s~~eil 265 (442)
+.......| + ..++.+.+||.+||..||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 211100000 0 0135577999999999999999999999
Q ss_pred cCcccccCC
Q 013487 266 EDEWFKKGY 274 (442)
Q Consensus 266 ~hp~~~~~~ 274 (442)
+||||++.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998644
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.24 Aligned_cols=255 Identities=26% Similarity=0.471 Sum_probs=219.0
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+...+..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999976654444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+.+++|.+.+... .++++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999999888653 3699999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH----HHHhhCCCCCCCCCCHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY----RKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~s~~~~~li 247 (442)
.....|++.|+|||++.+..+. .++|+||+|+++|+|++|..||......... ..+.......+..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999877664 8899999999999999999999876544322 2233334455666899999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 248 KRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.+||+.||++||| +.+++.||||+.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=356.35 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=205.1
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC---CCCCcceEEEEEEe-----C
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMAS-----K 85 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 85 (442)
+|++.+.||+|+||+||+|+++.+++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543211 1223455677777665 69999999998864 3
Q ss_pred CEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
..++++|||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999985 898888764 34899999999999999999999999999999999999999999999999998765
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC------------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 231 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 231 (442)
... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||...+......++...
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 321 122345689999999999877664 8999999999999999999999877655444433220
Q ss_pred ------CC---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 ------DF---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 ------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+ ...+.++..+.+||.+||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0112357888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=345.10 Aligned_cols=253 Identities=26% Similarity=0.534 Sum_probs=219.1
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 92 (442)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999755432 2345678899999999999999999998764 44689999
Q ss_pred EccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 93 EFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 93 E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 999999999998763 45899999999999999999999999999999999999999999999999998755322 22
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKR 249 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 249 (442)
......|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..+.. ..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999877664 789999999999999999999998777666666655544 4556689999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 013487 250 ILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~ 270 (442)
||+.||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.42 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=204.2
Q ss_pred cCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC-
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK- 85 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~- 85 (442)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 58999999999999999999852 445689999986432 223356788999999999 899999999988654
Q ss_pred CEEEEEEEccCCCChHHHHHhc----------------------------------------------------------
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (442)
..+|++|||++||+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccC
Q 013487 108 ----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183 (442)
Q Consensus 108 ----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 183 (442)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2377888999999999999999999999999999999999999999999999875432111111123346788999
Q ss_pred cccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHH-HHHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCC
Q 013487 184 PEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-YRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMT 260 (442)
Q Consensus 184 PE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~-~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s 260 (442)
||++.+..+. .++|||||||++|+|++ |..||.+...... ...+..+ ....|..+++++.+|+.+||..||.+|||
T Consensus 245 PE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 245 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred cHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999877764 89999999999999997 9999987554333 2333332 33456668999999999999999999999
Q ss_pred HHHHhc
Q 013487 261 ISQMLE 266 (442)
Q Consensus 261 ~~eil~ 266 (442)
+.++++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=348.32 Aligned_cols=256 Identities=29% Similarity=0.550 Sum_probs=220.3
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh------hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL------RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
+|.+...||+|++|.||+|.+..+++.+|+|.+...... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999999999999988654321 22345778999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.+++|||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987654211
Q ss_pred c----CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHH
Q 013487 168 E----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-DFSCPSWFSSG 242 (442)
Q Consensus 168 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 242 (442)
. ........|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112234688999999999877664 7899999999999999999999887655544444333 33456668999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+.++|++||+.||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=370.83 Aligned_cols=260 Identities=31% Similarity=0.587 Sum_probs=243.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...+.+.+++.+||-|+||.|=++..+.....+|+|++++..+.+....+++..|-.||..++.|.||++|-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34566788899999999999999998666667999999999998888899999999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||+||.|-||+|+..+...+.|++..+++|+..+++|++|||++||++|||||+|+++|.+|-+||.|||+|+....
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--- 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--- 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986543
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~l 246 (442)
+....+.||||.|+|||++.+++.+ .++|.||||+++||||+|.+||.+.+++..|..|.++ .+.+|..++..+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 4556789999999999999999987 8999999999999999999999999999999999987 467899999999999
Q ss_pred HHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 247 IKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 247 i~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
|+++...+|.+|.. +.+|.+|.||..
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999999999986 899999999974
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=354.55 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=215.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|++++++++||||+++++.+.+.+.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986542 2334567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++|++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 999999999999988899999999999999999999998 5999999999999999999999999999864422 22
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--------------------
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------- 231 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------- 231 (442)
....+|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 48899999999999999999999765543332222110
Q ss_pred -----------------CCCCCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 -----------------DFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 -----------------~~~~~~-~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
....|. .++.++.+|+.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001111 257889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=347.83 Aligned_cols=253 Identities=28% Similarity=0.556 Sum_probs=223.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+...+..|+++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665454567889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
|+.|++|.+++....++++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998754332 1234
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---HHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICRADFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 250 (442)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+. ..............|..++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5668999999999987665 5899999999999999999999987663 33333333355566777899999999999
Q ss_pred cCCCCCCCCCH--HHHhcCccc
Q 013487 251 LDPNPDTRMTI--SQMLEDEWF 270 (442)
Q Consensus 251 L~~dP~~R~s~--~eil~hp~~ 270 (442)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=356.60 Aligned_cols=261 Identities=32% Similarity=0.597 Sum_probs=239.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
.....+|..+..||+|+||+|-+|..+.|.+.+|||++.++-+......+--+.|-++|... +-|.++.++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45677899999999999999999999999999999999888766655555556777888766 57899999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||+.||+|.-.|+.-+.+.|..|..|+..|+-||-+||++||++||||.+||++|.+|++||+|||+++- +..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999863 223
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
......+.||||.|+|||++..++| +.++|+||+||+|||||.|++||++.+..++++.|...+..+|..+|.++.+++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 3445678999999999999999888 589999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCCH-----HHHhcCccccc
Q 013487 248 KRILDPNPDTRMTI-----SQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s~-----~eil~hp~~~~ 272 (442)
..+|.+.|.+|... .+|..||||+.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999864 68999999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=354.02 Aligned_cols=259 Identities=29% Similarity=0.550 Sum_probs=225.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765544445677899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC-
Q 013487 93 EFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED- 169 (442)
Q Consensus 93 E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 169 (442)
||+.|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998764 46899999999999999999999999999999999999999999999999998643221100
Q ss_pred --------------------------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH
Q 013487 170 --------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA 223 (442)
Q Consensus 170 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~ 223 (442)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999987766 489999999999999999999999888777
Q ss_pred HHHHHhhCCCCCCCC--CCHHHHHHHHHccCCCCCCCCC----HHHHhcCccccc
Q 013487 224 LYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMT----ISQMLEDEWFKK 272 (442)
Q Consensus 224 ~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 272 (442)
.+..+.......+.. ++..+.++|.+||..||++||| +++++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777766655555544 6899999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.30 Aligned_cols=259 Identities=30% Similarity=0.598 Sum_probs=223.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++.+...+..|++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999997665433445677889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc----
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---- 168 (442)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999998863211000
Q ss_pred ---------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC--
Q 013487 169 ---------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 237 (442)
Q Consensus 169 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 237 (442)
........|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+..+....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001122467889999999887666 58999999999999999999999988777777776655443332
Q ss_pred -CCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013487 238 -WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 272 (442)
Q Consensus 238 -~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 272 (442)
.++.++.++|.+||+.||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.71 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=221.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+...+..|++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998755432 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 99999999999774 56899999999999999999999999999999999999999999999999998754332 122
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRI 250 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 250 (442)
....+|++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.......+..+..+ .+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2345789999999999877764 8899999999999999999999988877766666665543 3446889999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 013487 251 LDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~ 270 (442)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=343.74 Aligned_cols=255 Identities=29% Similarity=0.530 Sum_probs=217.2
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh---hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV---LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... ........+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 5889999998864421 122345678999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc---
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR--- 167 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--- 167 (442)
+|||++|++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543211
Q ss_pred -cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHH
Q 013487 168 -EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGA 243 (442)
Q Consensus 168 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 243 (442)
.........|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223345689999999999877664 8899999999999999999999876654443333322 224556689999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.++|++||..+|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=349.05 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=208.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22234567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 94 FIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 94 ~~~gg~L~~~i~~~---~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|+. ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.+|.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 5888887643 46899999999999999999999999999999999999999999999999998644321 12
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------------- 231 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------- 231 (442)
......+++.|+|||++.+....+.++|+|||||++|+|++|.+||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2233467899999999876554458899999999999999999999876543222211100
Q ss_pred -CC---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 -DF---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 -~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.. .....+++++.+||++||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 0112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=368.18 Aligned_cols=251 Identities=31% Similarity=0.478 Sum_probs=214.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-C-----CCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-H-----PNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~ 84 (442)
...+|.+.+.||+|+||.|-+|++.+|++.||||+++.. .....+...|+.||..|+ | -|+|+++++|..
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 334899999999999999999999999999999999754 335677889999999997 4 489999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC--CceEEeeccch
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLS 160 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~--~~~kl~DFGla 160 (442)
.++.|||+|+..- +|.++|+.+. +++...++.++.||+.||.+||+.||||+|||||||||.+. ..+||+|||.|
T Consensus 260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999965 9999998875 68999999999999999999999999999999999999754 47999999999
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh----------
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------- 230 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------- 230 (442)
+.... ...+++-+..|+|||++.|.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 339 c~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 339 CFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 85432 33478889999999999999997 899999999999999999999998887666554421
Q ss_pred ------------------------------------------CCCCCCCC-----------CCHHHHHHHHHccCCCCCC
Q 013487 231 ------------------------------------------ADFSCPSW-----------FSSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 231 ------------------------------------------~~~~~~~~-----------~s~~~~~li~~~L~~dP~~ 257 (442)
.....|+. -...+.+||.+||.+||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 00001100 1235689999999999999
Q ss_pred CCCHHHHhcCccccc
Q 013487 258 RMTISQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~~eil~hp~~~~ 272 (442)
|+|..|+|+||||..
T Consensus 493 R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 493 RITPAQALNHPFLTG 507 (586)
T ss_pred cCCHHHHhcCccccc
Confidence 999999999999984
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=372.16 Aligned_cols=253 Identities=31% Similarity=0.506 Sum_probs=225.0
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|.|+..||.|+||+||+|+++.++-..|.|+|... ..+.++.+.-||.||..++||+||++++.|.-++.+||+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 588999999999999999999999999999998754 35568889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
+|.||-+...+-. ...+.+++++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...... -..-
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhh
Confidence 9999988776654 457999999999999999999999999999999999999999999999999987643221 1123
Q ss_pred ccccCCCcccCccccc-----ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC---CCCCCCHHHH
Q 013487 173 HTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS---CPSWFSSGAK 244 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~ 244 (442)
.++.|||+|||||++. ..+|+ .++|||||||+|.+|..+.+|-...+++..+.+|.+...+ .|+.++..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 4678999999999975 45676 8999999999999999999999999999888888776543 4777899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+++.+||.+||..||+++++|+||||+.
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 9999999999999999999999999984
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=356.67 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=194.7
Q ss_pred EeeecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEEEEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIYIVLE 93 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E 93 (442)
++.||+|+||+||+|.++ .++..||+|.+..... ...+.+|+.++++++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 568999999999999975 4678999999865432 2346789999999999999999999854 467899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ccCCceEEeeccch
Q 013487 94 FIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (442)
Q Consensus 94 ~~~gg~L~~~i~~~---------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll----~~~~~~kl~DFGla 160 (442)
|+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 888887532 258999999999999999999999999999999999999 45678999999999
Q ss_pred hhhhhcc-cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---------HHHHHHHhh
Q 013487 161 AISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---------MALYRKICR 230 (442)
Q Consensus 161 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~~~i~~ 230 (442)
....... ........+||+.|+|||++.+...++.++||||+||++|+|++|.+||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7653321 112234567899999999998766556899999999999999999999964321 011111100
Q ss_pred ----------------------------CCCCC----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 231 ----------------------------ADFSC----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 231 ----------------------------~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..... ....+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=386.62 Aligned_cols=270 Identities=30% Similarity=0.512 Sum_probs=221.0
Q ss_pred CCcccCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE
Q 013487 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (442)
Q Consensus 1 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 80 (442)
|-.+.......+++|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.|+||||+++++
T Consensus 1 Mp~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred CCccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 444555667788999999999999999999999999999999999876543 2334567889999999999999999999
Q ss_pred EEEe--CCEEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEEc
Q 013487 81 VMAS--KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-------GVFHRDLKPENLLLD 147 (442)
Q Consensus 81 ~~~~--~~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~-------givHrDlkp~NIll~ 147 (442)
+|.. ...+|+||||+++|+|.++|.. .+.+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 8854 4579999999999999999875 35799999999999999999999995 499999999999996
Q ss_pred c-----------------CCceEEeeccchhhhhhcccCCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHH
Q 013487 148 S-----------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVL 209 (442)
Q Consensus 148 ~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~l 209 (442)
. .+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 23589999999875432 2223456799999999998643 2345899999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 210 MAGFLPFDESNLMALYRKICRADFSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 210 l~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++|..||...+...............| ...+.++.+||..||..+|.+|||+.|+|.|||++...
T Consensus 237 LTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 237 CSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999999976554433333332222222 34689999999999999999999999999999998543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=365.99 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=207.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+|++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++++......|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999999864 356789999876432 2458999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
++||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999996 589999987888999999999999999999999999999999999999999999999999998754432222
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---HHHHHHHhh----------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICR---------------- 230 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~---------------- 230 (442)
.......||+.|+|||++.+..|. .++||||+||++|+|++|..||.+... ...+..+.+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 223346799999999999887775 889999999999999999999965431 111111110
Q ss_pred -------------CCCCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 231 -------------ADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 231 -------------~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+..|. .++.++.+||.+||..||++|||+.++|.||||.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111111 246788999999999999999999999999999863
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.64 Aligned_cols=248 Identities=36% Similarity=0.680 Sum_probs=219.9
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+.+..|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876554445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCc
Q 013487 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180 (442)
Q Consensus 101 ~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (442)
.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 9999988889999999999999999999999999999999999999999999999999987554321 2234578999
Q ss_pred ccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc--HHHHHHHHh--hCCCCCCCCCCHHHHHHHHHccCCCCC
Q 013487 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKIC--RADFSCPSWFSSGAKKLIKRILDPNPD 256 (442)
Q Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~~L~~dP~ 256 (442)
|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+..+. ......|...++++.++|.+||..||.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776664 78999999999999999999998766 566666665 345566777799999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q 013487 257 TRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 257 ~R~s-----~~eil~hp~~~~ 272 (442)
+||+ +.|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.79 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=219.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+...+..|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987554322 4677899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 93 EFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 93 E~~~gg~L~~~i~~~---~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|+++|++|.+.+... ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998765443221
Q ss_pred --CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-CC-----CCCCH
Q 013487 170 --GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CP-----SWFSS 241 (442)
Q Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~s~ 241 (442)
.......|++.|+|||++......+.++|+||+|+++|+|++|..||...+....+......... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12234568999999999877644468999999999999999999999887766555554443221 11 24678
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=347.81 Aligned_cols=257 Identities=33% Similarity=0.502 Sum_probs=220.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.++++++||||+++++.+......|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999989999999998644 233456788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999999998764 469999999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccccCCCcccCccccccc----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGA 243 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~ 243 (442)
......|++.|+|||++... ...+.++|+||+|+++|+|++|.+||...+.......+.... +..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345689999999998532 222468999999999999999999998877666665555442 23455689999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.++|.+||..||.+|||+.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=346.03 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=214.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 344568999999999999999999999999999999986543 22345678899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999998644321
Q ss_pred CCccccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC-----CCCC
Q 013487 169 DGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-----SWFS 240 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s 240 (442)
........|++.|+|||++. ...+ +.++|+||+||++|+|++|..||...................+ ..++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred ccccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 11223457899999999974 2334 4799999999999999999999976544333222222222211 2367
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
..+.++|.+||..||++|||++++++|||
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 88999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.56 Aligned_cols=255 Identities=31% Similarity=0.476 Sum_probs=212.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++......+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999998864431 1123356789999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++++.|..++.....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 9999988888887777899999999999999999999999999999999999999999999999999876533211 22
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------CC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------DF 233 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 233 (442)
....++..|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 33457889999999876554568999999999999999999999876544333222110 00
Q ss_pred CCC------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 SCP------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 ~~~------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..| +.++..+.+|+.+||+.||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 1357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=351.58 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=208.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 59999999999999999999999999999999875432 22234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 78887765 567999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCC-CCCcHHHHHHHHhhC----------------C---
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA----------------D--- 232 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~----------------~--- 232 (442)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+.+. .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877665568999999999999999998885 444433333322110 0
Q ss_pred C----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 F----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+ ...+.+++++.+||.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=345.19 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=212.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34579999999999999999999999999999999865421 224567899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||+++++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754321 11
Q ss_pred ccccccCCCcccCcccccc---cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC-----CCCCHH
Q 013487 171 LLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-----SWFSSG 242 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~ 242 (442)
......|++.|+|||.+.. ..+ +.++|+||+||++|+|++|..||...+.......+....+..+ ..++..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred ccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 1234568999999998853 223 4789999999999999999999976554333322222222222 236889
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
+.+||++||+.||++|||++++++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.65 Aligned_cols=254 Identities=24% Similarity=0.443 Sum_probs=206.6
Q ss_pred EEeeeccc--CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 17 LGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 17 i~~~LG~G--~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
+.++||+| +|++||++.++.+|+.||+|.++.... .....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 789999999999999999999976543 233466788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc----
Q 013487 95 IDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (442)
Q Consensus 95 ~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---- 168 (442)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999753 4589999999999999999999999999999999999999999999999986543211110
Q ss_pred -CCccccccCCCcccCccccccc--CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-----------
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS----------- 234 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----------- 234 (442)
........++..|+|||++.+. .| +.++||||+||++|+|++|..||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999998753 34 58999999999999999999999865544333222211110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 235 -----------------------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 235 -----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
....+++.+.+||.+||+.||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.17 Aligned_cols=240 Identities=18% Similarity=0.226 Sum_probs=210.1
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe----CCEEEEEEEc
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTKIYIVLEF 94 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 94 (442)
..||+|++|.||+|.. +|+.||+|.+.+.........+.+.+|+.+|++++||||+++++++.+ ...++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 788999999987654444456788899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
++||+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||++...... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 99999999999888899999999999999999999985 9999999999999999999999999998754321 13
Q ss_pred cccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 013487 174 TACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 249 (442)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+..+.+..+... .+..|..+++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 345 58999999999999999999999988888877776543 445555689999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 013487 250 ILDPNPDTRMTISQMLE 266 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~ 266 (442)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=347.90 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=222.0
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
..+....+|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 334455679999999999999999999999999999999875432 23466889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+|+||++|++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999998875 46899999999999999999999999999999999999999999999999998754322
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGA 243 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 243 (442)
. ......+|++.|+|||.+.+..+. .++|+|||||++|+|++|..||...+.......+... ....+..+++.+
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06655 169 Q--SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245 (296)
T ss_pred c--ccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence 1 122345789999999999876664 7899999999999999999999887665444443332 233455688999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||.+||..||.+|||+.++++||||+..
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=339.24 Aligned_cols=253 Identities=30% Similarity=0.598 Sum_probs=220.8
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||.+.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..|++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998765432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 999999999987643 57899999999999999999999999999999999999999999999999987543321 11
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 250 (442)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+..+....+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223458899999999887665 4789999999999999999999988877777766665544 35566899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 013487 251 LDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~ 270 (442)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=345.61 Aligned_cols=255 Identities=30% Similarity=0.491 Sum_probs=214.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999998765422 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|+ |++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999865 35689999999999999999999999999999999999999999999999999876543221 223
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-------------------C
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------------------F 233 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------~ 233 (442)
....|+..|+|||++.+....+.++||||+|+++|+|++|.+||.+.+....+..+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 446789999999998766655689999999999999999999997766544443332210 0
Q ss_pred C-----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 234 S-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 234 ~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
. ..+..+..+.+||.+||+.||.+|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.94 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=215.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-------hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-------RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
+|.+.+.||+|+||.||+|.+..+|+.+|+|.+...... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999999999999988643211 1223567889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
..++||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998754432
Q ss_pred ccCCccccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCC----CC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS----WF 239 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 239 (442)
..........|+..|+|||++.+.. ..+.++|+||||+++|+|++|..||...+.......+... ....+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234457899999999987654 2358899999999999999999999765554433332222 122222 35
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+.++.++|.+||..||.+|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=346.71 Aligned_cols=258 Identities=28% Similarity=0.483 Sum_probs=219.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+....+|++.+.||+|+||.||+|++..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+......
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 44557999999999999999999999999999999998765422 246688999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~-- 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--
Confidence 999999999999999865 56899999999999999999999999999999999999999999999999998754321
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKK 245 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ 245 (442)
........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....+..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 112234578999999999887666 48999999999999999999999877654333333222 22335568899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|+.+||..||++|||+.++++||||...
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=344.61 Aligned_cols=254 Identities=31% Similarity=0.507 Sum_probs=216.2
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|++.+.||+|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986543 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
+++++|.+.+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 999999888765 457999999999999999999999999999999999999999999999999998653221 12233
Q ss_pred cccCCCcccCccccccc----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHHHHHH
Q 013487 174 TACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKL 246 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~l 246 (442)
...|++.|+|||++... ...+.++|+||+||++|+|++|.+||...+.......+.... ...|..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 45789999999998421 222478999999999999999999998877665555554332 23455688999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|.+||+.||.+|||+.++++||||+..
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.73 Aligned_cols=262 Identities=33% Similarity=0.481 Sum_probs=218.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765432 123345677899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 889999998766 79999999999999999999999999999999999999999999999999987543321 1
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-----------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----------------- 233 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------------- 233 (442)
......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+....+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345688999999986655556899999999999999999888887665544444322100
Q ss_pred ------C-----CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCCCC
Q 013487 234 ------S-----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278 (442)
Q Consensus 234 ------~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 278 (442)
. .....+..+.++|.+||.+||++|||+.++++||||+....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 01224678999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=341.30 Aligned_cols=256 Identities=29% Similarity=0.508 Sum_probs=215.1
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh--hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIY 89 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 89 (442)
.|++.+.||+|+||.||+|.+..++..||+|.+..... ...+....+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68999999999999999999999999999999865432 122345678999999999999999999998865 46789
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc-c
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR-E 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-~ 168 (442)
+++||+++++|.+++...+.+++.....++.|++.||+|||++||+||||+|+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~l 246 (442)
........++..|+|||.+.+..+. .++|+||+||++|+|++|..||...........+... ....|..+++.+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1122345689999999999876664 8899999999999999999999876554443333222 334566688999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccc
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+ +||..+|++|||++|+++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 56778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=345.80 Aligned_cols=249 Identities=28% Similarity=0.469 Sum_probs=205.1
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHh---hCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK---LIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
.||+|+||.||+|.+..+++.+|+|++.+.............+|..+++ ..+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654332222233344544443 3479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccccc
Q 013487 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (442)
Q Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 176 (442)
||+|.+++..++.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999999998889999999999999999999999999999999999999999999999999998644321 123457
Q ss_pred CCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---HHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCC
Q 013487 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 253 (442)
|++.|+|||.+.+....+.++|+||+||++|+|++|..||.... ...............|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643334588999999999999999999996532 222222233334556677899999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccc
Q 013487 254 NPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 254 dP~~R~-----s~~eil~hp~~~~ 272 (442)
||.+|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.49 Aligned_cols=257 Identities=29% Similarity=0.524 Sum_probs=216.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh---hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV---LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
+|+..+.||+|++|.||.|.+..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48899999999999999999999999999999875432 122346788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhhccc-
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVRE- 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~- 168 (442)
+|||+.|++|.+++...+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999999888999999999999999999999999999999999999998776 599999999865433211
Q ss_pred -CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHH---h--hCCCCCCCCCCHH
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI---C--RADFSCPSWFSSG 242 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~s~~ 242 (442)
........|+..|+|||++.+..+. .++|+||+|+++|+|++|..||...........+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112234688999999999876664 8899999999999999999999754432222222 1 1233455668899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+.+++.+||..||.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.42 Aligned_cols=257 Identities=36% Similarity=0.665 Sum_probs=229.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 91 (442)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++ ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544455677889999999998 99999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC--
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED-- 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 169 (442)
|||+.+++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999998755432211
Q ss_pred ----------------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC
Q 013487 170 ----------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF 233 (442)
Q Consensus 170 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 233 (442)
.......|+..|+|||++.+..+ +.++|+||+|++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12223457899999999877654 5889999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCccc
Q 013487 234 SCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWF 270 (442)
Q Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~R~s~----~eil~hp~~ 270 (442)
..|..+++.+.+||.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=339.14 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=215.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh--hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 88 (442)
..|++.+.||+|+||.||.|.+..++..||+|.+..... ......+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999998864321 122346788999999999999999999998866 3578
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++|||++|++|.+++...+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKK 245 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 245 (442)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112234568999999999987665 48999999999999999999999876554444433322 22345567888999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+|++||. +|++|||++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.97 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=211.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC-----
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK----- 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~----- 85 (442)
-+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3679999999999999999999999999999999865431 235678899999998 699999999998653
Q ss_pred -CEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
..+|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999998864 3689999999999999999999999999999999999999999999999999875
Q ss_pred hhhcccCCccccccCCCcccCcccccc-----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC--CC
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SC 235 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~ 235 (442)
.... ........|++.|+|||++.+ ..+ +.++|+||+||++|+|++|..||...........+..... ..
T Consensus 161 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 161 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred cccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 4321 122345679999999999863 234 4789999999999999999999987665544444333222 12
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 236 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+..++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 23478999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=343.95 Aligned_cols=248 Identities=29% Similarity=0.487 Sum_probs=213.1
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443334455677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCC
Q 013487 101 FDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (442)
Q Consensus 101 ~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 178 (442)
.+++...+ .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99998766 799999999999999999999999999999999999999999999999999875432 1222345678
Q ss_pred CcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCC
Q 013487 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 254 (442)
..|+|||++.+..+ +.++|+||+|+++|+|++|..||..... ..+...+.......+..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999887665 4889999999999999999999976543 233333333445566678999999999999999
Q ss_pred CCCCC-----CHHHHhcCccccc
Q 013487 255 PDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 255 P~~R~-----s~~eil~hp~~~~ 272 (442)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8889999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=337.03 Aligned_cols=251 Identities=30% Similarity=0.508 Sum_probs=216.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999975532 24577889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999999999876 789999999999999999999999999999999999999999999999999987654321 12
Q ss_pred cccccCCCcccCccccccc---CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-----CCCCCCHHH
Q 013487 172 LHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-----CPSWFSSGA 243 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~ 243 (442)
.....++..|+|||.+.+. .++ .++|+||+|+++|+|++|.+||...+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345789999999998765 554 7899999999999999999999887655444444333222 223357889
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
.+++.+||..||..|||+.+++.|||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=344.47 Aligned_cols=255 Identities=32% Similarity=0.505 Sum_probs=216.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-+.|++.+.||+|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 467999999999999999999999999999999986542 33467788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||++|++|...+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 999999999887754 456899999999999999999999999999999999999999999999999987643221 11
Q ss_pred ccccccCCCcccCcccccc-----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHH
Q 013487 171 LLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSG 242 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~ 242 (442)
......+++.|+|||++.+ ..+ +.++|+|||||++|+|++|.+||...+......++.... ...+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 2234568899999999853 223 478999999999999999999998776655555554332 2334567899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.++|.+||..||++||++.++++||||..
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=349.08 Aligned_cols=265 Identities=29% Similarity=0.450 Sum_probs=217.3
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-- 85 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 85 (442)
+...+.+|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred CcccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 3456789999999999999999999999999999999986543211 1223456899999999999999999998755
Q ss_pred CEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+.+|+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 578999999975 88888775 3578999999999999999999999999999999999999999999999999987654
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 231 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 231 (442)
... .......+++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+.+..+...
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 321 12223346888999999876555568999999999999999999999888776665544321
Q ss_pred ------CCCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 232 ------DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 232 ------~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
.+..+ .++++.+.+||.+||..||++|||+.+++.||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 11111 2358889999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=346.85 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=214.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999989999999988654322 234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++++.|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 999999998887777779999999999999999999999999999999999999999999999999987543321 223
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------CC
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------DF 233 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 233 (442)
....++..|+|||++.+....+.++||||+|+++|+|++|.+||...+.......+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999999876555568899999999999999999999766544333222210 00
Q ss_pred ------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 ------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 ------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
...+.++..+.+|+.+||..||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=343.93 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=208.7
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHH---HHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE---ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
.||+|+||.||+|.+..+++.||+|++.+..............| +.+++...||||+++++.+...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999976543222212222333 344555679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccccc
Q 013487 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (442)
Q Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 176 (442)
||+|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999998654321 223457
Q ss_pred CCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---cHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCC
Q 013487 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 253 (442)
|++.|+|||++.+....+.++||||+|+++|+|++|..||... ................|..++.++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433458899999999999999999999876 3334444444445666777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccC
Q 013487 254 NPDTRM-----TISQMLEDEWFKKG 273 (442)
Q Consensus 254 dP~~R~-----s~~eil~hp~~~~~ 273 (442)
||.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=342.39 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=210.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++||||+++++.+...+..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999986542 2234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999998654 3578999999999999999999999999999999999999999999999999875432 223
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-------HHHHHHHhhCCC-CC-CCCCCHHH
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-------MALYRKICRADF-SC-PSWFSSGA 243 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~-~~-~~~~s~~~ 243 (442)
...+||+.|+|||++.+..+ +.++|+||+|+++|+|++|..||..... ......+..... .. ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45689999999999987766 4899999999999999999999964321 122222222221 11 23478899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+++.+||..||.+||+++++++||||+..
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=342.85 Aligned_cols=255 Identities=28% Similarity=0.499 Sum_probs=220.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||.|++|.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999875531 223466789999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||+++++|.+++... ++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999999875 89999999999999999999999999999999999999999999999999987654321 122
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCC-CCHHHHHHHHHc
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW-FSSGAKKLIKRI 250 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~~ 250 (442)
....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+..... ..+.. ++.++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34568899999999988775 4899999999999999999999987766555554444432 33334 789999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 013487 251 LDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|..||++|||++++++||||+..
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=359.32 Aligned_cols=250 Identities=32% Similarity=0.656 Sum_probs=219.8
Q ss_pred eEE--EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 15 YEL--GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 15 y~i--~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
|+| .++||.|-||+||-|.++++|+.||||+|++.++..+ ...++++|+.||..+.||+||.+--.+++.+.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 555 4789999999999999999999999999998876544 3588999999999999999999999999999999999
Q ss_pred EccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC---CceEEeeccchhhhhhcc
Q 013487 93 EFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQVR 167 (442)
Q Consensus 93 E~~~gg~L~~~i~--~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~ 167 (442)
|-+.| +..+.|- +.+++++...++++.||+.||.|||-+||+|+||||+|||+... -.+||||||+|++..+.
T Consensus 643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 99987 5555553 35789999999999999999999999999999999999999654 37999999999987653
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC--CC--CCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--SW--FSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~~~ 243 (442)
..-.+..|||.|+|||++.+++|+ ..-|+||+|||+|.-|+|..||.+.. ++..+|....+-+| +| +++++
T Consensus 721 --sFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~A 795 (888)
T KOG4236|consen 721 --SFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEA 795 (888)
T ss_pred --hhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHH
Confidence 344678899999999999999997 88999999999999999999997653 44455666666554 44 89999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+||+.+|+..-.+|.|+++.|.|||++.
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 99999999999999999999999999985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.48 Aligned_cols=253 Identities=30% Similarity=0.562 Sum_probs=222.0
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||.|+||.||.+.+..+++.+++|.+...... ......+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999998765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|++||+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999875 468999999999999999999999999999999999999999999999999987543322 12
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRI 250 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 250 (442)
.....|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999998877654 7899999999999999999999988877777776655443 3455799999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 013487 251 LDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~ 270 (442)
|..||.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=365.16 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=204.7
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+.+|++++||||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2345899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99996 5898888764 469999999999999999999999999999999999999999999999999997654322222
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC--------cHHHHHHHHhhCCC---------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--------NLMALYRKICRADF--------- 233 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--------~~~~~~~~i~~~~~--------- 233 (442)
.....+||+.|+|||++.+..++ .++|||||||+||+|++|..|+... ....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 23346799999999999887775 8999999999999999987654321 11222222221110
Q ss_pred --------------------CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 234 --------------------SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 234 --------------------~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+.| ++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11111 4568999999999999999999999999999974
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=347.04 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=219.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 44558999999999999999999999999999999998754322 245678999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999999999999865 568999999999999999999999999999999999999999999999999986543221
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKK 245 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ 245 (442)
.......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..++..+.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 12234578999999999987666 48899999999999999999999876553332222221 22334557889999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|+.+||..||++|||+.++++||||+...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=343.87 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=216.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCC-----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
.+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999986555 679999986442 233456788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
...|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999765 457888999999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 228 (442)
+.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999998754322211223344578899999998876664 89999999999999998 99999988877777776
Q ss_pred hhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 229 CRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 229 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.... ...|..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6543 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=336.19 Aligned_cols=254 Identities=31% Similarity=0.561 Sum_probs=218.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh--hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+|+..+.||+|++|+||+|.+..+++.|++|.+..... ...+..+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999988999999999865432 1233567789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
+||++|++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543321 2
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh--CCCCCCCCCCHHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~ 249 (442)
.....|++.|+|||.+......+.++|+||+|+++|+|++|..||...........+.. .....+..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34566899999999987655235889999999999999999999987664444333333 2234566689999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 013487 250 ILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~ 270 (442)
||+.+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=359.82 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=207.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCC-----CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
.++|++++.||+|+||.||+|++..+ +..||+|++..... ....+.+.+|+.+++.+ +||||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45799999999999999999996543 35799999975432 23356788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhc----------------------------------------------------------
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (442)
+..|+||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccc
Q 013487 108 ------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (442)
Q Consensus 108 ------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 175 (442)
.++++..+.+++.|++.||+|||++||+||||||+|||+++++.+||+|||+++..............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 24788889999999999999999999999999999999999999999999998754322111111223
Q ss_pred cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHccC
Q 013487 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~ 252 (442)
.+++.|+|||++.+..+ +.++||||+||++|+|++ |..||............... ....|..+++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 35667999999987666 489999999999999997 99999876544433333332 344566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 013487 253 PNPDTRMTISQMLE 266 (442)
Q Consensus 253 ~dP~~R~s~~eil~ 266 (442)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=343.81 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=216.9
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999886432 2333567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 93 EFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 93 E~~~gg~L~~~i~~~---~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||++|++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999998888763 379999999999999999999997 5999999999999999999999999999865422
Q ss_pred CCccccccCCCcccCcccccccCC-----CCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH---HhhC-CCCCCCCC
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK---ICRA-DFSCPSWF 239 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---i~~~-~~~~~~~~ 239 (442)
.......|++.|+|||.+.+... .+.++|+||+||++|+|++|..||...+....+.. +... ....|+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22344578999999999865432 25789999999999999999999976554443332 2222 23456668
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++++.+||.+||..+|++||++.++++||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=355.53 Aligned_cols=244 Identities=29% Similarity=0.438 Sum_probs=210.5
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
+.+++.||+|.||.||.|..+ ....||+|.+...... .+.+.+|+++|++|+|+|||++++++.....+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 345689999999999999993 3457999998754332 24566999999999999999999999998899999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 95 IDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 95 ~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
++.|+|.+++.. ...+...+...++.||++|++||+++++|||||-..||||+++..+||+|||||+...... -...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeec
Confidence 999999999997 4568999999999999999999999999999999999999999999999999999432211 0011
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHc
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~ 250 (442)
....-...|.|||.+....++ .++|||||||+||||+| |+.||.+.+..+..+.+.++ +++.|..+|+++.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 111224569999999988885 89999999999999999 99999999999999888876 6899999999999999999
Q ss_pred cCCCCCCCCCHHHHh
Q 013487 251 LDPNPDTRMTISQML 265 (442)
Q Consensus 251 L~~dP~~R~s~~eil 265 (442)
|..+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=345.88 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=205.1
Q ss_pred cccCeEEEeeecccCceEEEEEEEcC----------------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVE----------------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 74 (442)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 34689999999999999999998642 34479999987542 2334567889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEEccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013487 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-------------------RLKEDEARRYFQQLINAVDYCHSRGVF 135 (442)
Q Consensus 75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-------------------~l~~~~~~~~~~ql~~aL~~lH~~giv 135 (442)
|+++++++...+..+++|||+.+|+|.+++.... .++...+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 357778899999999999999999999
Q ss_pred eccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc--CC
Q 013487 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GF 213 (442)
Q Consensus 136 HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~--g~ 213 (442)
||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999875433221112233456789999999887666 489999999999999986 67
Q ss_pred CCCCCCcHHHHHHHHhh--------CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013487 214 LPFDESNLMALYRKICR--------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 265 (442)
Q Consensus 214 ~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 265 (442)
.||...+..+....+.. .....|+.++..+.+|+.+||..||.+|||+.+|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 88887665544433211 11234556789999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=334.17 Aligned_cols=252 Identities=33% Similarity=0.536 Sum_probs=219.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ....+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999765432 2346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhhcccCC
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~ 170 (442)
|++|++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 99999999999764 3489999999999999999999999999999999999998554 6899999998754332 1
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 249 (442)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... .+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234568999999999987665 478999999999999999999999887776666665543 34566689999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 013487 250 ILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~ 270 (442)
||..||.+|||+.|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=342.53 Aligned_cols=256 Identities=32% Similarity=0.534 Sum_probs=215.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2334577899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++++.+...+.....+++..+..++.|++.||.|||++|++|+||+|+||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999977777777667799999999999999999999999999999999999999999999999999876543221 133
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---------------------
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------------------- 231 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------------- 231 (442)
....+++.|+|||++.+....+.++|+||+|+++|+|++|.+||...+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 44678999999999987744468999999999999999999999876544332221110
Q ss_pred CC-----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 DF-----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 ~~-----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+ ..+..++.++.+||++||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1223358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=334.56 Aligned_cols=249 Identities=31% Similarity=0.580 Sum_probs=216.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+++|+|.+++... ..++++.+..++.|++.||.|||++||+|+||||+||+++.++.++++|||++....... ..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cc
Confidence 99999999988653 458999999999999999999999999999999999999999999999999987543321 12
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 250 (442)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999987665 4899999999999999999999998887777766665544 35566899999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 013487 251 LDPNPDTRMTISQMLED 267 (442)
Q Consensus 251 L~~dP~~R~s~~eil~h 267 (442)
|+.||.+|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=338.17 Aligned_cols=251 Identities=34% Similarity=0.660 Sum_probs=221.3
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||.|+||.||+|.+..+|+.+|+|++...........+.+.+|+.++++++||||+++++.+...+..|++|||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999766544445677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc------CCcccc
Q 013487 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE------DGLLHT 174 (442)
Q Consensus 101 ~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~------~~~~~~ 174 (442)
.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99999888899999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred ccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHccC
Q 013487 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF--SSGAKKLIKRILD 252 (442)
Q Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L~ 252 (442)
..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+....+..+.......|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568899999999877665 4889999999999999999999998888887777776666666555 8999999999999
Q ss_pred CCCCCCCCH---HHHhcCccccc
Q 013487 253 PNPDTRMTI---SQMLEDEWFKK 272 (442)
Q Consensus 253 ~dP~~R~s~---~eil~hp~~~~ 272 (442)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=334.67 Aligned_cols=263 Identities=29% Similarity=0.584 Sum_probs=239.1
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
.....+.+|++++.||+|+|++|.++++++|.+.+|+|+++++-+...+.+..++.|-.+.... +||.+|.++..|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3456788999999999999999999999999999999999998887777788888888888776 699999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+.+++|.||++||+|.-.++.+..++|+.++.|...|+.||.|||++||++||||.+|+|+|..|++||.|+|+++- .
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~ 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--G 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999863 2
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC--------CcHHHHHHHHhhCCCCCCC
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE--------SNLMALYRKICRADFSCPS 237 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~~~~~ 237 (442)
........+.||||.|.|||++.+..| +..+|+|+|||++++|++|+.||+- .+...+++-|......+|.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence 334556788999999999999999888 5999999999999999999999952 2344567778888899999
Q ss_pred CCCHHHHHHHHHccCCCCCCCCC------HHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s------~~eil~hp~~~~ 272 (442)
.+|-.+..+++..|++||++|.. +.++..|+||+.
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999999999999999999975 789999999984
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.47 Aligned_cols=256 Identities=32% Similarity=0.590 Sum_probs=217.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++.....+.+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999998765432 3467889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC-c-
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-L- 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~- 171 (442)
|+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999988789999999999999999999999999999999999999999999999999987654322111 1
Q ss_pred cccccCCCcccCcccccccC--CCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhh-CCCCCCCCC--CHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICR-ADFSCPSWF--SSGAKK 245 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~-~~~~~~~~~--s~~~~~ 245 (442)
....++++.|+|||++.+.. ..+.++||||+|+++|+|++|..||.... .......+.. .....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 13588999999999999999999997653 2222222222 233445544 899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+|.+||+.||.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.41 Aligned_cols=250 Identities=30% Similarity=0.510 Sum_probs=216.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|+||.||+|.+..++..+++|.+..... .+.+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999865431 567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999976 4468999999999999999999999999999999999999999999999999987654321 12
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 248 (442)
.....|+..|+|||++.+..++ .++||||+|+++|+|++|..||...+.......+... ....+..++.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2334588999999999877664 8899999999999999999999876655443333221 22334457889999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+||+.||++|||+.|+++||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=354.92 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=199.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
..+|++.+.||+|+||.||+|.+..+++.||+|+..+.. ...|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 346999999999999999999999999999999854332 34689999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||++.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999964 88888765 45799999999999999999999999999999999999999999999999999864322 12
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCC-CCCCcH----------HHHHHHHhh---CCCCCC
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNL----------MALYRKICR---ADFSCP 236 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~----------~~~~~~i~~---~~~~~~ 236 (442)
......||+.|+|||++.+..+. .++||||+||++|+|+++..| |..... ..+...+.. ....++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 22346799999999999887774 899999999999999985444 433211 011111100 000011
Q ss_pred ------------------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 ------------------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 ------------------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=342.01 Aligned_cols=253 Identities=29% Similarity=0.489 Sum_probs=210.2
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++.+.||.|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865432 22234568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 589888865 346899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------------C
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------------F 233 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------~ 233 (442)
.....+++.|+|||++.+....+.++||||||+++|+|++|..||...+......++.... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 2344678999999998776655688999999999999999999998765543332221100 0
Q ss_pred C-----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 S-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 ~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
. ..+.+++++.++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=338.89 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=213.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK-- 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 85 (442)
+...++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 4457889999999999999999999999999999999865321 235677899999998 799999999998653
Q ss_pred ---CEEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 86 ---TKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 86 ---~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
+..|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 368999999999999998753 4578999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCC----CCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-- 232 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-- 232 (442)
++........ ......|++.|+|||++..... .+.++||||+||++|+|++|.+||...+.......+....
T Consensus 174 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 174 VSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 9875432111 1233568999999999864331 2578999999999999999999998776554444444332
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 233 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 233 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
...+..++..+.+||.+||+.||++|||+.++++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 223445678899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.77 Aligned_cols=255 Identities=28% Similarity=0.490 Sum_probs=207.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+++|++.+.||+|++|.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 568999999999999999999999999999999998754311 112346689999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence 9999985 999988764 46899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhhC-----------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA----------------- 231 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~----------------- 231 (442)
.......+++.|+|||++.+....+.++||||+|+++|+|++|..||.... ..+....+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234578899999998765544588999999999999999999997654 22222211110
Q ss_pred ----CCCC---------CCCCC--HHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 ----DFSC---------PSWFS--SGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 ----~~~~---------~~~~s--~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.... .+.++ .++.+++.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.68 Aligned_cols=253 Identities=32% Similarity=0.477 Sum_probs=212.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC----
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT---- 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 86 (442)
.++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999999999999999875432 235688999999999 6999999999996644
Q ss_pred --EEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 87 --KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 87 --~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
.+|++|||+++++|.+++.. +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999998865 357999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccC----CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKG----YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--- 233 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 233 (442)
...... ........|++.|+|||++.... ..+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 654321 12223456899999999985432 234789999999999999999999987665554444444322
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=333.60 Aligned_cols=253 Identities=33% Similarity=0.594 Sum_probs=219.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIYIV 91 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv 91 (442)
+|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999875543 23345678899999999999999999997753 4578999
Q ss_pred EEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCH-----SRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH-----~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
|||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999876 357899999999999999999999 89999999999999999999999999999886
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCH
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSS 241 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 241 (442)
..... .......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..... ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54322 11334578999999999987665 4889999999999999999999998877666666665544 45667899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+.+++.+||..+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=351.05 Aligned_cols=260 Identities=28% Similarity=0.483 Sum_probs=213.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 356899999999999999999999999999999999865432 223345677899999999999999999988643
Q ss_pred --CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999965 888888654 899999999999999999999999999999999999999999999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC------------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 231 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 231 (442)
.. ........|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+....+..+...
T Consensus 169 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 169 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CC---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 32 1223345689999999999887775 8999999999999999999999876644433332110
Q ss_pred ----------CCC--------------C-------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCCC
Q 013487 232 ----------DFS--------------C-------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277 (442)
Q Consensus 232 ----------~~~--------------~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 277 (442)
... . +...++.+.+||.+||+.||++|||+.|+|+||||+..+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~ 321 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS 321 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence 000 0 112356789999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=336.49 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=211.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
-.+|++.+.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357999999999999999999875 455689999987542 223356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+||||+++|+|.+++... +.+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999999774 578999999999999999999999999999999999999999999999999865432111
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
. .......+++.|+|||++.+..+. .++||||+||++|++++ |..||...+.......+..+ ..+.|..++..+.+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0 111123456789999999877664 89999999999999775 99999888777766666544 34556678999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 013487 246 LIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~ 266 (442)
++.+||+.+|.+|||+.+|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.55 Aligned_cols=247 Identities=34% Similarity=0.608 Sum_probs=210.4
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHH-hhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++++...+.+|++|||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433333333445555544 455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999999888899999999999999999999999999999999999999999999999998864322 234568
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC----CCCCCHHHHHHHHHccCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC----PSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~~L~~ 253 (442)
++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+....+..+....... +..+++++.+++.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987764 589999999999999999999999888777776665544332 234789999999999999
Q ss_pred CCCCCC---CHHHHhcCccccc
Q 013487 254 NPDTRM---TISQMLEDEWFKK 272 (442)
Q Consensus 254 dP~~R~---s~~eil~hp~~~~ 272 (442)
||++|| +++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 5589999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.31 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=217.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++.+.||+|++|.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+.+|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999876532 234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||+.+++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999875543221
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-----cHHHHHHHHhhCC-CCCCCC-CCHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKICRAD-FSCPSW-FSSGA 243 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~ 243 (442)
....++..|+|||.+.+..+. .++|+||+|+++|+|++|..||... ........+.... ...+.. ++.++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 126789999999999887664 8899999999999999999999754 2233333333332 233333 78999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.++|.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=356.38 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=206.5
Q ss_pred ccCeEEEeeecccCceEEEEEEE-----cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
.++|++++.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 35667899999864431 22356788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC---------------------------------------------------------
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG--------------------------------------------------------- 108 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~--------------------------------------------------------- 108 (442)
+..|+||||++||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 109 ------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 109 ------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 46788899999999999999999999999999999999999999999999987543321111
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHH-HHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-YRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~-~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
......++..|+|||++.+..+. .++|||||||++|+|++ |..||........ ...+..+ ....|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 11223456789999999887764 89999999999999998 8999987654433 3333332 2334556789999999
Q ss_pred HHccCCCCCCCCCHHHHhcC
Q 013487 248 KRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~h 267 (442)
.+||+.||++|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.41 Aligned_cols=257 Identities=27% Similarity=0.525 Sum_probs=217.6
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC---CCCcceEEEEEEeCCEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 90 (442)
.|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+.+|+.+++.++ ||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999986542 2233567889999999996 9999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
+|||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 9999999999999866 479999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCC-CCHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW-FSSGAKKLIK 248 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~ 248 (442)
......|+..|+|||.+.+....+.++|+||+|+++|+|++|..||...+.......+..... ..+.. ++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 223456899999999987655446899999999999999999999988766554433332222 22222 6889999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
+||+.||++||++.+++.||||+....
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=343.59 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=208.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-- 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 86 (442)
...+++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3567889999999999999999999999999999999865432 1122345668999999999999999999886543
Q ss_pred ------EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 87 ------KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 87 ------~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
..|++|||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999975 8888776643 689999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccC--CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--C---
Q 013487 160 SAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--D--- 232 (442)
Q Consensus 160 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~--- 232 (442)
+......... .......++..|+|||.+.+....+.++|+||+|+++|+|++|..||...+.......+... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8755332211 12233467889999999876554458899999999999999999999876654333222110 0
Q ss_pred --------------CCCC-------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 --------------FSCP-------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 --------------~~~~-------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
...| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0001 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.70 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=218.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
...+|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3568999999999999999999999999999999986542 23346778999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||+++++|.+++...+.+++..++.++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999999888889999999999999999999997 69999999999999999999999999998644221
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-----------HHHHHHhhCC-CCCCC
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-----------ALYRKICRAD-FSCPS 237 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~ 237 (442)
.....+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...... .....+.... ...+.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred -ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 1234579999999999877655 47899999999999999999999865431 2223333222 22222
Q ss_pred C-CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 238 W-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 238 ~-~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
. ++.++.+|+.+||..||.+|||+.|+++||||.+...
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 2 7789999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.23 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=210.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS---- 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---- 84 (442)
...+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 45578999999999999999999999999999999986542 2245678899999988 69999999999853
Q ss_pred --CCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
.+.+|++|||+.+|+|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 46789999999999999998763 35889999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccc-----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-C
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-S 234 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~ 234 (442)
...... ........|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 169 ~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd06636 169 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245 (282)
T ss_pred hhhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence 754321 122344678999999999863 234 4789999999999999999999977654443333333221 1
Q ss_pred -CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 235 -CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 235 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+..++.++.+||.+||..||.+|||+.|+++||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=345.64 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=193.1
Q ss_pred EeeecccCceEEEEEEEcC--CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE--eCCEEEEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA--SKTKIYIVLE 93 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E 93 (442)
+..||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999754 567899999865432 234678999999999999999999884 4567899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ccCCceEEeeccch
Q 013487 94 FIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (442)
Q Consensus 94 ~~~gg~L~~~i~~~---------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll----~~~~~~kl~DFGla 160 (442)
|+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9975 888877532 248899999999999999999999999999999999999 56679999999999
Q ss_pred hhhhhccc-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH---------HHHHHHhh
Q 013487 161 AISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRKICR 230 (442)
Q Consensus 161 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------~~~~~i~~ 230 (442)
+....... ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76533211 112334578999999999987665568999999999999999999999643211 00000000
Q ss_pred ----------------------------CCCC----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 231 ----------------------------ADFS----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 231 ----------------------------~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.... .....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 011135668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.06 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=218.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
..|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|++|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999986533 233567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccC
Confidence 99999999998854 56899999999999999999999999999999999999999999999999998654321 1222
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHHHHHH
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~ 249 (442)
....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+... .......++..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 345789999999999876664 7899999999999999999999877665554444332 122223468899999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccCCCCC
Q 013487 250 ILDPNPDTRMTISQMLEDEWFKKGYKPP 277 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~~~~~~~~ 277 (442)
||..||.+|||++++++||||+....|.
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCcc
Confidence 9999999999999999999999765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.95 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=211.2
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||.|++|.||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++.+.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 1224567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 94 FIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~---~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|+.+ +|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++....... .
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 9986 8888887643 58999999999999999999999999999999999999999999999999987543211 1
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------------ 232 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------ 232 (442)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998766555689999999999999999999998776655444332110
Q ss_pred CC-----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 FS-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ~~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.. ..+.+++.+.+++.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.07 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=213.1
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKI 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 88 (442)
.+++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++... +..
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 356899999999999999999999999999999999754322 22344567899999999999999999998877 899
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|++|||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999999985 9999887654 58999999999999999999999999999999999999999999999999987544321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---------------
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--------------- 232 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------- 232 (442)
.......+++.|+|||.+.+....+.++|+||+|+++|+|++|.+||...+......++....
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 222345578999999998766555689999999999999999999998776555444332110
Q ss_pred ----------------CCCCCC-CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 ----------------FSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ----------------~~~~~~-~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..++.. +++.+.+||++||+.||++|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011222 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=339.52 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=208.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCE----
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK---- 87 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 87 (442)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865431 2223456788999999995 6999999999877665
Q ss_pred -EEEEEEccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccch
Q 013487 88 -IYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLS 160 (442)
Q Consensus 88 -~~lv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla 160 (442)
.|++|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887653 35799999999999999999999999999999999999998 899999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--------
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------- 232 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 232 (442)
...... ........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+.......+....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 644221 1112234578899999998765444689999999999999999999998766554443332210
Q ss_pred ---------CCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 233 ---------FSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 233 ---------~~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
...+ +.+++++.+||.+||..||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0001 23688899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=341.99 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=221.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
-|.++..||+|+||.||+|.++.+|+.+|||.+.-+. .++.+..||.||.+++.|+||++|+.|.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3788899999999999999999999999999986543 36778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||-.|++.|.+... .+++|+++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|...... -..-
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence 99999999998754 57999999999999999999999999999999999999999999999999998754321 1123
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHHHHHH
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~ 249 (442)
.+..|||.|||||++..-+|+ .++||||||++..+|..|++||.+-.+......|... .+..|..+|.++.++++.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 567899999999999999998 7899999999999999999999877665443333332 233455589999999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccC
Q 013487 250 ILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
||-++|++|.|+-++++|||.+..
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999999864
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=338.39 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=204.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++......|++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865432 11233567899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++..... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence 99996 577776654 356889999999999999999999999999999999999999999999999998753321 11
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhC------------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRA------------------ 231 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~------------------ 231 (442)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+.. +....+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2234467899999999876544457899999999999999999999765432 222111110
Q ss_pred --C-C--CCCC---------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 --D-F--SCPS---------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 --~-~--~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
. . ..+. ..++++.+++.+||..||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=332.77 Aligned_cols=253 Identities=32% Similarity=0.566 Sum_probs=212.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 46899999999999999999999999999999988654444445566788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988753 3458999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc--HHHHHHHHhhCCC-CCC-CCCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICRADF-SCP-SWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~-~~~-~~~s~~~ 243 (442)
.......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.... .......+..... +.+ ..++..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122345689999999999877764 78999999999999999999996543 2344444433332 222 3477899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+++.+||..+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.37 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=218.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+.|+..+.||.|+||.||.|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999875432 234577889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||++||+|.+++.. +++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 99999999999875 578999999999999999999999999999999999999999999999999986543221 112
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHcc
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRIL 251 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L 251 (442)
....++..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+... ....+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999987665 48899999999999999999999877665554444332 22333447889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccC
Q 013487 252 DPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 252 ~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+|++||++.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=337.26 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=210.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEE----
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA---- 83 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 83 (442)
....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3456799999999999999999999999999999998764321 234577899999999 6999999999873
Q ss_pred -eCCEEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 84 -SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 84 -~~~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
..+..|++|||++|++|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 44678999999999999988753 3568999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCccccccc----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--- 231 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--- 231 (442)
++...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...+.......+...
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 170 VSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred ceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 98754321 1122345689999999998532 11247899999999999999999999876654443333222
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
....|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222344568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=346.50 Aligned_cols=260 Identities=29% Similarity=0.471 Sum_probs=210.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----C
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----T 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 86 (442)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 468999999999999999999999999999999986422 223456678899999999999999999887544 3
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
..|+++||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 88887754 57999999999999999999999999999999999999999999999999998754322
Q ss_pred cc-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh---------------
Q 013487 167 RE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--------------- 230 (442)
Q Consensus 167 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 230 (442)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 12233467899999999876544446899999999999999999999977654332221110
Q ss_pred C-------CCC---------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 231 A-------DFS---------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 231 ~-------~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
. ..+ ..+..++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000 01235788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=353.38 Aligned_cols=257 Identities=32% Similarity=0.562 Sum_probs=225.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
-|..++.||-|+||+|.+++..+|...||+|.+++..+.......+++.|-.||..-..+-||+||..|++.+++|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47789999999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC---
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG--- 170 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--- 170 (442)
|++||++..++.+-+-|+|+.+++|+..|.+|+++.|..|++||||||+|||||.+|++||.||||++-++......
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999998654322110
Q ss_pred -------------------------------------ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCC
Q 013487 171 -------------------------------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213 (442)
Q Consensus 171 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~ 213 (442)
......||+.|+|||++...+|. ..+|+||.|||||+|+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence 11233699999999999999986 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHH--hhCCCCCC--CCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCccccc
Q 013487 214 LPFDESNLMALYRKI--CRADFSCP--SWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 272 (442)
Q Consensus 214 ~Pf~~~~~~~~~~~i--~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 272 (442)
+||-..+..+...++ ++..+.+| ..+|.++.+||.++.. +++.|.. ++|+..||||+.
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999877665544433 33333443 4589999999998764 5888875 778999999985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.33 Aligned_cols=247 Identities=26% Similarity=0.454 Sum_probs=206.1
Q ss_pred ccccCeEEEeee--cccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGRTL--GEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~~L--G~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
...++|++.+.+ |+|+||.||++.++.++..+|+|++....... .|+.....+ +||||+++++.+...+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 445678888777 99999999999999999999999987543211 122222222 6999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~ 165 (442)
..|+||||++||+|.+++.....++++.+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999999999888999999999999999999999999999999999999999988 999999998864422
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH----HHHHHhhCCCCCCCCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPSWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~ 241 (442)
.....|++.|+|||++.+..+. .++|+||+|+++|+|++|..||....... ............++.+++
T Consensus 163 ------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T PHA03390 163 ------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSK 235 (267)
T ss_pred ------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCH
Confidence 1234689999999999887775 78999999999999999999997543322 111222334455556899
Q ss_pred HHHHHHHHccCCCCCCCCC-HHHHhcCcccc
Q 013487 242 GAKKLIKRILDPNPDTRMT-ISQMLEDEWFK 271 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s-~~eil~hp~~~ 271 (442)
.+.+||.+||+.||.+||+ ++++|+||||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999999999996 69999999996
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=328.32 Aligned_cols=253 Identities=36% Similarity=0.665 Sum_probs=223.0
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999976542 23345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 94 FIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 94 ~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|+++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999874 679999999999999999999999999999999999999999999999999987654422
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIK 248 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 248 (442)
......+|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+............. ..|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233446789999999998877664 789999999999999999999988877777666655433 455568999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+||..+|++|||+.++|+||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.13 Aligned_cols=249 Identities=31% Similarity=0.567 Sum_probs=205.5
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeC--CEEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK--TKIYIV 91 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv 91 (442)
|++.+.||+|+||.||+|.+..++..||+|.+.+... ... .....+|+.+++++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865421 111 223457888898885 99999999999887 889999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+.+ +|.+.+... ..+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 888888764 56899999999999999999999999999999999999999 99999999998754322 1
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh------------------CC
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------------AD 232 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------~~ 232 (442)
......+++.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+..+....+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 223356889999999876656666899999999999999999999987765544333321 01
Q ss_pred CCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 FSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ~~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+..| +.++.++.+||.+||.+||++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=349.86 Aligned_cols=256 Identities=28% Similarity=0.458 Sum_probs=212.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 91 (442)
..|++.+.||+||.++||++...++ +.+|+|.+.... .+.+.+..+.+|+..|.+|+ |.+||+++++-..++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3699999999999999999998544 455555554332 45667889999999999995 99999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKHGRLKE-DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~-~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||-+- +|..++.......+ ..++.|..|++.|+.++|++||||.||||.|+|+-. |.+||+|||.|........+-
T Consensus 439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence 999865 99999988766444 689999999999999999999999999999999865 999999999998877665555
Q ss_pred ccccccCCCcccCcccccccCCC----------CCcccHhHHHHHHHHHhcCCCCCCCC-cHHHHHHHHhhCC--CCCCC
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYD----------GRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRAD--FSCPS 237 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~--~~~~~ 237 (442)
...+.+||+.|||||.+....+. +.++||||||||||+|+.|++||..- +...-+..|.... .++|.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~ 596 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD 596 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence 66778999999999998654332 67899999999999999999999753 2334444555442 34554
Q ss_pred CCCH-HHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSS-GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~-~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.-+. ++.++++.||..||++|||+.++|+|||++-
T Consensus 597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3333 3999999999999999999999999999874
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=330.73 Aligned_cols=253 Identities=31% Similarity=0.606 Sum_probs=217.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||+|.++.+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+...+..|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999999765432 2234677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc-eEEeeccchhhhhhcccCC
Q 013487 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-LKISDFGLSAISQQVREDG 170 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~-~kl~DFGla~~~~~~~~~~ 170 (442)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++++++. +||+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 999999999987654 4799999999999999999999999999999999999998864 699999998765432 11
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKR 249 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 249 (442)
......|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22335689999999998776654 889999999999999999999988776666655554433 3445578999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccc
Q 013487 250 ILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~ 270 (442)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.50 Aligned_cols=255 Identities=32% Similarity=0.587 Sum_probs=220.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIYIV 91 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv 91 (442)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.++++++||||+++++.+... +.++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999999999999998765432 34567889999999999999999999999988 899999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999876554322112
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHh--hCCCCCCCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKIC--RADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~~~~li~ 248 (442)
.....++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+. ......|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999877665 589999999999999999999998765 223333333 2334556667999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+||..||++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.03 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=213.7
Q ss_pred ccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+..+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 5679999999999999999998753 45789999987543 2234578899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCce
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG--------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~--------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~ 152 (442)
..|++|||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997653 37888999999999999999999999999999999999999999
Q ss_pred EEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC
Q 013487 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA 231 (442)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 231 (442)
||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998643221111112233467889999999887764 88999999999999998 99999887777777776665
Q ss_pred CCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 232 DFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 232 ~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
... .+..++..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 543 34568999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=305.57 Aligned_cols=256 Identities=31% Similarity=0.507 Sum_probs=217.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|.-.+.||+|++|+|++|++..+++.||+|.++.+. .++..-....+||.+++.++|.|||+++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35777889999999999999999999999999997654 23334567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||.. +|..+... ++.++.+.++.++.|++.||.+||++++.||||||.|+||+.+|.+|++|||+|+.+.-. -..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence 99976 88777655 467999999999999999999999999999999999999999999999999999876532 123
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC--CC---CC------CC--
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA--DF---SC------PS-- 237 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~---~~------~~-- 237 (442)
.....-|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|.+.+..+...+|... .. +. |.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445579999999999998877899999999999999986 88889999888777766431 10 00 10
Q ss_pred ----------------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 ----------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ----------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.++...++|++++|.-+|.+|++++..++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 13455789999999999999999999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=355.29 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=219.6
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|.-++.||.|+||-||.|++..|.+.||||.+....-...+.-..|..|+..|++++|||+|.+.++|-.+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678999999999999999999999999999866544444567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
|-| +-.|.+.-+ .++.+.++..+..+.+.||.|||+++.+|||||..|||+++.|.+||+|||.|.+..+ ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 976 666666543 5799999999999999999999999999999999999999999999999999987543 45
Q ss_pred cccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-CC-CCCCHHHHHHHH
Q 013487 174 TACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CP-SWFSSGAKKLIK 248 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~-~~~s~~~~~li~ 248 (442)
++.|||+||||||+. ...|+ -++|||||||+..+|.-.++|+...+.+..+.-|..+..+ .+ ..+|..+.+|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 788999999999975 23455 7899999999999999999999988888766666655432 22 236999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.||++-|.+|||.+++|.|+|+...-
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCC
Confidence 99999999999999999999998643
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.07 Aligned_cols=255 Identities=32% Similarity=0.548 Sum_probs=221.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+.|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765321 34677899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+++++|.+++.....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 999999999999988889999999999999999999999 999999999999999999999999999987554322 11
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---cHHHHHHHHhhCC-CCCCCC-CCHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRAD-FSCPSW-FSSGAKKL 246 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~-~~~~~~-~s~~~~~l 246 (442)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999877655 58999999999999999999999776 4445555554432 344455 78999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccccc
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
|.+||..+|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.25 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=215.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
...+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34569999999999999999999999999999999865543344455678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||+.| +|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 9999975 77776654 45799999999999999999999999999999999999999999999999999865322
Q ss_pred CccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCC-CCCCCHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSC-PSWFSSGAKK 245 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~~~~ 245 (442)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+.... ... +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 124568899999998752 2233578999999999999999999998877655444443322 222 2336889999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+|.+||..||++|||+.+++.||||....
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.83 Aligned_cols=254 Identities=27% Similarity=0.471 Sum_probs=217.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|.-.+.||+|++|.||+|.+..+++.+++|.++... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4556689999999999999999999999999886432 2234568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
|++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 9999999999887 679999999999999999999999999999999999999999999999999876543211 1223
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC---CCCCCCHHHHHHHHHc
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS---CPSWFSSGAKKLIKRI 250 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~ 250 (442)
...|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+...... .+..++..+.+++++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 45689999999999877664 8899999999999999999999887766666655544322 2233788999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCC
Q 013487 251 LDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|+.||++|||+.++++||||++..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=342.48 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=206.1
Q ss_pred CeEEEeeecccCceEEEEEEEcC--CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIY 89 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 89 (442)
+|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999764322223346678899999999999999999999888 8899
Q ss_pred EEEEccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc----CCceEEeeccch
Q 013487 90 IVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----YGVLKISDFGLS 160 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~----~~~~kl~DFGla 160 (442)
+||||+.+ +|.+.+... ..+++..++.++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777766432 36899999999999999999999999999999999999999 999999999998
Q ss_pred hhhhhccc-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH---------HHHHHh-
Q 013487 161 AISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---------LYRKIC- 229 (442)
Q Consensus 161 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------~~~~i~- 229 (442)
........ .......++++.|+|||++.+....+.++||||||+++|+|++|.+||....... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533221 1122345789999999998775544689999999999999999999997543221 000000
Q ss_pred -------------------------hCCCCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 230 -------------------------RADFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 230 -------------------------~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
......+ ...+.++.+++.+||..||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000111 1356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=336.46 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=211.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999865432 222345678899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhhhhccc
Q 013487 92 LEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~ 168 (442)
|||+++ +|.+.+..... +++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999964 88888766443 578899999999999999999999999999999999985 567999999998654321
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---C-------------
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---D------------- 232 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~------------- 232 (442)
........+++.|+|||++.+....+.++||||+|+++|+|++|.+||...+..+...++... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112234467899999999876554568999999999999999999999876654444332210 0
Q ss_pred ----C---C------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 233 ----F---S------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 233 ----~---~------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
. . ..+.+++.+.+++.+||+.||++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0 113367889999999999999999999999999999853
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=329.08 Aligned_cols=247 Identities=38% Similarity=0.726 Sum_probs=222.6
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+...+.+|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999877655555677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCc
Q 013487 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180 (442)
Q Consensus 101 ~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (442)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999987543321 12344568899
Q ss_pred ccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCC
Q 013487 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 260 (442)
Q Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 260 (442)
|+|||...+... +.++|+||||+++|+|++|..||...+.......+.......|..++..+.+++++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999877665 4789999999999999999999988887777777777777888888999999999999999999999
Q ss_pred H---HHHhcCccc
Q 013487 261 I---SQMLEDEWF 270 (442)
Q Consensus 261 ~---~eil~hp~~ 270 (442)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.51 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=211.7
Q ss_pred cCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46999999999999999999863 345679999886542 2345678899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEE
Q 013487 88 IYIVLEFIDGGELFDKIAKHG-------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~-------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl 154 (442)
.|++|||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||++++++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999997654 3899999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCCC
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF 233 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~ 233 (442)
+|||++................+++.|+|||++.+..+. .++|+|||||++|+|++ |.+||...+.......+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999998754322111122234467889999999876664 89999999999999998 9999988877777777766543
Q ss_pred -CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 -SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 445568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=356.37 Aligned_cols=245 Identities=36% Similarity=0.617 Sum_probs=216.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (442)
.....|.+...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++... +||||+++.+++.+....
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 35678999999999999999999999999999999998762 2234677676666 699999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-ccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL-DSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll-~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+|||++.||.|.+.|.....+. ..+..|+.+|+.|++|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999999999998876655 7888899999999999999999999999999999 58999999999998755432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-HHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
+.+.|-|..|+|||++...+|+ +++||||||++||+||+|..||..... .++...+..+.+. .++|.++++|
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDL 542 (612)
T ss_pred ----hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHH
Confidence 5677889999999999988886 999999999999999999999976544 4666666665555 7899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccc
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
|++||+.||.+|+++.+++.||||
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.16 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=213.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999997652 345799998864432 22234577899999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
+..|++|||+++|+|.+++...+ .++...+..++.|++.||.|||++||+||||||+||+++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 34567889999999999999999999999999999999999999999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-C
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-F 233 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~ 233 (442)
|||+++...............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.+..+....+..+. .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875432211111122345778999999887666 489999999999999998 799998887777666665443 3
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc------Cccccc
Q 013487 234 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE------DEWFKK 272 (442)
Q Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~~ 272 (442)
..+..+++.+.+++.+||+.||++|||+.++++ ||||+.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 456667899999999999999999999999987 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=341.40 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=210.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCE----EEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...+|++.+.||+|+||.||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998766654 8999986432 233456788999999999999999999998764
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..++++||+++|+|.+++.... .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 5789999999999999998754 588999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
...........++..|+|||++.+..+. .++|||||||++|+|++ |..||.+....+....+... ..+.++.++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2221112223456789999999877764 89999999999999997 99999887665554433332 345566789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=389.07 Aligned_cols=260 Identities=31% Similarity=0.555 Sum_probs=227.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
-+|+-+..||.|.||.||.|.+..||+..|+|.+...... ......+.+|..++..++|||+|++|++-......||.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3688899999999999999999999999999998765543 556778999999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc--cCC
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR--EDG 170 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~ 170 (442)
|||+||+|.+.++..+-.+|...+.|..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|......- -.+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999999988788899999999999999999999999999999999999999999999999987544321 234
Q ss_pred ccccccCCCcccCcccccccC--CCCCcccHhHHHHHHHHHhcCCCCCCCCc--HHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
.+....|||.|||||++.+.. -.+.++|||||||++.||+||+.||..-+ ..-+|........++|..+|++.+++
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHH
Confidence 566778999999999997654 23578999999999999999999997643 33444444445678888999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|.+||..||++|+++.|+++|.|-+..
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999999997654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.20 Aligned_cols=254 Identities=20% Similarity=0.340 Sum_probs=212.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEc----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNV----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.+..|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568999999999999999999863 455789999986432 2334567889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
..|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985332 37888899999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 228 (442)
+.+||+|||+++...............++..|+|||++.+..+ +.++|+||||+++|+|++ |.+||.+.+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222122233456778999999987666 489999999999999998 99999887766655555
Q ss_pred hhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 229 CRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 229 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
... ..+.+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 345566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.50 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=216.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchh--hhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQ--VLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 88 (442)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875431 11233467889999999999999999999998664 568
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKK 245 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 245 (442)
........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||..........++... ....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1122345689999999999876654 8899999999999999999999877655544444432 23457778999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.04 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=216.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999999999999999875432 234567899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 99999999998865 578999999999999999999999999999999999999999999999999987543211 112
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHcc
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRIL 251 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 251 (442)
....|+..|+|||.+.+..+. .++|+||+||++|+|++|..||...........+.... ...+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 234688999999999877664 78999999999999999999997665544443333322 2233457889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccC
Q 013487 252 DPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 252 ~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+|++|||+.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=336.20 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=209.9
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|++.+.||.|++|.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6789999999999999999999999999999875532 222345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 95 IDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 95 ~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 58999988766 6899999999999999999999999999999999999999999999999998654321 1122
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--------------------
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------------------- 232 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------- 232 (442)
....+++.|+|||++.+....+.++|+||+|+++|+|++|.+||...+.......+.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999998765544588999999999999999999998766543333222110
Q ss_pred ---------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 ---------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
....+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=345.79 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=213.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE----eCCEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA----SKTKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 88 (442)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875432 2234567788999999999999999998875 34578
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+. |+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 58999998888899999999999999999999999999999999999999999999999999865432211
Q ss_pred --CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh----------------
Q 013487 169 --DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------------- 230 (442)
Q Consensus 169 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------- 230 (442)
........|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 12223457899999999987654456899999999999999999999987654332221110
Q ss_pred ----------CCCCC-----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 231 ----------ADFSC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 231 ----------~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
..... .+..++++.++|.+||+.||.+|||+.+++.||||.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00001 1236889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=332.73 Aligned_cols=255 Identities=28% Similarity=0.488 Sum_probs=218.3
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
-|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37888999999999999999999999999999865432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
|+++++|.+++.. +.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhc
Confidence 9999999999875 568999999999999999999999999999999999999999999999999986543211 1123
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHccC
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 252 (442)
...|+..|+|||.+.+.... .++|+||+||++|+|++|..||...+.......+.... ...+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 35688999999998776654 78999999999999999999998776655555544332 23455688999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccCC
Q 013487 253 PNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 253 ~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+|.+||++.++++||||....
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=329.60 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=208.0
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 34568999999999999999999999999886543 223567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhhhhcccCCc
Q 013487 96 DGGELFDKIAKH-GRL--KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 96 ~gg~L~~~i~~~-~~l--~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
++++|.+++... ..+ ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++...... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCc
Confidence 999999999865 455 88889999999999999999999999999999999986 679999999998654321 122
Q ss_pred cccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcHH--HHHHH-HhhCCCCCCCCCCHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRK-ICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~~~li 247 (442)
.....|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||...... ..+.. ........|..+++++.+|+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 23346899999999986543 2358899999999999999999999764322 22211 22233455667899999999
Q ss_pred HHccCCCCCCCCCHHHHhcCccc
Q 013487 248 KRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+||+.+|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.50 Aligned_cols=245 Identities=27% Similarity=0.462 Sum_probs=204.0
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999876432 2334567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 99 ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 99 ~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999997654 589999999999999999999999999999999999999999999999999864332111000111123
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 255 (442)
+..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...+.......+... ....+..++..+.+|+.+||..||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999887666 478999999999999997 99999876655554444332 345566679999999999999999
Q ss_pred CCCCCHHHHhc
Q 013487 256 DTRMTISQMLE 266 (442)
Q Consensus 256 ~~R~s~~eil~ 266 (442)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.29 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=210.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..++|++.+.||+|+||.||.|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34679999999999999999998752 35679999886432 122345678999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
...+++|||+++|+|.+++.... .++...+..++.|++.||+|||+.|++||||||+||++++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999987632 35677889999999999999999999999999999999999999999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-C
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-F 233 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~ 233 (442)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999864432111111122356788999999987666 488999999999999999 799998887777666655544 3
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 234 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..+..++..+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=338.36 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=218.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
...|+....||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++.+...+..|++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3446667789999999999999999999999999865432 2245688999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 999999999987755 568999999999999999999999999999999999999999999999999986543221 12
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~ 248 (442)
....+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...+..++..+.++|.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 234678999999999987766 489999999999999999999998776655555444322 2223447889999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
+||+.+|.+|||+.++++||||.+...+
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 9999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.19 Aligned_cols=253 Identities=34% Similarity=0.603 Sum_probs=221.3
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999766432 2456789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
|+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999876543221 123
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHh-hCCCCCCCCCCHHHHHHHHHccC
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC-RADFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~ 252 (442)
...++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......... ......+..++..+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999877664 588999999999999999999998766544333333 33445666789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 013487 253 PNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 253 ~dP~~R~s~~eil~hp~~ 270 (442)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=338.61 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=210.2
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCE--EEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
....++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 34577899999999999999999999887765 566665432 2333456788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
+.+|++|||+++|+|.+++...+ .+++..++.++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 47899999999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 228 (442)
+.+||+|||++........ .....++..|+|||++.+..+ +.++||||+||++|+|++ |.+||...+..+....+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 9999999999863221110 111234567999999877665 489999999999999998 99999887777666665
Q ss_pred hhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 229 CRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 229 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
... ....+..+++++.+|+.+||+.+|++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 443 233455578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=354.23 Aligned_cols=249 Identities=26% Similarity=0.496 Sum_probs=219.9
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE--EEEEEEc
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK--IYIVLEF 94 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~lv~E~ 94 (442)
...||+|+|-+||+|.|..+|-.||.-.+....+. ....++++..|+.+|+.|+||||+++|+.|.+... +.+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 67899999999999999999999997665544433 34567899999999999999999999999987665 8899999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcc-CCceEEeeccchhhhhhcccCCc
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
+++|+|+.|+.+++.++...++.|++||+.||.|||++. |+|||||.+||+|+. .|.+||+|+|||++.+.. .
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----H 200 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----c
Confidence 999999999999999999999999999999999999995 999999999999984 689999999999987653 3
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhhCCCCC--CCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFSC--PSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~ 248 (442)
.....|||.|||||++. ..|+ ..+||||||+++.||.|+.+||.. .+..++|+++..+..+. ..--.++++++|.
T Consensus 201 aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred cceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 45578999999999987 5676 999999999999999999999976 67789999988875432 2223789999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+||.. ...|+|+.|+|.||||...
T Consensus 279 kCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHhcC-chhccCHHHHhhChhhccc
Confidence 99999 9999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=328.81 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=212.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998644 4579999886543 233456688899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|++|||+++++|.+++... +.+++..+..++.|++.||+|||++||+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999999999999999998664211
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
.........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+... ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111123456789999999877664 89999999999999998 99999877766666665543 33455668999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcC
Q 013487 246 LIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~h 267 (442)
|+.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.43 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=217.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 34679999999999999999999998899999999986442 223466889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 99999999999999876 458899999999999999999999999999999999999999999999999886543321
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKL 246 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~l 246 (442)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+... .+..+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 12234568999999999887666 47899999999999999999999876654433222221 122333467889999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|++||..+|.+||++.+++.||||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.98 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=205.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHH-HhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
++|++.+.||+|+||.||+|++..+|+.||+|.+....... . ...+..|+.+ ++.++||||+++++++...+..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987543221 1 2344456554 6677899999999999999999999
Q ss_pred EEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
|||++| +|.+.+.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999974 77776653 34689999999999999999999997 9999999999999999999999999998754321
Q ss_pred ccCCccccccCCCcccCccccccc---CCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhh-CCCCCC-CCCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICR-ADFSCP-SWFS 240 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~-~~~~~~-~~~s 240 (442)
.......|+..|+|||++.+. ...+.++|+||+||++|+|++|..||.... ..+....+.. .....| ..+|
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 111235688999999988642 122578999999999999999999997532 2222222222 223333 3478
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.++.++|.+||..+|.+|||+.++++||||+...
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=355.80 Aligned_cols=251 Identities=29% Similarity=0.513 Sum_probs=218.3
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCC
Q 013487 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGE 99 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 99 (442)
.||+|+||+||.|+|..|....|||.+.... ....+-+..||.+.++|+|.|||++++.+..++.+-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986442 3346778999999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEEeeccchhhhhhcccCCccccc
Q 013487 100 LFDKIAKH-GRL--KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTA 175 (442)
Q Consensus 100 L~~~i~~~-~~l--~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~ 175 (442)
|.+.+... |++ .|...-+|.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||-++.... -+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 99999775 667 7889999999999999999999999999999999997 579999999998875433 34456778
Q ss_pred cCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhcCCCCCCCCc--HHHHHHH-HhhCCCCCCCCCCHHHHHHHHHcc
Q 013487 176 CGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRK-ICRADFSCPSWFSSGAKKLIKRIL 251 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~-i~~~~~~~~~~~s~~~~~li~~~L 251 (442)
-||..|||||++... .-+|.++|||||||++.||.||++||-+.. ...+++. ..+...++|..+|.+++++|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999999643 334799999999999999999999997543 3344443 344567788889999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCCC
Q 013487 252 DPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 252 ~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
.+||..||++.++|++||++.+.+
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred CCCcccCccHHHhccCcccccCCC
Confidence 999999999999999999987643
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.31 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=211.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3679999999999999999999977 77889999886432 2223456888999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEee
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISD 156 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~D 156 (442)
..|++|||+.||+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997754 488999999999999999999999999999999999998765 599999
Q ss_pred ccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCC
Q 013487 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFS 234 (442)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~ 234 (442)
||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875422111111112233567999999987766 489999999999999997 99999987776666555443 345
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.|..++..+.+++.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=343.87 Aligned_cols=259 Identities=30% Similarity=0.429 Sum_probs=213.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (442)
...+|.+.+.||+|+||+||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 34689999999999999999999999999999999875422 222345677899999999999999999987644
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
...|+++||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 58999998888999999999999999999999999999999999999999999999999999875433
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh---------------
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--------------- 230 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 230 (442)
.. .......++..|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+.......+..
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 2234456899999999987544456899999999999999999999987654332221110
Q ss_pred --------C-----CC---CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 231 --------A-----DF---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 231 --------~-----~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
. .. ...+.+++++.+||++||+.||.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 0123478899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=326.93 Aligned_cols=252 Identities=33% Similarity=0.605 Sum_probs=213.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.++++++|+||+++++.+...+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999999999999998754444444567889999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999998864 345899999999999999999999999999999999999999999999999998654321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc--HHHHHHHHhhCCC-CCCC-CCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICRADF-SCPS-WFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~ 243 (442)
........|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.... .......+..+.. +.|. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 1122345689999999999877764 78999999999999999999996543 2334444443332 2333 578899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.++|.+||..+|++|||+.+|++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=332.59 Aligned_cols=259 Identities=30% Similarity=0.583 Sum_probs=218.4
Q ss_pred CeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhh-hHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (442)
.|++.+.||+|+||.||.|.+. .+|..||+|++...... .....+.+.+|+.+++.+ +||||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999998754332 223456788999999999 599999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++|||+++++|.+++....++++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhcCCCCCCCCc----HHHHHHHHhhCCCCCCCCCCHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPSWFSSGA 243 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 243 (442)
.......+|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||.... .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222346789999999998653 233578999999999999999999996432 23444444445556667789999
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRM-----TISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~-----s~~eil~hp~~~~~ 273 (442)
.+++.+||..||++|| ++.+++.||||+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.01 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=213.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC---
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (442)
...++|++.+.||+|+||.||+|.+..++..||+|.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 35678999999999999999999999999999999986532 22334566889999999999999999999987553
Q ss_pred ---EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 87 ---KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 87 ---~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.+++||||+ |++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 6789888764 67999999999999999999999999999999999999999999999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC----------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---------- 233 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------- 233 (442)
.. ......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+....+..+.....
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 169 DS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 22 123456789999999987644456899999999999999999999987665444433322110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 234 ---------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 234 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
...+.+++.+.++|.+||..||.+|||+.+++.||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 011346788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.25 Aligned_cols=257 Identities=29% Similarity=0.429 Sum_probs=208.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC------
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (442)
-++|++.+.||.|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3789999999999999999999999999999999865532 3356788999999999999999999876543
Q ss_pred --------CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEEee
Q 013487 86 --------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISD 156 (442)
Q Consensus 86 --------~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl~D 156 (442)
...|++|||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 358999999974 89888764 5799999999999999999999999999999999999998 456789999
Q ss_pred ccchhhhhhccc-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---
Q 013487 157 FGLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--- 232 (442)
Q Consensus 157 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--- 232 (442)
||++........ .+......|+..|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432111 1122334678999999987664445689999999999999999999998766544433322110
Q ss_pred ----------------------C-----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 233 ----------------------F-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 233 ----------------------~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
. ...+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0112467889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.37 Aligned_cols=246 Identities=28% Similarity=0.444 Sum_probs=214.4
Q ss_pred eeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 19 RTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.+++.++||||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999865 8899999997654222 4678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 96 DGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 96 ~gg~L~~~i~~~---------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999885 77999999999999999999999999999999999999999999999999998765443
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 244 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 244 (442)
..........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122334567889999999887665 489999999999999999 69999988877777776643 3456777899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcC
Q 013487 245 KLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~h 267 (442)
+++.+||..||.+|||+.|++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=329.66 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=213.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCC-----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3468999999999999999999986544 789999986443 222345678999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
...|++|||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999986532 36778999999999999999999999999999999999999999999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CC
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DF 233 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~ 233 (442)
|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999875443222222234457889999999876665 488999999999999998 99999887777666666544 34
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..|..++.++.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.42 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=215.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE--
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-- 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 87 (442)
...++|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 45678999999999999999999999999999999986542 122345667889999999999999999988765544
Q ss_pred ----EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 88 ----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 88 ----~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.|+++||+ |++|.+++.. .++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 5699998876 57999999999999999999999999999999999999999999999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC----------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---------- 233 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------- 233 (442)
.. ......+++.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+.....
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 134456889999999987654556899999999999999999999987766554444322110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 234 ---------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 234 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
.....+++.+.+||.+||+.||.+|||+.++++||||++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0012358899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.82 Aligned_cols=252 Identities=31% Similarity=0.566 Sum_probs=212.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||.||+|++..++..+|+|.+.............+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999999999999988765444444567788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998863 3468999999999999999999999999999999999999999999999999987553321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH--HHHHHHHhhCCCC-C-CCCCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL--MALYRKICRADFS-C-PSWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~ 243 (442)
......+|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||..... ......+.....+ . +..+++.+
T Consensus 161 --~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred --cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 223345789999999999877664 789999999999999999999975433 2333333333222 2 23478999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+++.+||..||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=335.60 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=213.6
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcC-------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceE
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKI 78 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 78 (442)
......++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 334455789999999999999999998743 23469999987542 223356788899999999 79999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 013487 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 142 (442)
Q Consensus 79 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~ 142 (442)
++++...+..|++|||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 4788899999999999999999999999999999
Q ss_pred cEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcH
Q 013487 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNL 221 (442)
Q Consensus 143 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~ 221 (442)
||+++.++.+||+|||++................+++.|+|||++.+..+ +.++|+||+||++|+|++ |..||...+.
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999875432211111112234578999999987666 489999999999999998 8999988777
Q ss_pred HHHHHHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 222 MALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 222 ~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+....+.... ...|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77666655543 35566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.01 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=214.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCC-----CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
.+.+|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 356789999999999999999997543 5789999987543 233456788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
+..++++||+.+++|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998632 347888899999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 228 (442)
+.+||+|||+++...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222222233456789999999877666 488999999999999998 89999888777777777
Q ss_pred hhCCC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 229 CRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 229 ~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..... +.+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66543 4567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.16 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=208.7
Q ss_pred eEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE----
Q 013487 15 YELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK---- 87 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 87 (442)
|++++.||+|+||.||.|.+..+ +..||+|.+..+.. .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999997643 47899999875432 23346678999999999999999999998765443
Q ss_pred --EEEEEEccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 88 --IYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 88 --~~lv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
.+++|||+++|+|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988543 3589999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 237 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (442)
++...............++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875433221111222345678999999876666 489999999999999999 99999887777766666554 345667
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.29 Aligned_cols=255 Identities=22% Similarity=0.403 Sum_probs=207.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999999999999999999765433344567788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 92 LEFIDGGELFDKIAKH-----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-----------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988642 23456678899999999999999999999999999999999999999999999
Q ss_pred hhhhhccc----------------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHH
Q 013487 161 AISQQVRE----------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL 224 (442)
Q Consensus 161 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~ 224 (442)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 75521100 001123479999999999988776 4899999999999999999999987554333
Q ss_pred HHH-HhhCCCCC--CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 225 YRK-ICRADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 225 ~~~-i~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
... ........ ...+++.+.+++.+||..||++|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222 11111111 12478899999999999999999886665543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=326.63 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=213.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
...+|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++...+.+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 3457999999999999999999999999999999986442 124568899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999999987643 588999999999999999999999999999999999999999999999999875433211
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
. ......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+.+..+... ....|..++.++.++
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1 11112345679999998877664 78999999999999998 99999888777776666543 345566789999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||+.||++|||+.++++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.77 Aligned_cols=264 Identities=28% Similarity=0.402 Sum_probs=216.0
Q ss_pred cccCeEE-EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH-----------HHHHHHHHHHHHhhCCCCCcceE
Q 013487 11 RVGKYEL-GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----------MVEQIKREISTMKLIKHPNVIKI 78 (442)
Q Consensus 11 ~~~~y~i-~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 78 (442)
.-++|.. .+.||+|+||+||+|.+..+++.||+|++......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567875 57799999999999999999999999998654322100 01246789999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 79 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
++++...+..|++|||+. |+|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 5999999888889999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhcc------------cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHH
Q 013487 159 LSAISQQVR------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR 226 (442)
Q Consensus 159 la~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 226 (442)
++....... .........+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987543110 01122234578899999998776555689999999999999999999998877655544
Q ss_pred HHhhCC-------C---------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 227 KICRAD-------F---------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 227 ~i~~~~-------~---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
.+.... + ......+.++.++|.+||+.||++|||++|++.||||+....
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 332200 0 001234788999999999999999999999999999987544
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.62 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=214.8
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCC-----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV 81 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 81 (442)
.....++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3445578999999999999999999986443 689999987543 223356688999999999 79999999999
Q ss_pred EEeCCEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 013487 82 MASKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (442)
Q Consensus 82 ~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIl 145 (442)
+...+.+|++|||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999999642 45889999999999999999999999999999999999
Q ss_pred EccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHH
Q 013487 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL 224 (442)
Q Consensus 146 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 224 (442)
++.++.+||+|||+++...............++..|+|||++.+..+. .++||||+||++|+|++ |..||...+..+.
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999998765432211112223356789999998776664 88999999999999997 9999998877777
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 225 YRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 225 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..+.... ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 76665543 34566688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=348.25 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=206.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCC-----CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 84 (442)
.-++|++++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.++++++ ||||+++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 356788999999999999999997533 3469999986543 2334567889999999996 9999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhc---------------------------------------------------------
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKH--------------------------------------------------------- 107 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------- 107 (442)
.+.+|+|||||++|+|.+++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999999988642
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q 013487 108 ---------------------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (442)
Q Consensus 108 ---------------------------------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~ 148 (442)
..+++..+..++.|++.||+|||+.||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 23677888999999999999999999999999999999999
Q ss_pred CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHH-HH
Q 013487 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-YR 226 (442)
Q Consensus 149 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~-~~ 226 (442)
++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999875433221112223456788999999987666 489999999999999997 9999987554333 33
Q ss_pred HHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 227 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 227 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+..+ ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33332 33455668999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.49 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=207.0
Q ss_pred eEEEeeecccCceEEEEEEEcCCCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------CC
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------KT 86 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 86 (442)
|.+++.||+|+||.||+|++..++. .+|+|.+.... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999987776 59999886543 233446778899999999999999999997643 23
Q ss_pred EEEEEEEccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 87 KIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
..+++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887432 34789999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCC
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSW 238 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 238 (442)
................+++.|+|||.+.+..+ +.++||||+|+++|+|++ |..||........+..+..+. ...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76533211111123346778999999987766 489999999999999999 899998877777776666543 345666
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++..+.++|.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=329.78 Aligned_cols=255 Identities=32% Similarity=0.463 Sum_probs=210.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIYI 90 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 90 (442)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875432 2345678899999999999999999998854 347899
Q ss_pred EEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 91 VLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
+|||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887653 345899999999999999999999999999999999999999999999999998644321
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-----HHHHHHHHhhCC-CCCC----
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKICRAD-FSCP---- 236 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~~-~~~~---- 236 (442)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||.... ..+....+.... ...+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12245678899999999877665 78999999999999999999997652 223333333211 1111
Q ss_pred --CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 237 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 237 --~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
..+++.+.++|.+||..||.+|||+.|+++||||++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=348.55 Aligned_cols=235 Identities=26% Similarity=0.448 Sum_probs=208.5
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
++.||.|+.|-||+|+. .++.||||.++.- -..+|+-|++|+||||+.+.+++.....+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 57899999999999997 5689999987522 23688889999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
|-|...++....+.......|..+|+.|+.|||.+.|+|||||.-||||+.+..+||+|||-++..... .....+||
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999988754432 44567899
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHccCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP 255 (442)
|..|||||++.+.+.. .++||||+||+|||||||..||.+.+...+.--+-.+ .++.|..+++.++-||+.||+-.|
T Consensus 274 TVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 9999999999998886 9999999999999999999999877655443222222 456788899999999999999999
Q ss_pred CCCCCHHHHhcCc
Q 013487 256 DTRMTISQMLEDE 268 (442)
Q Consensus 256 ~~R~s~~eil~hp 268 (442)
..|||+.+||.|-
T Consensus 353 RNRPSFrqil~Hl 365 (904)
T KOG4721|consen 353 RNRPSFRQILLHL 365 (904)
T ss_pred CCCccHHHHHHHH
Confidence 9999999999983
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.50 Aligned_cols=249 Identities=33% Similarity=0.558 Sum_probs=207.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEE-EEEe---C---
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIE-VMAS---K--- 85 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~-~~~~---~--- 85 (442)
+++|.+.|.+|||+.||+|++...|..||+|.+-.. ++..++.+++||.+|++|+ |+|||.+++ .... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 467789999999999999999888899999987543 5567889999999999996 999999999 3321 1
Q ss_pred CEEEEEEEccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCceEEeeccchh
Q 013487 86 TKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
-.++++||||.||.|.|++.. +.+|+|.++++||.|+++|+.+||... |+|||||-|||||+.+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 247799999999999999984 457999999999999999999999998 9999999999999999999999999986
Q ss_pred hhhhcc--cCC--cc---ccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC
Q 013487 162 ISQQVR--EDG--LL---HTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA 231 (442)
Q Consensus 162 ~~~~~~--~~~--~~---~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 231 (442)
..-..- ... .+ -....|+.|+|||++. +.+. ++|+|||+|||+||-|+....||++.... .|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence 422111 000 00 1234799999999863 4444 69999999999999999999999887433 36677
Q ss_pred CCCCCC--CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 232 DFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 232 ~~~~~~--~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.+.+|+ .++..+.+||+.||+.||.+||++.|++.+-+-
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 787776 589999999999999999999999999886543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=325.10 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=209.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
..+|++.+.||+|+||.||+|..+ .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++...+..|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 357999999999999999999884 4567999987644322 34678899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 9999999999998753 4689999999999999999999999999999999999999999999999999875322111 0
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIK 248 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 248 (442)
......++..|+|||++.+..+. .++|+||+|+++|+|++ |..||...+..+....+..+. ...|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122345689999999877664 89999999999999999 999999888777777776543 3345557889999999
Q ss_pred HccCCCCCCCCCHHHHhc
Q 013487 249 RILDPNPDTRMTISQMLE 266 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~ 266 (442)
+||+.||++|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=333.48 Aligned_cols=260 Identities=26% Similarity=0.450 Sum_probs=217.5
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEc-------CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcc
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVI 76 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv 76 (442)
.|.......+|.+.+.||+|+||.||.|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCch
Confidence 4556677789999999999999999999853 234579999886442 223456788999999999 799999
Q ss_pred eEEEEEEeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013487 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140 (442)
Q Consensus 77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlk 140 (442)
++++++......|++|||+++|+|.+++.... .++...+..++.|++.||.|||++|++|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 99999999999999999999999999997642 46778899999999999999999999999999
Q ss_pred CCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCC
Q 013487 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDES 219 (442)
Q Consensus 141 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~ 219 (442)
|+||+++.++.+||+|||+++...............+++.|+|||++.+..+. .++||||||+++|+|++ |..||...
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999998755432222222334567889999999876664 78999999999999998 88999988
Q ss_pred cHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 220 NLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 220 ~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..+....+.... ...+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8877777665543 34556688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=366.12 Aligned_cols=151 Identities=29% Similarity=0.624 Sum_probs=141.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+++|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999987655555566788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=328.48 Aligned_cols=264 Identities=29% Similarity=0.432 Sum_probs=211.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 86 (442)
+..|++...||+|+||.||+|..+.++. .+|||.+..++- ....-...-||+.+++.++||||+.+..++-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4579999999999999999997765544 689998865421 11233557799999999999999999999877 78
Q ss_pred EEEEEEEccCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC----CceEEeec
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDF 157 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~----~~~kl~DF 157 (442)
.+|+++||++. +|...|.-+. .++...++.++.||+.|+.|||++-|.||||||.|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999998 9999886543 58999999999999999999999999999999999999877 89999999
Q ss_pred cchhhhhhcccCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---------HHHHHH
Q 013487 158 GLSAISQQVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---------MALYRK 227 (442)
Q Consensus 158 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~~~ 227 (442)
|+|+++...-..- ......-|.+|+|||.+.|...++.++|+|+.|||+.||++-++.|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887543211 234456789999999999998888999999999999999999888854321 111112
Q ss_pred Hhh--CCC---------CCCCC--------------------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 228 ICR--ADF---------SCPSW--------------------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 228 i~~--~~~---------~~~~~--------------------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
|.. +.. ..|.+ -++.+.+|+.+||+.||.+|+|++|+|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 211 000 01111 24568899999999999999999999999999
Q ss_pred ccCCCCC
Q 013487 271 KKGYKPP 277 (442)
Q Consensus 271 ~~~~~~~ 277 (442)
.....|+
T Consensus 341 ~~d~lpp 347 (438)
T KOG0666|consen 341 TEDPLPP 347 (438)
T ss_pred ccCCCCC
Confidence 9876553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.15 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=204.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe-C
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS-K 85 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~ 85 (442)
++|++.+.||+|+||.||+|++.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 489999999999999999997543 45789999986543 222346678899999999 79999999998764 4
Q ss_pred CEEEEEEEccCCCChHHHHHhc----------------------------------------------------------
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (442)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5788999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCc
Q 013487 108 ---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184 (442)
Q Consensus 108 ---~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 184 (442)
.+++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999999764322111112233456789999
Q ss_pred ccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHH-HHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCH
Q 013487 185 EVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY-RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTI 261 (442)
Q Consensus 185 E~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 261 (442)
|++.+..+. .++||||+||++|+|++ |..||.+....+.+ ..+... ....|..+++++.+++.+||+.+|++|||+
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999887775 88999999999999997 99999775433332 223222 234455678999999999999999999999
Q ss_pred HHHhcC
Q 013487 262 SQMLED 267 (442)
Q Consensus 262 ~eil~h 267 (442)
.++++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=332.45 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=211.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCC----------------CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETG----------------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 74 (442)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999886544 4589999875532 234678899999999999999
Q ss_pred cceEEEEEEeCCEEEEEEEccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013487 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143 (442)
Q Consensus 75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~N 143 (442)
|+++++++...+..+++|||+.+++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998766 68999999999999999999999999999999999
Q ss_pred EEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc--CCCCCCCCcH
Q 013487 144 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNL 221 (442)
Q Consensus 144 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~ 221 (442)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875433222222234456788999999877665 489999999999999998 7889987766
Q ss_pred HHHHHHHhhC--------CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 222 MALYRKICRA--------DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 222 ~~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
...+...... ....+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555544321 12344557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.47 Aligned_cols=262 Identities=30% Similarity=0.455 Sum_probs=214.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK-- 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 85 (442)
....++|++.+.||+|+||.||+|.+..+++.+|+|.+.+... .......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 4567899999999999999999999998999999998864321 222345677899999999 999999999988653
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
...|+||||+.+ +|.+++... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 468999999975 999998775 789999999999999999999999999999999999999999999999999876543
Q ss_pred cccC---CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-----------
Q 013487 166 VRED---GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------- 231 (442)
Q Consensus 166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 231 (442)
.... .......||+.|+|||++.+....+.++|+||+|+++|+|++|..||.+.........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 23344568999999999876555568999999999999999999999776544333222111
Q ss_pred ----------------CC----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 ----------------DF----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 ----------------~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.. ...+.++.++.++|.+||+.||++|||+.++++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 0112268899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.34 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=207.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (442)
.+++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 4799999999999999999999999999999999986543221 1234567899999999999999999887443
Q ss_pred ---CEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 86 ---TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 86 ---~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
..+|++|||+.+ +|...+.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999976 67776654 4579999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccC---------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC
Q 013487 162 ISQQVRED---------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 232 (442)
Q Consensus 162 ~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 232 (442)
........ .......|++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54332111 111233578899999998765545688999999999999999999998877665544432210
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 F-----------------------SCP-------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ~-----------------------~~~-------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
. ..+ ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.75 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=218.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-----EE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----KI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 88 (442)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999999999999987542 12334567889999999999999999999987765 78
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++|||+.+ +|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 8999998888999999999999999999999999999999999999999999999999999876543221
Q ss_pred -CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC--------------
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-------------- 233 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------- 233 (442)
........+++.|+|||++.+....+.++|+||+|+++|+|++|.+||...+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 11234456899999999998774446899999999999999999999988776655554432110
Q ss_pred -----------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 234 -----------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 234 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
...+.++.++.+||.+||+.||.+|||+++++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 011235788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=334.93 Aligned_cols=259 Identities=29% Similarity=0.530 Sum_probs=211.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-- 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 86 (442)
...+++|++.+.||+|+||.||+|.++.+++.||+|.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3567899999999999999999999999999999999975432 1222346778999999999999999999987654
Q ss_pred --------EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeec
Q 013487 87 --------KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (442)
Q Consensus 87 --------~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DF 157 (442)
.+|+++||+++ +|.+.+... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999987 777776653 46899999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CC-
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DF- 233 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~- 233 (442)
|++........ .......+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99876543221 12223346788999999876554568999999999999999999999877655544333221 00
Q ss_pred --------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 --------------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 --------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.....++..+.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=316.04 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=206.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE-----eCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA-----SKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~ 86 (442)
-.||++.+.||+|+|+.||++.+..++..+|+|.+.... .+..+.+++|+...++++||||++++++.. ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 358999999999999999999999999999999997654 345788999999999999999999987653 234
Q ss_pred EEEEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCceEEeeccch
Q 013487 87 KIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
..|++++|...|+|.+.|+.. ..++|.++..|+.++++||++||+.. .+||||||.|||+++.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 599999999999999998753 26999999999999999999999998 999999999999999999999999998
Q ss_pred hhhhhcccCC-------ccccccCCCcccCcccccccCC--CCCcccHhHHHHHHHHHhcCCCCCCCCcHH--HHHHHHh
Q 013487 161 AISQQVREDG-------LLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRKIC 229 (442)
Q Consensus 161 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~i~ 229 (442)
+..+-.-.++ -......|.+|+|||.+.-+.+ .+.++|||||||+||+|+.|.-||+..-.. .+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7543211111 1122345899999999865433 368999999999999999999999632110 1111233
Q ss_pred hCCCCCC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 230 RADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 230 ~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+.+.+| +.+|+.+.+||+.||++||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 3444444 3489999999999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=329.66 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=211.3
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CEEEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIYIVL 92 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 92 (442)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998653 2233345678999999999999999999999888 8999999
Q ss_pred EccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+++ +|.+.+... ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 898888765 5799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC------------------
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------------------ 233 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------------ 233 (442)
.....++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23345788999999887655456899999999999999999999988776554444322100
Q ss_pred -----CC-------CCC-CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 -----SC-------PSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 -----~~-------~~~-~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.. ... +++.+.+++.+||..||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.33 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=211.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..++|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45679999999999999999998643 44568999876443 22345688999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
+..++||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997643 37899999999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i 228 (442)
+.+||+|||++................+++.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998754322111122334568899999999877664 78999999999999998 99999887777766666
Q ss_pred hhCCC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 229 CRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 229 ~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+.. ..+..++..+.+++.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55543 344557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=322.41 Aligned_cols=251 Identities=30% Similarity=0.531 Sum_probs=220.0
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999998765432 2335667789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 94 FIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 94 ~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998876 356899999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIK 248 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 248 (442)
......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+....+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 23345689999999999877664 789999999999999999999998887766666655544 344568899999999
Q ss_pred HccCCCCCCCCCHHHHhcCccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=358.12 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=197.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCC-CEEEEEE--------------ecchhhhhHHHHHHHHHHHHHHhhCCCCC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETG-DFVAIKI--------------VDRDQVLRHKMVEQIKREISTMKLIKHPN 74 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vaiK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 74 (442)
...++|++++.||+|+||+||+|..+... ...+.|. +.+...........+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999998865332 2233221 11111112234566889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEEccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
|+++++++...+..|++++++.+ +|.+++... .......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999964 788877543 224467788999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCC-CCCCC--cHHHHHH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDES--NLMALYR 226 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~--~~~~~~~ 226 (442)
|.+||+|||++....... .......+||+.|+|||++.+..|. .++|||||||++|+|++|.. ||... +....+.
T Consensus 304 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999997654321 1122346799999999999887775 89999999999999999875 44322 1111111
Q ss_pred HHhh------CCCC---------------------CC-----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 227 KICR------ADFS---------------------CP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 227 ~i~~------~~~~---------------------~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+.. ..++ .+ ..++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1111 0000 00 1145678889999999999999999999999999764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=318.89 Aligned_cols=249 Identities=35% Similarity=0.579 Sum_probs=214.6
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48999999999999999999998999999999876542 345778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999999876 5799999999999999999999999999999999999999999999999999876543221 3
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHHHHHHHHH
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 249 (442)
....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+............ ...+..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999887664 588999999999999999999998775444333333221 12222348999999999
Q ss_pred ccCCCCCCCCCHHHHhcCcc
Q 013487 250 ILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~ 269 (442)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=338.07 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=209.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (442)
.-++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 34789999999999999999999999999999999875421 222345678899999999999999999988543
Q ss_pred -CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7799887765 469999999999999999999999999999999999999999999999999987532
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 232 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 232 (442)
. ......|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2 22345689999999998764444588999999999999999999997665443333221100
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 233 -----------FSC--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 233 -----------~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
... ....++++.+||.+||+.||.+|||+.+++.||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000 0124788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=328.43 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=220.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
-....|++.+.||+|++|.||+|.+..++..|++|++..... ..+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 345679999999999999999999998999999999975432 3566889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+++||++|++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 9999999999999999877 89999999999999999999999999999999999999999999999999886543221
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCCCHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFSSGAKK 245 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~ 245 (442)
.......+++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..... ..+..++.++.+
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 122344578999999998877664 889999999999999999999987766555444433222 222337899999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+|.+||+.+|.+|||+.++++||||.+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.17 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=212.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|...+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.+.+..|++||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 46777889999999999999999999999999976544444455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|+.| +|.+.+.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.... ..
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 9965 77777765 4568999999999999999999999999999999999999999999999999875321 12
Q ss_pred ccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC--CCCCCCHHHHHHHH
Q 013487 173 HTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPSWFSSGAKKLIK 248 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~ 248 (442)
....|+..|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+.....+ ....++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 34578999999999842 233347899999999999999999999877655544444433221 12336788999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+||+.+|.+||++.+++.||||+..
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=323.96 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=204.9
Q ss_pred eecccCceEEEEEEE--cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 20 TLGEGSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.++||||+++++++. ....+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999975 4677899999986543 23345677899999999999999999999875 4567899999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC-Ccccccc
Q 013487 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED-GLLHTAC 176 (442)
Q Consensus 98 g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~ 176 (442)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998754322110 0112234
Q ss_pred CCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHccCCC
Q 013487 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 254 (442)
+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. .+.|..+++++.+||.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 478999999999999998 999998877766666665543 4567778999999999999999
Q ss_pred CCCCCCHHHHhc
Q 013487 255 PDTRMTISQMLE 266 (442)
Q Consensus 255 P~~R~s~~eil~ 266 (442)
|++|||+++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=330.53 Aligned_cols=254 Identities=27% Similarity=0.473 Sum_probs=214.1
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
-...||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3467999999999999999999999999885432 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccccc
Q 013487 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (442)
Q Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 176 (442)
+++|.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 9999987754 578999999999999999999999999999999999999999999999999876443211 1123456
Q ss_pred CCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHHHHHHccCC
Q 013487 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L~~ 253 (442)
|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+... .+.....+++.+.+++.+||+.
T Consensus 178 ~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 8999999999876665 48899999999999999999999877655544433322 2223344789999999999999
Q ss_pred CCCCCCCHHHHhcCcccccCCCCC
Q 013487 254 NPDTRMTISQMLEDEWFKKGYKPP 277 (442)
Q Consensus 254 dP~~R~s~~eil~hp~~~~~~~~~ 277 (442)
||.+||++.++++||||.+...|.
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred CcccCcCHHHHhcChHHhccCCCc
Confidence 999999999999999999877543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=330.40 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=208.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 89 (442)
++|++.+.||+|+||.||+|++..++. .+++|.+... ......+.+.+|+.+++++ +||||+++++++...+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999987765 4688877532 1223456788999999999 7999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 90 IVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
++|||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997643 478899999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC
Q 013487 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD 232 (442)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 232 (442)
|+|||++........ ......+..|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+....
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999863221100 1112235579999998877664 89999999999999997 999999888777777665542
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 233 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 233 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
...|..++..+.+|+.+||..||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34556689999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.46 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=209.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...+|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 34679999999999999999999877776 48999986443 23345678899999999999999999999875 4
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..++++||+++|+|.+.+... +.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999999764 5699999999999999999999999999999999999999999999999999876543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ..+.+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2111111122346789999999877765 89999999999999998 99999877666555544443 334556689999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+++.+||..||++|||+.++++
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=337.01 Aligned_cols=255 Identities=18% Similarity=0.352 Sum_probs=204.0
Q ss_pred eeeccc--CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 19 RTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 19 ~~LG~G--~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
..||+| +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|++|||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998755422 2345789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC-c--
Q 013487 97 GGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-L-- 171 (442)
Q Consensus 97 gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~-- 171 (442)
+|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++||+.+.......... .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 999999988643 58999999999999999999999999999999999999999999999998654322211110 0
Q ss_pred --cccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---------------
Q 013487 172 --LHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--------------- 233 (442)
Q Consensus 172 --~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------------- 233 (442)
.....++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 01123567799999987642 235899999999999999999999987654433322221110
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 234 --------------------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 234 --------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+.+..+++.+.+||++||..||++|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01112567899999999999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=325.91 Aligned_cols=248 Identities=24% Similarity=0.415 Sum_probs=212.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
..+|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999977 88999999875532 2345688999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+++|+|.+++... ..++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 9999999999999763 458999999999999999999999999999999999999999999999999987543211
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......++..|+|||++.+..+. .++||||||+++|+|++ |..||...+..+.+..+... ..+.+..+++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 111233456789999998876664 78999999999999998 89999887777776666543 3455667899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.14 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=210.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcC-------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVM 82 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 82 (442)
..++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34689999999999999999998642 34569999886432 223456788999999999 699999999999
Q ss_pred EeCCEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 013487 83 ASKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (442)
Q Consensus 83 ~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll 146 (442)
...+.+|++|||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999763 247888999999999999999999999999999999999
Q ss_pred ccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHH
Q 013487 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (442)
Q Consensus 147 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (442)
+.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+....+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999875433221111222334568999999987666 489999999999999999 89999888777777
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 226 RKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 226 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+.... ...+..++.++.+|+.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6665543 3456667899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.54 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=209.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|++|.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 457999999999999999999974 457899999875432 135678899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||++|++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997654 6899999999999999999999999999999999999999999999999998765421111
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
......++..|+|||++.+..+ +.++|+||||+++|+|++ |..||.+.+.......+... ..+.+..++..+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 0111223457999999887666 488999999999999999 99999887777666666543 3345566789999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||+.||.+||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.94 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=209.6
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 83 (442)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++.+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 34458999999999999999999852 345689999886542 223456788999999999 7999999999999
Q ss_pred eCCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
..+..|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++||+|+||||+|||++.++.+|++|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999999997643 38999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC--CCCCCC
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSW 238 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~ 238 (442)
...............+++.|+|||.+.+..+. .++||||+||++|+|++ |..||...+....+....... ...+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 54332111111223457889999999877664 89999999999999998 999998776555444443332 234556
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.++.+.+++.+||..+|++|||+.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=323.62 Aligned_cols=248 Identities=23% Similarity=0.416 Sum_probs=207.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999885 5678999998654322 245678999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||++|++|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++........ .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 999999999999764 46899999999999999999999999999999999999999999999999998754221110 0
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 249 (442)
.....++..|+|||.+.+..+. .++|+||+|+++|+|++ |..||...+..+....+... ....|..++..+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111234579999999877664 78999999999999999 89999887766666665544 345566689999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 013487 250 ILDPNPDTRMTISQMLED 267 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~h 267 (442)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.45 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=208.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|+||+||.|.+. .+..+|+|.+...... .+.+.+|+.++++++||||+++++++...+..|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 457999999999999999999874 3456999988754321 35678999999999999999999999998999999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+.+|+|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999999999764 3689999999999999999999999999999999999999999999999999864422111 0
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIK 248 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 248 (442)
......++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+.... ...+...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11112345679999999876664 78999999999999998 999998877766666665543 2345557899999999
Q ss_pred HccCCCCCCCCCHHHHhcC
Q 013487 249 RILDPNPDTRMTISQMLED 267 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~h 267 (442)
+||..||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.89 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=209.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
-.+|++.+.||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 356888999999999999999753 356689999876432 334567899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG---------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 151 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~---------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~ 151 (442)
..+++|||+++|+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997653 3788999999999999999999999999999999999999999
Q ss_pred eEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhh
Q 013487 152 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICR 230 (442)
Q Consensus 152 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 230 (442)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998644321111111223457889999999877764 88999999999999998 9999987776666655544
Q ss_pred C-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 231 A-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 231 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+ ....+..+++.+.+|+.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 34556678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.02 Aligned_cols=259 Identities=29% Similarity=0.572 Sum_probs=216.9
Q ss_pred CeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhh-hHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (442)
.|++.+.||+|++|.||+|.+. .++..||+|++.+.... .....+.+.+|+.+++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46788999998754432 223456788999999999 599999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+.+|+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543321
Q ss_pred CCccccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCc----HHHHHHHHhhCCCCCCCCCCHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPSWFSSGA 243 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 243 (442)
.......+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+ .......+.......|..++.++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11122356899999999986543 23578999999999999999999996432 23334445555566777789999
Q ss_pred HHHHHHccCCCCCCCCC---HHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMT---ISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s---~~eil~hp~~~~~ 273 (442)
.++|.+||+.||++||| +.++|+||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.41 Aligned_cols=249 Identities=22% Similarity=0.379 Sum_probs=208.9
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3468999999999999999999974 567799998764322 24678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||+++|+|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999998753 4588899999999999999999999999999999999999999999999999876432111
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++.++.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122335678999999877665 478999999999999998 99999887766666655543 233344578999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||..||++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.27 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=208.4
Q ss_pred CeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999999753 23568999886443 223356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 013487 89 YIVLEFIDGGELFDKIAKH------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~------------------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NI 144 (442)
|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred EEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHH
Q 013487 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223 (442)
Q Consensus 145 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 223 (442)
|+++++.+||+|||++...............+++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754332211112234567789999998776654 88999999999999998 999998887777
Q ss_pred HHHHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 224 LYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 224 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
....+... ....|..++.++.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655443 33456668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.45 Aligned_cols=252 Identities=19% Similarity=0.345 Sum_probs=207.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
..++|++.+.||+|+||+||+|.+..+++ .+++|.+.... .......+..|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 45689999999999999999999987776 47777765321 22334677889999999999999999998754 5
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..++++||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578999999999999999764 5689999999999999999999999999999999999999999999999999875433
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 243 (442)
...........++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.........+..+. ...+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 2222222345577889999999876664 89999999999999998 999998876665544444433 34455578899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+++.+||..||.+|||+.++++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=328.90 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=205.9
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 91 (442)
.+|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999998754322 33567889999999996 99999999999999999999
Q ss_pred EEccCCCChHH---HHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 92 LEFIDGGELFD---KIA--KHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 92 ~E~~~gg~L~~---~i~--~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
|||+.+ +|.+ .+. ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 5444 332 236799999999999999999999985 999999999999999999999999999875432
Q ss_pred cccCCccccccCCCcccCccccccc--CCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-HHHHHHHhhCCC-CC----CC
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADF-SC----PS 237 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~----~~ 237 (442)
. .......|++.|+|||++.+. ...+.++||||+||++|+|++|.+||..... ......+..... .. +.
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1 112334689999999998766 2345899999999999999999999976542 122222222211 11 12
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.++.++.+||.+||+.||.+|||++++++||||+.
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 37889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=326.60 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=204.5
Q ss_pred EEEeeecccCceEEEEEEEc----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNV----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57889999999999999997 34567999999543 2333467889999999999999999999999988889999
Q ss_pred EEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||+++|+|.+++... ..++......++.|++.||.|||+++++|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999987 67999999999999999999999999999999999999999999999999998765221111
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 247 (442)
.......+...|+|||.+.+..+ +.++||||||+++|++++ |..||...+.......+..+. ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456778999999987765 489999999999999999 789999888777777765543 455667899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||..||.+|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.35 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=214.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|...+.||+|+||.||+|.+..++..||+|.+........+....+.+|+.+++.++|||++++++++...+..|++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 38889999999999999999999999999999876543344456778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
|+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++..... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 9975 77777654 45689999999999999999999999999999999999999999999999998764322 2
Q ss_pred ccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-C-CCCCCHHHHHHHH
Q 013487 173 HTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-C-PSWFSSGAKKLIK 248 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~li~ 248 (442)
....|++.|+|||.+.. .+..+.++|+||+||++|+|++|..||...+.......+...... . +..+++.+.+|+.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 34568999999999742 233458899999999999999999999877666555555444322 2 2346889999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+||+.+|.+||++.++++|+|+....
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.65 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=205.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCC--------------CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcce
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETG--------------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 77 (442)
-++|++.+.||+|+||.||+|++..++ ..||+|.+.... .....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 358999999999999999999875432 358999987542 2334567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 013487 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHG------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (442)
Q Consensus 78 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIl 145 (442)
+++++...+..+++|||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986532 3678889999999999999999999999999999999
Q ss_pred EccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc--CCCCCCCCcHHH
Q 013487 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLMA 223 (442)
Q Consensus 146 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~ 223 (442)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432211111222345778999999887666 589999999999999988 678998766555
Q ss_pred HHHHHhh--------CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 224 LYRKICR--------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 224 ~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
....+.. .....++.+++.+.+|+.+||..||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4433221 112334557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.69 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=208.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCC--CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe----CC
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVET--GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS----KT 86 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 86 (442)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 8999999986432 2222355678899999999 59999999987532 25
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+++||+. ++|.+.+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6789999986 599999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cc--CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------
Q 013487 167 RE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 231 (442)
Q Consensus 167 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 231 (442)
.. ........||+.|+|||++.+....+.++||||+|+++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998866433458999999999999999999999876543332221110
Q ss_pred ------------C---CC---CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 ------------D---FS---CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 ------------~---~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
. .. ..+..+..+.+|+.+||+.||.+|||+.+++.|||+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 00 1122578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.72 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=204.3
Q ss_pred eeecccCceEEEEEEEcCCC---CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 19 RTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998765432 34567889999999999999999999876 45689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC-cccc
Q 013487 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-LLHT 174 (442)
Q Consensus 96 ~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 174 (442)
.+|+|.+++...+.+++..+..++.|++.||+|||+.|++|+||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999988889999999999999999999999999999999999999999999999999987553321110 0111
Q ss_pred ccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHccC
Q 013487 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 252 (442)
..++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+..+....+.... ...|..++..+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999977666 489999999999999998 999998877766666655443 35666789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 013487 253 PNPDTRMTISQMLE 266 (442)
Q Consensus 253 ~dP~~R~s~~eil~ 266 (442)
.||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=321.84 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=210.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+++|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 5679999999999999999999987665 59999986542 233457789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+++|||+++|+|.+++... +.++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999998764 568999999999999999999999999999999999999999999999999987543321
Q ss_pred cCCcccccc---CCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHH
Q 013487 168 EDGLLHTAC---GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 242 (442)
Q Consensus 168 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 242 (442)
......... .+..|+|||.+.+..+. .++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 24579999999877764 78999999999999886 99999887766666655433 23445567899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+.+++.+||..+|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=337.26 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=203.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 458999999999999999999853 5678899999975432 23356788999999999 689999999987554
Q ss_pred -CEEEEEEEccCCCChHHHHHhcC--------------------------------------------------------
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHG-------------------------------------------------------- 108 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~-------------------------------------------------------- 108 (442)
..++++|||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 56899999999999999986531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 109 -----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 109 -----------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
.++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 367778899999999999999999999999999999999999999999999875432111111122345
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHH-HHHHHhhC-CCCCCCCCCHHHHHHHHHccCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA-LYRKICRA-DFSCPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~d 254 (442)
++.|+|||++.+..+. .++||||+|+++|+|++ |..||....... ....+..+ ....|.+.++++.+++.+||..|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999999877664 88999999999999996 999997654332 22223222 34556678899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013487 255 PDTRMTISQMLED 267 (442)
Q Consensus 255 P~~R~s~~eil~h 267 (442)
|++|||+.++++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.47 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=211.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999999753 67889999987543 2234567889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~----------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NI 144 (442)
..|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997532 367888999999999999999999999999999999
Q ss_pred EEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHH
Q 013487 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223 (442)
Q Consensus 145 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 223 (442)
+++.++.+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998643322111112223356789999998877764 89999999999999997 889998877777
Q ss_pred HHHHHhhCCC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 224 LYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 224 ~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
....+..+.. ..|..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6666655543 456678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.13 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=206.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++.+. ....|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46799999999999999999998655 46999998754321 246789999999999999999999874 4568999
Q ss_pred EEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999999999999764 3578999999999999999999999999999999999999999999999999875433211
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......++..|+|||++.+..+ +.++|+||+|+++|+|++ |..||...........+... ..+.+..++..+.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 11123346678999999877666 489999999999999999 89999887766666655443 2344556899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||+.||++|||+.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=332.72 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=212.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCC-------CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVET-------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV 81 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 81 (442)
....+|++++.||+|+||.||+|++... +..||+|.+.... .....+.+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445799999999999999999986432 2368999886432 233457788999999999 79999999999
Q ss_pred EEeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 013487 82 MASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (442)
Q Consensus 82 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIl 145 (442)
+...+.+|++|||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999997632 3677888999999999999999999999999999999
Q ss_pred EccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHH
Q 013487 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL 224 (442)
Q Consensus 146 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 224 (442)
++.++.+||+|||+++...............++..|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999998754332111112223345679999999877665 78999999999999998 8999998887777
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCc
Q 013487 225 YRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 268 (442)
Q Consensus 225 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 268 (442)
...+.... ...+..++.++.+|+.+||..+|.+|||+.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77665543 345666789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=322.31 Aligned_cols=252 Identities=21% Similarity=0.377 Sum_probs=212.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
..++|++.+.||+|+||.||+|.++.+|. .+|+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34689999999999999999999877665 589998865532 3345678899999999999999999999887 7
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..+++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 889999999999999999874 4689999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
...........++..|+|||.+....+. .++|+||+|+++|++++ |..||...+..+....+... ..+.|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2111111122245689999998766664 89999999999999998 99999988777766666554 345666688999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=334.17 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=207.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC------
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (442)
..+|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4689999999999999999999999999999999875422 222345678999999999999999999998654
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..+|+++||+.+ +|.+.+ ...++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 356999999965 777665 34689999999999999999999999999999999999999999999999999864322
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--------------
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------- 231 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------- 231 (442)
......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+.......+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1234567899999999876444468999999999999999999999887654444332210
Q ss_pred ---------CCCC--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 ---------DFSC--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 ---------~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.... .+..++.+.+||.+||+.||.+|||+++++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 12357789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.91 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=212.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-..|...+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588889999999999999999999999999998754333334456788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+. |+|.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 99997 478777654 45689999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC--CCCCCCHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPSWFSSGAKKL 246 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~l 246 (442)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+.....+ .+..++..+.+|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 234568999999999753 222357899999999999999999999776655444444433322 233478899999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|.+||..+|.+||++.++++|||+...
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.36 Aligned_cols=252 Identities=34% Similarity=0.531 Sum_probs=211.1
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|++.+.||+|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++||||+++++++...+..|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999875542 223456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
+++ +|.+.+... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 888887763 579999999999999999999999999999999999999999999999999987554322 1223
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------CCC
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------DFS 234 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~ 234 (442)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+....+... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3457889999999877634468999999999999999999999877765544333211 000
Q ss_pred -----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 235 -----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 235 -----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..+.++.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=329.85 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=210.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 89 (442)
..++|++.+.||+|+||.||+|.+..++..||+|.+.+.. ......+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4578999999999999999999999999999999886542 222345678899999999999999999999865 56789
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
++|||+ +++|.+.+.. .++++..+..++.|++.||+|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 999998 5588887764 5689999999999999999999999999999999999999999999999999874322
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh-------------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------------- 230 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------- 230 (442)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+....+..+.+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223456788999999987644446899999999999999999999977654322211110
Q ss_pred -------CCCCC-----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 231 -------ADFSC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 231 -------~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
..... .+.+++.+.++|++||+.+|++|||+++++.||||...-.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00011 12367899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=320.03 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=209.7
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875543 79999886542 223456788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|++|||++|++|.+++... +.++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987654321
Q ss_pred cCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHH
Q 013487 168 EDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 244 (442)
Q Consensus 168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 244 (442)
... ......++..|+|||.+.+..+ +.++|+||+|+++|++++ |..||...+..+....+... ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 0111223568999999987666 489999999999999886 99999887766666655543 2344455789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 013487 245 KLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~ 266 (442)
+++.+||+.+|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=340.70 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=207.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 84 (442)
...+|.+++.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+|.++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3456888999999999999999964 345689999997543 2223456889999999997 9999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC--------------------------------------------------------
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG-------------------------------------------------------- 108 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~-------------------------------------------------------- 108 (442)
.+..++||||+++|+|.+++...+
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986532
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 013487 109 ------------------------------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (442)
Q Consensus 109 ------------------------------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll 146 (442)
.++...+..++.||+.||+|||+.|++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788999999999999999999999999999999
Q ss_pred ccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHH
Q 013487 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (442)
Q Consensus 147 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (442)
++++.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999875432211111223457889999999987666 488999999999999998 89999875544433
Q ss_pred HH-HhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 226 RK-ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 226 ~~-i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.. +..+ ....|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 3333 345566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.08 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=204.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcC----------------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVE----------------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 75 (442)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34469999986542 23345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEEccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 013487 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144 (442)
Q Consensus 76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NI 144 (442)
+++++++...+..|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987643 356778999999999999999999999999999999
Q ss_pred EEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc--CCCCCCCCcHH
Q 013487 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLM 222 (442)
Q Consensus 145 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~ 222 (442)
|++.++.++|+|||++................+++.|+|||+..+..+ +.++|+|||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875432211111222345678999998877665 489999999999999998 78999776654
Q ss_pred HHHHHHh--------hCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 223 ALYRKIC--------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 223 ~~~~~i~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+...... ....+.+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433221 1123445567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.58 Aligned_cols=250 Identities=31% Similarity=0.479 Sum_probs=206.6
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC---CCCCcceEEEEEEeCCE----
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMASKTK---- 87 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 87 (442)
|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988999999999975432 222334566788877766 59999999999988776
Q ss_pred -EEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 88 -IYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 88 -~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
++++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8998887643 48999999999999999999999999999999999999999999999999987653
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-----CC-----
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-----FS----- 234 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-----~~----- 234 (442)
.. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||...+..+...++.... ..
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 32 22234457899999999987766 488999999999999999999998877666555443210 00
Q ss_pred ------C-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 235 ------C-----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 235 ------~-----------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
. .+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=317.10 Aligned_cols=243 Identities=27% Similarity=0.494 Sum_probs=210.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 46899999999999999999987 478999999875532 356788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999999999998766 68999999999999999999999999999999999999999999999999987542211
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+... ....+..+++.+.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 12345667999999876655 478999999999999997 99999888777666555443 3345666899999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=319.46 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=206.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.++++++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 468999999999999999999875 5667999998754322 245889999999999999999999875 4568999
Q ss_pred EEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 9999999999999763 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++ |.+||.+.+..+....+... ..+.+...+..+.+|+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11112234567999999877665 489999999999999999 99999887776666666543 3455666889999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||..||.+|||++++.+
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.01 Aligned_cols=252 Identities=32% Similarity=0.537 Sum_probs=211.6
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997653 2233356677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||++++++.+||+|||++....... ....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence 985 999999886 579999999999999999999999999999999999999999999999999987543321 1223
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC------------------CCCC
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------------DFSC 235 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~~~~ 235 (442)
...++..|+|||.+.+....+.++|+||+||++|+|++|.+||...+.......+... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456788999999877644568999999999999999999999887655444333210 0001
Q ss_pred C-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 236 P-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 236 ~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+ +.++..+.++|.+||..||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.45 Aligned_cols=253 Identities=29% Similarity=0.525 Sum_probs=212.3
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+|.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888887777776542221 122234567899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988864 356899999999999999999999999999999999999975 67999999998654321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKL 246 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 246 (442)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. ..+..++.++.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1223345688999999998776665 789999999999999999999987776666666554433 3455678999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCccc
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=316.74 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=206.2
Q ss_pred eeecccCceEEEEEEEcC-CCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 19 RTLGEGSFAKVKFAKNVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
+.||+|++|.||+|.+.. ++. .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999776533 456789999999999999999999999988 8999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC-Ccc
Q 013487 96 DGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED-GLL 172 (442)
Q Consensus 96 ~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~ 172 (442)
++|+|.+.+.... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998764 6899999999999999999999999999999999999999999999999998765432111 111
Q ss_pred ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 013487 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 249 (442)
....++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+..+....+... ....+..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999998877764 78999999999999998 99999887777666655532 234455678999999999
Q ss_pred ccCCCCCCCCCHHHHhc
Q 013487 250 ILDPNPDTRMTISQMLE 266 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~ 266 (442)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=317.93 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=206.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-++|++.+.||+|+||.||+|.+ .+++.||+|.+...... .+.+.+|+.++++++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 35799999999999999999987 46788999998754422 356789999999999999999999874 4678999
Q ss_pred EEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+.+|+|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence 9999999999998754 368999999999999999999999999999999999999999999999999986543211 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......++..|+|||++.+..+ +.++||||+|+++|+|++ |.+||.+.+..+....+... ..+.+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11122345678999999877665 488999999999999998 99999887776666655443 3345566789999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||+.||++|||++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=320.92 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=209.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEcC----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVE----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 86 (442)
-++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999875 35789999876432 33446778899999999999999999998765 56
Q ss_pred EEEEEEEccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 87 KIYIVLEFIDGGELFDKIAKH--------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~--------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
..++++||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999998763 358899999999999999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCC
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCP 236 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~ 236 (442)
+++...............++..|+|||++.+..+ +.++||||||+++|++++ |.+||...+..+....+... ....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 9875432211111122345678999999987666 488999999999999999 99999887776666555443 23445
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=316.86 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=201.2
Q ss_pred eecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 20 TLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 345579999986542 2334567889999999999999999999875 4578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC-ccccc
Q 013487 98 GELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-LLHTA 175 (442)
Q Consensus 98 g~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 175 (442)
|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999875 4578999999999999999999999999999999999999999999999999987543221111 11112
Q ss_pred cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccCC
Q 013487 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~ 253 (442)
.+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ....|+..++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23578999999877665 488999999999999996 99999887776666555543 3466777899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 013487 254 NPDTRMTISQMLE 266 (442)
Q Consensus 254 dP~~R~s~~eil~ 266 (442)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=317.17 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=205.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999998654 4699998765432 2356788999999999999999999875 4568999
Q ss_pred EEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence 99999999999997643 47899999999999999999999999999999999999999999999999987543211 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||.+.........+... ....+..++..+.+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 11122345678999999877665 489999999999999999 99999887776666665543 2344566889999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||.+||.+||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=321.37 Aligned_cols=239 Identities=22% Similarity=0.326 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEEcCCCCE-------EEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETGDF-------VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~-------vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+.||+|+||.||+|.+..++.. +|+|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4699999999999998765543 8888875432 23456788899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc--------eEEeeccchhh
Q 013487 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--------LKISDFGLSAI 162 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~--------~kl~DFGla~~ 162 (442)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999998764
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhCCCCCCCCCCH
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRADFSCPSWFSS 241 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 241 (442)
... .....+++.|+|||++.+....+.++||||+|+++|+|++| ..||...+..... .........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 322 23356889999999998755446889999999999999998 5676655544332 233445566666788
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+|+.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.37 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=210.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3468999999999999999999985 557899999875432 23568899999999999999999999999899999
Q ss_pred EEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999997653 689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||.+.+.......+... ..+.+...+.++.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 01112234568999999987665 489999999999999998 99999887777666666544 334556678999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||+.||.+||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=322.47 Aligned_cols=250 Identities=32% Similarity=0.503 Sum_probs=206.9
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 93 (442)
|++.+.||+|++|+||+|.+..+++.||+|.+....... ......+|+..+++++ ||||+++++++...+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999999999999986543211 1223457899999999 9999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|+ +|+|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 779999888765 7899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------------C
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------D 232 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~ 232 (442)
.....++..|+|||++.+....+.++|+||+|+++++|++|.+||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865544468999999999999999999999876655444332210 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 233 FS-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 233 ~~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
.. ..+..+.++.++|++||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=328.73 Aligned_cols=248 Identities=25% Similarity=0.443 Sum_probs=198.4
Q ss_pred CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCChHHHH
Q 013487 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI 104 (442)
Q Consensus 25 ~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 104 (442)
++|.||.+++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 446677777777999999999976532 3345678999999999999999999999999999999999999999999999
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc-----CCccccccC
Q 013487 105 AKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-----DGLLHTACG 177 (442)
Q Consensus 105 ~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~g 177 (442)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 764 4589999999999999999999999999999999999999999999999998764322111 111233457
Q ss_pred CCcccCccccccc--CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-----------------------
Q 013487 178 TPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD----------------------- 232 (442)
Q Consensus 178 t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------------------- 232 (442)
+..|+|||++.+. .+ +.++|+||+||++|+|++|..||..............+.
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 8899999998753 34 478999999999999999999998655433322111100
Q ss_pred -----------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 233 -----------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 233 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
...+..++.++.+|+.+||..||++|||+.++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000112356788999999999999999999999999998644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=315.96 Aligned_cols=243 Identities=27% Similarity=0.483 Sum_probs=206.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEE-EeCCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM-ASKTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 89 (442)
...+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++||||+++++++ ...+..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 356899999999999999999986 47889999986432 245688999999999999999999975 4556799
Q ss_pred EEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
++|||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999999997654 3789999999999999999999999999999999999999999999999998643221
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
.....++..|+|||++.+..+. .++||||+||++|+|++ |..||...+.......+... ....++.+++.+.+
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred ----CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1234456789999998876664 78999999999999997 99999887777666665544 23445668999999
Q ss_pred HHHHccCCCCCCCCCHHHHhc
Q 013487 246 LIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~ 266 (442)
++.+||..||++|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.86 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=211.3
Q ss_pred eEEEeeecccCceEEEEEEEcCCC----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETG----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
+++.+.||+|+||.||+|.+..++ ..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 8899999865432 2246788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999977554 99999999999999999999999999999999999999999999999999875543211
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 246 (442)
... ....+++.|+|||.+.+..+ +.++|+||+|+++|+|++ |.+||...+.......+.... ...+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 01236789999999866555 589999999999999998 899998877777776665543 34566689999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||..||.+|||+.|+++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.00 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=209.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999976655 79999986542 222356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|++|||+++++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999998764 578999999999999999999999999999999999999999999999999987543321
Q ss_pred cCCcc-ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHH
Q 013487 168 EDGLL-HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 244 (442)
Q Consensus 168 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 244 (442)
..... .....++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11223457999999987666 489999999999999997 99999887776666666543 2233445789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 013487 245 KLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~ 266 (442)
+++.+||..||++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=318.80 Aligned_cols=242 Identities=26% Similarity=0.404 Sum_probs=201.6
Q ss_pred eeecccCceEEEEEEEcCCCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 19 RTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.++.++ +||||+++++++...+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988776 46888776322 233456788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 96 DGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 96 ~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997643 478899999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 237 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (442)
+........ ....+.++.|+|||++.+..+ +.++|+||||+++|+|++ |..||...+....+..+... ....+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 853221111 112234667999999877665 489999999999999997 99999887777766666543 234455
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.++.++.+|+.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.53 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=204.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++......|++|||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999977 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 99 ELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 99 ~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999999663 4689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 255 (442)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 489999999999999998 89999877766555555443 334556688999999999999999
Q ss_pred CCCCCHHHHhc
Q 013487 256 DTRMTISQMLE 266 (442)
Q Consensus 256 ~~R~s~~eil~ 266 (442)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=319.10 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=211.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+|++.+.||+|+||.||+|..+. +...|++|.+.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 579999999999999999999754 34679999886543 22346778999999999999999999999999899
Q ss_pred EEEEEEccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 88 IYIVLEFIDGGELFDKIAKHG---------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
.|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998766 68999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCCC--CC
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SC 235 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~ 235 (442)
++...... .........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..... ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 97643211 11112233567789999998776654 88999999999999998 8899987766666666554443 33
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 236 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..++..+.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 45688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=316.19 Aligned_cols=229 Identities=26% Similarity=0.423 Sum_probs=194.4
Q ss_pred cCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCChHHH
Q 013487 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDK 103 (442)
Q Consensus 24 G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 103 (442)
|.+|+||+|++..+++.||+|.+.+... ..+|...+....||||+++++++...+..|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 22344445556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccC
Q 013487 104 IAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183 (442)
Q Consensus 104 i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 183 (442)
+....++++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||++..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98888899999999999999999999999999999999999999999999999998754332 1233456788999
Q ss_pred cccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCH--
Q 013487 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-- 261 (442)
Q Consensus 184 PE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-- 261 (442)
||.+.+..+ +.++|+||+|+++|+|++|..||....... ........|.++++.+.+||.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999877666 478999999999999999999886432210 0112345678899999999999999999999985
Q ss_pred ---HHHhcCccc
Q 013487 262 ---SQMLEDEWF 270 (442)
Q Consensus 262 ---~eil~hp~~ 270 (442)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=309.24 Aligned_cols=253 Identities=25% Similarity=0.444 Sum_probs=208.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 90 (442)
+++.+++..||.|+.|.|++++.+.+|...|+|.+.+.. +.+..+++.+.+.++.... +|+||+.+++|..+..+++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 345566788999999999999999999999999998764 3445778888888877664 8999999999999999999
Q ss_pred EEEccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 91 VLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 91 v~E~~~gg~L~~~i--~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.||.+.. =.+.+ .-.++++|..+-++...++.||.||.++ ||+|||+||+|||+|+.|++|+||||.+..+-..
T Consensus 169 cMelMs~--C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 169 CMELMST--CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHHHHH--HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 9999853 22322 2246799999999999999999999876 8999999999999999999999999998654321
Q ss_pred cCCccccccCCCcccCcccccc---cCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhhCCCCC-C--CCCC
Q 013487 168 EDGLLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRADFSC-P--SWFS 240 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~-~--~~~s 240 (442)
..-....|.+.|||||-+.- ..|+ -.+||||||+.|+||.||+.||.+.+ ..+...++.....+. | ..+|
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 12234579999999999853 3454 78999999999999999999998854 345666666654432 2 2389
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+++++|+..||++|+.+||...++|+|||+..
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 99999999999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.18 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=208.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
-.+|.+.+.||+|+||.||+|.+..+ ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35689999999999999999997644 3469999886442 23345678899999999999999999998875 557
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999998744 58999999999999999999999999999999999999999999999999987543321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
.. ......+++.|+|||.+....+ +.++||||||+++|+|++ |..||...+..+....+... ....|..++..+.+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 YY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 10 1112234568999999877666 488999999999999986 99999888776666555544 34566778999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcC
Q 013487 246 LIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+||..+|.+|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.16 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=209.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999884 4778999988654322 24577899999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+++++|.+++... +.++++.+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 9999999999998764 4689999999999999999999999999999999999999999999999999864322111 1
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 248 (442)
......++..|+|||.+.+..+. .++|+||+|+++|+|++ |..||...+.......+..+ ....|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 11122345789999999876654 78999999999999998 99999888777766666554 23345557899999999
Q ss_pred HccCCCCCCCCCHHHHhcC
Q 013487 249 RILDPNPDTRMTISQMLED 267 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~h 267 (442)
+||..+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.09 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=200.2
Q ss_pred cCe-EEEeeecccCceEEEEEE----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--C
Q 013487 13 GKY-ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--K 85 (442)
Q Consensus 13 ~~y-~i~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 85 (442)
++| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 566 999999999999998865 33577899999987542 12234667899999999999999999998765 3
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..+|++|||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999999976 4699999999999999999999999999999999999999999999999999875543
Q ss_pred cccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH--HHH-------------HHHh
Q 013487 166 VRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALY-------------RKIC 229 (442)
Q Consensus 166 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~-------------~~i~ 229 (442)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2111 11122345677999999877665 48999999999999999999998653311 110 0011
Q ss_pred h-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 230 R-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 230 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
. ...+.+..++..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 122345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=358.95 Aligned_cols=257 Identities=31% Similarity=0.528 Sum_probs=209.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE------
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA------ 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------ 83 (442)
....+|+.++.||+||||.||+++++-+|..||||.|.... .......+.+|+..+.+|+|||||+++..+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 35667888999999999999999999999999999998664 4456788999999999999999999984331
Q ss_pred --------------------------------------------------------------------------------
Q 013487 84 -------------------------------------------------------------------------------- 83 (442)
Q Consensus 84 -------------------------------------------------------------------------------- 83 (442)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -------------------------eC--------CEEEEEEEccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 013487 84 -------------------------SK--------TKIYIVLEFIDGGELFDKIAKHGRL-KEDEARRYFQQLINAVDYC 129 (442)
Q Consensus 84 -------------------------~~--------~~~~lv~E~~~gg~L~~~i~~~~~l-~~~~~~~~~~ql~~aL~~l 129 (442)
.+ ..+||-||||+.-.|.+.|..+... ..+.++++|+||++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 00 2378999999997777777665544 4789999999999999999
Q ss_pred HHCCceeccCCCCcEEEccCCceEEeeccchhhhhh----------------cccCCccccccCCCcccCcccccccC--
Q 013487 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ----------------VREDGLLHTACGTPNYVAPEVLNDKG-- 191 (442)
Q Consensus 130 H~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~~-- 191 (442)
|++||+||||||.||++|+++.+||+|||+|+.... ....+..+...||-.|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 999999999999999999999999999999986220 01112345678999999999998776
Q ss_pred CCCCcccHhHHHHHHHHHhcCCCCCCCC-cHHHHHHHHhhCCCCCCCCC----CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 192 YDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRADFSCPSWF----SSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 192 ~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+..|+|+|||||||+||+. ||... ........+.++.++.|..+ -+....+|+.||+.||++|||+.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 33589999999999999984 67543 33455566666666666332 245678999999999999999999999
Q ss_pred Ccccc
Q 013487 267 DEWFK 271 (442)
Q Consensus 267 hp~~~ 271 (442)
+.||.
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99986
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=310.78 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=203.0
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 98 (442)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999986 468899999986543 2233456889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 99 ELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 99 ~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 999998754 458999999999999999999999999999999999999999999999999986432211 111112344
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccCCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 255 (442)
++.|+|||++.+..+ +.++||||+|+++|++++ |..||...+.......+... ....+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999877665 488999999999999998 99999887766665555444 335566789999999999999999
Q ss_pred CCCCCHHHHhc
Q 013487 256 DTRMTISQMLE 266 (442)
Q Consensus 256 ~~R~s~~eil~ 266 (442)
++|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.35 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=207.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
..++|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45679999999999999999999987776 47888876443 222344688999999999999999999998654
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999987754 589999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
...........++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+.........+... .++.++.++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 2211112234457789999998876664 88999999999999997 99999876655444444332 334455678999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+++.+||..||++||++.++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=320.02 Aligned_cols=259 Identities=23% Similarity=0.407 Sum_probs=208.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
....+.|++.+.||+|+||.||+|.+..+++.||+|.+.+... ......+.+|+.++..+ .||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4567889999999999999999999998999999999875432 12234556677766666 59999999999999999
Q ss_pred EEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.|++|||+.+ .|.+.+.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999864 77776655 4578999999999999999999997 5999999999999999999999999999865432
Q ss_pred cccCCccccccCCCcccCcccccccC---CCCCcccHhHHHHHHHHHhcCCCCCCCCcH-HHHHHHHhhCCC-CCC--CC
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADF-SCP--SW 238 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~~--~~ 238 (442)
.. ......+++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||..... .+.+..+..... ..+ ..
T Consensus 168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred CC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 11 112345788999999987543 234789999999999999999999976332 233444433322 222 23
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++.++.+|+.+||..||.+|||+.++++||||+..
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 68899999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.76 Aligned_cols=238 Identities=23% Similarity=0.305 Sum_probs=193.7
Q ss_pred eecccCceEEEEEEEcCC------------------------CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc
Q 013487 20 TLGEGSFAKVKFAKNVET------------------------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 75 (442)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999985321 2358899886442 2334567889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----
Q 013487 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---- 150 (442)
Q Consensus 76 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---- 150 (442)
+++++++...+..|+||||+++|+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 46789999999999999999999999999999999999997654
Q ss_pred ---ceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHh-cCCCCCCCCcHHHHHH
Q 013487 151 ---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYR 226 (442)
Q Consensus 151 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~ 226 (442)
.+|++|||++..... .....+++.|+|||.+.+....+.++||||+|+++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 489999998753221 122457889999999876544468999999999999984 7999998765544322
Q ss_pred HHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 227 KICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 227 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
........|...++++.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2233334455567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.02 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEEcC--CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 19 RTLGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999997532 44578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 97 GGELFDKIAKHGR-----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 97 gg~L~~~i~~~~~-----l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
+|+|.+++..... .++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999976532 46778899999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccCccccccc------CCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhh-CCCC-----CCCC
Q 013487 172 LHTACGTPNYVAPEVLNDK------GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICR-ADFS-----CPSW 238 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~-~~~~-----~~~~ 238 (442)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||......+....... .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1223456789999997532 233578999999999999999 8899987765555444332 2222 2334
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+++...+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.50 Aligned_cols=239 Identities=19% Similarity=0.294 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEcCC------------CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 19 RTLGEGSFAKVKFAKNVET------------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~------------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
+.||+|+||.||+|..... ...||+|+++... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985322 2358999876542 233456788999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc-------eEEeecc
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-------LKISDFG 158 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~-------~kl~DFG 158 (442)
..+++|||+++|+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998888754 56899999999999999999999999999999999999987664 8999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHh-cCCCCCCCCcHHHHHHHHhhCCCCCCC
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKICRADFSCPS 237 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (442)
++..... .....++..|+|||.+.+....+.++||||+||++|+|+ .|..||......+.. ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8764321 123457889999999875454568999999999999997 589999776544332 22333333334
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=315.15 Aligned_cols=245 Identities=19% Similarity=0.244 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 19 RTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3556799998865432 2233568889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 97 GGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 97 gg~L~~~i~~~~-----~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
+|+|.+++.... ..+...++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999987532 356778889999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccCcccccccC------CCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHh-hCCC--CCC---CC
Q 013487 172 LHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKIC-RADF--SCP---SW 238 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~-~~~~--~~~---~~ 238 (442)
....+|++.|+|||++.+.. ..+.++|+||+|+++|+|++ |..||...+..+...... .... ..| ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999986432 12578999999999999996 999998766554433322 2212 112 23
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.++.+.+++++|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 5788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=337.54 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=211.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.+...++..||+|.||+||+|.+-. .||||+++...... +.++.+++|+..+++-+|.||+-+.+++..+.. .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 3456778999999999999999843 59999998776544 478999999999999999999999999988777 999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
.-+|+|-+|..++.-. ..|.....+.|++|++.|+.|||.++|+|||||..||++.+++.+||+||||++.........
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999999988643 358888999999999999999999999999999999999999999999999998755444444
Q ss_pred ccccccCCCcccCccccccc---CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-----CCCCCCHH
Q 013487 171 LLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-----CPSWFSSG 242 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~ 242 (442)
.+...-|...|||||++... +| +..+||||+||++|||++|.+||...+..++.-.+-++... .-..++.+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence 56667789999999998633 44 58899999999999999999999977766665555554221 12336789
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+++|+..||..+|++||.+.+||.
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.71 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=202.7
Q ss_pred eeecccCceEEEEEEEcCCC------CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETG------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+.||+|+||.||+|.+.... ..+|+|.+.+.. .......+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999986544 679999886432 1223567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-----ceEEeeccch
Q 013487 93 EFIDGGELFDKIAKH-------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS 160 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-----~~kl~DFGla 160 (442)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+|++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999753 3478899999999999999999999999999999999999877 8999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCC
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 238 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 238 (442)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75432211111223345788999999987666 589999999999999998 99999877766665555433 3455666
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
++..+.++|.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=334.03 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=214.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC---E-EEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD---F-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
++-.+.+.||+|+||.||+|..+..+. . ||+|....+.......+..+.+|.++|++++|||||++||+.....-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999999875422 3 899988754434556688899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+|||+|+||+|.+++++.+. ++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+||||++......
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 999999999999999999874 9999999999999999999999999999999999999999999999999987543111
Q ss_pred cCCccccc-cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC--CCCCCCCCHHH
Q 013487 168 EDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~ 243 (442)
. .... .-...|+|||.+...-| +.++||||+||++||+++ |..||.+....+...++.... .+.|...+.++
T Consensus 317 ~---~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 317 M---KKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred e---ccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 1 1112 24568999999988766 499999999999999999 889999999999888885544 35566678899
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..++.+|+..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999875
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.64 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=201.6
Q ss_pred CeEEEeeecccCceEEEEEEE----cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--CE
Q 013487 14 KYELGRTLGEGSFAKVKFAKN----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TK 87 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 87 (442)
-|++.+.||+|+||.||+|.. ..++..||+|.+.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368899999999999999984 4578899999986442 233456789999999999999999999998775 67
Q ss_pred EEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+++|||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999999999999997654 5899999999999999999999999999999999999999999999999998765432
Q ss_pred ccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---------------HHHHHHHHhh
Q 013487 167 RED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------------LMALYRKICR 230 (442)
Q Consensus 167 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~~~~i~~ 230 (442)
... .......++..|+|||++.+..+. .++||||+|+++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 112235577789999998876664 88999999999999999876653211 0111111111
Q ss_pred -CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 231 -ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 231 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
...+.+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=310.23 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=205.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 3578999999999999999999864 45679999886432 224678899999999999999999999887 77899
Q ss_pred EEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||+++|+|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999764 3578889999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......++..|+|||++.+..+ +.++|+||+|+++|++++ |..||...+.......+... ..+.+...+.++.++
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred -ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 11112235677999999977655 478999999999999998 99999887776666655443 234455688999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||+.||++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=310.93 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEEcC---CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE-eCCEEEEEEEc
Q 013487 19 RTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA-SKTKIYIVLEF 94 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 94 (442)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999999753 34579999875422 2334567889999999999999999999765 45668999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC--Cc
Q 013487 95 IDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--GL 171 (442)
Q Consensus 95 ~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~ 171 (442)
+.+|+|.+++.... .++...+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99999999997643 4677888899999999999999999999999999999999999999999998744321110 11
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 249 (442)
.....+++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+.......+.... ...+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233467789999998876664 89999999999999999 577787776666665555443 34455678999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 013487 250 ILDPNPDTRMTISQMLED 267 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~h 267 (442)
||..+|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=309.77 Aligned_cols=242 Identities=26% Similarity=0.477 Sum_probs=204.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999864 77889999986432 235678999999999999999999998654 5799
Q ss_pred EEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||+.+|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997654 4789999999999999999999999999999999999999999999999998643221
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 246 (442)
......+..|+|||.+.+..+ +.++|+||+|+++|+|++ |.+||...+.......+..+. ...+..++..+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 122334678999999877665 488999999999999997 999998887776666655442 23345578999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||+.+|++|||++++++
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=313.61 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=205.4
Q ss_pred eEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-----
Q 013487 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----- 86 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 86 (442)
|.+.+.||+|+||.||+|.+. .++..||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 357889999986543 23334677889999999999999999999885432
Q ss_pred -EEEEEEEccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 87 -KIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 87 -~~~lv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
..+++++|+.+|+|.+++... ..++...+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347889999999998887532 2478899999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 237 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (442)
+................+++.|++||.+.+..+. .++||||||+++|+|++ |.+||...+....+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754321111111233456789999998877664 78999999999999999 89999887777666665544 344556
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.++..+.+++.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=313.67 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=199.4
Q ss_pred cCeEEEeeecccCceEEEEEE----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CC
Q 013487 13 GKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KT 86 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 86 (442)
.+|++.+.||+|+||.||.|. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999998 44678899999986542 2345678899999999999999999998643 35
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.++++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999876533
Q ss_pred cccCCcc-ccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH----------------HHHHH
Q 013487 166 VREDGLL-HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----------------LYRKI 228 (442)
Q Consensus 166 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----------------~~~~i 228 (442)
....... ....++..|+|||++.+..+ +.++||||+|+++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 2111011 11223456999999987666 489999999999999999887764332110 11111
Q ss_pred hh-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 229 CR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 229 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.. ..++.+..++.++.+|+.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 123344567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.55 Aligned_cols=236 Identities=20% Similarity=0.264 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCC----------CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 19 RTLGEGSFAKVKFAKNVETG----------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998776 3578887654421 14678899999999999999999999887 778
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-------ceEEeeccch
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-------VLKISDFGLS 160 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-------~~kl~DFGla 160 (442)
++||||+++|+|.+++...+ .++...+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999887 7999999998
Q ss_pred hhhhhcccCCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCCCCCCCC
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFSCPSW 238 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 238 (442)
..... .....++..|+|||++.+. ...+.++||||+|+++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75432 1234567889999998776 344589999999999999999 688887765333222222 22222222
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
....+.+++.+||..||.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3488999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=310.42 Aligned_cols=263 Identities=26% Similarity=0.438 Sum_probs=215.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (442)
.+++|+-...||+|.||.|++|+.+.+|+.||+|++-.++ .+...-....+|+.+|..|+|+|++.+++++.+
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 4568888999999999999999999999999999775432 122234556799999999999999999987743
Q ss_pred --CCEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
...+|+|+++|+. +|+-.+... .+++..++.++++++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+|+
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 3458999999987 898888776 579999999999999999999999999999999999999999999999999997
Q ss_pred hhhhccc--CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh--CCCC---
Q 013487 162 ISQQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFS--- 234 (442)
Q Consensus 162 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~--- 234 (442)
.+..... ........-|.+|++||.+.|...++++.|||..|||+.+|+++.+-+.+.+.......|.. +.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6543221 11233445699999999999988888999999999999999999999988876655443321 1110
Q ss_pred -----------------CCCC-------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 235 -----------------CPSW-------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 235 -----------------~~~~-------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
.|.. -++++.+|+.+||..||.+|++++++++|.||.+...
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 1110 1457899999999999999999999999999987543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=308.99 Aligned_cols=250 Identities=28% Similarity=0.543 Sum_probs=209.3
Q ss_pred CeEEEeeecccCceEEEEEEEcC-CCCEEEEEEecchhh-------hhHHHHHHHHHHHHHHhh-CCCCCcceEEEEEEe
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQV-------LRHKMVEQIKREISTMKL-IKHPNVIKIIEVMAS 84 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 84 (442)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 678999998853221 122345667788888865 799999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccc
Q 013487 85 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
.+..+++|||++|++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 6899999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC-CC-
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PS- 237 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~- 237 (442)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....... +.
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87543321 3345678999999999987665 589999999999999999999998877766666655544322 22
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+++.+.+++.+||+.||++|||+.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.98 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=214.1
Q ss_pred CeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.-+..+.||+|+||+||+|+... ....||||.++... +.+..++++||++++..++|||||++++++...+-+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45667899999999999998642 33569999987553 444678999999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEE
Q 013487 89 YIVLEFIDGGELFDKIAKHG--------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~--------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl 154 (442)
|||+|||..|||.+++.... +++..+...++.||+.|++||-++.+|||||-..|+||.++-.+||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 99999999999999997643 2778899999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD- 232 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~- 232 (442)
+||||++-.-....-.......-...|||||.+....|. .++||||+||+|||+++ |..||.+.+..+..+.+..+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 999999743222111111112235689999999988885 89999999999999998 999999999898888887775
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013487 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 265 (442)
Q Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 265 (442)
++.|..+|.++.+|+..||+.+|++|||+.||-
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 588999999999999999999999999999983
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.65 Aligned_cols=245 Identities=18% Similarity=0.287 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEEcCC--CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 19 RTLGEGSFAKVKFAKNVET--GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
+.||+|+||+||+|....+ ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999976433 2356677765432 22345678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcc
Q 013487 97 GGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (442)
Q Consensus 97 gg~L~~~i~~~~----~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 172 (442)
+|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999999997642 3567788899999999999999999999999999999999999999999987532211111112
Q ss_pred ccccCCCcccCcccccccC------CCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC------CCCCCCC
Q 013487 173 HTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD------FSCPSWF 239 (442)
Q Consensus 173 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 239 (442)
...+|++.|+|||++.... ..+.++||||||+++|+|++ |..||...+..+.+..+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457899999999975321 12478999999999999996 678998776666555543321 1223347
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
++.+.+++..|| .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=346.34 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=213.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCC-----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGD-----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.-++.+.||+|+||.||.|....... .||+|.+.+. .+.+....+.+|..+|+.++|||||++++++-+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 46778999999999999999864333 3888887654 3555678899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 89 YIVLEFIDGGELFDKIAKH-------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
++++|||.||+|..+|++. ..++..+...++.|++.|++||+++++|||||...|+|+++...+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999999886 248899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHH-HHhhCCCCCCCCC
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR-KICRADFSCPSWF 239 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~-~i~~~~~~~~~~~ 239 (442)
..........-....-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+... -...++++.|..+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C 929 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC 929 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence 3222111110000112357999999998666 589999999999999999 999999988887776 4455688999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+..+.+++..||+.+|++||++..|++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999997
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=315.83 Aligned_cols=252 Identities=30% Similarity=0.482 Sum_probs=205.9
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC--CCC----cceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPN----VIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpn----Iv~l~~~~~~ 84 (442)
..++|.++.++|+|+||+|-.+.|..++..||+|+++.- ....+..+-|+++|.++. -|+ ++.+.++|.-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 467999999999999999999999999999999998632 224566778999999994 233 7888889999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc--------------
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-------------- 148 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-------------- 148 (442)
.+++++|+|.+ |-++++++.+++ +++.+.++.+++||+.+++|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999999 559999998865 6889999999999999999999999999999999999932
Q ss_pred ------CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH
Q 013487 149 ------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM 222 (442)
Q Consensus 149 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~ 222 (442)
+..++++|||.|+.-.+.. .+...|..|+|||++.+-++. .++||||+||||+|+.+|...|...+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcH
Confidence 2368999999998644322 456789999999999999996 8999999999999999999999765433
Q ss_pred H---HHHHHhh------------------CCCCCCCC-------------------------CCHHHHHHHHHccCCCCC
Q 013487 223 A---LYRKICR------------------ADFSCPSW-------------------------FSSGAKKLIKRILDPNPD 256 (442)
Q Consensus 223 ~---~~~~i~~------------------~~~~~~~~-------------------------~s~~~~~li~~~L~~dP~ 256 (442)
+ +.+.|.. +.+..|.. -..++.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 2 3333321 11111110 013477999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 013487 257 TRMTISQMLEDEWFKKG 273 (442)
Q Consensus 257 ~R~s~~eil~hp~~~~~ 273 (442)
+|+|+.|+|.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999753
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=311.26 Aligned_cols=254 Identities=15% Similarity=0.177 Sum_probs=192.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhh--hHH-H-----HHHHHHHHHHHhhCCCCCcceE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVL--RHK-M-----VEQIKREISTMKLIKHPNVIKI 78 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~--~~~-~-----~~~~~~Ei~il~~l~hpnIv~l 78 (442)
..-++|++.+.||+|+||+||+|.+..+ +..+|+|+....... ... . ......+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999999877 667888865432210 000 0 0112233445566789999999
Q ss_pred EEEEEeCC----EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEE
Q 013487 79 IEVMASKT----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (442)
Q Consensus 79 ~~~~~~~~----~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl 154 (442)
++...... ..+++++++.. ++.+.+......++..+..++.|++.||+|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 45788888754 67777766666789999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhccc-----CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-H------
Q 013487 155 SDFGLSAISQQVRE-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-M------ 222 (442)
Q Consensus 155 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~------ 222 (442)
+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+. .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999976532111 111223479999999999988777 4899999999999999999999976532 1
Q ss_pred --HHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 223 --ALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 223 --~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+....+..+.... +..++.+.++++.|+..+|.+||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1122333333332 345889999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.52 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=203.8
Q ss_pred cCeEEEeeecccCceEEEEEEEc----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CC
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNV----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KT 86 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 86 (442)
..|++.+.||+|+||.||+|... .++..||+|++...... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56888999999999999999964 34789999998755432 346778999999999999999999999877 56
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..+++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7999999999999999997755 589999999999999999999999999999999999999999999999999876542
Q ss_pred cccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH---------------HHHHHh
Q 013487 166 VRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---------------LYRKIC 229 (442)
Q Consensus 166 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------------~~~~i~ 229 (442)
.... .......++..|+|||.+.+..+ +.++||||+|+++|+|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 01112234567999999877665 488999999999999999999986543221 111121
Q ss_pred h-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 230 R-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 230 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
. ...+.+..++.++.+|+.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 123445567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.56 Aligned_cols=242 Identities=30% Similarity=0.518 Sum_probs=198.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC------
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT------ 86 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 86 (442)
+-|...+.||+|+||.||+++++.+|+.||||.+++... ....+...+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 668889999999999999999999999999999987542 234678889999999999999999999865543
Q ss_pred EEEEEEEccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--cCC--ceEEeeccc
Q 013487 87 KIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYG--VLKISDFGL 159 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~--~~~--~~kl~DFGl 159 (442)
.-.++||||.||+|+..+... .+++|.+.+.++.++..||.|||++||+||||||.||++- ++| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 457999999999999999754 4799999999999999999999999999999999999984 334 479999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-----cHHHHHHHHh-----
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKIC----- 229 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~----- 229 (442)
|+-.+. +....+..||+.|.+||++....+++..+|.||+||++|++.||..||... +..-++..+.
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 986554 457788899999999999987666778999999999999999999999532 1112222221
Q ss_pred ---------------hCCCCCCCCCCHH----HHHHHHHccCCCCCCCC
Q 013487 230 ---------------RADFSCPSWFSSG----AKKLIKRILDPNPDTRM 259 (442)
Q Consensus 230 ---------------~~~~~~~~~~s~~----~~~li~~~L~~dP~~R~ 259 (442)
...++.|..+++. +..++..+|..||.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1223344444544 34678889999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=316.85 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=195.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-EEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-KIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lv 91 (442)
+.|.-.+.||+|+||.||+|... +|..||||.+....... ...+.+|+.++.+++|||+|+|+++|.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 46777789999999999999984 44899999876543221 344999999999999999999999999988 59999
Q ss_pred EEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~g---ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
+||++.|+|.+++.... +++.....+|+.+++.||+|||... |+||||||+|||+|++.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998766 7899999999999999999999964 999999999999999999999999999654321
Q ss_pred ccCCccccc-cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc------HHHHHHH-HhhCCC-----
Q 013487 167 REDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN------LMALYRK-ICRADF----- 233 (442)
Q Consensus 167 ~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~~~~~-i~~~~~----- 233 (442)
.....+. .||.+|+|||.+..... +.++||||+||+|.||++|+.|.+... ..+.... +..+..
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 2222233 89999999999876444 589999999999999999998887532 1111111 111111
Q ss_pred -CCC-CCCC--HH---HHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 -SCP-SWFS--SG---AKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 -~~~-~~~s--~~---~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
... ..++ .. +..+..+|++.+|.+||++.|+++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 1122 22 456788999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=312.05 Aligned_cols=267 Identities=30% Similarity=0.466 Sum_probs=223.1
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh----HHHHHHHHHHHHHHhhCCCCCcceEEEEE
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR----HKMVEQIKREISTMKLIKHPNVIKIIEVM 82 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 82 (442)
...+.-.+|-++.+||+|+|+.||+|.|....++||+|+-...+.++ ....+...+|..|.+.|.||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 44566778999999999999999999999999999999875443332 23567888999999999999999999999
Q ss_pred E-eCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEc---cCCceEEee
Q 013487 83 A-SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--GVFHRDLKPENLLLD---SYGVLKISD 156 (442)
Q Consensus 83 ~-~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~--givHrDlkp~NIll~---~~~~~kl~D 156 (442)
. +.+.+|-|+|||+|-+|.-++..+.-++|.+++.++-||+.||.||.+. -|+|-||||.|||+- ..|.+||.|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 6 4567899999999999999999999999999999999999999999987 599999999999994 568899999
Q ss_pred ccchhhhhhcccCC-----ccccccCCCcccCccccc-c--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHH-
Q 013487 157 FGLSAISQQVREDG-----LLHTACGTPNYVAPEVLN-D--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYR- 226 (442)
Q Consensus 157 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~- 226 (442)
|||+++++....+. ......||-+|++||.+. + .+..+.++||||+|||+|.++.|+.||...-.. ++++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 99999887644332 234467999999999864 2 345578999999999999999999999764332 3322
Q ss_pred -HHhh-CCCCCC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 227 -KICR-ADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 227 -~i~~-~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.|.+ .+..+| +.++++++++|++||+.--+.|..+.++-.||||...
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 2332 344444 5589999999999999999999999999999999753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.11 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=181.0
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCC----CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEE--
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVET----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEV-- 81 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-- 81 (442)
.....++|++.+.||+|+||.||+|++..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 344678999999999999999999999988 899999987643211 111111 1122222222222211
Q ss_pred ----EEeCCEEEEEEEccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013487 82 ----MASKTKIYIVLEFIDGGELFDKIAKHGR--------------------LKEDEARRYFQQLINAVDYCHSRGVFHR 137 (442)
Q Consensus 82 ----~~~~~~~~lv~E~~~gg~L~~~i~~~~~--------------------l~~~~~~~~~~ql~~aL~~lH~~givHr 137 (442)
......+++|+||+.+++|.+++..... ..+..+..++.||+.||+|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2355679999999999999999875431 1234567899999999999999999999
Q ss_pred cCCCCcEEEcc-CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCC---------------------CCC
Q 013487 138 DLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY---------------------DGR 195 (442)
Q Consensus 138 Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------~~~ 195 (442)
||||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+....+ .+.
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999999985 689999999999754322 1223346789999999997643221 124
Q ss_pred cccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC---------------------CCCCCCHHHHHHHHHccCCC
Q 013487 196 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS---------------------CPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 196 ~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~~s~~~~~li~~~L~~d 254 (442)
++||||+||+||+|+++..|++... ......+...... .....+....+||.+||+.|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 5699999999999999877765321 1111111111111 00111334568999999999
Q ss_pred CCCCCCHHHHhcCcccccC
Q 013487 255 PDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 255 P~~R~s~~eil~hp~~~~~ 273 (442)
|.+|||+.++|+||||+..
T Consensus 438 P~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 438 GRQRISAKAALAHPYFDRE 456 (566)
T ss_pred cccCCCHHHHhCCcCcCCC
Confidence 9999999999999999764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.85 Aligned_cols=250 Identities=26% Similarity=0.495 Sum_probs=204.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCC--E
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT--K 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 87 (442)
..++|++.+.+|+|.++.|+.|++..+++.++||++..-+ .+.+++|+.||..|. ||||++++++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 5678999999999999999999999999999999986432 367899999999997 999999999987654 4
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~ 166 (442)
..+++||+...+..... +.++...++.|+.+|+.||+|||+.||.|||+||.|++||. .-.++|+|+|+|..+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999886654443 45888999999999999999999999999999999999994 568999999999877543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHH-------------hhCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKI-------------CRAD 232 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i-------------~~~~ 232 (442)
. ...-...+..|--||.+..-+.+..+-|+||+||+|..|+..+-||.. .+..+..-+| .+..
T Consensus 187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2 234456788999999998877777999999999999999999999843 2222221111 1111
Q ss_pred -------------CCCCCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 -------------FSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 -------------~~~~~~-----------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+..+| .++++.+|+.++|..|-.+|+|+.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 111112 4799999999999999999999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.73 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=214.8
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-- 85 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 85 (442)
..+...+|.-++.+|.|+- .|..|.|..++++||+|.+..+.. .....++..+|..++..++|+||++++.+|.-.
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 4566678999999999999 888999999999999999877633 233467788999999999999999999998543
Q ss_pred ----CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 86 ----TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 86 ----~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
...|+|||++.. +|...+. -.++.+.+..++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 358999999976 8988887 347888999999999999999999999999999999999999999999999997
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC----------
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 231 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 231 (442)
..+. +-.+..+..|..|.|||++.+.+| ...+||||+||++.+|++|..-|.+.+..+.+.++...
T Consensus 167 ~e~~---~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 167 TEDT---DFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred ccCc---ccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 5432 234566788999999999999996 48999999999999999999999887765554443210
Q ss_pred -----------------CCC----CCCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 -----------------DFS----CPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 -----------------~~~----~~~~-----------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+. +|.+ -+..+++|+.+||..||++|.|++++|+|||++-++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 011 1111 134588999999999999999999999999998554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.33 Aligned_cols=240 Identities=46% Similarity=0.825 Sum_probs=208.1
Q ss_pred CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCChHHHH
Q 013487 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI 104 (442)
Q Consensus 25 ~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 104 (442)
+||.||+|.+..+++.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976543221 578889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCc
Q 013487 105 AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184 (442)
Q Consensus 105 ~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 184 (442)
.....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 887779999999999999999999999999999999999999999999999999987654321 33456789999999
Q ss_pred ccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhhCCCCCCCC---CCHHHHHHHHHccCCCCCCCCC
Q 013487 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFSCPSW---FSSGAKKLIKRILDPNPDTRMT 260 (442)
Q Consensus 185 E~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dP~~R~s 260 (442)
|.+.+..+. .++|+||+|+++++|++|..||.. .+.................. ++.++.+++.+||..||++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999876665 699999999999999999999987 55555555555444433322 7899999999999999999999
Q ss_pred HHHHhcCccc
Q 013487 261 ISQMLEDEWF 270 (442)
Q Consensus 261 ~~eil~hp~~ 270 (442)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.32 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=222.0
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe--
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS-- 84 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-- 84 (442)
..-.-+.|+|..+||.|.+|+||++.++++++..|+|+.+...- .-+.+..|.+||+.+ .|||++.+|++|.-
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34456789999999999999999999999999999999876532 236688899999988 59999999999853
Q ss_pred ---CCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 85 ---KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 85 ---~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
.+.+|+|||||.||+..|+++.- .++.|+.+..+++.++.||.+||.+.++|||||-.|||++++|.+|++|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 56899999999999999998764 5689999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCccccccc-----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS 234 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (442)
+...... -+.-.+..|||.|||||++... .|+ ..+|+||||++..||..|.+|+.+..+...+-.|.++..+
T Consensus 170 SaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP 246 (953)
T KOG0587|consen 170 SAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 246 (953)
T ss_pred eeeeecc--cccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence 8755432 2334677899999999998643 344 6899999999999999999999988887766666655432
Q ss_pred ---CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 235 ---CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 235 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.|..++.++.++|..||.+|-.+||+..++|+|||.+.
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 24558999999999999999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=311.21 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=190.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEc----------------CCCCEEEEEEecchhhhh-HH----------HHHHHH
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNV----------------ETGDFVAIKIVDRDQVLR-HK----------MVEQIK 61 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~----------------~~~~~vaiK~i~~~~~~~-~~----------~~~~~~ 61 (442)
+...++|++.+.||+|+||+||+|.+. ..++.||||.+....... .+ ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456779999999999999999999752 344679999986432110 00 112233
Q ss_pred HHHHHHhhCCCCCc-----ceEEEEEEe--------CCEEEEEEEccCCCChHHHHHhcC--------------------
Q 013487 62 REISTMKLIKHPNV-----IKIIEVMAS--------KTKIYIVLEFIDGGELFDKIAKHG-------------------- 108 (442)
Q Consensus 62 ~Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~~~-------------------- 108 (442)
.|+.++.+++|.++ +++++++.. .+..|+|+||+++|+|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777777766544 666666642 356899999999999999886421
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCc
Q 013487 109 ----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184 (442)
Q Consensus 109 ----~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 184 (442)
.++...++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....... ........+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 23556788999999999999999999999999999999999999999999986543211 1111123358999999
Q ss_pred ccccccC--------------------CC-CCcccHhHHHHHHHHHhcCCC-CCCCCcHH-----------HHHHHHhhC
Q 013487 185 EVLNDKG--------------------YD-GRASDVWSCGVILFVLMAGFL-PFDESNLM-----------ALYRKICRA 231 (442)
Q Consensus 185 E~~~~~~--------------------~~-~~~~DiwSlGvil~~ll~g~~-Pf~~~~~~-----------~~~~~i~~~ 231 (442)
|++.... |. ..+.|+||+||++|+|++|.+ ||...... ..++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9975422 11 134799999999999999986 77542211 111222223
Q ss_pred CCCCC--CCCCHHHHHHHHHccCCCC---CCCCCHHHHhcCccccc
Q 013487 232 DFSCP--SWFSSGAKKLIKRILDPNP---DTRMTISQMLEDEWFKK 272 (442)
Q Consensus 232 ~~~~~--~~~s~~~~~li~~~L~~dP---~~R~s~~eil~hp~~~~ 272 (442)
.+.++ ...++.+.+|+.+||..+| .+|+|++|+|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33333 3478999999999999866 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.50 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=211.7
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC------CCCcceEEEE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK------HPNVIKIIEV 81 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~ 81 (442)
....-++|.+....|+|-|++|..|.+..-|+.||||+|....+ +.+.=.+|++||++|+ --|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 34455689999999999999999999999999999999976543 2344458999999995 3589999999
Q ss_pred EEeCCEEEEEEEccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-CceEEeec
Q 013487 82 MASKTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDF 157 (442)
Q Consensus 82 ~~~~~~~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DF 157 (442)
|...+++|||+|...- .|.+.+.+.| +|....++.|++||+.||..|..+||+|.||||+|||+++. ..+|||||
T Consensus 503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 9999999999999864 9999998866 58899999999999999999999999999999999999965 46899999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 237 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (442)
|.|..... +.+..+.-+..|.|||++.|.+|+ ...|+||+||+||||.||+..|.+.+..+++.....-.-.+|.
T Consensus 582 GSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99875433 233445567789999999999997 8999999999999999999999998877665433211111110
Q ss_pred C-----------------------------------------------------C-------CHHHHHHHHHccCCCCCC
Q 013487 238 W-----------------------------------------------------F-------SSGAKKLIKRILDPNPDT 257 (442)
Q Consensus 238 ~-----------------------------------------------------~-------s~~~~~li~~~L~~dP~~ 257 (442)
. + -..+.+||.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 1 135779999999999999
Q ss_pred CCCHHHHhcCccccc
Q 013487 258 RMTISQMLEDEWFKK 272 (442)
Q Consensus 258 R~s~~eil~hp~~~~ 272 (442)
|.|+.|+|.||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=291.00 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=212.8
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-----EE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----KI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 88 (442)
+.+-.+.||-|+||.||.+.|..+|+.||+|.+..-. .+-...+.+.+|+++|...+|.|++..+++.+-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4556789999999999999999999999999875321 22234678889999999999999999999886554 46
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++.|++.. +|...|.....++.+.+.-+..||+.||+|||+.||.||||||.|+|++.|..+||||||+|+..+...
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~- 210 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD- 210 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-
Confidence 889999976 999999998999999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHh-------------------
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC------------------- 229 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~------------------- 229 (442)
...+....-|.+|+|||++.|...++.++||||+|||+.||+..+..|...++.+..+.|.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 2334455678999999999998878899999999999999999999997766554443331
Q ss_pred ----hCCCCCCCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 230 ----RADFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 230 ----~~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++....|.. -..+...++..+|..||++|++.++.+.|++...+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 222222211 23467899999999999999999999999998653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.36 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=203.6
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHh-hCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
-+..||.|+||+|++..++.+|+..|+|.|+.... +....++..|..... .-+.||||++|+....++.+|+.||+|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 35679999999999999999999999999987654 333567778887654 447999999999999999999999999
Q ss_pred CCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 96 DGGELFDKI-----AKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 96 ~gg~L~~~i-----~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+- +|..+- ..+..++|...-.+....+.||+||... .|+|||+||+|||+|..|.+||||||.+......
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--- 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--- 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH---
Confidence 64 443221 2345799999999999999999999876 8999999999999999999999999998754331
Q ss_pred CccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhhCCCCC---CC---CCC
Q 013487 170 GLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRADFSC---PS---WFS 240 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~---~~---~~s 240 (442)
-....-.|..+|+|||-+.. .+|+ -++|+||||++|||+.||..|+..-+ ..+...++..+.++. +. .++
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 11233568999999999853 4565 89999999999999999999998744 334445555555432 22 278
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+..+|.-||.+|-..||+..+++++||++..
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 999999999999999999999999999999853
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.69 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=208.9
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEcC--CCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVE--TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~--~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 80 (442)
++..+..-+...+.+.||.|-||.||.|+... .|+ .||||..+.+. ..+..+.+..|..+|+.++||||+++++
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 33334444445556789999999999999753 233 58999876543 2334788999999999999999999999
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
++.+ .-.|+|||+++-|+|..+++.+. .++......|+.||..||.|||+...|||||-..|||+.....+||+|||+
T Consensus 459 v~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 459 VCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 9965 56899999999999999998765 689999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccC--CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCC
Q 013487 160 SAISQQVREDGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSC 235 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~ 235 (442)
++..... ...+...| ..-|||||-+.-..+. .++|||-|||++||++. |..||.+....+..-.+-++ ++++
T Consensus 538 SR~~ed~---~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 538 SRYLEDD---AYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC 613 (974)
T ss_pred hhhcccc---chhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC
Confidence 9865432 22222233 3459999999877764 89999999999999876 99999887655555445444 6799
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013487 236 PSWFSSGAKKLIKRILDPNPDTRMTISQML 265 (442)
Q Consensus 236 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil 265 (442)
|+.+++.+..|+.+||+.+|.+||.+.+|.
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 999999999999999999999999987654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.24 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=217.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcC-CCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
++..+.+.||+|+||.|++|.+.. +|+ .||||++....... ....+.+|+.+|.+|+|||+++||++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 356678899999999999999873 444 59999997665432 57889999999999999999999999887 6788
Q ss_pred EEEEccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
||||++++|+|.+.+.+ ...|.......|+.||+.|+.||.+++.|||||-..|+|+-....+||+||||.+.+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999987 3458888999999999999999999999999999999999999999999999998665432
Q ss_pred cCCccc-cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHH
Q 013487 168 EDGLLH-TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 244 (442)
Q Consensus 168 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 244 (442)
..-.+. ...-...|+|||.+....+. .++|+|++||++|||++ |+.||.+.....+++++-.+ .++.|..+++++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 211111 11234579999999988885 89999999999999999 89999999998888888754 5688899999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+++..||..+|++|||+..|.+.-+..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999998665554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.99 Aligned_cols=204 Identities=31% Similarity=0.598 Sum_probs=186.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHH-----HHHHHHHHHHHhhCC---CCCcceEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM-----VEQIKREISTMKLIK---HPNVIKIIEV 81 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~---hpnIv~l~~~ 81 (442)
..+..|...+.||.|+||+|++|+++.+...|+||.|.|+++.-... +-.+-.||+||..|+ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 45667999999999999999999999999999999999887754322 334668999999997 9999999999
Q ss_pred EEeCCEEEEEEEcc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 82 MASKTKIYIVLEFI-DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 82 ~~~~~~~~lv~E~~-~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
|++.+++|++||-- +|.+||++|+.+..++|.++..+|+|++.|+++||++||+|||||-+|+.++.+|-+||+|||.|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 99999999999975 56799999999999999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCC
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 217 (442)
... .+++.....||..|.|||++.|.+|-|.+-|||++|++||.+...+.||-
T Consensus 718 a~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 754 35677889999999999999999999999999999999999999888873
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=292.37 Aligned_cols=130 Identities=29% Similarity=0.537 Sum_probs=115.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-----C---CCcceEEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----H---PNVIKIIEVMA 83 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~ 83 (442)
-++|.+.++||.|.|++||+|.|..+.+.||+|+++..+ ...+....||.+|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 379999999999999999999999999999999987543 35677889999999984 3 36999999996
Q ss_pred e----CCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEE
Q 013487 84 S----KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLL 146 (442)
Q Consensus 84 ~----~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll 146 (442)
. ..+++||+|+. |..|..+|... .+++...++.+++|++.||.|||.. ||+|.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 4 45899999999 66999999875 4799999999999999999999986 99999999999999
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.86 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=205.6
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+..+++.||+|-||.|.+++- ..+..||+|.++.... ......+.+||++|.+|+||||+++++++..++.+++++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 456789999999999999997 3468999999976543 3346889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 94 FIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|++.|+|.+++..+.. .......+++.||++|++||.+.++|||||.+.|+|+|.++++||+|||+++-.-.......
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999998843 34556677999999999999999999999999999999999999999999974322111111
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHh--cCCCCCCCCcHHHHHHHHhh--------CCCCCCCCCCH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM--AGFLPFDESNLMALYRKICR--------ADFSCPSWFSS 241 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll--~g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~ 241 (442)
-....-...|||||.+.-.++. .++|+|++|+++||++ +.+.||...+..+..+.... ..+..|+-++.
T Consensus 696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 1112235689999998877775 8999999999999976 47899988777666554322 12355677899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+.+|+-+||..|-.+|||++++-.
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHHHH
Confidence 9999999999999999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.08 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=219.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..-.|.+.||.|.||.|++|+.+..|+ .||||.++... .++....+..|..||-+.+||||++|.++.....-+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345788999999999999999987764 69999986543 3445678999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||.|||++|+|..++..+ +.|..-+...+++.|+.|++||-+.|+|||||-..|||++.+-.+|++||||++......
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 999999999999998764 678989999999999999999999999999999999999999999999999999775433
Q ss_pred CCccccccC--CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHH
Q 013487 169 DGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 244 (442)
Q Consensus 169 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 244 (442)
.....+.-| ...|.|||.+....+. .++||||+||++||.++ |+.||-+.+..+..+.|..+ .++.|..++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 222333333 3579999999888875 89999999999999776 99999998888888887665 6777888999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcC
Q 013487 245 KLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~h 267 (442)
+|+..||++|-.+||.+.||+.+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=291.10 Aligned_cols=242 Identities=26% Similarity=0.450 Sum_probs=211.0
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
...+.||-|.||.||.|++++-.-.||+|.++.+.. .++.+..|..+|+.++|||+|+|+++|..+.-+|||.|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345789999999999999999999999999865542 3677889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 96 DGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 96 ~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
..|.|.+++.+-.+ ++.-....++.||.+|++||..++++||||-..|+|+.++..+|++||||++++.... ..
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT----YT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT----YT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc----ee
Confidence 99999999987543 6667788889999999999999999999999999999999999999999999865421 12
Q ss_pred cccC---CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 013487 174 TACG---TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 174 ~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 248 (442)
...| ..-|.|||-+....+. .++|||+|||+|||+.| |-.||.+-+.-+.|..+-++ ...-|..+++...+|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2222 4569999999877775 89999999999999998 89999999988888766554 56778899999999999
Q ss_pred HccCCCCCCCCCHHHHhc
Q 013487 249 RILDPNPDTRMTISQMLE 266 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~ 266 (442)
.||+++|..||+++||-+
T Consensus 501 aCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHhcCCcccCccHHHHHH
Confidence 999999999999998743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.59 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=223.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-.+|++...+|.|++|.||+|+|+.+++..|+|+++... .....-+..|+-+++.++||||+.+++.|-.....|+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 458999999999999999999999999999999998654 23466788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||||.||+|.+.-.-.++++|.++....+..+.||+|||++|-+|||||-.|||+++.|.+|++|||.+...... -..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 999999999999888899999999999999999999999999999999999999999999999999987644321 112
Q ss_pred cccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC-----CCCCHHH
Q 013487 172 LHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-----SWFSSGA 243 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~ 243 (442)
-....|||+|||||+-. ..+|. ..+|||++|+...++---++|-.............+..+..| ..+++.+
T Consensus 169 rksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 34678999999999853 44564 899999999999999988888877777766666666555544 3478999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+|++.+|.++|++|||++.+|+|||...
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeecc
Confidence 99999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.19 Aligned_cols=237 Identities=21% Similarity=0.327 Sum_probs=187.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
..|...+.||+|+||.||+|++..++..||+|.+..... ....|+.++++++||||+++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 456667899999999999999999999999999864321 1235688999999999999999999999999999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH---SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH---~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999963 789999999999999999999 6699999999999999998888876 665443211
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-----HHHHHHHHh---------hCCC--
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKIC---------RADF-- 233 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~---------~~~~-- 233 (442)
.....||+.|+|||++.+..|. .++||||+||++|||++|+.||+... ......... ....
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1233688999999999887764 89999999999999999999996421 111111100 0000
Q ss_pred --CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 234 --SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 234 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..+.....++.+++.+||+.||++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000112356789999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=305.48 Aligned_cols=245 Identities=29% Similarity=0.420 Sum_probs=196.0
Q ss_pred EeeecccCceE-EEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 18 GRTLGEGSFAK-VKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 18 ~~~LG~G~fg~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
.+.+|.|+.|+ ||+|.. .|+.||||.+-.. ....+.+||..|+.- .|||||++|+.-.+....|+..|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 46789999986 899997 6789999976433 356778999999988 5999999999999999999999999
Q ss_pred CCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CC--ceEEeeccchhhhhhc
Q 013487 96 DGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YG--VLKISDFGLSAISQQV 166 (442)
Q Consensus 96 ~gg~L~~~i~~~~~----l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~--~~kl~DFGla~~~~~~ 166 (442)
.. +|.++++.++. ......+....|+++||++||+.+||||||||.||||+. ++ .++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 76 99999988521 111456888999999999999999999999999999975 34 6899999999865432
Q ss_pred cc-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhCCCCCC---CCCCH
Q 013487 167 RE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRADFSCP---SWFSS 241 (442)
Q Consensus 167 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~ 241 (442)
.. -+...+..||-+|+|||++..... ..++||+|+||++|+.++| ..||...-..+ ..|..+.+..- +.-..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH
Confidence 21 223456779999999999987655 4789999999999999985 89997654332 23444443321 11122
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.+||.+|+++||..||++.++|.||+|....
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 899999999999999999999999999998643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=277.52 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=203.4
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcC---CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 85 (442)
...+.|.++..||+|+|++||+|.+.. .++.||+|.+.... ...++.+|+++|..+. +.||+++.+.+..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 345679999999999999999999987 77899999987543 2456899999999995 99999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl~DFGla~~~~ 164 (442)
+...+||||.+..+..++... ++..+++.|++.++.||+++|.+||+||||||.|+|.+ ..+.-.|+|||+|...+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999887777654 67899999999999999999999999999999999998 46788999999997211
Q ss_pred hcc-------------------------------cCCcc-----------ccccCCCcccCcccccccCCCCCcccHhHH
Q 013487 165 QVR-------------------------------EDGLL-----------HTACGTPNYVAPEVLNDKGYDGRASDVWSC 202 (442)
Q Consensus 165 ~~~-------------------------------~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 202 (442)
... +.+.. ....|||+|+|||++...+-.++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 100 00000 112499999999999988888899999999
Q ss_pred HHHHHHHhcCCCCCCCCcH-----HHH---------HH------H--Hhh-C-------------C------CC--C---
Q 013487 203 GVILFVLMAGFLPFDESNL-----MAL---------YR------K--ICR-A-------------D------FS--C--- 235 (442)
Q Consensus 203 Gvil~~ll~g~~Pf~~~~~-----~~~---------~~------~--i~~-~-------------~------~~--~--- 235 (442)
|||+..++++..||..... .++ .+ . ++. . . .+ .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999943211 000 00 0 000 0 0 00 0
Q ss_pred -----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 236 -----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 236 -----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0114568899999999999999999999999999973
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.47 Aligned_cols=247 Identities=27% Similarity=0.474 Sum_probs=206.1
Q ss_pred EEEeeecccCceEEEEEEEc---CC----CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 16 ELGRTLGEGSFAKVKFAKNV---ET----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~---~~----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
.+.+.||+|+||.|++|.-. .. ...||+|....... ....+.+..|+.+|+.+ +||||+.+++.+...+.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 45669999999999999843 11 34699998865432 24578899999999999 59999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc
Q 013487 88 IYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 151 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~ 151 (442)
.++|+||+..|+|.+++.... .++..+...++.||+.|++||++..++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998866 3888999999999999999999999999999999999999999
Q ss_pred eEEeeccchhhhhhcccCCccccccCCC--cccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCc-HHHHHHH
Q 013487 152 LKISDFGLSAISQQVREDGLLHTACGTP--NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN-LMALYRK 227 (442)
Q Consensus 152 ~kl~DFGla~~~~~~~~~~~~~~~~gt~--~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~-~~~~~~~ 227 (442)
+||+|||+|+........ ......|+. .|||||.+....| +.++||||+||+|||+++ |..||.+.. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 999999999843321111 111122223 4999999998666 489999999999999998 899998854 5566665
Q ss_pred HhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 228 ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 228 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+..+ ....|..+++++.++++.||+.+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6655 45788899999999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=288.02 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=210.9
Q ss_pred EEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+..++||+|+||+||+|.+--.|+ +||||++...... +....+.+|+-+|.+|.|||++++++++.... +.+|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345799999999999999864454 6899988765433 23567889999999999999999999997765 7899
Q ss_pred EEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
++|+++|.|.|+++.+. .+.......|..||++||.|||.++++||||-..|+|+.+-..+||.|||+|.........-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 99999999999998764 68899999999999999999999999999999999999999999999999999876644332
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 248 (442)
......-.+.|+|-|.+....|. .++||||+||.+||++| |..|+++....++-..+..+ +++.|+.++.++.-++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22223345679999998887774 89999999999999998 99999998887776665554 57889999999999999
Q ss_pred HccCCCCCCCCCHHHHhc
Q 013487 249 RILDPNPDTRMTISQMLE 266 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~ 266 (442)
+||..|+..||+++++..
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999988754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=257.86 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=201.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEE-EEeCCEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV-MASKTKI 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~~ 88 (442)
..+.|.|.+.||+|.||++.+|+++.+++.+++|.+.++.. ..+.+.+|..---.| .|.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45679999999999999999999999999999999987653 356788888766666 48999998875 6778888
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--cCCceEEeeccchhhhhhc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~--~~~~~kl~DFGla~~~~~~ 166 (442)
+++|||++.|+|.+-+.. .++.|....+++.|+++|++|||+.++||||||.+||||- +.-.+||||||+.+..
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--- 173 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--- 173 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc---
Confidence 999999999999998877 5689999999999999999999999999999999999994 3448999999987632
Q ss_pred ccCCccccccCCCcccCcccccccC---C-CCCcccHhHHHHHHHHHhcCCCCCCCCcHH----HHHHHHhhC-CCCCCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKG---Y-DGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRA-DFSCPS 237 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~-~~~~~~ 237 (442)
+......--+..|.|||++.... + ..+.+|+|.||+++|.+|+|.+||...... ..+.++..+ ....|.
T Consensus 174 --g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 --GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred --CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 22333344577899999875322 1 136789999999999999999999743321 223333333 223343
Q ss_pred ---CCCHHHHHHHHHccCCCCCCC---CCHHHHhcCcccccCC
Q 013487 238 ---WFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKKGY 274 (442)
Q Consensus 238 ---~~s~~~~~li~~~L~~dP~~R---~s~~eil~hp~~~~~~ 274 (442)
.+|+.+..+.++-|.++|++| .++.......|.....
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 379999999999999999999 5566666677776543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=271.13 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=195.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhh--CCCCCcceEEEEEEeCC--
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMASKT-- 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~-- 86 (442)
.+..-++.+.||+|.||.||+|+. +++.||||++.... .+.+.+|-.|.+. ++|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 345677889999999999999997 56999999986543 4566777777664 47999999998865544
Q ss_pred --EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEEccCCceEEe
Q 013487 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---------GVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 87 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~---------givHrDlkp~NIll~~~~~~kl~ 155 (442)
.+++|++|.+.|+|.+++..+ .++.....+++.-++.||+|||+- .|+|||||..|||+.++++.-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 799999999999999999885 589999999999999999999973 59999999999999999999999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCC-----CCcccHhHHHHHHHHHhcC------------CCCCC-
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG------------FLPFD- 217 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlGvil~~ll~g------------~~Pf~- 217 (442)
|||||..+......+......||..|||||++.+.-.- -...||||+|.+||||++. ++||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999988876666666778999999999999764221 1358999999999999874 23443
Q ss_pred ----CCcHHHHHHHHhh--CCCCCCCC-----CCHHHHHHHHHccCCCCCCCCCHHH
Q 013487 218 ----ESNLMALYRKICR--ADFSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQ 263 (442)
Q Consensus 218 ----~~~~~~~~~~i~~--~~~~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~e 263 (442)
.++..++.....+ .+..+|.. --..+.+.+..||+.||+.|.|+.=
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 2344444444332 34444432 2356789999999999999999753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=266.70 Aligned_cols=248 Identities=24% Similarity=0.446 Sum_probs=195.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHh--hCCCCCcceEEEEEEeC--
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK--LIKHPNVIKIIEVMASK-- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~-- 85 (442)
++..+-++.+.||+|.||.||+|.+ -|+.||||++.... .....+|.+|.. .|+|+||+.+++.-...
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 4556789999999999999999998 67899999986432 245667777776 45999999999875332
Q ss_pred --CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEccCCceEEe
Q 013487 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~--------givHrDlkp~NIll~~~~~~kl~ 155 (442)
..+|+|.+|-+.|+|+|++.. ..++.+...+++..+++||++||.. .|+|||||..|||+..+|..-|+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 368999999999999999998 6799999999999999999999964 39999999999999999999999
Q ss_pred eccchhhhhhcc--cCCccccccCCCcccCcccccccC----CCC-CcccHhHHHHHHHHHhcC----------CCCCC-
Q 013487 156 DFGLSAISQQVR--EDGLLHTACGTPNYVAPEVLNDKG----YDG-RASDVWSCGVILFVLMAG----------FLPFD- 217 (442)
Q Consensus 156 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~~~-~~~DiwSlGvil~~ll~g----------~~Pf~- 217 (442)
|+|||....... -+-.....+||..|||||++...- +.+ ..+||||+|.++||++.. ++||.
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999997654432 122445679999999999986431 111 468999999999998752 67884
Q ss_pred ----CCcHHHHHHHHhhC--CCCCCC-CCCH----HHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 218 ----ESNLMALYRKICRA--DFSCPS-WFSS----GAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 218 ----~~~~~~~~~~i~~~--~~~~~~-~~s~----~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+++.+++.+-++-. ....|. |-+. .+..|++.||..||.-|.|+--|.+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 35556666554433 334444 3333 3457899999999999999877654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=245.85 Aligned_cols=213 Identities=44% Similarity=0.801 Sum_probs=187.3
Q ss_pred ecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCCh
Q 013487 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (442)
Q Consensus 21 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 100 (442)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654221 346788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhhhhcccCCccccccCC
Q 013487 101 FDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGT 178 (442)
Q Consensus 101 ~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 178 (442)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999876 47899999999999999999999999999999999999999 89999999999875433211 12345578
Q ss_pred CcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013487 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 258 (442)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987763445889999999999999 678899999999999999
Q ss_pred CCHHHHhcCc
Q 013487 259 MTISQMLEDE 268 (442)
Q Consensus 259 ~s~~eil~hp 268 (442)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=242.29 Aligned_cols=208 Identities=25% Similarity=0.482 Sum_probs=172.1
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEEEc
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
.-+..||+|++|.|=+.++..+|...|+|.+...- . .+..+++.+|+.+..+. .+|.+|.+|+.+.....+|+.||.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34578999999999999999999999999986542 2 33456777888876554 799999999999999999999999
Q ss_pred cCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 95 IDGGELFD----KIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 95 ~~gg~L~~----~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+.. +|.. .+...+.++|...-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||.+.....
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---- 201 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---- 201 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh----
Confidence 975 5533 355667899999999999999999999998 899999999999999999999999999875532
Q ss_pred Ccccc-ccCCCcccCccccc----ccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhhC
Q 013487 170 GLLHT-ACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRA 231 (442)
Q Consensus 170 ~~~~~-~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~ 231 (442)
+...+ ..|...|+|||.+. ..+|+ -++||||||+.++||.+++.||+. .++.+.+.++...
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 33334 56889999999874 33565 899999999999999999999975 4555666666554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=248.04 Aligned_cols=218 Identities=44% Similarity=0.744 Sum_probs=186.6
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|.+.+.||+|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999988999999999865432 2467888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~-l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
+.+++|.+++..... +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 999999999988776 89999999999999999999999999999999999999999999999999876543221 1234
Q ss_pred cccCCCcccCcccc-cccCCCCCcccHhHHHHHHHHHhcCCCCCCC--CcHHHHHHHHhhCCCCCC
Q 013487 174 TACGTPNYVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPFDE--SNLMALYRKICRADFSCP 236 (442)
Q Consensus 174 ~~~gt~~y~aPE~~-~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~ 236 (442)
...++..|++||.+ ....+. .++|+||||+++++|++|..||.. .+...+.+.+..+.....
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW 222 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence 56788899999998 444554 689999999999999999999977 444466667766654433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=292.78 Aligned_cols=262 Identities=32% Similarity=0.520 Sum_probs=213.0
Q ss_pred ccCe-EEEeeecccCceEEEEEEEcCCCCEEEEEEecch---hhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 12 VGKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD---QVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 12 ~~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
..+| ...+.+|.|++|.|+.+........++.|..... ..........+..|..+-..++|||++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3446 4578899999999998888777776777655421 11122233347788888999999999887777766666
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.+-.||||++ +|+..+...+.+...++..+++||+.||+|||+.||.|||+||+|++++.+|.+||+|||.+..+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999998899999999999999999999999999999999999999999999999999999887766
Q ss_pred cC--CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH--HHHhhCC-------CCCC
Q 013487 168 ED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY--RKICRAD-------FSCP 236 (442)
Q Consensus 168 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~--~~i~~~~-------~~~~ 236 (442)
.. ......+|+.+|+|||++.+..|++...||||+|++++.|.+|+.||......+.. ....... ...-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 65 45667899999999999999999999999999999999999999999765433221 1111111 1111
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
..++...+.+|.+||++||.+|+|+++|++++||+.-.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 23678889999999999999999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=292.00 Aligned_cols=199 Identities=21% Similarity=0.281 Sum_probs=146.2
Q ss_pred CCC-CCcceEEEEE-------EeCCEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013487 70 IKH-PNVIKIIEVM-------ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140 (442)
Q Consensus 70 l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlk 140 (442)
++| +||+++++++ .....++++||++ +++|.+++.. ...+++.++..++.||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777776 2334677889987 5599999975 3469999999999999999999999999999999
Q ss_pred CCcEEEccC-------------------CceEEeeccchhhhhhccc----------C----CccccccCCCcccCcccc
Q 013487 141 PENLLLDSY-------------------GVLKISDFGLSAISQQVRE----------D----GLLHTACGTPNYVAPEVL 187 (442)
Q Consensus 141 p~NIll~~~-------------------~~~kl~DFGla~~~~~~~~----------~----~~~~~~~gt~~y~aPE~~ 187 (442)
|+|||++.. +.+|++|||+++....... . ......+||+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4456666666543211000 0 001124689999999999
Q ss_pred cccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 188 ~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+..| +.++|||||||+||||++|.+|+..... ....+.....+ .+....+...+++.+||.+||.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88887 5899999999999999999998764321 11112111111 11112456778999999999999999999999
Q ss_pred Cccccc
Q 013487 267 DEWFKK 272 (442)
Q Consensus 267 hp~~~~ 272 (442)
||||..
T Consensus 265 h~~~~~ 270 (793)
T PLN00181 265 SEFINE 270 (793)
T ss_pred chhhhh
Confidence 999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=238.08 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=206.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC-----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CC
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD-----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KT 86 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 86 (442)
.|+++.-.+-+|+||.||.|.++.... .|-+|.+... .++-....+..|...+..+.|||++.+.++... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 467788889999999999997764332 3445554322 233356778889999999999999999998754 45
Q ss_pred EEEEEEEccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 87 KIYIVLEFIDGGELFDKIAKH--------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~--------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
..++++.+..-|.|..++..- +.++..+...++.|++.|++|||++||+|.||-..|++||+.-.+||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 677888888889999988721 236677888899999999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCC
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCP 236 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~ 236 (442)
+++...+......-........||+||.+....|. .++|+|||||+||||+| |+.|+.+-++.++..-+..+ ++..|
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 98865544333222333356689999999998886 89999999999999998 99999999999888877766 56788
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
-.+++++..++..||..+|++||+.+|+..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 889999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=229.71 Aligned_cols=256 Identities=36% Similarity=0.650 Sum_probs=213.9
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC-CcceEEEEEEeCCEEEEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP-NVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E 93 (442)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999997 78999999876544434577899999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhhcccC
Q 013487 94 FIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVRED 169 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~---~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 169 (442)
++.++++.+.+.... .+++..+..++.|++.+++|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887765 799999999999999999999999999999999999999988 7999999998754432221
Q ss_pred C----ccccccCCCcccCccccccc--CCCCCcccHhHHHHHHHHHhcCCCCCCCCcH----HHHHHHHhhCCCC-CCCC
Q 013487 170 G----LLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFS-CPSW 238 (442)
Q Consensus 170 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 238 (442)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999874 4556899999999999999999999887653 4444444444433 2222
Q ss_pred CC--------HHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 239 FS--------SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 239 ~s--------~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 478999999999999999999999998776643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=224.01 Aligned_cols=158 Identities=22% Similarity=0.293 Sum_probs=128.8
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccccc
Q 013487 98 GELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (442)
Q Consensus 98 g~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 176 (442)
|+|.+++... .+++++.++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 6899999874 46999999999999999999999999 999999999999999 9998754321 236
Q ss_pred CCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCC-------CCCCCCH--HHHHH
Q 013487 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFS-------CPSWFSS--GAKKL 246 (442)
Q Consensus 177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~--~~~~l 246 (442)
||+.|+|||++.+..|. .++||||+||++|+|++|..||...... .....+...... .+..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999888775 8999999999999999999999765432 233333222111 1112333 69999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccc
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=256.37 Aligned_cols=239 Identities=32% Similarity=0.613 Sum_probs=210.6
Q ss_pred eecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEEEEcc
Q 013487 20 TLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
++|+|+||+|++++.. ..+..+|+|+..+....... ...-..|..++..++ ||.+++++..++++...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999987643 56778999998876644332 225667888888886 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccc
Q 013487 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (442)
Q Consensus 96 ~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 175 (442)
.||+|+..+.....+.+.....+...++.+++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 999999999999999999999999999999999999999999999999999999999999999987643321 22
Q ss_pred cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCC
Q 013487 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP 255 (442)
|||..|||||++. ++. ..+|.||+|++.|+|++|..||.. +....|.+..+..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 333 789999999999999999999988 667778888999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q 013487 256 DTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 256 ~~R~s-----~~eil~hp~~~~ 272 (442)
.+|.- +.++++|++|+.
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 99986 579999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=237.31 Aligned_cols=169 Identities=20% Similarity=0.224 Sum_probs=134.6
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcC-CCCEEEEEEecchhh--hhHHHHHHHHHHHHHHhhCCCCCcce-EEEEEEeC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIK-IIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~~ 85 (442)
...++|++.+.||+|+||+||+|++.. +++.||||++..... ......+.+.+|+.+|+.++|+||+. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 566789999999999999999999876 778889998753211 12234567899999999999999985 4432
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL-KPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDl-kp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+..|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+...
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45799999999999963 211 11 1568899999999999999999999 9999999999999999999998665
Q ss_pred hcccCCc------cccccCCCcccCcccccc
Q 013487 165 QVREDGL------LHTACGTPNYVAPEVLND 189 (442)
Q Consensus 165 ~~~~~~~------~~~~~gt~~y~aPE~~~~ 189 (442)
....... +.+.++++.|+|||.+.-
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4332222 245678999999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=220.32 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=194.2
Q ss_pred CeEEEeeecccCceEEEEEEEcCCC-CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC----CCcceEEEEE-EeCCE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETG-DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH----PNVIKIIEVM-ASKTK 87 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 87 (442)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+........ ...+..|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997765 679999876543211 1257788998888862 6999999999 57888
Q ss_pred EEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-----CceEEeeccch
Q 013487 88 IYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISDFGLS 160 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-----~~~kl~DFGla 160 (442)
.|+||+.+ |.+|.+..... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 66999987544 479999999999999999999999999999999999999854 46999999999
Q ss_pred hhhhhcccCC-------c-cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH---HHHHHHh
Q 013487 161 AISQQVREDG-------L-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALYRKIC 229 (442)
Q Consensus 161 ~~~~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i~ 229 (442)
+........+ . .....||..|+++.+..+... +...|+||++.++.+|+.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8333211111 1 123459999999999988776 58999999999999999999999765532 2222222
Q ss_pred hCCCC--CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 230 RADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 230 ~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..... .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211 223346778888888888899999998777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-28 Score=253.60 Aligned_cols=410 Identities=25% Similarity=0.392 Sum_probs=290.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCC-CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVET-GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (442)
...|.+.+.||+|+|+.|-.+.+..+ ...+|.|.+.... ......+++..|..+.+.++ |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 56799999999999999999988544 4457777776553 33445677888999999997 999999999999999999
Q ss_pred EEEEccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEccCC-ceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKI-AKHG-RLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i-~~~~-~l~~~~~~~~~~ql~~aL~~lH-~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~ 165 (442)
++++|..||++++.+ ..+. ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 7766 7899999999999999999999 99999999999999999999 999999999998877
Q ss_pred -cccCCccccccC-CCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH-HHHhhC--CCCCCC--C
Q 013487 166 -VREDGLLHTACG-TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKICRA--DFSCPS--W 238 (442)
Q Consensus 166 -~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~~~--~~~~~~--~ 238 (442)
.+........|| ++.|.|||...+..|.++..|+||+|+++..+++|..||+........ ...... .+...+ .
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 666677888899 999999999999889999999999999999999999999876544322 222221 222333 3
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc-CCCCCCCC-cccccCccchhh-----------hh-cccccccccc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK-GYKPPHFD-KEEEVNLDDVDA-----------IF-NDSKENLVTE 304 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~-~~~~~~~~-~~~~~~~~~~~~-----------~~-~~~~~~~~~~ 304 (442)
++..+.+++.++|..+|..|.+++++..+||+.. ........ ......+..... .. ..........
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~ 337 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIA 337 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccCCccceeeecccCceEEE
Confidence 7899999999999999999999999999999987 11110000 000000000000 00 0000000000
Q ss_pred ccCC---------------CCCCC-hhh--hh-------ccCCCCCCccc------------hhh-hcccccccce--EE
Q 013487 305 KKEK---------------PVSMN-AFE--LI-------SRTKSFSLENL------------FEK-QTGLVKRETR--FT 344 (442)
Q Consensus 305 ~~~~---------------~~~~~-~~~--~~-------~~~~~~~~~~~------------~~~-~~~~~~~~~r--f~ 344 (442)
.... +.... -+. .+ ++++....+.+ .+. ..++....++ |.
T Consensus 338 ~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~~ 417 (601)
T KOG0590|consen 338 KRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSNGKL 417 (601)
T ss_pred EecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhccccc
Confidence 0000 00000 000 00 01111100000 000 0123345666 89
Q ss_pred eCCChhHHHHHHH---HHhcccCceEee-cCceeEEeeccCCCCcceE----EEEEEEEEeCC---eEEEEEEecCC---
Q 013487 345 SQRPPNEIMSKIE---EAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLS----VATEVFEVAPT---LHIVEVRKTGG--- 410 (442)
Q Consensus 345 s~~~~~~~~~~l~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~----~~~~i~~~~~~---~~~vdf~~~~G--- 410 (442)
+..++...++.|. +.+..+|+..+. +...+.+. .+|.|. ...+++.+..+ ...+++..+++
T Consensus 418 ~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~-----~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~a 492 (601)
T KOG0590|consen 418 TPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT-----ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLA 492 (601)
T ss_pred chhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-----cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcC
Confidence 9999999999999 777888876643 32222221 122222 36677888655 56799999999
Q ss_pred ----CchhHHHHHHHHHhccc
Q 013487 411 ----DTLEFHKFYKKFSSGLK 427 (442)
Q Consensus 411 ----d~le~~~~~~~~~~~l~ 427 (442)
++.||..++..+-..--
T Consensus 493 pE~~~~~~ydpr~vDiwS~~i 513 (601)
T KOG0590|consen 493 PEVLTGKEYDPRAVDVWSCGI 513 (601)
T ss_pred cccccccccCcchhhhhhccc
Confidence 99999999999888743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=242.90 Aligned_cols=223 Identities=30% Similarity=0.573 Sum_probs=179.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..-.+|..+++|..|++|-||+++|+.+.+.+|+| +++++..- ++ |+.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------Rn---ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------RN---ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------hc---cccccCCccee-------------
Confidence 34468999999999999999999999999999994 55544211 11 44444555555
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc-
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE- 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~- 168 (442)
|+=...++.-+.++.+. +.+++|+|+.||+|||+||+|++|+.-|++|+.|||++...-....
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 45555666666666655 7899999999999999999999999999999999999864211100
Q ss_pred -----------CC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC
Q 013487 169 -----------DG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 236 (442)
Q Consensus 169 -----------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (442)
.. .-...||||.|+||||+..++| |..+|+|++|+|+|+++-|..||.+.+.++++.+.......+|
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 00 1234599999999999999888 5999999999999999999999999999999998887766665
Q ss_pred CC---CCHHHHHHHHHccCCCCCCCC---CHHHHhcCcccccC
Q 013487 237 SW---FSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKKG 273 (442)
Q Consensus 237 ~~---~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~ 273 (442)
.. ++++++++|.++|+.+|..|. .+-++.+|+||+..
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 43 789999999999999999996 47789999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=196.94 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=195.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC-CCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 87 (442)
-...++|++++.||.|+||.+|+|....+|+.||||+-... +.. .++..|..+.+.|++ .+|..+..+..+...
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCC----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 35678999999999999999999999999999999986433 222 346689999999974 788888888888899
Q ss_pred EEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---cCCceEEeeccchhhh
Q 013487 88 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAIS 163 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~---~~~~~kl~DFGla~~~ 163 (442)
-.+|||+. |.+|.+...- ...++...+.-++-|++.-++|+|.++++||||||+|+|.. ....+.++|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 5577666543 24689999999999999999999999999999999999995 3457999999999876
Q ss_pred hhcccCC-----ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---cHHHHHHHHhhCCCCC
Q 013487 164 QQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADFSC 235 (442)
Q Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~ 235 (442)
....... .-....||..|.+--...+... +...|+-|+|.+|.++.-|.+||.+. +..+-+++|.....+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 5543322 1223468999999777766554 47889999999999999999999874 3446677777666555
Q ss_pred C-----CCCCHHHHHHHHHccCCCCCCCCCH
Q 013487 236 P-----SWFSSGAKKLIKRILDPNPDTRMTI 261 (442)
Q Consensus 236 ~-----~~~s~~~~~li~~~L~~dP~~R~s~ 261 (442)
| ..+|.++.-.+.-|-..-=++-|..
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 4 3478888888888866655666653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=199.66 Aligned_cols=242 Identities=22% Similarity=0.358 Sum_probs=190.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 91 (442)
-.|++++.||+|+||..+.|.+.-++++||||.-.+.. ..-+++.|.+..+.|. .++|...|.+..+..+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 37999999999999999999999999999999754332 2456888999999885 79999999998888888899
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-----CceEEeeccchhhhhh
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISDFGLSAISQQ 165 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-----~~~kl~DFGla~~~~~ 165 (442)
||+. |-+|.|+..-- ..|+.+.+..++.|++.-++|+|++.+|+|||||+|+||... ..+.|+|||+|+.+..
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9998 44665555433 469999999999999999999999999999999999999643 3689999999987765
Q ss_pred cccCC-----ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC---CcHHHHHHHHhhCCCCCC-
Q 013487 166 VREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSCP- 236 (442)
Q Consensus 166 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~- 236 (442)
..... .-....||..||+--...+.... ...|+-|||-+++++|-|.+||.+ .+..+-|++|-...-..|
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 43322 22345799999999888887764 889999999999999999999976 445566777754433322
Q ss_pred ----CCCCHHHHHHHHHccCCCCCCCCCH
Q 013487 237 ----SWFSSGAKKLIKRILDPNPDTRMTI 261 (442)
Q Consensus 237 ----~~~s~~~~~li~~~L~~dP~~R~s~ 261 (442)
..++.++..-++-.-..+=.+-|..
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 2356666665555544444555553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=201.49 Aligned_cols=174 Identities=13% Similarity=0.199 Sum_probs=136.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHH------HHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ------IKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
.-++|++.+.||.|+||.||++.+ ++..+|+|++.......+...+. +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999765 46689999997554434433344 6799999999999999999988664
Q ss_pred C--------CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEee
Q 013487 85 K--------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (442)
Q Consensus 85 ~--------~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~D 156 (442)
. +..+++|||++|.+|.+... +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 35789999999999987732 333 2456999999999999999999999999999988 99999
Q ss_pred ccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHh
Q 013487 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210 (442)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll 210 (442)
||........... ..+.....|. .++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 9987644221110 1134455666 7899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=197.72 Aligned_cols=143 Identities=23% Similarity=0.269 Sum_probs=114.1
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH-----------------------HHHHHHHHHHHHhhCCCCC
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----------------------MVEQIKREISTMKLIKHPN 74 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 74 (442)
...||+|+||.||+|.+. +|+.||+|+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 8999999999754211000 1133456999999998887
Q ss_pred cceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEEccCCceE
Q 013487 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~l-H~~givHrDlkp~NIll~~~~~~k 153 (442)
+.....+... ..++||||++|+++...+...+++++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544333222 2389999999988876655567899999999999999999999 799999999999999998 48899
Q ss_pred Eeeccchhhhh
Q 013487 154 ISDFGLSAISQ 164 (442)
Q Consensus 154 l~DFGla~~~~ 164 (442)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=192.09 Aligned_cols=144 Identities=22% Similarity=0.263 Sum_probs=116.0
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh----------------------h-HHHHHHHHHHHHHHhhCCCC
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL----------------------R-HKMVEQIKREISTMKLIKHP 73 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~----------------------~-~~~~~~~~~Ei~il~~l~hp 73 (442)
+.+.||+|++|.||+|.+. +|+.||||+++..... . ........+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998764210 0 01123456899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCce
Q 013487 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVL 152 (442)
Q Consensus 74 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~ 152 (442)
+|.....+.... .|+||||++|+++........++++..+..++.|++.+|.++|+ +||+||||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555444332 48999999998665543445678999999999999999999999 9999999999999999 7999
Q ss_pred EEeeccchhhhh
Q 013487 153 KISDFGLSAISQ 164 (442)
Q Consensus 153 kl~DFGla~~~~ 164 (442)
+|+|||+|+...
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=200.85 Aligned_cols=235 Identities=27% Similarity=0.351 Sum_probs=153.6
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC----------CCcceEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH----------PNVIKIIEVMA 83 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~ 83 (442)
....++.||.|+++.||.+.|..||+.+|+|+.....-......+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778999999999999999999999999999876553333457777777766555432 22333333322
Q ss_pred ---------eC---C-----EEEEEEEccCCCChHHHHH---hcCCC---CHHHH-HHHHHHHHHHHHHHHHCCceeccC
Q 013487 84 ---------SK---T-----KIYIVLEFIDGGELFDKIA---KHGRL---KEDEA-RRYFQQLINAVDYCHSRGVFHRDL 139 (442)
Q Consensus 84 ---------~~---~-----~~~lv~E~~~gg~L~~~i~---~~~~l---~~~~~-~~~~~ql~~aL~~lH~~givHrDl 139 (442)
.. + +.+++|+-+.+ +|.+.+. ..... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 23677887754 8877654 33322 12233 344599999999999999999999
Q ss_pred CCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccC-------CCCCcccHhHHHHHHHHHhcC
Q 013487 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG-------YDGRASDVWSCGVILFVLMAG 212 (442)
Q Consensus 140 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DiwSlGvil~~ll~g 212 (442)
+|+|++++.+|.++|+||+........ ......+..|.+||...... ..+.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999876533221 11134567899999875431 124788999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCC
Q 013487 213 FLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 213 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 258 (442)
..||+.......... .+.....+++..+.||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999986643321111 232223689999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=225.38 Aligned_cols=240 Identities=26% Similarity=0.396 Sum_probs=183.7
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchh-hhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQ-VLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.|...+.||++.|=+|.+|.+. .|. |++|++-++. ...-....+..+|++ ....+|||.+++.-+..+....|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7888999999999999999983 444 8899986543 112122233334555 55668999999998888888889999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh--hhhcccCC
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI--SQQVREDG 170 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~--~~~~~~~~ 170 (442)
+|... +|+|++..++.+..-+.+.++.||+.||.-||..||+|||||.+||||+.-+=+.|+||..-+. ..+.++..
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99987 9999999988899999999999999999999999999999999999999988899999976432 11112211
Q ss_pred ---ccccccCCCcccCcccccccC----------CCCCcccHhHHHHHHHHHhc-CCCCCCCCc-----------HHHHH
Q 013487 171 ---LLHTACGTPNYVAPEVLNDKG----------YDGRASDVWSCGVILFVLMA-GFLPFDESN-----------LMALY 225 (442)
Q Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~-----------~~~~~ 225 (442)
...+...-..|.|||-+.... .-+++-||||+||+++||++ |.+||.-+. .....
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL 259 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence 122223345699999876422 12467899999999999988 789985321 11112
Q ss_pred HHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 226 RKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 226 ~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++| -+..+++||..|++.||.+|.|+++.|+.
T Consensus 260 e~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 15689999999999999999999999984
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=181.86 Aligned_cols=192 Identities=14% Similarity=0.169 Sum_probs=143.1
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH-HHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-MVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 92 (442)
..+...|++|+||+|+.+.. .+.+++.+.+......... ....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999997765 6778887777654432221 1235789999999995 5889999886 4579999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEccCCceEEeeccchhhhhhcccC-C
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL-KPENLLLDSYGVLKISDFGLSAISQQVRED-G 170 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDl-kp~NIll~~~~~~kl~DFGla~~~~~~~~~-~ 170 (442)
||+.|.+|...+.. . ...++.|++.+|++||++||+|||| ||+|||++.+|.++|+|||+|......... .
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999998754321 1 2357899999999999999999999 799999999999999999999754432210 0
Q ss_pred c----------cccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCC
Q 013487 171 L----------LHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDES 219 (442)
Q Consensus 171 ~----------~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 219 (442)
. ......++.|++|+.-.-.. .+-...++++.|.-+|.++|+..|+-+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 11123688999998643221 1114578999999999999999887543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=196.46 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=181.8
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCC-----------------------------------EEEEEEecchh
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGD-----------------------------------FVAIKIVDRDQ 50 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----------------------------------~vaiK~i~~~~ 50 (442)
..++..+++|+|++.||+|..+.||.|.....|. +.|||.+-.-.
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 3567888999999999999999999987543111 24556542111
Q ss_pred h--hhHHHHHHHHHHHH------H--------Hhh--------CCCCCcceEEEEEEe----------------------
Q 013487 51 V--LRHKMVEQIKREIS------T--------MKL--------IKHPNVIKIIEVMAS---------------------- 84 (442)
Q Consensus 51 ~--~~~~~~~~~~~Ei~------i--------l~~--------l~hpnIv~l~~~~~~---------------------- 84 (442)
. .....++.+.+|.. . .+. -+|||||++..+|.+
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 1 11223333333321 0 111 259999999877632
Q ss_pred -----CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--cCC--ceEEe
Q 013487 85 -----KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYG--VLKIS 155 (442)
Q Consensus 85 -----~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~--~~~--~~kl~ 155 (442)
+..+|+||...+. +|..++-.+ ..+.....-++.|+++|+.|||.+||.|||+|.+|||+. +++ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 3468999998876 999998764 457778888999999999999999999999999999994 333 58999
Q ss_pred eccchhhhhhccc----CCccccccCCCcccCcccccccC-----CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHH
Q 013487 156 DFGLSAISQQVRE----DGLLHTACGTPNYVAPEVLNDKG-----YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR 226 (442)
Q Consensus 156 DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~ 226 (442)
|||.+-.-+..+- .+-.-..-|.-.-||||+....+ .+-.++|.|++|.+.||+++...||-......+-.
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 9998642221110 11112345778899999975432 11268999999999999999999997644332211
Q ss_pred H-Hhh-CCCCCCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCc
Q 013487 227 K-ICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDE 268 (442)
Q Consensus 227 ~-i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp 268 (442)
. ... .-...|..+++.+++|+..+|+.||.+|+| ++.+++-.
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence 1 111 234567779999999999999999999999 45566543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=188.47 Aligned_cols=245 Identities=21% Similarity=0.357 Sum_probs=196.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+..++...+..+|.+...|..|+|++. |..++.|++.-..+. ......+..|.-.|+...||||+.+++.+.++.+.
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 345556667788999999999999984 445666877654432 23345688899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCceEEe--eccchhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKIS--DFGLSAI 162 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~~kl~--DFGla~~ 162 (442)
.++..|++.|+|+..+..... .+..++.+++.+++.|++|||+.. |.---|....+++|++-+.+|+ |--++
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs-- 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS-- 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--
Confidence 999999999999999987654 577799999999999999999984 4444688899999998877664 32211
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCC--CCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh--CCCCCCCC
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSW 238 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~ 238 (442)
++. ....-+|.|++||.+..++.+ -.++|+|||+++||||.|.+.||.+-+..+.-.++.- -...+|+.
T Consensus 341 fqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippg 413 (448)
T KOG0195|consen 341 FQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPG 413 (448)
T ss_pred eec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCC
Confidence 111 112357899999999876644 3579999999999999999999998877765555433 35678999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHh
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQML 265 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil 265 (442)
++.....|++-|++.||.+||.++.|+
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999999988764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=180.50 Aligned_cols=133 Identities=20% Similarity=0.264 Sum_probs=107.9
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-----CCCCcceEEEEEEeCC---EEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-----KHPNVIKIIEVMASKT---KIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 89 (442)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 7777666 6998875432 2346789999999999 5799999999998874 434
Q ss_pred -EEEEc--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEEcc----CCceEEeeccc
Q 013487 90 -IVLEF--IDGGELFDKIAKHGRLKEDEARRYFQQLINAV-DYCHSRGVFHRDLKPENLLLDS----YGVLKISDFGL 159 (442)
Q Consensus 90 -lv~E~--~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL-~~lH~~givHrDlkp~NIll~~----~~~~kl~DFGl 159 (442)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 557999999976 456666 35678888777 9999999999999999999974 34799999543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=182.09 Aligned_cols=144 Identities=23% Similarity=0.258 Sum_probs=116.5
Q ss_pred CeEEEeeecccCceEEEEEE-EcCCCCEEEEEEecchhhh---------------------hHHHHHHHHHHHHHHhhCC
Q 013487 14 KYELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVL---------------------RHKMVEQIKREISTMKLIK 71 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~-~~~~~~~vaiK~i~~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 71 (442)
-|++.+.||+|+||.||+|. +..+|+.||+|+++..... .......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 6689999999998754210 0012234678999999997
Q ss_pred CC--CcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEcc
Q 013487 72 HP--NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENLLLDS 148 (442)
Q Consensus 72 hp--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g-ivHrDlkp~NIll~~ 148 (442)
+. .+.++++. ...|+||||+.|++|.........+....+..++.|++.+|.+||++| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455543 235899999999888776655566777788999999999999999999 99999999999999
Q ss_pred CCceEEeeccchhh
Q 013487 149 YGVLKISDFGLSAI 162 (442)
Q Consensus 149 ~~~~kl~DFGla~~ 162 (442)
++.++|+|||+|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=207.70 Aligned_cols=236 Identities=20% Similarity=0.335 Sum_probs=177.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|.|.+.||+|+||+||.|.+.. |+.||+|+-.....+.--...+++..++ .+. -+.|..+...+.-.+..++|+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHHccCCcceeee
Confidence 479999999999999999999966 9999999876655443322233332222 111 245666666666667788999
Q ss_pred EccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-------cCCceEEeeccchhhhhh
Q 013487 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-------SYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-------~~~~~kl~DFGla~~~~~ 165 (442)
||.+.|+|.+++...+.+++..+..+..|++..++.||.++|||+||||+|+||. ++--++|+|||.|--+..
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 9999999999999989999999999999999999999999999999999999993 234699999999865444
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-----CCCCCCC
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-----SCPSWFS 240 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~s 240 (442)
..........++|-.+-.+|+..|.++. ..+|.|.++.+++.||.|.+- + ...+.. .++..+.
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q----~~~g~~~~~~~~~~Ry~~ 921 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E----VKNGSSWMVKTNFPRYWK 921 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H----hcCCcceeccccchhhhh
Confidence 3334466778999999999999999985 999999999999999998531 1 222211 1222233
Q ss_pred HH-HHHHHHHccCCCCCCCCCHHHH
Q 013487 241 SG-AKKLIKRILDPNPDTRMTISQM 264 (442)
Q Consensus 241 ~~-~~~li~~~L~~dP~~R~s~~ei 264 (442)
.+ -.+++..+|+.|-..=|.+.++
T Consensus 922 ~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 922 RDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred HHHHHHHHHHHhCcCcccchhHHHH
Confidence 33 3468888888555555555554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=166.54 Aligned_cols=137 Identities=25% Similarity=0.328 Sum_probs=115.7
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-----HHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
+.||+|++|.||+|.+ +|..+++|+........ ......+.+|+.++..+.|++|.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 77789999765322111 1123567899999999999998887777777788899999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999876432 7889999999999999999999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=164.59 Aligned_cols=138 Identities=22% Similarity=0.321 Sum_probs=109.9
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-------------------HHHHHHHHHHHHHHhhCCCCC-
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-------------------HKMVEQIKREISTMKLIKHPN- 74 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-------------------~~~~~~~~~Ei~il~~l~hpn- 74 (442)
|.+.+.||+|+||.||+|.+ .+|+.||+|++....... ........+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999988 489999999876532100 001224678999999998774
Q ss_pred -cceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 75 -VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 75 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
+...++ ....+++|||++|++|.+.... .....++.+++.++.++|+.|++||||||+||++++++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 455543 2455899999999998765431 34667899999999999999999999999999999999999
Q ss_pred Eeeccchhhh
Q 013487 154 ISDFGLSAIS 163 (442)
Q Consensus 154 l~DFGla~~~ 163 (442)
|+|||++...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=162.41 Aligned_cols=133 Identities=21% Similarity=0.262 Sum_probs=108.4
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEecchhhh-----hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
.||+|+||.||+|.. ++..+++|........ .....+.+.+|+.+++.+.|+++....-++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 6788999986432211 111246778999999999988765555555566777999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
++|++|.+.+..... .++.|++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7899999999999999999999999999999 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=178.88 Aligned_cols=200 Identities=23% Similarity=0.368 Sum_probs=156.3
Q ss_pred HhhCCCCCcceEEEEEEeCCEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCcE
Q 013487 67 MKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGV-FHRDLKPENL 144 (442)
Q Consensus 67 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~gi-vHrDlkp~NI 144 (442)
|+.+.|.|+.++++...+....+.|.+||..|+|+|.+.. ...++.--...++++|+.||.|+|+.-| +|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678899999999999999999999999999999999988 3457777778889999999999999866 9999999999
Q ss_pred EEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCC------CCCcccHhHHHHHHHHHhcCCCCCCC
Q 013487 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY------DGRASDVWSCGVILFVLMAGFLPFDE 218 (442)
Q Consensus 145 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlGvil~~ll~g~~Pf~~ 218 (442)
++|....+||+|||+.................-..-|.|||++.+... -+.++||||+|++++++++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532111111111223456999999976422 24679999999999999999999976
Q ss_pred Cc----HHHHHHHHhh-CCCCCCC------CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 219 SN----LMALYRKICR-ADFSCPS------WFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 219 ~~----~~~~~~~i~~-~~~~~~~------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.. ..++...+.. +...+-+ .+.+++..++..||..+|.+||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2344444444 2221211 24557899999999999999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=183.02 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=165.8
Q ss_pred CeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE-------EE-
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE-------VM- 82 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-------~~- 82 (442)
.+.+.+..+..+++.+...+-..+ .+-++-+..+.+ +........+++-.+....|.+..-+.+ .+
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 345556666666666655443222 222333322222 1122344556666665555444333333 11
Q ss_pred ----EeCCEEEEEEEccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 83 ----ASKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 83 ----~~~~~~~lv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
....+.|+.|++|.-.+|.++|..... .+......++.|+..|++| +|.+|||+||.||+...++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 112358899999999999999975442 4566889999999999999 999999999999999999999999
Q ss_pred eccchhhhhhcc----cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhh
Q 013487 156 DFGLSAISQQVR----EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICR 230 (442)
Q Consensus 156 DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 230 (442)
|||+.+...... .........||+.||+||.+.+..|. .++||||||+||+||+. =..+|.. ...+..+..
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~ 474 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRD 474 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc
Confidence 999987654433 11123446799999999999999885 99999999999999997 2222221 122222333
Q ss_pred CCCCCCCCC-CHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 231 ADFSCPSWF-SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 231 ~~~~~~~~~-s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+.++...+. .+.-..|+..||.+.|.+||++.+.--|+|.
T Consensus 475 g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 475 GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 333311222 3455689999999999999988887777775
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=180.94 Aligned_cols=138 Identities=20% Similarity=0.245 Sum_probs=111.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-----hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.|...+.||+|+||+||+|.+... .+++|+...... ......+.+.+|+.+++.++|++|+....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 456688999999999999987443 344443321111 1112345688999999999999999888777777788
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
++||||++|++|.+.+. ....++.|++.+|.+||+.|++||||||+|||+ +++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999875 357789999999999999999999999999999 678999999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=154.89 Aligned_cols=138 Identities=25% Similarity=0.367 Sum_probs=101.1
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHH---------------------HHHHHHHHHhhCCCC--C
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---------------------QIKREISTMKLIKHP--N 74 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp--n 74 (442)
.+.||+|+||+||.|.+. +++.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 8999999998753221111111 124667777776543 3
Q ss_pred cceEEEEEEeCCEEEEEEEccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCce
Q 013487 75 VIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVL 152 (442)
Q Consensus 75 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~ 152 (442)
+.+.++. ...+++|||++|+.+.. .+... .. ...++.++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 5555543 23589999999954322 11111 11 16788999999999999999 9999999999999999 8999
Q ss_pred EEeeccchhhh
Q 013487 153 KISDFGLSAIS 163 (442)
Q Consensus 153 kl~DFGla~~~ 163 (442)
+++|||.|...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-19 Score=184.83 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=215.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
......+.+.+.+-+|+++.+..+.-..+|...++|+..+.........+.+..+-.++-...+|-++....-+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45778899999999999999999999899988888876544333333344455555544444567777665555667789
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc--
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV-- 166 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~-- 166 (442)
+++++|+.|++|...+...++.+++.++.++..+..+++|||+..+.|||++|.|+|+..+|+.+++|||........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999843211000
Q ss_pred --------------------cc-----C--CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC
Q 013487 167 --------------------RE-----D--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (442)
Q Consensus 167 --------------------~~-----~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 219 (442)
.. + ..-....||+.|.+||.+.+... +..+|+|+.|+++++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00 0 11223468999999999988766 58899999999999999999999999
Q ss_pred cHHHHHHHHhhCCCCCCC---CCCHHHHHHHHHccCCCCCCCCCHH---HHhcCcccccC
Q 013487 220 NLMALYRKICRADFSCPS---WFSSGAKKLIKRILDPNPDTRMTIS---QMLEDEWFKKG 273 (442)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~s~~---eil~hp~~~~~ 273 (442)
.....++.+.....+.|. ..+.++++++.++|..+|.+|..+. +...||||+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999888776654 3789999999999999999999987 99999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-17 Score=152.19 Aligned_cols=137 Identities=20% Similarity=0.330 Sum_probs=104.9
Q ss_pred eeec-ccCceEEEEEEEcCCCCEEEEEEecchhhh----h------HHHHHHHHHHHHHHhhCCCCCc--ceEEEEEEeC
Q 013487 19 RTLG-EGSFAKVKFAKNVETGDFVAIKIVDRDQVL----R------HKMVEQIKREISTMKLIKHPNV--IKIIEVMASK 85 (442)
Q Consensus 19 ~~LG-~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~----~------~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 85 (442)
..|| .|+.|+||.+.. .+..+++|.+...... . ......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 777778888776 3778999988653321 1 1223567899999999998875 6777664332
Q ss_pred C-E---EEEEEEccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 86 T-K---IYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 86 ~-~---~~lv~E~~~g-g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
. . .++|||+++| .+|.+.+.. .++++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 3599999997 688888765 4566553 578999999999999999999999999999999999999987
Q ss_pred hh
Q 013487 161 AI 162 (442)
Q Consensus 161 ~~ 162 (442)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-17 Score=140.21 Aligned_cols=132 Identities=23% Similarity=0.317 Sum_probs=112.8
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC--CCcceEEEEEEeCCEEEEEEEc
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 94 (442)
+.+.||+|.++.||++.+.. ..+++|....... ...+.+|+.+++.+.| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999843 7899999865432 3567899999999976 5899999988888899999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~---givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
+.|+.+... +......++.+++.+|+++|.. +++|+|++|+||++++.+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877543 5566778899999999999985 799999999999999999999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-15 Score=156.01 Aligned_cols=147 Identities=22% Similarity=0.398 Sum_probs=101.1
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--------------------------h-----HHHHHH
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--------------------------R-----HKMVEQ 59 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--------------------------~-----~~~~~~ 59 (442)
.+..|+. +.||+|++|.||.|+.+.+|+.||||+.+..-.. + .+..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 8999999999999999888999999999743100 0 011223
Q ss_pred HH------HHHHHHhhCC----CCCcceEEEEEEe-CCEEEEEEEccCCCChHHH--HHhcC----CCCHHHHHHHHHHH
Q 013487 60 IK------REISTMKLIK----HPNVIKIIEVMAS-KTKIYIVLEFIDGGELFDK--IAKHG----RLKEDEARRYFQQL 122 (442)
Q Consensus 60 ~~------~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~~~----~l~~~~~~~~~~ql 122 (442)
+. +|...+.++. +.+.+.+-.++.+ .+..++||||+.|+.|.+. +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 33 3444443332 3333333333322 3456799999999999774 33333 25555666666766
Q ss_pred HHHHHHHHHCCceeccCCCCcEEEccCC----ceEEeeccchhhhhh
Q 013487 123 INAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAISQQ 165 (442)
Q Consensus 123 ~~aL~~lH~~givHrDlkp~NIll~~~~----~~kl~DFGla~~~~~ 165 (442)
+ ..|++|+|+||.||+++.+| .++++|||++.....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5 58999999999999999888 999999999875443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-14 Score=145.45 Aligned_cols=233 Identities=18% Similarity=0.287 Sum_probs=160.3
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
|.+ ...+-++.+..-.|..+.++.+|.+.+++...- ...+.+.+-++-|+.++||||+++++.++..+.+|+|+|.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 555 333333333222466678899999998875542 4466788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH-~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
+. -|..++.+.+ ...+..-+.||+.||.||| +.+++|++|.-..|+++..|.+||++|.++........ ...
T Consensus 91 V~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~ 163 (690)
T KOG1243|consen 91 VR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAK 163 (690)
T ss_pred cc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccc
Confidence 86 4556666543 6677777999999999998 56899999999999999999999999998764433221 111
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCC
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 253 (442)
...---.|..|+.+.... -..|.|.|||++++++.|..+- .. ....+..++.....+..+-+--
T Consensus 164 ~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~~--~~-----------~~~~~~~ipk~~~~~~~k~~~~ 227 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLLT--KT-----------DLSNTGKIPKALIELYCKKLGA 227 (690)
T ss_pred cchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccCc--ch-----------hhhccCccchhHHHHHHHHhcc
Confidence 112223466777654332 3479999999999999993322 11 1112222344444555455555
Q ss_pred CCCCCCCHH----HH-hcCcccccCC
Q 013487 254 NPDTRMTIS----QM-LEDEWFKKGY 274 (442)
Q Consensus 254 dP~~R~s~~----ei-l~hp~~~~~~ 274 (442)
.+..||... ++ +-|+||+..+
T Consensus 228 ~~~~r~n~~~~~~~~~~~~gff~n~f 253 (690)
T KOG1243|consen 228 TELKRPNKLRFILECRLLGGFFRNDF 253 (690)
T ss_pred ccccccchhhHHHHHHhccccccchH
Confidence 566666532 22 3378887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-15 Score=153.74 Aligned_cols=255 Identities=20% Similarity=0.207 Sum_probs=194.0
Q ss_pred cCeEEEeeecc--cCceEEEEEEE--cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCE
Q 013487 13 GKYELGRTLGE--GSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (442)
Q Consensus 13 ~~y~i~~~LG~--G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (442)
..+.+...+|. |.+|.||.+.. ..++..+|+|.-+... .......+=.+|+...+.++ |+|.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 35677888999 99999999998 8899999999743221 11111233346777777774 9999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEEccC-CceEEeeccchh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLIN----AVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSA 161 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~ql~~----aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DFGla~ 161 (442)
.|+-+|+|. .+|..+...... +++..++..+.+... ||.++|+.+++|-|+||.||+...+ ...+++|||+..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999996 588888877665 899999999999999 9999999999999999999999998 889999999987
Q ss_pred hhhhcccCC---ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC--cHHHHHHHHhhCCCCCC
Q 013487 162 ISQQVREDG---LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--NLMALYRKICRADFSCP 236 (442)
Q Consensus 162 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~ 236 (442)
......-.. .....-|...|++||+..+. .+...|++|+|.+..+..+|..++... +......... -...+-
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~ 348 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFC 348 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhhh
Confidence 554432111 11223578899999998754 357899999999999988886665432 1111111111 011111
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...+..+...+..|++.+|..|++.+.++.|++...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 224666777999999999999999999999999863
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=145.88 Aligned_cols=141 Identities=23% Similarity=0.341 Sum_probs=97.6
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--hH-----------------------------HHHH------HH
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RH-----------------------------KMVE------QI 60 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~-----------------------------~~~~------~~ 60 (442)
.+.||.|++|.||+|+. .+|+.||||+.+..-.. .. +... .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999997 57899999998542100 00 0001 23
Q ss_pred HHHHHHHhhCC-----CCCc--ceEEEEEEeCCEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHH
Q 013487 61 KREISTMKLIK-----HPNV--IKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLIN-AVDYCHS 131 (442)
Q Consensus 61 ~~Ei~il~~l~-----hpnI--v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~-aL~~lH~ 131 (442)
.+|...+.++. +++| .+++. ...+..+++|||++|++|.+..... ... ....++.+++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 45565555552 3332 23332 2234568999999999998876532 122 23345556655 4788999
Q ss_pred CCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 132 ~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.|++|+|+||.||+++.+|.++++|||++....
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-13 Score=122.85 Aligned_cols=142 Identities=17% Similarity=0.214 Sum_probs=105.0
Q ss_pred EeeecccCceEEEEEEEcC------CCCEEEEEEecchhh--h-----------------hH----HHHHHHHHHHHHHh
Q 013487 18 GRTLGEGSFAKVKFAKNVE------TGDFVAIKIVDRDQV--L-----------------RH----KMVEQIKREISTMK 68 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~------~~~~vaiK~i~~~~~--~-----------------~~----~~~~~~~~Ei~il~ 68 (442)
...||.|.-+.||.|.... .+..+|+|+...... . +. ......++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 357899998743110 0 00 11223448999999
Q ss_pred hCC--CCCcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEE
Q 013487 69 LIK--HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLL 145 (442)
Q Consensus 69 ~l~--hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~l-H~~givHrDlkp~NIl 145 (442)
++. .-++.+++++ ...++||||+.++.+....-.+..++++.+..+..|++.+|..| |+.|++|+||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 995 3567777765 45689999998754533222334566677888899999999999 8999999999999999
Q ss_pred EccCCceEEeeccchhhhh
Q 013487 146 LDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 146 l~~~~~~kl~DFGla~~~~ 164 (442)
++ ++.+.|+|||.|....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4789999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-14 Score=144.14 Aligned_cols=253 Identities=19% Similarity=0.178 Sum_probs=189.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
-..++|..+..||.|.|+.|+....+ .++..|++|...+......+.+ .-..|+.+...+ .|.++++++..+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45678999999999999999998766 6777899998765433222222 223566666666 59999999988888888
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-CceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DFGla~~~~~~ 166 (442)
.|+-.|||.++++...+.-...+.+...++...|++.++.++|+..++|+|+||+||++..+ +..+++|||.++.+.-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 88999999999888777666678999999999999999999999999999999999999876 78899999987632110
Q ss_pred ccCCccccccCCCccc-CcccccccCCCCCcccHhHHHHHHHHHhcCCC-CCCCCcHHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 167 REDGLLHTACGTPNYV-APEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNLMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
.....+.-.+. .+|++........++|++|||.-+.+.++|.. ++.... ...+..+..+..+..+..++
T Consensus 421 -----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 421 -----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred -----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCCchHHhhh
Confidence 01111233344 34554443334589999999999999998853 332222 22344455555555568899
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+.+.+..+++..|+++.++..|+-|..
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhhh
Confidence 9999999999999999999988876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.1e-13 Score=120.57 Aligned_cols=127 Identities=21% Similarity=0.273 Sum_probs=96.5
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc-ceEEEEEEeCCEEEEEEEccC
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 96 (442)
.+.|+.|.++.||++... +..|++|+...... ......+|+.+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999873 77899998754321 12245789999998865554 45555433 33579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEEccCCceEEeeccchh
Q 013487 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV-----FHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~gi-----vHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
|.++.+. .......+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887543 11123467899999999999985 9999999999999 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-14 Score=135.08 Aligned_cols=202 Identities=16% Similarity=0.290 Sum_probs=142.0
Q ss_pred HHhhCCCCCcceEEEEEEeC-----CEEEEEEEccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 013487 66 TMKLIKHPNVIKIIEVMASK-----TKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRG--V 134 (442)
Q Consensus 66 il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~ql~~aL~~lH~~g--i 134 (442)
-+-.+-|.||++++.++.+. ....++.||++.|+|..++++.. .+....-.+|+-||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34445699999999988543 45789999999999999987643 5788888999999999999999995 9
Q ss_pred eeccCCCCcEEEccCCceEEeeccchhhhhhcccC--CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC
Q 013487 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 212 (442)
Q Consensus 135 vHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g 212 (442)
+|+++..+.|++..+|-+|+.--............ .......+-++|.|||.=..... +.++|||++|+...+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence 99999999999999998887632221111100000 01112346789999997544333 3679999999999999888
Q ss_pred CCCC-CCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 213 FLPF-DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 213 ~~Pf-~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
..-- ...+....-..+.+..+... ...-+.++.+||+..|..||++.+++-||.+-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 6542 22222121122222111111 22335789999999999999999999999753
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=98.08 Aligned_cols=62 Identities=56% Similarity=0.883 Sum_probs=49.2
Q ss_pred CCCCCChhhhhccCCCCCCccchhhhcc-cccccceEEeCCChhHHHHHHHHHhcccCceEee
Q 013487 308 KPVSMNAFELISRTKSFSLENLFEKQTG-LVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK 369 (442)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~ 369 (442)
+|..+|||++|++|+++||++||+.... .+++.+||+|..||+.|+++||++++.+|+.|++
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3678999999999999999999987654 3678999999999999999999999999999875
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-11 Score=107.99 Aligned_cols=135 Identities=21% Similarity=0.264 Sum_probs=100.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH-----HHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
..+++|+-+.+|.+.. -|.++++|.=-++....++ ..++-.+|..++.++.--+|.-.+=+..+++...++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999966 3445677754332222222 23456789999999876565555555566777789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++...+ +.++||||+...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99998888888775 245666677777889999999999999999998755 999999998743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.6e-11 Score=103.18 Aligned_cols=145 Identities=23% Similarity=0.256 Sum_probs=109.6
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-----hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
....|-+|+-+.|+.+.. .|+.+.||.-...... ..-...+..+|+++|.++.--+|.-..=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 678899999999999987 7888888864332221 122346678999999998755665555555666677899
Q ss_pred EEccCC-CChHHHHHhcCC-CCHHHH-HHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEeeccchhhh
Q 013487 92 LEFIDG-GELFDKIAKHGR-LKEDEA-RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAIS 163 (442)
Q Consensus 92 ~E~~~g-g~L~~~i~~~~~-l~~~~~-~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~DFGla~~~ 163 (442)
|||++| .++.+++..... -.++.. ..++++|-+.+.-||..+|+|+||..+||++..+| .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 477787766432 233333 78899999999999999999999999999997655 3589999998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.5e-11 Score=111.85 Aligned_cols=140 Identities=21% Similarity=0.332 Sum_probs=108.2
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC--CCcceEEEEEEeC---CEEEEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASK---TKIYIVLE 93 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E 93 (442)
+.||.|..+.||++... +|..+++|+....... .....+.+|..+++.+.+ .++.+++.+.... +..+++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3678999997654321 124567899999999975 4467777776554 36789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------------ 131 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~------------------------------------------ 131 (442)
|++|+++.+.+.. ..++++....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888776532 456777777888888888888874
Q ss_pred --------------CCceeccCCCCcEEEcc--CCceEEeeccchhh
Q 013487 132 --------------RGVFHRDLKPENLLLDS--YGVLKISDFGLSAI 162 (442)
Q Consensus 132 --------------~givHrDlkp~NIll~~--~~~~kl~DFGla~~ 162 (442)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.4e-10 Score=113.25 Aligned_cols=212 Identities=18% Similarity=0.244 Sum_probs=158.1
Q ss_pred CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe----CCEEEEEEEccCC-CC
Q 013487 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTKIYIVLEFIDG-GE 99 (442)
Q Consensus 25 ~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~g-g~ 99 (442)
-..+.|++....+|..|++|.++-.+... ......-+++++++.|+|||++.+++.+ ...+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34679999999999999999985443222 2223456778999999999999999863 4578999999986 57
Q ss_pred hHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 100 LFDKIAKH---------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 100 L~~~i~~~---------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
|.++--.. ...+|...|.|+.||..||.++|+.|...+-|.|.+||++.+-+++|+..|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 87764322 236789999999999999999999999999999999999998899999888755443
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCC-CCCCcHHHH-HHHHhhCCCCCCCCCCHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMAL-YRKICRADFSCPSWFSSG 242 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~ 242 (442)
... . |-+.+. .+-|.=.||.+++.|.||..- |........ ...| ...+|.+
T Consensus 445 ~d~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D 497 (655)
T KOG3741|consen 445 EDP--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTD 497 (655)
T ss_pred CCC--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHH
Confidence 311 0 122222 356899999999999999532 221111111 1222 2336899
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++++|.-+...++.+ -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999999988 789999876
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-11 Score=126.49 Aligned_cols=153 Identities=22% Similarity=0.363 Sum_probs=113.0
Q ss_pred HHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhccc------CCcc-ccccCCCcccCcccccccC
Q 013487 120 QQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE------DGLL-HTACGTPNYVAPEVLNDKG 191 (442)
Q Consensus 120 ~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~------~~~~-~~~~gt~~y~aPE~~~~~~ 191 (442)
.+...|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++........ +..+ .-..-...|.|||++...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~- 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT- 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence 3444999999987 899999999999999999999999998764332111 0000 001235679999999874
Q ss_pred CCCCcccHhHHHHHHHHHh-cCCCCCCCCcHHHHHHHH----hhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 192 YDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKI----CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 192 ~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+.++|++|+|+++|.+. .|..-+...+....+..- ..+.+.....+++++++=+.++|..++.-||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4468999999999999998 455555544332222211 11233445668999999999999999999999999999
Q ss_pred CcccccC
Q 013487 267 DEWFKKG 273 (442)
Q Consensus 267 hp~~~~~ 273 (442)
-|||.+.
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.3e-10 Score=99.26 Aligned_cols=128 Identities=27% Similarity=0.354 Sum_probs=85.1
Q ss_pred EEEEEEEcCCCCEEEEEEecchhh-----------------------hhHHHHHHHHHHHHHHhhCCCC--CcceEEEEE
Q 013487 28 KVKFAKNVETGDFVAIKIVDRDQV-----------------------LRHKMVEQIKREISTMKLIKHP--NVIKIIEVM 82 (442)
Q Consensus 28 ~V~~a~~~~~~~~vaiK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 82 (442)
.||.|.. ..|..+|+|+...... .........++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899988 5677999998743110 0112245678999999999755 567777553
Q ss_pred EeCCEEEEEEEccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 83 ASKTKIYIVLEFID--GGELFDKIAKHGRLKEDEARRYFQQLINAVDY-CHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 83 ~~~~~~~lv~E~~~--gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~-lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
..++||||+. |..+...... .++.+....++.+++..+.. +|+.||+|+||.+.||+++++ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 6555443322 12245667788888886555 579999999999999999986 999999998
Q ss_pred hhhh
Q 013487 160 SAIS 163 (442)
Q Consensus 160 a~~~ 163 (442)
|...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.5e-09 Score=99.06 Aligned_cols=132 Identities=16% Similarity=0.091 Sum_probs=94.0
Q ss_pred EEEEEEEcCCCCEEEEEEecchhhhh---H-----HHHHHHHHHHHHHhhCCCCC--cceEEEEEEe-----CCEEEEEE
Q 013487 28 KVKFAKNVETGDFVAIKIVDRDQVLR---H-----KMVEQIKREISTMKLIKHPN--VIKIIEVMAS-----KTKIYIVL 92 (442)
Q Consensus 28 ~V~~a~~~~~~~~vaiK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~lv~ 92 (442)
.|..+.. .|+.|.+|......... . .-...+.+|...+.+|..-+ ++.++.+.+. ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555543 56789999664322110 0 00113778999888884333 3344444432 23578999
Q ss_pred EccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-------CCceEEeeccchh
Q 013487 93 EFIDGG-ELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-------YGVLKISDFGLSA 161 (442)
Q Consensus 93 E~~~gg-~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-------~~~~kl~DFGla~ 161 (442)
|++++- +|.+++.. ..+.++.....++.+++..+.-||+.||+|+|++|.|||++. ++.+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 78888754 345677788899999999999999999999999999999975 4689999999764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-09 Score=99.84 Aligned_cols=137 Identities=24% Similarity=0.355 Sum_probs=104.3
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-----h--h------------HHHHHHHHHHHHHHhhCCCC--
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----L--R------------HKMVEQIKREISTMKLIKHP-- 73 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~--~------------~~~~~~~~~Ei~il~~l~hp-- 73 (442)
+.++..||.|.-|.||.|.+. .|.++|+|.-+.... . + .-.....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999984 789999996432100 0 0 11234678999999999644
Q ss_pred CcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 74 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
.|.+.+++ +...+||||++|-.|... +++.+.+..++..|+.-+.-+-..|++|+|+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777765 567899999999776433 223556666777777777777799999999999999999999999
Q ss_pred Eeeccchh
Q 013487 154 ISDFGLSA 161 (442)
Q Consensus 154 l~DFGla~ 161 (442)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99996543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6e-09 Score=101.09 Aligned_cols=232 Identities=17% Similarity=0.196 Sum_probs=150.4
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEE------EeCC-E
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVM------ASKT-K 87 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~------~~~~-~ 87 (442)
..++.||+|+.+.+|-.-. -+. .+.|++.+....... .-+..|... .||-+-.=+.+- .... .
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999995432 222 345888876532211 112223333 466543312111 1222 3
Q ss_pred EEEEEEccCCCCh-HHHHHh---c---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 88 IYIVLEFIDGGEL-FDKIAK---H---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 88 ~~lv~E~~~gg~L-~~~i~~---~---~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
+-++|..++|..= .++... . .-...+-+.+.++.|+.+.+.||.+|.+-+|+.++|+|+++++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7789998887532 222221 1 12556788999999999999999999999999999999999999999986543
Q ss_pred hhhhhcccCCccccccCCCcccCccccc-----ccCCCCCcccHhHHHHHHHHHhcC-CCCCCCC-------cHHHHHHH
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAG-FLPFDES-------NLMALYRK 227 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~-------~~~~~~~~ 227 (442)
.+. ..+....-..|.+.|.+||.-. +.+. +...|.|.||+++|++|.| ..||.+- +..+. .
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~ 238 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--D 238 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--h
Confidence 222 1222333456899999999754 2223 3678999999999999886 9999642 11110 1
Q ss_pred HhhC-----------CCCCC---CC--CCHHHHHHHHHccCC--CCCCCCCHH
Q 013487 228 ICRA-----------DFSCP---SW--FSSGAKKLIKRILDP--NPDTRMTIS 262 (442)
Q Consensus 228 i~~~-----------~~~~~---~~--~s~~~~~li~~~L~~--dP~~R~s~~ 262 (442)
|..+ ..+.| +| ++++++.|..+|+.. +|.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1111 11111 22 689999999999976 467899964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-08 Score=89.98 Aligned_cols=105 Identities=20% Similarity=0.392 Sum_probs=84.9
Q ss_pred HHHHHHHHHHhhCCCC--CcceEEEEEEeC----CEEEEEEEccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013487 58 EQIKREISTMKLIKHP--NVIKIIEVMASK----TKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130 (442)
Q Consensus 58 ~~~~~Ei~il~~l~hp--nIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH 130 (442)
....+|...+..|..- .+.+.+.+.... ...++|+|+++|. +|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4577888888777432 345555555442 2458999999984 79999887555788888999999999999999
Q ss_pred HCCceeccCCCCcEEEccCC---ceEEeeccchhh
Q 013487 131 SRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 162 (442)
Q Consensus 131 ~~givHrDlkp~NIll~~~~---~~kl~DFGla~~ 162 (442)
++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=86.61 Aligned_cols=141 Identities=21% Similarity=0.265 Sum_probs=101.9
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh---------------------HHHHHHHHHHHHHHhhCC--CCC
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR---------------------HKMVEQIKREISTMKLIK--HPN 74 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~--hpn 74 (442)
...|+.|.-++||+|.. .++..+|+|++......- .......++|...|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777888899999987 678899999985432211 111234567888888884 556
Q ss_pred cceEEEEEEeCCEEEEEEEccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCce
Q 013487 75 VIKIIEVMASKTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVL 152 (442)
Q Consensus 75 Iv~l~~~~~~~~~~~lv~E~~~gg~L-~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~ 152 (442)
+.+.+.+.. -.+|||++....+ .-.+. +.++..+++..+..+++..+.-|-. .|+||+||+.=|||+. +|.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 677776653 3699999964311 11111 1234445799999999999999887 8999999999999999 8999
Q ss_pred EEeeccchhhhhh
Q 013487 153 KISDFGLSAISQQ 165 (442)
Q Consensus 153 kl~DFGla~~~~~ 165 (442)
.|+|||-|....+
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999998765443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=85.71 Aligned_cols=139 Identities=18% Similarity=0.285 Sum_probs=90.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHH------HHHHHHHHHhhCCC---CCcceEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE------QIKREISTMKLIKH---PNVIKIIEVM 82 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~------~~~~Ei~il~~l~h---pnIv~l~~~~ 82 (442)
-++|.+.+.+-......|.+..- +|..+++|.............. ...+++..+..+.. -....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 45788888888877777776654 6788999987543322221111 12344444444432 2223322222
Q ss_pred E-----eCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeec
Q 013487 83 A-----SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (442)
Q Consensus 83 ~-----~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DF 157 (442)
+ -....+++|||++|.+|.+... +++ .+...+..++.-+|+.|++|+|.+|.|+++++++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 1 1234568999999988866532 333 2446677889999999999999999999999655 999999
Q ss_pred cchh
Q 013487 158 GLSA 161 (442)
Q Consensus 158 Gla~ 161 (442)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.2e-07 Score=86.22 Aligned_cols=134 Identities=17% Similarity=0.183 Sum_probs=84.5
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC--cceEEEEEEeCCEEEEEEEccC
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN--VIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 96 (442)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 24567889876422 1245689999999886433 5777888878888899999999
Q ss_pred CCC-hHHHH--------------Hh-----c----CCCCHHH-HHHHHHH----------HHH-HHHHHHH----CCcee
Q 013487 97 GGE-LFDKI--------------AK-----H----GRLKEDE-ARRYFQQ----------LIN-AVDYCHS----RGVFH 136 (442)
Q Consensus 97 gg~-L~~~i--------------~~-----~----~~l~~~~-~~~~~~q----------l~~-aL~~lH~----~givH 136 (442)
|.+ +...+ .. + ...+... ...+..+ +.. ..++|.+ ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11111 10 0 0011000 0111111 111 1122221 24789
Q ss_pred ccCCCCcEEEccCCceEEeeccchhh
Q 013487 137 RDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 137 rDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.3e-07 Score=82.15 Aligned_cols=138 Identities=18% Similarity=0.161 Sum_probs=97.7
Q ss_pred cccCceEEEEEEEcCCCCEEEEEEecchh--hhh-HHHHHHHHHHHHHHhhCCC--CCcceEEEEEE--eC--CEEEEEE
Q 013487 22 GEGSFAKVKFAKNVETGDFVAIKIVDRDQ--VLR-HKMVEQIKREISTMKLIKH--PNVIKIIEVMA--SK--TKIYIVL 92 (442)
Q Consensus 22 G~G~fg~V~~a~~~~~~~~vaiK~i~~~~--~~~-~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~--~~--~~~~lv~ 92 (442)
|+|+-+.|+.... .|+.+-+|.-.... ... +.-...+.+|+..+..|.. -.+.++..... .. -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688889998775 33356677543110 000 1124678899999998853 22555542211 11 2357899
Q ss_pred EccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc--eEEeeccchh
Q 013487 93 EFIDG-GELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGLSA 161 (442)
Q Consensus 93 E~~~g-g~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~--~kl~DFGla~ 161 (442)
|-+.| -+|.+++... .+.++.....++.+++..+.-||+.|+.|+|+.+.||+++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 5888888663 34577788899999999999999999999999999999987777 9999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.4e-09 Score=108.60 Aligned_cols=243 Identities=18% Similarity=0.201 Sum_probs=168.4
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 88 (442)
-....|...+-+++|+.+++++.+...+...+ .+.+... ...+-++++|.+++||| .+..++-++.+...
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 33445667788899999999999987666555 6666433 34567889999999999 77778888888899
Q ss_pred EEEEEccCCC-ChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 89 YIVLEFIDGG-ELFDK-IAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 89 ~lv~E~~~gg-~L~~~-i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
++.|+++.+| +-... -...-.+.+-+.....+.-+.+++++|+.--+|+| ||+..+ +..|..||+.+..+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999887 22111 11111233334445566667889999998778998 777765 78899999987654332
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC------CCCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP------SWFS 240 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------~~~s 240 (442)
. .-.+..+|+.++|||+.....+. ...|.|++|+=-.+|.-|.+|-..+-. ....+-.+ ...| .|-+
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~-p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNG-PNSPMLTDKSAWSP 457 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCC-CCccccchhhhcCc
Confidence 1 23556799999999999888886 788999999877778778777543210 00000000 0001 1111
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..-.++...|+..-|..|+....++-|.+|...
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 122247778999999999999999999998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.3e-07 Score=97.59 Aligned_cols=205 Identities=20% Similarity=0.233 Sum_probs=146.1
Q ss_pred HHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE----EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013487 57 VEQIKREISTMKLIKHPNVIKIIEVMASKTKI----YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132 (442)
Q Consensus 57 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~ 132 (442)
+....-|+..+..+.|+|++.++.+-...... .+..++|++-++...++.-+..+.+.++.+..++++||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34445566677888999999999887544332 34568999999999999999999999999999999999999999
Q ss_pred CceeccCCCC---cEEEccCCceEEe--eccchhhhhhcccCCccccccCCCcccCcccccccCCC-CCcccHhHHHHHH
Q 013487 133 GVFHRDLKPE---NLLLDSYGVLKIS--DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVIL 206 (442)
Q Consensus 133 givHrDlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DiwSlGvil 206 (442)
...|.-+... +-..+..+...++ ||+.+........ .....-+..+.|||......+. +...|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6666655544 4444566677777 8887654433211 1222345678888887665543 2336999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 207 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 207 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+..|..+-........ .. +........+++.+|+.-++++|+++.+++.|||.+..
T Consensus 383 ~~~~~~~~i~~~~~~~~~---~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPVS---LL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhcCcccccccchhh---hh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999988655322211111 11 11112277889999999999999999999999998753
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.5e-06 Score=80.30 Aligned_cols=137 Identities=22% Similarity=0.312 Sum_probs=82.6
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC--CcceEEEEE---EeCCEEEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEVM---ASKTKIYIVL 92 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~ 92 (442)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999844 58999997644 2346677899998888533 356666643 2334579999
Q ss_pred EccCCCChHH----------------HHH---hc----CCCCHHH------HHH---------------HHHHHHH-HHH
Q 013487 93 EFIDGGELFD----------------KIA---KH----GRLKEDE------ARR---------------YFQQLIN-AVD 127 (442)
Q Consensus 93 E~~~gg~L~~----------------~i~---~~----~~l~~~~------~~~---------------~~~ql~~-aL~ 127 (442)
++++|..+.. .+. .. .++.... ... ....+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 0111000 000 0111222 233
Q ss_pred HHHH-------CCceeccCCCCcEEEc-cCCceEEeeccchh
Q 013487 128 YCHS-------RGVFHRDLKPENLLLD-SYGVLKISDFGLSA 161 (442)
Q Consensus 128 ~lH~-------~givHrDlkp~NIll~-~~~~~kl~DFGla~ 161 (442)
.+++ ..++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3599999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.6e-07 Score=90.77 Aligned_cols=142 Identities=22% Similarity=0.326 Sum_probs=89.8
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhh--h-------------------------H----HHHH------HHH
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--R-------------------------H----KMVE------QIK 61 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~-------------------------~----~~~~------~~~ 61 (442)
..|+.++-|.||.|+. .+|+.||||+.+..-.. + . +..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6788999999999999 45999999987531100 0 0 0011 233
Q ss_pred HHHHHHhhCC-----CCCcceEEEEEEeCCEEEEEEEccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013487 62 REISTMKLIK-----HPNVIKIIEVMASKTKIYIVLEFIDGGELFDK--IAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134 (442)
Q Consensus 62 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~--i~~~~~l~~~~~~~~~~ql~~aL~~lH~~gi 134 (442)
+|...+.++. .|+|.-..=+++-.+.-.++|||++|-.+.+. +.. .+++.+.+...+.++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 4555555442 34332222222334556899999999888777 444 4455332222111111 222334799
Q ss_pred eeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 135 vHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+|.|.+|.||+++.+|.+-+.|||+.....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999999999999999976543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.7e-06 Score=78.90 Aligned_cols=135 Identities=16% Similarity=0.139 Sum_probs=83.6
Q ss_pred eecccCc-eEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEEEEccCC
Q 013487 20 TLGEGSF-AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLEFIDG 97 (442)
Q Consensus 20 ~LG~G~f-g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g 97 (442)
.|-.|.. +.||+.... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 789998753 4678889875432 234668999988884 44466788877776778999999999
Q ss_pred CChHHHHH-------------------hcC----CCCHH------HHHHHHH----------------HHHHHHHHHH--
Q 013487 98 GELFDKIA-------------------KHG----RLKED------EARRYFQ----------------QLINAVDYCH-- 130 (442)
Q Consensus 98 g~L~~~i~-------------------~~~----~l~~~------~~~~~~~----------------ql~~aL~~lH-- 130 (442)
.+|..... .-. ++... .....+. .+...++.|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 76653310 000 01100 0000000 0111122221
Q ss_pred -----HCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 131 -----SRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 131 -----~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
...++|+|+.|.|||+++++...|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999987789999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.3e-06 Score=89.85 Aligned_cols=145 Identities=17% Similarity=0.371 Sum_probs=91.4
Q ss_pred EeeecccCceEEEEEEEcCCC--CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCc--ceEEEEEEeC---CEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETG--DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNV--IKIIEVMASK---TKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 89 (442)
.+.|+.|.+..+|+......+ ..+++|......... ....+.+|+.+|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 677899999999998775432 367778754322111 1346789999999995 6665 7777777654 4678
Q ss_pred EEEEccCCCChHH--------------------HH---HhcC----CC---------CHHHHHHHHHH------------
Q 013487 90 IVLEFIDGGELFD--------------------KI---AKHG----RL---------KEDEARRYFQQ------------ 121 (442)
Q Consensus 90 lv~E~~~gg~L~~--------------------~i---~~~~----~l---------~~~~~~~~~~q------------ 121 (442)
+||||++|..+.+ .+ ..-. .+ ...++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999854321 11 1100 01 01223322222
Q ss_pred ---HHHHHHHHHH-----------CCceeccCCCCcEEEccC-Cc-eEEeeccchhhhh
Q 013487 122 ---LINAVDYCHS-----------RGVFHRDLKPENLLLDSY-GV-LKISDFGLSAISQ 164 (442)
Q Consensus 122 ---l~~aL~~lH~-----------~givHrDlkp~NIll~~~-~~-~kl~DFGla~~~~ 164 (442)
+...+++|.. ..++|+|++|.||+++.+ +. .-|.||++++..+
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2223455632 249999999999999853 33 5799999987643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1e-05 Score=70.53 Aligned_cols=129 Identities=20% Similarity=0.272 Sum_probs=91.3
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcce-EEEEEEeCCEEEEEEEcc
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK-IIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lv~E~~ 95 (442)
..+.||+|++|.||++.. .|..+|+|+-..+. ....+..|.++|..+...++.+ +|.+.. .++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 367899999999999998 45689999865443 2456889999999998777654 444432 34559999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEEEccCCceEEeeccchhhh
Q 013487 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK-PENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 96 ~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlk-p~NIll~~~~~~kl~DFGla~~~ 163 (442)
.|-.|.+.-... + ++-...+++.---|-..||-|..|. |...++-.++.+.|+||..|+..
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 998876654321 2 2233445555445667799999997 55555555569999999988743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.7e-05 Score=68.31 Aligned_cols=131 Identities=21% Similarity=0.278 Sum_probs=92.9
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhh-------------hhHHHHHHHHHHHHHHhhCC------CCCcceE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-------------LRHKMVEQIKREISTMKLIK------HPNVIKI 78 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l 78 (442)
...||+|+.-.||.- ......+||+...... .......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999999843 2334577899876540 01112345566666655554 8899999
Q ss_pred EEEEEeCCEEEEEEEccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC--C
Q 013487 79 IEVMASKTKIYIVLEFIDG------GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--G 150 (442)
Q Consensus 79 ~~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~--~ 150 (442)
+++.+++-..-+|+|.+.. -+|.+++.. +.+++ .+...+-.-.+||-+++|+.+|++|.||++..+ +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998642 368888855 44665 334445555678899999999999999999633 2
Q ss_pred --ceEEee
Q 013487 151 --VLKISD 156 (442)
Q Consensus 151 --~~kl~D 156 (442)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-07 Score=103.30 Aligned_cols=254 Identities=17% Similarity=0.090 Sum_probs=166.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 88 (442)
..|++.=.+|-|.+++-..-+.+.. -+.+|+....... .+-..+....|..-++...|+++...+.-... ....
T Consensus 1229 e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee 1306 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEE 1306 (2724)
T ss_pred hhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHH
Confidence 3455555555555544332222111 2445554322211 11123444455556667789998887665533 3456
Q ss_pred EEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEccCCceEEeeccc
Q 013487 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~g-----ivHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
|..++|+.+|.+++.|.+. .++.+.-+....++.+.+..-+|+.. .+|+++|+-|.+|..+-++|++++|+
T Consensus 1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gL 1386 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGL 1386 (2724)
T ss_pred HHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccc
Confidence 8999999999999998764 34556666666777788888888762 78999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSW 238 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 238 (442)
.++..+. ........++|.|++|++...-.+. .++|+|..|+-+|....|..||-.-....+...+.... +..+..
T Consensus 1387 dKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l 1463 (2724)
T KOG1826|consen 1387 DKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKL 1463 (2724)
T ss_pred ccccCch--HhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccccc
Confidence 8843221 1233445688999999998877775 55999999999999999988875433333322233322 233333
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
.|.++-.+...+|-..-..||.-..++.-+.|-
T Consensus 1464 ~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1464 KPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred CCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 455555566666666677888887777766654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.5e-05 Score=74.36 Aligned_cols=74 Identities=9% Similarity=0.081 Sum_probs=46.5
Q ss_pred EeeecccCceE-EEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC---CcceEEEEEEeC---CEEEE
Q 013487 18 GRTLGEGSFAK-VKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP---NVIKIIEVMASK---TKIYI 90 (442)
Q Consensus 18 ~~~LG~G~fg~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 90 (442)
++.|+.|+... ||... ..+++|+..... ....+.+|..+++.+... -+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 35677777764 88652 357778754321 234688999999888532 344555443332 23588
Q ss_pred EEEccCCCChH
Q 013487 91 VLEFIDGGELF 101 (442)
Q Consensus 91 v~E~~~gg~L~ 101 (442)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999986663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.09 E-value=1e-05 Score=54.72 Aligned_cols=43 Identities=19% Similarity=0.346 Sum_probs=38.0
Q ss_pred cceEEEEEEEEEe-CCeEEEEEEecCCCchhHHHHHHHHHhccc
Q 013487 385 GQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 427 (442)
Q Consensus 385 ~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~~~~~~~l~ 427 (442)
..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 4588999999998 899999999999999999999999988774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.5e-05 Score=67.18 Aligned_cols=128 Identities=23% Similarity=0.300 Sum_probs=91.6
Q ss_pred cCeEEEeeecccCc-eEEEEEEEcCCCCEEEEEEecc---h-------hhhhH--------HHHHHHHHHHHHHhhCC--
Q 013487 13 GKYELGRTLGEGSF-AKVKFAKNVETGDFVAIKIVDR---D-------QVLRH--------KMVEQIKREISTMKLIK-- 71 (442)
Q Consensus 13 ~~y~i~~~LG~G~f-g~V~~a~~~~~~~~vaiK~i~~---~-------~~~~~--------~~~~~~~~Ei~il~~l~-- 71 (442)
.+++..+.||.|+. |.||++.- .|..+|+|+... . ..... .....+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67889999999999 99999997 677999999311 0 00000 23446778888877774
Q ss_pred -CCCc--ceEEEEEEeC------------------CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013487 72 -HPNV--IKIIEVMASK------------------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130 (442)
Q Consensus 72 -hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH 130 (442)
+.++ +++++++.-. ....||-||++... .+. ..-+.++.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 5566 9999987322 12457888876643 222 234567778888999
Q ss_pred HCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 131 ~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999976 3489999853
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.8e-05 Score=79.98 Aligned_cols=140 Identities=23% Similarity=0.353 Sum_probs=87.6
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-----------------------------HHHHHHH------HH
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----------------------------HKMVEQI------KR 62 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----------------------------~~~~~~~------~~ 62 (442)
.+.||.-+.|.|++|+.+. |+.||+|+-+.. +.+ .+..+.+ .+
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 3689999999999999955 999999986431 110 0111112 23
Q ss_pred HHHHHh----hCCCCC------cceEEEEEEeCCEEEEEEEccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013487 63 EISTMK----LIKHPN------VIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCH 130 (442)
Q Consensus 63 Ei~il~----~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~--~i~~~~~l~~~~~~~~~~ql~~aL~~lH 130 (442)
|.+... .+.|-+ |.++|-.+ .....++|||++|..+.| .|.+.+ ++...+...+.+... +-|=
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf 318 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIF 318 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHH
Confidence 333332 333544 44444333 345689999999986655 455543 555543333333222 2233
Q ss_pred HCCceeccCCCCcEEEcc----CCceEEeeccchhhhh
Q 013487 131 SRGVFHRDLKPENLLLDS----YGVLKISDFGLSAISQ 164 (442)
Q Consensus 131 ~~givHrDlkp~NIll~~----~~~~kl~DFGla~~~~ 164 (442)
..|++|.|=+|.||+++. ++.+.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 468999999999999983 6789999999976443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00019 Score=71.87 Aligned_cols=80 Identities=18% Similarity=0.171 Sum_probs=55.2
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhh--hh--HHHHHHHHHHHHHHhhCC---CCCcceEEEEEEeCCEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LR--HKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 90 (442)
.+.||.|.+..||++.+...++.|+||.-...-. .. .-..++...|...|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999864446899997531100 00 112456777888888763 3567888877 4456789
Q ss_pred EEEccCCCC
Q 013487 91 VLEFIDGGE 99 (442)
Q Consensus 91 v~E~~~gg~ 99 (442)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=67.09 Aligned_cols=75 Identities=21% Similarity=0.305 Sum_probs=48.5
Q ss_pred EeeecccCceEEEEEEEcC-CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEEEEEEEcc
Q 013487 18 GRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~ 95 (442)
++.|..|-...+|++.... .+..|++|+...... ..-...+|+.+++.+...+ ..+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4677888888999987543 356888997653321 1123357898998885333 444544332 2 3799999
Q ss_pred CCCCh
Q 013487 96 DGGEL 100 (442)
Q Consensus 96 ~gg~L 100 (442)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00033 Score=62.98 Aligned_cols=99 Identities=16% Similarity=0.288 Sum_probs=79.2
Q ss_pred HHHHHHHhhCCC-CCcceEEEEEEeCCEEEEEEEccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 013487 61 KREISTMKLIKH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDK---IAKHGRLKEDEARRYFQQLINAVDYCHS---RG 133 (442)
Q Consensus 61 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---i~~~~~l~~~~~~~~~~ql~~aL~~lH~---~g 133 (442)
..|.-+++.+.+ +++++++|.+.. +++.||...+++... +..--..+.....+++.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368888999976 699999999833 678899987766421 1111235788999999999999999998 35
Q ss_pred ceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 134 VFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 134 ivHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.2e-05 Score=71.85 Aligned_cols=136 Identities=17% Similarity=0.200 Sum_probs=82.9
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC--CcceEEE------EEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIE------VMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 89 (442)
.+.|..|....+|+... .+..+++|+.... . .+.+..|+.++..+.+- .+.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 66788888889998865 3346888987541 1 24566788888877432 2445443 123345678
Q ss_pred EEEEccCCCChHH----H----------HHhc-CCCC--------HHHHH------------HHHHHHHHHHHHHHH---
Q 013487 90 IVLEFIDGGELFD----K----------IAKH-GRLK--------EDEAR------------RYFQQLINAVDYCHS--- 131 (442)
Q Consensus 90 lv~E~~~gg~L~~----~----------i~~~-~~l~--------~~~~~------------~~~~ql~~aL~~lH~--- 131 (442)
+++++++|..+.. . +... ..+. ..... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 0 0000 0000 00000 011112334444443
Q ss_pred ----CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 132 ----RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 132 ----~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
.+++|+|+.|.||++++++...|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=6.9e-05 Score=70.89 Aligned_cols=133 Identities=17% Similarity=0.213 Sum_probs=77.5
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc-ceEEEEEEeCCEEEEEEEccCCC
Q 013487 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg 98 (442)
.+..|-...+|+.. .++..+++|...... ....-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45668888899887 356678889754321 1110124678899998864333 34444332 26899999986
Q ss_pred ChHHH----------H-------HhcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeccC
Q 013487 99 ELFDK----------I-------AKHG----RLKE-DEARRYFQQL---------INAVDYCHS--------RGVFHRDL 139 (442)
Q Consensus 99 ~L~~~----------i-------~~~~----~l~~-~~~~~~~~ql---------~~aL~~lH~--------~givHrDl 139 (442)
.+... + .... +++. ..+..+..++ ...++.+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 54311 1 1110 1111 1222332222 111222222 24899999
Q ss_pred CCCcEEEccCCceEEeeccchhh
Q 013487 140 KPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 140 kp~NIll~~~~~~kl~DFGla~~ 162 (442)
.|.||++++++ +.++||+.|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.82 E-value=2.5e-05 Score=74.32 Aligned_cols=134 Identities=18% Similarity=0.293 Sum_probs=98.7
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-----hHH--------------HHHHHHHHHHHHhhCC-C-C
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHK--------------MVEQIKREISTMKLIK-H-P 73 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~--------------~~~~~~~Ei~il~~l~-h-p 73 (442)
|.++++||-|.-+.+|.+-+ ..|++.++|+-+..+.. ... ..-...+|...|+.|. | -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56789999999999999998 67889999964322110 000 0123457888898884 3 3
Q ss_pred CcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 74 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
-|.+.+++ +..++|||++.|-.|...-. ...+..+...+..-+--|..+|++|+|..--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 35555554 56789999999977754321 223455667777778889999999999999999999999999
Q ss_pred Eeeccc
Q 013487 154 ISDFGL 159 (442)
Q Consensus 154 l~DFGl 159 (442)
++||--
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999964
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00042 Score=67.10 Aligned_cols=77 Identities=12% Similarity=0.082 Sum_probs=54.8
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC---CCcceEEEEEEe---CCEEEE
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH---PNVIKIIEVMAS---KTKIYI 90 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~l 90 (442)
-.+.||.|..+.||..... ++ .+.+|...... ....+..|...|+.|.- -.|.++++++.. .+..++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3678999999999998652 23 46677743210 12467789999988842 367888877654 366899
Q ss_pred EEEccCCCCh
Q 013487 91 VLEFIDGGEL 100 (442)
Q Consensus 91 v~E~~~gg~L 100 (442)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00033 Score=68.10 Aligned_cols=137 Identities=20% Similarity=0.273 Sum_probs=80.3
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC--CcceEEEE------EEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEV------MASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~ 89 (442)
.+.++.|....+|++.. .+| .+++|+.+... . .+.+..|+.++..|... .+.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56777887789998864 334 57789875421 1 23455677777777422 24444432 12245678
Q ss_pred EEEEccCCCChH-----------HH---HHhc-CCCC---------HHH----HH----------HHHHHHHHHHHHHHH
Q 013487 90 IVLEFIDGGELF-----------DK---IAKH-GRLK---------EDE----AR----------RYFQQLINAVDYCHS 131 (442)
Q Consensus 90 lv~E~~~gg~L~-----------~~---i~~~-~~l~---------~~~----~~----------~~~~ql~~aL~~lH~ 131 (442)
++++|++|.++. .. +... ..++ ... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 11 1100 0110 000 00 011123334555542
Q ss_pred -------CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 132 -------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 132 -------~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
.+++|+|+++.||++++++...|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877999999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00086 Score=65.53 Aligned_cols=136 Identities=18% Similarity=0.219 Sum_probs=74.1
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC--CcceEEE------EEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIE------VMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 89 (442)
.+.|+.|....+|.... .+| .+++|++... . .+.+..|+.+++.|... .+.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~---~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERL---T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEeccC---C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35566777788998875 233 6888987521 1 12334455666555311 1333332 123356679
Q ss_pred EEEEccCCCChH-----------HHHH---hc-CCC--------CH----HHH-----------HHHHHH-HHHHHHHHH
Q 013487 90 IVLEFIDGGELF-----------DKIA---KH-GRL--------KE----DEA-----------RRYFQQ-LINAVDYCH 130 (442)
Q Consensus 90 lv~E~~~gg~L~-----------~~i~---~~-~~l--------~~----~~~-----------~~~~~q-l~~aL~~lH 130 (442)
++++|++|..+. ..+. .. ..+ .. +.. ...+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999986431 1111 00 001 00 000 011111 111222332
Q ss_pred -------HCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 131 -------SRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 131 -------~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
..|+||+|+.|.||+++++...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999976656899999764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00052 Score=66.63 Aligned_cols=142 Identities=24% Similarity=0.276 Sum_probs=97.3
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchh--------h--------------hhHHH-HHHHHHHHHHHhhCCCC
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQ--------V--------------LRHKM-VEQIKREISTMKLIKHP 73 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~--------~--------------~~~~~-~~~~~~Ei~il~~l~hp 73 (442)
|-..|..|.-+.||.|.. .+|..+|||++...- . ....+ .-....|++-|++|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345677899999999987 678889999874210 0 01122 23456788889888755
Q ss_pred CcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEccCCce
Q 013487 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYGVL 152 (442)
Q Consensus 74 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH-~~givHrDlkp~NIll~~~~~~ 152 (442)
+|.-.--+.. ....+||+++.+...-.=.-++..++...+..+-+|++.-+.-|- .+++||.||+--|+|+.+ |.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 5432211111 234689999854222111123356888899999999999988875 569999999999999975 889
Q ss_pred EEeeccchhh
Q 013487 153 KISDFGLSAI 162 (442)
Q Consensus 153 kl~DFGla~~ 162 (442)
.|+|-+-+.-
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999886543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.001 Score=64.42 Aligned_cols=142 Identities=15% Similarity=0.225 Sum_probs=89.5
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC--CCcceEEEEEEeCC--EEEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKT--KIYI 90 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~l 90 (442)
..+++.+..|..-.+|...+. ++.+++. ... ............+|..+++.+.- .-+...++.+.+.. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 344555544544455655553 7888888 321 11222345667789999888743 23344455555444 6799
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHHH--------------------------------------
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHS-------------------------------------- 131 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~-ql~~aL~~lH~-------------------------------------- 131 (442)
||+|++|..+.+... +......++. .+...|.-||+
T Consensus 103 v~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 103 VMEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 999999854332221 1111123333 66666666665
Q ss_pred --------------------CCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 132 --------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 132 --------------------~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..++|+|+.+.|++++.++.+-+.||+++.+.++
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2589999999999999999999999999876443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=63.96 Aligned_cols=76 Identities=14% Similarity=0.148 Sum_probs=48.5
Q ss_pred EeeecccCceEEEEEEEcC------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYI 90 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 90 (442)
++.|..|-...+|++.... +++.+++|+..... .......+|..+++.+...+ ..+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556667777899887643 25789999865432 11234568888888885333 3455555432 35
Q ss_pred EEEccCCCChH
Q 013487 91 VLEFIDGGELF 101 (442)
Q Consensus 91 v~E~~~gg~L~ 101 (442)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89998886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0032 Score=61.90 Aligned_cols=84 Identities=15% Similarity=0.116 Sum_probs=52.7
Q ss_pred eecccCceEEEEEEEcCCCCEEEEEEecch-hhhh---HHHHHHHHHHHHHHhhCC--CC-CcceEEEEEEeCCEEEEEE
Q 013487 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLR---HKMVEQIKREISTMKLIK--HP-NVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 20 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~-~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~ 92 (442)
.||.|....||++.+...++.|+||--... .+.. +-..++..-|...|+... -| .+.++|.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998544468999864311 1000 112456667888887763 34 46666554 455667999
Q ss_pred EccCCC-ChHHHHH
Q 013487 93 EFIDGG-ELFDKIA 105 (442)
Q Consensus 93 E~~~gg-~L~~~i~ 105 (442)
|+++.. .|...+.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 998543 3434443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0027 Score=64.30 Aligned_cols=161 Identities=24% Similarity=0.299 Sum_probs=103.2
Q ss_pred HHHHHHHHHhhCCCCCcceEEEEEEeC-CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013487 59 QIKREISTMKLIKHPNVIKIIEVMASK-TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137 (442)
Q Consensus 59 ~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHr 137 (442)
++.-...+++.+.|+|...++++.... ....+|||++.- +|.+....+. +-..... .+|+.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhhc--------------cccccee
Confidence 455667788999999999999987543 347789999954 8988887654 2211111 2222222
Q ss_pred cCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCC
Q 013487 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217 (442)
Q Consensus 138 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 217 (442)
| .++++| -+++. | |- ..++++||||+|.++.++.-|..-|.
T Consensus 92 -----~-------~~~~td-~~~t~------------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLTK------------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----h-------hhhccc-ccccc------------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 223333 11110 0 10 11258999999999999999877776
Q ss_pred CCcHHHHHHHHhhCCCCCC------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 218 ESNLMALYRKICRADFSCP------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.....+....+.+-..... -.++.....++.+|+...|..||...++.+++-|...+
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 5544444333332211110 11466778899999999999999999999999997654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0066 Score=60.78 Aligned_cols=84 Identities=13% Similarity=0.080 Sum_probs=54.4
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-hhH---HHHHHHHHHHHHHhhCC---CCCcceEEEEEEeCCEEE
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRH---KMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 89 (442)
-.+.||.|....||+..+. +..++||.-..... ... ....+...|...|+.+. ..++.+++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678899999999998873 45688887541111 000 12445556677776663 357888888776 4467
Q ss_pred EEEEccCCC--ChHHHH
Q 013487 90 IVLEFIDGG--ELFDKI 104 (442)
Q Consensus 90 lv~E~~~gg--~L~~~i 104 (442)
++||+++++ .+.+.+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 889999772 344443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.006 Score=60.35 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=79.1
Q ss_pred EeeecccCceEEEEEEEcC----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc-ceEEEEEEeCCEEEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVL 92 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~ 92 (442)
...|-.|-.-.+|++.... +++.|++|+..... ...+++ .+|..+++.+..-++ .++++.+.. . .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 3455558888899987432 34689999875432 112232 578999888864443 355565532 2 578
Q ss_pred EccCCCChHHH----------H-------HhcC-C----C-CHHHHHHHHHHHH-----------------HHHHHH---
Q 013487 93 EFIDGGELFDK----------I-------AKHG-R----L-KEDEARRYFQQLI-----------------NAVDYC--- 129 (442)
Q Consensus 93 E~~~gg~L~~~----------i-------~~~~-~----l-~~~~~~~~~~ql~-----------------~aL~~l--- 129 (442)
+|++|.+|... + .... + . ..+.+..+..++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877665311 1 0000 0 1 1123333332221 111111
Q ss_pred -H----HCCceeccCCCCcEEEcc-CCceEEeeccchh
Q 013487 130 -H----SRGVFHRDLKPENLLLDS-YGVLKISDFGLSA 161 (442)
Q Consensus 130 -H----~~givHrDlkp~NIll~~-~~~~kl~DFGla~ 161 (442)
. ...++|+|+++.||++++ ++.+.++||.+|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999986 4789999999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0072 Score=57.84 Aligned_cols=31 Identities=23% Similarity=0.413 Sum_probs=25.8
Q ss_pred CceeccCCCCcEEEccCCc-eEEeeccchhhh
Q 013487 133 GVFHRDLKPENLLLDSYGV-LKISDFGLSAIS 163 (442)
Q Consensus 133 givHrDlkp~NIll~~~~~-~kl~DFGla~~~ 163 (442)
.++|+|++|.||++++++. .-|+||+.+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 569999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=56.44 Aligned_cols=29 Identities=31% Similarity=0.544 Sum_probs=25.4
Q ss_pred CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 132 ~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999998 678999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0081 Score=59.87 Aligned_cols=86 Identities=16% Similarity=0.159 Sum_probs=55.0
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecch-hhhh--HHHHHHHHHHHHHHhhCC--CC-CcceEEEEEEeCCEEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLR--HKMVEQIKREISTMKLIK--HP-NVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~-~~~~--~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 91 (442)
.+.||.|.-.-||++.+...+..|+||--... ++.. +-..++..-|..+|+... .| ++.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67899999999999998444567888854211 0100 113567778888888763 34 56666654 45566789
Q ss_pred EEccCCC-ChHHHHH
Q 013487 92 LEFIDGG-ELFDKIA 105 (442)
Q Consensus 92 ~E~~~gg-~L~~~i~ 105 (442)
||+++.. .|.+.+.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9988543 3444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.021 Score=56.13 Aligned_cols=139 Identities=17% Similarity=0.274 Sum_probs=77.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc-ceEEEEEEeCCEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIY 89 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 89 (442)
..++. .|..|-.-.+|+...... +..|++|+..... ...+ .-.+|..+++.+..-++ .++++++. .+
T Consensus 16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 33444 444477778898875432 3478999875432 1111 23578888888865444 45565553 22
Q ss_pred EEEEccCCCChHH----------HH-------HhcC-C----C-CHHHHHHHHHHH----------------------HH
Q 013487 90 IVLEFIDGGELFD----------KI-------AKHG-R----L-KEDEARRYFQQL----------------------IN 124 (442)
Q Consensus 90 lv~E~~~gg~L~~----------~i-------~~~~-~----l-~~~~~~~~~~ql----------------------~~ 124 (442)
+|.+|++|..|.. .+ .... + . ....+..|+.++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 4888887755421 11 1100 0 1 112233333222 11
Q ss_pred HHHH---HH-HCC----ceeccCCCCcEEEcc-CCceEEeeccchh
Q 013487 125 AVDY---CH-SRG----VFHRDLKPENLLLDS-YGVLKISDFGLSA 161 (442)
Q Consensus 125 aL~~---lH-~~g----ivHrDlkp~NIll~~-~~~~kl~DFGla~ 161 (442)
-+.. +. +.+ .+|.|+.|.|||+++ ++.++++||.+|.
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1211 11 222 799999999999975 5789999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.042 Score=53.41 Aligned_cols=29 Identities=17% Similarity=0.154 Sum_probs=27.0
Q ss_pred CceeccCCCCcEEEccCCceEEeeccchh
Q 013487 133 GVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 133 givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
++||+|+.+.|+|+++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.015 Score=53.11 Aligned_cols=30 Identities=33% Similarity=0.600 Sum_probs=21.5
Q ss_pred CceeccCCCCcEEE-ccCCceEEeeccchhh
Q 013487 133 GVFHRDLKPENLLL-DSYGVLKISDFGLSAI 162 (442)
Q Consensus 133 givHrDlkp~NIll-~~~~~~kl~DFGla~~ 162 (442)
.++|+|+.|.||++ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.074 Score=51.11 Aligned_cols=74 Identities=16% Similarity=0.223 Sum_probs=47.3
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC---CCCcceEEEEEEeCCEEEEEEE
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E 93 (442)
-.+.+|-|....+|... .+++.+.+|+-.... ...+..|..-|+.|. .-.+.+++.+....+.-|++||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 36778889999999887 677889999876221 234667777777773 4568889998888777899999
Q ss_pred ccCCC
Q 013487 94 FIDGG 98 (442)
Q Consensus 94 ~~~gg 98 (442)
|.+.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 98765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.046 Score=54.77 Aligned_cols=75 Identities=23% Similarity=0.282 Sum_probs=44.4
Q ss_pred EeeecccCceEEEEEEEcCC-CCE-----EEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVET-GDF-----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYI 90 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 90 (442)
.+.|..|-...+|++..... +.. |.+++.... ....-.-.+|+.+++.+...+ -.++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 44555588889999875432 222 444432111 111112347899999996544 4556666542 58
Q ss_pred EEEccCCCCh
Q 013487 91 VLEFIDGGEL 100 (442)
Q Consensus 91 v~E~~~gg~L 100 (442)
+.||++|-+|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999988665
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.027 Score=55.84 Aligned_cols=60 Identities=18% Similarity=0.208 Sum_probs=44.6
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEEcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLLLDS 148 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~l-H~~givHrDlkp~NIll~~ 148 (442)
..++-+|..|..+..++... ..+|+...+++.--+.|+--+ --.+.+|.|+.|.||++--
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 45666788888888877654 456677777777777776554 3458999999999999953
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.027 Score=55.00 Aligned_cols=87 Identities=22% Similarity=0.319 Sum_probs=61.5
Q ss_pred CCCCCcceEEEEE-EeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEc
Q 013487 70 IKHPNVIKIIEVM-ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLD 147 (442)
Q Consensus 70 l~hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~ 147 (442)
...++..+.+-+- ....+.|++|++- |+.| ..+.. -..+++..++.+.+..++-+... ..-|||+...||||+
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId 356 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID 356 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Ccee-eeeec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence 3344444444333 2334567777774 3333 33322 34678889999999988888776 689999999999999
Q ss_pred cCCceEEeeccchhh
Q 013487 148 SYGVLKISDFGLSAI 162 (442)
Q Consensus 148 ~~~~~kl~DFGla~~ 162 (442)
+|++-|+||-+++.
T Consensus 357 -~GnvtLIDfklsRl 370 (488)
T COG5072 357 -EGNVTLIDFKLSRL 370 (488)
T ss_pred -cCceEEEEeeeeec
Confidence 89999999999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.42 Score=54.20 Aligned_cols=30 Identities=30% Similarity=0.478 Sum_probs=25.8
Q ss_pred CCceeccCCCCcEEEccCC--ceE-Eeeccchh
Q 013487 132 RGVFHRDLKPENLLLDSYG--VLK-ISDFGLSA 161 (442)
Q Consensus 132 ~givHrDlkp~NIll~~~~--~~k-l~DFGla~ 161 (442)
.+++|+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 555 99999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.11 Score=47.57 Aligned_cols=85 Identities=18% Similarity=0.237 Sum_probs=58.9
Q ss_pred HHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--Cce
Q 013487 58 EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--GVF 135 (442)
Q Consensus 58 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~--giv 135 (442)
..++.+.+++.++. +|+++..- ..-.+-+++|+|-.... .. ..++..=+.+|.-.|+. +.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~----~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NF----SNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------ch----hHHHHHhHHHHHHhhccCCCee
Confidence 34578888888773 57887732 44456799999854211 00 11111124667788854 799
Q ss_pred eccCCCCcEEEccCCceEEeeccc
Q 013487 136 HRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 136 HrDlkp~NIll~~~~~~kl~DFGl 159 (442)
|+|-.|+||+-|..|.+||.|=+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999764
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.76 E-value=1.1 Score=43.95 Aligned_cols=70 Identities=14% Similarity=0.072 Sum_probs=40.9
Q ss_pred CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC--cceEE---E--EEEeCCEEEEEEEccCC
Q 013487 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN--VIKII---E--VMASKTKIYIVLEFIDG 97 (442)
Q Consensus 25 ~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~g 97 (442)
.-..||.... .++..+++|+.+.... ....+..|+..+..|.... ++... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3456888765 4567799998753321 1345667777777663211 22211 1 12335677889999887
Q ss_pred CC
Q 013487 98 GE 99 (442)
Q Consensus 98 g~ 99 (442)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 53
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 442 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-70 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-70 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-70 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-70 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-70 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-69 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-69 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-67 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-66 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-66 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-65 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-65 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-65 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-64 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-64 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-64 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-64 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-62 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-62 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-53 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-53 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-53 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-52 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-52 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-50 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-50 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-49 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-49 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-49 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-49 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-49 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-49 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-48 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-48 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-48 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-48 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-48 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-48 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-48 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-48 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-48 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-48 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-48 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-48 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-48 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-48 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-48 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-48 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-48 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-48 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-48 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-48 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-48 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-48 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-48 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-48 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-47 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-47 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-47 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-47 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-47 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-47 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-47 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-47 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-47 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-47 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-47 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-47 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-47 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-47 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-47 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-47 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-47 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-47 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-47 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-47 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-47 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-47 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-47 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-47 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-47 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-47 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-46 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-46 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-46 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-46 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-46 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-46 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-46 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-45 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-45 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-45 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-45 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-45 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-45 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-45 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-45 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-45 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-45 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-45 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-45 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-45 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-45 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-45 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-45 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-45 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-45 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-45 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-45 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-45 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-45 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-45 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-45 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-44 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-44 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-44 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-44 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-44 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-44 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-44 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-44 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-44 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-44 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-44 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-44 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-44 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-44 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-44 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-44 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-44 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-44 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-44 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-44 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-44 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-44 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-44 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-43 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-43 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-43 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-43 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-43 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-43 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-43 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-43 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-43 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-43 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-43 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-43 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-43 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-43 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-43 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-43 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-43 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-42 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-42 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-42 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-42 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-42 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-42 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-42 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-42 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-42 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-42 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-42 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-41 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-41 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-41 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-41 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-41 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-41 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-41 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-41 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-41 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-41 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-41 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-40 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-40 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-40 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-40 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-40 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-40 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-40 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-40 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-40 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-40 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-40 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-39 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-39 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-39 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-39 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-39 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-39 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-39 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-39 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-39 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-39 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-39 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-39 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-39 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-39 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-39 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-39 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-39 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-39 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-39 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-39 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-39 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-39 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-39 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-39 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-39 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-39 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-39 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-39 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-39 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-39 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-39 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-38 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-38 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-38 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-38 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-38 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-38 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-38 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-38 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-38 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-38 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-38 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-38 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-38 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-38 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-38 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-38 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-38 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-37 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-37 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-36 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-36 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-36 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-36 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-36 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-36 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-35 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-35 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-35 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-35 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-35 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-34 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-33 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-33 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-33 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-33 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-33 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-33 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-33 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-33 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-33 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-33 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-33 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-33 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-33 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-33 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-33 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-33 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-33 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-33 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-32 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-32 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-32 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-32 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-32 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-32 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-32 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-32 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-32 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-31 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-31 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-31 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-31 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-31 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-31 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-31 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-30 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-30 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-30 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-30 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-30 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-30 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-30 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-29 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-27 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-27 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-27 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-27 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-27 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-27 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-27 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-27 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-27 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-27 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-27 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-27 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-27 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-27 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-27 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-27 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-27 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-27 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-27 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-27 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-27 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-27 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-27 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-27 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-27 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-27 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-27 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-27 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-27 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-27 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-26 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-26 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-26 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-26 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-26 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-26 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-26 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-26 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-26 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-26 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-25 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-25 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-25 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-25 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-25 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-25 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-25 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-25 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-25 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-25 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-25 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-25 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-25 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-25 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-25 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-25 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-25 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-25 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-25 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-25 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-24 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-24 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-24 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-24 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-22 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-21 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-19 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-19 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-19 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-19 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-19 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-19 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-19 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-19 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-19 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-17 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-09 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 9e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 547 bits (1410), Expect = 0.0
Identities = 146/468 (31%), Positives = 246/468 (52%), Gaps = 63/468 (13%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R ++G Y LG TLG G+F KVK K+ TG VA+KI++R ++ +V +I+REI +
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
KL +HP++IK+ +V+++ + I++V+E++ GGELFD I K+GRL E E+RR FQQ+++ VD
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
YCH V HRDLKPEN+LLD++ KI+DFGLS + + + L T+CG+PNY APEV+
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI 187
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247
+ + Y G D+WS GVIL+ L+ G LPFD+ ++ L++KIC F P + + L+
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247
Query: 248 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD---------------- 291
K +L +P R TI + E EWFK+ F ++ + +D
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEE 307
Query: 292 ----AIFNDSKEN--------LVTEKKEKPVSMNAFELISRTKSFSLEN----------- 328
++N + ++ ++ ++ + + + S SF ++
Sbjct: 308 EVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVP 367
Query: 329 ------------------LFEKQTGLVKRE--TRFTSQRPPNEIMSKIEEAAKPLGFNVR 368
K G+ K + SQ PN+IM+++ A K L + +
Sbjct: 368 FLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWK 427
Query: 369 KGN-YKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEF 415
N Y ++++ ++ ++++V ++++ R + LE
Sbjct: 428 VVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-176
Identities = 124/272 (45%), Positives = 182/272 (66%), Gaps = 3/272 (1%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R ++G Y LG TLG G+F KVK ++ TG VA+KI++R ++ +V +IKREI +
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
KL +HP++IK+ +V+++ T ++V+E++ GGELFD I KHGR++E EARR FQQ+++AVD
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
YCH V HRDLKPEN+LLD++ KI+DFGLS + + + L T+CG+PNY APEV+
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI 182
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247
+ + Y G D+WSCGVIL+ L+ G LPFD+ ++ L++KI F P + + L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242
Query: 248 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 279
+L +P R TI + E EWFK+ F
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 489 bits (1261), Expect = e-174
Identities = 127/327 (38%), Positives = 194/327 (59%), Gaps = 13/327 (3%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
+ S+ +G Y + TLGEGSF KVK A + +T VA+K + R + + M +++REI
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
S +KL++HP++IK+ +V+ + T I +V+E+ GGELFD I + R+ EDE RR+FQQ+I
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
A++YCH + HRDLKPENLLLD +KI+DFGLS I + + L T+CG+PNY AP
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAP 176
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244
EV+N K Y G DVWSCG++L+V++ G LPFD+ + L++K+ + P + S GA+
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVN-------LDDVDAIFNDS 297
LI+R++ +P R+TI ++ D WF EE + + S
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFS 296
Query: 298 KENLVT--EKKEKPVSMNAFELISRTK 322
++ +V E A+ L+ +
Sbjct: 297 EDYIVEALRSDENNEVKEAYNLLHENQ 323
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-174
Identities = 105/267 (39%), Positives = 151/267 (56%), Gaps = 5/267 (1%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V ++L +TLGEG++ +V+ A N T + VA+KIVD + + E IK+EI K++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+K Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+KPENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFSCPSW--FSSGAKKLIK 248
+ DVWSCG++L ++AG LP+D+ S+ Y W S L+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYK 275
+IL NP R+TI + +D W+ K K
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-173
Identities = 105/292 (35%), Positives = 151/292 (51%), Gaps = 5/292 (1%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V ++L +TLGEG++ +V+ A N T + VA+KIVD + + E IK+EI K++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+K Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+KPENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFSCPSW--FSSGAKKLIK 248
+ DVWSCG++L ++AG LP+D+ S+ Y W S L+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
+IL NP R+TI + +D W+ K K
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQ 295
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 485 bits (1250), Expect = e-173
Identities = 94/287 (32%), Positives = 154/287 (53%), Gaps = 7/287 (2%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE-QIKREISTMKL 69
+GKY +G LGEGS+ KVK + ET A+KI+ + ++ R E +K+EI ++
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 70 IKHPNVIKIIEVM--ASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINA 125
++H NVI++++V+ K K+Y+V+E+ G E+ D + R +A YF QLI+
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
++Y HS+G+ H+D+KP NLLL + G LKIS G++ D T+ G+P + PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 186 VLND-KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244
+ N + G D+WS GV L+ + G PF+ N+ L+ I + ++ P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD 291
L+K +L+ P R +I Q+ + WF+K + P + D D
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 481 bits (1241), Expect = e-170
Identities = 108/345 (31%), Positives = 170/345 (49%), Gaps = 19/345 (5%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+Y+ + +G G+F + ++ T + VA+K ++R + E ++REI + +
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSL 73
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPN+++ EV+ + T + I++E+ GGEL+++I GR EDEAR +FQQL++ V YCH
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 131 SRGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
S + HRDLK EN LLD LKI DFG S S + GTP Y+APEVL
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLL 190
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK----ICRADFSCPS--WFSSG 242
+ YDG+ +DVWSCGV L+V++ G PF++ YRK I +S P S
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV-NLDDVDAIFNDSKENL 301
LI RI +P TR++I ++ WF K ++ + + +
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310
Query: 302 -VTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTS 345
+ + P N T + L++ + + E S
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDS 353
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 465 bits (1200), Expect = e-165
Identities = 94/281 (33%), Positives = 144/281 (51%), Gaps = 6/281 (2%)
Query: 2 SVKVPASRT---RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE 58
+ ++P +Y GR LG+G FAK + +T + A KIV + +L+ E
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
++ EIS + + H +V+ +++VLE L + + L E EAR Y
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
+Q++ Y H V HRDLK NL L+ +KI DFGL+ + + CGT
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGT 178
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW 238
PNY+APEVL+ KG+ DVWS G I++ L+ G PF+ S L Y +I + ++S P
Sbjct: 179 PNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 279
+ A LI+++L +P R TI+++L DE+F GY P
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-164
Identities = 93/267 (34%), Positives = 140/267 (52%), Gaps = 3/267 (1%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+Y GR LG+G FAK + +T + A KIV + +L+ E++ EIS + +
Sbjct: 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
H +V+ +++VLE L + + L E EAR Y +Q++ Y H
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
V HRDLK NL L+ +KI DFGL+ + + CGTPNY+APEVL+ K
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKK 216
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250
G+ DVWS G I++ L+ G PF+ S L Y +I + ++S P + A LI+++
Sbjct: 217 GHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275
Query: 251 LDPNPDTRMTISQMLEDEWFKKGYKPP 277
L +P R TI+++L DE+F GY P
Sbjct: 276 LQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-162
Identities = 90/274 (32%), Positives = 150/274 (54%), Gaps = 4/274 (1%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
++ +++G LG+GSFA V A+++ TG VAIK++D+ + + MV++++ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVD 127
+KHP+++++ +Y+VLE GE+ + E+EAR + Q+I +
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y HS G+ HRDL NLLL +KI+DFGL+ + +T CGTPNY++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247
+ G SDVWS G + + L+ G PFD + K+ AD+ PS+ S AK LI
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243
Query: 248 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 281
++L NP R+++S +L+ + + D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-160
Identities = 122/302 (40%), Positives = 184/302 (60%), Gaps = 4/302 (1%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
+ +G Y L +T+G+G+FAKVK A+++ TG VAIKI+D+ Q L ++++ RE+
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVR 66
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
MK++ HPN++K+ EV+ ++ +Y+++E+ GGE+FD + HGR+KE EAR F+Q+++A
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
V YCH + + HRDLK ENLLLD+ +KI+DFG S + G L CG P Y APE
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245
+ K YDG DVWS GVIL+ L++G LPFD NL L ++ R + P + S+ +
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK 305
L+KR L NP R T+ Q+++D W G++ E LD D D + +
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQ 303
Query: 306 KE 307
+E
Sbjct: 304 EE 305
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-160
Identities = 93/300 (31%), Positives = 158/300 (52%), Gaps = 32/300 (10%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK------ 55
S ++ +Y L +G+GS+ VK A N + A+K++ + +++R
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 56 -----------------MVEQIKREISTMKLIKHPNVIKIIEVM--ASKTKIYIVLEFID 96
+EQ+ +EI+ +K + HPNV+K++EV+ ++ +Y+V E ++
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156
G + + + L ED+AR YFQ LI ++Y H + + HRD+KP NLL+ G +KI+D
Sbjct: 122 QGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFL 214
FG+S + D LL GTP ++APE L++ K + G+A DVW+ GV L+ + G
Sbjct: 181 FGVSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 215 PFDESNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
PF + +M L+ KI P + K LI R+LD NP++R+ + ++ W +
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-159
Identities = 91/283 (32%), Positives = 160/283 (56%), Gaps = 8/283 (2%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
++P + + +++GR LG+G F V A+ + +A+K++ + Q+ + + Q++RE
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
I ++HPN++++ + +IY++LEF GEL+ ++ KHGR E + + ++L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+A+ YCH R V HRD+KPENLL+ G LKI+DFG S + +R T CGT +Y+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLP 180
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 243
PE++ K +D + D+W GV+ + + G PFD + +R+I D P + S G+
Sbjct: 181 PEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKGYK---PPHFDKEE 283
K LI ++L +P R+ + ++E W K + PP + +
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-156
Identities = 88/279 (31%), Positives = 155/279 (55%), Gaps = 5/279 (1%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
+ + +E+GR LG+G F V A+ ++ +A+K++ + Q+ + + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
++HPN++++ T++Y++LE+ G ++ ++ K + E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
+ YCHS+ V HRD+KPENLLL S G LKI+DFG S + R CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245
++ + +D + D+WS GV+ + + G PF+ + Y++I R +F+ P + + GA+
Sbjct: 178 MIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 284
LI R+L NP R + ++LE W P + +E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 436 bits (1122), Expect = e-153
Identities = 87/320 (27%), Positives = 146/320 (45%), Gaps = 16/320 (5%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE-----QI 60
KY LG G+F V A + E V +K + +++VL +E ++
Sbjct: 17 ACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYF 119
EI+ + ++H N+IK++++ ++ +V+E G +LF I +H RL E A F
Sbjct: 77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T CGT
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTI 193
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF 239
Y APEVL Y G ++WS GV L+ L+ PF E + A P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLV 247
Query: 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE 299
S L+ +L P P+ R T+ +++ D W + + EE ++ ++ +
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAAS 307
Query: 300 NLVTEKKEKPVSMNAFELIS 319
L + A EL
Sbjct: 308 -LEMGNRSLSDVAQAQELCG 326
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 427 bits (1101), Expect = e-150
Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 19/285 (6%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ---IKREIS 65
+Y LG LG+G F V + VAIK++ R++VL + E++
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 66 TMKLI----KHPNVIKIIEVMASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQ 120
+ + HP VI++++ ++ +VLE + +LFD I + G L E +R +F
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTP 179
Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG A+ D GT
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFDGTR 202
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF 239
Y PE ++ Y + VWS G++L+ ++ G +PF+ ++I A+ P+
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHV 256
Query: 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 284
S LI+R L P P +R ++ ++L D W + + + +
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 422 bits (1087), Expect = e-148
Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 17/291 (5%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMV---EQIKR 62
+Y++G LG G F V V VAIK V++D++ + ++
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 63 EISTMKLIKH--PNVIKIIEVMASKTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYF 119
E+ +K + VI++++ ++LE + +LFD I + G L+E+ AR +F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGT 178
Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG A+ + D + GT
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGT 211
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW 238
Y PE + Y GR++ VWS G++L+ ++ G +PF+ +I R
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR 265
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDD 289
SS + LI+ L P R T ++ W + P + +L
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-139
Identities = 67/329 (20%), Positives = 136/329 (41%), Gaps = 50/329 (15%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK----- 55
++ V + Y + RTL +G F K+ + + F A+K ++ + + +
Sbjct: 19 LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKS 76
Query: 56 ---------MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK 106
+ K E+ + IK+ + ++ + ++YI+ E+++ +
Sbjct: 77 NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136
Query: 107 HGRLK--------EDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDF 157
L + + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDF
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPF 216
G S D + + GT ++ PE +++ Y+G D+WS G+ L+V+ +PF
Sbjct: 197 GESEY----MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 217 -DESNLMALYRKICRADFSCP-------------------SWFSSGAKKLIKRILDPNPD 256
+ +L+ L+ I + P ++ S+ +K L NP
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 257 TRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
R+T L+ EW + +E+
Sbjct: 313 ERITSEDALKHEWLADTNIEDLREFSKEL 341
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-113
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 36/298 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E LG+G+F +V A+N + AIK + + + + I E+ + + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQ 62
Query: 74 NVIKIIEV-------------MASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYF 119
V++ + K+ ++I +E+ + G L+D I + DE R F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ------------VR 167
+Q++ A+ Y HS+G+ HRDLKP N+ +D +KI DFGL+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227
L +A GT YVA EVL+ G+ D++S G+I F ++ + + +K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240
Query: 228 ICRADFSCPSWF----SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 281
+ P F KK+I+ ++D +P+ R +L W ++ +
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-113
Identities = 106/281 (37%), Positives = 152/281 (54%), Gaps = 19/281 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMK 68
+Y + +TLG G+ +VK A +T VAIKI+ + + ++ EI +K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+ HP +IKI ++ YIVLE ++GGELFDK+ + RLKE + YF Q++ AV Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 129 CHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
H G+ HRDLKPEN+LL S ++KI+DFG S I + E L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 186 VLNDKGYD--GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWF- 239
VL G RA D WS GVILF+ ++G+ PF + ++L +I +F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 240 -SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 279
S A L+K++L +P R T + L W + F
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 344 bits (883), Expect = e-112
Identities = 89/443 (20%), Positives = 159/443 (35%), Gaps = 55/443 (12%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
G +E+ LG G F V + +TG+ VAIK ++ L K E+ EI MK +
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL 69
Query: 71 KHPNVIKIIEVMASKTKI------YIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQ 121
HPNV+ EV K+ + +E+ +GG+L + + LKE R
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGT 178
+ +A+ Y H + HRDLKPEN++L + KI D G + + + L GT
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGT 186
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFSCPS 237
Y+APE+L K Y D WS G + F + GF PF + + K+
Sbjct: 187 LQYLAPELLEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 238 WF-----------------------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274
+ + ++ ++ +L + R T Q F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL- 304
Query: 275 KPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAF-ELISRTKSFSLEN-LFEK 332
+ + + ++ N + T + ++ + + E +
Sbjct: 305 --------DSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQ 356
Query: 333 QTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATE 392
+GL + +Q + + + L F + + SV+
Sbjct: 357 ASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRK--TVYEPQISLPAHPESVSIV 414
Query: 393 VFEVAPTLHIVEVRKTGGDTLEF 415
+ + L +R+ G +
Sbjct: 415 LQDPKRPLTYTHLRRVWGQIWQT 437
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-109
Identities = 104/274 (37%), Positives = 151/274 (55%), Gaps = 19/274 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMK 68
+Y + +TLG G+ +VK A +T VAI+I+ + + ++ EI +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+ HP +IKI ++ YIVLE ++GGELFDK+ + RLKE + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 129 CHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
H G+ HRDLKPEN+LL S ++KI+DFG S I + E L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
Query: 186 VLNDKGYD--GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWF- 239
VL G RA D WS GVILF+ ++G+ PF + ++L +I +F W
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 240 -SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
S A L+K++L +P R T + L W +
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-109
Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 13/281 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG+G+F+ V+ + TG A KI++ + L + ++++RE + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ + + ++ Y+V + + GGELF+ I E +A QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HR+LKPENLLL S +K++DFGL+ V + H GTP Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y + D+W+CGVIL++L+ G+ PF + + LY +I D+ P W + AK L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYK-PPHFDKEEEVN 286
I +L NP R+T Q L+ W + +++ V+
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-108
Identities = 100/271 (36%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y L T+G GS+ +VK A T A K + + V + V++ K+EI MK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+I++ E T IY+V+E GGELF+++ +E +A R + +++AV YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
V HRDLKPEN L + LK+ DFGL+A + ++ T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y G D WS GV+++VL+ G+ PF + KI F W S A+ L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
I+R+L +P R+T Q LE EWF+K
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-108
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 19/278 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + + +G G +KV N E AIK V+ ++ ++ ++ + EI+ + ++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 86
Query: 74 N--VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ +I++ + + IY+V+E +L + K + E + Y++ ++ AV H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ H DLKP N L+ G+LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 192 YD----------GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPSW 238
SDVWS G IL+ + G PF + N ++ I + P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
+ ++K L +P R++I ++L + + P
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-106
Identities = 93/275 (33%), Positives = 145/275 (52%), Gaps = 20/275 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----HKMVEQIKREISTMK 68
KY+ +G G + V+ + TG A+KI++ ++ E +RE ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 69 -LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
+ HP++I +I+ S + +++V + + GELFD + + L E E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
+ H+ + HRDLKPEN+LLD +++SDFG S + L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPEIL 271
Query: 188 ------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW- 238
GY G+ D+W+CGVILF L+AG PF + + R I FS P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 239 -FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
SS K LI R+L +P+ R+T Q L+ +F++
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-106
Identities = 88/285 (30%), Positives = 137/285 (48%), Gaps = 23/285 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDR------DQVLRHKMVEQIKREISTM 67
YE LG G + V+ + T A+KI+D ++ E +E+ +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 68 KLIK-HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
+ + HPN+I++ + + T ++V + + GELFD + + L E E R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H + HRDLKPEN+LLD +K++DFG S + L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEI 194
Query: 187 L------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW 238
+ N GY G+ D+WS GVI++ L+AG PF M + R I F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 239 --FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP--PHF 279
+S K L+ R L P R T + L +F++ HF
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF 298
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-105
Identities = 90/279 (32%), Positives = 152/279 (54%), Gaps = 12/279 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG+G+F+ V+ + TG A KI++ + L + ++++RE + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 88
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ + + ++ Y+V + + GGELF+ I E +A QQ++ ++ YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HR+LKPENLLL S +K++DFGL+ V + H GTP Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y + D+W+CGVIL++L+ G+ PF + + LY +I D+ P W + AK L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
I +L NP R+T Q L+ W + ++
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 303
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-105
Identities = 97/266 (36%), Positives = 148/266 (55%), Gaps = 13/266 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + LG+GSF +V K+ T A+K++++ ++K I RE+ +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ E++ + YIV E GGELFD+I K R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPEN+LL+S +KI DFGLS +++ + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y DVWS GVIL++L++G PF N + +++ F P W S AK L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKK 272
I+++L +P R+T +Q LE W +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-105
Identities = 90/270 (33%), Positives = 144/270 (53%), Gaps = 17/270 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ R LG G+F V + +G IK +++D+ +EQI+ EI +K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHP 80
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDYC 129
N+IKI EV +YIV+E +GGEL ++I A+ L E +Q++NA+ Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 130 HSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
HS+ V H+DLKPEN+L + +KI DFGL+ + + D A GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF---SSGA 243
+ D+WS GV+++ L+ G LPF ++L + +K + + + A
Sbjct: 198 FK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273
L+K++L +P+ R + +Q+L EWFK+
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-105
Identities = 100/272 (36%), Positives = 146/272 (53%), Gaps = 15/272 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ LG G+F++V K TG A+K + + R +E EI+ +K IKH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHE 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ + ++ S T Y+V++ + GGELFD+I + G E +A QQ+++AV Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLL + + I+DFGLS + ++G++ TACGTP YVAPEVL K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQK 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y +A D WS GVI ++L+ G+ PF E L+ KI +F P W S AK
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
I +L+ +P+ R T + L W
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 76/344 (22%), Positives = 144/344 (41%), Gaps = 25/344 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + + +G G +KV N E AIK V+ ++ ++ ++ + EI+ + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 74 N--VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ +I++ + + IY+V+E +L + K + E + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ H DLKP N L+ G+LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 192 YD----------GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPSW 238
SDVWS G IL+ + G PF + N ++ I + P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSK 298
+ ++K L +P R++I ++L + + P ++ + +++ +
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV--NQMAKGTTEEMKYVLG--- 300
Query: 299 ENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETR 342
LV + A L N +T KR +
Sbjct: 301 -QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-105
Identities = 75/345 (21%), Positives = 143/345 (41%), Gaps = 25/345 (7%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
Y + + +G G +KV N E AIK V+ ++ ++ ++ + EI+ + ++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQ 113
Query: 73 PN--VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+ +I++ + + IY+V+E +L + K + E + Y++ ++ AV H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
G+ H DLKP N L+ G+LK+ DFG++ Q + + G NY+ PE + D
Sbjct: 173 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 191 GYD----------GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPS 237
SDVWS G IL+ + G PF + N ++ I + P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDS 297
+ ++K L +P R++I ++L + + P ++ + +++ +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP--VNQMAKGTTEEMKYVLG-- 347
Query: 298 KENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETR 342
LV + A L N +T KR +
Sbjct: 348 --QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-101
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 52/311 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ L LG+G+ A V ++ +TGD AIK+ + L + V+ RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKN 68
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYC 129
++K+ + T +++EF G L+ + + L E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 130 HSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
G+ HR++KP N++ D V K++DFG + + +D + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPD 185
Query: 186 VL--------NDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADF 233
+ + K Y D+WS GV + G LPF + KI
Sbjct: 186 MYERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 234 SC-------------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 268
S ++ IL+ + + Q +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 269 WFKKGYKPPHF 279
H
Sbjct: 305 SDILHRGNSHH 315
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-101
Identities = 92/279 (32%), Positives = 152/279 (54%), Gaps = 11/279 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y+L LG+G+F+ V+ V G A I++ ++ ++++RE +L+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ + ++ + Y++ + + GGELF+ I E +A QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
V HR+LKPENLLL S +K++DFGL+ + E GTP Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y G+ D+W+CGVIL++L+ G+ PF + + LY++I DF P W + AK L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
I ++L NP R+T ++ L+ W +E
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 98/267 (36%), Positives = 145/267 (54%), Gaps = 17/267 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+ LG G+ + V K T A+K++ + + ++ EI + + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+IK+ E+ + T+I +VLE + GGELFD+I + G E +A +Q++ AV Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLL + LKI+DFGLS I V L+ T CGTP Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSW--FSSGAKK 245
Y G D+WS G+I ++L+ GF PF DE ++R+I F P W S AK
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKK 272
L+++++ +P R+T Q L+ W
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-100
Identities = 95/278 (34%), Positives = 151/278 (54%), Gaps = 19/278 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIK 71
YEL +G+G F+ V+ N ETG A+KIVD + E +KRE S ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLK----EDEARRYFQQLINAVD 127
HP++++++E +S +Y+V EF+DG +L +I K E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 128 YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDG-LLHTACGTPNYVA 183
YCH + HRD+KP +LL S +K+ FG++ Q+ E G + GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--F 239
PEV+ + Y G+ DVW CGVILF+L++G LPF + L+ I + + W
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
S AK L++R+L +P R+T+ + L W K+ +
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 70/360 (19%), Positives = 132/360 (36%), Gaps = 53/360 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ L LG+G+ A V ++ +TGD AIK+ + L + V+ RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKN 68
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYC 129
++K+ + T +++EF G L+ + + L E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 130 HSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
G+ HR++KP N++ D V K++DFG + + +D + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPD 185
Query: 186 VL--------NDKGYDGRASDVWSCGVILFVLMAGFLPFDE----SNLMALYRKICRADF 233
+ + K Y G D+WS GV + G LPF + KI
Sbjct: 186 MYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 234 S-------------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 268
S ++ IL+ + + Q +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 269 WFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTE-KKEKPVSMNAFELISRTKSFSLE 327
H +++ + ++ K+ + + ELI + LE
Sbjct: 305 SDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLE 364
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 6e-99
Identities = 95/270 (35%), Positives = 150/270 (55%), Gaps = 15/270 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLI 70
YE+G LG G FA V+ + TG A K + + ++ R E+I+RE++ ++ I
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPN+I + ++ +KT + ++LE + GGELFD +A+ L EDEA ++ +Q+++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 131 SRGVFHRDLKPENLLLDSYGV----LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
S+ + H DLKPEN++L V +K+ DFG++ + GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEI 182
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSG 242
+N + G +D+WS GVI ++L++G PF I DF + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
AK I+R+L +P RMTI+Q LE W K
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 2e-98
Identities = 97/266 (36%), Positives = 148/266 (55%), Gaps = 13/266 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + LG+GSF +V K+ T A+K++++ ++K I RE+ +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ E++ + YIV E GGELFD+I K R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 134 VFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPEN+LL+S +KI DFGLS +++ + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y DVWS GVIL++L++G PF N + +++ F P W S AK L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKK 272
I+++L +P R+T +Q LE W +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-98
Identities = 89/310 (28%), Positives = 140/310 (45%), Gaps = 51/310 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIK 71
KY L +G+GS+ V+ A +T AIKI++++++ + K VE+IK E+ MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR---------------------- 109
HPN+ ++ EV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 ------------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--Y 149
+E +Q+ +A+ Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 150 GVLKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVIL 206
+K+ DFGLS E + T GTP +VAPEVLN G D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 207 FVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPDTRMTIS 262
+L+ G +PF N ++ F P++ S A+ L+ +L+ N D R
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 263 QMLEDEWFKK 272
+ L+ W +
Sbjct: 327 RALQHPWISQ 336
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 5e-98
Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 22/284 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKH 72
YE+ +G GS++ K + T A+KI+D+ + EI + + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
PN+I + +V +Y+V E + GGEL DKI + E EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 133 GVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
GV HRDLKP N+L + ++I DFG + + E+GLL T C T N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFD---ESNLMALYRKICRA--DFSCPSW--FSS 241
+GYD A D+WS GV+L+ ++ G+ PF + + +I S W S
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
AK L+ ++L +P R+T + +L W + P + +
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 9e-98
Identities = 106/327 (32%), Positives = 172/327 (52%), Gaps = 18/327 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y+ R LG+GSF +V K+ TG A+K++ + QV + E + RE+ +K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ E K Y+V E GGELFD+I R E +A R +Q+++ + Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 134 VFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLLL+S ++I DFGLS + GT Y+APEVL+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y DVWS GVIL++L++G PF+ +N + +K+ + F P W S AK L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK- 305
I+++L P R++ L+ EW + + ++ V++ +D + ++ T+K
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQT-----YTKEQISVDVPSLDNAILNIRQFQGTQKL 316
Query: 306 KEKPVSMNAFELISRTKSFSLENLFEK 332
+ + +L S+ ++ L +F K
Sbjct: 317 AQAALLYMGSKLTSQDETKELTAIFHK 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 5e-97
Identities = 90/283 (31%), Positives = 145/283 (51%), Gaps = 15/283 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLI 70
Y++G LG G FA VK + TG A K + + Q R E+I+RE+S ++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
H NVI + +V ++T + ++LE + GGELFD +A+ L E+EA + +Q+++ V+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 131 SRGVFHRDLKPENLLLDS----YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
++ + H DLKPEN++L +K+ DFGL+ + + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEI 189
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSG 242
+N + G +D+WS GVI ++L++G PF I DF + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
AK I+++L R+TI + L W + E V
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 7e-97
Identities = 96/282 (34%), Positives = 145/282 (51%), Gaps = 15/282 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM---VEQIKREISTMKLI 70
Y+ G LG G FA VK + TG A K + + + + E I+RE+S +K I
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPNVI + EV +KT + ++LE + GGELFD +A+ L E+EA + +Q++N V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 131 SRGVFHRDLKPENLLLDSY----GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
S + H DLKPEN++L +KI DFGL+ + GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEI 188
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSG 242
+N + G +D+WS GVI ++L++G PF + +F + S+
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 284
AK I+R+L +P RMTI L+ W K ++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAS 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-96
Identities = 109/367 (29%), Positives = 175/367 (47%), Gaps = 32/367 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y+ + LG G++ +V ++ T AIKI+ + + ++ E++ +KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ + K Y+V+E GGELFD+I + E +A +Q+++ V Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 134 VFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLLL+S ++KI DFGLSA+ + GT Y+APEVL K
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
Y DVWS GVILF+L+AG+ PF + RK+ + F P W S GAK L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAI--FNDSK------ 298
IK++L + R++ Q LE W K+ E + ++ + F +S+
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAA 331
Query: 299 -----ENLVTEKKEKPVSMNAFELISRTKS--FSLENLFEKQTGLVKRETRFTSQRPPNE 351
L ++ +E + F I + + L + G K + +
Sbjct: 332 LLYMASKLTSQ-EETKELTDIFRHIDKNGDGQLDRQELID---GYSKLSGEEVAVFDLPQ 387
Query: 352 IMSKIEE 358
I S+++
Sbjct: 388 IESEVDA 394
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-95
Identities = 90/283 (31%), Positives = 146/283 (51%), Gaps = 15/283 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLI 70
Y++G LG G FA VK + TG A K + + Q R E+I+RE+S ++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
HPN+I + +V ++T + ++LE + GGELFD +A+ L E+EA + +Q+++ V+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 131 SRGVFHRDLKPENLLLDS----YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
++ + H DLKPEN++L +K+ DFGL+ + + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEI 189
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSG 242
+N + G +D+WS GVI ++L++G PF I DF + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 285
AK I+++L R+TI + L W + E V
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 2e-95
Identities = 96/282 (34%), Positives = 145/282 (51%), Gaps = 22/282 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM----------VEQIKRE 63
Y R LG G++ +V K AIK++ + Q + + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
IS +K + HPN+IK+ +V K Y+V EF +GGELF++I + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
+ + Y H + HRD+KPEN+LL++ +KI DFGLS+ +D L GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAY 213
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW 238
Y+APEVL K Y DVWSCGVI+++L+ G+ PF N + +K+ + F W
Sbjct: 214 YIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 239 --FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
S AK+LIK +L + + R T + L W KK +
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-95
Identities = 94/282 (33%), Positives = 156/282 (55%), Gaps = 27/282 (9%)
Query: 14 KYELG---RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
Y+L + LGEGSF+ + + ++ A+KI+ + +M ++EI+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLC 62
Query: 71 K-HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ HPN++K+ EV + ++V+E ++GGELF++I K E EA ++L++AV +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 130 HSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H GV HRDLKPENLL +KI DFG + + ++ L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKICRA--DFSCPS 237
LN GYD + D+WS GVIL+ +++G +PF + + + +KI + F +
Sbjct: 181 LNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 238 W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
W S AK LI+ +L +P+ R+ +S + +EW + G +
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-93
Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 16/286 (5%)
Query: 14 KYEL-GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
Y L + LG G FA V+ + TG A K + + + +I EI+ ++L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87
Query: 73 -PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYC 129
P VI + EV + ++I ++LE+ GGE+F + E++ R +Q++ V Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 130 HSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H + H DLKP+N+LL G +KI DFG+S + L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEI 204
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSG 242
LN A+D+W+ G+I ++L+ PF + Y I + D+S ++ S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD 288
A I+ +L NP+ R T L W ++ F EE +
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 3e-93
Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 15/271 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + LG G F V + K V + +K+EIS + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
N++ + E S ++ ++ EFI G ++F++I L E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 133 GVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ H D++PEN++ + +KI +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
A+D+WS G +++VL++G PF + I A F ++ S A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
+ R+L +RMT S+ L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-92
Identities = 98/354 (27%), Positives = 164/354 (46%), Gaps = 40/354 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHP 73
+ LG G KV N T + A+K++ + +RE+ + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 74 NVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVD 127
++++I++V A + + IV+E +DGGELF +I G E EA + + A+
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 128 YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
Y HS + HRD+KPENLL S +LK++DFG +++ L T C TP YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKETTSHNSLTTPCYTPYYVAP 232
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRA--DFSCPSW 238
EVL + YD ++ D+WS GVI+++L+ G+ PF ++ +A + +I +F P W
Sbjct: 233 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 239 --FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFND 296
S K LI+ +L P RMTI++ + W + K P + L +
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QTPLHTSRVL--K 343
Query: 297 SKENLVTEKKEKPVSMNAFELISRTKSFSLENLFE-KQTGLVKRETRFTSQRPP 349
+ + KE+ S A + + ++ + + L+KR + +
Sbjct: 344 EDKERWEDVKEEMTSALATMRVDY-EQIKIKKIEDASNPLLLKRRKKARALEAA 396
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 5e-92
Identities = 86/294 (29%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 14 KYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
Y+L LGEG+ A+V+ N+ T A+KI+++ + ++ RE+ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+++IE + + Y+V E + GG + I K E EA Q + +A+D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 132 RGVFHRDLKPENLLLDSYG---VLKISDFGLSAI-----SQQVREDGLLHTACGTPNYVA 183
+G+ HRDLKPEN+L + +KI DF L + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 184 PEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---------------MA 223
PEV+ YD R D+WS GVIL++L++G+ PF
Sbjct: 190 PEVVEAFSEEASIYDKRC-DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 224 LYRKICRADFSCPS--W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273
L+ I + P W S AK LI ++L + R++ +Q+L+ W +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 5e-92
Identities = 93/305 (30%), Positives = 150/305 (49%), Gaps = 32/305 (10%)
Query: 14 KYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIK 71
Y+L + LG G KV + TG A+K++ + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASG 80
Query: 72 HPNVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINA 125
P+++ I++V K + I++E ++GGELF +I + G E EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ + HS + HRD+KPENLL S VLK++DFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYV 196
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRA--DFSCP 236
APEVL + YD ++ D+WS GVI+++L+ GF PF ++ + R+I F P
Sbjct: 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 237 SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIF 294
W S AK+LI+ +L +P R+TI+Q + W + P L + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 295 NDSKE 299
++ KE
Sbjct: 316 DEVKE 320
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 1e-90
Identities = 90/362 (24%), Positives = 154/362 (42%), Gaps = 25/362 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG G+F V TG+ A K V E +++EI TM +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 214
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSR 132
++ + + ++ ++ EF+ GGELF+K+ +H ++ EDEA Y +Q+ + + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 133 GVFHRDLKPENLLLDSYGV--LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
H DLKPEN++ + LK+ DFGL + + + GT + APEV K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
G +D+WS GV+ ++L++G PF N R + + ++ S K
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKK 306
I+++L +P+TRMTI Q LE W G P + ++++ T+
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY-------TKIRDSIKTKYD 443
Query: 307 EKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFN 366
P + IS S + R+ + + K G +
Sbjct: 444 AWPEPLPPLGRISNYSSLRK----HRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQS 499
Query: 367 VR 368
Sbjct: 500 AN 501
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-90
Identities = 49/305 (16%), Positives = 103/305 (33%), Gaps = 53/305 (17%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
R G LG+ A + ETG+ + + + ++Q+K E+ ++L+
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 71 ----------------------KHPNVIKIIEVMASKTKIYIVLEFI-----------DG 97
K P K+I V + ++++ F G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157
L + H L + Q+I + H G+ H L+P +++LD G + ++ F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLND----------KGYDGRASDVWSCGVILF 207
DG + + + PE+ + + D W+ G++++
Sbjct: 251 EHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 208 VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
+ LP + + I F + L++ L + R+ Q +E
Sbjct: 305 WIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360
Query: 268 EWFKK 272
+++
Sbjct: 361 PEYEQ 365
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 4e-90
Identities = 77/272 (28%), Positives = 132/272 (48%), Gaps = 14/272 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG G+F V TG K ++ L +K EIS M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHP 108
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
+I + + K ++ ++LEF+ GGELFD+IA ++ E E Y +Q + + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 133 GVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ H D+KPEN++ ++ +KI DFGL+ + D ++ T + APE+++ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKL 246
G +D+W+ GV+ +VL++G PF + + + + R +F ++ S AK
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
IK +L P R+T+ LE W K +
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-89
Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 16/282 (5%)
Query: 14 KYELGRT--LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
Y + +T LG G F +V + TG +A KI+ + K E++K EIS M +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD 144
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCH 130
H N+I++ + SK I +V+E++DGGELFD+I + L E + + +Q+ + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 131 SRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
+ H DLKPEN+L + +KI DFGL +++ + L GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGL---ARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAK 244
+D+WS GVI ++L++G PF N I D + S AK
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVN 286
+ I ++L R++ S+ L+ W +++ N
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 2e-89
Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 23/284 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + LGEG F+ V + + G F A+K + + E+ +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNHP 86
Query: 74 NVIKIIEV----MASKTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINA 125
N+++++ +K + +++L F G L+++I K L ED+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-------SQQVREDGLLHTACGT 178
++ H++G HRDLKP N+LL G + D G S+Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 179 PNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADFSC 235
+Y APE+ + + + +DVWS G +L+ +M G P+D + S
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 236 PSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
P SS +L+ ++ +P R I +L + P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 9e-88
Identities = 82/281 (29%), Positives = 139/281 (49%), Gaps = 16/281 (5%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+R YE+ T+G GS+ + + + G + K +D + + + E++ ++
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE 61
Query: 70 IKHPNVIKIIE--VMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLI 123
+KHPN+++ + + + T +YIV+E+ +GG+L I K + L E+ R QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 124 NAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
A+ CH R V HRDLKP N+ LD +K+ DFGL+ I + T GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGT 179
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PS 237
P Y++PE +N Y+ + SD+WS G +L+ L A PF + L KI F P
Sbjct: 180 PYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
+S ++I R+L+ R ++ ++LE+ + + H
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 3e-87
Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 34/292 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKH 72
+ + R L EG FA V A++V +G A+K + + I +E+ MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNEEEKNRAIIQEVCFMKKLSGH 85
Query: 73 PNVIKII-------EVMASKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQL 122
PN+++ E + +++L + G+L + + K G L D + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 123 INAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSAI-------SQQVREDGLLH 173
AV + H + + HRDLK ENLLL + G +K+ DFG + S + L+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 174 ---TACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
T TP Y PE+++ G D+W+ G IL++L PF++ + I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----I 261
Query: 229 CRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
+S P + LI+ +L NP+ R++I++++ + +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 9e-87
Identities = 79/277 (28%), Positives = 141/277 (50%), Gaps = 10/277 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + +GEGSF K K+ E G IK ++ + + K E+ +RE++ + +KHP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHS 131
N+++ E +YIV+++ +GG+LF +I K +ED+ +F Q+ A+ + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R + HRD+K +N+ L G +++ DFG++ + L GTP Y++PE+ +K
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRI 250
Y+ SD+W+ G +L+ L F+ ++ L KI F +S + L+ ++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 251 LDPNPDTRMTISQMLEDEWFKKG---YKPPHFDKEEE 284
NP R +++ +LE + K + P EE
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEF 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 3e-85
Identities = 78/244 (31%), Positives = 136/244 (55%), Gaps = 1/244 (0%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ G+ LGEGSF+ V A+ + T AIKI+++ +++ V + RE M + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+K+ K+Y L + GEL I K G E R Y ++++A++Y H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRDLKPEN+LL+ ++I+DFG + + + ++ GT YV+PE+L +K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-C 210
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
++SD+W+ G I++ L+AG PF N +++KI + ++ P F A+ L++++L +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 255 PDTR 258
R
Sbjct: 271 ATKR 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 1e-82
Identities = 80/286 (27%), Positives = 140/286 (48%), Gaps = 11/286 (3%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
+ + + + +G G F++V A + G VA+K V ++ K +EI
Sbjct: 25 DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEID 84
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQ 121
+K + HPNVIK ++ IVLE D G+L I + + E +YF Q
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
L +A+++ HSR V HRD+KP N+ + + GV+K+ D GL + H+ GTP Y
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYY 202
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRADFSC--PS 237
++PE +++ GY+ SD+WS G +L+ + A PF D+ NL +L +KI + D+
Sbjct: 203 MSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEE 283
+S ++L+ ++P+P+ R ++ + + +
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-81
Identities = 79/317 (24%), Positives = 119/317 (37%), Gaps = 52/317 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKH 72
+ LG GS V F G VA+K + D + EI + + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDH 68
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINA 125
PNVI+ + +YI LE L D + KE +Q+ +
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGV-------------LKISDFGLSAI--SQQVREDG 170
V + HS + HRDLKP+N+L+ + + ISDFGL S Q
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 171 LLHTACGTPNYVAPEVLNDKGYD------GRASDVWSCGVILFVLM-AGFLPFDESNLMA 223
L+ GT + APE+L + R+ D++S G + + ++ G PF +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246
Query: 224 LYRKICRADFSCPSW-------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
I R FS + A LI +++D +P R T ++L F K
Sbjct: 247 -ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
Query: 277 PHF-----DKEEEVNLD 288
F D+ E N D
Sbjct: 306 LEFLLKVSDRLEIENRD 322
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-81
Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 33/276 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ +G G F +V AK+ G IK V + E+ +RE+ + + H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVN 65
Query: 75 VIKIIE----------------VMASKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEAR 116
++ + ++I +EF D G L I + +L + A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176
F+Q+ VDY HS+ + +RDLKP N+ L +KI DFGL ++ DG +
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSK 182
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 236
GT Y++PE ++ + Y + D+++ G+IL L+ E++ + +
Sbjct: 183 GTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII--S 237
Query: 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
F K L++++L P+ R S++L K
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 3e-80
Identities = 64/291 (21%), Positives = 118/291 (40%), Gaps = 24/291 (8%)
Query: 8 SRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
S VGK + LG G+ + + + + VA+K + + RE+
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQ 69
Query: 66 TMK-LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLI 123
++ +HPNVI+ + YI +E L + + K E QQ
Sbjct: 70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTT 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLSA-ISQQVREDGLLHTACG 177
+ + + HS + HRDLKP N+L+ ISDFGL ++ G
Sbjct: 129 SGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 178 TPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFS 234
T ++APE+L++ + D++S G + + +++ G PF +S +
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248
Query: 235 CPSWF---SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 282
C A++LI++++ +P R + +L+ +F K F ++
Sbjct: 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-79
Identities = 84/307 (27%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHP 73
+ LG G KV N T + A+K++ + +RE+ + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 74 NVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVD 127
++++I++V A + + IV+E +DGGELF +I G E EA + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 128 YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
Y HS + HRD+KPENLL S +LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRA--DFSCPSW 238
E + YD ++ D+WS GVI+++L+ G+ PF ++ +A + +I +F P W
Sbjct: 169 ETTG-EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 239 --FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFND 296
S K LI+ +L P RMTI++ + W + K P L + + D
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 286
Query: 297 SKENLVT 303
KE + +
Sbjct: 287 VKEEMTS 293
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 4e-78
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 31/290 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E + LG G F V AKN AIK + R E++ RE+ + ++HP
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHP 63
Query: 74 NVIKIIEV------------MASKTKIYIVLEFIDGGELFDKIAKHGRLK---EDEARRY 118
+++ + K +YI ++ L D + ++
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI----------SQQVRE 168
F Q+ AV++ HS+G+ HRDLKP N+ V+K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 228
GT Y++PE ++ Y D++S G+ILF L+ F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLYPF--STQMERVRTLTDV 240
Query: 229 CRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
F + +++ +L P+P R ++E+ F+ P
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 243 bits (624), Expect = 6e-78
Identities = 98/316 (31%), Positives = 169/316 (53%), Gaps = 40/316 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ RTLG GSF +V ++ G + A+K++ ++ V+R K VE E + ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I++ +I++++++I+GGELF + K R A+ Y ++ A++Y HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD G +KI+DFG + + +T CGTP+Y+APEV++ K Y
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
++ D WS G++++ ++AG+ PF +SN M Y KI A+ P +F+ K L+ R++ +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 255 PDTRMTISQMLEDE-----WFK---------KGYKPP-------------HFDK--EEEV 285
R+ Q ++ WFK + + P FDK EE++
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDI 301
Query: 286 NL-----DDVDAIFND 296
N D +F D
Sbjct: 302 NYGVQGEDPYADLFRD 317
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 6e-78
Identities = 94/313 (30%), Positives = 160/313 (51%), Gaps = 37/313 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ +TLG GSF +V K+ E+G+ A+KI+D+ +V++ K +E E ++ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++K+ + +Y+V+E++ GGE+F + + GR E AR Y Q++ +Y HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPENLL+D G ++++DFG + R G T CGTP +APE++ KGY
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGY-N 216
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
+A D W+ GV+++ + AG+ PF + +Y KI PS FSS K L++ +L +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 255 PDTRMTISQMLEDE-----WFK---------KGYKPP------------HFDK--EEEVN 286
R + ++ WF + + P +FD EEE+
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336
Query: 287 L---DDVDAIFND 296
+ + F +
Sbjct: 337 VSINEKCGKEFTE 349
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 5e-77
Identities = 44/301 (14%), Positives = 87/301 (28%), Gaps = 47/301 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
K +L L G + V ++VE + A+K+ +E++ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 74 NVIKIIEVM--------------------------ASKTKIYIVLEFIDG-----GELFD 102
+ + + + +++ D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 103 KIAKHGRLKEDEARRYF-QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161
+ + A QLI S+G+ H P+NL + G L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL- 241
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLPFDESN 220
+ + Y E LN A + W G+ ++ + FLPF
Sbjct: 242 ----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 221 --LMALYRKICRA-------DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
+ +++ F + K LI R L+ + R+ + +E F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 272 K 272
+
Sbjct: 358 Q 358
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-76
Identities = 63/261 (24%), Positives = 111/261 (42%), Gaps = 10/261 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ LG GS+ +V ++ E G A+K ++ S K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
+++ + +Y+ E G L G L E + Y + + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
G+ H D+KP N+ L G K+ DFGL ++ G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 193 DGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 251
A+DV+S G+ + + LP L + +F + SS + ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 252 DPNPDTRMTISQMLEDEWFKK 272
+P+P R T +L ++
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-75
Identities = 50/307 (16%), Positives = 101/307 (32%), Gaps = 44/307 (14%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
R R G LG+ A + ETG+ + + + ++Q+K
Sbjct: 70 ESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 63 EISTMKL----------------------IKHPNVIKIIEVMASKTKIYIVLEFID---- 96
E+ ++L +K P K+I V + ++++ F
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 97 -------GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149
G L + H L + Q+I + H G+ H L+P +++LD
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 247
Query: 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD----GRASDVWSCGVI 205
G + ++ F + + P A +L + A D W+ G+
Sbjct: 248 GGVFLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 206 LFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 265
++ + LP + + I F + L++ L + R+ Q +
Sbjct: 307 IYWIWCADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362
Query: 266 EDEWFKK 272
E +++
Sbjct: 363 ETPEYEQ 369
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-69
Identities = 76/301 (25%), Positives = 150/301 (49%), Gaps = 31/301 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
E+ R +G+GSF KV + +T A+K +++ + + V + +E+ M+ ++HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVF 135
+ + + +++V++ + GG+L + ++ KE+ + + +L+ A+DY ++ +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK---GY 192
HRD+KP+N+LLD +G + I+DF ++A+ + + + T GT Y+APE+ + + GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAM---LPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 193 DGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249
A D WS GV + L+ G P+ ++ + + PS +S L+K+
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 250 ILDPNPDTRM-TISQMLEDEWFK---------KGYKPP--------HFDKE---EEVNLD 288
+L+PNPD R +S + + K P + D EE+ L+
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFELEEMILE 313
Query: 289 D 289
Sbjct: 314 S 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 221 bits (563), Expect = 2e-68
Identities = 42/287 (14%), Positives = 95/287 (33%), Gaps = 34/287 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ LGEG+FA+V A + + +K+ + Q+ +K
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER---LK 122
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-----LKEDEARRYFQQLI 123
+K + +V E G L + I + + + + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 124 NAVDYCHSRGVFHRDLKPENLLL-----------DSYGVLKISDFGLSAISQQVREDGLL 172
++ H + H D+KP+N +L D L + D G S + + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA 231
C T + E+L++K ++ D + ++ ++ G ++ + R
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 232 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE---DEWFKKGYK 275
W + +L+ + +L + F++ Y
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-67
Identities = 92/319 (28%), Positives = 153/319 (47%), Gaps = 32/319 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ + LG+G+F KV + TG + A+KI+ ++ ++ V E ++ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+ + + ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RD+K ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
RA D W GV+++ +M G LPF + L+ I + P S AK L+ +L +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 255 PDTRMTISQMLEDE-----WFK---------KGYKPP------------HFDKE---EEV 285
P R+ E +F K PP +FD E + +
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSI 303
Query: 286 NLDDVDAIFNDSKENLVTE 304
+ D + L
Sbjct: 304 TITPPDRYDSLGLLELDQR 322
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-67
Identities = 89/307 (28%), Positives = 152/307 (49%), Gaps = 28/307 (9%)
Query: 1 MSVKVPASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE 58
++ + P+ + ++ + L + LG+GSF KV A+ +T F AIK + +D VL VE
Sbjct: 3 LNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE 62
Query: 59 QIKREISTMKL-IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR 117
E + L +HP + + +K ++ V+E+++GG+L I + A
Sbjct: 63 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 122
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y ++I + + HS+G+ +RDLK +N+LLD G +KI+DFG+ + + D +T CG
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCG 180
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 237
TP+Y+APE+L + Y + D WS GV+L+ ++ G PF + L+ I + P
Sbjct: 181 TPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 239
Query: 238 WFSSGAKKLIKRILDPNPDTRM-TISQMLEDEWFK---------KGYKPP---------- 277
W AK L+ ++ P+ R+ + + F+ K PP
Sbjct: 240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 299
Query: 278 --HFDKE 282
+FDKE
Sbjct: 300 CSNFDKE 306
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-67
Identities = 89/305 (29%), Positives = 147/305 (48%), Gaps = 31/305 (10%)
Query: 6 PASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
P+S + + +G+GSF KV A++ F A+K++ + +L+ K + I E
Sbjct: 29 PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 64 ISTM-KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
+ + K +KHP ++ + + K+Y VL++I+GGELF + + E AR Y ++
Sbjct: 89 RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+A+ Y HS + +RDLKPEN+LLDS G + ++DFGL + + + T CGTP Y+
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYL 206
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 242
APEVL+ + Y R D W G +L+ ++ G PF N +Y I ++
Sbjct: 207 APEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS 265
Query: 243 AKKLIKRILDPNPDTRMTISQMLED----EWFK---------KGYKPP------------ 277
A+ L++ +L + R+ + +F K PP
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLR 325
Query: 278 HFDKE 282
HFD E
Sbjct: 326 HFDPE 330
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 89/311 (28%), Positives = 156/311 (50%), Gaps = 33/311 (10%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVL-RHKMV 57
SV + R +EL R LG+G + KV + TG A+K++ + ++ K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 58 EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR 117
K E + ++ +KHP ++ +I + K+Y++LE++ GGELF ++ + G ED A
Sbjct: 66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF 125
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y ++ A+ + H +G+ +RDLKPEN++L+ G +K++DFGL + + + + HT CG
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCG 183
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 237
T Y+APE+L G+ RA D WS G +++ ++ G PF N KI + + P
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP 242
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP------ 277
+ + A+ L+K++L N +R+ E +F+ + +PP
Sbjct: 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQ 302
Query: 278 ------HFDKE 282
FD +
Sbjct: 303 SEEDVSQFDSK 313
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-66
Identities = 85/309 (27%), Positives = 155/309 (50%), Gaps = 31/309 (10%)
Query: 2 SVKVPASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ 59
+R R+ + LG+GSF KV ++ T + A+KI+ +D V++ VE
Sbjct: 7 KFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC 66
Query: 60 IKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
E + L K P + ++ + ++Y V+E+++GG+L I + GR KE A Y
Sbjct: 67 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY 126
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
++ + + S+G+ +RDLK +N++LDS G +KI+DFG+ + + + T CGT
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGT 184
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW 238
P+Y+APE++ + Y G++ D W+ GV+L+ ++AG PF+ + L++ I + + P
Sbjct: 185 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 243
Query: 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP------- 277
S A + K ++ +P R+ E + +F+ K +PP
Sbjct: 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG 303
Query: 278 ----HFDKE 282
+FD+
Sbjct: 304 RNAENFDRF 312
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 6e-66
Identities = 93/296 (31%), Positives = 154/296 (52%), Gaps = 31/296 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
+E R LG+GSF KV A+ ETGD A+K++ +D +L+ VE E + L HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ ++ + +++ V+EF++GG+L I K R E AR Y ++I+A+ + H +G
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLD G K++DFG+ + + T CGTP+Y+APE+L + Y
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY- 201
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
G A D W+ GV+L+ ++ G PF+ N L+ I + P+W A ++K +
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261
Query: 254 NPDTRM-TISQMLEDE-----WFK---------KGYKPP------------HFDKE 282
NP R+ +++Q E +FK + +PP +FD +
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPD 317
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-65
Identities = 89/313 (28%), Positives = 158/313 (50%), Gaps = 35/313 (11%)
Query: 1 MSVKVPASRTRVG--KYELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHK 55
++ V + ++EL + LG+GSF KV K + A+K++ + +
Sbjct: 10 ITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 56 MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA 115
V K E + + HP ++K+ ++ K+Y++L+F+ GG+LF +++K E++
Sbjct: 70 RVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 128
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
+ Y +L A+D+ HS G+ +RDLKPEN+LLD G +K++DFGLS + + + ++
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSF 186
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC 235
CGT Y+APEV+N +G+ +++D WS GV++F ++ G LPF + I +A
Sbjct: 187 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 245
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP---- 277
P + S A+ L++ + NP R+ +E +F + PP
Sbjct: 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPA 305
Query: 278 --------HFDKE 282
+FD E
Sbjct: 306 TGRPEDTFYFDPE 318
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 8e-65
Identities = 97/311 (31%), Positives = 155/311 (49%), Gaps = 32/311 (10%)
Query: 1 MSVKVPASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE 58
M V + + RV ++E + LG+G+F KV K TG + A+KI+ ++ ++ V
Sbjct: 134 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
E ++ +HP + + + ++ V+E+ +GGELF +++ ED AR Y
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 119 FQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
++++A+DY HS + V +RDLK ENL+LD G +KI+DFGL + +++ + T CG
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCG 311
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 237
TP Y+APEVL D Y GRA D W GV+++ +M G LPF + L+ I + P
Sbjct: 312 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP------ 277
AK L+ +L +P R+ E +F K PP
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVT 430
Query: 278 ------HFDKE 282
+FD+E
Sbjct: 431 SETDTRYFDEE 441
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-64
Identities = 78/254 (30%), Positives = 141/254 (55%), Gaps = 13/254 (5%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
++L R +G GS+AKV + +T A+K+V ++ V + ++ ++ E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + ++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 187
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMA---------LYRKICRADFSCPSWFSSGAK 244
G + D W+ GV++F +MAG PFD L++ I P S A
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247
Query: 245 KLIKRILDPNPDTR 258
++K L+ +P R
Sbjct: 248 SVLKSFLNKDPKER 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-64
Identities = 88/314 (28%), Positives = 153/314 (48%), Gaps = 38/314 (12%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ R + YE+ + +G G+F +V+ ++ T A+K++ + ++++ E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M P V+++ +Y+V+E++ GG+L + + + E AR Y +++
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVV 178
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNY 181
A+D HS G HRD+KP+N+LLD G LK++DFG ++ ++G++ TA GTP+Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDY 235
Query: 182 VAPEVLNDKGYD---GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI--CRADFSCP 236
++PEVL +G D GR D WS GV L+ ++ G PF +L+ Y KI + + P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295
Query: 237 S--WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFK---------KGYKPP----- 277
S AK LI L + + R+ + ++ +FK + P
Sbjct: 296 DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 354
Query: 278 -------HFDKEEE 284
+FD EE
Sbjct: 355 SSDIDTSNFDDLEE 368
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-63
Identities = 80/316 (25%), Positives = 145/316 (45%), Gaps = 40/316 (12%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
KV R +E+ + +G G+F +V K A+KI+++ ++L+ + E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQL 122
+ + + +Y+V+++ GG+L ++K RL E+ AR Y ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPN 180
+ A+D H HRD+KP+N+L+D G ++++DFG ++ EDG + A GTP+
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPD 241
Query: 181 YVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADF 233
Y++PE+L Y G D WS GV ++ ++ G PF +L+ Y KI + F
Sbjct: 242 YISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300
Query: 234 SCPSW---FSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFK-------KGYKPP--- 277
P+ S AK LI+R++ R+ I + +F + + P
Sbjct: 301 QFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIP 359
Query: 278 ---------HFDKEEE 284
+FD +++
Sbjct: 360 EVSSPTDTSNFDVDDD 375
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 77/254 (30%), Positives = 141/254 (55%), Gaps = 13/254 (5%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
++L R +G GS+AKV + +T A+++V ++ V + ++ ++ E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + ++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMA---------LYRKICRADFSCPSWFSSGAK 244
G + D W+ GV++F +MAG PFD L++ I P S A
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 245 KLIKRILDPNPDTR 258
++K L+ +P R
Sbjct: 291 SVLKSFLNKDPKER 304
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-63
Identities = 83/294 (28%), Positives = 151/294 (51%), Gaps = 29/294 (9%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
+ LG+GSF KV ++ T + A+KI+ +D V++ VE E + L K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ ++ + ++Y V+E+++GG+L I + GR KE A Y ++ + + S+G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY- 519
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
G++ D W+ GV+L+ ++AG PF+ + L++ I + + P S A + K ++
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579
Query: 254 NPDTRMTISQMLEDE-----WFK---------KGYKPP-----------HFDKE 282
+P R+ E + +F+ K +PP +FD+
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNAENFDRF 633
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 7e-63
Identities = 83/319 (26%), Positives = 147/319 (46%), Gaps = 40/319 (12%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK 61
V++ R + +E+ + +G G+F++V K +TG A+KI+++ +L+ V +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 62 REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQ 120
E + + ++ + +Y+V+E+ GG+L ++K G R+ + AR Y
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGT 178
+++ A+D H G HRD+KP+N+LLD G ++++DFG ++R DG + A GT
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGT 226
Query: 179 PNYVAPEVLNDKGYD------GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--R 230
P+Y++PE+L G G D W+ GV + + G PF + Y KI +
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286
Query: 231 ADFSCPS---WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFK-------KGYKPP 277
S P A+ I+R+L P+TR+ +F + PP
Sbjct: 287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPP 345
Query: 278 ------------HFDKEEE 284
+FD E+
Sbjct: 346 FTPDFEGATDTCNFDLVED 364
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-62
Identities = 71/335 (21%), Positives = 123/335 (36%), Gaps = 73/335 (21%)
Query: 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD-------RDQVLR------ 53
ASR +E + +G G F V AKN AIK + R++V+R
Sbjct: 1 ASRYL-TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 59
Query: 54 ------------------------------------------HKMVEQIKREISTMKLIK 71
++ +I M
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDE---ARRYFQQLINAVDY 128
N + ++ + K +YI ++ L D + + L++ E F Q+ AV++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED----------GLLHTACGT 178
HS+G+ HRDLKP N+ V+K+ DFGL Q E+ GT
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPS 237
Y++PE ++ Y D++S G+ILF L+ F E + + + F +
Sbjct: 240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFT 296
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
+++ +L P+P R + ++E+ F+
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-62
Identities = 51/284 (17%), Positives = 99/284 (34%), Gaps = 35/284 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ +G G F V G AIK + ++ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYC 129
+V++ A + I E+ +GG L D I+++ R KE E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 130 HSRGVFHRDLKPENLLLDSYGVL-------------------KISDFGLSAISQQVREDG 170
HS + H D+KP N+ + + KI D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185
Query: 171 LLHTACGTPNYVAPEVLN-DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC 229
G ++A EVL + + +D+++ + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241
Query: 230 RADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
+ P S +L+K ++ P+P+ R + +++
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 8e-61
Identities = 78/254 (30%), Positives = 147/254 (57%), Gaps = 13/254 (5%)
Query: 16 ELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLIK 71
EL + LG G++ KV + +TG A+K++ + ++ + K E + E ++ I+
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 72 H-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
P ++ + ++TK++++L++I+GGELF +++ R E E + Y +++ A+++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--N 188
G+ +RD+K EN+LLDS G + ++DFGLS E + CGT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGG 235
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAK 244
D G+ +A D WS GV+++ L+ G PF ++++ + R+I +++ P S+ AK
Sbjct: 236 DSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
Query: 245 KLIKRILDPNPDTR 258
LI+R+L +P R
Sbjct: 295 DLIQRLLMKDPKKR 308
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 8e-61
Identities = 71/330 (21%), Positives = 135/330 (40%), Gaps = 44/330 (13%)
Query: 6 PASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
+G+ + R LG G F +V + TG A K +++ ++ + K + E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELF----DKIAKHGRLKEDEARRYF 119
+ + ++ + +KT + +V+ ++GG++ + + +E A Y
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
Q+++ +++ H R + +RDLKPEN+LLD G ++ISD GL+ + GTP
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTP 353
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRADFSC 235
++APE+L + Y + D ++ GV L+ ++A PF L +++ +
Sbjct: 354 GFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP---- 277
P FS +K + +L +P+ R+ D F+ PP
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472
Query: 278 -------------HFDKEEEVNLDDVDAIF 294
F + V + D F
Sbjct: 473 SRTVYAKNIQDVGAFSTVKGVAFEKADTEF 502
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-60
Identities = 82/282 (29%), Positives = 137/282 (48%), Gaps = 20/282 (7%)
Query: 8 SRTRVGKYEL-----GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
S YE LG+G++ V +++ +AIK + + + +
Sbjct: 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHE 68
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEA--RRYF 119
EI+ K +KH N+++ + + I I +E + GG L + +K G LK++E Y
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGT 178
+Q++ + Y H + HRD+K +N+L+++Y GVLKISDFG S + T GT
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGT 186
Query: 179 PNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFS- 234
Y+APE+++ +GY G+A+D+WS G + + G PF + A K+
Sbjct: 187 LQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245
Query: 235 -CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275
P S+ AK I + +P+PD R + +L DE+ K K
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 78/325 (24%), Positives = 135/325 (41%), Gaps = 43/325 (13%)
Query: 6 PASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
R V K + R LG+G F +V + TG A K +++ ++ + K E
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQ 121
++ + V+ + +K + +VL ++GG+L I G+ E A Y +
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
+ ++ H + +RDLKPEN+LLD +G ++ISD GL + V E + GT Y
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEGQTIKGRVGTVGY 351
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPS 237
+APEV+ ++ Y + D W+ G +L+ ++AG PF + + R +
Sbjct: 352 MAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP------ 277
FS A+ L ++L +P R+ E FK +PP
Sbjct: 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470
Query: 278 --------HFDKE---EEVNLDDVD 291
++ + V L+ D
Sbjct: 471 AIYCKDVLDIEQFSTVKGVELEPTD 495
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-59
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 16/264 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+G GSF +V K+ +TG A+K V + E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPR 111
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + + + I +E ++GG L I + G L ED A Y Q + ++Y H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 135 FHRDLKPENLLLDSYGVL-KISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLNDK 190
H D+K +N+LL S G + DFG + + GT ++APEV+ K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLI 247
D D+WS ++ ++ G P+ + L KI P + + I
Sbjct: 232 PCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 248 KRILDPNPDTRMTISQMLEDEWFK 271
+ L P R + ++
Sbjct: 291 QEGLRKEPVHRASAMELRRKVGKA 314
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 1e-58
Identities = 79/332 (23%), Positives = 140/332 (42%), Gaps = 51/332 (15%)
Query: 4 KVPASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIK------IVDRDQVLRHK 55
K + + + R +G G F +V + +TG A+K I +
Sbjct: 178 KNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA 236
Query: 56 MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA 115
+ E + +S + P ++ + + K+ +L+ ++GG+L +++HG E +
Sbjct: 237 LNE--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
R Y ++I +++ H+R V +RDLKP N+LLD +G ++ISD GL+ H +
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHAS 350
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRAD 232
GT Y+APEVL ++D +S G +LF L+ G PF + + R
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGYKPP- 277
P FS + L++ +L + + R+ E +F+ + Y PP
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 278 ----------------HFDKE--EEVNLDDVD 291
FD+E + + L D D
Sbjct: 471 IPPRGEVNAADAFDIGSFDEEDTKGIKLLDSD 502
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-57
Identities = 63/271 (23%), Positives = 124/271 (45%), Gaps = 18/271 (6%)
Query: 13 GKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
G++ +G GSF V + ET VA + ++ + ++ K E +K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 72 HPNVIKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
HPN+++ + K I +V E + G L + + +K R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 128 YCHSRG--VFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
+ H+R + HRDLK +N+ + G +KI D GL+ + + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAP 199
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD--FSCPSWFSS 241
E+ + YD + DV++ G+ + + P+ + N +YR++ S
Sbjct: 200 EMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
K++I+ + N D R +I +L +F++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 7e-55
Identities = 84/316 (26%), Positives = 135/316 (42%), Gaps = 66/316 (20%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
KYE +GEGS+ V +N +TG VAIK + L + IK REI +K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVD 127
+KHPN++ ++EV K ++++V E+ D D+ + + E + Q + AV+
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVN 116
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV---- 182
+CH HRD+KPEN+L+ + V+K+ DFG + ++ + + V
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRW 167
Query: 183 --APEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA------ 231
+PE+L D Y G DVW+ G + L++G P S++ LY I +
Sbjct: 168 YRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGK-SDVDQLY-LIRKTLGDLIP 224
Query: 232 -------------DFSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLE 266
P S A L+K L +P R+T Q+L
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
Query: 267 DEWFKKGYKPPHFDKE 282
+F+ + KE
Sbjct: 285 HPYFENIREIEDLAKE 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-54
Identities = 87/315 (27%), Positives = 139/315 (44%), Gaps = 60/315 (19%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-REISTMKLI 70
+ KYE +GEGS+ V +N +TG VAIK KMV++I REI +K +
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQL 81
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+H N++ ++EV K + Y+V EF+D + + L ++Y Q+IN + +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGF 139
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV----- 182
CHS + HRD+KPEN+L+ GV+K+ DFG + ++ + + V
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----DEVATRWY 190
Query: 183 -APEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA------- 231
APE+L D Y G+A DVW+ G ++ + G P D S++ LY I
Sbjct: 191 RAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGEPLFPGD-SDIDQLY-HIMMCLGNLIPR 247
Query: 232 ------------DFSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLED 267
P S L K+ L +PD R +++L
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307
Query: 268 EWFKKGYKPPHFDKE 282
++F+ F +E
Sbjct: 308 DFFQMDGFAERFSQE 322
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-53
Identities = 60/133 (45%), Positives = 94/133 (70%)
Query: 307 EKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFN 366
E P+ MNAFE+I+ ++ +L LF+++ VKR+TRF S+R P+EI++ IE A +GF
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 367 VRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 426
N+K +L+G + + GQL+V E++EVAP+L +V+VRK G+TLE+HKFYKK S L
Sbjct: 62 SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121
Query: 427 KDVVWQAEENKEE 439
++++W+A E +
Sbjct: 122 ENIIWRATEGIPK 134
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-52
Identities = 78/273 (28%), Positives = 136/273 (49%), Gaps = 15/273 (5%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ +G+GSF +V + T VAIKI+D ++ +E I++EI+ + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V K TK++I++E++ GG D + + G L E + ++++ +DY HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRD+K N+LL +G +K++DFG++ Q +T GTP ++APEV+ YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP----SWFSSGAKKLIKR 249
+A D+WS G+ L G P E + M L+ I + + P +S K+ ++
Sbjct: 199 KA-DIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNN---PPTLEGNYSKPLKEFVEA 253
Query: 250 ILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 282
L+ P R T ++L+ ++ + K + E
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 74/268 (27%), Positives = 136/268 (50%), Gaps = 14/268 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ +GEGS V A+ +G VA+K++D + R E + E+ M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHF 102
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
NV+++ + ++++++EF+ GG L D I RL E++ + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +++LL G +K+SDFG A Q ++ + GTP ++APEV++ Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 194 GRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIK 248
D+WS G I+ + M P F +S + A+ R + + S + ++
Sbjct: 220 TEV-DIWSLG-IMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKP 276
R+L +P R T ++L+ + + P
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTGLP 304
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-51
Identities = 77/268 (28%), Positives = 134/268 (50%), Gaps = 14/268 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAI+ ++ Q + E I EI M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNP 77
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 194 GRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIK 248
+ D+WS G I+ + M P +E+ L ALY I P S+ + +
Sbjct: 195 PKV-DIWSLG-IMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLN 251
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKP 276
R L+ + + R + ++L+ ++ K
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLKIAKPL 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-51
Identities = 63/265 (23%), Positives = 119/265 (44%), Gaps = 19/265 (7%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+G+ +G GSF V K + GD VA+K++ + ++ K E+ ++ +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWH---GD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + + ++ IV ++ +G L+ + A + + + +Q +DY H++
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRDLK N+ L +KI DFGL+ + G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 194 --GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICR-----ADFSCPSWFSSGAKK 245
SDV++ G++L+ LM G LP+ +N + + R S K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 246 LIKRILDPNPDTR---MTISQMLED 267
L+ L D R I +E+
Sbjct: 261 LMAECLKKKRDERPSFPRILAEIEE 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-51
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 19/274 (6%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ +G GSF V A+ + G VA+KI+ +Q + V + RE++ MK ++HPN
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ---QLINAVDYCHS 131
++ + + + IV E++ G L+ + K G ++ + RR + ++Y H+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 132 RG--VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
R + HR+LK NLL+D +K+ DFGLS + + +A GTP ++APEVL D
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLI 247
+ + SDV+S GVIL+ L P+ N + + P + +I
Sbjct: 214 EPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 248 KRILDPNPDTR---MTISQMLEDEWFKKGYKPPH 278
+ P R TI +L K PP+
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLR-PLIKSAVPPPN 305
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 84/334 (25%), Positives = 137/334 (41%), Gaps = 83/334 (24%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MSV S T + +Y LGEG++ +V A + T + VAIK + ++ E
Sbjct: 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--------RL-EHE 72
Query: 61 K--------REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKE 112
+ RE+S +K ++H N+I++ V+ +++++ E+ + +L + K+ +
Sbjct: 73 EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM 131
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISDFGLSAISQQVR 167
+ + QLIN V++CHSR HRDLKP+NLLL VLKI DFGL+ R
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R 185
Query: 168 EDGLLHTACGTPN-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--F 213
A G P Y PE+L + Y + D+WS I ++
Sbjct: 186 -------AFGIPIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPL 237
Query: 214 LPFDESNLMALYRKICRA----------------DFS--------------CPSWFSSGA 243
P D S + L+ KI D+ +
Sbjct: 238 FPGD-SEIDQLF-KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEG 295
Query: 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
L+ +L+ +P R++ LE +F P
Sbjct: 296 LDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 6e-50
Identities = 89/330 (26%), Positives = 136/330 (41%), Gaps = 79/330 (23%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M++ V +R +YE LGEG FA V A++ T VAIK + + +
Sbjct: 1 MALDVK---SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI------KLGHRSEA 51
Query: 61 K--------REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRL 110
K REI ++ + HPN+I +++ K+ I +V +F++ + L
Sbjct: 52 KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVL 109
Query: 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170
+ Y + ++Y H + HRDLKP NLLLD GVLK++DFGL+
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA---------- 159
Query: 171 LLHTACGTPN-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPF 216
+ G+PN Y APE+L + Y G D+W+ G IL L+ FLP
Sbjct: 160 ---KSFGSPNRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPG 215
Query: 217 DESNLMALYRKICRA----------DFSC-------PSW-----------FSSGAKKLIK 248
D S+L L +I D S+ LI+
Sbjct: 216 D-SDLDQLT-RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 273
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
+ NP R+T +Q L+ ++F P
Sbjct: 274 GLFLFNPCARITATQALKMKYFSNRPGPTP 303
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 66/297 (22%), Positives = 127/297 (42%), Gaps = 40/297 (13%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
E+G +G+G F +V + + G+ VAI+++D ++ ++ KRE+ + +H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWH---GE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRG 133
V+ + S + I+ G L+ + L ++ R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVL--- 187
+ H+DLK +N+ D+ G + I+DFGL + Q R + L G ++APE++
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 188 ------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------ADFSC 235
+ + + SDV++ G I + L A PF A+ ++ +
Sbjct: 210 SPDTEEDKLPFS-KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGM 268
Query: 236 PSWFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKKGYK----PPHFDKEEEV 285
++ + R + MLE K + P HF K E+
Sbjct: 269 GKEI----SDILLFCWAFEQEERPTFTKLMDMLEK--LPKRNRRLSHPGHFWKSAEL 319
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 16/269 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+++ LGEGS+ V A + ETG VAIK V + +++I +EIS M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSP 84
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSR 132
+V+K T ++IV+E+ G + D I ++ L EDE Q + ++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRD+K N+LL++ G K++DFG++ Q +T GTP ++APEV+ + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 193 DGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLI 247
+ A D+WS G I + MA P D + A++ I F P +S +
Sbjct: 203 NCVA-DIWSLG-ITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFV 259
Query: 248 KRILDPNPDTRMTISQMLEDEWFKKGYKP 276
K+ L +P+ R T +Q+L+ + +
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFVRSAKGV 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-49
Identities = 82/274 (29%), Positives = 142/274 (51%), Gaps = 19/274 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+ LG+G+F KV AKN ETG A K+++ +E EI + HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSR 132
++K++ K++I++EF GG + + + L E + + +Q++ A+++ HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-----L 187
+ HRDLK N+L+ G ++++DFG+SA + ++ + GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSG 242
D YD +A D+WS G I + MA P + + + L KI ++D PS +S
Sbjct: 195 KDTPYDYKA-DIWSLG-ITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVE 251
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
+ +K LD NP+TR + +Q+LE +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-48
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 18/277 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHP 73
E +G G+ +V + +TG +A+K + R + ++I ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-R 132
+++ + T ++I +E + K G + E + ++ A+ Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL----- 187
GV HRD+KP N+LLD G +K+ DFG+S ++ +D + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD---FSCPSWFSSGA 243
YD R +DVWS G+ L L G P+ + K+ + + FS
Sbjct: 202 TKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260
Query: 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 280
+ +K L + R +++LE + K+ Y+ D
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKR-YETLEVD 296
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 75/280 (26%), Positives = 133/280 (47%), Gaps = 25/280 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL +G G+ A V+ A + VAIK ++ ++ ++++ +EI M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 74
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD--------KIAKHGRLKEDEARRYFQQLINAV 126
++ K ++++V++ + GG + D K G L E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLL--HTACGTPNYVA 183
+Y H G HRD+K N+LL G ++I+DFG+SA ++ T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 184 PEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYR---------KICRAD 232
PEV+ +GYD +A D+WS G+ L G P+ + M L + D
Sbjct: 195 PEVMEQVRGYDFKA-DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
+ +K+I L +P+ R T +++L ++F+K
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 85/306 (27%), Positives = 136/306 (44%), Gaps = 69/306 (22%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------REIS 65
KYE +GEG++ V AKN ET + VA+K V ++ + REI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--------RL-DDDDEGVPSSALREIC 53
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLI 123
+K +KH N++++ +V+ S K+ +V EF D + FD +G L + + + QL+
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLL 111
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN-- 180
+ +CHSR V HRDLKP+NLL++ G LK+++FGL+ A VR C +
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------CYSAEVV 163
Query: 181 ---YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRA--- 231
Y P+VL K Y + D+WS G I L P L +I R
Sbjct: 164 TLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGT 221
Query: 232 -------------DFSC-PSW------------FSSGAKKLIKRILDPNPDTRMTISQML 265
D+ P + ++ + L++ +L NP R++ + L
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
Query: 266 EDEWFK 271
+ +F
Sbjct: 282 QHPYFS 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-48
Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 36/269 (13%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
E+ +G G+F V AK VAIK ++ + + E+ + + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI---NAVDYCHSR 132
+K+ A + +V+E+ +GG L++ + L A + V Y HS
Sbjct: 64 VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 ---GVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
+ HRDLKP NLLL + VLKI DFG + Q + G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADF------SCPSWFSS 241
Y DV+S G+IL+ ++ PFDE + P
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI-- 233
Query: 242 GAKKLIKRILDPNPDTR---MTISQMLED 267
+ L+ R +P R I +++
Sbjct: 234 --ESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 77/328 (23%), Positives = 128/328 (39%), Gaps = 85/328 (25%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-------- 61
+ +++ LG G++A V N TG +VA+K ++K
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK--------------EVKLDSEEGTP 47
Query: 62 ----REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG-----ELFDKIAKHGRLKE 112
REIS MK +KH N++++ +V+ ++ K+ +V EF+D + L+
Sbjct: 48 STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGL 171
+ + + QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---- 163
Query: 172 LHTACGTPN-----YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMA 223
+ Y AP+VL + Y + D+WSCG IL ++ G P ++
Sbjct: 164 ----TFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGT-NDEEQ 217
Query: 224 LYRKICRA----------------DF------------------SCPSWFSSGAKKLIKR 249
L I + +
Sbjct: 218 LK-LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG 276
Query: 250 ILDPNPDTRMTISQMLEDEWFKKGYKPP 277
+L NPD R++ Q L WF + Y
Sbjct: 277 LLQLNPDMRLSAKQALHHPWFAEYYHHA 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIV----DRDQVLRHKMVEQIKREISTMKLIK 71
E + +G+G F V + V+ VAIK + + + ++ +RE+ M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCH 130
HPN++K+ +V+EF+ G+L+ ++ +K R + ++Y
Sbjct: 82 HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 131 SRG--VFHRDLKPENLLLDSYG-----VLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
++ + HRDL+ N+ L S K++DFGLS S + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 184 PEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNL--MALYRKICRADF--SCPS 237
PE + + Y +D +S +IL+ ++ G PFDE + + I + P
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 238 WFSSGAKKLIKRILDPNPDTR---MTISQMLED 267
+ +I+ +P R I + L +
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 50/270 (18%), Positives = 107/270 (39%), Gaps = 33/270 (12%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
L E ++ + G+ + +K++ + + + E +++ HPN
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 75 VIKIIEVMAS--KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD----- 127
V+ ++ S ++ ++ G L++ + + D+++ + A+D
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGM 124
Query: 128 -YCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
+ H+ + L ++++D +IS + Q P +VAP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAP 177
Query: 185 EVLNDKGYDG--RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFS 240
E L K D R++D+WS V+L+ L+ +PF + + M + K+ + P S
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 241 SGAKKLIKRILDPNPDTR---MTISQMLED 267
KL+K ++ +P R I +LE
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 63/277 (22%), Positives = 116/277 (41%), Gaps = 35/277 (12%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
G LG+G F + + ETG+ + +K + R + +E+ M+ ++HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGV 134
+K I V+ ++ + E+I GG L I + + + + + + Y HS +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAI------------SQQVREDGLLHTACGTPNYV 182
HRDL N L+ + ++DFGL+ + S + + +T G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRKICRADF 233
APE++N + YD DV+S G++L ++ + + C +
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247
Query: 234 SCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 267
CP F + R D +P+ R + + LE
Sbjct: 248 -CPPSFF----PITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 69/323 (21%), Positives = 123/323 (38%), Gaps = 90/323 (27%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK------------ 61
Y LGEG++A V K+ T + VA+K +I+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK--------------EIRLEHEEGAPCTAI 48
Query: 62 REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYF 119
RE+S +K +KH N++ + +++ ++ + +V E++D + D + + +
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFL 106
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
QL+ + YCH + V HRDLKP+NLL++ G LK++DFGL+ R A P
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIP 153
Query: 180 N-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALY 225
Y P++L Y D+W G I + + G P + L+
Sbjct: 154 TKTYDNEVVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLH 211
Query: 226 RKICRA-------------------DFSCPSW-----------FSSGAKKLIKRILDPNP 255
I R ++ P + S L+ ++L
Sbjct: 212 -FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEG 270
Query: 256 DTRMTISQMLEDEWFKKGYKPPH 278
R++ ++ +F + H
Sbjct: 271 RNRISAEDAMKHPFFLSLGERIH 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 88/311 (28%), Positives = 135/311 (43%), Gaps = 81/311 (26%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------REIS 65
KY +GEG++ V A+N G+ A+K + ++ E+ REIS
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI--------RL-EKEDEGIPSTTIREIS 52
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLI 123
+K +KH N++K+ +V+ +K ++ +V E +D +L D G L+ A+ + QL+
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLL 110
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN--- 180
N + YCH R V HRDLKP+NLL++ G LKI+DFGL+ R A G P
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGIPVRKY 157
Query: 181 --------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKIC 229
Y AP+VL K Y D+WS G I ++ G P S L +I
Sbjct: 158 THEIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLM-RIF 214
Query: 230 RA----------------DFSC--PSW-----------FSSGAKKLIKRILDPNPDTRMT 260
R + + L+ ++L +P+ R+T
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
Query: 261 ISQMLEDEWFK 271
Q LE +FK
Sbjct: 275 AKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 79/317 (24%), Positives = 136/317 (42%), Gaps = 82/317 (25%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK------- 61
+ + KY+ +GEG++ V AK+ G VA+K + ++ +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI--------RL-DAEDEGIPSTA 66
Query: 62 -REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRY 118
REIS +K + HPN++ +I+V+ S+ + +V EF++ ++ D+ L++ + + Y
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIY 124
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
QL+ V +CH + HRDLKP+NLL++S G LK++DFGL+ R A G
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171
Query: 179 PN-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMAL 224
P Y AP+VL K Y + D+WS G I ++ G P ++ L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFPGV-TDDDQL 229
Query: 225 YRKICRA-------------------DFSCPSW-----------FSSGAKKLIKRILDPN 254
KI + + F L+ +L +
Sbjct: 230 P-KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 255 PDTRMTISQMLEDEWFK 271
P+ R++ + +FK
Sbjct: 289 PNKRISARDAMNHPYFK 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 27/270 (10%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKHP 73
L +G G F KV A GD VA+K D + +E +++E ++KHP
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+I + V + + +V+EF GG L ++ R+ D + Q+ ++Y H
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 134 ---VFHRDLKPENLLLDSYG--------VLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ HRDLK N+L+ +LKI+DFGL+ + +A G ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWM 181
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFS 240
APEV+ + + SDVWS GV+L+ L+ G +PF + +A+ + PS
Sbjct: 182 APEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 241 SGAKKLIKRILDPNPDTR---MTISQMLED 267
KL++ +P+P +R I L
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-46
Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ R +G GSF V FA++V + VAIK + ++ + I +E+ ++ ++HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N I+ + ++V+E+ G L+E E + + Y HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEV---LND 189
+ HRD+K N+LL G++K+ DFG ++ ++ ++ GTP ++APEV +++
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAK 244
YDG+ DVWS G I + +A P F+ + + ALY I + + W S +
Sbjct: 228 GQYDGKV-DVWSLG-ITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFR 283
Query: 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
+ L P R T +L+ + + P
Sbjct: 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 74/323 (22%), Positives = 124/323 (38%), Gaps = 68/323 (21%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKRE 63
P +YE +G G++ V A++ +G FVA+K V + RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 64 ISTMKLIK---HPNVIKIIEVMASK-----TKIYIVLEFIDG--GELFDKIAKHGRLKED 113
++ ++ ++ HPNV+++++V A+ K+ +V E +D DK G L +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAE 120
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173
+ +Q + +D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ R
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R------ 168
Query: 174 TACGTPN----------YVAPEVLNDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNL 221
Y APEVL Y D+WS G I + + S
Sbjct: 169 -IYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGN-SEA 225
Query: 222 MALYRKICRA----------------DFSCPSW-----------FSSGAKKLIKRILDPN 254
L KI + P +L+ +L N
Sbjct: 226 DQLG-KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN 284
Query: 255 PDTRMTISQMLEDEWFKKGYKPP 277
P R++ + L+ + K P
Sbjct: 285 PHKRISAFRALQHSYLHKDEGNP 307
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 77/287 (26%), Positives = 133/287 (46%), Gaps = 25/287 (8%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
G +EL +G G++ +V ++V+TG AIK++D + E+IK+EI+ +K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 72 HPNVIKIIE------VMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLI 123
H N+ ++++V+EF G + D K K LKE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 184 PEVL-----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSC-- 235
PEV+ D YD ++ D+WS G+ + G P + + M AL+ I R
Sbjct: 198 PEVIACDENPDATYDFKS-DLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 255
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 282
+S + I+ L N R Q+++ + + +
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 65/317 (20%), Positives = 119/317 (37%), Gaps = 59/317 (18%)
Query: 13 GKYELGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
G YEL +G+G V A+ TG++V ++ ++ + +MV ++ E+ KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDY 128
HPN++ + ++++V F+ G D + E Q ++ A+DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-----ISQQVREDGLLHTACGTPNYVA 183
H G HR +K ++L+ G + +S + +Q + +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 184 PEVL--NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKI------------ 228
PEVL N +GYD ++ D++S G+ L G +PF + L K+
Sbjct: 204 PEVLQQNLQGYDAKS-DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 229 ---------------------------------CRADFSCPSWFSSGAKKLIKRILDPNP 255
FS +++ L NP
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 256 DTRMTISQMLEDEWFKK 272
D R + S +L +FK+
Sbjct: 323 DARPSASTLLNHSFFKQ 339
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 71/263 (26%), Positives = 131/263 (49%), Gaps = 12/263 (4%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y++ LG G + V A++ VAIK + + + +++ +RE+ + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
N++ +I+V Y+V+E+I+G L + I HG L D A + Q+++ + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC--GTPNYVAPEVLNDK 190
+ HRD+KP+N+L+DS LKI DFG I++ + E L T GT Y +PE +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFG---IAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKICRADFSCPSWFSSG----AKK 245
D +D++S G++L+ ++ G PF+ E+ + + I + + +
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 246 LIKRILDPNPDTR-MTISQMLED 267
+I R + + R TI +M +D
Sbjct: 247 VILRATEKDKANRYKTIQEMKDD 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 59/311 (18%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REIST 66
V KYE +G+G+F +V A++ +TG VA+K +VL E REI
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKI 69
Query: 67 MKLIKHPNVIKIIEVMASK--------TKIYIVLEFIDG--GELFDKIAKHGRLKEDEAR 116
++L+KH NV+ +IE+ +K IY+V +F + L + E +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIK 127
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTA 175
R Q L+N + Y H + HRD+K N+L+ GVLK++DFGL+ A S +T
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 176 C-GTPNYVAPEVL-NDKGYDGRASDVWSCGVI---LFV---LMAG----------F---- 213
T Y PE+L ++ Y G D+W G I ++ +M G
Sbjct: 188 RVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 214 ------------LP-FDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 260
+++ L+ ++ + A LI ++L +P R+
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLDPAQRID 305
Query: 261 ISQMLEDEWFK 271
L ++F
Sbjct: 306 SDDALNHDFFW 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 67/311 (21%), Positives = 119/311 (38%), Gaps = 53/311 (17%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E LG G+ V + +G +A K++ + ++ + QI RE+ + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG- 133
++ S +I I +E +DGG L + K GR+ E + +I + Y +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRD+KP N+L++S G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--------------- 238
+ SD+WS G+ L + G P + L +
Sbjct: 209 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 239 -----------------------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEW 269
FS + + + L NP R + Q++ +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 270 FKKGYKPPHFD 280
K+ D
Sbjct: 328 IKR-SDAEEVD 337
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 63/276 (22%), Positives = 117/276 (42%), Gaps = 26/276 (9%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHP 73
+ +G G++ V + +G +A+K + + K +Q+ ++ M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK------HGRLKEDEARRYFQQLINAVD 127
+++ + + +I +E + FDK K + E+ + + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 128 YCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ + HRD+KP N+LLD G +K+ DFG+S Q V A G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDA-GCRPYMAPER 196
Query: 187 L----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRAD-----FSCP 236
+ + +GYD R SDVWS G+ L+ L G P+ + N + ++ + D S
Sbjct: 197 IDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
FS + L + R ++L+ +
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 61/272 (22%), Positives = 120/272 (44%), Gaps = 22/272 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHP 73
E LG G++ V+ ++V +G +A+K + + + +++ ++ +M+ + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDY 128
+ + + ++I +E +D DK K + ED + ++ A+++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 129 CHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV- 186
HS V HRD+KP N+L+++ G +K+ DFG+S + +D G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181
Query: 187 ---LNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD--FSCPSWFS 240
LN KGY + SD+WS G+ + L P+ +++ FS
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
+ + L N R T ++++ +F
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 76/325 (23%), Positives = 129/325 (39%), Gaps = 84/325 (25%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIK--------R 62
+YE +GEG++ KV A+++ G FVA+K V ++ + + R
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--------RV-QTGEEGMPLSTIR 60
Query: 63 EISTMKLIK---HPNVIKIIEV-----MASKTKIYIVLEFIDG--GELFDKIAKHGRLKE 112
E++ ++ ++ HPNV+++ +V +TK+ +V E +D DK+ + G +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPT 119
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172
+ + QL+ +D+ HS V HRDLKP+N+L+ S G +K++DFGL+ R
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R----- 168
Query: 173 HTACGTPN----------YVAPEVLNDKGYDGRASDVWSCGVILFVLMAG--FLPFDESN 220
Y APEVL Y D+WS G I + S+
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGS-SD 224
Query: 221 LMALYRKICRA----------------DFSCPSW-----------FSSGAKKLIKRILDP 253
+ L KI + S K L+ + L
Sbjct: 225 VDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283
Query: 254 NPDTRMTISQMLEDEWFKKGYKPPH 278
NP R++ L +F+ +
Sbjct: 284 NPAKRISAYSALSHPYFQDLERCKE 308
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 87/344 (25%), Positives = 139/344 (40%), Gaps = 75/344 (21%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R + Y + +G GSF V AK ++G+ VAIK +VL+ K + RE+ M
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN--RELQIM 101
Query: 68 KLIKHPNVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKH-----GRLKEDEAR 116
+ + H N++++ S + +VL+++ E ++A+H L +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVK 159
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTA 175
Y QL ++ Y HS G+ HRD+KP+NLLLD VLK+ DFG + +
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---------- 209
Query: 176 CGTPN--YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAG---FLPFDESNLMA 223
G PN Y+ APE+ Y + DVWS G +L L+ G F + +
Sbjct: 210 -GEPNVSYICSRYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 224 LYRKIC--------------RADFSCPSW------------FSSGAKKLIKRILDPNPDT 257
K+ +F P A L R+L+ P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 258 RMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 301
R+T + +F + P + N D A+FN + + L
Sbjct: 328 RLTPLEACAHSFFDELRDP----NVKLPNGRDTPALFNFTTQEL 367
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 14/214 (6%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD----RDQVLRHKMVEQIKREIS 65
T+ G Y L R +G G V A++ VA+K++ D V R +M +RE
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRM----QREAR 86
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
T ++ P+V+ I + ++Y+ + I+G +L + + G L A +Q+ +A
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVA 183
+D H+ G HRD+KPEN+L+ + + DFG I+ ++ L GT Y+A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMA 203
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
PE ++ R +D+++ +L+ + G P+
Sbjct: 204 PERFSESHATYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-43
Identities = 30/127 (23%), Positives = 54/127 (42%), Gaps = 7/127 (5%)
Query: 308 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 367
MNAF++IS + F+L LF R RF S ++ ++EE V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 368 -RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK-KFSSG 425
+K + MK++G +KG ++ E+ ++ L ++EVRK +
Sbjct: 61 AKKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116
Query: 426 LKDVVWQ 432
++V +
Sbjct: 117 FVELVHE 123
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-42
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 15/267 (5%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YELG LG G ++V A+++ VA+K++ D + +RE + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 73 PNVIKI----IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
P ++ + + YIV+E++DG L D + G + A A+++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC--GTPNYVAPEV 186
H G+ HRD+KP N+++ + +K+ DFG+ A + + + TA GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKICRADFSCPSWFSSG--- 242
D R SDV+S G +L+ ++ G PF +S + Y+ + R D PS G
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSA 248
Query: 243 -AKKLIKRILDPNPDTR-MTISQMLED 267
++ + L NP+ R T ++M D
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 91/339 (26%), Positives = 140/339 (41%), Gaps = 78/339 (23%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + +G GSF V AK VE+ + VAIK V +D+ RE+ M+++KHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHP 92
Query: 74 NVIKIIEVMAS------KTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQL 122
NV+ + S + + +VLE++ E + ++H + + Y QL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPN- 180
+ ++ Y HS G+ HRD+KP+NLLLD GVLK+ DFG + I PN
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-----------PNV 199
Query: 181 -YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKICR- 230
Y+ APE+ Y D+WS G ++ LM G F ES + L I +
Sbjct: 200 SYICSRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE-IIKV 257
Query: 231 ----------------ADFSCPSW------------FSSGAKKLIKRILDPNPDTRMTIS 262
+ P A LI R+L+ P R+T
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 263 QMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 301
+ L +F + + N ++ +FN +KE L
Sbjct: 318 EALCHPFFDELRTG----EARMPNGRELPPLFNWTKEEL 352
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-40
Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 32/265 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKL 69
G+YE+ + G + A + G V +K + D + E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ----AMAMAERQFLAE 135
Query: 70 IKHPNVIKIIEV-----MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
+ HP++++I YIV+E++ G L +L EA Y +++
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILP 193
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL-SAISQQVREDGLLHTACGTPNYVA 183
A+ Y HS G+ + DLKPEN++L + K+ D G S I+ G GTP + A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS----FG---YLYGTPGFQA 245
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 243
PE++ + A+D+++ G L L + + L +
Sbjct: 246 PEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PVLKTYDSYGR-- 299
Query: 244 KKLIKRILDPNPDTR-MTISQMLED 267
L++R +DP+P R T +M
Sbjct: 300 --LLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-40
Identities = 58/209 (27%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKH 72
Y+L R LG G +++V A N+ + V +KI+ + + IKREI ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGG 90
Query: 73 PNVIKIIEVM---ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
PN+I + +++ S+T + E ++ + L + + R Y +++ A+DYC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146
Query: 130 HSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL- 187
HS G+ HRD+KP N+++D + L++ D+GL+ +E + + + PE+L
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF 216
+ + YD + D+WS G +L ++ PF
Sbjct: 204 DYQMYD-YSLDMWSLGCMLASMIFRKEPF 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 87/344 (25%), Positives = 133/344 (38%), Gaps = 63/344 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
++L LGEG++ V A + TG+ VAIK ++ + REI +K KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINA 125
N+I I + + +YI+ E + D ++ L +D + + Q + A
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP--NYV- 182
V H V HRDLKP NLL++S LK+ DFGL+ I + D T + +V
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 183 -----APEV-LNDKGYDGRASDVWSCGVILFVLMAG---F-----------------LPF 216
APEV L Y RA DVWSCG IL L F P
Sbjct: 185 TRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 217 DESNLMAL-----------YRKICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQ 263
+++L + A P + L++R+L +P R+T +
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 264 MLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 307
LE + + + P +E + F K+
Sbjct: 303 ALEHPYLQTYHDP----NDEPEGEPIPPSFFEFDHYKEALTTKD 342
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 73/341 (21%), Positives = 134/341 (39%), Gaps = 73/341 (21%)
Query: 3 VKVPASRTRVG-KYE-LGRTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVE 58
VK+ + R RV +E G +G G++ V A K+ + A+K ++ +
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-- 66
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKT--KIYIVLEF--------IDGGELFDKIAKHG 108
REI+ ++ +KHPNVI + +V S K++++ ++ I K
Sbjct: 67 ---REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 109 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDFGLS-AIS 163
+L + Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + +
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 164 QQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESN 220
++ L T Y APE+L + Y +A D+W+ G I L+ + +
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 221 LMALYR-------KICRA----------------DFSC--PSW----------------- 238
+ +I + S +
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 239 ---FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
S A L++++L +P R+T Q ++D +F + P
Sbjct: 303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 36/225 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+YE+ +G GS+ V A + VAIK + R V + + I REI+ + + H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNH 111
Query: 73 PNVIKIIEVMASKT-----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
+V+K+++++ K ++Y+VLE D + L E + L+ V
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN------ 180
Y HS G+ HRDLKP N L++ +K+ DFGL+ + + L + +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 181 ------------YV------APEV-LNDKGYDGRASDVWSCGVIL 206
+V APE+ L + Y A DVWS G I
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIF 274
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 79/313 (25%), Positives = 125/313 (39%), Gaps = 59/313 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y + LG G V A + + VAIK IV D V+ REI ++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS----VKHALREIKIIRRLDH 67
Query: 73 PNVIKIIEVMASKTK--------------IYIVLEFIDGGELFD--KIAKHGRLKEDEAR 116
N++K+ E++ +YIV E+++ D + + G L E+ AR
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHAR 123
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLS-AISQQVREDGLLHT 174
+ QL+ + Y HS V HRDLKP NL +++ VLKI DFGL+ + G L
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 175 ACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPF----------------- 216
T Y +P + L+ Y +A D+W+ G I ++ G F
Sbjct: 184 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 217 --DESNLMALYRKICRADFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQ 263
E + L I + + S A +++IL +P R+T +
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
Query: 264 MLEDEWFKKGYKP 276
L + P
Sbjct: 303 ALSHPYMSIYSFP 315
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 57/296 (19%), Positives = 114/296 (38%), Gaps = 56/296 (18%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L +G+G + +V G+ VA+KI R + + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 76 IKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ I S T+++++ + + G L+D + L R + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 132 R--------GVFHRDLKPENLLLDSYGVLKISDFGLSAI--SQQVREDGLLHTACGTPNY 181
+ HRDLK +N+L+ G I+D GL+ + + D + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 182 VAPEVLNDKGYDG-----RASDVWSCGVILFVLMAGF----------LPFDESN-----L 221
+APEVL++ + D+W+ G++L+ + PF +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 222 MALYRKICR-----------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ + +C + + KL+K NP R+T ++ +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKK 295
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 81/333 (24%), Positives = 137/333 (41%), Gaps = 71/333 (21%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y+ +G G++ V A + +TG VA+K + R + + + RE+ +K +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMKH 87
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLIN 124
NVI +++V +Y+V + D I K +L +D + Q++
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV-- 182
+ Y HS + HRDLKP NL ++ LKI DFGL+ R T YV
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMT-----GYVAT 192
Query: 183 ----APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------A 231
APE+ LN Y+ + D+WS G I+ L+ G F ++ + + I R A
Sbjct: 193 RWYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 232 DF--------------SCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ S + A L++++L + D R+T +Q L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
Query: 267 DEWFKKGYKP------PHFDKEEEVNLDDVDAI 293
+F + + P +D+ E +D
Sbjct: 312 HAYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 83/335 (24%), Positives = 137/335 (40%), Gaps = 70/335 (20%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y +GEG++ V A + VAIK + H+ Q REI + +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRH 84
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINA 125
N+I I +++ + T +YIV + ++ D K+ K L D + Q++
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV--- 182
+ Y HS V HRDLKP NLLL++ LKI DFGL+ ++ + T YV
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATR 195
Query: 183 ---APEV-LNDKGYDGRASDVWSCGVILFVLMAG-------------------------- 212
APE+ LN KGY ++ D+WS G IL +++
Sbjct: 196 WYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 213 FLPFDES----NLMALYRKICRADFSCPSWF---SSGAKKLIKRILDPNPDTRMTISQML 265
L + N + + ++ F S A L+ ++L NP R+ + Q L
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWN--RLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 266 EDEWFKKGYKP-------PHFDKEEEVNLDDVDAI 293
+ ++ Y P F + E++ + +
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 82/334 (24%), Positives = 140/334 (41%), Gaps = 73/334 (21%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
Y + +G G++ V A + TG VAIK + R + ++ + RE+ +K ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRH 83
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLIN 124
NVI +++V Y+V+ F+ D K+ KH +L ED + Q++
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV-- 182
+ Y H+ G+ HRDLKP NL ++ LKI DFGL+ R+ T YV
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVT 188
Query: 183 ----APEV-LNDKGYDGRASDVWSCGVILFVLMAG------------------------- 212
APEV LN Y + D+WS G I+ ++ G
Sbjct: 189 RWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247
Query: 213 -FLPFDES----NLMALYRKICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQML 265
F+ +S N M ++ + DF+ + S A L++++L + + R+T + L
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 266 EDEWFKKGYKP------PHFDKEEEVNLDDVDAI 293
+F+ + +D + +D
Sbjct: 307 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEW 340
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 80/373 (21%), Positives = 140/373 (37%), Gaps = 92/373 (24%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY LG+TLG GSF V ++E+G A+K +VL+ RE+ MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRY--KNRELDIMKVLDHV 60
Query: 74 NVIKIIEVMASKTK--------------------------------------IYIVLEFI 95
N+IK+++ + + +++E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 96 DGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY- 149
+ K+ K + + Y QL AV + HS G+ HRD+KP+NLL++S
Sbjct: 121 P--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFV 208
LK+ DFG + + + + C + Y APE+ L Y + D+WS G +
Sbjct: 179 NTLKLCDFGSAKKL--IPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGE 234
Query: 209 LMAGFLPF---DESNLMALYRKIC--------------RADFSCPSW----FS------- 240
L+ G F + + +I + P+ +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 241 -SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD-----DVDAIF 294
S A L+++IL PD R+ + + +F + + N ++ +F
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLF 354
Query: 295 NDSKENLVTEKKE 307
N S L
Sbjct: 355 NFSPYELSIIPGN 367
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 47/273 (17%), Positives = 85/273 (31%), Gaps = 43/273 (15%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
VP +R G+Y L G + A + VA+ VD VL ++++
Sbjct: 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRT 82
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
+ I P V ++++V+ ++ +V E+I GG L + A R Q L
Sbjct: 83 LRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAA 140
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
A D H GV P + + G + ++ +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD 178
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPSWFS 240
D+ G L+ L+ P E+ L R P+
Sbjct: 179 A--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADID 229
Query: 241 SGA----KKLIKRILDPNPDTR--MTISQMLED 267
+ R + + R T+ +++
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 82/411 (19%), Positives = 155/411 (37%), Gaps = 72/411 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y+ + +G G+ V A + VAIK + R +++ + RE+ MK + H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNH 120
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
N+I ++ V + +Y+V+E +D L I L + Q++ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y APEV
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC----------------- 229
+ GY D+WS G I+ ++ + F + + + K+
Sbjct: 235 ILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 230 ------------RADFS-------------CPSWFSSGAKKLIKRILDPNPDTRMTISQM 264
F +S A+ L+ ++L +P R+++
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 265 LEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDS-------KENLVTE----KKEKPVSMN 313
L+ + Y P + E D ++ KE + E +++ +
Sbjct: 354 LQHPYINVWYDP---AEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVV 410
Query: 314 AFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG 364
+ + + + + + T Q ++ S +E +A PLG
Sbjct: 411 KGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLG 461
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 73/334 (21%), Positives = 133/334 (39%), Gaps = 61/334 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y+ + +G G+ V A + VAIK + R +++ + RE+ MK + H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNH 83
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
N+I ++ V + +YIV+E +D L I L + Q++ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGI 140
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y APEV
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC----------------- 229
+ GY D+WS G I+ ++ G + F ++ + + K+
Sbjct: 198 ILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 230 -------------------------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 264
AD +S A+ L+ ++L + R+++ +
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 265 LEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSK 298
L+ + Y P + E D ++ +
Sbjct: 317 LQHPYINVWYDP---SEAEAPPPKIPDKQLDERE 347
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 86/333 (25%), Positives = 144/333 (43%), Gaps = 72/333 (21%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
Y +G G++ V A + +G+ VAIK + R + ++ + RE+ +K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQH 82
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V + Y+V+ F+ +L + + E++ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---- 182
Y HS GV HRDLKP NL ++ LKI DFGL+ R T YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188
Query: 183 --APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC---------- 229
APEV L+ Y+ + D+WS G I+ ++ G F + + +I
Sbjct: 189 YRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 230 --------------------RADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
R DF+ P S A L++++L+ + D R+T +Q L
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 268 EWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 300
+F+ P D EEE + F+DS E+
Sbjct: 307 PFFE-----PFRDPEEE---TEAQQPFDDSLEH 331
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 70/352 (19%), Positives = 133/352 (37%), Gaps = 69/352 (19%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
SR + ++++ R G+G+F V+ K TG VAIK +V++ RE+ M
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NRELQIM 70
Query: 68 KLIK---HPNVIKIIEVMASKTK-------IYIVLEFIDGGELFDKIAKHG-----RLKE 112
+ + HPN++++ + + + +V+E++ + + ++
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPP 128
Query: 113 DEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVRED 169
+ + QLI ++ H S V HRD+KP N+L++ + G LK+ DFG +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP- 187
Query: 170 GLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAG---------------- 212
+ C + Y APE+ ++ Y A D+WS G I +M G
Sbjct: 188 -NVAYIC-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 213 ----------FLPFDESNLMALY-RKICRADFS-----CPSWFSSGAKKLIKRILDPNPD 256
L + + +S + A L+ +L P+
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 257 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD-AIFNDSKENLVTEKKE 307
RM + L +F + + P + N D+ +F + +
Sbjct: 305 ERMKPYEALCHPYFDELHDP----ATKLPNNKDLPEDLFRFLPNEIEVMSEA 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
Y + +G GS+ V A + T VAIK V+R + + + I REI+ + +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--MFEDLIDCKRILREITILNRLKS 84
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ-QLIN 124
+I++ +++ +YIVLE D D K+ K +E + L+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP----- 179
++ H G+ HRDLKP N LL+ +K+ DFGL+ ++ +++
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 180 ---------NYV------APEV-LNDKGYDGRASDVWSCGVILFVLMAG 212
++V APE+ L + Y ++ D+WS G I L+
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 78/368 (21%), Positives = 143/368 (38%), Gaps = 86/368 (23%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMK-LIK 71
KYEL + LG+G++ V + + TG+ VA+K + ++ Q REI + L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELSG 67
Query: 72 HPNVIKIIEVMASKTK--IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ-QLINAV 126
H N++ ++ V+ + +Y+V ++++ D + + L E ++Y QLI +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANIL-EPVHKQYVVYQLIKVI 122
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN------ 180
Y HS G+ HRD+KP N+LL++ +K++DFGLS +R N
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 181 -------YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAG---F---------- 213
YV APE+ L Y + D+WS G IL ++ G F
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 214 ----------------------------------LPFDESNLMALYRKICRADFSCPSWF 239
+ + K + +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE 299
+ A L+ ++L NP+ R++ + L+ + + P EE + ND+ +
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP----NEEPNCDHIITIPINDNVK 357
Query: 300 NLVTEKKE 307
+ + + +
Sbjct: 358 HSIDDYRN 365
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 60/295 (20%), Positives = 122/295 (41%), Gaps = 54/295 (18%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L ++G+G F +V K G+ VA+KI R + + EI +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98
Query: 76 IKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ I + + T++++V ++ + G LFD + ++ + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 132 RGVF--------HRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGTPNY 181
V HRDLK +N+L+ G I+D GL+ + D + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 182 VAPEVLNDKG------YDGRASDVWSCGVILFVLMAGF----------LPFDE-----SN 220
+APEVL+D RA D+++ G++ + + LP+ + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 221 LMALYRKICR---------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ + + +C SC + K+++ N R+T ++ +
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEAL--RVMAKIMRECWYANGAARLTALRIKK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 62/304 (20%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
RT + ++ + +G+G + +V K G+ VA+K+ + + EI
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTV 86
Query: 69 LIKHPNVIKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
L++H N++ I + S T++Y++ ++ + G L+D + L + ++
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVS 145
Query: 125 AVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHT 174
+ + H+ + HRDLK +N+L+ G I+D GL+ D +T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 175 ACGTPNYVAPEVL------NDKGYDGRASDVWSCGVIL----------FVLMAGFLPFDE 218
GT Y+ PEVL N A D++S G+IL ++ LP+ +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 219 -----SNLMALYRKICR-----------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 262
+ + +C + C KL+ NP +R+T
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTAL 320
Query: 263 QMLE 266
++ +
Sbjct: 321 RVKK 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 66/333 (19%), Positives = 121/333 (36%), Gaps = 59/333 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQ-------IKREIS 65
Y + R + GS+ V + G VAIK + + R + + REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 66 TMKLIKHPNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
+ HPN++ + ++ + +Y+V E + +L I + + +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFM 140
Query: 121 -QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
++ + H GV HRDL P N+LL + I DF L +++ D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL---AREDTADANKTHYVTHR 197
Query: 180 NYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAG-------------------------- 212
Y APE+ + KG+ + D+WS G ++ +
Sbjct: 198 WYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 213 FLPFDESNLMALYRKICRADFSCPSWF------SSGAKKLIKRILDPNPDTRMTISQMLE 266
+ S Y + ++ +W A LI ++L+ NP R++ Q L
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 267 DEWFKKGYKP------PHFDKEEEVNLDDVDAI 293
+F+ + P + ++ DV +
Sbjct: 317 HPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 58/295 (19%), Positives = 108/295 (36%), Gaps = 50/295 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L G F V K ++VA+KI + K Q + E+ ++ +KH
Sbjct: 25 PLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPI----QDKQSWQNEYEVYSLPGMKHE 78
Query: 74 NVIKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
N+++ I + ++++ F + G L D + + + +E + + + Y
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137
Query: 130 HSR----------GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
H + HRD+K +N+LL + I+DFGL+ + + G H GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 180 NYVAPEVLNDKGYDG----RASDVWSCGVIL--------------------FVLMAGFLP 215
Y+APEVL D+++ G++L F G P
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 216 FDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL----DPNPDTRMTISQMLE 266
E + K R W ++ + D + + R++ + E
Sbjct: 258 SLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 70/269 (26%), Positives = 108/269 (40%), Gaps = 31/269 (11%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMKLIKH 72
LG +G G+F +V + VA+K + +E +K H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLKAKFLQEARILKQYSH 171
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHS 131
PN++++I V K IYIV+E + GG+ + G L+ + ++Y S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY----VAPEVL 187
+ HRDL N L+ VLKISDFG+S + DG+ + G APE L
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSS 241
N Y SDVWS G++L+ G P+ + + + CP
Sbjct: 288 NYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV-- 344
Query: 242 GAKKLIKRILDPNPDTR---MTISQMLED 267
+L+++ P R TI Q L+
Sbjct: 345 --FRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 66/333 (19%), Positives = 125/333 (37%), Gaps = 83/333 (24%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
+Y L R LG G F+ V AK++ VA+KIV D+ E + EI ++ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 72 ----------HPNVIKIIEV----MASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEA 115
+++K+++ + + +V E + G L K +H +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 116 RRYFQQLINAVDYCHSR-GVFHRDLKPENLLLD------SYGVLKISDFGLSAISQQVRE 168
++ +QL+ +DY H R G+ H D+KPEN+L++ + +KI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WY 188
Query: 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD---------ES 219
D + T Y +PEVL + +D+WS ++F L+ G F+ +
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 220 NLMALYRKIC---------RADFSCPSWFSSGAKK------------------------- 245
+ +A ++ ++ + S G +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 246 -----LIKRILDPNPDTRMTISQMLEDEWFKKG 273
+ +L +P R ++ W K
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 62/304 (20%), Positives = 110/304 (36%), Gaps = 61/304 (20%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L +G G + V VA+K+ ++ ++ I + L++H N+
Sbjct: 16 KLLELIGRGRYGAVYKGS--LDERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNI 69
Query: 76 IKII-----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+ I + + +V+E+ G L ++ H + R + + Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128
Query: 131 S---------RGVFHRDLKPENLLLDSYGVLKISDFGLS------AISQQVREDGLLHTA 175
+ + HRDL N+L+ + G ISDFGLS + + ED +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 176 CGTPNYVAPEVL------NDKGYDGRASDVWSCGVIL----------------------F 207
GT Y+APEVL D + D+++ G+I F
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 208 VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA-----KKLIKRILDPNPDTRMTIS 262
G P E + + R+ R F +W + K+ I+ D + + R+T
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 263 QMLE 266
E
Sbjct: 308 XAEE 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 64/266 (24%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LG G + +V + VA+K + D + + ++ E + MK IKHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNL 278
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
++++ V + YI+ EF+ G L D + + R + Q+ +A++Y +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDK 190
HR+L N L+ ++K++DFGLS ++ G + APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAK 244
+ SDVW+ GV+L+ + G P+ +L +Y + + CP
Sbjct: 395 KFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV----Y 449
Query: 245 KLIKRILDPNPDTR---MTISQMLED 267
+L++ NP R I Q E
Sbjct: 450 ELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 30/208 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMK 68
+ + LG+G+F V+ + TG+ VA+K L+H E ++ REI +K
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------KLQHSTEEHLRDFEREIEILK 66
Query: 69 LIKHPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINA 125
++H N++K V S + + +++E++ G L D + KH R+ + +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP 179
++Y ++ HRDL N+L+++ +KI DFGL+ + Q +V+E G P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------P 180
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVIL 206
+ APE L + + ASDVWS GV+L
Sbjct: 181 IFWYAPESLTESKFS-VASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 30/208 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMK 68
+ + LG+G+F V+ + TG+ VA+K L+H E ++ REI +K
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------KLQHSTEEHLRDFEREIEILK 97
Query: 69 LIKHPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINA 125
++H N++K V S + + +++E++ G L D + KH R+ + +Y Q+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP 179
++Y ++ HRDL N+L+++ +KI DFGL+ + Q +V+E G P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------P 211
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVIL 206
+ APE L + + ASDVWS GV+L
Sbjct: 212 IFWYAPESLTESKFS-VASDVWSFGVVL 238
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ R LGEG F KV N TG+ VA+K + D +H+ K+EI ++ +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLY 91
Query: 72 HPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
H ++IK + +V+E++ G L D + +H + + + QQ+ + Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYL 150
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTPNYV- 182
H++ HRDL N+LLD+ ++KI DFGL+ A+ + +VREDG P V
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202
Query: 183 --APEVLNDKGYDGRASDVWSCGVIL 206
APE L + + ASDVWS GV L
Sbjct: 203 WYAPECLKEYKFY-YASDVWSFGVTL 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L LG+GSF V+ + + +G VA+K + D + + + ++ RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
N+I++ V + +V E G L D++ KH G RY Q+ + Y S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV---APEVL 187
+ HRDL NLLL + ++KI DFGL A+ Q D APE L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAWCAPESL 196
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPFDE 218
+ + ASD W GV L+ + G P+
Sbjct: 197 KTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMK 68
+ LG+G+F V+ + TG VA+K L+H +Q + REI +K
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILK 79
Query: 69 LIKHPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINA 125
+ ++K V + + +V+E++ G L D + +H RL Y Q+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ-----VREDGLLHTACGTP 179
++Y SR HRDL N+L++S +KI+DFGL+ + VRE G P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVIL 206
+ APE L+D + R SDVWS GV+L
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVL 220
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ R LGEG F KV+ + TG+ VA+K + + H +K+EI ++ +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLY 81
Query: 72 HPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDY 128
H N++K + I +++EF+ G L + + K+ ++ + +Y Q+ +DY
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP-NY 181
SR HRDL N+L++S +KI DFGL+ AI V++D P +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFW 195
Query: 182 VAPEVLNDKGYDGRASDVWSCGVIL 206
APE L + ASDVWS GV L
Sbjct: 196 YAPECLMQSKFY-IASDVWSFGVTL 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L +T+G+G F V G+ VA+K + D + E S M ++H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76
Query: 76 IKIIEV-MASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSR 132
++++ V + K +YIV E++ G L D + GR L D ++ + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLND 189
HRDL N+L+ V K+SDFGL+ + ++ G L P V APE L +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALRE 188
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
K + SDVWS G++L+ + G +P+ L + ++
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LG G + +V + VA+K + D + + ++ E + MK IKHPN+
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNL 71
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++++ V + YI+ EF+ G L D + + Q+ +A++Y +
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDK 190
HRDL N L+ ++K++DFGLS ++ G P + APE L
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPF 216
+ SDVW+ GV+L+ + G P+
Sbjct: 188 KFS-IKSDVWAFGVLLWEIATYGMSPY 213
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 62/332 (18%), Positives = 125/332 (37%), Gaps = 79/332 (23%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+ + R +G+G+F +V ++++ + A+K+V R+ K K E +K I++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNI---KKYTRSAKIEADILKKIQN 90
Query: 73 -----PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINA 125
N++K + ++ E + G L++ I ++ ++ + Y +++ A
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT----------A 175
++Y + H DLKPEN+LLD K + + + A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 176 CGTPNYV----------APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLM 222
+Y APEV+ + G+D +SD+WS G +L L G L F + +
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 223 AL---------YRKICRADFSCPSW-FSSGAKKL-------------------------- 246
A+ + A + S + KL
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328
Query: 247 -------IKRILDPNPDTRMTISQMLEDEWFK 271
+ IL +P R + +++L+ ++ +
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L LG G F +V VA+K + + + + E + MK ++H +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLA----EANLMKQLQHQRL 70
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+++ V ++ IYI+ E+++ G L D K +L ++ Q+ + + R
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDK 190
HRDL+ N+L+ KI+DFGL+ ++ ED G P + APE +N
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLA----RLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPF 216
+ SDVWS G++L ++ G +P+
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPY 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 16 ELGRTLGEGSFAKVK--FAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L +T+G+G F V + + VA+K + D + E S M ++H
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK----VAVKCIKND-----ATAQAFLAEASVMTQLRHS 246
Query: 74 NVIKIIEV-MASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCH 130
N+++++ V + K +YIV E++ G L D + GR L D ++ + A++Y
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLND 189
HRDL N+L+ V K+SDFGL+ + ++ G L P + APE L +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALRE 360
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICR 230
K + SDVWS G++L+ + G +P+ L + ++ +
Sbjct: 361 KKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YE+ + +G+GSF +V A + + VA+K+V R+ + Q EI ++ ++
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 73 ------PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLIN 124
NVI ++E + I + E + L++ I K+ R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+D H + H DLKPEN+LL G +K+ DFG S Q ++T + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL 224
APEV+ Y D+WS G IL L+ G+ DE + +A
Sbjct: 267 APEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 51/224 (22%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 16 ELGRTLGEGSFAKV------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+ + LG G+F V + V+ VAIK + K ++I E M
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATS--PKANKEILDEAYVMAS 73
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDY 128
+ +P+V +++ + + + ++ + + G L D + +H + + Q+ ++Y
Sbjct: 74 VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPE 185
R + HRDL N+L+ + +KI+DFGL ++ + + + A G P ++A E
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 186 VLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
+ + Y SDVWS GV ++ ++ G P+D + +
Sbjct: 190 SILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 62/265 (23%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L LG+G F +V T VAIK + + ++ E MK ++H +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 241
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
+++ V S+ IYIV E++ G L D + L+ + Q+ + + Y
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKG 191
HRDL+ N+L+ V K++DFGL ++ + ++ P + APE
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAKK 245
+ SDVWS G++L + G +P+ + ++ R CP
Sbjct: 358 FTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HD 412
Query: 246 LIKRILDPNPDTR---MTISQMLED 267
L+ + P+ R + LED
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLED 437
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 17 LGRTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ LG G+F VK + + VA+KI+ +++ + +++ E + M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++++I + +V+E + G L + ++ +K+ Q+ + Y
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--------TPNYVAPEV 186
HRDL N+LL + KISDFGLS + +R D + A APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLS---KALRADENYYKAQTHGKWPVKWY----APEC 191
Query: 187 LNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+N + SDVWS GV+++ G P+
Sbjct: 192 INYYKFSS-KSDVWSFGVLMWEAFSYGQKPY 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 62/265 (23%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L LG+G F +V T VAIK + + ++ E MK ++H +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 324
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
+++ V S+ IYIV E++ G L D + L+ + Q+ + + Y
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKG 191
HRDL+ N+L+ V K++DFGL ++ + ++ P + APE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAKK 245
+ SDVWS G++L + G +P+ + ++ R CP
Sbjct: 441 FTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HD 495
Query: 246 LIKRILDPNPDTR---MTISQMLED 267
L+ + P+ R + LED
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFLED 520
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 13 GKYE-------LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
G E L + LG G F VK K D VA+K++ + + + E
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQ----EAQ 55
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLIN 124
TM + HP ++K V + + IYIV E+I G L + + HG+ L+ + +
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NY 181
+ + S HRDL N L+D +K+SDFG++ + D ++ GT P +
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT----RYVLDDQYVSSVGTKFPVKW 171
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
APEV + Y SDVW+ G++++ V G +P+
Sbjct: 172 SAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPY 206
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 79/336 (23%), Positives = 130/336 (38%), Gaps = 83/336 (24%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGD-FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+YE+ TLGEG+F KV + + G VA+KIV ++ + E + EI ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNV---DRYCEAARSEIQVLEHLN 69
Query: 72 HP------NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLI 123
++++E I IV E + G +D I ++G + D R+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGV-------------------LKISDFGLSAISQ 164
+V++ HS + H DLKPEN+L +K+ DFG SA
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT-- 185
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNL 221
+D T T +Y APEV+ G+ + DVWS G IL GF F D
Sbjct: 186 --YDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 222 MA------------LYRKICRADF-----------------------------SCPSWFS 240
+A + +K + +
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
LI+++L+ +P R+T+ + L+ +F K
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 13 GKYE-------LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--RE 63
GK+ + +G G F V + VAIK +R + + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIK------TIREGAMSEEDFIEE 53
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQL 122
M + HP ++++ V + I +V EF++ G L D + G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P- 179
+ Y V HRDL N L+ V+K+SDFG++ + D ++ GT P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPV 169
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ +PEV + Y SDVWS GV+++ V G +P+
Sbjct: 170 KWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPY 206
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ + +G G +V + + VAIK + R + E S M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDV--PVAIKALKAGYTERQR--RDFLSEASIMGQF 107
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
HPN+I++ V+ IV E+++ G L + H G+ + + + + Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEV 186
G HRDL N+L+DS V K+SDFGLS + + + +T G + APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEA 225
Query: 187 LNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + + ASDVWS GV+++ VL G P+
Sbjct: 226 IAFRTFSS-ASDVWSFGVVMWEVLAYGERPY 255
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 51/224 (22%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 16 ELGRTLGEGSFAKV------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+ + LG G+F V + V+ VAIK + K ++I E M
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATS--PKANKEILDEAYVMAS 73
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDY 128
+ +P+V +++ + + + ++ + + G L D + +H + + Q+ ++Y
Sbjct: 74 VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPE 185
R + HRDL N+L+ + +KI+DFGL ++ + + + A G P ++A E
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 186 VLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
+ + Y SDVWS GV ++ ++ G P+D + +
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
ELGR +GEG F V +N VAIK + E+ +E TM+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
HP+++K+I V ++ ++I++E GEL + L Y QL A+ Y
Sbjct: 74 DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEV 186
S+ HRD+ N+L+ S +K+ DFGLS + ED + A P ++APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS----RYMEDSTYYKASKGKLPIKWMAPES 188
Query: 187 LNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+N + + ASDVW GV ++ +LM G PF
Sbjct: 189 INFRRFTS-ASDVWMFGVCMWEILMHGVKPF 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YE+ +G+GSF +V A + ++VAIKI+ ++ + + Q + E+ ++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 73 P------NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLIN 124
++ + + + +V E + L+D + + + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 125 AVDYCHSR--GVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPN 180
A+ + + + H DLKPEN+LL + +KI DFG S+ + ++ +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSC----QLGQRIYQYIQSRF 223
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL 224
Y +PEVL YD A D+WS G IL + G F +E + M
Sbjct: 224 YRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 17 LGRTLGEGSFAKVKFAK-NVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+ +G G F +V +G VAIK + + + E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
N+I++ V++ + I+ E+++ G L + + G + + + + Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLN 188
HRDL N+L++S V K+SDFGLS + + E +T G + APE ++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAIS 223
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVWS G++++ V+ G P+
Sbjct: 224 YRKFTS-ASDVWSFGIVMWEVMTYGERPY 251
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKM 56
V + S V +G G F V + A+K ++R
Sbjct: 17 HVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKI--HCAVKSLNRI--TDIGE 69
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMA-SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDE 114
V Q E MK HPNV+ ++ + S+ +VL ++ G+L + I +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-------AISQQVR 167
+ Q+ + Y S+ HRDL N +LD +K++DFGL+ S +
Sbjct: 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
L P V A E L + + SDVWS GV+L+ ++ G P+
Sbjct: 190 TGAKL------P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L + LG G F +V A + VA+K + + + E + MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+K+ V +K IYI+ EF+ G L D K + + + + Q+ + + R
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDK 190
HRDL+ N+L+ + V KI+DFGL+ +V ED G + APE +N
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPF 216
+ SDVWS G++L ++ G +P+
Sbjct: 361 SFT-IKSDVWSFGILLMEIVTYGRIPY 386
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 71/337 (21%), Positives = 122/337 (36%), Gaps = 83/337 (24%)
Query: 13 GKYELGRTLGEGSFAKV-KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+YE+ LGEG+F KV + + VA+KI+ R+ K E + EI+ +K IK
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNV---GKYREAARLEINVLKKIK 74
Query: 72 HP------NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLI 123
+ + + + I E + G F+ + ++ R QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGV-------------------LKISDFGLSAISQ 164
+A+ + H + H DLKPEN+L + ++++DFG SA
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT-- 190
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNL 221
+ T T +Y PEV+ + G+ + DVWS G ILF GF F +
Sbjct: 191 --FDHEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREH 247
Query: 222 MAL-----------------------------------------YRKICRADFSCPSWFS 240
+ + K ++ S
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
L++R+L+ +P R+T+++ L +F
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 16 ELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L R LGEG F +V + + VA+K +D L +K E+ E MK + H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
P+++K+I ++ + +I++E GEL + ++ LK Y Q+ A+ Y S
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLN 188
HRD+ N+L+ S +K+ DFGLS + ED + A T P +++PE +N
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLS----RYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVW V ++ +L G PF
Sbjct: 188 FRRFTT-ASDVWMFAVCMWEILSFGKQPF 215
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LG G F VK+ K D VAIK++ + + +E E M + H +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKL 81
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGV 134
+++ V + I+I+ E++ G L + + + R + + + + A++Y S+
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKG 191
HRDL N L++ GV+K+SDFGLS + D ++ G+ P + PEVL
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPF 216
+ SD+W+ GV+++ + G +P+
Sbjct: 198 FS-SKSDIWAFGVLMWEIYSLGKMPY 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 44/230 (19%), Positives = 96/230 (41%), Gaps = 32/230 (13%)
Query: 16 ELGRTLGEGSFAKV------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+ LG G F V ++++ V IK+++ + + + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKI--PVCIKVIEDKSG--RQSFQAVTDHMLAIGS 71
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD- 127
+ H ++++++ + + + +V +++ G L D +++ Q L+N V
Sbjct: 72 LDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQI 124
Query: 128 -----YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P- 179
Y G+ HR+L N+LL S ++++DFG+ + + D P
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV---ADLLPPDDKQLLYSEAKTPI 181
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
++A E ++ Y SDVWS GV ++ ++ G P+ L + +
Sbjct: 182 KWMALESIHFGKYTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 17 LGRTLGEGSFAKVKFAK-NVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ + +G G F +V + + + VAIK + + + E S M HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSR 132
N+I++ V+ + IV E+++ G L + KH + + + + + + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLND 189
G HRDL N+L++S V K+SDFGL + + E +T G + +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAY 224
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVWS G++L+ V+ G P+
Sbjct: 225 RKFTS-ASDVWSYGIVLWEVMSYGERPY 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
ELGR +GEG F V +N VAIK + E+ +E TM+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
HP+++K+I V ++ ++I++E GEL + L Y QL A+ Y
Sbjct: 449 DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVL 187
S+ HRD+ N+L+ S +K+ DFGL S+ + + + G P ++APE +
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
N + + ASDVW GV ++ +LM G PF
Sbjct: 565 NFRRFTS-ASDVWMFGVCMWEILMHGVKPF 593
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKM 56
V + S V +G G F V + A+K ++R
Sbjct: 81 HVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKI--HCAVKSLNRI--TDIGE 133
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMA-SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDE 114
V Q E MK HPNV+ ++ + S+ +VL ++ G+L + I +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-------AISQQVR 167
+ Q+ + + S+ HRDL N +LD +K++DFGL+ S +
Sbjct: 194 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
L P V A E L + + SDVWS GV+L+ ++ G P+
Sbjct: 254 TGAKL------P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 16 ELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
LGR LG+G F V + + + VA+K++ + ++ +E+ RE + MK H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 73 PNVIKIIEV------MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-A 125
P+V K++ V ++L F+ G+L + R+ E+ Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 126 VD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHT 174
VD Y SR HRDL N +L + ++DFGLS I L
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL-- 201
Query: 175 ACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
P V A E L D Y SDVW+ GV ++ ++ G P+
Sbjct: 202 ----P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 14 KYELGRT--------LGEGSFAKVKFAK-NVETGDF-VAIKIVDRDQVLRHKMVEQIKRE 63
K L R LG G+F V+ + VAIK++ + E++ RE
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMRE 60
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQL 122
M + +P ++++I V ++ + +V+E GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P- 179
+ Y + HRDL N+LL + KISDFGLS +D P
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPL 177
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ APE +N + + SDVWS GV ++ L G P+
Sbjct: 178 KWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPY 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 34/232 (14%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMV 57
V +P R R +G+G F V AIK + R ++
Sbjct: 14 VLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRI--QCAIKSLSRITEMQQV-- 66
Query: 58 EQIKREISTMKLIKHPNVIKIIEV-MASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEA 115
E RE M+ + HPNV+ +I + + + +++L ++ G+L I R +
Sbjct: 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-------AISQQVRE 168
+ Q+ ++Y + HRDL N +LD +K++DFGL+ S Q
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 169 DGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
L P V A E L + SDVWS GV+L+ +L G P+
Sbjct: 187 HARL------P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPY 229
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 13/203 (6%)
Query: 21 LGEGSFAKVKFAK-NVETGDF-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+F V+ + VAIK++ + E++ RE M + +P ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRL 401
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
I V ++ + +V+E GG L + + Q+ + Y + HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDG 194
+L N+LL + KISDFGLS +D + APE +N + +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 195 RASDVWSCGVILF-VLMAGFLPF 216
SDVWS GV ++ L G P+
Sbjct: 519 -RSDVWSYGVTMWEALSYGQKPY 540
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ R LG+GSF V AK V + VAIK V+ +R + + E S MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEF 85
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---KIAKHGRLKEDEARRYFQQLIN-AV 126
+V++++ V++ +++E + G+L + A ++I A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 127 D------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTA 175
+ Y ++ HRDL N ++ +KI DFG++ I + GLL
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL--- 202
Query: 176 CGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V +PE L D + SDVWS GV+L
Sbjct: 203 ---P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 61/216 (28%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
LG+ LGEG F V K VA+K + D + +E+ E + MK
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSL--KVAVKTMKLDNS-SQREIEEFLSEAACMKDF 93
Query: 71 KHPNVIKIIEV-----MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN- 124
HPNVI+++ V K ++L F+ G+L + RL+ Q L+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKF 152
Query: 125 AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLH 173
VD Y +R HRDL N +L + ++DFGLS I +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211
Query: 174 TACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V A E L D+ Y SDVW+ GV +
Sbjct: 212 -----P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 34/214 (15%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
L R LG G+F +V + VA+K + + + E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD-- 127
H N+++ I V +I++E + GG+L + + + L++ A D
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 128 ----YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-AISQQ----VREDGLLHTA 175
Y HRD+ N LL G V KI DFG++ I + +L
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML--- 207
Query: 176 CGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V PE + + +D WS GV+L
Sbjct: 208 ---P--VKWMPPEAFMEGIFTS-KTDTWSFGVLL 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 70/372 (18%), Positives = 120/372 (32%), Gaps = 125/372 (33%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
G+Y + R LG G F+ V + +++ FVA+K+V + E EI +K ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRN 92
Query: 72 ----HPNVIKIIEVMAS-------KTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRY 118
PN +++++ T I +V E + G L I K + L ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 119 FQQLINAVDYCHSR-GVFHRDLKPENLLL------------------------------- 146
QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 147 ------------------DSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-YVAPEVL 187
+KI+D G + + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK------------------IC 229
GY+ +D+WS + F L G F+ + R I
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 230 RADFSCPSWFSSGAKK------------------------------LIKRILDPNPDTRM 259
+S + G K + +L+ P+ R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 260 TISQMLEDEWFK 271
T ++ L W
Sbjct: 385 TAAECLRHPWLN 396
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 51/228 (22%)
Query: 16 ELGRTLGEGSFAKVK--FAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
G+TLG G+F KV A + D VA+K++ L + E + E+ + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSYL 83
Query: 71 -KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------FDKIAKHGRLKEDEARRY 118
H N++ ++ ++ E+ G+L +++DE
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 119 FQQLI-------NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171
+ L+ + + S+ HRDL N+LL + KI DFGL ++ ++ D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIKNDS- 199
Query: 172 LHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
NYV APE + + Y SDVWS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 39/217 (17%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDF--VAIKIV--DRDQVLRHKMVEQIKREISTMKLI-K 71
+GEG+F +V A+ + G AIK + + E+ + +
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA----GELEVLCKLGH 84
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY---------FQQL 122
HPN+I ++ + +Y+ +E+ G L D + K L+ D A QQL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 123 IN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ--QVREDGLLH 173
++ A D Y + HRDL N+L+ V KI+DFGLS + + G L
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL- 203
Query: 174 TACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
P V A E LN Y SDVWS GV+L+
Sbjct: 204 -----P--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 46/225 (20%), Positives = 82/225 (36%), Gaps = 40/225 (17%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF-------VAIKIVDRDQVLRHKMVEQIKREISTMK 68
+LG+G+F K+ E GD+ V +K++D+ E S M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVD 127
+ H +++ V + +V EF+ G L + K+ + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 128 YCHSRGVFHRDLKPENLLLDSYG--------VLKISDFGLSAISQQVREDGLLHTACGTP 179
+ + H ++ +N+LL +K+SD G+ S V
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI---SITVLPK---------- 174
Query: 180 NY-------VAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ V PE + + A+D WS G L+ + G P
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 38/216 (17%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMK 68
L R LG G+F +V N + VA+K + +++ E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIIS 129
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD 127
H N+++ I V +I+LE + GG+L + + + L++ A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 128 ------YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-AISQQ----VREDGLLH 173
Y HRD+ N LL G V KI DFG++ I + +L
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML- 248
Query: 174 TACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V PE + + +D WS GV+L
Sbjct: 249 -----P--VKWMPPEAFMEGIFTS-KTDTWSFGVLL 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIK--REISTMK 68
L R LGEG+F KV N+ VA+K + +D + + RE +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KD----PTLAARKDFQREAELLT 72
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYF 119
++H +++K V + +V E++ G+L I G+ ++ +
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 120 QQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VR 167
Q+++ A Y S+ HRDL N L+ + ++KI DFG+S + V
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
+L P + PE + + + SDVWS GVIL
Sbjct: 193 GHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVIL 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 47/224 (20%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ G+TLG G+F KV A G VA+K++ E + E+ M +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 71 -KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY-------FQQL 122
+H N++ ++ + ++ E+ G+L + + + R+ E + + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 123 IN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
++ + + S+ HRD+ N+LL + V KI DFGL ++ + D
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMND------ 217
Query: 176 CGTPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
NY+ APE + D Y SDVWS G++L+
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-20
Identities = 47/220 (21%), Positives = 82/220 (37%), Gaps = 40/220 (18%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
LGE F KV G+ VAIK + + E+ + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAMLRARL 69
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQ 121
+HPNV+ ++ V+ + ++ + G+L + + + ++
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 122 LIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VRED 169
++ Y S V H+DL N+L+ +KISD GL + + +
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 170 GLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
LL P + APE + + SD+WS GV+L
Sbjct: 190 SLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVL 220
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 53/219 (24%), Positives = 84/219 (38%), Gaps = 40/219 (18%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
L LGEG+F KV N+ VA+K + ++ + +RE + ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL--------FDKIAKHGRLKEDEARRYFQQL 122
+H ++++ V + +V E++ G+L D G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 123 IN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDG 170
+ A Y HRDL N L+ V+KI DFG+S I V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 171 LLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
+L P + PE + + + SDVWS GV+L
Sbjct: 221 ML------P--IRWMPPESILYRKFT-TESDVWSFGVVL 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 48/229 (20%)
Query: 16 ELGRTLGEGSF-----AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
LG+TLGEG F A K VA+K++ + + + E + +K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQV 83
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------------FDKIAKHGRLKED 113
HP+VIK+ + + +++E+ G L D
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 114 EARRYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ 165
E LI+ A Y + HRDL N+L+ +KISDFGLS + ++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 166 ----VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
R G + P V A E L D Y SDVWS GV+L+
Sbjct: 204 DSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 16 ELGRTLGEGSFAKVKFAK-------NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
LG+ LGEG+F +V A+ + VA+K++ D + + E+ MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--SDLVSEMEMMK 95
Query: 69 LI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRY 118
+I KH N+I ++ +Y+++E+ G L + + + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 119 FQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----V 166
F+ L++ Y S+ HRDL N+L+ V+KI+DFGL+ I+
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 REDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
+G L P V APE L D+ Y SDVWS GV+++
Sbjct: 216 TTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 47/226 (20%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIK--REIST 66
LG+ LGEG+F +V + VA+K++ D + E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEM 127
Query: 67 MKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEAR 116
MK+I KH N+I ++ +Y+++E+ G L + + E +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 117 RYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ--- 165
+ L++ A Y S+ HRDL N+L+ V+KI+DFGL+ I
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 166 -VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
+G L P V APE L D+ Y SDVWS GV+L+
Sbjct: 248 KKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 16 ELGRTLGEGSFAKVKFAK-------NVETGDFVAIKIVDRDQVLRHKMVEQIK--REIST 66
LG+ LGEG F +V A+ + VA+K++ D + E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEM 139
Query: 67 MKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEAR 116
MK+I KH N+I ++ +Y+++E+ G L + + + E +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 117 RYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ--- 165
F+ L++ Y S+ HRDL N+L+ V+KI+DFGL+ I+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 166 -VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
+G L P V APE L D+ Y SDVWS GV+++
Sbjct: 260 KKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 42/223 (18%)
Query: 16 ELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+LG+ LG G+F +V A T VA+K++ H + E+ + I
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 87
Query: 71 -KHPNVIKIIEV-MASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYF 119
H NV+ ++ + +++EF G L K +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 120 QQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VR 167
+ LI + + SR HRDL N+LL V+KI DFGL+ I + +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
D L P + APE + D+ Y SDVWS GV+L+
Sbjct: 208 GDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 48/228 (21%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
E R +GEG+F +V A + + VA+K++ + + +RE + M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEF 107
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------------FDKIAKHGRLKED 113
+PN++K++ V A + ++ E++ G+L D +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 114 EARRYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ 165
+ + A Y R HRDL N L+ V+KI+DFGLS I
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 166 ----VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
+ + P + PE + Y SDVW+ GV+L
Sbjct: 228 DYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 60/235 (25%)
Query: 16 ELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMK 68
E G+ LG G+F KV A VA+K++ D R ++ E+ M
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM----SELKMMT 103
Query: 69 LI-KHPNVIKIIEVMASKTKIYIVLEFIDGGEL----------------FDKIAKHGRLK 111
+ H N++ ++ IY++ E+ G+L + K +
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 112 EDEARRYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
ED F+ L+ A + + HRDL N+L+ V+KI DFGL ++
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---AR 220
Query: 165 QVREDGLLHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
+ D NYV APE L + Y + SDVWS G++L+
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
+ +G+ +G G+F +++ KN+ T ++VAIK+ R Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAP---QLHLEYRFYKQLGS 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ ++ +VLE + +LFD + LK QLI+ ++Y
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKT--VLMIAIQLISRMEYV 121
Query: 130 HSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS-----AISQQV---REDGLLHTAC 176
HS+ + +RD+KPEN L+ G V+ I DF L+ +++ RE L
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL---T 178
Query: 177 GTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMALYRKICR 230
GT Y++ + G + R D+ + G + + G LP L Y+KI
Sbjct: 179 GTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 24/233 (10%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
K+ LGR +G GSF ++ N++T + VAIK+ + +H Q+ E ++++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KH---PQLLYESKIYRILQG 61
Query: 72 HPNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ + +V++ + +LF+ ++ LK Q+IN V++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFV 119
Query: 130 HSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-----AISQQVREDGLLHTACGTPNY 181
HS+ HRD+KP+N L+ + I DFGL+ + Q GT Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 182 VAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMALYRKICR 230
+ V G + R D+ S G +L + G LP Y KI
Sbjct: 180 AS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 30/236 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y LGR +G GSF + ++ G+ VAIK+ +H Q+ E K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP---QLHIESKIYKMMQG 63
Query: 73 -PNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ I A +V+E + +LF+ ++ LK Q+I+ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYI 121
Query: 130 HSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-----AISQQ---VREDGLLHTACGT 178
HS+ HRD+KP+N L+ ++ I DFGL+ A + Q RE+ L GT
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL---TGT 178
Query: 179 PNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMALYRKICR 230
Y + + G + R D+ S G +L G LP + Y +I
Sbjct: 179 ARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 51/229 (22%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRD--QVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+G G F KV + + G VA+K + Q + + + EI T+ +HP+++ +
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE-----EFETEIETLSFCRHPHLVSL 100
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD------YCHSR 132
I + ++ ++ ++++ G L + +G + + Q+L + Y H+R
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSA---------ISQQVREDGLLHTACGTPNYVA 183
+ HRD+K N+LLD V KI+DFG+S +S V+ GT Y+
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK---------GTLGYID 209
Query: 184 PE-----VLNDKGYDGRASDVWSCGVILFVLMAG------FLPFDESNL 221
PE L +K SDV+S GV+LF ++ LP + NL
Sbjct: 210 PEYFIKGRLTEK------SDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 32/238 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
Y++GR +GEGSF + N+ VAIK R Q++ E T K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP---QLRDEYRTYKLLAG 64
Query: 72 HPNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ + +V++ + +L D + +K +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT--VAMAAKQMLARVQSI 122
Query: 130 HSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS-----AISQQV---REDGLLHTAC 176
H + + +RD+KP+N L+ ++ + DFG+ +++Q RE L
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL---S 179
Query: 177 GTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMALYRKICR 230
GT Y++ + G + R D+ + G + + G LP + Y +I
Sbjct: 180 GTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.1 bits (186), Expect = 2e-15
Identities = 38/192 (19%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV-----DRDQVLRHKMVEQIKREISTMK 68
K + +GEG F +V VAIKI+ D K E+I EI K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 69 LI---------KHPNVIKIIEV------------------------------MASKTKIY 89
+ + I + V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDS 148
IVLEF GG +++ A+ QL ++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 149 YGVLKISDFGLS 160
+ K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 8e-14
Identities = 58/272 (21%), Positives = 96/272 (35%), Gaps = 84/272 (30%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKII 79
+GEG F V K VA+K + + ++ +Q +EI M +H N+++++
Sbjct: 39 MGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 80 -------------EVMASKTKIYIVLEFIDGGELFDKIAKHG-----RLK--EDEARRYF 119
M + + L L R K + A
Sbjct: 97 GFSSDGDDLCLVYVYMPNGS-----LLDR----LSCLDGTPPLSWHMRCKIAQGAAN--- 144
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL---------SAISQQVREDG 170
+++ H HRD+K N+LLD KISDFGL + ++ ++
Sbjct: 145 -----GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV--- 196
Query: 171 LLHTACGTPNYVAPE----VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLM 222
GT Y+APE + K SD++S GV+L ++ G DE L+
Sbjct: 197 ------GTTAYMAPEALRGEITPK------SDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 223 ALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
D +K I+ +D
Sbjct: 245 ---------DIKEEIEDE---EKTIEDYIDKK 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 46/233 (19%), Positives = 91/233 (39%), Gaps = 40/233 (17%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
++ LG+ +G G F + A + A +V + ++ + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE----YQENGPLFSELKFYQRVAK 92
Query: 73 PNVIKIIEVMASKTKI-------------------YIVLEFIDGGELFDKIAKHGRLKED 113
+ IK + ++V+E + G +L ++G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLS------AISQQ 165
+ ++++ ++Y H H D+K NLLL + + ++D+GLS +Q
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 166 VRED-GLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 215
+E+ H GT + + L+ KG R SDV G + + G LP
Sbjct: 212 YQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 42/223 (18%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G F KV + + G VA+K + ++ ++ Q + E+ + + H N++++
Sbjct: 38 LGRGGFGKV-YKGRLADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 81 VMASKTKIYIVLEFIDGG----ELFDKIAKHGRLKEDEARRYFQQLINAV---------- 126
+ T+ +V ++ G L ++ L D +R I A+
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPL--DWPKRQ---RI-ALGSARGLAYLH 148
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TA-CGTPNYVA 183
D+C + + HRD+K N+LLD + DFGL+ + + H TA GT ++A
Sbjct: 149 DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIGHIA 203
Query: 184 PE-----VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
PE ++K +DV+ GV+L L+ G FD + L
Sbjct: 204 PEYLSTGKSSEK------TDVFGYGVMLLELITGQRAFDLARL 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 36/242 (14%), Positives = 80/242 (33%), Gaps = 55/242 (22%)
Query: 13 GKYELGRTLGEGSF-----AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+++G +G+G F A + +++V + +K+ D + E+
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFY 87
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH--------GRLKED---EAR 116
+ P I+ + + ++ G + G +
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVP-KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 117 RYF---------QQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLS----- 160
+ F ++++ ++Y H H D+K NLLL+ + + + D+GL+
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 161 -----AISQQVREDGLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGF 213
A + GT + + ++ G R D+ G + + G
Sbjct: 207 EGVHKAYAA--DPKRCH---DGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 214 LP 215
LP
Sbjct: 259 LP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 1e-11
Identities = 75/458 (16%), Positives = 136/458 (29%), Gaps = 138/458 (30%)
Query: 39 DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH----PNVI----KIIEVMASKTKIYI 90
FV + D K V+ + + I + + I H + + ++ + SK + +
Sbjct: 28 AFVD----NFDC----KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE-EM 78
Query: 91 VLEFIDGGE------LFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144
V +F++ L I R R Y +Q R + D N
Sbjct: 79 VQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ----------RDRLYND----NQ 124
Query: 145 LLDSYGVLKISDF-GL-SAISQQVREDGL-LH--TACGTPNYVAPEVLNDKGYDGRASDV 199
+ Y V ++ + L A+ + + + G +VA +V +
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-TWVALDVCLSYKVQCKMDF- 182
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN----P 255
+ F L E+ L L +KL+ +I DPN
Sbjct: 183 ---KI--FWLNLKNCNSPETVLEML-------------------QKLLYQI-DPNWTSRS 217
Query: 256 DTRMTISQMLEDEWFKKGYKPPHFDKEEEVN----LDDV------DAIFNDSKENLVTEK 305
D I + + + N L +V +A FN S + L+T
Sbjct: 218 DHSSNIKLRIHSI---QAELRRLLKSKPYENCLLVLLNVQNAKAWNA-FNLSCKILLT-T 272
Query: 306 KEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRET-----RFTSQRP---PNEI----- 352
+ K V+ F + T SL+ L E ++ RP P E+
Sbjct: 273 RFKQVT--DFLSAATTTHISLD---HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 353 --MSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGG 410
+S I E+ + N+K + DK + S+
Sbjct: 328 RRLSIIAESIRD--GLATWDNWK-HVNCDKLTTIIESSLNVL------------------ 366
Query: 411 DTLEFHKFYKKFSSGLKDV---------VWQAEENKEE 439
+ E+ K + + S +W +
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 62/495 (12%), Positives = 139/495 (28%), Gaps = 162/495 (32%)
Query: 44 KIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDK 103
++ + V R + ++++ + ++L NV +I+ + K ++ L+ ++ K
Sbjct: 124 QVFAKYNVSRLQPYLKLRQAL--LELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 104 IAKH------GRLKEDEAR-RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156
+ E Q+L+ +D + H + ++
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---HSIQAELRR 236
Query: 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS----------CGVIL 206
+ + E+ LL VL +V + C ++L
Sbjct: 237 L----LKSKPYENCLL-------------VL-L--------NVQNAKAWNAFNLSCKILL 270
Query: 207 ------------------FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
L + + +L K + + L +
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK----------YLDCRPQDLPR 320
Query: 249 RILDPNPDTRMTISQMLEDE---WFKKGYKPPHFDKEEEV------NLDDVD-------- 291
+L NP I++ + D W +K + DK + L+ +
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATW--DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 292 AIFNDSKENLVTEKKEKPVSMNAFELI----SRTKSFSLENLFEKQTGLVKRETRFTSQ- 346
++F S + LI ++ + N K + + K+ T
Sbjct: 379 SVFPPS----A------HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 347 -------RPPNEIMSK-----IEEAAKPLGFNVRKGNYKMKLQGDK-----TGRKGQLSV 389
+ E ++ P F+ + + D+ G L
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFD---SDDLIPPYLDQYFYSHIGH--HLKN 483
Query: 390 A--TEVFEVAPTLHI------VEVRKTG---------GDTLEFHKFYKKF---------- 422
E + + + ++R +TL+ KFYK +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543
Query: 423 -SSGLKDVVWQAEEN 436
+ + D + + EEN
Sbjct: 544 LVNAILDFLPKIEEN 558
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 51/347 (14%), Positives = 104/347 (29%), Gaps = 107/347 (30%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD-RDQV-----LRHKMV-EQI 60
+ + + + T E K K ++ + D +V R ++ E I
Sbjct: 287 THISLDHHSMTLTPDE---VKSLLLK------YLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
+ ++T KH N K+ ++ S ++ L+ E R+ F
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIES---------SLN------------VLEPAEYRKMFD 376
Query: 121 QLINAVDYCHSRGVFHRDLK-PENLL------LDSYGVLKISD--FGLSAISQQVRE--- 168
+L VF P LL + V+ + + S + +Q +E
Sbjct: 377 RL----------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 169 ---DGLLHTACGTPNYVAPEVLNDK---GYDG-RASDVWSC------GVILFVL---MAG 212
L N A L+ Y+ + D + +
Sbjct: 427 SIPSIYLELKVKLENEYA---LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 213 FLPFDESNLM-ALY-------RKICRADFSCPSWFSSGA--------KKLIKRILDPNPD 256
+ L ++ +KI +W +SG+ K I D +P
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRH---DSTAWNASGSILNTLQQLKFYKPYICDNDPK 540
Query: 257 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNL------DDVDAIFNDS 297
++ +L+ F + + + +L + +AIF ++
Sbjct: 541 YERLVNAILD---FLPKIE-ENLICSKYTDLLRIALMAEDEAIFEEA 583
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 35/239 (14%), Positives = 82/239 (34%), Gaps = 49/239 (20%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDF--------VAIKIVDRDQVLRHKMV----EQI 60
+++L + + A T ++K+ +D L ++
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKI----YIVLEFIDGGELFDKIAKHGRLKEDEAR 116
+++ K + ++ I M ++VL + G L + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSPK 153
Query: 117 RYF---------QQLINAVDYCHSRGVFHRDLKPENLLL--DSYGVLKISDFGLSAI--- 162
+L++A+++ H H ++ EN+ + + + ++ +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 163 -SQQV--RED-GLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 215
+ V E H G +++ ++ KG R SD+ S G + + GFLP
Sbjct: 214 SGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 25/99 (25%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL---ARDIYKD---------PD 248
Query: 181 YV------------APEVLNDKGYDGRASDVWSCGVILF 207
YV APE + D+ Y + SDVWS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 13/171 (7%)
Query: 16 ELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+LG+ LG G+F +V A T VA+K++ H + E+ + I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 71 -KHPNVIKIIEVM-ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
H NV+ ++ + +++EF G L + R K +E Y +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
G DLK + S S F V E+
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-07
Identities = 16/86 (18%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 344 TSQRPPNEIMSKIEEAAKPLGFNVR-KGNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLH 401
TS PN++M +I + + K + + + + EV ++ +L+
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 402 IVEVRKTGGDTLEFHKFYKKFSSGLK 427
V ++ G ++ F K ++ LK
Sbjct: 94 GVRFKRISGTSIAFKNIASKIANELK 119
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 28/165 (16%), Positives = 55/165 (33%), Gaps = 28/165 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKI---------------VDRDQVLRHKMVEQ 59
+G+ +GEG + V + E +K D +
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 60 IKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF 119
+ E ++ ++ V K+ +++E ID EL+ ++ +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYR-------VRVENPDEVL 199
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
++ V + RG+ H DL N+L+ + I DF S
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 243
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 442 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.98 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.75 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.51 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.08 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.26 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.41 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.85 | |
| 3ost_A | 128 | Serine/threonine-protein kinase KCC4; kinase assoc | 82.55 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.16 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-69 Score=522.46 Aligned_cols=262 Identities=31% Similarity=0.599 Sum_probs=244.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|++++|||||++++++++.+.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999998876655555788999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+|||||+||+|+++|.+.+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876554444
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 249 (442)
....+.||||.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+..+++.++....+.+|..+|+++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 556788999999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHHH------HhcCccccc
Q 013487 250 ILDPNPDTRMTISQ------MLEDEWFKK 272 (442)
Q Consensus 250 ~L~~dP~~R~s~~e------il~hp~~~~ 272 (442)
||++||++|||++| |++||||+.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999988 588999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-69 Score=512.36 Aligned_cols=263 Identities=47% Similarity=0.882 Sum_probs=224.8
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
..+..+++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|++++||||+++++++.+.+
T Consensus 7 ~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 7 ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34567899999999999999999999999999999999998776555555678999999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||| +|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999999999 679999999999999999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
.....+.|||+.|+|||++.+..|++.++||||+||++|+|++|.+||.+.+...++..+..+.+.+|.++|+++++|
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 234467899999999999999998888999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|.+||+.||++|||++|+++||||+..
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-66 Score=508.39 Aligned_cols=261 Identities=29% Similarity=0.568 Sum_probs=230.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|++|+|||||++++++.+.+.+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 3467999999999999999999999999999999999876543 345678999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|||||+||+|+++|...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999999997653 57999999999999999999999999999999999999999999999999998654321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCCCCHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKL 246 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 246 (442)
....+.|||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+..+++.++..+.+ +.+..+|+++.+|
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred --ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 234567899999999999998885 899999999999999999999999999999998888765 4566799999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|.+||++||++|||++|+|+||||++..
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-66 Score=503.48 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=230.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-..|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997654322 35678999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999986543 2234
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~ 248 (442)
..+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+.+..+..... ..+..+|+++++||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 5678999999999999988885 899999999999999999999999988888888776532 233458999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
+||+.||++|||++|+|+||||++...
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-66 Score=498.66 Aligned_cols=257 Identities=32% Similarity=0.622 Sum_probs=227.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.++|++++.||+|+||+||+|++. .+++.||+|++++...... ....+.+|+.+|++++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999984 4678999999976543222 134577899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+|||||+||+|++++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999975433 2
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 248 (442)
.....+.|||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+..+++..+....+.+|..+|+++.+||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2345678999999999999988886 899999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCC-----HHHHhcCccccc
Q 013487 249 RILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 249 ~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
+||++||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 589999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-63 Score=509.55 Aligned_cols=407 Identities=36% Similarity=0.665 Sum_probs=317.5
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
......+++|.+++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34567889999999999999999999999999999999999876544434467889999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 245 (442)
.....+.|||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+..+..+.+..|..+++++.+
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp ---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred ---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence 23456789999999999999888877899999999999999999999999988889999998888889999999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccCCCCCCCCcccccCcc--c---hhhh---hccccccc----cc----------
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD--D---VDAI---FNDSKENL----VT---------- 303 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~--~---~~~~---~~~~~~~~----~~---------- 303 (442)
||.+||+.||.+|||+.|+++||||+.......+......... + .... +....+.. ..
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 325 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVA 325 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC------------------------
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHH
Confidence 9999999999999999999999999875432211111000000 0 0000 00000000 00
Q ss_pred -----cccCCCCCCChh---------------------hhhccCCCC------CCccch--hh---hcccccccceEEeC
Q 013487 304 -----EKKEKPVSMNAF---------------------ELISRTKSF------SLENLF--EK---QTGLVKRETRFTSQ 346 (442)
Q Consensus 304 -----~~~~~~~~~~~~---------------------~~~~~~~~~------~~~~~~--~~---~~~~~~~~~rf~s~ 346 (442)
...........+ ..+..+.+. .++... .. .+...++++++.|.
T Consensus 326 y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~ 405 (476)
T 2y94_A 326 YHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQ 405 (476)
T ss_dssp -------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEEC
T ss_pred HHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccC
Confidence 000000000000 000000000 011000 00 12235779999999
Q ss_pred CChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEeCCeEEEEEEecCCCchhH
Q 013487 347 RPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEF 415 (442)
Q Consensus 347 ~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le~ 415 (442)
.+|.+||.+|.+|++.+|+.|++ +.|.|++....+.....+.|.+++|+++++.+||||++..|+.++|
T Consensus 406 ~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 406 SRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp SCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 99999999999999999999976 6799998876554456678999999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-64 Score=503.66 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=230.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
..+|++.+.||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997654322 35688999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcc
Confidence 999999999999875 6799999999999999999999999999999999999999999999999999986543 2234
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~ 248 (442)
..+.|||+.|||||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+..+.... +..+..+|+++++||.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 5678999999999999988885 89999999999999999999999998888888877653 3344568999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+||..||++|||++|+|+||||++..
T Consensus 383 ~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-64 Score=479.33 Aligned_cols=254 Identities=25% Similarity=0.484 Sum_probs=222.1
Q ss_pred ccCe-EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe----CC
Q 013487 12 VGKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KT 86 (442)
Q Consensus 12 ~~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 86 (442)
-++| ++.+.||+|+||+||+|.++.++..||+|++...... ....+.+.+|+.+|++++|||||++++++.+ .+
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3566 7888999999999999999999999999999866533 3446789999999999999999999999865 35
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEcc-CCceEEeeccchhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSAIS 163 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~-~~~~kl~DFGla~~~ 163 (442)
.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999999999999999999999999999999 999999999999984 799999999999753
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-cHHHHHHHHhhCCC--CCCCCCC
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRADF--SCPSWFS 240 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~s 240 (442)
. .....+.||||.|+|||++.+ .| +.++|||||||+||+|+||.+||.+. +...++..+..+.. ..+..++
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 3 234567899999999999875 56 48999999999999999999999764 45566666665533 3445688
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+++.+||.+||+.||++|||++|+|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-63 Score=484.71 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=224.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.++.|++.+.||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.++|||||++++++.+.+.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456799999999999999999999999999999999865432 379999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 169 (442)
|||||+||+|+++|...+++++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999988 6999999999865443221
Q ss_pred C---ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCCCHHH
Q 013487 170 G---LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFSSGA 243 (442)
Q Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 243 (442)
. .....||||.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+...++.++..... ..|+.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 1 22346899999999999998886 899999999999999999999998777777777766553 3577899999
Q ss_pred HHHHHHccCCCCCCCCCHHHH-------------hcCcccccCC
Q 013487 244 KKLIKRILDPNPDTRMTISQM-------------LEDEWFKKGY 274 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~ei-------------l~hp~~~~~~ 274 (442)
.+||.+||++||.+|||+.|+ |+|||+....
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999999999999999999997 5789987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=485.15 Aligned_cols=260 Identities=28% Similarity=0.387 Sum_probs=225.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------CC
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------KT 86 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 86 (442)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976542 23346778899999999999999999999764 36
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+|||||. |+|++++...+++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999996 689999999999999999999999999999999999999999999999999999999999999764332
Q ss_pred --ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC---------
Q 013487 167 --REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--------- 235 (442)
Q Consensus 167 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 235 (442)
.......+.|||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+.+..|.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 223345678999999999999988887899999999999999999999999998887777664321110
Q ss_pred ----------------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 236 ----------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 236 ----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+.+|+++.+||.+||..||++|||++|+|+||||++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123689999999999999999999999999999998654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=499.31 Aligned_cols=260 Identities=26% Similarity=0.463 Sum_probs=230.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHH---HHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI---KREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
...+++|++++.||+|+||+||+|+++.+|+.||||++++..+........+ ++++.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4568899999999999999999999999999999999987765433222333 4456777788999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+.+|+|||||+||+|+++|...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999976533
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---cHHHHHHHHhhCCCCCCCCCCHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADFSCPSWFSSG 242 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~ 242 (442)
....+.||||.|+|||++.+...++.++|||||||+||+|++|.+||.+. +...+...+......+|..+|++
T Consensus 345 ----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 345 ----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp ----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 23467899999999999975443458999999999999999999999764 34566777888888999999999
Q ss_pred HHHHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
+++||.+||+.||.+|++ ++||++||||+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 799999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=460.72 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=204.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (442)
.+++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 3567999999999999999999999999999999997653 3344678899999999999999999999987544
Q ss_pred --------EEEEEEEccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 87 --------KIYIVLEFIDGGELFDKIAKHGRL---KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 87 --------~~~lv~E~~~gg~L~~~i~~~~~l---~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
.+|+|||||+||+|.+++...+.+ ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 379999999999999999887654 456789999999999999999999999999999999999999999
Q ss_pred eccchhhhhhcccC----------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-HHH
Q 013487 156 DFGLSAISQQVRED----------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MAL 224 (442)
Q Consensus 156 DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~ 224 (442)
|||+|+........ ....+.|||+.|+|||++.+..|+ .++|||||||+||+|++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999875442221 123456899999999999988885 89999999999999996 8865432 233
Q ss_pred HHHHhhCCCC-CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 225 YRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 225 ~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...+....++ .+...++.+.+||.+||++||++|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 3334333321 11224677899999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-60 Score=454.24 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=223.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
-++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 467999999999999999999875 357889999997542 334678999999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
.+|+|||||+||+|.+++...+ .+++.++..++.|++.||+|||+++|+||||||+|||+++++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999999997643 699999999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC
Q 013487 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD 232 (442)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 232 (442)
|+|||+|+..............+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..++...+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999866543332233446799999999999988885 89999999999999998 999999998888888887765
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+.|..+|+++.+|+.+||+.||++|||+.+| |+|+++
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 56788899999999999999999999999999 467753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=463.27 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=209.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
.-++|++.+.||+|+||+||+|+++ .+++.||+|.+.+.. ...++.+|+.+|+.+ +||||+++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 4468999999999999999999985 467889999986543 134578999999998 6999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-CceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DFGla~~~~~ 165 (442)
.+|+|||||+||+|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999999983 59999999999999999999999999999999999999876 8999999999974332
Q ss_pred cc--------------------------cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC-
Q 013487 166 VR--------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE- 218 (442)
Q Consensus 166 ~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~- 218 (442)
.. ......+.|||+.|+|||++.+..+++.++||||+||++|+|++|.+||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 112345578999999999998877667999999999999999999999954
Q ss_pred CcHHHHHHHHhh--------------------------------------CCC----------------CCCCCCCHHHH
Q 013487 219 SNLMALYRKICR--------------------------------------ADF----------------SCPSWFSSGAK 244 (442)
Q Consensus 219 ~~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~s~~~~ 244 (442)
.+..+....+.. ... .....+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 333333222211 000 11123789999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+||++||+.||++|+|++|+|+||||+.
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=484.49 Aligned_cols=260 Identities=33% Similarity=0.606 Sum_probs=235.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 457899999999999999999999999999999999976542 23567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC--CceEEeeccchhhhhhc
Q 013487 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQV 166 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~--~~~kl~DFGla~~~~~~ 166 (442)
+|||||+||+|+++|.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 99999999999999964 4679999999999999999999999999999999999999854 8999999999986543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSG 242 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 242 (442)
.....+.|||+.|+|||++.+.+|. .++|||||||++|+|++|.+||.+.+..+.+..+....+.++ ..+|++
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred --CCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 3445678999999999999998885 899999999999999999999999999999999888766554 358999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
+++||.+||..||.+|||+.|+|+||||+....+
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999999999999999999999976554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=450.10 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=214.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
..+|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357899999999999999999864 467899999997542 344678999999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc
Q 013487 87 KIYIVLEFIDGGELFDKIAKH---------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 151 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~---------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~ 151 (442)
.+|+|||||+||+|.+++... +++++.++..++.|++.||+|||+++|+||||||+|||+++++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999999764 35899999999999999999999999999999999999999999
Q ss_pred eEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhh
Q 013487 152 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICR 230 (442)
Q Consensus 152 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 230 (442)
+||+|||+|+..............+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..+....+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999866543333344567899999999999988885 89999999999999999 9999999888888888776
Q ss_pred C-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 231 A-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 231 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+ ..+.|..+++++.+|+.+||+.||++|||+.||+++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5 467788899999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=446.04 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=224.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...+.+++.+.||+|+||+||+|... .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45678999999999999999999863 467889999996542 22345779999999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~ 148 (442)
.+.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999653 35899999999999999999999999999999999999999
Q ss_pred CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHH
Q 013487 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 227 (442)
Q Consensus 149 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 227 (442)
++++||+|||+|+..............+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876554444455667899999999999988875 89999999999999998 8999999988888888
Q ss_pred HhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 228 ICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 228 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..+. .+.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77654 56788899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=442.61 Aligned_cols=267 Identities=43% Similarity=0.818 Sum_probs=244.5
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
.......+++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34456788999999999999999999999999999999999987653 33456778899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+.+|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999997553
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
. .......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+.......+..+.+..|..+++++.
T Consensus 166 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 242 (328)
T 3fe3_A 166 V---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 242 (328)
T ss_dssp S---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred C---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 3 2345678999999999999998888889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
+||++||..||.+|||++|+++||||+....
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 9999999999999999999999999986543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=442.99 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=206.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.+++++.+.||+|+||+||+|++.. .||||+++.... ..+..+.+.+|+.+|++++|||||++++++.. +.+|+|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 4678899999999999999998643 599999875432 34457789999999999999999999998754 568999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||+||+|.+++... +++++..+..++.|++.||+|||++||+||||||+|||+++++++||+|||+|+.........
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999999764 579999999999999999999999999999999999999999999999999998765443344
Q ss_pred ccccccCCCcccCcccccccC--CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH-HhhCCC-----CCCCCCCHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK-ICRADF-----SCPSWFSSG 242 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~-i~~~~~-----~~~~~~s~~ 242 (442)
...+.+||+.|+|||++.+.. .++.++|||||||+||||+||..||.+.+....... +..+.. ..+..++++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 556789999999999996432 235899999999999999999999987655444333 333211 234568999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
+.+|+.+||+.||++|||+.||+++-.
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=439.06 Aligned_cols=261 Identities=34% Similarity=0.645 Sum_probs=233.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
...+++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 46678999999999999999999999999999999999877655555567788999999988 79999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+++..+......+|.++++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 12334567999999999999888775 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCCH------HHHhcCccccc
Q 013487 248 KRILDPNPDTRMTI------SQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s~------~eil~hp~~~~ 272 (442)
++||+.||.+||++ +++++||||+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999998 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=432.11 Aligned_cols=260 Identities=32% Similarity=0.630 Sum_probs=238.6
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35789999999999999999999999999999999998765444445677889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999874322 22
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 249 (442)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+...++..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34466799999999999988777 48999999999999999999999999988999999888888999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHhcCccccc
Q 013487 250 ILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 250 ~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
||+.||.+|| +++|+++||||+.
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=440.83 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=216.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCC-----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC-CCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~ 85 (442)
.++|++++.||+|+||+||+|.+..++ +.||+|.+.... .....+.+.+|+.+|++++| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 368999999999999999999986543 579999987543 23345778999999999975 9999999998664
Q ss_pred -CEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~ 148 (442)
+.+|+|||||++|+|.++|... ..+++..+..++.||+.||+|||+++|+||||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999763 34899999999999999999999999999999999999999
Q ss_pred CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHH-HHHH
Q 013487 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM-ALYR 226 (442)
Q Consensus 149 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~ 226 (442)
++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+.. ....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999865443222233457899999999999988875 89999999999999998 99999886543 4444
Q ss_pred HHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 227 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 227 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+..+ .+..|..+++++.+|+.+||+.||++|||+.||++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 45444 467788899999999999999999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=439.28 Aligned_cols=264 Identities=45% Similarity=0.860 Sum_probs=237.9
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.+...+++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 45678999999999999999999999999999999999998665433334567889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||+ +|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 999999999 789999999989999999999999999999999999999999999999999999999999999976543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+..+.......|..+++++.+|
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL 238 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 234567799999999999998887778999999999999999999999887766666666666777888899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|++||+.||.+|||++|+++||||+...
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 9999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=425.33 Aligned_cols=257 Identities=34% Similarity=0.714 Sum_probs=238.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 46789999999999999999999999999999999998765444344677889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 249 (442)
...+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+....+..+......+|+.+++++.+||.+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999887775 8999999999999999999999999999999999998889999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHhcCccccc
Q 013487 250 ILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 250 ~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
||..||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 8999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=431.32 Aligned_cols=262 Identities=31% Similarity=0.591 Sum_probs=236.6
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
....+++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 356788999999999999999999999999999999999876544334456788999999877 8999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+...++..+......+|.++++++.+|
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 12234567999999999999887774 8999999999999999999999999999999999888888999999999999
Q ss_pred HHHccCCCCCCCCCHH-HHhcCccccc
Q 013487 247 IKRILDPNPDTRMTIS-QMLEDEWFKK 272 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~-eil~hp~~~~ 272 (442)
|.+||..||.+||++. ++++||||+.
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccC
Confidence 9999999999999998 9999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=426.36 Aligned_cols=259 Identities=33% Similarity=0.674 Sum_probs=239.8
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
....+++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44678999999999999999999999999999999999987655444456788899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
...+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+....+..+..+...+|..+++++.+||
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred ---CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 23467899999999999887775 89999999999999999999999999999999999998899999999999999
Q ss_pred HHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 248 KRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
.+||+.||.+||+ +++|++||||+.
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999998 999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=428.17 Aligned_cols=262 Identities=30% Similarity=0.574 Sum_probs=236.9
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
....+++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 356788999999999999999999999999999999999876554444567788999999988 7999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
........|||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+......+|..+++++.+|
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1223456799999999999988777 48999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 247 IKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 247 i~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
|.+||..||.+||+ ++++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999994 799999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=433.70 Aligned_cols=262 Identities=29% Similarity=0.583 Sum_probs=232.5
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
....+++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 345678999999999999999999999999999999999887655555567788999999887 8999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999999999989999999999999999999999999999999999999999999999999999874222
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---------cHHHHHHHHhhCCCCCCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---------NLMALYRKICRADFSCPS 237 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~ 237 (442)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|.+||... ....++..+......+|.
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred -CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 22345678999999999999988774 8999999999999999999999632 334567778888889999
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCH------HHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~------~eil~hp~~~~ 272 (442)
.+++++.+||++||+.||.+||++ +||++||||+.
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999999984 89999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=423.82 Aligned_cols=261 Identities=30% Similarity=0.593 Sum_probs=235.2
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
...+++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35678999999999999999999999999999999999887665666678899999999988 89999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC---------CcHHHHHHHHhhCCCCCCCC
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---------SNLMALYRKICRADFSCPSW 238 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 238 (442)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .+...++..+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2233456799999999999988777 4899999999999999999999965 33445667777888888999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCH------HHHhcCccccc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 272 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~------~eil~hp~~~~ 272 (442)
+++++.+||.+||+.||.+||++ +++++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=424.30 Aligned_cols=260 Identities=33% Similarity=0.575 Sum_probs=233.2
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
....++|++++.||+|+||+||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 3456789999999999999999999999999999999986543211 1246788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----ceEEeeccchh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSA 161 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~----~~kl~DFGla~ 161 (442)
+.+|+||||++||+|++++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999999888999999999999999999999999999999999999998777 79999999997
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----C
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----S 237 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 237 (442)
.... .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+....+.++ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred EcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 6443 2234567899999999999887774 899999999999999999999999998888888888776665 4
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+++++.+||.+||..||.+|||+.|+++||||+.
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 58999999999999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=424.99 Aligned_cols=261 Identities=31% Similarity=0.593 Sum_probs=229.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHH-HhhCCCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 87 (442)
....++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4567899999999999999999999999999999999988765555556677788877 577899999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999875322
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++..+......+|+.+++++.+||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 22345678999999999999887775 89999999999999999999999999999999999988888999999999999
Q ss_pred HHccCCCCCCCCCH----HHHhcCccccc
Q 013487 248 KRILDPNPDTRMTI----SQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s~----~eil~hp~~~~ 272 (442)
.+||+.||.+||++ .++++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999986 69999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=424.42 Aligned_cols=264 Identities=26% Similarity=0.524 Sum_probs=236.2
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
......+++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34556788999999999999999999999999999999999876654444567888999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+.+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCccccccCCCcccCcccccccC--CCCCcccHhHHHHHHHHHhcCCCCCCC---CcHHHHHHHHhhCCCCCCCCCC
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSCPSWFS 240 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~~~~s 240 (442)
.....+.+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.. .........+.......|..++
T Consensus 168 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 ---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp ---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred ---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 23456789999999999987432 235899999999999999999999974 3455666677777888899999
Q ss_pred HHHHHHHHHccCCCCCCCCC-HHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s-~~eil~hp~~~~ 272 (442)
+++.+||.+||+.||.+||+ ++++++||||+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=417.15 Aligned_cols=263 Identities=39% Similarity=0.660 Sum_probs=226.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 4578999999999999999999999999999999999755422 23466889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999765443333
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCCCC--CCCCHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP--SWFSSGAKKL 246 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~l 246 (442)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..........+ ..+++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 44556789999999999988887778999999999999999999999876543 33333333333223 3489999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|.+||..||.+|||+.|+++||||++..
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHccCChhhCcCHHHHhhChhhcccc
Confidence 9999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=430.17 Aligned_cols=260 Identities=33% Similarity=0.650 Sum_probs=232.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 34567899999999999999999999999999999999866533 33467789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---cCCceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~---~~~~~kl~DFGla~~~~~ 165 (442)
|+||||+.||+|++.+...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999999999999999999999999999999999999999999999999998 467899999999975543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC----CCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~ 241 (442)
. .......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....+..+..+.+..+. .+++
T Consensus 166 ~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 166 E--QQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp T--CCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred C--CceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 2 2234567899999999999887774 8999999999999999999999999998888888887665543 4799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=432.89 Aligned_cols=261 Identities=33% Similarity=0.627 Sum_probs=228.2
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 44678999999999999999999999999999999999876554455567788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999998999999999999999999999998 9999999999999999999999999999875322
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22334567899999999999887774 89999999999999999999999999999999998888899999999999999
Q ss_pred HHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 248 KRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
.+||+.||.+|| |++|+++||||+.
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-53 Score=411.64 Aligned_cols=261 Identities=33% Similarity=0.624 Sum_probs=225.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhh-HHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
....++|++.+.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999985 689999999998654322 2335667899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999987533
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|+.+++++.
T Consensus 173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 HD--GTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred cC--CccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 21 223456789999999999988777 489999999999999999999999999888888888888889999999999
Q ss_pred HHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
+||.+||..||.+|| ++.++++||||+.
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999 8999999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=405.92 Aligned_cols=259 Identities=27% Similarity=0.475 Sum_probs=227.6
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+...++|++.+.||+|+||+||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 3456789999999999999999999999999999999997654322 3567899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 169 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc-
Confidence 99999999999999999874 6999999999999999999999999999999999999999999999999998754332
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAK 244 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~ 244 (442)
.......+||+.|+|||++.+..|. .++||||+||++|+|++|..||...+.......+... ....|..+++.+.
T Consensus 170 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 170 -QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp -TCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred -ccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 2234456899999999999888774 8999999999999999999999888776555544332 3345667899999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=401.18 Aligned_cols=262 Identities=32% Similarity=0.675 Sum_probs=235.8
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
....+++|++.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35678999999999999999999999999999999999976654444445678999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.|+||||+++|+|.+.+.....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999864332
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.......|..+++++.+||
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred --ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 22345679999999999987666 489999999999999999999999999888888888888889999999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 248 KRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHhccChhhCCCHHHHhhCccccCCc
Confidence 999999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=416.69 Aligned_cols=258 Identities=34% Similarity=0.676 Sum_probs=231.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345689999999999999999999999999999999976543 2334677899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEeeccchhhhhhc
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQV 166 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~ 166 (442)
+||||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~- 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 183 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT-
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC-
Confidence 9999999999999999888999999999999999999999999999999999999998654 599999999875542
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC----CCCHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSG 242 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 242 (442)
.......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....+..+..+.+..|. .++++
T Consensus 184 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 184 --SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp --CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred --CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 2234567899999999999887775 8999999999999999999999999888888888887665553 37999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.+||.+||+.||.+|||+.++|+||||..
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=427.57 Aligned_cols=261 Identities=31% Similarity=0.548 Sum_probs=229.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999998754433333456789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....... .
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 223 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 223 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence 99999999999999876 579999999999999999999999999999999999999999999999999997543321 1
Q ss_pred CccccccCCCcccCcccccccC---CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCC--CCCCHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCP--SWFSSG 242 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~ 242 (442)
....+.+||+.|+|||++.+.+ +++.++|||||||++|+|++|.+||.+.+....+.++... .+.+| ..+|++
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence 1234678999999999998655 2358999999999999999999999999988888887654 23444 468999
Q ss_pred HHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 243 AKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 243 ~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
+++||.+||+.+|.+ |++++||++||||+.
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 999999999999999 999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=411.27 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=229.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4679999999999999999999999999999999987542 234568899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc--CCceEEeeccchhhhhhcc
Q 013487 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~ 167 (442)
||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999999997754 7999999999999999999999999999999999999987 78999999999976543
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 243 (442)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ +.+|+++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 233456789999999999987655 4899999999999999999999999998888888888776655 3589999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||.+||..||.+|||+.|+|+||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=401.66 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=218.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4789999999999999999999999999999999976542 233456788999999999999999999999999999999
Q ss_pred EEccCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i-~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+.+ +|.+.+ ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999987 555554 4467899999999999999999999999999999999999999999999999999975432 223
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCC-CCCCcHHHHHHHHhhC--C---------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICRA--D--------------- 232 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~--~--------------- 232 (442)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+.......+... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345568999999999998877567999999999999999988777 5555555555544321 0
Q ss_pred ------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 233 ------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 233 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
....+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01123468899999999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=414.74 Aligned_cols=258 Identities=38% Similarity=0.748 Sum_probs=217.4
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|++..+++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 45679999999999999999999999999999999997654322 45779999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc--eEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~--~kl~DFGla~~~~~~~ 167 (442)
+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999999999998899999999999999999999999999999999999999987765 99999999874322
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc----HHHHHHHHhhCCCCCCC--CCCH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPS--WFSS 241 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~--~~s~ 241 (442)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|..||...+ .......+.......|. .+++
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 2223456799999999999988887666999999999999999999998643 34455556555555554 4799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.+||.+||..||.+|||+.|+++||||.+..
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 999999999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=398.56 Aligned_cols=265 Identities=46% Similarity=0.868 Sum_probs=231.3
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
......++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45567899999999999999999999999999999999997655433344667899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
..|+||||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 246 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 246 (442)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+.......|..++..+.+|
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 222345679999999999988777668999999999999999999999998888888888888888888899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|.+||+.||.+|||+.++++||||++..
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=404.88 Aligned_cols=264 Identities=34% Similarity=0.675 Sum_probs=221.8
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-----------------------HHHHHHHHH
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----------------------HKMVEQIKR 62 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~ 62 (442)
......+++|++.+.||+|+||.||+|++..+++.||+|++.+..... ....+.+.+
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp ----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHH
T ss_pred CCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 344567899999999999999999999999999999999997654221 112456889
Q ss_pred HHHHHhhCCCCCcceEEEEEEe--CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013487 63 EISTMKLIKHPNVIKIIEVMAS--KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140 (442)
Q Consensus 63 Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlk 140 (442)
|+.+++.++||||+++++++.+ .+.+|+||||+++|+|.+++. .+++++..++.++.||+.||+|||++||+|||||
T Consensus 86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 9999999999999999999986 578999999999999988654 4679999999999999999999999999999999
Q ss_pred CCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCC--CCCcccHhHHHHHHHHHhcCCCCCCC
Q 013487 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDE 218 (442)
Q Consensus 141 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~ 218 (442)
|+|||++.++.+||+|||++...... .......+||+.|+|||++.+... .+.++|||||||++|+|++|..||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999998754331 223445689999999999976543 35789999999999999999999999
Q ss_pred CcHHHHHHHHhhCCCCCC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 219 SNLMALYRKICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+.......+.......| +.+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 888777777766655444 468999999999999999999999999999999963
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=426.21 Aligned_cols=262 Identities=27% Similarity=0.497 Sum_probs=228.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998754433333445889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-
Confidence 99999999999999987 5789999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccCCCcccCcccccc----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCC---CC
Q 013487 169 DGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS---WF 239 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~---~~ 239 (442)
.......+||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+..+.+.++... .+.+|. .+
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 112334689999999999872 333458999999999999999999999999988888887643 345554 38
Q ss_pred CHHHHHHHHHccCCCCCC--CCCHHHHhcCccccc
Q 013487 240 SSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 272 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~--R~s~~eil~hp~~~~ 272 (442)
|+++++||++||..+|++ |++++|+++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999999988 999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=408.83 Aligned_cols=260 Identities=37% Similarity=0.593 Sum_probs=230.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3455789999999999999999999999999999999976543211 1246788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----ceEEeeccchh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSA 161 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~----~~kl~DFGla~ 161 (442)
+..|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999999888999999999999999999999999999999999999999887 89999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----C
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----S 237 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 237 (442)
.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......+ .
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 6532 2234567899999999999877764 899999999999999999999999888887777776665554 4
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 57999999999999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=398.38 Aligned_cols=265 Identities=33% Similarity=0.705 Sum_probs=237.6
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
.+.....+++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 45667788999999999999999999999999999999999976554333345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+..|+||||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999986443
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
. ......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+.......|..++.++.
T Consensus 166 ~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 166 S----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240 (284)
T ss_dssp S----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHH
T ss_pred c----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHH
Confidence 2 123456799999999999887764 89999999999999999999999988888888888888888899999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+||.+||..||.+|||+.++++||||+...
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999999999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=444.77 Aligned_cols=261 Identities=30% Similarity=0.569 Sum_probs=238.2
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
...+++|++.+.||+|+||+||+|+++.+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34678999999999999999999999999999999999876554444567788999999988 69999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+++..+......+|..+++++.+||
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22345678999999999999888874 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCCH-----HHHhcCccccc
Q 013487 248 KRILDPNPDTRMTI-----SQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s~-----~eil~hp~~~~ 272 (442)
++||+.||.+||++ +||++||||+.
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999997 99999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=408.37 Aligned_cols=269 Identities=28% Similarity=0.425 Sum_probs=214.2
Q ss_pred CCcccCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE
Q 013487 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (442)
Q Consensus 1 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 80 (442)
|+.....+...+++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (329)
T 3gbz_A 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKS 100 (329)
T ss_dssp ----------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEE
T ss_pred ceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEE
Confidence 445556677889999999999999999999999999999999999976542 2334566789999999999999999999
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-----cCCceEEe
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-----SYGVLKIS 155 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-----~~~~~kl~ 155 (442)
++.+.+.+|+||||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 101 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999999999999985 9999999999999999999999999999999999999999999999994 45569999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CC
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DF 233 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~ 233 (442)
|||+|...... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..+....+... ..
T Consensus 180 Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 180 DFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99999865432 223445678999999999987665569999999999999999999999988776665554331 00
Q ss_pred C---------CCC-------------------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 234 S---------CPS-------------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 234 ~---------~~~-------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
. .+. .+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0 001 167899999999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=406.89 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=195.7
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----E
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----K 87 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 87 (442)
..+|.+.+.||+|+||+||+|++ +|+.||||+++..... ......|+..+.+++|||||++++++...+ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 35799999999999999999997 6889999999755321 123346777778899999999999997653 6
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEccCCceEEeeccc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~--------givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
+|+|||||+||+|.+++.. .+++++.+.+++.|++.||+|||++ +|+||||||+|||++.++++||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 8999999999999999976 5699999999999999999999987 999999999999999999999999999
Q ss_pred hhhhhhccc--CCccccccCCCcccCcccccccCC-----CCCcccHhHHHHHHHHHhcCCCCCCCC-------------
Q 013487 160 SAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDES------------- 219 (442)
Q Consensus 160 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~------------- 219 (442)
|+....... .......+||+.|+|||++.+... ++.++|||||||+||||+||.+||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 976543221 122345689999999999976421 246899999999999999997765321
Q ss_pred --cHHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 220 --NLMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 220 --~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
....+...+..... ..|.. .+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22334444443332 23322 23467899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=410.55 Aligned_cols=258 Identities=36% Similarity=0.666 Sum_probs=223.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH--HHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.-++|++.+.||+|+||+||+|.++.+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34689999999999999999999999999999999976543211 1246788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc---eEEeeccchh
Q 013487 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSA 161 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~---~kl~DFGla~ 161 (442)
|+||||++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999887653 25899999999999999999999999999999999999987655 9999999997
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----C
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----S 237 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 237 (442)
..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+ ...+..+..+.+..+ .
T Consensus 182 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 182 QLGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp ECCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHT
T ss_pred EecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccc
Confidence 65432 222345789999999999988777 489999999999999999999998754 455666666665544 4
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 58999999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=421.07 Aligned_cols=261 Identities=28% Similarity=0.504 Sum_probs=226.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998765444444566889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|........
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 9999999999999998754 799999999999999999999999999999999999999999999999999975433211
Q ss_pred CCccccccCCCcccCcccccc------cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCC---C
Q 013487 169 DGLLHTACGTPNYVAPEVLND------KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCP---S 237 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~---~ 237 (442)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+.+.++... ....| .
T Consensus 218 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 218 -VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp -EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred -cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 12235689999999999873 222358999999999999999999999999888888877653 23334 5
Q ss_pred CCCHHHHHHHHHccCCCCCCC---CCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R---~s~~eil~hp~~~~ 272 (442)
.+|+++++||++||. +|.+| ++++|+++||||+.
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 689999999999999 99998 59999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=394.91 Aligned_cols=265 Identities=35% Similarity=0.586 Sum_probs=240.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 34667899999999999999999999999999999999876555555677899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++|||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999998754322
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 248 (442)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+.+..+.......|..+++.+.+||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence 122345679999999999987766 4899999999999999999999999888888888888888888899999999999
Q ss_pred HccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
+||+.||.+|||++|+++||||.....+
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHcccChhhCcCHHHHhhChheecCCcC
Confidence 9999999999999999999999876644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=403.45 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=216.2
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
......++|++.+.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 44567889999999999999999999994 689999999975532 2234567889999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.+|+||||++| +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999986 8888776654 599999999999999999999999999999999999999999999999999976532
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--C-----------
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--D----------- 232 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~----------- 232 (442)
. .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+... .
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 1 223445689999999999987655568999999999999999999999876655444443220 0
Q ss_pred --------CC---------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 --------FS---------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 --------~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+. ..+.+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 00 11236789999999999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=396.37 Aligned_cols=262 Identities=34% Similarity=0.636 Sum_probs=208.7
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 45678999999999999999999999999999999999765543333457789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999999875 579999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.......|..++.++.+||
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 167 --EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred --CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 12235679999999999987666 489999999999999999999998877666666666666777888999999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccC
Q 013487 248 KRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||..||.+|||++++++||||...
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=412.14 Aligned_cols=264 Identities=24% Similarity=0.428 Sum_probs=221.0
Q ss_pred cccccCeEEEeeeccc--CceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 9 RTRVGKYELGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G--~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
....++|++.+.||+| +||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 3567899999999999 999999999999999999999986643 3456778899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999876 679999999999999999999999999999999999999999999999999875432
Q ss_pred hcc-----cCCccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-----
Q 013487 165 QVR-----EDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD----- 232 (442)
Q Consensus 165 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----- 232 (442)
... ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+.......+..+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 211 1122234589999999999987 345 589999999999999999999998755443332222111
Q ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 233 -----------------------------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 233 -----------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
.+.+..+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 113345789999999999999999999999999999998
Q ss_pred cCC
Q 013487 272 KGY 274 (442)
Q Consensus 272 ~~~ 274 (442)
...
T Consensus 339 ~~~ 341 (389)
T 3gni_B 339 QIK 341 (389)
T ss_dssp GC-
T ss_pred HHh
Confidence 643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=396.82 Aligned_cols=256 Identities=32% Similarity=0.506 Sum_probs=215.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 7899999999975532 222245678999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+.+ +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 999988764 67999999999999999999999999999999999999999999999999999765421 12
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--C----------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--D---------------- 232 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~---------------- 232 (442)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345679999999999987655568999999999999999999999988766655544321 0
Q ss_pred --C---------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 --F---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 --~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+ .....+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 011347899999999999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=402.98 Aligned_cols=265 Identities=35% Similarity=0.587 Sum_probs=240.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34568999999999999999999999999999999998765555556788999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 249 (442)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+.+..+.......|..+++.+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 22345679999999999987766 48999999999999999999999998888888888888888888999999999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccCCCCC
Q 013487 250 ILDPNPDTRMTISQMLEDEWFKKGYKPP 277 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~~~~~~~~ 277 (442)
||+.||.+|||+.|+++||||...+.+.
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=430.76 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=232.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998765544444567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-- 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence 99999999999999987654 99999999999999999999999999999999999999999999999999975432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc----HHHHHHHHhhCCCCCCCCCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPSWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 243 (442)
.......+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+ ...+...+......+|..+|+++
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 2234567999999999999887775 89999999999999999999998753 45666667777777888899999
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
.+||.+||+.||.+|| +++|+++||||+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999 8999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=426.49 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=233.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876654444467788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999997543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC----cHHHHHHHHhhCCCCCCCCCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCPSWFS 240 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s 240 (442)
.. .......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||... ....+...+......+|..++
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 32 1223456999999999999987775 8999999999999999999999765 346677778888888899999
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
+++.+||.+||+.||.+||+ +++|++||||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 589999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=389.91 Aligned_cols=260 Identities=33% Similarity=0.665 Sum_probs=232.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 3456899999999999999999999999999999999976653 334467788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc---eEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~---~kl~DFGla~~~~~ 165 (442)
|++|||++||+|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999999999899999999999999999999999999999999999999987665 99999999865432
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 241 (442)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.......| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 223345679999999999988776 4899999999999999999999999888888888777765544 35799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=409.57 Aligned_cols=255 Identities=35% Similarity=0.629 Sum_probs=223.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
....++|++.+.||+|+||+||+|.++.+++.||+|++.+... ...+|+.++.++ +||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 3456789999999999999999999999999999999976542 234688888887 79999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-C---ceEEeeccchhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-G---VLKISDFGLSAIS 163 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~---~~kl~DFGla~~~ 163 (442)
+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+... + .+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999999998999999999999999999999999999999999999998533 3 5999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC---CcHHHHHHHHhhCCCCCC----
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSCP---- 236 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~---- 236 (442)
.. ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.. .+..++...+..+.+..+
T Consensus 171 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 171 RA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp BC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred cC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 33 22345677999999999999877765 899999999999999999999975 456677777777766554
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4589999999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=396.76 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=217.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 679999999999999999999999999999999986553 2334467788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999998754422 223
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--------------------
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------------- 231 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------- 231 (442)
....+||+.|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 345689999999999987555568999999999999999999999887766554433211
Q ss_pred -CCCCC----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 -DFSCP----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 -~~~~~----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+.+ +.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 11111 3478899999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=413.23 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=211.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCC--
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT-- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 86 (442)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 46789999999999999999999999999999999986542 23344677889999999997 999999999997654
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.+|+||||+. |+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999998 489998876 57999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH
Q 013487 167 -------------------REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (442)
Q Consensus 167 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (442)
.........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122345578999999999998755556899999999999999999999998887766655
Q ss_pred HhhCC-C----------------------------------------------CCCCCCCHHHHHHHHHccCCCCCCCCC
Q 013487 228 ICRAD-F----------------------------------------------SCPSWFSSGAKKLIKRILDPNPDTRMT 260 (442)
Q Consensus 228 i~~~~-~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s 260 (442)
+.... . ..+..+++++.+||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 53210 0 011256889999999999999999999
Q ss_pred HHHHhcCcccccC
Q 013487 261 ISQMLEDEWFKKG 273 (442)
Q Consensus 261 ~~eil~hp~~~~~ 273 (442)
++|+|+||||+..
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=402.79 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=207.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 35789999999999999999999999999999999975432 1123567899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 91 VLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
||||++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 999998764 358999999999999999999999999999999999999999999999999987653
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CC---------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DF--------- 233 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~--------- 233 (442)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 21 223345689999999999987555568999999999999999999999988776665554321 00
Q ss_pred -----------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 234 -----------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 234 -----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
..+..+++++.+||.+||+.||++|||+.|+|+||||++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 011246889999999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=408.54 Aligned_cols=259 Identities=30% Similarity=0.560 Sum_probs=229.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999976532 2245788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc--CCceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~--~~~~kl~DFGla~~~~~ 165 (442)
|+||||+.||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999997654 7999999999999999999999999999999999999974 57899999999975432
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 241 (442)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 233455689999999999988776 4899999999999999999999999888888777777655433 35799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=403.09 Aligned_cols=256 Identities=37% Similarity=0.690 Sum_probs=205.7
Q ss_pred ccccCeEEE---eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeC
Q 013487 10 TRVGKYELG---RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~---~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 85 (442)
....+|++. +.||+|+||.||+|.+..+++.||+|++.+.. ...+.+|+.+++.+. ||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 445778886 88999999999999999999999999997542 345678999999997 99999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEeeccchhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 162 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~DFGla~~ 162 (442)
...|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999999999999999999999999999999999999999999999999999998766 899999999975
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-------HHHHHHHHhhCCCCC
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKICRADFSC 235 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~ 235 (442)
.... .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||...+ ..+....+..+.+..
T Consensus 159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCCC--CCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 4332 2334567899999999999887775 89999999999999999999997643 346667777776655
Q ss_pred CC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 236 PS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 236 ~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+. .+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 53 4799999999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=389.12 Aligned_cols=257 Identities=39% Similarity=0.661 Sum_probs=231.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+...++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 345678999999999999999999999999999999997654322 46788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla~~~~~ 165 (442)
|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999999998999999999999999999999999999999999999999 7889999999999875432
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC----CCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~ 241 (442)
.......+||+.|+|||++.+. .+.++||||+|+++|+|++|..||...+.......+..+....|. .+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2334567899999999998754 458999999999999999999999999888888888887776664 5899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=423.28 Aligned_cols=261 Identities=36% Similarity=0.627 Sum_probs=229.7
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH----------HHHHHHHHHHHHHhhCCCCCcceE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH----------KMVEQIKREISTMKLIKHPNVIKI 78 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l 78 (442)
+...++|++++.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4567899999999999999999999999999999999976543211 235678899999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEe
Q 013487 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKIS 155 (442)
Q Consensus 79 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~ 155 (442)
++++.+...+|+|||||+||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999989999999999999999999999999999999999999999776 69999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC 235 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (442)
|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+..
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999976543 233456789999999999874 45 589999999999999999999999999999988888887665
Q ss_pred C----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 236 P----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 236 ~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+ ..+|+++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 4 45899999999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=425.06 Aligned_cols=260 Identities=36% Similarity=0.645 Sum_probs=232.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45578999999999999999999999999999999997665433334677899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccchhhhhhc
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla~~~~~~ 166 (442)
+||||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 999999999999999999999999999999999999999999999999999999999 4678999999999976543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC--CC--CCCHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PS--WFSSG 242 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~--~~s~~ 242 (442)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+.. |. .+|++
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 182 --SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp --CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred --ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 233456789999999999876 45 589999999999999999999999999888888888776544 32 38999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=390.59 Aligned_cols=263 Identities=39% Similarity=0.655 Sum_probs=227.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3568999999999999999999999999999999999765432 23577889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||++|++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999988888999999999999999999999999999999999999999999999999998765433333
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCCC--CCCCCHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSC--PSWFSSGAKKL 246 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~~~~l 246 (442)
......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.. ..+..+....... ...+++.+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 34456789999999999988777668899999999999999999999876543 2333333332222 23589999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|.+||+.||.+|||+.|+++||||++..
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=422.14 Aligned_cols=262 Identities=37% Similarity=0.639 Sum_probs=230.2
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+...++|++.+.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 3456789999999999999999999999999999999997654322 235678899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---cCCceEEeeccchhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQ 164 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~---~~~~~kl~DFGla~~~~ 164 (442)
+|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999999989999999999999999999999999999999999999995 45679999999997654
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC--CC--CCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PS--WFS 240 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~--~~s 240 (442)
. .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+.. |. .+|
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred C---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 3 233456789999999999976 35 589999999999999999999999999888888887776543 32 379
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
+++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=421.07 Aligned_cols=258 Identities=36% Similarity=0.647 Sum_probs=224.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+...++|++++.||+|+||+||+|++..++..||+|++.+..... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 445668999999999999999999999999999999997654322 1246688999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC---CceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~---~~~kl~DFGla~~~~~ 165 (442)
|+|||||+||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999999998999999999999999999999999999999999999999764 4599999999976543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 241 (442)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+..+ ..+|+
T Consensus 192 ---~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 192 ---QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp ---TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred ---CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 223456789999999999864 45 5899999999999999999999999999888888887766543 24799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 9999999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=396.22 Aligned_cols=260 Identities=33% Similarity=0.575 Sum_probs=230.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
....++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3456789999999999999999999999999999999976543211 1246788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----ceEEeeccchh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSA 161 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~----~~kl~DFGla~ 161 (442)
+..|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888999999999999999999999999999999999999999888 79999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----C
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----S 237 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 237 (442)
.... .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 5433 223345679999999999987776 4899999999999999999999999888888877777665554 4
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 57999999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=394.23 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=213.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh--HHHHHHHHHHHHHHhhCC---CCCcceEEEEEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIK---HPNVIKIIEVMA 83 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~ 83 (442)
....++|++.+.||+|+||+||+|++..+++.||+|++....... ......+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 455689999999999999999999999999999999997543111 111234567777777664 999999999998
Q ss_pred eCC-----EEEEEEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEee
Q 013487 84 SKT-----KIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (442)
Q Consensus 84 ~~~-----~~~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~D 156 (442)
... .++++|||+.+ +|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 58999999975 99999988764 99999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CC
Q 013487 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FS 234 (442)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~ 234 (442)
||+|..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+.......+.... ..
T Consensus 164 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 164 FGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999976543 2334567899999999999887774 89999999999999999999999888777666654310 00
Q ss_pred -------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 235 -------------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 235 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
..+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0124688999999999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=419.44 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=213.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (442)
...++|++++.||+|+||+||+|++..+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 35689999999999999999999999999999999997653 3344567888999999999999999999999654
Q ss_pred --CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
..+|+||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 468999999987 57777643 5999999999999999999999999999999999999999999999999999765
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC----------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---------- 233 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------- 233 (442)
.. .......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 215 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 215 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred CC---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 43 2344567899999999999988875 899999999999999999999999887766655533100
Q ss_pred -----------------CCCCCC---------------CHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 234 -----------------SCPSWF---------------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 234 -----------------~~~~~~---------------s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
.++..+ ++++.+||.+||..||++|||++|+|+||||+....
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 000001 467899999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=387.59 Aligned_cols=258 Identities=34% Similarity=0.601 Sum_probs=220.2
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+...++|++.+.||+|+||.||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 345778999999999999999999999999999999999765422 225678899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccch
Q 013487 88 IYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLS 160 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla 160 (442)
.|+||||++||+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999999988543 679999999999999999999999999999999999999 45678999999999
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC---C
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---S 237 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---~ 237 (442)
...... ......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+.......+.......+ .
T Consensus 175 ~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 175 ELFKSD---EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred eecCCc---ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence 765432 22345679999999999864 44 5899999999999999999999999887777666655443332 2
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 37899999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=400.64 Aligned_cols=256 Identities=36% Similarity=0.641 Sum_probs=209.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++...+.+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999997543 2356789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEeeccchhhhhhc
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAISQQV 166 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~DFGla~~~~~~ 166 (442)
+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999999889999999999999999999999999999999999999975 88999999999876543
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCCCC----CCCCH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~ 241 (442)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+..+.......+ ..++.
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 223356789999999999988776 48999999999999999999999765544 35666666554332 34789
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.+||.+||..||++|||+.|+|+||||+...
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=407.78 Aligned_cols=255 Identities=34% Similarity=0.638 Sum_probs=210.4
Q ss_pred cccccCeEEE-eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHH-hhCCCCCcceEEEEEEe--
Q 013487 9 RTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMAS-- 84 (442)
Q Consensus 9 ~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-- 84 (442)
+..+++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4567889987 7899999999999999999999999998643 2456788887 45589999999999876
Q ss_pred --CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEeec
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~DF 157 (442)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 667999999999999999998754 5999999999999999999999999999999999999997 789999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH----HHHHHHhhCCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRADF 233 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~ 233 (442)
|++..... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+.. .....+..+.+
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99875432 2234577899999999999887775 8999999999999999999999765432 23444555554
Q ss_pred CCC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 234 SCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 234 ~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
..+ ..+++++.+||.+||+.||.+|||+.|+++||||.....
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 443 348999999999999999999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=390.86 Aligned_cols=264 Identities=33% Similarity=0.632 Sum_probs=228.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-HHHHHHHHHHHHHHhhCCCCCcceEEEEE--EeCCE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVM--ASKTK 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~ 87 (442)
.+++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5789999999999999999999999999999999998654322 23457789999999999999999999998 44567
Q ss_pred EEEEEEccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.|+||||+.++ |.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999986 7777765 35699999999999999999999999999999999999999999999999999876544
Q ss_pred cccCCccccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
...........||+.|+|||++.+.. +.+.++||||||+++|+|++|..||...+.......+.......+..+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 33333445667999999999987643 33578999999999999999999999998888888888888888888999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 245 KLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
+||.+||+.||.+|||+.|+++||||++...
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=392.27 Aligned_cols=263 Identities=32% Similarity=0.572 Sum_probs=218.9
Q ss_pred CCcccccCeEEE-eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 7 ASRTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 7 ~~~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
-++...++|++. +.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 345667789995 789999999999999999999999999976532 2246788999999885 79999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc---eEEeeccchh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSA 161 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~---~kl~DFGla~ 161 (442)
.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999999999999999889999999999999999999999999999999999999998776 9999999987
Q ss_pred hhhhccc-----CCccccccCCCcccCcccccc-----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-----------
Q 013487 162 ISQQVRE-----DGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESN----------- 220 (442)
Q Consensus 162 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----------- 220 (442)
....... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 5432211 112345679999999999875 334 489999999999999999999997653
Q ss_pred ----HHHHHHHHhhCCCCCC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 221 ----LMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 221 ----~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.......+.......| ..+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345566666666665 3589999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=415.30 Aligned_cols=261 Identities=30% Similarity=0.387 Sum_probs=200.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-----C
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-----K 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 85 (442)
..++|++.+.||+|+||+||+|++..+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 4578999999999999999999999999999999996542 234456788999999999999999999999843 3
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 57999999985 69999999988999999999999999999999999999999999999999999999999999986542
Q ss_pred ccc-------------------------CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc---------
Q 013487 166 VRE-------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--------- 211 (442)
Q Consensus 166 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~--------- 211 (442)
... .......+||+.|+|||++.....++.++|||||||+||+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 211 1234556899999999987555545699999999999999998
Q ss_pred --CCCCCCCCcH--------------------HHHHHHHhh----------------------CCC---------CCCCC
Q 013487 212 --GFLPFDESNL--------------------MALYRKICR----------------------ADF---------SCPSW 238 (442)
Q Consensus 212 --g~~Pf~~~~~--------------------~~~~~~i~~----------------------~~~---------~~~~~ 238 (442)
|.+||.+.+. .+....+.. ..+ ...+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6777765431 111111110 000 01133
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 58999999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=404.53 Aligned_cols=255 Identities=31% Similarity=0.531 Sum_probs=224.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH-----HHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-----KMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...++|++.+.||+|+||+||+|++..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 345789999999999999999999999999999999986543211 123456789999999999999999999999
Q ss_pred CCEEEEEEEccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 85 KTKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 85 ~~~~~lv~E~~~gg-~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999776 99999999889999999999999999999999999999999999999999999999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHH
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 243 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 243 (442)
.. .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHH
Confidence 33 23345678999999999999888877899999999999999999999976432 2334455667789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||.+||+.||.+|||+.++++||||+..
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=398.27 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=212.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 4789999999999999999999999999999999975431 11122455799999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 999985 8999887754 5999999999999999999999999999999999999999999999999998754321 22
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--C---------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--F--------------- 233 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~--------------- 233 (442)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+.... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 33456789999999999875555689999999999999999999999988776665543310 0
Q ss_pred --C-----------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 234 --S-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 234 --~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
. .++.+++++.+||.+||+.||.+|||++|+|+||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0 1123688999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=400.06 Aligned_cols=264 Identities=27% Similarity=0.393 Sum_probs=219.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----- 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 84 (442)
..+++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 4678999999999999999999999999999999998655422 2223456789999999999999999999977
Q ss_pred ---CCEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 85 ---KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 85 ---~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
.+.+|+||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999986 777776654 57999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcc--cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCC
Q 013487 161 AISQQVR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW 238 (442)
Q Consensus 161 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 238 (442)
....... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+.......++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7654221 12233556899999999999876655699999999999999999999999988776666554321111110
Q ss_pred --------------------------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 239 --------------------------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 239 --------------------------------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
.++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 2677999999999999999999999999999986544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=397.01 Aligned_cols=267 Identities=24% Similarity=0.442 Sum_probs=224.9
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..+....++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 34556788999999999999999999999999999999999876555556677899999999999999999999998765
Q ss_pred C----EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 86 T----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 86 ~----~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
. ..|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4 359999999999999999998999999999999999999999999999999999999999999999999999997
Q ss_pred hhhhcccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC----C
Q 013487 162 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC----P 236 (442)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~ 236 (442)
........ ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+............... +
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 65432211 223346799999999999887764 89999999999999999999999888777666655544332 2
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+++++.+||.+||+.||.+||+..+++.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 3489999999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=407.19 Aligned_cols=263 Identities=28% Similarity=0.398 Sum_probs=211.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (442)
...++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 35678999999999999999999999999999999997542 3344567889999999999999999999999776
Q ss_pred -CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
..+|+||||+.| +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 579999999974 999999998889999999999999999999999999999999999999999999999999998654
Q ss_pred hcccC--------------------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-----------C
Q 013487 165 QVRED--------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-----------F 213 (442)
Q Consensus 165 ~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-----------~ 213 (442)
..... ......+||+.|+|||++.....++.++||||+||++|+|++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32211 2346678999999999975555456999999999999999984 4
Q ss_pred CCCCCCcH-----------------HHHHHHH------------------------hhCCCCCC-------CCCCHHHHH
Q 013487 214 LPFDESNL-----------------MALYRKI------------------------CRADFSCP-------SWFSSGAKK 245 (442)
Q Consensus 214 ~Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~~-------~~~s~~~~~ 245 (442)
++|.+.+. .+....+ .......+ +.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44433320 1111111 11111111 347999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
||.+||+.||.+|||++|+|+||||+...
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=398.29 Aligned_cols=262 Identities=33% Similarity=0.559 Sum_probs=221.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh--hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
.++|++.+.||+|+||.||+|.+..++..||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46899999999999999999999999999999999766432 2234678899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 013487 90 IVLEFIDGGELFDKIAK----------------------------------------HGRLKEDEARRYFQQLINAVDYC 129 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~----------------------------------------~~~l~~~~~~~~~~ql~~aL~~l 129 (442)
+||||++||+|.+++.. ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998852 11246788999999999999999
Q ss_pred HHCCceeccCCCCcEEEccCC--ceEEeeccchhhhhhcccCC--ccccccCCCcccCccccccc-CCCCCcccHhHHHH
Q 013487 130 HSRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDG--LLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGV 204 (442)
Q Consensus 130 H~~givHrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv 204 (442)
|++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999997654322211 23456899999999998752 33458999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 205 ILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 205 il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++|+|++|..||.+.+..+....+.......+. .+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 999999999999998888877777766544332 279999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=388.98 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=222.5
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|+..+.||+|+||.||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488899999999999999999999999999999754322 24568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
|++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccc
Confidence 9999999998865 57999999999999999999999999999999999999999999999999998754332 12234
Q ss_pred cccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCCCHHHHHHHHHc
Q 013487 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~ 250 (442)
..+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..... ..+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 56899999999999877664 899999999999999999999998887777766655432 22335789999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCC
Q 013487 251 LDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|+.||++|||+.++++||||....
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=397.10 Aligned_cols=258 Identities=34% Similarity=0.611 Sum_probs=226.7
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-----hhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3679999999999999999999999999999999865431 1123456788999999999 799999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+..|+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875443
Q ss_pred cccCCccccccCCCcccCccccccc-----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---- 236 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 236 (442)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+....+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2234567899999999998643 2235899999999999999999999998888777777777665443
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+++.+.+||.+||..||.+|||+.++++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 347899999999999999999999999999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=395.57 Aligned_cols=261 Identities=30% Similarity=0.455 Sum_probs=220.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...+++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 457889999999999999999999999999999999986543 2334456788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|+||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999999998888888999999999999999999999999999999999999999999999999999754432
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-----------------
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------------- 231 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------- 231 (442)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223445679999999999987655568999999999999999999999887765544433210
Q ss_pred --CCCC------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 232 --DFSC------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 232 --~~~~------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.... .+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0111 1246899999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=400.28 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=214.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (442)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 4578999999999999999999999999999999996543 23445678899999999999999999999997653
Q ss_pred --EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 87 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 7899999876 679999999999999999999999999999999999999999999999999987543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-----------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----------- 233 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 233 (442)
. .....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234568999999999998744456899999999999999999999998877665554432100
Q ss_pred --------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 234 --------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 234 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
...+..++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11234689999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=388.02 Aligned_cols=257 Identities=37% Similarity=0.688 Sum_probs=226.8
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 45667999999999999999999999999999999999754321 235688999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla~~~~~ 165 (442)
|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999999988899999999999999999999999999999999999999 7889999999999865322
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 241 (442)
......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+..+....+ ..+++
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 162 ----GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ----BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ----CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 233456799999999999887764 899999999999999999999999888888888777654433 45799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++.+||.+||..||.+|||+.|+++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=395.68 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=217.4
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-----CCCcceEEEE
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----HPNVIKIIEV 81 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~ 81 (442)
......++|++.+.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.+. ||||++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 34456689999999999999999999999999999999997432 23456778999999986 9999999999
Q ss_pred EEeCCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-----------
Q 013487 82 MASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----------- 148 (442)
Q Consensus 82 ~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~----------- 148 (442)
+...+..|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 99999999999999 889999998765 5999999999999999999999999999999999999975
Q ss_pred --------------CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCC
Q 013487 149 --------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL 214 (442)
Q Consensus 149 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~ 214 (442)
++.+||+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCC
Confidence 78999999999975332 23456899999999999988775 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHhhCCCCCC--------------------------C--------------------CCCHHHHHHHH
Q 013487 215 PFDESNLMALYRKICRADFSCP--------------------------S--------------------WFSSGAKKLIK 248 (442)
Q Consensus 215 Pf~~~~~~~~~~~i~~~~~~~~--------------------------~--------------------~~s~~~~~li~ 248 (442)
||...+..+....+.....+.| . ..++.+.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9988776665554433222111 1 12367889999
Q ss_pred HccCCCCCCCCCHHHHhcCcccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+||+.||.+|||+.|+|+||||+
T Consensus 338 ~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999995
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=400.25 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=217.9
Q ss_pred cCeEE--EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 13 GKYEL--GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 13 ~~y~i--~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..|++ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 6789999999999999999999999999976532 235678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--ccCCceEEeeccchhhhhhcc
Q 013487 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL--DSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll--~~~~~~kl~DFGla~~~~~~~ 167 (442)
||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999999988764 469999999999999999999999999999999999999 56789999999999765432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 243 (442)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+++++
T Consensus 243 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 243 --EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp --CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred --cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 23345679999999999977665 4899999999999999999999999888888888777665444 3589999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=384.74 Aligned_cols=262 Identities=24% Similarity=0.422 Sum_probs=222.5
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
....-++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 44566789999999999999999999999999999999976554555667889999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.|+||||++||+|.+++...+++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997654321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC-----CCCCCCHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-----CPSWFSSG 242 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~ 242 (442)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.............+ .++.+++.
T Consensus 166 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 166 -LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred -ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 122345679999999999988776 48999999999999999999999988877665555444322 24568999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+.++|.+||..||.+||+..+.+.+.|..
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999999666666667654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=393.28 Aligned_cols=260 Identities=26% Similarity=0.452 Sum_probs=215.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC--CCcceEEEEEEeCCEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIY 89 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~ 89 (442)
-++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++| |||+++++++.+.+.+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 45799999999999999999998 5689999999976543 33456788999999999986 99999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||| +.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|.........
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9999 55789999999999999999999999999999999999999999999999997 688999999999865543333
Q ss_pred CccccccCCCcccCcccccc----------cCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhh--CCCCCC
Q 013487 170 GLLHTACGTPNYVAPEVLND----------KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICR--ADFSCP 236 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~--~~~~~~ 236 (442)
......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.... .......+.. .....|
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 33456789999999999865 1334589999999999999999999998643 2233333333 244567
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 237 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
...+.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 778899999999999999999999999999999986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=382.47 Aligned_cols=257 Identities=36% Similarity=0.641 Sum_probs=224.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4689999999999999999999999999999999976543211 1246788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----ceEEeeccchhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAISQ 164 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~----~~kl~DFGla~~~~ 164 (442)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999999888999999999999999999999999999999999999998877 89999999987543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFS 240 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 240 (442)
.. ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+ ..++
T Consensus 164 ~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 AG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred CC---CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 32 22345679999999999987776 4899999999999999999999999888777777766655443 4578
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.+.+||.+||..||.+|||+.++++||||+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=382.23 Aligned_cols=262 Identities=31% Similarity=0.529 Sum_probs=228.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh------hhHHHHHHHHHHHHHHhhCC-CCCcceEEEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV------LRHKMVEQIKREISTMKLIK-HPNVIKIIEV 81 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 81 (442)
....++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ......+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 4567899999999999999999999999999999999975431 11234567889999999995 9999999999
Q ss_pred EEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 82 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 82 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
+...+..|+||||+++++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999998899999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccc-----cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 236 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (442)
.... .......+||+.|+|||++.+ ....+.++||||||+++|+|++|..||...+.......+.......+
T Consensus 173 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 173 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 5432 223455689999999999852 22335899999999999999999999998888877777777655443
Q ss_pred ----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 237 ----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 237 ----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+++.+.+||.+||+.||.+|||+.|+++||||++.
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 2478999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=400.11 Aligned_cols=258 Identities=25% Similarity=0.444 Sum_probs=216.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC--CCCcceEEEEEEeCCEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l 90 (442)
.+|++.+.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 359999999999999999999864 89999999976543 3445678999999999996 5999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||| +.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 56789999999989999999999999999999999999999999999999996 5899999999998654433223
Q ss_pred ccccccCCCcccCccccccc----------CCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhhC--CCCCCC
Q 013487 171 LLHTACGTPNYVAPEVLNDK----------GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA--DFSCPS 237 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~~~~ 237 (442)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... .......+... ....|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 34567899999999998652 234589999999999999999999998753 33444444443 345677
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+.+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 7899999999999999999999999999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=395.89 Aligned_cols=263 Identities=29% Similarity=0.430 Sum_probs=215.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh--HHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
....++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 456789999999999999999999999999999999997543221 112346789999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999986 8888887654 689999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCC---C-----
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFS---C----- 235 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~---~----- 235 (442)
. .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+... ... .
T Consensus 165 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 165 P--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp C--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred C--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2 233456789999999999977655568999999999999999999999988877666655431 000 0
Q ss_pred ------------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 236 ------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 236 ------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
...+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 033578999999999999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=379.01 Aligned_cols=254 Identities=24% Similarity=0.456 Sum_probs=218.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe----CCE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTK 87 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 87 (442)
-..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3458999999999999999999999999999999976543 33456788999999999999999999999865 466
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEc-cCCceEEeeccchhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSAISQ 164 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~ 164 (442)
+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999999889999999999999999999999999 99999999999998 78999999999986533
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhhCCC--CCCCCCCH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRADF--SCPSWFSS 241 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s~ 241 (442)
. ......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.... .......+..... ..+...++
T Consensus 184 ~----~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 A----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred c----cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 2 23345679999999998874 34 589999999999999999999998744 4455554544322 23455789
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
++.+||.+||+.||.+|||+.++++||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=391.35 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=221.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++.+.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997654444455678899999999999999999999999999999999
Q ss_pred EccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~-~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+. |+|.+.+. ...++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9998 58888775 456799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC--CCCCCCHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPSWFSSGAKKL 246 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~l 246 (442)
....+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+.....+ .+..+++.+.+|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23568999999999985 3344 58999999999999999999999888776666665554332 234589999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 247 IKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|.+||+.||.+|||++++++||||....
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=394.70 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=218.8
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----CE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----TK 87 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 87 (442)
++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999997533 334457788999999999999999999999765 36
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
.|+||||+.| +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 8999999985 99999876 569999999999999999999999999999999999999999999999999997654332
Q ss_pred c-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---------------
Q 013487 168 E-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------------- 231 (442)
Q Consensus 168 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------- 231 (442)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 223455689999999999876665568999999999999999999999887655544443210
Q ss_pred -------CCC---------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 -------DFS---------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 -------~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
..+ ..+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 000 1134689999999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=405.51 Aligned_cols=258 Identities=39% Similarity=0.675 Sum_probs=210.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-----HHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----HKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
..++|++.+.||+|+||+||+|.+..+++.||+|++.+..... ......+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999999999999999998654321 1223457899999999999999999999854
Q ss_pred CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEEeeccchhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 162 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl~DFGla~~ 162 (442)
+..|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999999889999999999999999999999999999999999999997554 599999999986
Q ss_pred hhhcccCCccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCCCC---
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP--- 236 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--- 236 (442)
... .......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... .....+..+....+
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 543 233456789999999999864 223347999999999999999999999764432 33444555544433
Q ss_pred -CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 347999999999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=378.13 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=216.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (442)
...++|++.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++..+ +||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 35678999999999999999999999999999999997653322 2356778899999999 899999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC---------------
Q 013487 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--------------- 149 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~--------------- 149 (442)
|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999875 679999999999999999999999999999999999999844
Q ss_pred ----CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH
Q 013487 150 ----GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225 (442)
Q Consensus 150 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 225 (442)
..+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|.+|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 4799999999875432 123469999999999987655567999999999999999999887655432
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 226 RKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 226 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+.... ...|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2333333 35667799999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=392.49 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=222.1
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.....++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 3456789999999999999999999999999999999997652 33456788999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.|+||||++||+|.+++...+.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999999999988999999999999999999999996 9999999999999999999999999998765432
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH-------------------
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK------------------- 227 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~------------------- 227 (442)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 22456899999999999887764 899999999999999999999987665433221
Q ss_pred -----------------------HhhCCC-CCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 228 -----------------------ICRADF-SCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 228 -----------------------i~~~~~-~~~-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+..... ..+ ..++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111 112 2368899999999999999999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=396.68 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=209.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC---
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 35789999999999999999999999999999999997643 23345677889999999999999999999997665
Q ss_pred ---EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 87 ---KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 87 ---~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.+|+||||+.| +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 78999999975 7888885 45899999999999999999999999999999999999999999999999999754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC---------
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--------- 234 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------- 234 (442)
.. .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......
T Consensus 178 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 178 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cc---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 32 2233456899999999999887775 8999999999999999999999988877666655432110
Q ss_pred -------------C--------------CCC------CCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 235 -------------C--------------PSW------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 235 -------------~--------------~~~------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
. |.. .++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 0 000 146789999999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=394.87 Aligned_cols=262 Identities=30% Similarity=0.574 Sum_probs=224.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhh-hHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
..+++|++.+.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45579999999999999999999984 58999999999754321 111234567899999999 69999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999987543
Q ss_pred hcccCCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhcCCCCCCCC----cHHHHHHHHhhCCCCCCCCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCPSWF 239 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 239 (442)
... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+.......|..+
T Consensus 211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 221 1223456899999999999853 23458999999999999999999999643 34455666666777788889
Q ss_pred CHHHHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 240 SSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
+..+.+||.+||..||.+|| |++++++||||+.
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=398.98 Aligned_cols=251 Identities=28% Similarity=0.429 Sum_probs=211.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (442)
..++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45789999999999999999999999999999999865432 22479999999999999999999844
Q ss_pred --------------------------------CCEEEEEEEccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 013487 85 --------------------------------KTKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDY 128 (442)
Q Consensus 85 --------------------------------~~~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~ql~~aL~~ 128 (442)
...+++||||++| +|.+.+. ....+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3458999999985 7666554 45789999999999999999999
Q ss_pred HHHCCceeccCCCCcEEEc-cCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHH
Q 013487 129 CHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207 (442)
Q Consensus 129 lH~~givHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (442)
||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+...++.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999998 689999999999975433 223345688999999999987665568999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhhC-----------------CCC------------CCCCCCHHHHHHHHHccCCCCCCC
Q 013487 208 VLMAGFLPFDESNLMALYRKICRA-----------------DFS------------CPSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 208 ~ll~g~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~s~~~~~li~~~L~~dP~~R 258 (442)
+|++|.+||.+.+..+....+... ... +|..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999988776665554321 011 344578999999999999999999
Q ss_pred CCHHHHhcCccccc
Q 013487 259 MTISQMLEDEWFKK 272 (442)
Q Consensus 259 ~s~~eil~hp~~~~ 272 (442)
||+.|+|+||||+.
T Consensus 314 ~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 314 INPYEAMAHPFFDH 327 (383)
T ss_dssp CCHHHHHTSGGGHH
T ss_pred CCHHHHhcCHHHHH
Confidence 99999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=390.99 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=210.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC---
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (442)
..+++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 35678999999999999999999999999999999997543 2234577899999999999999999999985543
Q ss_pred ------------------------------------------------------EEEEEEEccCCCChHHHHHhcCC---
Q 013487 87 ------------------------------------------------------KIYIVLEFIDGGELFDKIAKHGR--- 109 (442)
Q Consensus 87 ------------------------------------------------------~~~lv~E~~~gg~L~~~i~~~~~--- 109 (442)
..|++|||++||+|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999988654
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC----------CccccccCCC
Q 013487 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED----------GLLHTACGTP 179 (442)
Q Consensus 110 l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~ 179 (442)
.++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 456678999999999999999999999999999999999999999999999765432111 1234467999
Q ss_pred cccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC-CCCCCHHHHHHHHHccCCCCCCC
Q 013487 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRILDPNPDTR 258 (442)
Q Consensus 180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R 258 (442)
.|+|||++.+..+. .++||||+||++|+|++|..|+... ......+.....+. +...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999887774 8999999999999999998775322 22222333322221 12357888999999999999999
Q ss_pred CCHHHHhcCccccc
Q 013487 259 MTISQMLEDEWFKK 272 (442)
Q Consensus 259 ~s~~eil~hp~~~~ 272 (442)
||+.|+++||||+.
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=385.10 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=205.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhh-CCCCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL-IKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv 91 (442)
++|++.+.||+|+||+||+|++..+++.||+|++......... ......|+..+.. .+||||+++++++.+.+..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 6799999999999999999999999999999998654322222 3334455555544 4899999999999999999999
Q ss_pred EEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence 9999 568988887654 599999999999999999999999999999999999999999999999999875433 22
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC--CCCCCCCHHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIK 248 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~ 248 (442)
.....+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||..... ...+..... ..+..+++++.+||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHH
Confidence 3345679999999999876 45 5899999999999999999766655432 222333222 234568999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+||+.||++|||++|+++||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=378.98 Aligned_cols=260 Identities=31% Similarity=0.553 Sum_probs=226.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE--eCCE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA--SKTK 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~ 87 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 357899999999999999999999999999999999976543 2344678899999999999999999999874 4678
Q ss_pred EEEEEEccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEccCCceEEeecc
Q 013487 88 IYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~ql~~aL~~lH~~g-----ivHrDlkp~NIll~~~~~~kl~DFG 158 (442)
.|+||||++||+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999997643 4999999999999999999999999 9999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCC
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPS 237 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~ 237 (442)
++...... .......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+.. ..|.
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 238 (279)
T 2w5a_A 162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred hheeeccc--cccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence 98764331 1122346799999999999887764 899999999999999999999999888777777777655 5667
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+++++.+||.+||+.||.+|||+.|+++|+|+...
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 789999999999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=387.09 Aligned_cols=259 Identities=32% Similarity=0.517 Sum_probs=221.6
Q ss_pred cccCeEEE-eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEE
Q 013487 11 RVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (442)
Q Consensus 11 ~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (442)
.-++|.+. +.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+. ||||+++++++...+..
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34578887 89999999999999999999999999997654222 23467889999999995 69999999999999999
Q ss_pred EEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEeeccchhhh
Q 013487 89 YIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAIS 163 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~DFGla~~~ 163 (442)
|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998654 67999999999999999999999999999999999999997 789999999999765
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCC
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWF 239 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 239 (442)
... ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.......+ ..+
T Consensus 185 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 185 GHA---CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp ------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred CCc---cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 432 223456899999999999887764 899999999999999999999999888877777666544333 347
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 99999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=395.67 Aligned_cols=261 Identities=24% Similarity=0.524 Sum_probs=227.8
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHH--------------HHHHHHHHHHHHhhCC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK--------------MVEQIKREISTMKLIK 71 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~ 71 (442)
.......++|++.+.||+|+||.||+|.+ +++.||+|++......... ..+.+.+|+.+++.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34456678999999999999999999999 8999999999765432211 1267889999999999
Q ss_pred CCCcceEEEEEEeCCEEEEEEEccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCC
Q 013487 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDK------IAK--HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPE 142 (442)
Q Consensus 72 hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~--~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~ 142 (442)
||||+++++++.+.+..|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 666 5679999999999999999999999 99999999999
Q ss_pred cEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhcCCCCCCCCcH
Q 013487 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNL 221 (442)
Q Consensus 143 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~ 221 (442)
||+++.++.+||+|||++...... .....+||+.|+|||++.+. .+.+.++||||+|+++|+|++|..||...+.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999998754322 33456799999999999877 4543489999999999999999999988766
Q ss_pred -HHHHHHHhhCCCCCC-------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 222 -MALYRKICRADFSCP-------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 222 -~~~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
......+.......| ..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 677777777766666 568999999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.98 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=201.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (442)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3478999999999999999999999999999999997543 2334467788999999999999999999998654
Q ss_pred -CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
..+|++||++ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 6799998876 679999999999999999999999999999999999999999999999999997543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 231 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 231 (442)
. .....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2345689999999999987555568999999999999999999999988776655544321
Q ss_pred ----------CCCC--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 ----------DFSC--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 ----------~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.... .+..++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0001 123588999999999999999999999999999998644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=382.86 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=215.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++...+..|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 4567899999999999999999987 688999999976543 3344677899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 90 IVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+||||++||+|.+++...+. +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987654 999999999999999999999999 9999999999999999999999999987543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHh--hCCCCCCCCCCHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSWFSSG 242 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~s~~ 242 (442)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+. ......|..++++
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp -------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 32 122345689999999999988777 489999999999999999999999988777666553 3455677889999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc--CcccccC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLE--DEWFKKG 273 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~--hp~~~~~ 273 (442)
+.+||.+||+.||.+|||+.++++ +++++..
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 999999999999999999999998 4666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=406.11 Aligned_cols=249 Identities=16% Similarity=0.204 Sum_probs=206.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHH---HHhhCCCCCcceEE-------EE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS---TMKLIKHPNVIKII-------EV 81 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~ 81 (442)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999998654444445678899995 45555799999998 77
Q ss_pred EEeCCE-----------------EEEEEEccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 013487 82 MASKTK-----------------IYIVLEFIDGGELFDKIAKHGRLKE-------DEARRYFQQLINAVDYCHSRGVFHR 137 (442)
Q Consensus 82 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~~~~l~~-------~~~~~~~~ql~~aL~~lH~~givHr 137 (442)
+.+.+. .|++|||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766543 89999999 6799999988766666 7888899999999999999999999
Q ss_pred cCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCccccccc-----------CCCCCcccHhHHHHHH
Q 013487 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-----------GYDGRASDVWSCGVIL 206 (442)
Q Consensus 138 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwSlGvil 206 (442)
||||+|||++.+|.+||+|||+|.... ......+| +.|+|||++.+. .| +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 999999999999999999999987432 23456678 999999999877 56 5899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 207 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 207 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
|+|++|..||.+.+.......+. ..+..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999997765443332222 334568999999999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=398.80 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=214.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC------CCCCcceEEEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI------KHPNVIKIIEVMA 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~ 83 (442)
....+|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 45668999999999999999999999999999999997543 2345677888888777 5789999999999
Q ss_pred eCCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc--eEEeeccc
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGL 159 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~--~kl~DFGl 159 (442)
..+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999998764 4999999999999999999999999999999999999999887 99999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-------
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------- 232 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------- 232 (442)
|.... ....+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 249 a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 249 SCYEH-----QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CEETT-----CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceecC-----CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 86432 234467899999999999988774 89999999999999999999999887765554433210
Q ss_pred -------------CC---------------------------------------CCCCCCHHHHHHHHHccCCCCCCCCC
Q 013487 233 -------------FS---------------------------------------CPSWFSSGAKKLIKRILDPNPDTRMT 260 (442)
Q Consensus 233 -------------~~---------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s 260 (442)
.. .+...++++.+||.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 00 01123788999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 013487 261 ISQMLEDEWFKKGY 274 (442)
Q Consensus 261 ~~eil~hp~~~~~~ 274 (442)
++|+|+||||++..
T Consensus 403 a~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 403 PGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHHTSTTTC---
T ss_pred HHHHhCChhhccCC
Confidence 99999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=378.42 Aligned_cols=259 Identities=37% Similarity=0.638 Sum_probs=227.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
+...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 45678999999999999999999999999999999999765432 22356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC---CceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~---~~~kl~DFGla~~~~~ 165 (442)
|++|||+.+++|.+.+...+.+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999888899999999999999999999999999999999999999754 4799999999876533
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 241 (442)
. .......||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+..+....+ ..+++
T Consensus 177 ~---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 177 N---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp C---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred C---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 2 223445689999999998764 4 5899999999999999999999999888887777777655433 35799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
++.+||.+||..||.+|||+.++++||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=377.90 Aligned_cols=259 Identities=31% Similarity=0.497 Sum_probs=218.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3456789999999999999999999999999999999875432 2356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998876 4679999999999999999999999999999999999999999999999999986433221
Q ss_pred cCCccccccCCCcccCccccc-----ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCC
Q 013487 168 EDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWF 239 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 239 (442)
. .....+||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.......+..... ..+..+
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence 1 123457999999999984 3344 5899999999999999999999998887776666655443 234568
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 9999999999999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=384.26 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=211.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEe--CC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS--KT 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~ 86 (442)
...++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 34578999999999999999999999999999999987442 356789999999997 9999999999988 67
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~ 165 (442)
..+++|||+.+++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 79999999999999988753 89999999999999999999999999999999999999776 899999999975433
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-cHHHHHH-------------HHhhC
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYR-------------KICRA 231 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~-------------~i~~~ 231 (442)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +...... .+...
T Consensus 184 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 ---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp ---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 223455689999999999987555568999999999999999999999543 2211111 11111
Q ss_pred CCCC------------------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 DFSC------------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 ~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.... +..+++++.+||.+||+.||.+|||++|+|+||||+.-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 1111 11278999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=375.95 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=203.6
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++.+.+..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456789999999999999999999999999999999976532 2233445556666688899999999999999999999
Q ss_pred EEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 90 IVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+||||++| +|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999985 87776643 56899999999999999999999998 99999999999999999999999999987654
Q ss_pred hcccCCccccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhh-CCCCCC-CC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICR-ADFSCP-SW 238 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~-~~~~~~-~~ 238 (442)
.. ......+||+.|+|||++. .....+.++||||+|+++|+|++|..||.. ............ .....+ ..
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 32 2233457999999999972 233345899999999999999999999986 333333333333 333333 45
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 8999999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=384.71 Aligned_cols=260 Identities=39% Similarity=0.675 Sum_probs=214.7
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-----hHHHHHHHHHHHHHHhhCCCCCcceEEEEEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 83 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 34567899999999999999999999999999999999765321 1122345789999999999999999999997
Q ss_pred eCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc---eEEeeccch
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLS 160 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~---~kl~DFGla 160 (442)
..+ .|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 765 8999999999999999998889999999999999999999999999999999999999987664 999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCCCC-
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP- 236 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~- 236 (442)
..... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+..+.....
T Consensus 165 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 165 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp EECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred eeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 75432 122345679999999999742 233358999999999999999999999765432 33334444444332
Q ss_pred ---CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 237 ---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 237 ---~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 357999999999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=384.38 Aligned_cols=262 Identities=30% Similarity=0.428 Sum_probs=217.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (442)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 45679999999999999999999999999999999996432 333456788999999999999999999988654
Q ss_pred -CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
...|++|||+. |+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999997 599998876 579999999999999999999999999999999999999999999999999997643
Q ss_pred hcccC--------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-----
Q 013487 165 QVRED--------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----- 231 (442)
Q Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----- 231 (442)
..... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 22111 11234579999999999876555568999999999999999999999988765544333210
Q ss_pred -------------------CCC--------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 232 -------------------DFS--------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 232 -------------------~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
... .++.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 000 11357899999999999999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=376.97 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=226.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-..|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 35699999999999999999999999999999999765422 2357788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||++|++|.+++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--cc
Confidence 999999999999875 679999999999999999999999999999999999999999999999999987543321 22
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHc
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~ 250 (442)
....+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... ...+..++..+.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence 3456799999999999887765 89999999999999999999999887776666655443 345567899999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCC
Q 013487 251 LDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
|..||.+|||+.++++||||....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999998644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=389.08 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=220.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-------CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV 81 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 81 (442)
...++|++++.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 44578999999999999999999975 345579999997553 334567899999999999 89999999999
Q ss_pred EEeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 013487 82 MASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (442)
Q Consensus 82 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIl 145 (442)
+...+.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999998754 4789999999999999999999999999999999999
Q ss_pred EccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHH
Q 013487 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL 224 (442)
Q Consensus 146 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~ 224 (442)
++.+|.+||+|||+|................||+.|+|||++.+..|. .++|||||||++|+|++ |..||.+.+..+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999755433222233445678999999999887764 89999999999999999 9999998887777
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 225 YRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 225 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
...+..+. ...|..+++++.+||.+||..||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76666553 45677799999999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=377.87 Aligned_cols=256 Identities=30% Similarity=0.502 Sum_probs=217.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..-++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999997543 1356789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~-~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 9999999999999997 4567999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC---CCCCCCCCHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKK 245 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ 245 (442)
........||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... +..+..+++.+.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 1223456799999999999887765 89999999999999999999998877665554444332 3345557999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
||.+||..||.+|||+.++++||||+..
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=381.62 Aligned_cols=262 Identities=27% Similarity=0.490 Sum_probs=198.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 445789999999999999999999999999999999875532 223567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 90 IVLEFIDGGELFDKIAK--------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~--------~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999999874 4569999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcc---cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-----
Q 013487 162 ISQQVR---EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----- 233 (442)
Q Consensus 162 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (442)
...... ........+||+.|+|||++.+....+.++||||||+++|+|++|..||...+.............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 654321 112234567999999999987633345899999999999999999999987665544433333221
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 234 -----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 234 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.....+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1223478999999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=390.39 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=224.2
Q ss_pred ccccCeEEEeeecccCceEEEEEE-----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...++|++.+.||+|+||+||+|. +..++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 345789999999999999999999 44577899999986432 23345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---ceEE
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKI 154 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~-------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~---~~kl 154 (442)
....|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999998753 489999999999999999999999999999999999999555 5999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD- 232 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~- 232 (442)
+|||+|+..............+||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999865544333344556789999999999887775 89999999999999998 999999998888887776654
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...+..+++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4566778999999999999999999999999999988753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=381.78 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
....++|++.+.||+|+||.||+|.+..++. .||+|++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3455689999999999999999999987765 8999999765432 23467889999999999999999999999877
Q ss_pred CEE------EEEEEccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 86 TKI------YIVLEFIDGGELFDKIAKHG------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 86 ~~~------~lv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
... +++|||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 99999999999999986543 599999999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-
Q 013487 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA- 231 (442)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 231 (442)
|+|||+|................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999765443222223344578899999999887764 89999999999999999 99999988877777766654
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCC-------HHHHhcCcccccCC
Q 013487 232 DFSCPSWFSSGAKKLIKRILDPNPDTRMT-------ISQMLEDEWFKKGY 274 (442)
Q Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s-------~~eil~hp~~~~~~ 274 (442)
....+..+++++.+||.+||+.||.+||| ++++++|||+....
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 45667789999999999999999999999 78889999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=377.83 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=215.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe---
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS--- 84 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--- 84 (442)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 4567899999999999999999999999999999999875432 135678999999999 79999999999977
Q ss_pred ---CCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 85 ---KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 85 ---~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
.+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56899999999999999999875 4799999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCccccc-----ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS 234 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (442)
+...... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+.....+
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 8765432 12234567999999999986 3334 58999999999999999999999888776666555554332
Q ss_pred --CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 235 --CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 235 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 234579999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=381.60 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=215.9
Q ss_pred ccCCCcccccCeEEEeeecccCceEEEEEEE-cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC------Ccc
Q 013487 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKN-VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP------NVI 76 (442)
Q Consensus 4 ~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv 76 (442)
.........++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +|+
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 3444555668999999999999999999999 5688999999997432 2356788999999988665 499
Q ss_pred eEEEEEEeCCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc------
Q 013487 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS------ 148 (442)
Q Consensus 77 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~------ 148 (442)
++++++...+..|+||||+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 889999998876 6899999999999999999999999999999999999987
Q ss_pred -------------CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCC
Q 013487 149 -------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP 215 (442)
Q Consensus 149 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~P 215 (442)
++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..|
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCS
T ss_pred cCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCC
Confidence 67899999999875332 23456899999999999887775 899999999999999999999
Q ss_pred CCCCcHHHHHHHHhhCCCCC--------------------------------------------CCCCCHHHHHHHHHcc
Q 013487 216 FDESNLMALYRKICRADFSC--------------------------------------------PSWFSSGAKKLIKRIL 251 (442)
Q Consensus 216 f~~~~~~~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~li~~~L 251 (442)
|...+..+....+.....+. +...++++.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 98877655443332111111 1112467889999999
Q ss_pred CCCCCCCCCHHHHhcCccccc
Q 013487 252 DPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 252 ~~dP~~R~s~~eil~hp~~~~ 272 (442)
+.||.+|||+.|+++||||+.
T Consensus 314 ~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 314 EYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp CSSTTTSCCHHHHTTSGGGGG
T ss_pred CcCcccccCHHHHhcCHHHHH
Confidence 999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=396.33 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=208.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (442)
...+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999865431 234799999999999999999988532
Q ss_pred -CEEEEEEEccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-CceEEeeccc
Q 013487 86 -TKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGL 159 (442)
Q Consensus 86 -~~~~lv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-~~~kl~DFGl 159 (442)
..+++||||+.+ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999986 6665554 35679999999999999999999999999999999999999955 6789999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh---------
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--------- 230 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------- 230 (442)
|+..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 204 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9754332 2234568999999999997764456899999999999999999999998776655544332
Q ss_pred --------CCCC------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 231 --------ADFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 231 --------~~~~------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
..+. +++.+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1111 123468999999999999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=377.58 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=212.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE------
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA------ 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------ 83 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 45679999999999999999999999999999999987542 344677889999999999999999999873
Q ss_pred --------eCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEE
Q 013487 84 --------SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKI 154 (442)
Q Consensus 84 --------~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl 154 (442)
..+..|+||||+. |+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++ +++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4478999999998 599999865 6799999999999999999999999999999999999997 5679999
Q ss_pred eeccchhhhhhcc-cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC
Q 013487 155 SDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF 233 (442)
Q Consensus 155 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 233 (442)
+|||++....... .........||+.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999997654321 122334567899999999987645556899999999999999999999998876655554432210
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 234 ------------------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 234 ------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
..++.+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 01235799999999999999999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=392.84 Aligned_cols=254 Identities=30% Similarity=0.434 Sum_probs=208.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-- 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 86 (442)
.....+|++.+.||+|+||+||+|.+..++. ||+|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3455689999999999999999999977766 78887754431 1237999999999999999999995543
Q ss_pred ----EEEEEEEccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEEeec
Q 013487 87 ----KIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDF 157 (442)
Q Consensus 87 ----~~~lv~E~~~gg~L~~~i----~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl~DF 157 (442)
.+|+||||++++ +.+.+ .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 388999999875 43333 2356799999999999999999999999999999999999999 7999999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC------
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------ 231 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------ 231 (442)
|+|+..... ......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 187 G~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999765332 22345678999999999987665568999999999999999999999988766555544321
Q ss_pred -----------CCC------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 -----------DFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 -----------~~~------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
... +++.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 011 2234789999999999999999999999999999998643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=386.24 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=213.9
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE--
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI-- 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-- 88 (442)
.-++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 3468999999999999999999999999999999997643 2344567888999999999999999999999877654
Q ss_pred ----EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 89 ----YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 89 ----~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
|+||||+. ++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 58888774 459999999999999999999999999999999999999999999999999997543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 232 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 232 (442)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 23456799999999999874445689999999999999999999999887666555543210
Q ss_pred -----------C--------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 233 -----------F--------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 233 -----------~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
. ..++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123468999999999999999999999999999999853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=381.26 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=210.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--E
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--K 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 87 (442)
..-++|++.+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34568999999999999999999999999999999997654322 2466789999999999999999999998765 7
Q ss_pred EEEEEEccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ccCCceEEeeccch
Q 013487 88 IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll----~~~~~~kl~DFGla 160 (442)
.|+||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999987543 9999999999999999999999999999999999999 78888999999999
Q ss_pred hhhhhcccCCccccccCCCcccCcccccc-------cCCCCCcccHhHHHHHHHHHhcCCCCCCCC----cHHHHHHHHh
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLND-------KGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKIC 229 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~ 229 (442)
..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... ........+.
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 76543 223345679999999999863 233458999999999999999999999632 2233444443
Q ss_pred hCCC---------------------CCC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 230 RADF---------------------SCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 230 ~~~~---------------------~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
.+.. +.+ ..+++.+.+||.+||+.||++|||++|+|+||-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 3221 111 123567889999999999999999999999984
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=379.62 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=222.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34578999999999999999999997 355889999997543 33456788999999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKH------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~------------------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlk 140 (442)
.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999999874 569999999999999999999999999999999
Q ss_pred CCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCC
Q 013487 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDES 219 (442)
Q Consensus 141 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~ 219 (442)
|+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999865443332333456789999999999887764 89999999999999999 99999998
Q ss_pred cHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 220 NLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 220 ~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..+....+..+.. ..|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88877777766543 5677899999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=377.43 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=219.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
....++|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456789999999999999999999986665 49999997542 333457789999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+..|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999755 579999999999999999999999999999999999999999999999999997654
Q ss_pred hcccCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCH
Q 013487 165 QVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 241 (442)
Q Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 241 (442)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..+.+..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 322111 12234567889999999877764 89999999999999999 99999998888877776655 4566777999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+.+||.+||..||.+|||+.++++
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=371.81 Aligned_cols=255 Identities=29% Similarity=0.525 Sum_probs=208.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (442)
..++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 457899999999999999999999999999999999643 2345778899999999999999999998854
Q ss_pred -------CCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEee
Q 013487 85 -------KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (442)
Q Consensus 85 -------~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~D 156 (442)
.+..|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 467899999999999999998654 578999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhcc------------cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-cHHH
Q 013487 157 FGLSAISQQVR------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMA 223 (442)
Q Consensus 157 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~ 223 (442)
||++....... ........+||+.|+|||++.+....+.++||||+||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987543211 11223456799999999999876555689999999999999998 66543 3344
Q ss_pred HHHHHhhCCCCCCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 224 LYRKICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 224 ~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
....+.......|+ ..++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 55555554444443 35677999999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=393.37 Aligned_cols=254 Identities=17% Similarity=0.200 Sum_probs=195.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC--CCCCcceEE-------EEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI--KHPNVIKII-------EVM 82 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~ 82 (442)
...|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+++|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999876544455567788886555544 699988865 555
Q ss_pred EeC-----------------CEEEEEEEccCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 013487 83 ASK-----------------TKIYIVLEFIDGGELFDKIAKHG-RLKEDEA------RRYFQQLINAVDYCHSRGVFHRD 138 (442)
Q Consensus 83 ~~~-----------------~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~------~~~~~ql~~aL~~lH~~givHrD 138 (442)
... ..+|+||||++ |+|.+++...+ .+++... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 34899999999 79999998743 3444444 56669999999999999999999
Q ss_pred CCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCC
Q 013487 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPF 216 (442)
Q Consensus 139 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf 216 (442)
|||+|||++.+|.+||+|||+|+.... ......+|+.|+|||++.+ ..| +.++|||||||++|+|++|..||
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999975432 1224567799999999976 455 58999999999999999999999
Q ss_pred CCCcHHH--HHHH-----HhhCCC--CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 217 DESNLMA--LYRK-----ICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 217 ~~~~~~~--~~~~-----i~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
....... .+.. .....+ +.+..+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 8764321 1100 011122 223468999999999999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=394.29 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=196.2
Q ss_pred cccCeEE-EeeecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--C
Q 013487 11 RVGKYEL-GRTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--K 85 (442)
Q Consensus 11 ~~~~y~i-~~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 85 (442)
..+.|++ ++.||+|+||+||+|.++ .+++.||+|++..... ...+.+|+.+|+.++||||+++++++.. .
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3456887 568999999999999976 5788999999975532 2357789999999999999999999954 6
Q ss_pred CEEEEEEEccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ccCCce
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVL 152 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~---------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll----~~~~~~ 152 (442)
..+|+||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999975 888887632 249999999999999999999999999999999999999 678899
Q ss_pred EEeeccchhhhhhcc-cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH---------
Q 013487 153 KISDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--------- 222 (442)
Q Consensus 153 kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--------- 222 (442)
||+|||+|+...... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998654321 1123455789999999999988665679999999999999999999999765431
Q ss_pred HHHHHHhhC--CCCC------------------------------------CCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 013487 223 ALYRKICRA--DFSC------------------------------------PSWFSSGAKKLIKRILDPNPDTRMTISQM 264 (442)
Q Consensus 223 ~~~~~i~~~--~~~~------------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ei 264 (442)
+....+... .... ....++.+.+||.+||..||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 222222110 0000 01127789999999999999999999999
Q ss_pred hcCcccccCCC
Q 013487 265 LEDEWFKKGYK 275 (442)
Q Consensus 265 l~hp~~~~~~~ 275 (442)
|+||||+....
T Consensus 332 L~hp~f~~~~~ 342 (405)
T 3rgf_A 332 MQDPYFLEDPL 342 (405)
T ss_dssp HTSGGGTSSSC
T ss_pred hcChhhccCCC
Confidence 99999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=388.89 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=207.4
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC--------CCCcceEEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--------HPNVIKIIE 80 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~ 80 (442)
....++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 345588999999999999999999999999999999997542 34567889999999985 788999999
Q ss_pred EEE----eCCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCC---
Q 013487 81 VMA----SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYG--- 150 (442)
Q Consensus 81 ~~~----~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~--- 150 (442)
++. ....+|+||||+ +++|.+.+... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 987 556899999999 55777777654 4699999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------------ceEEeeccchhhhhhcccCCccccccCCCcccCc
Q 013487 151 ----------------------------------------------VLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184 (442)
Q Consensus 151 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 184 (442)
.+||+|||+|..... .....+||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCC
Confidence 799999999875432 23456899999999
Q ss_pred ccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc------HHHHHHHHhh--CC------------------------
Q 013487 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN------LMALYRKICR--AD------------------------ 232 (442)
Q Consensus 185 E~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~~~~~i~~--~~------------------------ 232 (442)
|++.+..|. .++|||||||++|+|++|..||...+ .......+.. +.
T Consensus 263 E~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 263 EVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred hhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999988775 89999999999999999999997543 1121111111 00
Q ss_pred ----------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 233 ----------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 233 ----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+..+...++.+.+||.+||+.||++|||++|+|+||||+
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011122346788999999999999999999999999997
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.13 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=211.7
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
.+..+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 34556789999999999999999999999999999999999987655555567889999999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+..|++|||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999987654
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCCCH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFSS 241 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~ 241 (442)
... .......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..... ..++.+++
T Consensus 186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 186 DEK-LTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred ccc-cccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence 321 1223456799999999999877664 899999999999999999999998776654444433221 34566899
Q ss_pred HHHHHHHHccCCCCCCCC-CHHHHhc
Q 013487 242 GAKKLIKRILDPNPDTRM-TISQMLE 266 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~-s~~eil~ 266 (442)
++.+||.+||+.||.+|| |++++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999999 7888775
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=383.11 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=203.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE-
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK- 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 87 (442)
...+++|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+|+..++.++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 35678999999999999999999999999999999998654322 2345577888888999999999999865433
Q ss_pred ------EEEEEEccCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEcc-CCceEE
Q 013487 88 ------IYIVLEFIDGGELFDK----IAKHGRLKEDEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLDS-YGVLKI 154 (442)
Q Consensus 88 ------~~lv~E~~~gg~L~~~----i~~~~~l~~~~~~~~~~ql~~aL~~lH--~~givHrDlkp~NIll~~-~~~~kl 154 (442)
+++||||+.++ |.+. +.....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 88999999874 4433 345677999999999999999999999 999999999999999996 899999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-- 232 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-- 232 (442)
+|||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+..
T Consensus 174 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999765432 223456799999999999776655699999999999999999999999887766665543210
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 233 ------------------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 233 ------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
...+...++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0111225678999999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=384.31 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=209.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh--------hhHHHHHHHHHHHHHHhhCCCCCcceEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--------LRHKMVEQIKREISTMKLIKHPNVIKIIEV 81 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 81 (442)
...++|++.+.||+|+||.||+|.+.. |..||+|++..... ......+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 356799999999999999999999854 89999999864321 233445789999999999999999999999
Q ss_pred EEe-----CCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 82 MAS-----KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 82 ~~~-----~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
+.. ...+|+||||+. |+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 843 347899999998 58888877544 69999999999999999999999999999999999999999999999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC----
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---- 231 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---- 231 (442)
|||++..... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999974332 222345679999999999987555568999999999999999999999988766655544321
Q ss_pred -------------------C-CC--------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 232 -------------------D-FS--------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 232 -------------------~-~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
. .. .++.+++.+.+||.+||+.||.+|||+.|+++||||+..+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0 00 12346889999999999999999999999999999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=380.88 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=213.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE---
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK--- 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 87 (442)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 3478999999999999999999999999999999997643 234456778899999999999999999999987654
Q ss_pred ---EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 88 ---IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 88 ---~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+|++|||+. |+|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999998 58988774 359999999999999999999999999999999999999999999999999987543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 231 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 231 (442)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 1345678999999999987444568999999999999999999999987766554443220
Q ss_pred -----------------C-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 -----------------D-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 -----------------~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
. ...++.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 11234578999999999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=376.13 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=214.3
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
|......++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp CCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 44445678999999999999999999999999999999988543 334567889999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+..|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999999999987 5679999999999999999999999999999999999999999999999999997543
Q ss_pred hcccC------------CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH-----HHHH
Q 013487 165 QVRED------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-----LYRK 227 (442)
Q Consensus 165 ~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-----~~~~ 227 (442)
..... ......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||....... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 32111 111256899999999999887775 89999999999999999999986532110 0001
Q ss_pred HhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 228 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 228 i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.. ....|+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FL--DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HH--HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc--cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 11245678999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=385.18 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=215.2
Q ss_pred cccCeEEEeeecccCceEEEEEE-----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
..++|++.+.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45789999999999999999999 55677899999997543 233457789999999999 79999999999987
Q ss_pred CCE-EEEEEEccCCCChHHHHHhcCC------------------------------------------------------
Q 013487 85 KTK-IYIVLEFIDGGELFDKIAKHGR------------------------------------------------------ 109 (442)
Q Consensus 85 ~~~-~~lv~E~~~gg~L~~~i~~~~~------------------------------------------------------ 109 (442)
.+. +++||||++||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 554 8999999999999999987543
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccccC
Q 013487 110 ------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (442)
Q Consensus 110 ------------l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 177 (442)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999999999999999999976543322223345678
Q ss_pred CCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHH-HHHHHhhC-CCCCCCCCCHHHHHHHHHccCCC
Q 013487 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA-LYRKICRA-DFSCPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~d 254 (442)
|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+... ....+... ....|..+++++.+||.+||+.|
T Consensus 258 t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp CGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 9999999999887775 89999999999999998 999998765433 33333333 45667789999999999999999
Q ss_pred CCCCCCHHHHhcC
Q 013487 255 PDTRMTISQMLED 267 (442)
Q Consensus 255 P~~R~s~~eil~h 267 (442)
|.+|||+.|+++|
T Consensus 337 P~~Rps~~ell~~ 349 (359)
T 3vhe_A 337 PSQRPTFSELVEH 349 (359)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=382.09 Aligned_cols=255 Identities=31% Similarity=0.544 Sum_probs=222.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCC--CCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIK--HPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~ 84 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 456789999999999999999999999999999999976543210 11244668999999996 5999999999999
Q ss_pred CCEEEEEEEccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEEeeccchhh
Q 013487 85 KTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAI 162 (442)
Q Consensus 85 ~~~~~lv~E~~~g-g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl~DFGla~~ 162 (442)
.+..+++||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999999986 89999999989999999999999999999999999999999999999999 789999999999876
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHH
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 242 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 242 (442)
... ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+ .+.......+..++++
T Consensus 200 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 200 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 269 (320)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence 532 233456799999999999887776788999999999999999999997643 2344555667789999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+.+||.+||+.||.+|||++++++||||+...
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999999999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=374.94 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=220.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 83 (442)
.....+|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 445678999999999999999999983 455889999997543 3345678899999999999999999999999
Q ss_pred eCCEEEEEEEccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAKHGR------------------------LKEDEARRYFQQLINAVDYCHSRGVFHRDL 139 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~~~~------------------------l~~~~~~~~~~ql~~aL~~lH~~givHrDl 139 (442)
..+..|+||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999987543 899999999999999999999999999999
Q ss_pred CCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCC
Q 013487 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDE 218 (442)
Q Consensus 140 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~ 218 (442)
||+|||++.++.+||+|||++................+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.+
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998755432222223345678899999999877664 89999999999999999 9999998
Q ss_pred CcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 219 SNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 219 ~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+.......+... ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8777666666554 345667799999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=382.75 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=223.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCC-------CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVET-------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIE 80 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 80 (442)
....++|++++.||+|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 34557999999999999999999997543 3579999997553 334567889999999999 8999999999
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NI 144 (442)
++...+..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998754 499999999999999999999999999999999999
Q ss_pred EEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHH
Q 013487 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223 (442)
Q Consensus 145 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~ 223 (442)
|++.++.+||+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865443322333455678999999999887764 89999999999999999 999999988888
Q ss_pred HHHHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 224 LYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 224 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
....+... ....|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87777665 445677799999999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.48 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=218.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 4568999999999999999999985 5778999999765432 2468899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999999999764 4589999999999999999999999999999999999999999999999999975433211
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+... ....|..+++.+.+|+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 240 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHH
Confidence 122344578899999999877764 89999999999999999 99999998888887777665 4455667899999999
Q ss_pred HHccCCCCCCCCCHHHHhcC
Q 013487 248 KRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~h 267 (442)
.+||+.||.+|||+.++++|
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=367.40 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=209.4
Q ss_pred CcccCCCcccccCeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceE
Q 013487 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78 (442)
Q Consensus 2 ~~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 78 (442)
....+......++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++
T Consensus 4 ~~s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 4 GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp -----CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceE
Confidence 344455566778999999999999999999999654 4569999986542 33456788999999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeec
Q 013487 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (442)
Q Consensus 79 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DF 157 (442)
++++. .+..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 99984 567899999999999999998754 6999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSC 235 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~ 235 (442)
|++........ .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+....+... ..+.
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (281)
T 1mp8_A 161 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred ccccccCcccc-cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC
Confidence 99976543211 122334578899999999877764 89999999999999996 99999987776666666554 3566
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 236 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77899999999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=370.35 Aligned_cols=261 Identities=25% Similarity=0.445 Sum_probs=212.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC--CCCcceEEEEEEeCCEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASKTKI 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 88 (442)
.-++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++...+..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3457999999999999999999985 588999999976543 3345678899999999997 59999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
|++|| +.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+++ +.+||+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99999 567899999999899999999999999999999999999999999999999965 8999999999986544333
Q ss_pred CCccccccCCCcccCccccccc----------CCCCCcccHhHHHHHHHHHhcCCCCCCCCc-HHHHHHHHhhC--CCCC
Q 013487 169 DGLLHTACGTPNYVAPEVLNDK----------GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA--DFSC 235 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~~ 235 (442)
.......+||+.|+|||++.+. ...+.++||||||+++|+|++|..||.... .......+... ....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 2233456799999999998752 234589999999999999999999997653 22333333332 3456
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 236 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
|...+.++.+||.+||..||.+|||+.|+++||||+....
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 6778999999999999999999999999999999986543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=382.41 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=213.8
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CC-----CcceEEE
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HP-----NVIKIIE 80 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~ 80 (442)
......++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|+++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 34456789999999999999999999999999999999997542 23566778999888885 55 4999999
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEc--cCCceEE
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLD--SYGVLKI 154 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH--~~givHrDlkp~NIll~--~~~~~kl 154 (442)
++...+..|+||||+.| +|.+++... +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999965 999999876 46999999999999999999999 46999999999999995 5788999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS 234 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (442)
+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 203 ~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 203 VDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999975432 23457899999999999988775 8999999999999999999999988776665554331000
Q ss_pred -------------------------------------CCCC---------------------------CCHHHHHHHHHc
Q 013487 235 -------------------------------------CPSW---------------------------FSSGAKKLIKRI 250 (442)
Q Consensus 235 -------------------------------------~~~~---------------------------~s~~~~~li~~~ 250 (442)
.|.. .++++.+||.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 0000 013789999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 013487 251 LDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
|+.||++|||++|+|+||||+..
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=376.92 Aligned_cols=254 Identities=32% Similarity=0.592 Sum_probs=213.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhC----CCCCcceEEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLI----KHPNVIKIIEVM 82 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~~~ 82 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 456789999999999999999999999999999999976543221 1233456799999998 899999999999
Q ss_pred EeCCEEEEEEEc-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCceEEeeccch
Q 013487 83 ASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS 160 (442)
Q Consensus 83 ~~~~~~~lv~E~-~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~-~~~~~kl~DFGla 160 (442)
...+..+++||+ +.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999999988999999999999999999999999999999999999999 8899999999998
Q ss_pred hhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCC
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 240 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 240 (442)
..... ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||.... .+.......+..++
T Consensus 188 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 188 ALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVS 257 (312)
T ss_dssp EECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSC
T ss_pred hhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCC
Confidence 76543 223456799999999999887776668999999999999999999997643 23445667778899
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
+.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=371.76 Aligned_cols=259 Identities=30% Similarity=0.446 Sum_probs=215.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC---CCCCcceEEEEEE--
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMA-- 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-- 83 (442)
...++|++.+.||+|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34589999999999999999999995 678899999987543211 1123455777777766 8999999999987
Q ss_pred ---eCCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeecc
Q 013487 84 ---SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 84 ---~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFG 158 (442)
.....++||||+. |+|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5678999999998 59999998754 49999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC-------
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------- 231 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------- 231 (442)
++...... ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+...
T Consensus 166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ccccccCC---CCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 98764432 223456799999999999887764 8999999999999999999999988776666555321
Q ss_pred C--------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 232 D--------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 232 ~--------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
. ...+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0 012245789999999999999999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=385.69 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=217.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3468999999999999999999999999999999987542 33345678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999999998754 5999999999999999999999999999999999999999999999999998753321111
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ..+.|..+++++.+||
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 111122356789999999877664 89999999999999998 99999988877766665544 4567778999999999
Q ss_pred HHccCCCCCCCCCHHHHhc
Q 013487 248 KRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~ 266 (442)
.+||+.||.+|||+.++++
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=366.54 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=213.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
...+|.....||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 3444555559999999999999999999999999987543 2335678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhhhhc
Q 013487 91 VLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQV 166 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~ 166 (442)
||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999999998753 4678999999999999999999999999999999999987 899999999998754332
Q ss_pred ccCCccccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcHH--HHHHH-HhhCCCCCCCCCCHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRK-ICRADFSCPSWFSSG 242 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~ 242 (442)
........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... ..... ........|..++++
T Consensus 177 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 177 --NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred --CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence 12234567999999999987643 2358999999999999999999999764322 22221 223344667778999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+.+||.+||+.||.+|||+.++++||||+...
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999998543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.52 Aligned_cols=254 Identities=21% Similarity=0.356 Sum_probs=209.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEE----EEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFV----AIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
...++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998887754 777665332 223356788999999999999999999999876
Q ss_pred CEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
. .++++||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 78999999999999999874 579999999999999999999999999999999999999999999999999998765
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 242 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 242 (442)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....+..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887775 89999999999999999 99999987776666655544 35667778999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=375.53 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=211.9
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCC-CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC------cceEEE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETG-DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN------VIKIIE 80 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~ 80 (442)
.....++|++.+.||+|+||+||+|.+..++ ..||+|++.... ...+.+.+|+.+++.++|++ ++.+++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 3456689999999999999999999998777 689999997532 23567788999999987655 999999
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE------------
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL------------ 146 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll------------ 146 (442)
++...+..|+||||+ +++|.+.+.... ++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999999999 567878777654 69999999999999999999999999999999999999
Q ss_pred -------ccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC
Q 013487 147 -------DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (442)
Q Consensus 147 -------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 219 (442)
+.++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCC
Confidence 6678999999999875332 23456899999999999887775 8999999999999999999999887
Q ss_pred cHHHHHHHHhhCCCCCC--------------------------------------------CCCCHHHHHHHHHccCCCC
Q 013487 220 NLMALYRKICRADFSCP--------------------------------------------SWFSSGAKKLIKRILDPNP 255 (442)
Q Consensus 220 ~~~~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~~~L~~dP 255 (442)
+.......+.......| ...+.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 76554433322111111 0124578899999999999
Q ss_pred CCCCCHHHHhcCccccc
Q 013487 256 DTRMTISQMLEDEWFKK 272 (442)
Q Consensus 256 ~~R~s~~eil~hp~~~~ 272 (442)
.+|||+.|+++||||+.
T Consensus 323 ~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAG 339 (355)
T ss_dssp TTSCCHHHHTTSGGGGG
T ss_pred hhCcCHHHHhcChhhcC
Confidence 99999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=377.79 Aligned_cols=254 Identities=35% Similarity=0.619 Sum_probs=185.6
Q ss_pred cccccCeEEEe-eecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe---
Q 013487 9 RTRVGKYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--- 84 (442)
Q Consensus 9 ~~~~~~y~i~~-~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 84 (442)
....++|++.+ .||+|+||+||+|.+..+++.||+|++..... ...+....++.++||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 45678999965 69999999999999999999999999865421 11222334567799999999999976
Q ss_pred -CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEeecc
Q 013487 85 -KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFG 158 (442)
Q Consensus 85 -~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~DFG 158 (442)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 556899999999999999998764 6999999999999999999999999999999999999986 4559999999
Q ss_pred chhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHH----HHHHhhCCCC
Q 013487 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL----YRKICRADFS 234 (442)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~ 234 (442)
++..... ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.... ...+......
T Consensus 177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp TCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cceeccc----cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 9875432 233456899999999999776664 899999999999999999999976654332 2222222222
Q ss_pred CC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 235 CP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 235 ~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+ ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 22 35799999999999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=361.79 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=217.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45678999999999999999999885 6678999999765432 245789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999999998765 499999999999999999999999999999999999999999999999999875433211
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 246 (442)
.......+|+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+.... ...|..+++.+.+|
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 112234567789999999877764 89999999999999999 999999888877777666554 44566689999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 013487 247 IKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~h 267 (442)
|.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=377.04 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=216.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 4568999999999999999999973 456789999997543 223457789999999999 89999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG-----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 141 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~-----------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp 141 (442)
.+..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 999999999999999999998754 279999999999999999999999999999999
Q ss_pred CcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCc
Q 013487 142 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN 220 (442)
Q Consensus 142 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~ 220 (442)
+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999865443322233445678999999999887764 89999999999999998 999998766
Q ss_pred HHHHHHHHhhC--CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 221 LMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 221 ~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
........... ....|..+++++.+||.+||..||.+|||+.++++|..-
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 54444443333 345677789999999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=377.43 Aligned_cols=259 Identities=20% Similarity=0.361 Sum_probs=217.6
Q ss_pred cCCCcccccCeEEEeeecccCceEEEEEEEcCCCCE----EEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE
Q 013487 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (442)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 80 (442)
+.......++|++.+.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred HHHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 344455678999999999999999999999888876 67777643321 112345678999999999999999999
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
++. .+..++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 986 46689999999999999999875 5799999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 237 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 237 (442)
|+...............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|.
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC
Confidence 9876544333344556788899999999887764 89999999999999999 99999988777666666554 456677
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.++.++.+||.+||..||.+|||+.++++|
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=362.63 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=217.0
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 345668999999999999999999885 6778999999765432 24578999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999997543321
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 245 (442)
. .......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.... ...|..+++.+.+
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred c-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 1 11233457889999999988776 489999999999999998 999999988887777776653 4556678999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDE 268 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp 268 (442)
||.+||+.||.+|||+.++++|-
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHHH
Confidence 99999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=366.35 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=212.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCC-------EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGD-------FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM 82 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 82 (442)
...++|++.+.||+|+||+||+|++..+++ .||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 456799999999999999999999988774 699999875432 2346788999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc--------eE
Q 013487 83 ASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--------LK 153 (442)
Q Consensus 83 ~~~~~~~lv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~--------~k 153 (442)
.+.+..|+||||++||+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987665 999999999999999999999999999999999999998887 99
Q ss_pred EeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhCC
Q 013487 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRAD 232 (442)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~ 232 (442)
|+|||++..... .....||+.|+|||++.+....+.++||||||+++|+|++| .+||...+.... .......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhcc
Confidence 999999864422 12356899999999998744456899999999999999995 556655554433 3344455
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
...|...++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 56677789999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=380.37 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=209.7
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-----------CCCc
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----------HPNV 75 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnI 75 (442)
+.....++|++.+.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.++++++ ||||
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchH
Confidence 344556799999999999999999999999999999999975432 3456788999998886 8999
Q ss_pred ceEEEEEEeCC----EEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEcc
Q 013487 76 IKIIEVMASKT----KIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDS 148 (442)
Q Consensus 76 v~l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~ 148 (442)
+++++++...+ .++++|||+ |++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999987654 789999999 88999999874 4599999999999999999999998 9999999999999953
Q ss_pred ------CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-
Q 013487 149 ------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL- 221 (442)
Q Consensus 149 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~- 221 (442)
.+.+||+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 34899999999875432 23456799999999999887774 899999999999999999999976431
Q ss_pred -----HHHHHHHh------------------------------------------hCCCCCCCCCCHHHHHHHHHccCCC
Q 013487 222 -----MALYRKIC------------------------------------------RADFSCPSWFSSGAKKLIKRILDPN 254 (442)
Q Consensus 222 -----~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~d 254 (442)
......+. ......+..+++++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 11111111 1112233334678899999999999
Q ss_pred CCCCCCHHHHhcCcccccCC
Q 013487 255 PDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 255 P~~R~s~~eil~hp~~~~~~ 274 (442)
|.+|||++|+|+||||+...
T Consensus 322 P~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 322 PRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred ccccCCHHHHhhChhhhccc
Confidence 99999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=371.37 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=220.2
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEc-------CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKII 79 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 79 (442)
.....++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3445689999999999999999999985 466789999997543 334467789999999999 899999999
Q ss_pred EEEEeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013487 80 EVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143 (442)
Q Consensus 80 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~N 143 (442)
+++...+..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999998754 38999999999999999999999999999999999
Q ss_pred EEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHH
Q 013487 144 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM 222 (442)
Q Consensus 144 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~ 222 (442)
||++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999875543222122234467889999999987666 489999999999999999 99999998887
Q ss_pred HHHHHHhhCC-CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 223 ALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 223 ~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+....+.... ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777666553 45667789999999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=369.67 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=221.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 34578999999999999999999986 467889999997543 23345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEE
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKH----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~----------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl 154 (442)
.+..|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 99999999999999999998763 35799999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD- 232 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~- 232 (442)
+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 999999765443222223345678999999999877764 89999999999999999 899999988887777766654
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 35667789999999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.86 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=216.2
Q ss_pred cccCeEEEeeecccCceEEEEEEE-----cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 346899999999999999999995 4577899999997553 223457789999999999 89999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll 146 (442)
.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999998754 48999999999999999999999999999999999999
Q ss_pred ccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHH
Q 013487 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (442)
Q Consensus 147 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (442)
+.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999765543322223345678899999999887764 89999999999999999 99999876544333
Q ss_pred HHHhh-C-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 226 RKICR-A-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 226 ~~i~~-~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..... . ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33322 2 334466789999999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=371.19 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=217.8
Q ss_pred ccccCeEEEeeecccCceEEEEEE-----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...++|++.+.||+|+||.||+|. +..++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 456799999999999999999999 55678899999996432 23345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEE
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKI 154 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~-------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl 154 (442)
.+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998763 4899999999999999999999999999999999999994 446999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-C
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-D 232 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~ 232 (442)
+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999999765443322333455689999999999877764 89999999999999998 99999988877777766655 3
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...+..+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 4556778999999999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=358.55 Aligned_cols=250 Identities=29% Similarity=0.509 Sum_probs=205.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh-HHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...++|++.+.||+|+||.||+|.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 3568999999999999999999998 48899999987543222 22356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEEcc--------CCceEEeec
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPENLLLDS--------YGVLKISDF 157 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g---ivHrDlkp~NIll~~--------~~~~kl~DF 157 (442)
|+||||++|++|.+++. .+++++..+..++.|++.||+|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999886 467999999999999999999999999 899999999999986 778999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC--CCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSC 235 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~ 235 (442)
|++....... .....||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+.... .+.
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 9997544321 2345799999999999887764 89999999999999999999999887776666555443 455
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 236 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 67789999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=358.47 Aligned_cols=249 Identities=18% Similarity=0.317 Sum_probs=217.1
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC--
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-- 85 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 85 (442)
.....++|++.+.||+|+||.||+|.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567889999999999999999999984 88999999976542 333457799999999999999999999999887
Q ss_pred CEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCceEEeeccchh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
+..++||||++||+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998866 4899999999999999999999999 9999999999999999999999999865
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCC--CcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC--CCCCCC
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG--RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS 237 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~ 237 (442)
... ....+||+.|+|||++.+..+.. .++||||+|+++|+|++|..||...+.......+... ....|.
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 322 23457899999999998765542 3799999999999999999999988877766665544 345677
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+++++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 79999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.18 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=199.9
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...+++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++..+++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 3467899999999999999999999999999999999976542 222344455666678888999999999999999999
Q ss_pred EEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
|+||||+ ++.+...... .+.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 5455555443 46799999999999999999999995 9999999999999999999999999998754332
Q ss_pred ccCCccccccCCCcccCcccccc----cCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhhCCCC-CC--CC
Q 013487 167 REDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFS-CP--SW 238 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~-~~--~~ 238 (442)
......+||+.|+|||++.+ ....+.++||||+|+++|+|++|..||.. .+.......+...... .| ..
T Consensus 179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred ---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 22345679999999999852 22335899999999999999999999987 3444555555544332 22 34
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 7999999999999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=362.42 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=222.2
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
.......++|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3445567889999999999999999999999999999999975432 346788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
+..|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999998744 4999999999999999999999999999999999999999999999999999765
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCH
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 241 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 241 (442)
.... ........+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 4321 1122334578899999999887764 89999999999999999 99999988776666665554 4566777999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+.+||.+||..||.+|||+.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=363.59 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=209.3
Q ss_pred cccccCeEEEeeecccCceEEEEEE----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
....++|++.+.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456799999999999999999998 56789999999987542 3346778999999999999999999999854
Q ss_pred --CCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
...+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 356899999999999999998755 49999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH----------------HH
Q 013487 162 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----------------AL 224 (442)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----------------~~ 224 (442)
........ .......||+.|+|||++.+..+. .++||||+|+++|+|++|..||...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 65432211 122334577889999999887774 8999999999999999999998754322 11
Q ss_pred HHHHh-hCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 225 YRKIC-RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 225 ~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
...+. ....+.|..+++++.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22222 2345667789999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=374.22 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=210.5
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
...-++|++.+.||+|+||+||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 3445689999999999999999999999999999999875432 23577999999999 89999999999999999
Q ss_pred EEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc-----eEEeeccchh
Q 013487 88 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-----LKISDFGLSA 161 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~-----~kl~DFGla~ 161 (442)
.|+||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8999999987 367999999999999999999999999999999999999998887 9999999997
Q ss_pred hhhhcccCC-----ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---cHHHHHHHHhhCCC
Q 013487 162 ISQQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADF 233 (442)
Q Consensus 162 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~ 233 (442)
......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 643322111 1246789999999999998777 48999999999999999999999873 34445555443322
Q ss_pred CCC-----CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 SCP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 ~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+ ..++ ++.+|+..||+.||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222 2244 9999999999999999999988876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=360.66 Aligned_cols=256 Identities=31% Similarity=0.552 Sum_probs=207.8
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34678999999999999999999999999999999999765444555677889999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 89 YIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999864 4569999999999999999999999999999999999999999999999999987654
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC--cHHHHHHHHhhCCCCC--CCCCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--NLMALYRKICRADFSC--PSWFS 240 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~--~~~~s 240 (442)
... .......||+.|+|||++.+..+. .++||||||+++|+|++|..||.+. +.......+....+.. +..++
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 321 223456799999999999887764 8999999999999999999999754 3334444554444322 24589
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=368.78 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=216.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEE--EEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFV--AIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
...++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45689999999999999999999999888865 999886432 233456788999999999 8999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 150 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~ 150 (442)
..|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999998764 699999999999999999999999999999999999999999
Q ss_pred ceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 013487 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKIC 229 (442)
Q Consensus 151 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 229 (442)
.+||+|||++...... .......+++.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998643221 112334678899999999876664 89999999999999998 999999988888877776
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 230 RA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 230 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+ ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65 345667789999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=368.38 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=215.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEE-----cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 83 (442)
...++|++.+.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 3457899999999999999999985 3577899999997653 233456788999999999 6999999999987
Q ss_pred eCC-EEEEEEEccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 013487 84 SKT-KIYIVLEFIDGGELFDKIAKHGR----------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (442)
Q Consensus 84 ~~~-~~~lv~E~~~gg~L~~~i~~~~~----------------l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll 146 (442)
..+ .+|++|||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 754 58999999999999999987654 8999999999999999999999999999999999999
Q ss_pred ccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHH-HH
Q 013487 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM-AL 224 (442)
Q Consensus 147 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~ 224 (442)
+.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.. ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999999765432222223345689999999999887774 89999999999999998 99999876543 33
Q ss_pred HHHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 225 YRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 225 ~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
...+..+ ....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3333333 456677789999999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=370.04 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=215.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCC-----EEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEe
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD-----FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (442)
..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 45689999999999999999999987665 79999997543 233467789999999999 89999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKH--------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 150 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~--------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~ 150 (442)
.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 99999999999999999998753 3589999999999999999999999999999999999999999
Q ss_pred ceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 013487 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKIC 229 (442)
Q Consensus 151 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~ 229 (442)
.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.........+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999865443222223345678899999999887764 89999999999999998 999998765444433333
Q ss_pred hC--CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 230 RA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 230 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.. ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 32 344567789999999999999999999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=369.74 Aligned_cols=254 Identities=21% Similarity=0.362 Sum_probs=209.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEE----EEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFV----AIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
...++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45678999999999999999999998888765 566554322 122356788999999999999999999999876
Q ss_pred CEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
. .++++||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 78999999999999999874 569999999999999999999999999999999999999999999999999998765
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 242 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 242 (442)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.+..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887775 89999999999999999 99999988777666665554 35667779999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+.+||.+||..||.+|||+.|+++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=354.81 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=217.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 3468999999999999999999995 6788999999765432 2568899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+|||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999999999875 4689999999999999999999999999999999999999999999999999875432111
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+..+ ....|..+++.+.+|+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 238 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 238 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence 112334678899999999877764 89999999999999999 89999998887777777665 3445667899999999
Q ss_pred HHccCCCCCCCCCHHHHhcC
Q 013487 248 KRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~h 267 (442)
.+||+.||.+|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=364.61 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=208.4
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcC---CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
.....++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34455789999999999999999998865 556899999875532 33446778999999999999999999999977
Q ss_pred CC-----EEEEEEEccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceE
Q 013487 85 KT-----KIYIVLEFIDGGELFDKIA------KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (442)
Q Consensus 85 ~~-----~~~lv~E~~~gg~L~~~i~------~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~k 153 (442)
.+ ..|++|||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 55 3599999999999999984 335699999999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-
Q 013487 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA- 231 (442)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 231 (442)
|+|||++................+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999999765433222223345678899999999887764 89999999999999999 99999988777766666554
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 232 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 445667789999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=359.85 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=214.9
Q ss_pred ccccCeEEEe-eecccCceEEEEEEE--cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGR-TLGEGSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~-~LG~G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...++|++.+ .||+|+||.||+|.+ ..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 3456899998 999999999999954 5677899999997653 2233467899999999999999999999999 567
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
..|+||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999999888999999999999999999999999999999999999999999999999998754332
Q ss_pred ccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 167 RED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 167 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++.+
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 112234567899999999877664 89999999999999999 99999998877777666654 345677899999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.++|.+||+.||.+|||+.++++
T Consensus 250 ~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 250 YDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=360.97 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=211.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (442)
..-++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +|+||+++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 455679999999999999999999999999999999865432 23577899999999 799999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc-----eEEeeccchhh
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-----LKISDFGLSAI 162 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~-----~kl~DFGla~~ 162 (442)
|+||||+ |++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 899999998754 5999999999999999999999999999999999999987776 99999999976
Q ss_pred hhhcccC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC---cHHHHHHHHhhCCC-
Q 013487 163 SQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADF- 233 (442)
Q Consensus 163 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~- 233 (442)
....... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||... +....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 5432221 12345679999999999988776 48999999999999999999999873 33344443332211
Q ss_pred ----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 234 ----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 234 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
..+..+++++.+|+.+||+.||.+|||++++++.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1234679999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=357.03 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=211.0
Q ss_pred CCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHH----HHHHHHHHHHHhhCCCCCcceEEEEE
Q 013487 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM----VEQIKREISTMKLIKHPNVIKIIEVM 82 (442)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~ 82 (442)
......++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34456689999999999999999999999999999999986544322211 26788999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCc-----eEE
Q 013487 83 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGV-----LKI 154 (442)
Q Consensus 83 ~~~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~-----~kl 154 (442)
.+.. ++||||+++|+|.+.+.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7766 69999999999999886554 6999999999999999999999999 999999999999988776 999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCccccccc-CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH--HHHHHhhC
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNLMA--LYRKICRA 231 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~--~~~~i~~~ 231 (442)
+|||++.... ......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||...+... ....+...
T Consensus 171 ~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 171 ADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp CCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred CCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9999986432 233456899999999998432 223589999999999999999999998654322 23333332
Q ss_pred --CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 232 --DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 232 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34566778999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=356.99 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=214.4
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcC---CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEE
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM 82 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 82 (442)
+......++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3445677899999999999999999999753 33469999987653 233467889999999999999999999998
Q ss_pred EeCCEEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 83 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 83 ~~~~~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
.+ +..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 65 45689999999999999997754 59999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCC
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 239 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 239 (442)
....... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ..+.|..+
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTC
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCC
Confidence 6543211 122345678899999999877764 89999999999999998 99999876665555555444 45567778
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.50 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=191.8
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHH-HHhhCCCCCcceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+. +++.++||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 445799999999999999999999999999999999975431 223344555555 77888999999999999999999
Q ss_pred EEEEEccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 89 YIVLEFIDGGELFDKIAK-----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~ql~~aL~~lH~~-givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999986 88877763 56799999999999999999999999 999999999999999999999999999875
Q ss_pred hhhcccCCccccccCCCcccCccccc----ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCC-CC-
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADF-SC- 235 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~-~~- 235 (442)
.... ......+||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.. .....+..+.. ..
T Consensus 176 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 176 LVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp ---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred cccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 4332 1223457999999999983 3444 58999999999999999999999875432 22222222221 11
Q ss_pred ---CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 236 ---PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 236 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+..+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1347999999999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.45 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=217.6
Q ss_pred ccccCeEEEe-eecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGR-TLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~-~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 3456788887 9999999999999864 467789999997643 334567889999999999999999999999 456
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 689999999999999999654 4699999999999999999999999999999999999999999999999999876533
Q ss_pred ccc-CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHH
Q 013487 166 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSG 242 (442)
Q Consensus 166 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 242 (442)
... ........||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+....+..+. ...|..++++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 211 1112334578999999999876664 89999999999999998 999999887777776666553 5667789999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
+.+||.+||+.||.+|||+.+++++.+
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999998854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=361.40 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=210.0
Q ss_pred cccccCeEEEeeecccCceEEEEEE----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 84 (442)
...-.+|++.+.||+|+||.||+|+ +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3445679999999999999999999 567899999999975532 2235678899999999999999999999987
Q ss_pred C--CEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 85 K--TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 85 ~--~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
. +.+|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 678999999999999999954 4579999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---------------HHHHH
Q 013487 162 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------------LMALY 225 (442)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~~ 225 (442)
........ .......||+.|+|||++.+..+. .++||||+|+++|+|++|..|+.... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 65432211 223445688999999999887765 89999999999999999998864321 11222
Q ss_pred HHHhh-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 226 RKICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 226 ~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+.. .....|..+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22222 245667789999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=374.31 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=207.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.++++++||||+++++++...+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 34568999999999999999999987 467789999987542 3344677899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999999998754 699999999999999999999999999999999999999999999999999986543
Q ss_pred cccCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHH
Q 013487 166 VREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 242 (442)
Q Consensus 166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 242 (442)
..... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278 (373)
T ss_dssp --------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 22111 11223457889999999887775 89999999999999998 99999988877777766554 34556678999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+.+||.+||+.||.+|||+.++++
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCcChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=363.26 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=212.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCC----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETG----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
....+|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34568999999999999999999987554 359999997543 233456788999999999999999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
+..|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999765 579999999999999999999999999999999999999999999999999997654
Q ss_pred hcccCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCH
Q 013487 165 QVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 241 (442)
Q Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 241 (442)
...... ......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ..+.+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 322111 12223468899999999877764 89999999999999999 99999988877777776655 4556677899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+.+||.+||+.||.+|||+.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=366.68 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=203.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-- 86 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 86 (442)
....++|++.+.||+|+||+||+|++. ++.||+|++..... ......+|+.++++++||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 355678999999999999999999884 78999999975432 2344567999999999999999999997743
Q ss_pred --EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEEEccCCceEE
Q 013487 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR----------GVFHRDLKPENLLLDSYGVLKI 154 (442)
Q Consensus 87 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~----------givHrDlkp~NIll~~~~~~kl 154 (442)
.+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 47999999999999999977 4699999999999999999999999 9999999999999999999999
Q ss_pred eeccchhhhhhcccCCccccccCCCcccCcccccccCC----CCCcccHhHHHHHHHHHhcCCCCCCCCc----------
Q 013487 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY----DGRASDVWSCGVILFVLMAGFLPFDESN---------- 220 (442)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------- 220 (442)
+|||+|...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976554333333445789999999999976422 2357899999999999999999996532
Q ss_pred ------HHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 221 ------LMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 221 ------~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.......+..... ..+.. .++++.+||.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222221 11111 23459999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=357.74 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=198.6
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
....-++|++.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.+++.++||||++++++. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34556789999999999999999998643 599999975532 344567889999999999999999999965 5567
Q ss_pred EEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.++||||+.|++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999999999643 56999999999999999999999999999999999999999999999999999765443
Q ss_pred ccCCccccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCC-----CCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFS-----CPS 237 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~-----~~~ 237 (442)
.........+||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.. .....+...... .+.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred cccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 3333445668999999999986 3334 47899999999999999999999875544 334444443322 233
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 238 WFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 238 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+++.+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 57899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=355.62 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=212.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (442)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4468999999999999999999999999999999997543 245689999999999999999998864
Q ss_pred ----------CCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCce
Q 013487 85 ----------KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (442)
Q Consensus 85 ----------~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~ 152 (442)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45689999999999999999764 579999999999999999999999999999999999999999999
Q ss_pred EEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC
Q 013487 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 232 (442)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 232 (442)
||+|||++...... ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||... ......+...
T Consensus 162 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~- 234 (284)
T 2a19_B 162 KIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG- 234 (284)
T ss_dssp EECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT-
T ss_pred EECcchhheecccc---ccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc-
Confidence 99999998755432 223456799999999999887764 8999999999999999999988532 2233333332
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+..+++.+.+||.+||..||.+|||+.|+++|+|.-.
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 345668999999999999999999999999999988754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.21 Aligned_cols=244 Identities=27% Similarity=0.487 Sum_probs=211.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC-EE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-KI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 88 (442)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 34578999999999999999999984 7799999997553 2356889999999999999999999987655 79
Q ss_pred EEEEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 89 YIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
|+||||+++|+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 341 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence 999999999999999987654 79999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHH
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 244 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 244 (442)
......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++++.
T Consensus 342 ----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 342 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 12234678999999999887775 89999999999999998 99999887766666666554 4567788999999
Q ss_pred HHHHHccCCCCCCCCCHHHHhc
Q 013487 245 KLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s~~eil~ 266 (442)
+||.+||+.||.+|||+.++++
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=354.47 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=212.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE-
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI- 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 88 (442)
-.|++.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 357788999999999999999765554 79999987532 334567889999999999999999999999876655
Q ss_pred EEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+++|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999987 4568999999999999999999999999999999999999999999999999997543322
Q ss_pred --cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 168 --EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 168 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
.........+|+.|+|||++.+..+. .++||||+|+++|+|++ |.+||...+.......+... ....+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence 12233445788999999999887765 89999999999999999 55666666666555555544 345677789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+||.+||+.||.+|||+.++++.
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.70 Aligned_cols=253 Identities=16% Similarity=0.212 Sum_probs=200.9
Q ss_pred cCeEEEeeecccCceEEEEEEEcC---CCCEEEEEEecchhhhhH---H-----HHHHHHHHHHHHhhCCCCCcceEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRH---K-----MVEQIKREISTMKLIKHPNVIKIIEV 81 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~---~-----~~~~~~~Ei~il~~l~hpnIv~l~~~ 81 (442)
++|++.+.||+|+||.||+|.+.. ++..||+|++........ . ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 788999999875431110 0 12346688999999999999999999
Q ss_pred EEe----CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC--ceEEe
Q 013487 82 MAS----KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--VLKIS 155 (442)
Q Consensus 82 ~~~----~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~--~~kl~ 155 (442)
+.. ....|+||||+ |++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 988 78899999999 999999998888999999999999999999999999999999999999999877 99999
Q ss_pred eccchhhhhhcccC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC--cHHHHHHHH
Q 013487 156 DFGLSAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--NLMALYRKI 228 (442)
Q Consensus 156 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~i 228 (442)
|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... +........
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 99999765432211 12245689999999999988766 48999999999999999999999652 222222111
Q ss_pred hhCCCCCC---------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 229 CRADFSCP---------SWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 229 ~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.......| ..+++++.+||.+||..||++|||+.++++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11111111 2578999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=361.08 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=206.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE----eCCE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA----SKTK 87 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 87 (442)
-++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 357999999999999999999999999999999986542 334677889999999999999999999986 3457
Q ss_pred EEEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 88 IYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999876 467999999999999999999999999999999999999999999999999987643
Q ss_pred hhcccC-------CccccccCCCcccCcccccccCC--CCCcccHhHHHHHHHHHhcCCCCCCCCcHH--HHHHHHh-hC
Q 013487 164 QQVRED-------GLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRKIC-RA 231 (442)
Q Consensus 164 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~i~-~~ 231 (442)
...... .......||+.|+|||++.+... .+.++||||||+++|+|++|..||...... .....+. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 221110 01123468999999999875442 258999999999999999999999542110 1111111 12
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCc
Q 013487 232 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 268 (442)
Q Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 268 (442)
..+.++.+++++.+||.+||+.||.+|||+.+++++-
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 3344556899999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.20 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=211.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCC---CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEE-Ee
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM-AS 84 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~ 84 (442)
+....+|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 344567999999999999999999976433 358999987532 334567889999999999999999999985 55
Q ss_pred CCEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.+..|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 67889999999999999999764 45899999999999999999999999999999999999999999999999999754
Q ss_pred hhccc--CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCC
Q 013487 164 QQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWF 239 (442)
Q Consensus 164 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 239 (442)
..... ........||+.|+|||++.+..+. .++||||+|+++|+|++ |.+||...+.......+.... ...|..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence 33221 1123345678899999999887765 89999999999999999 678887776666655555544 3456678
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+.++|.+||+.||.+|||+.++++.
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=369.37 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=210.1
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4568999999999999999999997 478999999986543 223567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999987643 589999999999999999999999999999999999999999999999999875433
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH------H-HHHHhhCCC-----
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA------L-YRKICRADF----- 233 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~------~-~~~i~~~~~----- 233 (442)
..........+||+.|+|||++.+..+. .++||||||+++|+|++|..||....... . ........+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 2222333456799999999999877764 89999999999999999999997543211 1 011111111
Q ss_pred -----CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcc
Q 013487 234 -----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 234 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
..++..+..+.+++.+||+.||++|||+.|++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111123567889999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=361.23 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=213.2
Q ss_pred ccccCeEEEeeecccCceEEEEEE----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE--
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA-- 83 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-- 83 (442)
..-++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 445789999999999999999999 56788999999997543 334567899999999999999999999886
Q ss_pred eCCEEEEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
.....|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 45679999999999999999987 35699999999999999999999999999999999999999999999999999976
Q ss_pred hhhcccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH---------------HHHH
Q 013487 163 SQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------------ALYR 226 (442)
Q Consensus 163 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~~ 226 (442)
....... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 5432211 12234568889999999987766 48999999999999999999999654432 2222
Q ss_pred HHhh-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 227 KICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 227 ~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+.. .....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 2345677799999999999999999999999999765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.69 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=214.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. .+.+|+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 4468999999999999999999985 567899999975432 2467889999999999999999999986 567899
Q ss_pred EEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 999999999999997543 689999999999999999999999999999999999999999999999999986432211
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+|
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred -eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111234567899999999877764 89999999999999999 99999998887777776654 456677899999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
|.+||+.||.+|||+.+|++
T Consensus 418 i~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHH
Confidence 99999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=356.68 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=207.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcC-CCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...++|++.+.||+|+||+||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 445689999999999999999998643 344 69999987654444456778999999999999999999999998765
Q ss_pred EEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.++||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 88999999999999999774 5699999999999999999999999999999999999999999999999999876533
Q ss_pred cccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC--CCCCCCCCH
Q 013487 166 VRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSWFSS 241 (442)
Q Consensus 166 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~ 241 (442)
.... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... .+.+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2211 122345678899999999877664 89999999999999999 999999988887777776543 345567899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.++|.+||..||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999973
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=382.70 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=217.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
...+|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+|++++||||+++++++.....+|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 44679999999999999999999999999999999975432 24668899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999999864 3589999999999999999999999999999999999999999999999999976532111
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++.+.+|
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -eecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112234567889999999877764 89999999999999999 99999988776666665544 456677899999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
|.+||+.||.+|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.04 Aligned_cols=245 Identities=26% Similarity=0.482 Sum_probs=206.7
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-CE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-TK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~ 87 (442)
....++|++.+.||+|+||+||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 35568999999999999999999987 48899999987543 246788999999999999999999987544 47
Q ss_pred EEEEEEccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.|+||||+++|+|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999987654 89999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
. .....+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....+..+++.+
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 2 2344688999999999877764 89999999999999998 99999988776666666554 445677789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.++|.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=367.27 Aligned_cols=251 Identities=15% Similarity=0.204 Sum_probs=200.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCC-----CCEEEEEEecchhhhhHH---H-----HHHHHHHHHHHhhCCCCCcceEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHK---M-----VEQIKREISTMKLIKHPNVIKII 79 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~---~-----~~~~~~Ei~il~~l~hpnIv~l~ 79 (442)
++|++.+.||+|+||.||+|.+..+ ++.||+|++......... . .....+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3899999999999999999999764 578999998754311110 0 12344567778888999999999
Q ss_pred EEEEeC----CEEEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--cCCce
Q 013487 80 EVMASK----TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVL 152 (442)
Q Consensus 80 ~~~~~~----~~~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~--~~~~~ 152 (442)
+++... ...|+||||+ ||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 5689999999 99999999876 5799999999999999999999999999999999999999 88999
Q ss_pred EEeeccchhhhhhcccCC-----ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH
Q 013487 153 KISDFGLSAISQQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (442)
Q Consensus 153 kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (442)
||+|||+|+......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+..
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 999999997654432211 1234569999999999988776 4899999999999999999999985322111111
Q ss_pred H------------hhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 228 I------------CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 228 i------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
. ....+ .+..+++++.+|+..||..||.+|||+.+|++
T Consensus 273 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 0 00011 12457999999999999999999999999886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.85 Aligned_cols=236 Identities=32% Similarity=0.601 Sum_probs=196.0
Q ss_pred CcccccCeEEE-eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHH-hhCCCCCcceEEEEEEe-
Q 013487 8 SRTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMAS- 84 (442)
Q Consensus 8 ~~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~- 84 (442)
.+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 35678899998 7899999999999999999999999998643 2456788887 66689999999999987
Q ss_pred ---CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEee
Q 013487 85 ---KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISD 156 (442)
Q Consensus 85 ---~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~D 156 (442)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 778999999999999999998865 6999999999999999999999999999999999999998 78999999
Q ss_pred ccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH----HhhCC
Q 013487 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK----ICRAD 232 (442)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~----i~~~~ 232 (442)
||++.... +..+ +.++||||+||++|+|++|..||...+....... +....
T Consensus 164 fg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred cccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 99875321 1223 4789999999999999999999987654433221 11222
Q ss_pred CCCC----CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 233 FSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 233 ~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
...| ..+++++.+||.+||+.||.+|||+.|+++||||+.....
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 3333 4579999999999999999999999999999999875543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=352.85 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=205.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEE-EEeCCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEV-MASKTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~ 89 (442)
..++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.++|++++..+.. ....+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999875432 2357899999999998876655554 46778899
Q ss_pred EEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla~~~~~ 165 (442)
+||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8899999974 4579999999999999999999999999999999999999 4889999999999876543
Q ss_pred cccC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---HHHHHHHHhhCCCCC--
Q 013487 166 VRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADFSC-- 235 (442)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~-- 235 (442)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 2221 11245689999999999988776 489999999999999999999997632 222233332222222
Q ss_pred ---CCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 236 ---PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 236 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+..+++++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 2568999999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=374.74 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=207.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC--EE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--KI 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~ 88 (442)
.-++|++.+.||+|+||+||+|++..+|+.||+|++....... ..+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 4568999999999999999999999999999999997654322 2466789999999999999999999998765 78
Q ss_pred EEEEEccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----ccCCceEEeeccchh
Q 013487 89 YIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSA 161 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll----~~~~~~kl~DFGla~ 161 (442)
|+||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976543 9999999999999999999999999999999999999 778889999999997
Q ss_pred hhhhcccCCccccccCCCcccCcccccc--------cCCCCCcccHhHHHHHHHHHhcCCCCCCC----CcHHHHHHHHh
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLND--------KGYDGRASDVWSCGVILFVLMAGFLPFDE----SNLMALYRKIC 229 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~----~~~~~~~~~i~ 229 (442)
..... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.. ....+....+.
T Consensus 165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp ECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred EccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 65432 22345679999999999865 233 4789999999999999999999963 22234444444
Q ss_pred hCCCC---------------------CCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 230 RADFS---------------------CPS----WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 230 ~~~~~---------------------~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+... .+. .+++.+.+||.+||+.||++|||+.|++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 33211 111 134678899999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=349.97 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=212.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.. +..|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3478999999999999999999984 5678999999754321 3568899999999999999999999864 56899
Q ss_pred EEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||||++|++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999999997643 699999999999999999999999999999999999999999999999999875433211
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..+ ....+..+++++.+|
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 11223457889999999987666 489999999999999999 99999988877777766554 345566789999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
|.+||..||.+|||+.++++
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=358.49 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=209.2
Q ss_pred cccccCe-EEEeeecccCceEEEEEEE----cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE
Q 013487 9 RTRVGKY-ELGRTLGEGSFAKVKFAKN----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (442)
Q Consensus 9 ~~~~~~y-~i~~~LG~G~fg~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 83 (442)
...-++| ++++.||+|+||+||+|.. ..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 3445566 9999999999999988754 4578899999997653 3345677899999999999999999999998
Q ss_pred e--CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 84 S--KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 84 ~--~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
+ ...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 7 46899999999999999999764 59999999999999999999999999999999999999999999999999997
Q ss_pred hhhhcccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH---------------HHH
Q 013487 162 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------------ALY 225 (442)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~ 225 (442)
........ .......||+.|+|||++.+..+. .++||||||+++|+|++|..||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 65432111 123345688899999999887765 8999999999999999999999764322 111
Q ss_pred HHHhh-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 226 RKICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 226 ~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+.. .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222 244567778999999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=353.93 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=201.8
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEE-EEeCCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEV-MASKTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~ 89 (442)
..++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+.. +...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 45789999999999999999999999999999998765432 2347789999999998776665554 47788899
Q ss_pred EEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla~~~~~ 165 (442)
++|||+ +|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8899999985 4579999999999999999999999999999999999999 7899999999999976543
Q ss_pred cccC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---HHHHHHHhhCCCCCC-
Q 013487 166 VRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICRADFSCP- 236 (442)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~- 236 (442)
.... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+. ......+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 2221 12335689999999999988776 4899999999999999999999976432 122222222222222
Q ss_pred ----CCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 237 ----SWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 237 ----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 557999999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=371.43 Aligned_cols=250 Identities=28% Similarity=0.378 Sum_probs=193.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 91 (442)
+.|.+.+.||+|+||+||.+. ..+|+.||||.+..+. .+.+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 345667899999999998764 4689999999986543 24567899999876 899999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC-------------Cc
Q 013487 92 LEFIDGGELFDKIAKHGRLK-------EDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-------------GV 151 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~-------~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~-------------~~ 151 (442)
||||. |+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 59999998765433 23457799999999999999999999999999999754 48
Q ss_pred eEEeeccchhhhhhcccC--CccccccCCCcccCcccccc------cCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHH
Q 013487 152 LKISDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLND------KGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM 222 (442)
Q Consensus 152 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~ 222 (442)
+||+|||+|......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999765432211 12345689999999999975 2334689999999999999999 99999765443
Q ss_pred HHHHHHhhCCCCCCC-------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 223 ALYRKICRADFSCPS-------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 223 ~~~~~i~~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
. ..+.......+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 223333332221 13578999999999999999999999999999963
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=362.33 Aligned_cols=245 Identities=15% Similarity=0.217 Sum_probs=203.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCC--------CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcce-------
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVET--------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK------- 77 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------- 77 (442)
++|++.+.||+|+||.||+|++..+ ++.||+|++... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 7999999999999999999999874 889999998754 34678999999999999987
Q ss_pred --------EEEEEEe-CCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 013487 78 --------IIEVMAS-KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (442)
Q Consensus 78 --------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll 146 (442)
+++++.. .+..|+||||+ ||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777765 78899999999 99999999986 789999999999999999999999999999999999999
Q ss_pred ccCC--ceEEeeccchhhhhhcccC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC
Q 013487 147 DSYG--VLKISDFGLSAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (442)
Q Consensus 147 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~ 219 (442)
+.++ .+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9988 9999999999765433221 12234589999999999988776 48999999999999999999999875
Q ss_pred c--HHHHHHH---HhhCCCCCC------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 220 N--LMALYRK---ICRADFSCP------SWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 220 ~--~~~~~~~---i~~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
. ....... ........+ ..+++++.+||.+||..||.+|||++++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3 2222222 222222221 1368999999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=372.38 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=196.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+|++.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 499999999999999764 3446889999999975432 2245899999999 7999999999999999999999
Q ss_pred EccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CC--ceEEeeccchhhhhhc
Q 013487 93 EFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YG--VLKISDFGLSAISQQV 166 (442)
Q Consensus 93 E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~--~~kl~DFGla~~~~~~ 166 (442)
||+. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+|......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9997 59999998754 4566678899999999999999999999999999999953 23 5789999999765432
Q ss_pred cc-CCccccccCCCcccCccccccc--CCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCCCCC---CCCC
Q 013487 167 RE-DGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFSC---PSWF 239 (442)
Q Consensus 167 ~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 239 (442)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||................... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 11 1233457899999999999742 223478999999999999999 999997665544433322222211 1224
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 566899999999999999999999999999964
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=372.65 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=209.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+|++++||||+++++++.. +..|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34679999999999999999999964 467999999765422 3568899999999999999999999866 67899
Q ss_pred EEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 334 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 334 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence 99999999999999753 569999999999999999999999999999999999999999999999999997654321
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+|
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1112234578899999999877764 89999999999999999 99999988887777776654 456677899999999
Q ss_pred HHHccCCCCCCCCCHHHHhc
Q 013487 247 IKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~ 266 (442)
|.+||+.||++|||++++++
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.16 Aligned_cols=245 Identities=16% Similarity=0.201 Sum_probs=200.9
Q ss_pred ccCeEEEeeecccCceEEEEEE-----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC---CCCcceEEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMA 83 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~ 83 (442)
-++|++.+.||+|+||+||+|. +..+++.||+|++.... ...+.+|+.+++.++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3579999999999999999994 67889999999997543 235667888888886 999999999999
Q ss_pred eCCEEEEEEEccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc----------
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAK-----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---------- 148 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---------- 148 (442)
..+..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred -CCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH
Q 013487 149 -YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (442)
Q Consensus 149 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (442)
++.+||+|||+|...............+||+.|+|||++.+..|. .++|||||||++|+|++|..||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999765433334455667899999999999988764 899999999999999999999965432100
Q ss_pred HhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 228 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 228 i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.....+ ...+.++...+++..||+.+|.+|++..+.+.+
T Consensus 294 ~~~~~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 KPEGLF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EECSCC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred eechhc-cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000111 112357789999999999999999765444443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=349.73 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=197.3
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhh--CCCCCcceEEEEEEe--
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMAS-- 84 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~-- 84 (442)
....++|++.+.||+|+||+||+|.+ +++.||+|++.... .....+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34678999999999999999999988 68899999987543 2334556666665 799999999998644
Q ss_pred --CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEEccCCceEE
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH--------SRGVFHRDLKPENLLLDSYGVLKI 154 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH--------~~givHrDlkp~NIll~~~~~~kl 154 (442)
....|+||||+++|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999965 57999999999999999999999 999999999999999999999999
Q ss_pred eeccchhhhhhcccC--CccccccCCCcccCcccccccCCC-----CCcccHhHHHHHHHHHhcC----------CCCCC
Q 013487 155 SDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG----------FLPFD 217 (442)
Q Consensus 155 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf~ 217 (442)
+|||+|......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998754332111 112345899999999999876332 2689999999999999999 88885
Q ss_pred CCc----HHHHHHHHhhCC---CCCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 218 ESN----LMALYRKICRAD---FSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 218 ~~~----~~~~~~~i~~~~---~~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
... ............ ...|.. +++++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 421 122222222211 122211 3467999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.86 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=209.0
Q ss_pred EeeecccCceEEEEEEE--cCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEcc
Q 013487 18 GRTLGEGSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 95 (442)
.+.||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+|++++||||+++++++.. +..++||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 34899999999999965 4567889999997653 223345778999999999999999999999965 4588999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc-CCcccc
Q 013487 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-DGLLHT 174 (442)
Q Consensus 96 ~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~ 174 (442)
.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9999999999988999999999999999999999999999999999999999999999999999986543221 112233
Q ss_pred ccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccC
Q 013487 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILD 252 (442)
Q Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~ 252 (442)
..||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+||.+||+
T Consensus 532 ~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 4578899999999887775 89999999999999998 99999998888877777665 456778899999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 013487 253 PNPDTRMTISQMLE 266 (442)
Q Consensus 253 ~dP~~R~s~~eil~ 266 (442)
.||++|||+.++++
T Consensus 611 ~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 611 YDVENRPGFAAVEL 624 (635)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.28 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=202.3
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCC---CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE-eCCEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA-SKTKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 88 (442)
..|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 45899999999999999999986433 368999986432 3345678899999999999999999999864 45688
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999999998654 58899999999999999999999999999999999999999999999999997543322
Q ss_pred cCC--ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 168 EDG--LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+....+..+ ....|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 12334578899999999887774 89999999999999999 78899876655555555544 345567789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.++|.+||+.||.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=357.15 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=188.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEE--------
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMA-------- 83 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~-------- 83 (442)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 38999999999999999999999999999999986542 334567889999999996 999999999983
Q ss_pred eCCEEEEEEEccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEccCCceEEeecc
Q 013487 84 SKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFG 158 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~~~~~~kl~DFG 158 (442)
....++++|||+. |+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 4456899999996 599888765 567999999999999999999999999 9999999999999999999999999
Q ss_pred chhhhhhcccC----------CccccccCCCcccCccccc---ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH
Q 013487 159 LSAISQQVRED----------GLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225 (442)
Q Consensus 159 la~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~ 225 (442)
++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 98764332111 1112457999999999983 3334 58999999999999999999999876544333
Q ss_pred HHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 226 RKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 226 ~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
... .....+...+..+.+||.+||+.||.+|||+.|+++|.+-
T Consensus 263 ~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 263 NGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 221 1233345578899999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=349.61 Aligned_cols=243 Identities=27% Similarity=0.453 Sum_probs=200.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||+||+|.+ +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4567899999999999999999998 47889999986442 34678899999999999999999998764 478
Q ss_pred EEEEccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEEEccCCc-eEEeeccchhh
Q 013487 90 IVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHS---RGVFHRDLKPENLLLDSYGV-LKISDFGLSAI 162 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~ql~~aL~~lH~---~givHrDlkp~NIll~~~~~-~kl~DFGla~~ 162 (442)
+||||++||+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998765 37899999999999999999999 89999999999999998886 79999999875
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc--HHHHHHHHhh-CCCCCCCCC
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICR-ADFSCPSWF 239 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~-~~~~~~~~~ 239 (442)
... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||.... .......+.. .....+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 432 12345699999999999887764 89999999999999999999997543 2223323332 334556678
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+.+||.+||+.||.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=355.52 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=203.8
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-hhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 345569999999999999986 688999999865421 22334677899999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 93 EFIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 93 E~~~gg~L~~~i~~---~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||++||+|.+++.. ..++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999999874 346999999999999999999999999999999999999999999999999998765432222
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH----HHHHHHhhCC----------C-C
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRAD----------F-S 234 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~----------~-~ 234 (442)
......+||+.|+|||++.+. + +.++||||||+++|+|++|..||...... .....+.... . .
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 223446799999999998754 4 58999999999999999999999765432 1222221111 1 1
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+...+..+.+++.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122245778999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=359.97 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=206.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3457899999999999999999986 578999999997653211 1235789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 90 IVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~ql~~aL~~lH~~---givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
+||||+.||+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999998654 399999999999999999999999 999999999999999999999999999976
Q ss_pred hhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc--------HHHHHHHHhhC-CC
Q 013487 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--------LMALYRKICRA-DF 233 (442)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~-~~ 233 (442)
.... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||+... ........... ..
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 5432 1223345669999999999987766 489999999999999999999996321 11111111110 00
Q ss_pred ----------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 234 ----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 234 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
..+...+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0111124678999999999999999999999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=357.25 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=195.4
Q ss_pred CCcccCCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEE
Q 013487 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (442)
Q Consensus 1 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 80 (442)
|....+.....+++|++.+.||+|+||.||+|.+ +++.||+|++...... ......|+..++.++||||+++++
T Consensus 1 m~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp --------CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCcccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhhee
Confidence 4555566778899999999999999999999977 7899999999754311 112234444455689999999998
Q ss_pred EEEe-----CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEE
Q 013487 81 VMAS-----KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---------GVFHRDLKPENLLL 146 (442)
Q Consensus 81 ~~~~-----~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~---------givHrDlkp~NIll 146 (442)
.+.. ...+|+||||++||+|.+++... ..++..+..++.||+.||+|||++ ||+||||||+|||+
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence 6532 33679999999999999999764 458999999999999999999999 99999999999999
Q ss_pred ccCCceEEeeccchhhhhhcc------cCCccccccCCCcccCcccccccC------CCCCcccHhHHHHHHHHHhcCCC
Q 013487 147 DSYGVLKISDFGLSAISQQVR------EDGLLHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMAGFL 214 (442)
Q Consensus 147 ~~~~~~kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~~ll~g~~ 214 (442)
+.++.+||+|||+|....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 999999999999997543211 112233567999999999987631 22368999999999999999977
Q ss_pred CCCCC-c-----------------HHHHHHHHhhC--CCCCCCC------CCHHHHHHHHHccCCCCCCCCCHHHHhc--
Q 013487 215 PFDES-N-----------------LMALYRKICRA--DFSCPSW------FSSGAKKLIKRILDPNPDTRMTISQMLE-- 266 (442)
Q Consensus 215 Pf~~~-~-----------------~~~~~~~i~~~--~~~~~~~------~s~~~~~li~~~L~~dP~~R~s~~eil~-- 266 (442)
||... . ........... ...+|.. +++++.+||.+||+.||++|||+.|+++
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 66321 1 11111111111 2223332 3347999999999999999999999954
Q ss_pred ----CcccccCC
Q 013487 267 ----DEWFKKGY 274 (442)
Q Consensus 267 ----hp~~~~~~ 274 (442)
++|-++..
T Consensus 314 ~~ll~~~~~~~~ 325 (336)
T 3g2f_A 314 AELMMIWERNKS 325 (336)
T ss_dssp HHHHHCCCC---
T ss_pred HHHHHHHHhccc
Confidence 57766544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=380.28 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=210.8
Q ss_pred cCeEEEe-eecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 13 GKYELGR-TLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 13 ~~y~i~~-~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
+++.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 3456655 8999999999999876 355679999997642 12235678899999999999999999999976 5689
Q ss_pred EEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||+.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999999754 4599999999999999999999999999999999999999999999999999986533211
Q ss_pred C-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 169 D-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
. .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 111223467899999999887775 89999999999999998 99999988877777777665 35677889999999
Q ss_pred HHHHccCCCCCCCCCHHHHh---cCccccc
Q 013487 246 LIKRILDPNPDTRMTISQML---EDEWFKK 272 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil---~hp~~~~ 272 (442)
||.+||+.||.+|||+.+++ ++.|+..
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999875 4455543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=351.79 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=196.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhh--CCCCCcceEEEEEEeC--
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMASK-- 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~-- 85 (442)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... .....+|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34578999999999999999999984 8899999986443 1233445555544 4899999999999887
Q ss_pred --CEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEccCCceEEe
Q 013487 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 86 --~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~--------givHrDlkp~NIll~~~~~~kl~ 155 (442)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999976 4799999999999999999999999 99999999999999999999999
Q ss_pred eccchhhhhhcccC--CccccccCCCcccCcccccccCCCCC-----cccHhHHHHHHHHHhcC----------CCCCCC
Q 013487 156 DFGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGR-----ASDVWSCGVILFVLMAG----------FLPFDE 218 (442)
Q Consensus 156 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwSlGvil~~ll~g----------~~Pf~~ 218 (442)
|||+|......... ......+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99998654332211 11235689999999999987665532 38999999999999999 777754
Q ss_pred C-----cHHHHHHHHhhC--CCCCCC-----CCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 219 S-----NLMALYRKICRA--DFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 219 ~-----~~~~~~~~i~~~--~~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
. ........+... ....|. .+++++.+||.+||+.||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2 122222222222 222222 245679999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=351.23 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=209.2
Q ss_pred ccccCeEEEeeecccCceEEEEEE----EcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (442)
...++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 445679999999999999999998 46789999999987542 33467789999999999999999999998664
Q ss_pred C--EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 86 T--KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 86 ~--~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
+ .+++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 7899999999999999998764 599999999999999999999999999999999999999999999999999876
Q ss_pred hhhcccC-CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH----------------HHH
Q 013487 163 SQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----------------ALY 225 (442)
Q Consensus 163 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----------------~~~ 225 (442)
....... .......+++.|+|||++.+..+. .++||||||+++|+|++|..||...... .+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 5432111 112234578889999999877664 8999999999999999999998654211 111
Q ss_pred HHHhh-CCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 226 RKICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 226 ~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+.. ...+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222 234567779999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=389.54 Aligned_cols=261 Identities=29% Similarity=0.426 Sum_probs=207.8
Q ss_pred CCCcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-
Q 013487 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS- 84 (442)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 84 (442)
+.++..+++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ----------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 445567799999999999999999999999999999999987542 33456778999999999999999999998755
Q ss_pred -----CCEEEEEEEccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc---eE
Q 013487 85 -----KTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LK 153 (442)
Q Consensus 85 -----~~~~~lv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~---~k 153 (442)
.+..|+||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +|
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEE
Confidence 677899999999999999998754 5999999999999999999999999999999999999997765 99
Q ss_pred EeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHH-------
Q 013487 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR------- 226 (442)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~------- 226 (442)
|+|||++..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||........+.
T Consensus 165 L~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 165 IIDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240 (676)
T ss_dssp ECSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---
T ss_pred Eccccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhccc
Confidence 999999976543 2233456899999999999887775 89999999999999999999997653322110
Q ss_pred --HH-----hhCCC------CCCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 227 --KI-----CRADF------SCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 227 --~i-----~~~~~------~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+ ..+.. +.|. .+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00 01111 1111 24678999999999999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=374.34 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=213.9
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.. +.+|+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 45679999999999999999999964 467999999765422 3568899999999999999999999866 67899
Q ss_pred EEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 91 VLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999999753 5699999999999999999999999999999999999999999999999999976432111
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......++..|+|||++.+..+. .++|||||||+||+|++ |..||.+.+..+....+..+ ....|..+++.+.+|
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111234567899999999877764 89999999999999999 99999988887777776654 456677899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 013487 247 IKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~h 267 (442)
|.+||+.||++|||+++|++.
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=354.02 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=208.8
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
....++|++.+.||+|+||.||+|.+.. .+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3456899999999999999999999854 4999998754321 12234567899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+++|||++|++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999999998755 699999999999999999999999999999999999998 6899999999987543211
Q ss_pred ---cCCccccccCCCcccCccccccc--------CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC-
Q 013487 168 ---EDGLLHTACGTPNYVAPEVLNDK--------GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC- 235 (442)
Q Consensus 168 ---~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~- 235 (442)
.........||+.|+|||++.+. ...+.++||||||+++|+|++|..||...+.......+.....+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 12233445699999999998752 223589999999999999999999999988877776666554332
Q ss_pred -CCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 236 -PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 236 -~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+..++.++.+||.+||..||.+|||+.++++
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2347899999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.62 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=213.9
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCC---CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
...++|++.+.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3456899999999999999999998654 4569999886532 3345678899999999999999999999984 46
Q ss_pred EEEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999999999999998654 689999999999999999999999999999999999999999999999999976533
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
.. ........+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|+.+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1122335678899999999877764 89999999999999997 99999998887777776655 456778899999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.+||.+||..||.+|||+.++++.
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=361.44 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=207.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC-CCcceEEEEEEeCCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASKTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~ 89 (442)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999998754322 346789999999986 66667777778889999
Q ss_pred EEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---ccCCceEEeeccchhhhhh
Q 013487 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll---~~~~~~kl~DFGla~~~~~ 165 (442)
+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8899999985 4679999999999999999999999999999999999999 6889999999999976543
Q ss_pred cccC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---HHHHHHHHhhCCC----
Q 013487 166 VRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADF---- 233 (442)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~---- 233 (442)
.... ......+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 2221 112356899999999999887774 89999999999999999999997643 3333333332211
Q ss_pred -CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 -SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+..+++++.+||.+||..||.+||++.+|++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 222457999999999999999999999988765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.41 Aligned_cols=248 Identities=18% Similarity=0.233 Sum_probs=194.5
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC-CCc---------c------
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNV---------I------ 76 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v------ 76 (442)
..|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+++|+.+++.++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999874433333346778999999999987 321 1
Q ss_pred ------eEEEEEEe-----CCEEEEEEEccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 013487 77 ------KIIEVMAS-----KTKIYIVLEFIDGGELFDKIAK-------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138 (442)
Q Consensus 77 ------~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~-------~~~l~~~~~~~~~~ql~~aL~~lH~~givHrD 138 (442)
.+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111111 22467777776 5699988841 23477888999999999999999999999999
Q ss_pred CCCCcEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCccccc----------ccCCCCCcccHhHHHHHHHH
Q 013487 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN----------DKGYDGRASDVWSCGVILFV 208 (442)
Q Consensus 139 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DiwSlGvil~~ 208 (442)
|||+|||++.++.+||+|||+++..... ....+| +.|+|||++. +..| +.++|||||||++|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence 9999999999999999999998754332 456788 9999999993 3334 479999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 209 LMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 209 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
|++|..||...+.......+. .....+|+++.+||.+||+.||.+|||+.++++||||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999998776544333332 223457899999999999999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=363.68 Aligned_cols=244 Identities=21% Similarity=0.254 Sum_probs=196.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-----hHHHHHHHHHHHHHHhhCC---------CCCcc
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIK---------HPNVI 76 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv 76 (442)
..++|++.+.||+|+||+||+|++ +|+.||+|++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 7899999999865321 1122466788999988885 88888
Q ss_pred eEEEEEE------------------------------eCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013487 77 KIIEVMA------------------------------SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126 (442)
Q Consensus 77 ~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL 126 (442)
++.+++. ..+.+|+||||+++|++.+.+.. +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 8877653 26789999999999988777754 6789999999999999999
Q ss_pred HHHH-HCCceeccCCCCcEEEccCC--------------------ceEEeeccchhhhhhcccCCccccccCCCcccCcc
Q 013487 127 DYCH-SRGVFHRDLKPENLLLDSYG--------------------VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185 (442)
Q Consensus 127 ~~lH-~~givHrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 185 (442)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999887 899999999986532 2458999999999
Q ss_pred cccccCCCCCcccHhHHHHH-HHHHhcCCCCCCCCcH-HHHHHHHhhC-CCCC------CCCCCHHHHHHHHHccCCCCC
Q 013487 186 VLNDKGYDGRASDVWSCGVI-LFVLMAGFLPFDESNL-MALYRKICRA-DFSC------PSWFSSGAKKLIKRILDPNPD 256 (442)
Q Consensus 186 ~~~~~~~~~~~~DiwSlGvi-l~~ll~g~~Pf~~~~~-~~~~~~i~~~-~~~~------~~~~s~~~~~li~~~L~~dP~ 256 (442)
++.+.. +.++||||+|++ .+++++|..||..... ......+... .... ++.+++++.+||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998765 589999998777 7789999999965322 1222233211 1111 1136789999999999987
Q ss_pred CCCCHHHHh-cCcccc
Q 013487 257 TRMTISQML-EDEWFK 271 (442)
Q Consensus 257 ~R~s~~eil-~hp~~~ 271 (442)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=344.92 Aligned_cols=247 Identities=21% Similarity=0.380 Sum_probs=202.1
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhh--CCCCCcceEEEEEEeCC---
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 86 (442)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|+++++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46899999999999999999998 58999999997542 2456788888887 78999999999998876
Q ss_pred -EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEEccCCceEEeec
Q 013487 87 -KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH--------SRGVFHRDLKPENLLLDSYGVLKISDF 157 (442)
Q Consensus 87 -~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH--------~~givHrDlkp~NIll~~~~~~kl~DF 157 (442)
.+|+||||+++|+|.+++.. .++++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999976 56999999999999999999999 899999999999999999999999999
Q ss_pred cchhhhhhcccC--CccccccCCCcccCcccccccCCC-----CCcccHhHHHHHHHHHhcC----------CCCCCCC-
Q 013487 158 GLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG----------FLPFDES- 219 (442)
Q Consensus 158 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf~~~- 219 (442)
|++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998754332111 023455799999999998765332 1579999999999999999 8899654
Q ss_pred ----cHHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 220 ----NLMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 220 ----~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
........+..... ..|.. .++.+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23344444433322 22221 23578899999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=334.80 Aligned_cols=225 Identities=19% Similarity=0.206 Sum_probs=190.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999999999999999998765544556788999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+||||++|++|.+++.. + ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999954 3 4666789999999999999999999999999999999999999998554
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHH---HHhhCCCC----CCCCCCHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR---KICRADFS----CPSWFSSG 242 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~----~~~~~s~~ 242 (442)
|++| .+.++|||||||++|+|++|..||.+.+...... +....... .++.++++
T Consensus 175 -----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 -----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp -----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred -----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 3332 3589999999999999999999998765322110 11111111 23458999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+.+||.+||+.||.+| |+.++++.
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=376.33 Aligned_cols=243 Identities=23% Similarity=0.373 Sum_probs=201.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcC-CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE-
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK- 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 87 (442)
...++|++.+.||+|+||+||+|.+.. +++.||||++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 345899999999999999999999976 78999999986432 23445678899999999999999999999987655
Q ss_pred ----EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhh
Q 013487 88 ----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (442)
Q Consensus 88 ----~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~ 163 (442)
.|+||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988765 79999999999999999999999999999999999999985 8999999998754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHH
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 243 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 243 (442)
... ...+||+.|+|||++.+. + +.++|||||||++|+|++|.+||.+...... . ........++.+
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~~l 297 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYDSY 297 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCHHH
T ss_pred ccC------CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCHHH
Confidence 321 456799999999998764 3 5899999999999999999999875321100 0 000001136789
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=319.50 Aligned_cols=233 Identities=14% Similarity=0.115 Sum_probs=163.8
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhh-------hhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-------LRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-------~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 90 (442)
..++.|++|.++.++..-.|+.||+|++.+... ......+.+.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456788888888888888999999999976421 1233467799999999999 69999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||++||+|.++|...+++++. .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 99999999999999999988875 48899999999999999999999999999999999999999999865432 23
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 250 (442)
...+.|||+.|+|||++.+.. ..++|+||+|++++.|.++..|+. ..... .+.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHH
Confidence 456689999999999998653 367999999999988877644431 11111 1111 11345666777
Q ss_pred cCCCCCCCCCHHHHhcCcccc
Q 013487 251 LDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 251 L~~dP~~R~s~~eil~hp~~~ 271 (442)
+..+|..|+.......|+|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 778888888777777777754
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=230.39 Aligned_cols=131 Identities=45% Similarity=0.846 Sum_probs=119.1
Q ss_pred CCCCCChhhhhccCCCCCCccchhhhcccccccceEEeCCChhHHHHHHHHHhcccCceEeecCceeEEeeccCCCCcce
Q 013487 308 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQL 387 (442)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 387 (442)
.|..+|||++|++|+++|||+||+..+..++|+|||+|..|++.|+++||++++++||.|+++++++++++..++++|.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 46779999999999999999999876555789999999999999999999999999999999888999999999999999
Q ss_pred EEEEEEEEEeCCeEEEEEEecCCCchhHHHHHHHHHhccccccccccchhh
Q 013487 388 SVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKE 438 (442)
Q Consensus 388 ~~~~~i~~~~~~~~~vdf~~~~Gd~le~~~~~~~~~~~l~~iv~~~~~~~~ 438 (442)
++.+|||+|+|+++||||||++||++||+++|++|++.|+||||.+.++.+
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC------
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCCc
Confidence 999999999999999999999999999999999999999999998666543
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=209.52 Aligned_cols=120 Identities=23% Similarity=0.375 Sum_probs=105.6
Q ss_pred CCCCChhhhhccCCCCCCccchhhhcccccccceEEeCCChhHHHHHHHHHhcccCceEeecCceeEEeeccCCCCcceE
Q 013487 309 PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLS 388 (442)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 388 (442)
|..+|||++|++|+++|||+||+... ..+|+|||+|..||+.|+++||++++++||+|++++++ +++.++++|.|+
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~-~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~ 78 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDAR-KYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFA 78 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGC-SSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEE
T ss_pred cccccHHHHHHHCcCCCchHhcCccc-ccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEE
Confidence 56799999999999999999997632 24789999999999999999999999999999987775 666788999999
Q ss_pred EEEEEEEEeCCeEEEEEEecCCCchhHHHHH-HHHHhcccccccc
Q 013487 389 VATEVFEVAPTLHIVEVRKTGGDTLEFHKFY-KKFSSGLKDVVWQ 432 (442)
Q Consensus 389 ~~~~i~~~~~~~~~vdf~~~~Gd~le~~~~~-~~~~~~l~~iv~~ 432 (442)
+.+|||||+|+++||||||++||++||++|| ++|++.|+||||.
T Consensus 79 v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 79 MVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999976 6899999999994
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=268.66 Aligned_cols=189 Identities=21% Similarity=0.203 Sum_probs=145.5
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh-----hHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
...+.||+|+||+||+|. ..+..+++|........ .....+.+.+|+.++++++||||+++..+....+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346789999999999994 46788999986543322 12235668999999999999999955555556677799
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||++||+|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999876 6789999999999999999999999999999999 99999999998654322111
Q ss_pred -----ccccccCCCcccCcccccc--cCCCCCcccHhHHHHHHHHHhcCCCCCC
Q 013487 171 -----LLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFD 217 (442)
Q Consensus 171 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~ 217 (442)
.....+||+.|+|||++.. ..|. ..+|+||..+-..+...++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 2246789999999999976 5564 67899999988888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=222.19 Aligned_cols=145 Identities=20% Similarity=0.273 Sum_probs=116.1
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---------------HHHHHHHHHHHHHhhCCCCCcceEEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---------------KMVEQIKREISTMKLIKHPNVIKIIE 80 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~ 80 (442)
.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|+.++| +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence 3449999999999999999 8899999999964321110 235678899999999984 44444
Q ss_pred EEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccch
Q 013487 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (442)
Q Consensus 81 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla 160 (442)
++.. +..|+||||++||+|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 4433 45699999999999988 42 234567999999999999999999999999999999 999999999987
Q ss_pred hhhhhcccCCccccccCCCcccCccccc
Q 013487 161 AISQQVREDGLLHTACGTPNYVAPEVLN 188 (442)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (442)
+ .+..|.|||++.
T Consensus 240 ~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 240 V---------------EVGEEGWREILE 252 (282)
T ss_dssp E---------------ETTSTTHHHHHH
T ss_pred e---------------ECCCCCHHHHHH
Confidence 5 244578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=191.89 Aligned_cols=139 Identities=22% Similarity=0.284 Sum_probs=110.1
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCE--EEEEEecchhhh---------------------hHHHHHHHHHHHHHHhhCC
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVL---------------------RHKMVEQIKREISTMKLIK 71 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~--vaiK~i~~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 71 (442)
|++.+.||+|+||.||+|.+..+|+. ||||++...... .......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999788988 999997543211 0112346889999999998
Q ss_pred CCCc--ceEEEEEEeCCEEEEEEEccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCc
Q 013487 72 HPNV--IKIIEVMASKTKIYIVLEFIDG-G----ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPEN 143 (442)
Q Consensus 72 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH-~~givHrDlkp~N 143 (442)
|++| ..+++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8754 444443 346899999942 3 67665432 345678899999999999999 9999999999999
Q ss_pred EEEccCCceEEeeccchhh
Q 013487 144 LLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 144 Ill~~~~~~kl~DFGla~~ 162 (442)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-19 Score=176.62 Aligned_cols=136 Identities=18% Similarity=0.241 Sum_probs=102.5
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh---------------hHH----HHHHHHHHHHHHhhCCCCCc
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---------------RHK----MVEQIKREISTMKLIKHPNV 75 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~---------------~~~----~~~~~~~Ei~il~~l~hpnI 75 (442)
|++++.||+|+||.||+|.+ .+|+.||||+++..... ... ..-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999998 57999999987532110 000 11123568888888865554
Q ss_pred c--eEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---
Q 013487 76 I--KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--- 150 (442)
Q Consensus 76 v--~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~--- 150 (442)
. ..++. .. .++||||++|++|.... ..+.+..++.||+.+|.+||++|||||||||.|||++++|
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 3 33332 22 37999999998886542 2234567899999999999999999999999999998877
Q ss_pred -------ceEEeeccchh
Q 013487 151 -------VLKISDFGLSA 161 (442)
Q Consensus 151 -------~~kl~DFGla~ 161 (442)
.+.|+||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 38999998654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-13 Score=128.28 Aligned_cols=142 Identities=18% Similarity=0.164 Sum_probs=115.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (442)
..++.|++...+|.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.+++++....+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 4567899999999999999999975 36889999986432111 235789999999884 67888999999999999
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------- 131 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~------------------------------------- 131 (442)
|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999876531 223345788999999999999
Q ss_pred ----------------------CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 132 ----------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 132 ----------------------~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
.+++|+|++|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876666799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.6e-12 Score=119.84 Aligned_cols=137 Identities=15% Similarity=0.181 Sum_probs=103.6
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC--cceEEEEEEeCCE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN--VIKIIEVMASKTK 87 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~ 87 (442)
..+..|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+.
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 3455677766656677799999965 567789999976431 234678999999885444 5678998888888
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---------------------------------- 133 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g---------------------------------- 133 (442)
.|+||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999999998883 2 1122 2356778888888888753
Q ss_pred ------------------------ceeccCCCCcEEEccCCceEEeeccchh
Q 013487 134 ------------------------VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 134 ------------------------ivHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
++|+|++|.||++++++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999865
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.25 E-value=3.7e-11 Score=98.06 Aligned_cols=86 Identities=17% Similarity=0.297 Sum_probs=76.9
Q ss_pred eEEeCCChhHHHHHHHHHhcccCceEeec-CceeEEeeccCCCCcceEEEEEEEEEe-CCeEEEEEEecCCCchhHHHHH
Q 013487 342 RFTSQRPPNEIMSKIEEAAKPLGFNVRKG-NYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFY 419 (442)
Q Consensus 342 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~ 419 (442)
..+|..+|++|+.+|+++++.+|+.++++ .|++......+...+.+.|.+||+++. +++++|+|+|.+||.+.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 45799999999999999999999999865 489888776555667899999999996 8999999999999999999999
Q ss_pred HHHHhccc
Q 013487 420 KKFSSGLK 427 (442)
Q Consensus 420 ~~~~~~l~ 427 (442)
.+|...|+
T Consensus 112 ~~il~~L~ 119 (120)
T 3ose_A 112 SKIANELK 119 (120)
T ss_dssp HHHHHHCC
T ss_pred HHHHHHhc
Confidence 99988775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.8e-11 Score=118.86 Aligned_cols=141 Identities=17% Similarity=0.305 Sum_probs=107.5
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEEEEec--chhhhhHHHHHHHHHHHHHHhhCC--CCCcceEEEEEEeC---CEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASK---TKI 88 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~ 88 (442)
.-.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34678999999999998863 4678889775 32211 12356789999999997 45688899888766 458
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------- 131 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~------------------------------------- 131 (442)
|+||||++|..+.+.. -..++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999998775421 2347788889999999999999997
Q ss_pred ---------------------CCceeccCCCCcEEEccCCc--eEEeeccchhh
Q 013487 132 ---------------------RGVFHRDLKPENLLLDSYGV--LKISDFGLSAI 162 (442)
Q Consensus 132 ---------------------~givHrDlkp~NIll~~~~~--~kl~DFGla~~ 162 (442)
.+++|+|++|.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-11 Score=118.91 Aligned_cols=182 Identities=17% Similarity=0.189 Sum_probs=124.1
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCC--cceEEEEEEeCC---EEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPN--VIKIIEVMASKT---KIYIV 91 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lv 91 (442)
.+.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 46889986433 23567889999998883 333 445555543333 35899
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS---------------------------------------- 131 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~---------------------------------------- 131 (442)
|++++|.+|.+... ..++.++...++.|+...|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988876443 347888888999999999999996
Q ss_pred ------------------CCceeccCCCCcEEEcc--CCceEEeeccchhhhhhcccCCccccccCCCcc---cCcccc-
Q 013487 132 ------------------RGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNY---VAPEVL- 187 (442)
Q Consensus 132 ------------------~givHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~- 187 (442)
..++|+|++|.||++++ .+.+.|+||+.+....... .......+ ..|+..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHH
Confidence 13699999999999998 5568999999876432211 00001111 222221
Q ss_pred ---cccCCC---------CCcccHhHHHHHHHHHhcCCCCCC
Q 013487 188 ---NDKGYD---------GRASDVWSCGVILFVLMAGFLPFD 217 (442)
Q Consensus 188 ---~~~~~~---------~~~~DiwSlGvil~~ll~g~~Pf~ 217 (442)
...+.. ....+.|++|.++|.+.+|..||-
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111110 012589999999999999988774
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-09 Score=88.70 Aligned_cols=85 Identities=14% Similarity=0.221 Sum_probs=75.4
Q ss_pred EEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEe-CCeEEEEEEecCCCchhHHHHHH
Q 013487 343 FTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFYK 420 (442)
Q Consensus 343 f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~~ 420 (442)
.+|+.+|++|+..|.++++++|+.|+. +.|.+......+...+.+.|.+||+++. .+++.|+|+|.+||.+.|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 568899999999999999999999986 6788888665444567899999999994 78999999999999999999999
Q ss_pred HHHhccc
Q 013487 421 KFSSGLK 427 (442)
Q Consensus 421 ~~~~~l~ 427 (442)
+|...|+
T Consensus 113 ~IL~eLk 119 (126)
T 1v5s_A 113 KIANELK 119 (126)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9999887
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=1.9e-08 Score=78.99 Aligned_cols=89 Identities=18% Similarity=0.324 Sum_probs=76.8
Q ss_pred ccceEEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEeCCeEEEEEEecCCC------
Q 013487 339 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGD------ 411 (442)
Q Consensus 339 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd------ 411 (442)
..-...|...|.++|..|.+|++.+|+.|+. +.|.+++....+.....+.|.+++|++.++.+|+||++..||
T Consensus 8 W~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~ 87 (106)
T 4eai_A 8 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGG 87 (106)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSS
T ss_pred ceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCC
Confidence 3456788899999999999999999999986 579999987644444568899999999999999999999994
Q ss_pred --chhHHHHHHHHHhccc
Q 013487 412 --TLEFHKFYKKFSSGLK 427 (442)
Q Consensus 412 --~le~~~~~~~~~~~l~ 427 (442)
.++|-++|.++...|.
T Consensus 88 ~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 88 SHTIEFFEMCANLIKILA 105 (106)
T ss_dssp CHHHHHHHHHHHHHHHCC
T ss_pred cCcEeHHHHHHHHHHHHh
Confidence 8999999998877663
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.3e-07 Score=88.54 Aligned_cols=138 Identities=16% Similarity=0.194 Sum_probs=102.3
Q ss_pred CeEEEeeecccCc-eEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEEEE
Q 013487 14 KYELGRTLGEGSF-AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 14 ~y~i~~~LG~G~f-g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 91 (442)
.|+.. .+..|.. +.||+......+..+++|+-... ....+.+|...|+.+. +--|.+++.+..+.+..|+|
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 44443 3334544 47999888777788999986433 2456788999998884 33477889999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------------------------------------- 132 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~--------------------------------------- 132 (442)
||+++|.++.+..... ......+..++...|..||+.
T Consensus 99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999998887766542 223445677777777777750
Q ss_pred -------------------CceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 133 -------------------GVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 133 -------------------givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999999877778999997753
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.72 E-value=1e-07 Score=79.22 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=64.2
Q ss_pred cccceEEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 013487 338 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 414 (442)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 414 (442)
+..-...|..+|.+||..|.+|++.+|+.||+ +.|.+++..+.+.....+.|.+++|++.++.+||||++..||+.|
T Consensus 4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 34566778899999999999999999999986 679999988755433468899999999999999999999999744
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.2e-07 Score=89.04 Aligned_cols=134 Identities=21% Similarity=0.249 Sum_probs=98.1
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC---CcceEEEEEE-eCCEEEEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP---NVIKIIEVMA-SKTKIYIVLE 93 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E 93 (442)
.+.++.|....||+. +..+++|+.... .....+.+|..+|+.+.+. .|.+++.+.. ..+..|++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888999999988 567888985322 2356788999999999642 3667777664 4456789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR----------------------------------------- 132 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~----------------------------------------- 132 (442)
+++|..|.+..- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876422 2356666666777777777776653
Q ss_pred -------------------CceeccCCCCcEEEcc---CCc-eEEeeccchhhh
Q 013487 133 -------------------GVFHRDLKPENLLLDS---YGV-LKISDFGLSAIS 163 (442)
Q Consensus 133 -------------------givHrDlkp~NIll~~---~~~-~kl~DFGla~~~ 163 (442)
.++|+|++|.||+++. ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3499999999999987 455 489999987643
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=2.8e-07 Score=77.62 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=65.0
Q ss_pred cccceEEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 013487 338 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 414 (442)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 414 (442)
+......|..+|.+||..|.+|++.+|+.|++ +.|.++++...+.....+.|.+++|++.++.+||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 56777889999999999999999999999986 679999987644333467899999999999999999999999876
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2.1e-07 Score=76.86 Aligned_cols=90 Identities=16% Similarity=0.200 Sum_probs=74.9
Q ss_pred cccceEEeCCChhHHHHHHHHHhcccCceEeec----------CceeEEeeccCCC-----CcceEEEEEEEEEeCCeEE
Q 013487 338 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----------NYKMKLQGDKTGR-----KGQLSVATEVFEVAPTLHI 402 (442)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~ 402 (442)
+......|..+|.+||..|.+|++.+|+.|++. .|.|++....+.. ...+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 567778899999999999999999999999864 4888887754321 2357899999999999999
Q ss_pred EEEEecCCC---------------c----hhHHHHHHHHHhccc
Q 013487 403 VEVRKTGGD---------------T----LEFHKFYKKFSSGLK 427 (442)
Q Consensus 403 vdf~~~~Gd---------------~----le~~~~~~~~~~~l~ 427 (442)
|||++..|+ . ++|-.+|.+|...|+
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 999999999 5 899999988877664
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.48 E-value=8.1e-07 Score=71.51 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=61.2
Q ss_pred ccceEEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEeCCeEEEEEEecCCCchhH
Q 013487 339 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEF 415 (442)
Q Consensus 339 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le~ 415 (442)
..-...|...|.++|..|.+|++.+|+.|++ +.|.+++....+.....+.+.+++|++.+..+|+||++..||..|.
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~ 85 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ 85 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC------
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhc
Confidence 3445667888999999999999999999986 5799999876555555678999999999999999999999996443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=7.5e-07 Score=88.37 Aligned_cols=81 Identities=15% Similarity=0.120 Sum_probs=51.1
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhh-hhH---HHHHHHHHHHHHHhhCCC--C-CcceEEEEEEeCCEEE
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRH---KMVEQIKREISTMKLIKH--P-NVIKIIEVMASKTKIY 89 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~ 89 (442)
-.+.||.|..+.||++.+..++..+++|....... ... ...+.+..|..+++.+.. | .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999998766678899998643210 000 012456778888887742 3 34566654 344568
Q ss_pred EEEEccCCCC
Q 013487 90 IVLEFIDGGE 99 (442)
Q Consensus 90 lv~E~~~gg~ 99 (442)
+|||+++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.30 E-value=3.4e-06 Score=71.76 Aligned_cols=89 Identities=19% Similarity=0.247 Sum_probs=73.2
Q ss_pred cccceEEeCCChhHHHHHHHHHhcccCceEeec----CceeEEeeccCC---------CCcceEEEEEEEEEeCCeEEEE
Q 013487 338 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----NYKMKLQGDKTG---------RKGQLSVATEVFEVAPTLHIVE 404 (442)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~vd 404 (442)
+......|..+|.+||..|.+|++.+|+.|++. .|.|++.+..+. ....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 456667889999999999999999999999873 789998865221 1234889999999999999999
Q ss_pred EEecCC----------------------CchhHHHHHHHHHhccc
Q 013487 405 VRKTGG----------------------DTLEFHKFYKKFSSGLK 427 (442)
Q Consensus 405 f~~~~G----------------------d~le~~~~~~~~~~~l~ 427 (442)
|+ ..| .+..|-.+|.+|.-.|.
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa 173 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA 173 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence 99 788 77889999988877664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.2e-06 Score=85.40 Aligned_cols=83 Identities=6% Similarity=0.168 Sum_probs=56.6
Q ss_pred EEEeee-cccCceEEEEEEEc--C----CCCEEEEEEecchh---hhhHHHHHHHHHHHHHHhhCC-C--CCcceEEEEE
Q 013487 16 ELGRTL-GEGSFAKVKFAKNV--E----TGDFVAIKIVDRDQ---VLRHKMVEQIKREISTMKLIK-H--PNVIKIIEVM 82 (442)
Q Consensus 16 ~i~~~L-G~G~fg~V~~a~~~--~----~~~~vaiK~i~~~~---~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~ 82 (442)
...+.| +.|....+|+.... . ++..+++|+..... ... ...+.+|+.+++.+. + -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345778 88999999988753 1 25678999865432 101 134678888888884 3 3577888877
Q ss_pred EeC---CEEEEEEEccCCCChH
Q 013487 83 ASK---TKIYIVLEFIDGGELF 101 (442)
Q Consensus 83 ~~~---~~~~lv~E~~~gg~L~ 101 (442)
.+. +..|+|||+++|..+.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 655 3568999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=2e-05 Score=75.89 Aligned_cols=135 Identities=13% Similarity=0.148 Sum_probs=77.5
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-----CCCcceEE-E--EEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----HPNVIKII-E--VMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 89 (442)
.+.|+.|..+.||++... + ..+++|+..... ..+..|..+++.|. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET-T-EEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC-C-CCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 456677788999998763 3 358999987521 22334555555442 34444310 0 123467789
Q ss_pred EEEEccCCCChH--------------HHHHh-cCCC--C-----------HH--------H-------------------
Q 013487 90 IVLEFIDGGELF--------------DKIAK-HGRL--K-----------ED--------E------------------- 114 (442)
Q Consensus 90 lv~E~~~gg~L~--------------~~i~~-~~~l--~-----------~~--------~------------------- 114 (442)
++|+|++|.++. ..+.. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986531 11111 0111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 115 ----ARRYFQQLINAVDYCHS-------------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 115 ----~~~~~~ql~~aL~~lH~-------------~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
...+..++..++++|++ .+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666652 579999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00016 Score=69.18 Aligned_cols=75 Identities=17% Similarity=0.247 Sum_probs=60.0
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC---CCCcceEEEEEEeCCEEEEEEEc
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
.+.|+.|....+|+... ++..+++|+..... ...+..|...|+.|. ...+.+++.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 57789999999999875 46788899875431 356788999888883 36688899988888899999999
Q ss_pred cCCCCh
Q 013487 95 IDGGEL 100 (442)
Q Consensus 95 ~~gg~L 100 (442)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00019 Score=64.16 Aligned_cols=122 Identities=16% Similarity=0.099 Sum_probs=81.5
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccccc
Q 013487 98 GELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (442)
Q Consensus 98 g~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 175 (442)
-+|.+.+... .+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|++-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3788888764 589999999999999999887622 2222334457999999999988774 2110
Q ss_pred cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHccCC
Q 013487 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 253 (442)
.....+.|||... .-.+.+.=|||||+++|.-+--..|- ..+..+|+++.+||..|...
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 1233577888763 22346788999999999987533332 22345899999999999866
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=8e-05 Score=74.30 Aligned_cols=31 Identities=16% Similarity=0.296 Sum_probs=27.4
Q ss_pred HCCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 131 ~~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
...++|+|++|.||+++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45799999999999999877 99999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.63 E-value=7.8e-05 Score=70.75 Aligned_cols=71 Identities=13% Similarity=0.057 Sum_probs=45.1
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc-ceEEEEEEeCCEEEEEEEcc-
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFI- 95 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~- 95 (442)
.+.|+.|....+|++ ..+++|+...... ..-...+|..+++.+...++ .+++.+ +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 788999999999998 5688898764310 11123468888877742222 456554 333457899999
Q ss_pred CCCCh
Q 013487 96 DGGEL 100 (442)
Q Consensus 96 ~gg~L 100 (442)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00028 Score=67.78 Aligned_cols=136 Identities=13% Similarity=0.161 Sum_probs=72.6
Q ss_pred EeeecccCceE-EEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC--CCcceEEEEEEeCCEEEEEEEc
Q 013487 18 GRTLGEGSFAK-VKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 18 ~~~LG~G~fg~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 94 (442)
.+.|+.|+... +|+... .++..+++|...... .+.+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34566565554 556653 236677777654321 0234567777776642 23566776643333 789999
Q ss_pred cCCCChHHHHHhcC--------------------------CCCHHHHH-------H-HH------------HHHHHHHHH
Q 013487 95 IDGGELFDKIAKHG--------------------------RLKEDEAR-------R-YF------------QQLINAVDY 128 (442)
Q Consensus 95 ~~gg~L~~~i~~~~--------------------------~l~~~~~~-------~-~~------------~ql~~aL~~ 128 (442)
+.|..+.+.+.... .++..... . +. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 97766655443210 12221110 0 00 011122223
Q ss_pred H------HHCCceeccCCCCcEEEccC----CceEEeeccchhh
Q 013487 129 C------HSRGVFHRDLKPENLLLDSY----GVLKISDFGLSAI 162 (442)
Q Consensus 129 l------H~~givHrDlkp~NIll~~~----~~~kl~DFGla~~ 162 (442)
+ +...++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3 12469999999999999874 6899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0004 Score=66.26 Aligned_cols=138 Identities=12% Similarity=0.138 Sum_probs=77.5
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC--cceEEEE------EEeCCEE
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN--VIKIIEV------MASKTKI 88 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~ 88 (442)
-.+.|+.|....+|++... +| .+++|+..... ..+.+..|+.+++.|...+ +.+++.. ....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 3567888888999998763 33 68899886521 1234556777777663211 2333211 1234678
Q ss_pred EEEEEccCCCChHH--------------HHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHH
Q 013487 89 YIVLEFIDGGELFD--------------KIAKH-GRL--------KEDEARR---------------YFQQLINAVDYCH 130 (442)
Q Consensus 89 ~lv~E~~~gg~L~~--------------~i~~~-~~l--------~~~~~~~---------------~~~ql~~aL~~lH 130 (442)
+++|++++|..+.. .+... ..+ ....-.. +-..+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 99999999864310 11110 011 1000000 0011344455555
Q ss_pred H-------CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 131 S-------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 131 ~-------~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
+ .+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3 369999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00072 Score=64.64 Aligned_cols=75 Identities=13% Similarity=0.131 Sum_probs=46.9
Q ss_pred eeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCC--CcceEEEE-----EEeCCEEEEE
Q 013487 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEV-----MASKTKIYIV 91 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lv 91 (442)
..|+ |....||++.. .+|+.+++|+...... . .+.+..|..+++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998765 4566799999863321 1 23566788877776421 23333332 2235677899
Q ss_pred EEccCCCC
Q 013487 92 LEFIDGGE 99 (442)
Q Consensus 92 ~E~~~gg~ 99 (442)
|++++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998854
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0023 Score=59.98 Aligned_cols=78 Identities=10% Similarity=0.046 Sum_probs=54.4
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-C--CCcceEEEEEEeCCEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-H--PNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 90 (442)
+..-++.+|.|..+.||+... .+|+.|++|+........ ...+..|...|+.|. . --+.+++.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 345678899999999999987 678899999865332111 234678999988884 2 2355555542 2 378
Q ss_pred EEEccCCCC
Q 013487 91 VLEFIDGGE 99 (442)
Q Consensus 91 v~E~~~gg~ 99 (442)
+|||..++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00038 Score=69.59 Aligned_cols=73 Identities=11% Similarity=0.093 Sum_probs=49.2
Q ss_pred EeeecccCceEEEEEEEcC-------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 89 (442)
.+.|+.|....+|++.... .+..+++|+..... . .+.+.+|..+++.+...+ ..++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 5678889889999998753 35789999884321 1 123447888888885333 366776553 2 2
Q ss_pred EEEEccCCCC
Q 013487 90 IVLEFIDGGE 99 (442)
Q Consensus 90 lv~E~~~gg~ 99 (442)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00042 Score=68.04 Aligned_cols=137 Identities=16% Similarity=0.116 Sum_probs=82.2
Q ss_pred EeeecccCceEEEEEEEcC-------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (442)
.+.|..|-...+|++.... ++..+++|+..... .....+.+|..+++.|. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567668888899988642 35789999863211 11344568999998884 3334667766543 2
Q ss_pred EEEEccCCCChHH----------HH-------Hhc-C----CC--CHHHHHHHHHHHHH-------------------HH
Q 013487 90 IVLEFIDGGELFD----------KI-------AKH-G----RL--KEDEARRYFQQLIN-------------------AV 126 (442)
Q Consensus 90 lv~E~~~gg~L~~----------~i-------~~~-~----~l--~~~~~~~~~~ql~~-------------------aL 126 (442)
+||||++|..|.. .+ ... . .. -..++.+|..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998855421 11 111 0 11 13456666655532 23
Q ss_pred HHHH----H----CCceeccCCCCcEEEccC----CceEEeeccchhh
Q 013487 127 DYCH----S----RGVFHRDLKPENLLLDSY----GVLKISDFGLSAI 162 (442)
Q Consensus 127 ~~lH----~----~givHrDlkp~NIll~~~----~~~kl~DFGla~~ 162 (442)
+.|. . ..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 258999999999999876 7899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0022 Score=61.83 Aligned_cols=31 Identities=19% Similarity=0.305 Sum_probs=27.5
Q ss_pred CCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 132 ~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0012 Score=64.41 Aligned_cols=74 Identities=11% Similarity=0.062 Sum_probs=44.7
Q ss_pred EeeecccCceEEEEEEEcC--------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE--------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKI 88 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 88 (442)
.+.|+.|....+|++.... .+..+++|+...... .......|..+++.+...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5677888888999998643 136889998754211 0112357888888775333 45666554 22
Q ss_pred EEEEEccCCCC
Q 013487 89 YIVLEFIDGGE 99 (442)
Q Consensus 89 ~lv~E~~~gg~ 99 (442)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.017 Score=58.08 Aligned_cols=75 Identities=17% Similarity=0.216 Sum_probs=48.4
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc-ceEEEEEEeCCEEEEEEEccC
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 96 (442)
.+.|+.|....+|++.....+..+++|+..... . ... ...+|..+++.|...++ .++++.+. +. +||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence 567888988999999875445789999875321 0 001 12589999998865444 56777662 32 5999998
Q ss_pred CCCh
Q 013487 97 GGEL 100 (442)
Q Consensus 97 gg~L 100 (442)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.13 Score=50.99 Aligned_cols=75 Identities=17% Similarity=0.162 Sum_probs=48.0
Q ss_pred EeeecccCceEEEEEEEcCC-------CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVET-------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (442)
.+.|..|-...+|++..... +..+++++..... ...-...+|..+++.+. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45677788889999987521 5789999864321 11112357888888874 33345666543 22 6
Q ss_pred EEEEccCCCCh
Q 013487 90 IVLEFIDGGEL 100 (442)
Q Consensus 90 lv~E~~~gg~L 100 (442)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.41 E-value=0.24 Score=48.62 Aligned_cols=29 Identities=31% Similarity=0.422 Sum_probs=25.1
Q ss_pred ceeccCCCCcEEE------ccCCceEEeeccchhh
Q 013487 134 VFHRDLKPENLLL------DSYGVLKISDFGLSAI 162 (442)
Q Consensus 134 ivHrDlkp~NIll------~~~~~~kl~DFGla~~ 162 (442)
++|+|+.+.|||+ ++++.+.++||.+|+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.16 E-value=2.8 Score=37.16 Aligned_cols=82 Identities=16% Similarity=0.127 Sum_probs=63.3
Q ss_pred CCCCcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCcEEEccC
Q 013487 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD-YCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 71 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~-~lH~~givHrDlkp~NIll~~~ 149 (442)
.||+. -..+-.+++.+.+.++.-+++.=+..+. .++....++++.+|+...+ ++ ..-+|--|+|+||++|.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 58888 4555578888888888876665566664 3688888888888877655 33 456777899999999999
Q ss_pred CceEEeeccc
Q 013487 150 GVLKISDFGL 159 (442)
Q Consensus 150 ~~~kl~DFGl 159 (442)
+.++|.-.|+
T Consensus 121 ~~p~i~hRGi 130 (219)
T 4ano_A 121 LEPFFLHVGV 130 (219)
T ss_dssp CCEEESCCEE
T ss_pred CcEEEEEcCC
Confidence 9999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.85 E-value=2 Score=38.07 Aligned_cols=115 Identities=20% Similarity=0.310 Sum_probs=78.9
Q ss_pred CCCCcceEEEEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC
Q 013487 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 150 (442)
Q Consensus 71 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~ 150 (442)
.||+.+.. .+-.+.+.+.+.++.-+.+.=+..+. .++....++++.+|+...+++ ..-+|--|+|+||+++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 58999877 56677787777777665443333343 368889999999998877444 4457778999999999999
Q ss_pred ceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCccc-HhHHHHHHHHHhcCCCCCC
Q 013487 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD-VWSCGVILFVLMAGFLPFD 217 (442)
Q Consensus 151 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D-iwSlGvil~~ll~g~~Pf~ 217 (442)
.+++.--|+-.. ++|. .-...| .-.+=+++..+++++..|+
T Consensus 117 ~p~i~~RGik~~-------------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV-------------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT-------------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC-------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999998775321 1222 111222 2345678888999888773
|
| >3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A | Back alignment and structure |
|---|
Probab=82.55 E-value=17 Score=28.93 Aligned_cols=85 Identities=13% Similarity=0.180 Sum_probs=60.7
Q ss_pred eEEeCCChhHHHHHHHHHhc---ccCc-eEeecCceeEEeeccCCCC----cceEEEEEEEEEeCCe-EEEEEEecCCCc
Q 013487 342 RFTSQRPPNEIMSKIEEAAK---PLGF-NVRKGNYKMKLQGDKTGRK----GQLSVATEVFEVAPTL-HIVEVRKTGGDT 412 (442)
Q Consensus 342 rf~s~~~~~~~~~~l~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~----~~l~~~~~i~~~~~~~-~~vdf~~~~Gd~ 412 (442)
.+++..+...+...|...++ ..|+ .++.+.....+.+.....+ ..+.|.++|++=. +. .+|-|++.+|..
T Consensus 28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs 106 (128)
T 3ost_A 28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST 106 (128)
T ss_dssp CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence 56788888888888888874 5665 3443333333434322211 3577999999755 66 999999999999
Q ss_pred hhHHHHHHHHHhccc
Q 013487 413 LEFHKFYKKFSSGLK 427 (442)
Q Consensus 413 le~~~~~~~~~~~l~ 427 (442)
--|++++..|..-|+
T Consensus 107 stf~klv~eiEkVL~ 121 (128)
T 3ost_A 107 KTLTKLATEIQIILQ 121 (128)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998877654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.16 E-value=0.082 Score=53.10 Aligned_cols=64 Identities=14% Similarity=0.119 Sum_probs=18.2
Q ss_pred EEEeeecccCceEEEEEEEcCCCCEEEE------EEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETGDFVAI------KIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 83 (442)
.+.+.|| ||.||.|.......+||+ |....... ..+....+.+|..+++.++|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 3455666 999999998765668888 65543222 2233456778899999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 442 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-92 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-89 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-87 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-83 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-81 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-81 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-80 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-80 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-79 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-78 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-77 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-76 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-75 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-73 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-72 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-72 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-72 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-70 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-66 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-61 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-60 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-60 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-57 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-56 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 2e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (709), Expect = 4e-92
Identities = 86/259 (33%), Positives = 148/259 (57%), Gaps = 5/259 (1%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+GR LG+G F V A+ ++ +A+K++ + Q+ + + Q++RE+ ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ T++Y++LE+ G ++ ++ K + E Y +L NA+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+KPENLLL S G LKI+DFG S + T CGT +Y+ PE++ + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
D+WS GV+ + + G PF+ + Y++I R +F+ P + + GA+ LI R+L
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 254 NPDTRMTISQMLEDEWFKK 272
NP R + ++LE W
Sbjct: 242 NPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 270 bits (692), Expect = 2e-89
Identities = 105/267 (39%), Positives = 150/267 (56%), Gaps = 5/267 (1%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V ++L +TLGEG++ +V+ A N T + VA+KIVD + + E IK+EI K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+K Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+KPENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKICRADFSCPSW--FSSGAKKLIK 248
+ DVWSCG++L ++AG LP+D S+ Y W S L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYK 275
+IL NP R+TI + +D W+ K K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (676), Expect = 8e-87
Identities = 81/264 (30%), Positives = 142/264 (53%), Gaps = 1/264 (0%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ R ++ G+ LGEGSF+ V A+ + T AIKI+++ +++ V + RE M
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+ HP +K+ K+Y L + GEL I K G E R Y ++++A++Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
H +G+ HRDLKPEN+LL+ ++I+DFG + + + ++ GT YV+PE+L
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
+K ++SD+W+ G I++ L+AG PF N +++KI + ++ P F A+ L++
Sbjct: 184 EKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242
Query: 249 RILDPNPDTRMTISQMLEDEWFKK 272
++L + R+ +M K
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (653), Expect = 2e-83
Identities = 83/271 (30%), Positives = 140/271 (51%), Gaps = 13/271 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ LG+G+F KV A+N ET A K++D + +E EI + HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 70
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRG 133
++K+++ + ++I++EF GG + + + R L E + + +Q ++A++Y H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRDLK N+L G +K++DFG+SA + R + GTP ++APEV+ +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 194 GR----ASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKL 246
R +DVWS G+ L + P E N M + KI +++ + PS +SS K
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
+K+ L+ N D R T SQ+L+ + P
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 251 bits (643), Expect = 1e-81
Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 12/293 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ R +G GSF V FA++V + VAIK + ++ + I +E+ ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N I+ + ++V+E+ G L+E E + + Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL---NDK 190
+ HRD+K N+LL G++K+ DFG ++I ++ GTP ++APEV+ ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--FSSGAKKLIK 248
YDG+ DVWS G+ L P N M+ I + + +S + +
Sbjct: 190 QYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 249 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 301
L P R T +L+ + + P + D V + N +
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKM 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 253 bits (646), Expect = 2e-81
Identities = 87/272 (31%), Positives = 137/272 (50%), Gaps = 14/272 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG G+F V TG+ A K V E +++EI TM +++HP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 83
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSR 132
++ + + ++ ++ EF+ GGELF+K+A +H ++ EDEA Y +Q+ + + H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 133 GVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
H DLKPEN++ + LK+ DFGL+A + + GT + APEV K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----SCPSWFSSGAKKL 246
G +D+WS GV+ ++L++G PF N R + D+ S S S K
Sbjct: 201 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
I+++L +P+TRMTI Q LE W G P
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 249 bits (637), Expect = 4e-80
Identities = 88/358 (24%), Positives = 155/358 (43%), Gaps = 37/358 (10%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ Y++ LG G+F V TG K ++ L +K EIS M
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMN 81
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVD 127
+ HP +I + + K ++ ++LEF+ GGELFD+IA ++ E E Y +Q +
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 128 YCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
+ H + H D+KPEN++ ++ +KI DFGL + ++ D ++ T + APE
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL---ATKLNPDEIVKVTTATAEFAAPE 198
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241
+++ + +D+W+ GV+ +VL++G PF + + + + R D+ S S
Sbjct: 199 IVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 301
AK IK +L P R+T+ LE W K + +N ++ +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR--------YNKIRQKI 309
Query: 302 VTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEA 359
+ + P A I R +FS R+ R + + + +EA
Sbjct: 310 KEKYADWPAPQPA---IGRIANFSSL-----------RKHRPQEYQIYDSYFDR-KEA 352
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 4e-80
Identities = 80/272 (29%), Positives = 134/272 (49%), Gaps = 16/272 (5%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+R YE+ T+G GS+ + + + G + K +D + + + E++ ++
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE 59
Query: 70 IKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLI 123
+KHPN+++ + + +T +YIV+E+ +GG+L I K + L E+ R QL
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 124 NAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
A+ CH R V HRDLKP N+ LD +K+ DFGL+ I + GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGT 177
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPS 237
P Y++PE +N Y+ SD+WS G +L+ L A PF + L KI F P
Sbjct: 178 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236
Query: 238 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 269
+S ++I R+L+ R ++ ++LE+
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 6e-80
Identities = 73/269 (27%), Positives = 130/269 (48%), Gaps = 10/269 (3%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
KY +G+G+ V A +V TG VAI+ ++ Q E I EI M+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKN 76
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
PN++ ++ ++++V+E++ GG L D + + E + ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIKR 249
D+WS G++ ++ G P+ N + I + P S+ + + R
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 250 ILDPNPDTRMTISQMLEDEWFKKGYKPPH 278
LD + + R + ++L+ ++ K
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (625), Expect = 3e-79
Identities = 85/275 (30%), Positives = 136/275 (49%), Gaps = 19/275 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH------KMVEQIKREISTM 67
YE LG G + V+ + T A+KI+D ++ E +E+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 68 -KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
K+ HPN+I++ + + T ++V + + GELFD + + L E E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H + HRDLKPEN+LLD +K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 187 L-----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSW- 238
+ ++ G+ D+WS GVI++ L+AG PF M + R I + F P W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 239 -FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
+S K L+ R L P R T + L +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 243 bits (620), Expect = 4e-78
Identities = 105/314 (33%), Positives = 164/314 (52%), Gaps = 24/314 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y+ LG G+F++V A++ T VAIK + + + ++ EI+ + IKHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ + ++ S +Y++++ + GGELFD+I + G E +A R Q+++AV Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 134 VFHRDLKPENLLL---DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLL D + ISDFGLS + +L TACGTP YVAPEVL K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSW--FSSGAKKL 246
Y +A D WS GVI ++L+ G+ PF + N L+ +I +A+ F P W S AK
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKK 306
I+ +++ +P+ R T Q L+ W + + K+N K
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS---------VSEQIKKNFAKSKW 294
Query: 307 EKPVSMNAFELISR 320
++ + NA ++
Sbjct: 295 KQ--AFNATAVVRH 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 4e-77
Identities = 92/312 (29%), Positives = 152/312 (48%), Gaps = 29/312 (9%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL-IKHP 73
+ L + LG+GSF KV A+ +T F AIK + +D VL VE E + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ + +K ++ V+E+++GG+L I + A Y ++I + + HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLD G +KI+DFG+ + D +T CGTP+Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
+ D WS GV+L+ ++ G PF + L+ I + P W AK L+ ++
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 254 NPDTRMTI-SQMLEDEWFK---------KGYKPP------------HFDKE---EEVNLD 288
P+ R+ + + + F+ K PP +FDKE E+ L
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLS 300
Query: 289 DVDAIFNDSKEN 300
D +S +
Sbjct: 301 FADRALINSMDQ 312
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 8e-77
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 15/271 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + LG G F V + K V ++ +K+EIS + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHR 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
N++ + E S ++ ++ EFI G ++F++I L E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 133 GVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ H D++PEN++ + +KI +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKL 246
A+D+WS G +++VL++G PF + I A+++ S A
Sbjct: 179 VVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
+ R+L +RMT S+ L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 7e-76
Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E LG G+ V + +G +A K++ + ++ + QI RE+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR- 132
++ S +I I +E +DGG L + K GR+ E + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRD+KP N+L++S G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 193 DGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRADFS--------------- 234
SD+WS G+ L + G P D L ++ D +
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 235 --------------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 268
FS + + + L NP R + Q++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 269 WFKK 272
+ K+
Sbjct: 300 FIKR 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 5e-75
Identities = 68/270 (25%), Positives = 126/270 (46%), Gaps = 18/270 (6%)
Query: 13 GKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
G++ + +G GSF V + ET VA + +D+ L ++ K E +K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 72 HPNVIKIIEVMASKTK----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
HPN+++ + S K I +V E + G L + + +K R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 128 YCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
+ H+R + HRDLK +N+ + G +KI D GL+ + GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRA--DFSCPSWFSS 241
E+ +K YD + DV++ G+ + + P+ E N +YR++ S
Sbjct: 183 EMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
K++I+ + N D R +I +L +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 6e-75
Identities = 83/282 (29%), Positives = 139/282 (49%), Gaps = 20/282 (7%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---QIKREISTMKL 69
+Y++G LG G F V V VAIK V++D++ + ++ E+ +K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 70 IK--HPNVIKIIEVMASKTKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAV 126
+ VI++++ ++LE + +LFD I + G L+E+ AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 127 DYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
+CH+ GV HRD+K EN+L+D + G LK+ DFG A+ +D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 245
+ Y GR++ VWS G++L+ ++ G +PF+ +I R SS +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 246 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNL 287
LI+ L P R T ++ W + P + E++L
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHL 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 234 bits (597), Expect = 2e-74
Identities = 88/263 (33%), Positives = 154/263 (58%), Gaps = 11/263 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ RTLG GSF +V ++ G + A+K++ ++ V+R K VE E + ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I++ +I++++++I+GGELF + K R A+ Y ++ A++Y HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD G +KI+DFG + V +T CGTP+Y+APEV++ K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN- 179
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 254
++ D WS G++++ ++AG+ PF +SN M Y KI A+ P +F+ K L+ R++ +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 255 PDTRM-----TISQMLEDEWFKK 272
R+ + WFK+
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-74
Identities = 98/287 (34%), Positives = 148/287 (51%), Gaps = 24/287 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK---MVEQIKREISTMKLI 70
Y+ G LG G FA VK + TG A K + + + + E I+RE+S +K I
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPNVI + EV +KT + ++LE + GGELFD +A+ L E+EA + +Q++N V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 131 SRGVFHRDLKPENLLLDSYGV----LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
S + H DLKPEN++L V +KI DFGL + ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS----CPSWFSSG 242
+N + +D+WS GVI ++L++G PF + ++ S S+
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 243 AKKLIKRILDPNPDTRMTISQMLEDEWFK---------KGYKPPHFD 280
AK I+R+L +P RMTI L+ W K + P F+
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 8e-73
Identities = 94/312 (30%), Positives = 154/312 (49%), Gaps = 31/312 (9%)
Query: 9 RTRVGKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+ Y+ + LG G KV N T + A+K++ + + +RE+
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELH 58
Query: 68 -KLIKHPNVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQ 120
+ + P++++I++V A + + IV+E +DGGELF +I G E EA +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQVREDGLLHTACG 177
+ A+ Y HS + HRD+KPENLL S +LK++DFG +++ L T C
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLTTPCY 175
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI------CRA 231
TP YVAPEVL + YD ++ D+WS GVI+++L+ G+ PF ++ +A+ + +
Sbjct: 176 TPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
Query: 232 DFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDD 289
+F P W S K LI+ +L P RMTI++ + W + K P L +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294
Query: 290 VDAIFNDSKENL 301
+ D KE +
Sbjct: 295 DKERWEDVKEEM 306
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 227 bits (580), Expect = 1e-72
Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 10/268 (3%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YELG LG G ++V A+++ VA+K++ D + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 73 PNVIKIIEVMASKTK----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
P ++ + + ++T YIV+E++DG L D + G + A A+++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL 187
H G+ HRD+KP N+++ + +K+ DFG++ I+ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGA 243
D R SDV+S G +L+ ++ G PF + +++ + R D PS S+
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 244 KKLIKRILDPNPDTRMTISQMLEDEWFK 271
++ + L NP+ R + + + +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 2e-72
Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 14/263 (5%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
G+ +G+ +G GSF V K VA+K+++ + ++ K E+ ++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRH 63
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHS 131
N++ + + ++ IV ++ +G L+ + + + + +Q +DY H+
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN--D 189
+ + HRDLK N+ L +KI DFGL+ + + G+ ++APEV+ D
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------SCPSWFSSGA 243
K SDV++ G++L+ LM G LP+ N + + S
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 244 KKLIKRILDPNPDTRMTISQMLE 266
K+L+ L D R Q+L
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 4e-72
Identities = 91/330 (27%), Positives = 161/330 (48%), Gaps = 32/330 (9%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ + ++ + LG+G+F KV + TG + A+KI+ ++ ++ V E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+HP + + + ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
HSR V +RD+K ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIK 248
D Y RA D W GV+++ +M G LPF + L+ I + P S AK L+
Sbjct: 179 DNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 249 RILDPNPDTRM-----TISQMLEDEWFK---------KGYKPP------------HFDKE 282
+L +P R+ +++E +F K PP +FD E
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDE 297
Query: 283 ---EEVNLDDVDAIFNDSKENLVTEKKEKP 309
+ + + D + L ++++
Sbjct: 298 FTAQSITITPPDRYDSLGLLELDQREEQEM 327
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 229 bits (585), Expect = 4e-72
Identities = 82/341 (24%), Positives = 153/341 (44%), Gaps = 28/341 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--- 71
+ + R +G G F +V + +TG A+K +D+ ++ + E + L+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
P ++ + + K+ +L+ ++GG+L +++HG E + R Y ++I +++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R V +RDLKP N+LLD +G ++ISD GL+ H + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADFSCPSWFSSGAKKLIK 248
++D +S G +LF L+ G PF + + R P FS + L++
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 249 RILDPNPDTRMT-----ISQMLEDEWFK---------KGYKPPHFDKEEEVNLDDVDAIF 294
+L + + R+ ++ E +F+ + Y PP EVN D I
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 301
Query: 295 N----DSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFE 331
+ D+K + + ++ + R + E +F+
Sbjct: 302 SFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFD 342
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (568), Expect = 8e-70
Identities = 95/317 (29%), Positives = 164/317 (51%), Gaps = 35/317 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+++ +TLG GSF +V K+ E+G+ A+KI+D+ +V++ K +E E ++ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++K+ + +Y+V+E++ GGE+F + + GR E AR Y Q++ +Y HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLKPENLL+D G ++++DFG + R G T CGTP +APE++ KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 253
+A D W+ GV+++ + AG+ PF + +Y KI PS FSS K L++ +L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 254 NPDTRM-----TISQMLEDEWFK---------KGYKPP------------HFDKEEEVNL 287
+ R ++ + +WF + + P +FD EE
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEE--- 332
Query: 288 DDVDAIFNDSKENLVTE 304
+++ N+ TE
Sbjct: 333 EEIRVSINEKCGKEFTE 349
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-67
Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 18/258 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ +L +T+G+G F V G+ VA+K + D + E S M ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 74 NVIKIIEVMA-SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCH 130
N+++++ V+ K +YIV E++ G L D + GR L D ++ + A++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
HRDL N+L+ V K+SDFGL+ + + T + APE L +K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 175
Query: 191 GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIK 248
+ SDVWS G++L+ + + G +P+ L + ++ + P +++K
Sbjct: 176 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 249 RILDPNPDTRMTISQMLE 266
+ R + Q+ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-66
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 44/316 (13%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
V+ P V KYE +G+G+F +V A++ +TG VA+K V + + R
Sbjct: 1 VECPFCD-EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALR 58
Query: 63 EISTMKLIKHPNVIKIIEVMASKT--------KIYIVLEFIDGGELFDKIAKHGRLKEDE 114
EI ++L+KH NV+ +IE+ +K IY+V +F + + E
Sbjct: 59 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 118
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--GLL 172
+R Q L+N + Y H + HRD+K N+L+ GVLK++DFGL+ +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 232
T Y PE+L + G D+W G I+ + + I +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 233 FSCPS--------------------------------WFSSGAKKLIKRILDPNPDTRMT 260
S A LI ++L +P R+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 261 ISQMLEDEWFKKGYKP 276
L ++F P
Sbjct: 299 SDDALNHDFFWSDPMP 314
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 1e-65
Identities = 79/325 (24%), Positives = 131/325 (40%), Gaps = 40/325 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y +GEG++ V A + VAIK + + ++ REI + +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 73 PNVIKIIEVMASKT----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N+I I +++ + T K ++ + G +L+ + K L D + Q++ + Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL 187
HS V HRDLKP NLLL++ LKI DFGL+ G L T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI------------------- 228
+ ++ D+WS G IL +++ F + + I
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 229 -CRADFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
S P S A L+ ++L NP R+ + Q L + ++ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 277 PHFDKEEEVNLDDVDAIFNDSKENL 301
E D++ + + KE L
Sbjct: 305 SDEPIAEAPFKFDME-LDDLPKEKL 328
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-65
Identities = 74/291 (25%), Positives = 114/291 (39%), Gaps = 32/291 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK--MVEQIKREISTMKLIKHP 73
E LGEG FA V A++ T VAIK + K + REI ++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+I +++ K+ I +V +F++ L + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRDLKP NLLLD GVLK++DFGL+ + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----------------- 236
G D+W+ G IL L+ + + +I +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 237 -----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
S LI+ + NP R+T +Q L+ ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-65
Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 34/296 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ +GEG++ V A+N TG+ VA+K + D + REIS +K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 74 NVIKIIEVMASKTKIYIVLEFID-GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
N++K+++V+ ++ K+Y+V EF+ + F + + + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
V HRDLKP+NLL+++ G +K++DFGL+ T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------------DFS 234
A D+WS G I ++ F + + +I R S
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 235 CPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP-PH 278
P W + L+ ++L +P+ R++ L +F+ KP PH
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-64
Identities = 66/260 (25%), Positives = 111/260 (42%), Gaps = 10/260 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
L LG+GSF V+ + VA+K + D + + + ++ RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
H N+I++ V+ + + +V E G L D++ KH G RY Q+ + Y
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPNYVAPEVLND 189
S+ HRDL NLLL + ++KI DFGL Q + ++ + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 190 KGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSWFSSGAKKL 246
+ + ASD W GV L+ + G P+ N + KI + P +
Sbjct: 189 RTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 247 IKRILDPNPDTRMTISQMLE 266
+ + P+ R T + +
Sbjct: 248 MVQCWAHKPEDRPTFVALRD 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 6e-64
Identities = 60/260 (23%), Positives = 101/260 (38%), Gaps = 13/260 (5%)
Query: 21 LGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+F V+ VAIK++ + E++ RE M + +P ++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
I V + +V+E GG L + K + Q+ + Y + HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 138 DLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
DL N+LL + KISDFGLS A+ + APE +N + + R
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 197 SDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPN 254
SDVWS GV ++ ++ G P+ + + I + CP L+
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 255 PDTRMTIS---QMLEDEWFK 271
+ R Q + ++
Sbjct: 253 WEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-64
Identities = 55/261 (21%), Positives = 111/261 (42%), Gaps = 11/261 (4%)
Query: 19 RTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
+ LG G+F VK + + VA+KI+ + + +++ E + M+ + +P ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 71
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
++I + ++ +V+E + G L + ++ +K+ Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 137 RDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 195
RDL N+LL + KISDFGLS A+ + APE +N + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 196 ASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDP 253
SDVWS GV+++ + G P+ + + + + CP+ L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 254 NPDTRMTISQ---MLEDEWFK 271
+ + R + L + ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-63
Identities = 84/331 (25%), Positives = 145/331 (43%), Gaps = 49/331 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + +G G++ V A + TG VAIK + R ++ RE+ +K ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHE 77
Query: 74 NVIKIIEVMASK------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
NVI +++V T Y+V+ F+ G K+ KH +L ED + Q++ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y H+ G+ HRDLKP NL ++ LKI DFGL+ + D + T Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF-------- 239
+ + D+WS G I+ ++ G F S+ + ++I + + P+ F
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 240 -----------------------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276
S A L++++L + + R+T + L +F+ +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 277 ---PHFDKEEEVNLDDVDAIFNDSKENLVTE 304
P K ++ + DDVD ++ K E
Sbjct: 311 EDEPQVQKYDD-SFDDVDRTLDEWKRVTYKE 340
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-63
Identities = 78/342 (22%), Positives = 133/342 (38%), Gaps = 53/342 (15%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R + Y + +G GSF V AK ++G+ VAIK V +D+ RE+ M
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIM 67
Query: 68 KLIKHPNVIKIIEVMAS------KTKIYIVLEFIDGG---ELFDKIAKHGRLKEDEARRY 118
+ + H N++++ S + + +VL+++ L + Y
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACG 177
QL ++ Y HS G+ HRD+KP+NLLLD VLK+ DFG ++Q+ +
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS---AKQLVRGEPNVSYIC 184
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 237
+ Y APE++ + DVWS G +L L+ G F + + +I + +
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 238 W-----------------------------FSSGAKKLIKRILDPNPDTRMTISQMLEDE 268
A L R+L+ P R+T +
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 269 WFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPV 310
+F + P + N D A+FN + + L + +
Sbjct: 305 FFDELRDPNV----KLPNGRDTPALFNFTTQELSSNPPLATI 342
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-62
Identities = 58/256 (22%), Positives = 107/256 (41%), Gaps = 10/256 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ LG G F VK+ K VAIK++ + ++ E M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRG 133
++++ V + I+I+ E++ G L + + R + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
HRDL N L++ GV+K+SDFGLS E + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 194 GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRIL 251
+ SD+W+ GV+++ + + G +P++ I + P S ++
Sbjct: 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 252 DPNPDTRMTISQMLED 267
D R T +L +
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-62
Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 35/285 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTM- 67
E G+ LG G+F KV A VA+K++ E + E+ M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-------------------- 107
+L H N++ ++ IY++ E+ G+L + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 108 ---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
L ++ + Q+ +++ + HRDL N+L+ V+KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223
+ A ++APE L + Y SDVWS G++L+ + + G P+ + A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 224 LYRKICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ K+ + F P + + +++ + R + +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 201 bits (511), Expect = 3e-62
Identities = 79/288 (27%), Positives = 126/288 (43%), Gaps = 33/288 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +GEG++ V A+N G+ A+K + ++ + REIS +K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ +V+ +K ++ +V E +D G L+ A+ + QL+N + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRDLKP+NLL++ G LKI+DFGL+ T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS---------------- 237
D+WS G I ++ G F + +I R + S
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 238 -------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272
L+ ++L +P+ R+T Q LE +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-61
Identities = 79/294 (26%), Positives = 131/294 (44%), Gaps = 34/294 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYE +GEG++ V AKN ET + VA+K V D + REI +K +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ +V+ S K+ +V EF D + +G L + + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRDLKP+NLL++ G LK+++FGL+ T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 194 GRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICRADFSCPS--------------- 237
+ D+WS G I L P F +++ ++I R +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 238 --------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 277
++ + L++ +L NP R++ + L+ +F + PP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD-FCPP 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-61
Identities = 75/278 (26%), Positives = 147/278 (52%), Gaps = 16/278 (5%)
Query: 11 RVG--KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRH-KMVEQIKREI 64
+VG +EL + LG G++ KV + + +TG A+K++ + +++ K E + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 65 STMKLIKH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
++ I+ P ++ + ++TK++++L++I+GGELF +++ R E E + Y +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
A+++ H G+ +RD+K EN+LLDS G + ++DFGLS +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWF 239
V +A D WS GV+++ L+ G PF ++++ + R+I +++ P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 240 SSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 272
S+ AK LI+R+L +P R+ ++ E +F+K
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 8e-61
Identities = 58/263 (22%), Positives = 114/263 (43%), Gaps = 14/263 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L LG G F +V VA+K + + + + E + MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHS 131
++++ V+ ++ IYI+ E+++ G L D + +L ++ Q+ + +
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R HRDL+ N+L+ KI+DFGL+ + + E A + APE +N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 192 YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKR 249
+ + SDVWS G++L ++ G +P+ + + + R P +L++
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 250 ILDPNPDTRMTISQMLE--DEWF 270
P+ R T + +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 1e-60
Identities = 63/261 (24%), Positives = 106/261 (40%), Gaps = 12/261 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
++ + +G G F +V G FVAIK + K E S M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCH 130
HPNVI + V+ T + I+ EF++ G L G+ + + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA---CGTPNYVAPEVL 187
HRDL N+L++S V K+SDFGLS + D +A + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 188 NDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245
+ + SDVWS G++++ +M+ G P+ + + I + P S +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 246 LIKRILDPNPDTRMTISQMLE 266
L+ + + R Q++
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-60
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 25/299 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHP 73
+ +GEG+F +V A+ + G + I + E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARR 117
N+I ++ + +Y+ +E+ G L D + K L +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
+ + +DY + HRDL N+L+ V KI+DFGL S+
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRL 188
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRA-DFSC 235
++A E LN Y SDVWS GV+L+ ++ G P+ LY K+ +
Sbjct: 189 PVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 236 PSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKKGYKPPHFDKEEEVNLDDVDA 292
P L+++ P R + +Q+L + ++ + E+ +D
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDC 306
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 3e-60
Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 12/278 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ LG G + +V + VA+K + D VE+ +E + MK IKHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHS 131
N+++++ V + YI+ EF+ G L D + + R + Q+ +A++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ HRDL N L+ ++K++DFGLS + A + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICR-ADFSCPSWFSSGAKKLIKR 249
+ SDVW+ GV+L+ + G P+ +L +Y + + P +L++
Sbjct: 193 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 250 ILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNL 287
NP R + +++ + F+ ++ E E L
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVEKEL 287
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-60
Identities = 57/255 (22%), Positives = 100/255 (39%), Gaps = 10/255 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ +G G F V D VAIK + + E E M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++++ V + I +V EF++ G L D + G + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRDL N L+ V+K+SDFG++ + + +PEV + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 194 GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRIL 251
SDVWS GV+++ + + G +P++ + + I P S+ +++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 252 DPNPDTRMTISQMLE 266
P+ R S++L
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-60
Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 15/271 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
L LG+G F +V T VAIK + + E +E MK ++H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHS 131
++++ V+ S+ IYIV E++ G L D + L+ + Q+ + + Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
HRDL+ N+L+ V K++DFGL+ + + E A + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKR 249
+ SDVWS G++L + G +P+ + ++ R CP L+ +
Sbjct: 191 FTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 250 ILDPNPDTRMTISQMLE--DEWFKKGYKPPH 278
P+ R T + +++F +P +
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYF-TSTEPQY 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 6e-60
Identities = 67/260 (25%), Positives = 112/260 (43%), Gaps = 11/260 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ ELGR +GEG F V + + VAIK + E+ +E TM+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYC 129
HP+++K+I V+ ++ ++I++E GEL + L Y QL A+ Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
S+ HRD+ N+L+ S +K+ DFGLS + ++APE +N
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 183
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLI 247
+ + ASDVW GV ++ +LM G PF + +I + P L+
Sbjct: 184 RRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 248 KRILDPNPDTRMTISQMLED 267
+ +P R +++
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 7e-60
Identities = 63/294 (21%), Positives = 107/294 (36%), Gaps = 28/294 (9%)
Query: 11 RVG-KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
RVG +Y LGR +G GSF + ++ G+ VAIK+ Q+ E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKM 58
Query: 70 IKHPNVIKIIE-VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
++ I I A +V+E + + Q+I+ ++Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 129 CHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI-----SQQVREDGLLHTACGTPN 180
HS+ HRD+KP+N L+ ++ I DFGL+ + Q GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD---ESNLMALYRKICRADFSCP- 236
Y + R D+ S G +L G LP+ + Y +I S P
Sbjct: 179 YASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 237 ----SWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKKGYKPPH-FDKE 282
+ S + D + + Q+ + + ++G+ + FD
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-59
Identities = 72/312 (23%), Positives = 130/312 (41%), Gaps = 47/312 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y+ +G G++ V A + +TG VA+K + R ++ RE+ +K +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 77
Query: 74 NVIKIIEVMASKTKI----YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
NVI +++V + + L G + I K +L +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
HS + HRDLKP NL ++ LKI DFGL+ + T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF---------- 239
+ + D+WS G I+ L+ G F ++ + + I R + +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 240 ---------------------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP-- 276
+ A L++++L + D R+T +Q L +F + + P
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 277 ----PHFDKEEE 284
+D+ E
Sbjct: 313 EPVADPYDQSFE 324
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 5e-59
Identities = 60/284 (21%), Positives = 106/284 (37%), Gaps = 34/284 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
E R +GEG+F +V A+ E VA+K++ + M +RE + M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMA 71
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR------------------- 109
+PN++K++ V A + ++ E++ G+L + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 110 -----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
L E +Q+ + Y R HRDL N L+ V+KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNLMA 223
++ PE + Y SDVW+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 224 LYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ + + +CP L++ P R + +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-58
Identities = 51/257 (19%), Positives = 106/257 (41%), Gaps = 5/257 (1%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDR--DQVLRHKMVEQIKREISTMKLIKH 72
++ + LG G+F V + G+ V I + + + K ++I E M + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
P+V +++ + + T I G L + + Q+ ++Y R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRDL N+L+ + +KI+DFGL+ + ++ ++A E + + Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 193 DGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRI 250
SDVWS GV ++ LM G P+D + + + + P + ++ +
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 251 LDPNPDTRMTISQMLED 267
+ D+R +++ +
Sbjct: 250 WMIDADSRPKFRELIIE 266
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 42/297 (14%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGD-FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+YE +GEG++ KV A++++ G FVA+K V R Q M RE++ ++ +
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHL 64
Query: 71 K---HPNVIKIIEVMAS-----KTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEARRYFQQ 121
+ HPNV+++ +V +TK+ +V E +D + + + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
L+ +D+ HS V HRDLKP+N+L+ S G +K++DFGL+ I + T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 181
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS------- 234
APEVL Y D+WS G I + F S+ + KI
Sbjct: 182 RAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 235 --------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
+ K L+ + L NP R++ L +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-57
Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 29/280 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGD-------FVAIKIVDRDQVLRHKMVEQIKREIST 66
+ LG+ LGEG+F +V A+ + VA+K++ D K + + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 67 MK-LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------R 109
MK + KH N+I ++ +Y+++E+ G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
L + Q+ ++Y S+ HRDL N+L+ V+KI+DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 228
++APE L D+ Y + SDVWS GV+L+ + G P+ + L++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 229 CRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267
PS ++ +++ P R T Q++ED
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 8e-57
Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM- 67
+ G+TLG G+F KV A + VA+K++ L + E + E+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG------------------R 109
L H N++ ++ ++ E+ G+L + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
L ++ + Q+ + + S+ HRDL N+LL + KI DFGL+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 228
+ A ++APE + + SDVWS G+ L+ L + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 229 CRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ F P + ++K D +P R T Q+++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (469), Expect = 6e-56
Identities = 49/291 (16%), Positives = 94/291 (32%), Gaps = 29/291 (9%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
Y++GR +GEGSF + N+ VAIK R Q++ E T KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 73 -PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ + +V++ + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 132 RGVFHRDLKPENLLLDSY-----GVLKISDFGLSAI-----SQQVREDGLLHTACGTPNY 181
+ + +RD+KP+N L+ ++ + DFG+ ++Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAG---FLPFDESNLMALYRKICRADFSCPSW 238
++ + R D+ + G + + G + + Y +I S P
Sbjct: 180 MSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 239 -----FSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKKGYKPPH-FD 280
F K + + D + + + FD
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 185 bits (469), Expect = 2e-55
Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 54/300 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKH 72
Y+L R LG G +++V A N+ + V +KI L+ ++IKREI ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 89
Query: 73 PNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
PN+I + +++ +V E ++ + L + + R Y +++ A+DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 131 SRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
S G+ HRD+KP N+++D L++ D+GL+ + + + PE+L D
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSC---------- 235
+ D+WS G +L ++ PF D + + K+ +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 236 ------------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271
S A + ++L + +R+T + +E +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-55
Identities = 57/260 (21%), Positives = 104/260 (40%), Gaps = 11/260 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ +G G F +V + VAIK + K E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF 66
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYC 129
H N+I++ V++ + I+ E+++ G L K G + + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLN 188
+ HRDL N+L++S V K+SDFGLS + + E + + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 189 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 246
+ + ASDVWS G++++ +M G P+ E + + + I P S +L
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 247 IKRILDPNPDTRMTISQMLE 266
+ + R + ++
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-54
Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 22/290 (7%)
Query: 14 KYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
K + R LG+GSF V K E VAIK V+ +R + + E S MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----------LKEDEARRY 118
+V++++ V++ +++E + G+L + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
++ + + Y ++ HRDL N ++ +KI DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKICRAD-FSCP 236
+++PE L D + SDVWS GV+L+ + P+ + + R + P
Sbjct: 199 VRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 237 SWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKKGYKPPHFDKEEE 284
+L++ NP R + +++ E + G++ F EE
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-53
Identities = 60/286 (20%), Positives = 115/286 (40%), Gaps = 15/286 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+G G F V ++ A+K ++R V Q E MK
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDF 85
Query: 71 KHPNVIKIIEV-MASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDY 128
HPNV+ ++ + + S+ +VL ++ G+L + + + + Q+ + +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEV 186
S+ HRDL N +LD +K++DFGL+ D + + A ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 187 LNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAK 244
L + + SDVWS GV+L+ LM G P+ + N + + + P +
Sbjct: 206 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 245 KLIKRILDPNPDTRMTISQMLED-EWFKKGYKPPHFDKEEE--VNL 287
+++ + P + R + S+++ + H+ VN+
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 310
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-52
Identities = 77/356 (21%), Positives = 139/356 (39%), Gaps = 61/356 (17%)
Query: 2 SVKVPASRTRV-GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
SV+V S V +Y+ + +G G+ V A + VAIK + R ++
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRA 63
Query: 61 KREISTMKLIKHPNVIKIIEVMASK------TKIYIVLEFIDGGELFDKIAKHGRLKEDE 114
RE+ MK + H N+I ++ V + +Y+V+E +D L +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHER 120
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174
Q++ + + HS G+ HRDLKP N+++ S LKI DFGL+ + ++
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 177
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS 234
T Y APEV+ GY D+WS G I+ ++ + F + + + K+ +
Sbjct: 178 YVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 235 CPSWF------------------------------------------SSGAKKLIKRILD 252
F +S A+ L+ ++L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 253 PNPDTRMTISQMLEDEWFKKGYKPPHFD----KEEEVNLDDVDAIFNDSKENLVTE 304
+P R+++ L+ + Y P + + + LD+ + + KE + E
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-51
Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ +LG+ LG G+F +V A T VA+K++ H + E+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 71
Query: 69 LIKHPNVIKIIE--VMASKTKIYIVLEFIDGGELFDKIAKHGR----------------L 110
I H + + + +++EF G L + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170
+ Y Q+ +++ SR HRDL N+LL V+KI DFGL+ + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKIC 229
A ++APE + D+ Y SDVWS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 230 RAD--FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266
+ P + + + + P R T S+++E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 55/295 (18%), Positives = 121/295 (41%), Gaps = 48/295 (16%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L ++G+G F +V K G+ VA+KI R + + EI +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 73 PNVIKIIEVM----ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N++ I + T++++V ++ + G LFD + ++ + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAH 115
Query: 129 CHS--------RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGT 178
H + HRDLK +N+L+ G I+D GL+ + D + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 179 PNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFD---------------E 218
Y+APEVL+D + +D+++ G++ + + +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 219 SNLMALYRKIC--RADFSCPSWFSS-----GAKKLIKRILDPNPDTRMTISQMLE 266
++ + + +C + + P+ + S K+++ N R+T ++ +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 4e-42
Identities = 61/355 (17%), Positives = 116/355 (32%), Gaps = 74/355 (20%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y L R LG G F+ V AK++ VA+KIV D+V E + EI ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 68
Query: 73 PNVIKIIEV---------------MASKTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEAR 116
+ K + + + +V E + L K +H + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 117 RYFQQLINAVDYC-HSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHT 174
+ +QL+ +DY G+ H D+KPEN+L++ + ++ + D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY--------- 225
+ T Y +PEVL + +D+WS ++F L+ G F+ +
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 226 ---------------------------------------RKICRADFSCPSWFSSGAKKL 246
+ + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 247 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF---DKEEEVNLDDVDAIFNDSK 298
+ +L +P R ++ W K D+E + D+ F + +
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 7e-22
Identities = 34/213 (15%), Positives = 67/213 (31%), Gaps = 42/213 (19%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---------------DRDQVLRHKMVEQ 59
+G+ +GEG + V + E +K D +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 60 IKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF 119
+ E ++ ++ V K+ +++E ID + R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
++ V + RG+ H DL N+L+ G+ I DF S + +L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDV--- 165
Query: 180 NYVAPEVLND---KGYDGRASDVWSCGVILFVL 209
+ + Y D+ S I +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.3 bits (214), Expect = 2e-21
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 344 TSQRPPNEIMSKIEEAAKPLGFNVR-KGNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLH 401
TS P+++M +I + + + + + + + EV ++ +L+
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 402 IVEVRKTGGDTLEFHKFYKKFSSGLK 427
V ++ G ++ F K ++ LK
Sbjct: 76 GVRFKRISGTSIAFKNIASKIANELK 101
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 442 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.67 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.0 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.66 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-66 Score=485.63 Aligned_cols=258 Identities=33% Similarity=0.694 Sum_probs=240.3
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++++.||+|+||+||+|+++.+++.||+|++.+....+....+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 35789999999999999999999999999999999998766555455678899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999975432
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 249 (442)
......+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+..+.+..+.+..+..|..+|+++.+||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 234567899999999999988875 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHHHHhcCccccc
Q 013487 250 ILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
||+.||++|||++|+|+||||+.
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-65 Score=487.37 Aligned_cols=262 Identities=39% Similarity=0.662 Sum_probs=228.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 468999999999999999999999999999999999865432 234678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||||+||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999998765444444
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH-HHHHHHhhCCCCCC--CCCCHHHHHHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP--SWFSSGAKKLI 247 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li 247 (442)
...+.+||+.|+|||++.+..|++.++||||+||++|+|++|.+||...+.. ..+..+.......+ ..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5567899999999999998888778899999999999999999999775543 33333333332222 34799999999
Q ss_pred HHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 248 KRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
.+||+.||++|||++|+|+||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998644
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-65 Score=485.91 Aligned_cols=261 Identities=31% Similarity=0.608 Sum_probs=235.7
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
..++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999987765555556789999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+.........
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998765444444
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 250 (442)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+++.++....+.+|..+|+++++||++|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 55677899999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHH------HhcCccccc
Q 013487 251 LDPNPDTRMTISQ------MLEDEWFKK 272 (442)
Q Consensus 251 L~~dP~~R~s~~e------il~hp~~~~ 272 (442)
|+.||.+|||++| +++||||+.
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999988 577888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-63 Score=486.41 Aligned_cols=260 Identities=32% Similarity=0.620 Sum_probs=242.0
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 35789999999999999999999999999999999998876555555778899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
+|||||+||+|++++...+.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999975432 23
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 249 (442)
....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+++..+....+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 345678999999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCC-----HHHHhcCccccc
Q 013487 250 ILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 250 ~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
||++||.+|++ ++|+++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-63 Score=472.33 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=226.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
-.+|++.+.||+|+||+||+|+++.+|+.||+|++.+..... .+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 357999999999999999999999999999999997654332 46788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--ccc
Confidence 999999999998766 57999999999999999999999999999999999999999999999999999765332 233
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC---CCCCCCCCCHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIK 248 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 248 (442)
....+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+.......+... .+..|..+|+++++||.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 4567899999999999988775 8999999999999999999999988776665554433 34456679999999999
Q ss_pred HccCCCCCCCCCHHHHhcCccccc
Q 013487 249 RILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 249 ~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-62 Score=473.99 Aligned_cols=256 Identities=34% Similarity=0.719 Sum_probs=239.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+.+|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999987665444556789999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||||.||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999976432
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 250 (442)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+....|+.+|+++.++|.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 33567999999999999988886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCC-----CHHHHhcCccccc
Q 013487 251 LDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 251 L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
|..||.+|+ |++++++||||+.
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhhCHHhccccchhhHHHHHcCccccc
Confidence 999999996 8999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-62 Score=463.17 Aligned_cols=256 Identities=31% Similarity=0.561 Sum_probs=218.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe--CCEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKI 88 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 88 (442)
+.++|++.+.||+|+||+||+|+++.+|+.||+|++++.... ....+.+.+|+.+|++++||||+++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 468999999999999999999999999999999999876543 3446778999999999999999999999864 4568
Q ss_pred EEEEEccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEEccCCceEEeeccc
Q 013487 89 YIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~ql~~aL~~lH~~g-----ivHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998864 457999999999999999999999976 99999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC-CCCCC
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW 238 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 238 (442)
|+..... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..++...+..+.+ ..|..
T Consensus 161 a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeecccC--CCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 9875432 2234567899999999999888775 899999999999999999999999998888888887765 45677
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCccc
Q 013487 239 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 270 (442)
Q Consensus 239 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 270 (442)
+|+++.+||.+||+.||++|||++|+|+|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-62 Score=470.95 Aligned_cols=257 Identities=37% Similarity=0.707 Sum_probs=215.2
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.-++|++.+.||+|+||+||+|+++.+|+.||+|++.+..... ..+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3467999999999999999999999999999999998765332 24568899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---cCCceEEeeccchhhhhhcc
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~---~~~~~kl~DFGla~~~~~~~ 167 (442)
|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||+. ++|.+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-- 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-- 162 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence 999999999999999999999999999999999999999999999999999999995 578999999999986543
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 243 (442)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+.......+ +.+|+++
T Consensus 163 -~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 163 -GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred -CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 2345567899999999999988875 899999999999999999999999988888888887765443 4589999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||.+||+.||++|||++|+++||||+..
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-61 Score=475.62 Aligned_cols=259 Identities=33% Similarity=0.674 Sum_probs=240.6
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
....+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+...
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence 34557899999999999999999999999999999999987665554556788999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999976432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 247 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 247 (442)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+.++.......|..+|+++.+||
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred ---ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 23467899999999999988875 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 248 KRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
++||..||.+|+ |++++++||||+.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccC
Confidence 999999999995 9999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-62 Score=465.82 Aligned_cols=254 Identities=32% Similarity=0.517 Sum_probs=224.4
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
+.|++++.||+|+||+||+|+++.+|+.||+|++++... ...+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976532 23467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||+||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...... ..
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 99999999999765 4579999999999999999999999999999999999999999999999999987543321 12
Q ss_pred cccccCCCcccCccccc-----ccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC---CCCCCCCHHH
Q 013487 172 LHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFSSGA 243 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 243 (442)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|.+||.+.+..+.+.++..... ..|..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34678999999999984 3334 5899999999999999999999999888877777776643 3455689999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+||.+||+.||++|||++|+|+||||+.
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-61 Score=466.94 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=228.9
Q ss_pred CeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEE
Q 013487 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (442)
Q Consensus 14 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 93 (442)
.|++.+.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987665555667789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCccc
Q 013487 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (442)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 173 (442)
||.||+|..++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999975432 24
Q ss_pred cccCCCcccCccccccc--CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC--CCCCCCHHHHHHHHH
Q 013487 174 TACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPSWFSSGAKKLIKR 249 (442)
Q Consensus 174 ~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~ 249 (442)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.....+ .+..+|+++.+||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 57899999999998643 22358999999999999999999999988888777777666543 234589999999999
Q ss_pred ccCCCCCCCCCHHHHhcCcccccCC
Q 013487 250 ILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
||+.||.+|||++|+|+||||....
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-61 Score=453.79 Aligned_cols=252 Identities=25% Similarity=0.490 Sum_probs=219.7
Q ss_pred cCe-EEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe----CCE
Q 013487 13 GKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTK 87 (442)
Q Consensus 13 ~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 87 (442)
++| ++.+.||+|+||+||+|++..++..||+|++...... ....+.+.+|+++|++++||||+++++++.+ ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 455 7888999999999999999999999999999766533 3346789999999999999999999999865 456
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEc-cCCceEEeeccchhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSAISQ 164 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~g--ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~ 164 (442)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 8999999999999999999999999999999999999999999999 99999999999997 57899999999997543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCC-cHHHHHHHHhhCCC--CCCCCCCH
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRADF--SCPSWFSS 241 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~s~ 241 (442)
. ....+.+||+.|+|||++.+ +| +.++||||+||++|+|++|..||.+. +...++..+..+.. ..+..+++
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred C----CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 2 33456789999999999875 45 58999999999999999999999764 45556666655432 23445799
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
++.+||.+||++||++|||++|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-61 Score=470.98 Aligned_cols=260 Identities=32% Similarity=0.594 Sum_probs=233.6
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
..++++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4577899999999999999999999999999999999976542 2356788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--cCCceEEeeccchhhhhh
Q 013487 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~--~~~~~kl~DFGla~~~~~ 165 (442)
|+|||||+||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999999954 46799999999999999999999999999999999999996 468899999999976543
Q ss_pred cccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCCH
Q 013487 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 241 (442)
Q Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 241 (442)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+.......+ +.+|+
T Consensus 179 ---~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 179 ---KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ---TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ---ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2344568899999999999988875 899999999999999999999999999898888888766554 34899
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
++++||.+||..||++|||++|+|+||||+....
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999999999999999999999987544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-61 Score=470.95 Aligned_cols=260 Identities=30% Similarity=0.555 Sum_probs=233.9
Q ss_pred CcccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+...++|++++.||+|+||+||+|++..+|+.||||++++.... ..+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 345678899999999999999999999999999999999765422 24578899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc--cCCceEEeeccchhhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAISQ 164 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~--~~~~~kl~DFGla~~~~ 164 (442)
+|+|||||+||+|++.+...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999999999999876654 699999999999999999999999999999999999998 67899999999998654
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFS 240 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 240 (442)
. .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+..+....+..| +.+|
T Consensus 181 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 181 P---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp T---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred C---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 3 3445678899999999999988775 899999999999999999999999998888888888766554 4589
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
+++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-61 Score=460.30 Aligned_cols=258 Identities=37% Similarity=0.604 Sum_probs=232.3
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.-++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44679999999999999999999999999999999976543221 135778999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----ceEEeeccchhhh
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAIS 163 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~----~~kl~DFGla~~~ 163 (442)
+|+|||||+||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.+| .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999999989999999999999999999999999999999999999998776 5999999998765
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCC----CCC
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWF 239 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 239 (442)
.. .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+.......+ +.+
T Consensus 168 ~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 168 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp TT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred CC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 43 233456789999999999988766 5899999999999999999999999998888888888766554 468
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 240 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
|+++++||++||+.||++|||++|+|+||||+.
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-61 Score=467.08 Aligned_cols=258 Identities=31% Similarity=0.586 Sum_probs=235.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHh-hCCCCCcceEEEEEEeCCEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 90 (442)
+++|++++.||+|+||+||+|.++.+|+.||||++++.........+.+.+|+.++. .++||||+++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765544444566667777665 6899999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ..
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--cc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999754332 23
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRI 250 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 250 (442)
.....+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+++..+....+.+|..+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 34557899999999999988886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHH-HHhcCccccc
Q 013487 251 LDPNPDTRMTIS-QMLEDEWFKK 272 (442)
Q Consensus 251 L~~dP~~R~s~~-eil~hp~~~~ 272 (442)
|+.||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=470.91 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=218.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.-++|++.+.||+|+||+||+|++..+|+.||+|++++.. .....+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3568999999999999999999999999999999997653 23345778999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 99999999999999999999999999999999999999997 59999999999999999999999999999865432
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHH------------------------
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY------------------------ 225 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~------------------------ 225 (442)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23467899999999999998875 8999999999999999999999765432110
Q ss_pred ------------------HHHhhCC-CCCC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 226 ------------------RKICRAD-FSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 226 ------------------~~i~~~~-~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
..+.... ...| ..+|.++.+||.+||..||.+|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0011111 1111 125889999999999999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-60 Score=468.32 Aligned_cols=258 Identities=26% Similarity=0.468 Sum_probs=225.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHH---HHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---QIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~---~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
.+++|++.+.||+|+||+||+|++..+|+.||||++.+.......... ...+|+.+++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467999999999999999999999999999999999876543332222 33445777888899999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999975533
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH---HHHHHHHhhCCCCCCCCCCHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICRADFSCPSWFSSGAK 244 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~ 244 (442)
......+||+.|+|||++.+...++.++|||||||+||+|++|..||.+.+. ......+.......|..+|+++.
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 2345678999999999997655456899999999999999999999976543 34444555566777888999999
Q ss_pred HHHHHccCCCCCCCCC-----HHHHhcCccccc
Q 013487 245 KLIKRILDPNPDTRMT-----ISQMLEDEWFKK 272 (442)
Q Consensus 245 ~li~~~L~~dP~~R~s-----~~eil~hp~~~~ 272 (442)
+||.+||+.||.+||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.4e-60 Score=449.00 Aligned_cols=258 Identities=31% Similarity=0.546 Sum_probs=230.3
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh------hHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEe
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL------RHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS 84 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 84 (442)
.++|++.+.||+|+||+||+|++..+|+.||||++++.... .....+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999765422 1234567889999999997 9999999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
++.+|+|||||+||+|.+++...++++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997654
Q ss_pred hcccCCccccccCCCcccCccccccc-----CCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC--
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 237 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 237 (442)
. .......+||+.|+|||++.+. ..++.++||||+||+||+|++|..||.+.+.......+..+....+.
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 2234567899999999998642 23367899999999999999999999999988888888877654433
Q ss_pred --CCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 238 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 238 --~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-60 Score=459.35 Aligned_cols=255 Identities=27% Similarity=0.490 Sum_probs=231.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (442)
.+++|++++.||+|+||+||+|+++.+|+.||+|++++.... ...+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 578999999999999999999999999999999999865422 3457899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC--CceEEeeccchhhhhhcc
Q 013487 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQVR 167 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~--~~~kl~DFGla~~~~~~~ 167 (442)
|||||+||+|+++|...+ .+++++++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 999999999999998765 79999999999999999999999999999999999999854 5899999999875432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC----CCCHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGA 243 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~ 243 (442)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+.+..+....+.++. .+|+++
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 2345567899999999999887775 8999999999999999999999999999999999888776653 589999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||.+||..||.+|||++|+|+||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-60 Score=449.25 Aligned_cols=253 Identities=31% Similarity=0.545 Sum_probs=224.1
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhH---HHHHHHHHHHHHHhhCC--CCCcceEEEEEEeC
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIK--HPNVIKIIEVMASK 85 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 85 (442)
.-++|++++.||+|+||+||+|++..+|+.||||++.+...... .....+.+|+.+|++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 35789999999999999999999999999999999986543221 11234668999999996 89999999999999
Q ss_pred CEEEEEEEccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-CCceEEeeccchhhh
Q 013487 86 TKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAIS 163 (442)
Q Consensus 86 ~~~~lv~E~~~g-g~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-~~~~kl~DFGla~~~ 163 (442)
+..|+||||+.+ +++.+++...+.++++.++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 688999999899999999999999999999999999999999999999985 579999999999754
Q ss_pred hhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCCCCCHHH
Q 013487 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 243 (442)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 243 (442)
.. ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+ .+......+++.+|+++
T Consensus 162 ~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 KD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp CS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred cc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 32 334567899999999999988887788999999999999999999998643 35667778888999999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 244 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
.+||.+||+.||++|||++|+|+||||++.
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-59 Score=448.79 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=216.7
Q ss_pred EEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhh--HHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEc
Q 013487 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (442)
Q Consensus 17 i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 94 (442)
.++.||+|+||+||+|+++.+|+.||||+++...... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 12245688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCcccc
Q 013487 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174 (442)
Q Consensus 95 ~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 174 (442)
+.|+++...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .....+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence 999888888777788999999999999999999999999999999999999999999999999999765432 233456
Q ss_pred ccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCC--------------------C
Q 013487 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--------------------S 234 (442)
Q Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------------------~ 234 (442)
.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+...++.+... .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 78999999999998766667999999999999999999999999887777666543100 0
Q ss_pred C--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 235 C--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 235 ~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
. .+.+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0 123578999999999999999999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=441.78 Aligned_cols=262 Identities=29% Similarity=0.470 Sum_probs=219.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4689999999999999999999999999999999976542 233456788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~-~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
|||+.++.+..... ...++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 99998754433333 345699999999999999999999999999999999999999999999999999976543 233
Q ss_pred ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------------
Q 013487 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------------ 232 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------ 232 (442)
.....+||+.|+|||++....+.+.++||||+||++|+|++|..||.+.+..+...++....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 45567899999999999888888899999999999999999999999887766555443210
Q ss_pred CCCC-----------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 233 FSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 233 ~~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
...+ +.+|+++.+||++||..||++|||++|+|+||||++-..|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0011 1357899999999999999999999999999999876554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=450.50 Aligned_cols=255 Identities=34% Similarity=0.627 Sum_probs=216.4
Q ss_pred cccccCeEEEe-eecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhh-CCCCCcceEEEEEEe--
Q 013487 9 RTRVGKYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL-IKHPNVIKIIEVMAS-- 84 (442)
Q Consensus 9 ~~~~~~y~i~~-~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~-- 84 (442)
...+++|++.. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++||||+++++++.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 34688999875 699999999999999999999999998643 346689998755 589999999999976
Q ss_pred --CCEEEEEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc---CCceEEeec
Q 013487 85 --KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (442)
Q Consensus 85 --~~~~~lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~---~~~~kl~DF 157 (442)
...+|+|||||+||+|+++|...+ ++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 467999999999999999998753 6999999999999999999999999999999999999985 567999999
Q ss_pred cchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHH----HHHHhhCCC
Q 013487 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL----YRKICRADF 233 (442)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~ 233 (442)
|+|+.... .......+||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+.... ...+....+
T Consensus 159 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 159 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp TTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred ceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 99976543 2344667899999999999988875 899999999999999999999977654333 333444455
Q ss_pred CCCC----CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 234 SCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 234 ~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
.+|. .+|+++.+||++||+.||++|||+.|+++||||++...
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 5543 37999999999999999999999999999999986554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-57 Score=434.54 Aligned_cols=257 Identities=31% Similarity=0.453 Sum_probs=220.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999995 889999999976543 223356788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
|||+.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999999888888887889999999999999999999999999999999999999999999999999999865432 122
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-------------------
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------------- 232 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------- 232 (442)
.....|++.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3445799999999999888877899999999999999999999999887776655543210
Q ss_pred ----------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 ----------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...++.+++++.+||++||+.||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112336889999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-57 Score=430.92 Aligned_cols=261 Identities=24% Similarity=0.448 Sum_probs=219.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC---
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (442)
..-++|++.+.||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+.+|+.++||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 45578999999999999999999999999999999998776666667788999999999999999999999997654
Q ss_pred -EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhh
Q 013487 87 -KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (442)
Q Consensus 87 -~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 165 (442)
.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999998865432
Q ss_pred cc-cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCC----CCCCC
Q 013487 166 VR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC----PSWFS 240 (442)
Q Consensus 166 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s 240 (442)
.. ........+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++....... ++.+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 21 22234567899999999999887775 89999999999999999999999988888777776655433 34589
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCcccc
Q 013487 241 SGAKKLIKRILDPNPDTRMTISQMLEDEWFK 271 (442)
Q Consensus 241 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 271 (442)
+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999544445577764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=434.57 Aligned_cols=264 Identities=27% Similarity=0.364 Sum_probs=217.7
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-----
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----- 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 84 (442)
..+++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 4589999999999999999999999999999999998765432 2235667899999999999999999998855
Q ss_pred ---CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 85 ---KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 85 ---~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
.+.+|++|||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999988777776777789999999999999999999999999999999999999999999999999997
Q ss_pred hhhhcc--cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCCCCC--
Q 013487 162 ISQQVR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 237 (442)
Q Consensus 162 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 237 (442)
...... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+.......+.......++
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 544321 2233455689999999999987755568999999999999999999999988776665554332111110
Q ss_pred ------------------------------CCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 238 ------------------------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 238 ------------------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
..++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 0267788999999999999999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-56 Score=428.36 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=223.4
Q ss_pred CCcccCCCc---ccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcce
Q 013487 1 MSVKVPASR---TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77 (442)
Q Consensus 1 ~~~~~~~~~---~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 77 (442)
|++..|... ...++|++.+.||+|+||+||+|+++.+++.||||+++.+.. ..+.+.+|+.+|++++|||||+
T Consensus 2 ~~p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp CCTTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEec
Confidence 677777654 245689999999999999999999999999999999976542 2456889999999999999999
Q ss_pred EEEEEEeCCEEEEEEEccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEe
Q 013487 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (442)
Q Consensus 78 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~ 155 (442)
+++++.+.+.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 999999999999999999999999999764 468999999999999999999999999999999999999999999999
Q ss_pred eccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCC-CCCCCcHHHHHHHHhhC-CC
Q 013487 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNLMALYRKICRA-DF 233 (442)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~~~~~~~~~i~~~-~~ 233 (442)
|||+|+...... ........||+.|+|||++.+..|+ .++||||+||++|+|++|.. ||.+.+....+..+..+ ..
T Consensus 158 DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~ 235 (287)
T d1opja_ 158 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235 (287)
T ss_dssp CCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccceeecCCCC-ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC
Confidence 999998654321 1122334589999999999988875 89999999999999999655 55666666666655544 45
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
+.|..+|+++.+||.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 677789999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=435.62 Aligned_cols=252 Identities=22% Similarity=0.369 Sum_probs=216.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC-----EEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCC
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD-----FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (442)
++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999876554 69999986543 223456788999999998 8999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG-----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~-----------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~N 143 (442)
.+|+|||||+||+|.++|.... .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997642 48999999999999999999999999999999999
Q ss_pred EEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHH
Q 013487 144 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM 222 (442)
Q Consensus 144 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~ 222 (442)
||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876554333344567789999999999887775 89999999999999998 89999886655
Q ss_pred HHHHHHhhC--CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 223 ALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 223 ~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
....++... .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555555444 456677899999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=425.66 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=206.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++++.||+|+||+||+|+.+ ..||||+++..... ....+.+.+|+.+|++++||||++++++.. .+.+|+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 468999999999999999999853 35999999765432 334678899999999999999999999864 4568999
Q ss_pred EEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCC
Q 013487 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 170 (442)
||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999999764 569999999999999999999999999999999999999999999999999998765444444
Q ss_pred ccccccCCCcccCcccccccC--CCCCcccHhHHHHHHHHHhcCCCCCCCCcHHH-HHHHHhhCCC-----CCCCCCCHH
Q 013487 171 LLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKICRADF-----SCPSWFSSG 242 (442)
Q Consensus 171 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~-----~~~~~~s~~ 242 (442)
...+.+||+.|+|||++.+.. .++.++||||+||+||||+||..||.+.+... ....+..+.. ..+..+|++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 556678999999999986532 23589999999999999999999998765443 3333333321 234568999
Q ss_pred HHHHHHHccCCCCCCCCCHHHHhcCc
Q 013487 243 AKKLIKRILDPNPDTRMTISQMLEDE 268 (442)
Q Consensus 243 ~~~li~~~L~~dP~~R~s~~eil~hp 268 (442)
+.+||.+||+.||++|||++||+++-
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=423.85 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=212.5
Q ss_pred eeecccCceEEEEEEEc--CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEEEccC
Q 013487 19 RTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (442)
Q Consensus 19 ~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 96 (442)
+.||+|+||+||+|.+. .+++.||||++.... .+....+.+.+|+.+|++++||||+++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999865 455789999997543 2334567899999999999999999999998654 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc-CCccccc
Q 013487 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-DGLLHTA 175 (442)
Q Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~ 175 (442)
+|+|.+++....++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999976543221 1122345
Q ss_pred cCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHccCC
Q 013487 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDP 253 (442)
Q Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~ 253 (442)
.||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+....+..+ ..+.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 799999999999887774 89999999999999998 89999998888888777765 4577888999999999999999
Q ss_pred CCCCCCCHHHH---hcCcccc
Q 013487 254 NPDTRMTISQM---LEDEWFK 271 (442)
Q Consensus 254 dP~~R~s~~ei---l~hp~~~ 271 (442)
||++|||+++| |+|+|+.
T Consensus 250 dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHhh
Confidence 99999999998 5666653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=429.33 Aligned_cols=258 Identities=29% Similarity=0.420 Sum_probs=213.5
Q ss_pred ccccCeEEEeeecccCceEEEEEEEcCC-CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC---CCCCcceEEEEEEe-
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNVET-GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMAS- 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~- 84 (442)
..-++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.| +||||+++++++..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 3457999999999999999999999765 5679999997643221 1223455788777766 79999999999853
Q ss_pred ----CCEEEEEEEccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 85 ----KTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 85 ----~~~~~lv~E~~~gg~L~~~i~-~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
...+|++|||+.+|.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 357899999999987754443 345699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC-------
Q 013487 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------- 232 (442)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------- 232 (442)
+...... ......+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+....+....
T Consensus 163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhccc---ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 8754332 234567899999999999988885 89999999999999999999999988777666553210
Q ss_pred --------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 --------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
...+..+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0122347899999999999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-55 Score=424.71 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=209.5
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCC---EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
..++|++.+.||+|+||+||+|+++.+++ .||+|.+.... .....+.+.+|+.+|++++|||||++++++...+.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 35789999999999999999999987665 58899886543 23446778999999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999988774 46999999999999999999999999999999999999999999999999999865543
Q ss_pred ccCCc---cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCH
Q 013487 167 REDGL---LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 241 (442)
Q Consensus 167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 241 (442)
..... .....||+.|+|||++.+..|+ .++|||||||++|||+| |.+||.+.+..++...+..+ ..+.|..+++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence 22111 1224579999999999887775 89999999999999998 89999998888887777665 4566777999
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 242 GAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 242 ~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
++.+||.+||+.||++|||+.||+++
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999998875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=419.83 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=223.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
+++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4789999999999999999999999999999999976543 334578899999999999999999999999999999999
Q ss_pred EEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
++++.|++|...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999765432 223
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCC-CCCcHHHHHHHHhhC-------------------
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRA------------------- 231 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~------------------- 231 (442)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+..+....+...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567899999999988877779999999999999999999886 455555555443221
Q ss_pred ----------CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 232 ----------DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 232 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
....+..+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 01122336889999999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=421.32 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=218.7
Q ss_pred cCeEEEee-ecccCceEEEEEEEcCC--CCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 13 GKYELGRT-LGEGSFAKVKFAKNVET--GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 13 ~~y~i~~~-LG~G~fg~V~~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
++|.+.+. ||+|+||+||+|.++.+ +..||||+++... .....+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 56888885 99999999999987643 4579999997543 33456788999999999999999999999875 4579
Q ss_pred EEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999999997654 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
.......+||+.|+|||++.+..|+ .++||||+||++|||+| |..||.+.+..+....+..+ ..+.|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1223346799999999999887775 89999999999999998 99999988877777777765 45778889999999
Q ss_pred HHHHccCCCCCCCCCHHHH---hcCcccc
Q 013487 246 LIKRILDPNPDTRMTISQM---LEDEWFK 271 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~ei---l~hp~~~ 271 (442)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999887 6788875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=431.90 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=213.4
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (442)
.-++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 4578999999999999999999999999999999997654 34455778999999999999999999999997655
Q ss_pred --EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 87 --~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+|+||||+ |++|...+. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 556766654 5789999999999999999999999999999999999999999999999999997543
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCC------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 232 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 232 (442)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+....
T Consensus 173 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 173 -----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp -----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred -----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 234567899999999999887777899999999999999999999998877655543332110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 233 -------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 233 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
......+++++.+||.+||..||++|||+.|+|+||||+.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 01223478999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=430.01 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=215.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----EE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----KI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 88 (442)
.+|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997653 3445678899999999999999999999997653 23
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+++++|+.||+|++++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556678999999976 4799999999999999999999999999999999999999999999999999976544322
Q ss_pred -CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC----------------
Q 013487 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------------- 231 (442)
Q Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------- 231 (442)
.......+||+.|+|||++.....++.++||||+||++|+|++|..||...+...........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 233466789999999999977666679999999999999999999999887655444332110
Q ss_pred --------C-C------CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCCC
Q 013487 232 --------D-F------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 276 (442)
Q Consensus 232 --------~-~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 276 (442)
. . ...+.+|+++.+||.+||+.||.+|||++|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 0 0123468899999999999999999999999999999865543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=416.25 Aligned_cols=248 Identities=23% Similarity=0.407 Sum_probs=208.6
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
.+|++.+.||+|+||+||+|.+. +++.||||+++..... .+.+.+|+.++++++||||+++++++...+.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 47999999999999999999985 6778999999765432 256889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+++|+|.+++... ..++++.+..++.|++.||+|||++||+||||||+|||+++++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999999998765 4689999999999999999999999999999999999999999999999999986543222 22
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 249 (442)
.....||+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+..+....+..+ ....|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3346799999999999988875 89999999999999999 67788888887777777665 345677789999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 013487 250 ILDPNPDTRMTISQMLED 267 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~h 267 (442)
||+.||++|||++||++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=418.23 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=217.2
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++.+.||+|+||+||+|.++ ++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 368999999999999999999984 6778999999765422 3568899999999999999999998754 567999
Q ss_pred EEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+++|+|.+++.... ++++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+...... .
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 99999999999775443 59999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
.......||+.|+|||++.+..|+ .++||||+||++|+|+|| .+||...+..+....+..+ ....|..+++++.+||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence 223346789999999999877775 899999999999999995 6667777777777777665 4566788999999999
Q ss_pred HHccCCCCCCCCCHHHHhc--Cccccc
Q 013487 248 KRILDPNPDTRMTISQMLE--DEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~--hp~~~~ 272 (442)
.+||+.||++|||++++++ |+||..
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999999999998 788864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=426.68 Aligned_cols=262 Identities=30% Similarity=0.578 Sum_probs=226.2
Q ss_pred ccccCeEEEeeecccCceEEEEEEEc---CCCCEEEEEEecchhhhh-HHHHHHHHHHHHHHhhCCC-CCcceEEEEEEe
Q 013487 10 TRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKH-PNVIKIIEVMAS 84 (442)
Q Consensus 10 ~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 84 (442)
..+++|++++.||+|+||+||+|.+. .+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45689999999999999999999974 478999999997654321 1234567899999999976 899999999999
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
...+|++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997653
Q ss_pred hcccCCccccccCCCcccCcccccccC-CCCCcccHhHHHHHHHHHhcCCCCCCCCcH----HHHHHHHhhCCCCCCCCC
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCPSWF 239 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~ 239 (442)
.. ......+.+|++.|+|||.+.+.. +++.++|||||||+||+|++|..||.+.+. ..+.........+.|..+
T Consensus 181 ~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 181 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 32 223345678999999999997654 446799999999999999999999976543 344455556677788889
Q ss_pred CHHHHHHHHHccCCCCCCCC-----CHHHHhcCccccc
Q 013487 240 SSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 272 (442)
Q Consensus 240 s~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~ 272 (442)
|+++.+||.+||++||++|| |++|+++||||+.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999999999999999999 5899999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=431.13 Aligned_cols=252 Identities=28% Similarity=0.387 Sum_probs=210.9
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------C
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------K 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~ 85 (442)
--+|+..+.||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 3479999999999999999999999999999999976532 23479999999999999999999854 3
Q ss_pred CEEEEEEEccCCCChH---HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchh
Q 013487 86 TKIYIVLEFIDGGELF---DKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSA 161 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~---~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~ 161 (442)
.++|+|||||++|.+. ........+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 3589999999876432 2334566799999999999999999999999999999999999999775 89999999987
Q ss_pred hhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhC----------
Q 013487 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 231 (442)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 231 (442)
.... .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||...+..+.+..+.+.
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 5433 233456789999999999887666679999999999999999999999888766655544320
Q ss_pred -------CCC------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccC
Q 013487 232 -------DFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 273 (442)
Q Consensus 232 -------~~~------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 273 (442)
... ..+.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 123468999999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-55 Score=409.96 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=220.7
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 92 (442)
++|++++.||+|+||+||+|++ .+++.||||++++.... .+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5799999999999999999998 47789999999865432 256889999999999999999999999999999999
Q ss_pred EccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccCCc
Q 013487 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (442)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 171 (442)
||+++|+|.+++.. ...+++..+.+++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999998655 4579999999999999999999999999999999999999999999999999997654322 222
Q ss_pred cccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 013487 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKR 249 (442)
Q Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 249 (442)
....+||+.|+|||++.+..|+ .++||||+||++|+|+| |..||.+.+..++..++..+ ....|..+++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3346799999999999988875 89999999999999998 89999999988888888775 456677789999999999
Q ss_pred ccCCCCCCCCCHHHHhcC
Q 013487 250 ILDPNPDTRMTISQMLED 267 (442)
Q Consensus 250 ~L~~dP~~R~s~~eil~h 267 (442)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=426.64 Aligned_cols=257 Identities=26% Similarity=0.368 Sum_probs=216.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeC-----C
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----T 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 86 (442)
-++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999986542 334466788999999999999999999998643 3
Q ss_pred EEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 34666777889999998865 5799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhhCCCC------------
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS------------ 234 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------------ 234 (442)
...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 2356789999999999888887789999999999999999999999988776665554332111
Q ss_pred -----------C--------CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCCC
Q 013487 235 -----------C--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 275 (442)
Q Consensus 235 -----------~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 275 (442)
. ...+++++++||.+||..||.+|||+.|+|+||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0 1236899999999999999999999999999999987543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=410.09 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=207.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCC---CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (442)
++|++++.||+|+||+||+|++..++ ..||+|.++... .....+.+.+|+.+|++++||||+++++++. .+.+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 58999999999999999999987544 468888886432 3445678999999999999999999999985 56789
Q ss_pred EEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhccc
Q 013487 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 168 (442)
+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~- 162 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 162 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc-
Confidence 999999999999987654 469999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 013487 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKL 246 (442)
Q Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 246 (442)
.......+||+.|+|||++.+..|. .++|||||||++|+|++ |.+||.+.+..+.+..+..+. .+.|+.+|+++.+|
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2223456789999999999887775 89999999999999998 899999988888888777664 57788899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 013487 247 IKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~h 267 (442)
|.+||+.||++|||+.||++|
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-54 Score=418.23 Aligned_cols=250 Identities=25% Similarity=0.461 Sum_probs=209.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEe--CCE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS--KTK 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 87 (442)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .+.+.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997543 356789999999995 9999999999974 456
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC-ceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~ 166 (442)
+|+|||||.+|+|.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999997763 5699999999999999999999999999999999999998655 6999999999765432
Q ss_pred ccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcH-HHHHHHHh-------------hCC
Q 013487 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKIC-------------RAD 232 (442)
Q Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~-------------~~~ 232 (442)
......+||+.|+|||++.+...++.++||||+||++|+|++|..||..... ......+. ...
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2345678999999999988776667999999999999999999999965432 11111110 000
Q ss_pred CC------------------------CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCccccc
Q 013487 233 FS------------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 272 (442)
Q Consensus 233 ~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 272 (442)
.. ....+++++.+||++||..||++|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 01126889999999999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=416.10 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=212.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCC----EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++||||+++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988876 57888775432 222356789999999999999999999999865 56
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+++|||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7888999999999987764 579999999999999999999999999999999999999999999999999998765443
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 245 (442)
.........||+.|+|||++.+..|+ .++|||||||++|+|+| |.+||.+.+..++...+..+. .+.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33334445789999999999888775 89999999999999998 899999888777777776654 5677889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCcc
Q 013487 246 LIKRILDPNPDTRMTISQMLEDEW 269 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~hp~ 269 (442)
||.+||..||.+|||+.||++|..
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999843
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=405.01 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=208.4
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCC----CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETG----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (442)
...|++.+.||+|+||+||+|.++.++ ..||||+++... .......+.+|+.+|++++|||||++++++.+.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 357999999999999999999987654 369999997543 23345678899999999999999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhc
Q 013487 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 166 (442)
.++||||+.+|+|.+.+... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999987765 57999999999999999999999999999999999999999999999999999865443
Q ss_pred ccCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHH
Q 013487 167 REDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA-DFSCPSWFSSGA 243 (442)
Q Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 243 (442)
.... .....+||+.|+|||++.+..|+ .++|||||||++|||++| .+||...+..+....+..+ ..+.|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 2211 22345789999999999887775 899999999999999995 5666667777777766654 456677799999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+||.+||+.||++|||+.||++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=421.85 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=205.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe------
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (442)
.+++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+|++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 56899999999999999999999999999999999986643 34456788999999999999999999999953
Q ss_pred CCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhh
Q 013487 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (442)
Q Consensus 85 ~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~ 164 (442)
.+.+|+|||||.|+ +.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 47899999999775 55554 3569999999999999999999999999999999999999999999999999987654
Q ss_pred hcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHHHhh--------------
Q 013487 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR-------------- 230 (442)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------- 230 (442)
.. ......+||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+......++..
T Consensus 171 ~~---~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc---cccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 32 234566899999999999987775 899999999999999999999988776655444321
Q ss_pred --------CCCCCC--------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCcccccCC
Q 013487 231 --------ADFSCP--------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 274 (442)
Q Consensus 231 --------~~~~~~--------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 274 (442)
...... ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 100000 01356789999999999999999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-53 Score=408.18 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=220.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.++|++.+.||+|+||+||+|+++ .+++.||||+++... ..+..+.+.+|+.+|++++||||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 457999999999999999999975 356789999997543 3345678899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 013487 87 KIYIVLEFIDGGELFDKIAKHG------------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 142 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~~------------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~ 142 (442)
..+++|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999997532 3889999999999999999999999999999999
Q ss_pred cEEEccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCC-CCCCCCcH
Q 013487 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNL 221 (442)
Q Consensus 143 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~-~Pf~~~~~ 221 (442)
|||+|.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999876655444455667899999999999988876 8999999999999999985 78998888
Q ss_pred HHHHHHHhhCCC-CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 222 MALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 222 ~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+....+..+.. +.|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888777654 467789999999999999999999999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=404.59 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=212.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 91 (442)
.++|++++.||+|+||+||+|+++.+ +.||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 47899999999999999999999655 57999999765432 3568899999999999999999999854 567999
Q ss_pred EEccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC
Q 013487 92 LEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 169 (442)
|||+++|+|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...... .
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~ 168 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 168 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-c
Confidence 999999999988754 3579999999999999999999999999999999999999999999999999997654322 1
Q ss_pred CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 013487 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLI 247 (442)
Q Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 247 (442)
......+||+.|+|||++.+..+. .++||||+||++|+|++| .+||...+..+....+..+ ..+.+..+++++.+||
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence 223446799999999999887775 899999999999999995 5666777777777776654 4567888999999999
Q ss_pred HHccCCCCCCCCCHHHHhc--Cccccc
Q 013487 248 KRILDPNPDTRMTISQMLE--DEWFKK 272 (442)
Q Consensus 248 ~~~L~~dP~~R~s~~eil~--hp~~~~ 272 (442)
.+||+.||++|||+++|++ ++||..
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999999987 788865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=406.16 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=218.6
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCC-------CEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETG-------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVM 82 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 82 (442)
..++|++++.||+|+||.||+|++..++ ..||+|+++++. .......+.+|...+.++ +||||+++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3479999999999999999999986554 379999997654 233456788898888888 799999999999
Q ss_pred EeCCEEEEEEEccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 013487 83 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (442)
Q Consensus 83 ~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll 146 (442)
.+++.+|+||||+++|+|.++|.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 99999999999999999999997653 48999999999999999999999999999999999999
Q ss_pred ccCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHH
Q 013487 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (442)
Q Consensus 147 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (442)
+.++.+||+|||+++..............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999877665544455667899999999999988875 89999999999999998 79999998888888
Q ss_pred HHHhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 226 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 226 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..+..+ .+..|.++++++.+||.+||+.||.+|||+.|+++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 777654 45778889999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=407.98 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=203.2
Q ss_pred cCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC-
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK- 85 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~- 85 (442)
++|++++.||+|+||+||+|.+.. +++.||+|+++... .....+.+.+|..++.++ +||||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 689999999999999999999754 44689999987543 223345677788777776 689999999987654
Q ss_pred CEEEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC
Q 013487 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~ 149 (442)
..+++|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999999754 248999999999999999999999999999999999999999
Q ss_pred CceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHH-HH
Q 013487 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALY-RK 227 (442)
Q Consensus 150 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~-~~ 227 (442)
+++||+|||+|+..............+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+....+ ..
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999865544333344567899999999999887774 899999999999999986 5788776544333 33
Q ss_pred HhhC-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 228 ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 228 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+..+ .+..|..+++++.+||.+||+.||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333 456777899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=402.35 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=206.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-CCCC--EEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-ETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (442)
-++|++.+.||+|+||.||+|++. .+++ .||||++.+......+..+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467999999999999999999865 3333 689999987665555667889999999999999999999999966 467
Q ss_pred EEEEEccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
++||||+++|+|.+.+..+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 8999999999999877654 469999999999999999999999999999999999999999999999999998654432
Q ss_pred cCC-ccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhCC--CCCCCCCCHHH
Q 013487 168 EDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSWFSSGA 243 (442)
Q Consensus 168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~ 243 (442)
... .....+||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+.+.. ++.+..+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 222 2234568889999999988766 488999999999999998 899999999988888887664 35567789999
Q ss_pred HHHHHHccCCCCCCCCCHHHHhc
Q 013487 244 KKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 244 ~~li~~~L~~dP~~R~s~~eil~ 266 (442)
.+||.+||+.||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=405.50 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=216.0
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCE--EEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeCCE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (442)
..++|++.+.||+|+||+||+|.++.+|.. ||||.+.... .....+.+.+|+.+|+++ +||||+++++++.+.+.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 456999999999999999999999888875 6777765332 233456789999999999 79999999999999999
Q ss_pred EEEEEEccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCc
Q 013487 88 IYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 151 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~ 151 (442)
+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999999754 56899999999999999999999999999999999999999999
Q ss_pred eEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhh
Q 013487 152 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICR 230 (442)
Q Consensus 152 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~ 230 (442)
+||+|||+|+..... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+++..+..
T Consensus 166 ~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 999999998754332 222456799999999999888775 899999999999999996 568988898888888776
Q ss_pred C-CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 231 A-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 231 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
+ .++.|..+++++.+||.+||+.||++|||+.||++|
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 556777899999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=396.80 Aligned_cols=244 Identities=26% Similarity=0.480 Sum_probs=208.1
Q ss_pred cccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CCEEE
Q 013487 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIY 89 (442)
Q Consensus 11 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 89 (442)
..++|++++.||+|+||.||+|++ +|..||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 467899999999999999999998 47789999997553 24568899999999999999999998854 56689
Q ss_pred EEEEccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcc
Q 013487 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 90 lv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 167 (442)
+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999999999997654 589999999999999999999999999999999999999999999999999875432
Q ss_pred cCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 013487 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKK 245 (442)
Q Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 245 (442)
.....++|+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+..+....+..+ ..+.|..+++++.+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 2345678999999999988777 489999999999999998 79999988888888777664 55778889999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcC
Q 013487 246 LIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 246 li~~~L~~dP~~R~s~~eil~h 267 (442)
||.+||..||++|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=401.78 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=224.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcC-----CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (442)
.++|++++.||+|+||+||+|.+.. ++..||||+++... .......+.+|+.++++++||||+++++++...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 3789999999999999999999853 35789999997543 3334567899999999999999999999999999
Q ss_pred EEEEEEEccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEee
Q 013487 87 KIYIVLEFIDGGELFDKIAKH----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (442)
Q Consensus 87 ~~~lv~E~~~gg~L~~~i~~~----------~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~D 156 (442)
..++||||+++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||+++++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999999988654 2468899999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcC-CCCCCCCcHHHHHHHHhhCC-CC
Q 013487 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRAD-FS 234 (442)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~-~~ 234 (442)
||+|+..............+||+.|+|||.+.+..+. .++||||+||++|+|++| .+||.+.+..+.+..+..+. .+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999876554443444556799999999999887775 899999999999999998 68999998888888877654 45
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc------Ccccc
Q 013487 235 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE------DEWFK 271 (442)
Q Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~ 271 (442)
.|..+++.+.+||.+||+.||++|||+.+|++ +|+|+
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 67789999999999999999999999999998 56654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-52 Score=399.53 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=215.6
Q ss_pred ccCeEEEeeecccCceEEEEEEEc-----CCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhC-CCCCcceEEEEEEeC
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (442)
.++|++++.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+++.+ +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 378999999999999999999863 466789999997654 233456788999999999 699999999999999
Q ss_pred CEEEEEEEccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc
Q 013487 86 TKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 147 (442)
Q Consensus 86 ~~~~lv~E~~~gg~L~~~i~~~~------------------~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~ 147 (442)
+.+|++||||++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997653 589999999999999999999999999999999999999
Q ss_pred cCCceEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhc-CCCCCCCCcHHHHHH
Q 013487 148 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 226 (442)
Q Consensus 148 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~ 226 (442)
.++.+|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654433334445789999999999987766 589999999999999998 677777666555444
Q ss_pred HHhhC--CCCCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 227 KICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 227 ~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
++... ....|..+++++.+||.+||+.||.+|||++||++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 44332 34556678999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=386.23 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=205.5
Q ss_pred EEEeeecccCceEEEEEEEcCCC---CEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEe-CCEEEEE
Q 013487 16 ELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIYIV 91 (442)
Q Consensus 16 ~i~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv 91 (442)
.+.+.||+|+||+||+|++..++ ..||||.+++.. .....+.+.+|+.+|++++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 44789999999999999986543 369999987432 44457889999999999999999999999765 5689999
Q ss_pred EEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccchhhhhhcccC-
Q 013487 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED- 169 (442)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 169 (442)
||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999887554 5778899999999999999999999999999999999999999999999999865432221
Q ss_pred -CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCC-CcHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 013487 170 -GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRA-DFSCPSWFSSGAKKL 246 (442)
Q Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 246 (442)
.......||+.|+|||++.+..+ +.++||||||+++|||++|..||.. .+..+....+..+ ....|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 12233568999999999988777 4899999999999999997766654 4444455555544 456678899999999
Q ss_pred HHHccCCCCCCCCCHHHHhcC
Q 013487 247 IKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 247 i~~~L~~dP~~R~s~~eil~h 267 (442)
|.+||..||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=382.87 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=204.0
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCC-cceEEEEEEeCCEEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYIV 91 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv 91 (442)
++|++++.||+|+||+||+|++..+|+.||||++..... .+.+.+|+++++.++|+| |+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 479999999999999999999999999999999875432 134678999999998665 55566677888999999
Q ss_pred EEccCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc---cCCceEEeeccchhhhhhcc
Q 013487 92 LEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQVR 167 (442)
Q Consensus 92 ~E~~~gg~L~~~i-~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~---~~~~~kl~DFGla~~~~~~~ 167 (442)
|||+.+ +|.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999965 555554 4456899999999999999999999999999999999999986 45579999999998654322
Q ss_pred cC-----CccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHHHHHHH---HhhC----C-CC
Q 013487 168 ED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK---ICRA----D-FS 234 (442)
Q Consensus 168 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---i~~~----~-~~ 234 (442)
.. ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||........... .... . ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 123456899999999999988875 899999999999999999999977554332221 1111 1 11
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCHH---HHhcCcccccCCC
Q 013487 235 CPSWFSSGAKKLIKRILDPNPDTRMTIS---QMLEDEWFKKGYK 275 (442)
Q Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~R~s~~---eil~hp~~~~~~~ 275 (442)
.+..+|+++.+||.+||+.||++||+++ ++|+|+|.+..+.
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 2346899999999999999999999976 5678888776554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-48 Score=372.88 Aligned_cols=248 Identities=20% Similarity=0.289 Sum_probs=206.0
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC-CCcceEEEEEEeCCEEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l 90 (442)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3689999999999999999999999999999999865432 2346789999999975 899999999999999999
Q ss_pred EEEccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-----CCceEEeeccchhhhh
Q 013487 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-----YGVLKISDFGLSAISQ 164 (442)
Q Consensus 91 v~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~-----~~~~kl~DFGla~~~~ 164 (442)
||||+ ||+|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 679999887654 6999999999999999999999999999999999999974 5789999999998654
Q ss_pred hccc-----CCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCc---HHHHHHHHhhCCC---
Q 013487 165 QVRE-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADF--- 233 (442)
Q Consensus 165 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~--- 233 (442)
.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+ ....+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3221 1223456899999999999988775 89999999999999999999997543 3333333322111
Q ss_pred --CCCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 013487 234 --SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 266 (442)
Q Consensus 234 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 266 (442)
..++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123457899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=373.34 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=194.5
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCcceEEEEEEeCC----E
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----K 87 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 87 (442)
..+|.+.+.||+|+||.||+|++ +|+.||||+++..... ......|+..++.++||||+++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46799999999999999999987 6889999999754321 122335666677889999999999997654 6
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEEEccCCceEEeeccc
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS--------RGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~--------~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
+|+||||+++|+|.+++.+. +++.+....++.|++.||+|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 89999999999999999874 69999999999999999999997 5999999999999999999999999999
Q ss_pred hhhhhhccc--CCccccccCCCcccCcccccccCC-----CCCcccHhHHHHHHHHHhcCCCCCCCC-------------
Q 013487 160 SAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDES------------- 219 (442)
Q Consensus 160 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~------------- 219 (442)
++....... .......+||+.|+|||++.+... .+.++|||||||+||+|+||..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 976543221 123345789999999999876432 246899999999999999998877421
Q ss_pred --cHHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 013487 220 --NLMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 267 (442)
Q Consensus 220 --~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~h 267 (442)
.............. ..|.. ....+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22233333333222 22221 12458899999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-47 Score=373.03 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=196.1
Q ss_pred cCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-----------CCCcceEEEE
Q 013487 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----------HPNVIKIIEV 81 (442)
Q Consensus 13 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~ 81 (442)
+||++++.||+|+||+||+|++..+|+.||||+++++.. ..+.+.+|+.+++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 579999999999999999999999999999999986542 2356778888888775 5789999988
Q ss_pred EEe--CCEEEEEEEccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCc----
Q 013487 82 MAS--KTKIYIVLEFIDGGELFDK---IAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGV---- 151 (442)
Q Consensus 82 ~~~--~~~~~lv~E~~~gg~L~~~---i~~~~~l~~~~~~~~~~ql~~aL~~lH~-~givHrDlkp~NIll~~~~~---- 151 (442)
+.. ....+++|+++..+..... ......+++..++.++.|++.||+|||+ +||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 4667777777765543332 2334579999999999999999999998 89999999999999986653
Q ss_pred --eEEeeccchhhhhhcccCCccccccCCCcccCcccccccCCCCCcccHhHHHHHHHHHhcCCCCCCCCcHH------H
Q 013487 152 --LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM------A 223 (442)
Q Consensus 152 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~------~ 223 (442)
+|++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|..||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999875432 23567899999999999988885 8999999999999999999999654321 0
Q ss_pred HHHH---Hhh---------------------------------------CCCCCCCCCCHHHHHHHHHccCCCCCCCCCH
Q 013487 224 LYRK---ICR---------------------------------------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 261 (442)
Q Consensus 224 ~~~~---i~~---------------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 261 (442)
.... ... .....+...++++.+||.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1100 000 0001111235779999999999999999999
Q ss_pred HHHhcCcccccC
Q 013487 262 SQMLEDEWFKKG 273 (442)
Q Consensus 262 ~eil~hp~~~~~ 273 (442)
+|+|+||||+..
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhcCcccCCC
Confidence 999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.5e-27 Score=208.46 Aligned_cols=137 Identities=20% Similarity=0.279 Sum_probs=110.1
Q ss_pred eEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhh---------------hHHHHHHHHHHHHHHhhCCCCCcceEE
Q 013487 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---------------RHKMVEQIKREISTMKLIKHPNVIKII 79 (442)
Q Consensus 15 y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 79 (442)
|.+++.||+|+||+||+|++ .+|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999998 57899999987532110 111234566799999999999999988
Q ss_pred EEEEeCCEEEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCceEEeeccc
Q 013487 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (442)
Q Consensus 80 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~~givHrDlkp~NIll~~~~~~kl~DFGl 159 (442)
++.. .+++|||++++.+. .+++..+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 27999999986553 25666778899999999999999999999999999999965 489999999
Q ss_pred hhhhh
Q 013487 160 SAISQ 164 (442)
Q Consensus 160 a~~~~ 164 (442)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 86543
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.46 E-value=1.4e-13 Score=106.74 Aligned_cols=88 Identities=16% Similarity=0.260 Sum_probs=80.4
Q ss_pred cceEEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEe-CCeEEEEEEecCCCchhHHH
Q 013487 340 ETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHK 417 (442)
Q Consensus 340 ~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~ 417 (442)
....+|..||++|+.+|++|++.+|+.|++ ++|.++.....+++++.++|.+||+++. +++++|+|+|.+||.++|++
T Consensus 12 sv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~ 91 (102)
T d1ul7a_ 12 SMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 91 (102)
T ss_dssp CCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHH
T ss_pred eeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHH
Confidence 445679999999999999999999999976 4699999998888899999999999995 79999999999999999999
Q ss_pred HHHHHHhccc
Q 013487 418 FYKKFSSGLK 427 (442)
Q Consensus 418 ~~~~~~~~l~ 427 (442)
+|.+|...|+
T Consensus 92 l~~~il~~l~ 101 (102)
T d1ul7a_ 92 IASKIANELK 101 (102)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHhcc
Confidence 9999988774
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.67 E-value=4.5e-08 Score=88.93 Aligned_cols=144 Identities=17% Similarity=0.152 Sum_probs=102.1
Q ss_pred cccccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCE
Q 013487 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (442)
Q Consensus 9 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (442)
...++.|+..+..+-++.+.||+.. .++..+++|......... ...+.+|...++.+. +--+.+++.+....+.
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 3456789988887666778999875 456677888876443211 235678888888774 4346788888888999
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 013487 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------ 131 (442)
Q Consensus 88 ~~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~------------------------------------ 131 (442)
.|+||++.+|.++.+..... .....++.++...+..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999998876544221 1223345555566666664
Q ss_pred -----------------------CCceeccCCCCcEEEccCCceEEeeccchhh
Q 013487 132 -----------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (442)
Q Consensus 132 -----------------------~givHrDlkp~NIll~~~~~~kl~DFGla~~ 162 (442)
..++|+|+.|.||++++++..-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999999876677999997653
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.59 E-value=1.1e-07 Score=76.36 Aligned_cols=73 Identities=18% Similarity=0.343 Sum_probs=63.8
Q ss_pred eEEeCCChhHHHHHHHHHhcccCceEee-cCceeEEeeccCCCCcceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 013487 342 RFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 414 (442)
Q Consensus 342 rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 414 (442)
.+.|...|.+||..|.+|++.||+.|++ +.|.|++..........+.|.+++|+++++.|||||++..|+-.|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 4568889999999999999999999986 679999998877666788899999999999999999999998665
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=1.4e-06 Score=78.35 Aligned_cols=134 Identities=15% Similarity=0.194 Sum_probs=86.9
Q ss_pred ccCeEEEeeecccC-ceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC--CCCcceEEEEEEeCCEE
Q 013487 12 VGKYELGRTLGEGS-FAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASKTKI 88 (442)
Q Consensus 12 ~~~y~i~~~LG~G~-fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 88 (442)
+..++... +..|. .+.||+... .++..+++|...... ...+..|...++.+. .-.+.+++.+..+.+..
T Consensus 10 l~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~ 81 (255)
T d1nd4a_ 10 LFGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 81 (255)
T ss_dssp TTTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred ccCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence 34455543 34444 478998876 566778889865432 234667888888774 23367788888888899
Q ss_pred EEEEEccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013487 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------- 131 (442)
Q Consensus 89 ~lv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~ql~~aL~~lH~------------------------------------- 131 (442)
+++|++++|.++.+. ..+.. ....++...|.-||+
T Consensus 82 ~~v~~~i~G~~~~~~-----~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 82 WLLLGEVPGQDLLSS-----HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp EEEEECCSSEETTTS-----CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEeeeccccccc-----cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 999999998665321 11111 111223333333332
Q ss_pred --------------C-------CceeccCCCCcEEEccCCceEEeeccchh
Q 013487 132 --------------R-------GVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 132 --------------~-------givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
. .++|+|+.|.||++++++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 37999999999999987667899999764
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.15 E-value=4.3e-06 Score=65.64 Aligned_cols=89 Identities=15% Similarity=0.230 Sum_probs=67.8
Q ss_pred ccceEEeCCChhHHHHHHHHHhcccCceEeecC----------ceeEEeeccC-----CCCcceEEEEEEEEEeCCeEEE
Q 013487 339 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN----------YKMKLQGDKT-----GRKGQLSVATEVFEVAPTLHIV 403 (442)
Q Consensus 339 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~-----~~~~~l~~~~~i~~~~~~~~~v 403 (442)
......|...|.+||..|.+|++.+|+.|++.+ |.|+++...+ ....-+.|.+++|+++++.+||
T Consensus 3 WhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLl 82 (127)
T d2qrda1 3 WHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFML 82 (127)
T ss_dssp CEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEE
T ss_pred ceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEE
Confidence 445677899999999999999999999998643 7788875422 2233577999999999999999
Q ss_pred EEE-----ecCC--------------CchhHHHHHHHHHhccc
Q 013487 404 EVR-----KTGG--------------DTLEFHKFYKKFSSGLK 427 (442)
Q Consensus 404 df~-----~~~G--------------d~le~~~~~~~~~~~l~ 427 (442)
||+ .+.| .+.+|-.+|.+|.-.|.
T Consensus 83 DFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 83 DVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 997 2222 24678888877766553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=2.4e-06 Score=82.33 Aligned_cols=81 Identities=16% Similarity=0.146 Sum_probs=50.7
Q ss_pred EeeecccCceEEEEEEEcCCCCEEEEEEecch-hhhh---HHHHHHHHHHHHHHhhCC-C--CCcceEEEEEEeCCEEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLR---HKMVEQIKREISTMKLIK-H--PNVIKIIEVMASKTKIYI 90 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~-~~~~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 90 (442)
.+.||.|....||++.+..+++.|++|.-... .... .....+...|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999998888889999964321 1000 001344567888887663 2 346666654 4455678
Q ss_pred EEEccCCCCh
Q 013487 91 VLEFIDGGEL 100 (442)
Q Consensus 91 v~E~~~gg~L 100 (442)
+||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.94 E-value=1.4e-05 Score=66.07 Aligned_cols=89 Identities=19% Similarity=0.229 Sum_probs=64.0
Q ss_pred cccceEEeCCChhHHHHHHHHHhcccCceEeec----CceeEEeeccCC---------CCcceEEEEEEEEEeCCeEEEE
Q 013487 338 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----NYKMKLQGDKTG---------RKGQLSVATEVFEVAPTLHIVE 404 (442)
Q Consensus 338 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~vd 404 (442)
+......|..+|-++|..|.+|++.+|+.|++. .|.|++.+..+. ....+.|.+++|+++++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 567888999999999999999999999999864 388888764221 1124779999999999999999
Q ss_pred EEec-----CC----------------CchhHHHHHHHHHhcc
Q 013487 405 VRKT-----GG----------------DTLEFHKFYKKFSSGL 426 (442)
Q Consensus 405 f~~~-----~G----------------d~le~~~~~~~~~~~l 426 (442)
|+-. .| .+.+|-.+|.+|.-.|
T Consensus 125 FK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL 167 (171)
T d2qlva1 125 FKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL 167 (171)
T ss_dssp EEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred EecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence 9732 12 2356777777665554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00052 Score=63.56 Aligned_cols=67 Identities=13% Similarity=0.160 Sum_probs=43.3
Q ss_pred eEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCCCCc--ceEE-----EEEEeCCEEEEEEEccCCC
Q 013487 27 AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV--IKII-----EVMASKTKIYIVLEFIDGG 98 (442)
Q Consensus 27 g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lv~E~~~gg 98 (442)
-.||++.. .+|+.|++|+.+.... . .+++..|...+..|...+| +..+ ..+......+.+++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 57999887 6788899999865432 1 3557778888877742221 1111 1234567788999998773
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.00 E-value=0.0011 Score=62.98 Aligned_cols=74 Identities=12% Similarity=0.097 Sum_probs=50.0
Q ss_pred EeeecccCceEEEEEEEcC-------CCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCC-CCCcceEEEEEEeCCEEE
Q 013487 18 GRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (442)
Q Consensus 18 ~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (442)
++.|+.|-.=.+|++.... .++.|.+++..... . .-...+|..+++.+. +.-..++++++.. .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888888999998643 34568888865221 1 123558999998885 4334577777643 5
Q ss_pred EEEEccCCCCh
Q 013487 90 IVLEFIDGGEL 100 (442)
Q Consensus 90 lv~E~~~gg~L 100 (442)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.66 E-value=0.0028 Score=57.92 Aligned_cols=143 Identities=15% Similarity=0.158 Sum_probs=74.8
Q ss_pred ccCeEEEeeecccCceEEEEEEEcCCCCEEEEEEecchhhhhHHHHHHHHHHHHHHhhCCC-----CCcceEE---EEEE
Q 013487 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-----PNVIKII---EVMA 83 (442)
Q Consensus 12 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l~---~~~~ 83 (442)
+++..-.+.|..|---+.|+.... +| .+++|+..... ..+.+..|+.+|..|.. |..+... .+..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 344444555667777888988763 34 58899986432 12345567777777642 2222110 0122
Q ss_pred eCCEEEEEEEccCCCChHH--------------HHHhcC---------CC------------------CHHHHHHHHHHH
Q 013487 84 SKTKIYIVLEFIDGGELFD--------------KIAKHG---------RL------------------KEDEARRYFQQL 122 (442)
Q Consensus 84 ~~~~~~lv~E~~~gg~L~~--------------~i~~~~---------~l------------------~~~~~~~~~~ql 122 (442)
.......++.+..|..... .+.... .. ........+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 3455666777766533211 000000 00 001112222223
Q ss_pred HHHHHHHHH----CCceeccCCCCcEEEccCCceEEeeccchh
Q 013487 123 INAVDYCHS----RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (442)
Q Consensus 123 ~~aL~~lH~----~givHrDlkp~NIll~~~~~~kl~DFGla~ 161 (442)
...+.-.+. .|++|+|+.++||+++++...-|.||+.|.
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 333333222 479999999999999988877899999764
|